PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Marques, CJ; Carvalho, F; Sousa, M; Barros, A				Marques, CJ; Carvalho, F; Sousa, M; Barros, A			Genomic imprinting in disruptive spermatogenesis	LANCET			English	Article							HUMAN H19; GENES	The possibility of imprinting disease transmission by assisted reproductive technologies has been raised after births of children with Angelman's and Beckwith-Wiedemann's syndromes. To investigate whether imprinting defects were associated with disturbed spermatogenesis, we studied two oppositely imprinted genes in spermatozoan DNA from normozoospermic and oligozoospermic patients. In the mesodermal specific transcript gene (MEST), bisulphite genomic sequencing showed that maternal imprinting was correctly erased in all 123 patients. However, methylation of the H19 gene did not change in any of 27 normozoospermic individuals (0%, 95% CI 0-13%), compared with methylation changes in eight moderate (17%, 8-31%, p=0.026) and 15 severe (30%, 18-45%, p=0.002) oligozoospermic patients. Our data suggest an association between abnormal genomic imprinting and hypospermatogenesis, and that spermatozoa from oligozoospermic patients carry a raised risk of transmitting imprinting errors.	Univ Porto, Inst Biomed Sci Abel Salazar, Cell Biol Lab, P-4099003 Oporto, Portugal; Univ Porto, Fac Med, Dept Genet, P-4100 Oporto, Portugal; Ctr Reprod Genet A Barros, Oporto, Portugal	Universidade do Porto; Universidade do Porto	Sousa, M (corresponding author), Univ Porto, Inst Biomed Sci Abel Salazar, Cell Biol Lab, P-4099003 Oporto, Portugal.	msousa@icbas.up.pt	Carvalho, Filipa/L-2566-2013; Sousa, Mário/A-7340-2019; Marques, Joana/B-5564-2008; Barros, Alberto/L-3094-2013	Carvalho, Filipa/0000-0001-9546-4614; Sousa, Mário/0000-0002-3009-3290; Marques, Joana/0000-0002-5658-3773; Barros, Alberto/0000-0002-8700-3698				Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Gosden R, 2003, LANCET, V361, P1975, DOI 10.1016/S0140-6736(03)13592-1; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619	5	247	263	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2004	363	9422					1700	1702		10.1016/S0140-6736(04)16256-9	http://dx.doi.org/10.1016/S0140-6736(04)16256-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822NG	15158633				2022-12-01	WOS:000221546300012
J	Smith, D; Channer, K				Smith, D; Channer, K			For and against - Primary angioplasty should be first line treatment for acute myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THROMBOLYTIC THERAPY; MORTALITY		Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Smith, D (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	dagobert@eurobell.co.uk; kevin.channer@sth.nhs.uk						APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; *DEP HLTH, 2000, NAT SERV FRAM COR HE; FathOrdoubadi F, 1997, AM HEART J, V134, P62, DOI 10.1016/S0002-8703(97)70107-8; French JK, 1999, J AM COLL CARDIOL, V34, P62, DOI 10.1016/S0735-1097(99)00166-7; Garcia E, 1999, J AM COLL CARDIOL, V33, P605, DOI 10.1016/S0735-1097(98)00644-5; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; SMITH LDR, 1997, HEART, V77, P46	11	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2004	328	7450					1254	1255		10.1136/bmj.328.7450.1254	http://dx.doi.org/10.1136/bmj.328.7450.1254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15155508	Green Published			2022-12-01	WOS:000221677200032
J	Clutton-Brock, TH; Coulson, T; Milner, JM				Clutton-Brock, TH; Coulson, T; Milner, JM			Red deer stocks in the Highlands of Scotland	NATURE			English	Editorial Material									Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Hedmark Univ Coll, N-2480 Evenstad, Koppand, Norway	University of Cambridge; Imperial College London; Inland Norway University of Applied Sciences	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@cam.ac.uk	Coulson, Tim/AAL-8148-2021; Milner, Jos M./G-7722-2012	Coulson, Tim/0000-0001-9371-9003; Milner, Jos M./0000-0003-0229-3655				[Anonymous], 1977, ECOLOGY RED DEER RES; [Anonymous], IMPACT VERTEBRATE HE; BEAUMONT D, 1994, OUR PINEWOOD HERITAG, P73; Caughley G., 1981, P7; CAUGHLEY G, 1986, RANGELANDS RESOURCE, P135; Clutton-Brock T. H., 1989, RED DEER HIGHLANDS; Clutton-Brock TH, 2002, HIGHLAND DEER HERD I, P237; CLUTTONBROCK TH, 1992, NATURE, V358, P11; Darling FR., 1963, HERD RED DEER STUDY; HARTDAVIS D, 1978, MONARCH GLEN; HESTER AI, 1998, VEGETATION SURVEY AB; HUNT JF, 2003, IMPACTS WILD DEER SC; MILNER JM, 2002, HIGHLAND DEER HERD I, P109	13	61	62	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					261	262		10.1038/429261a	http://dx.doi.org/10.1038/429261a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152241				2022-12-01	WOS:000221505900030
J	Muntner, P; He, J; Cutler, JA; Wildman, RP; Whelton, PK				Muntner, P; He, J; Cutler, JA; Wildman, RP; Whelton, PK			Trends in blood pressure among children and adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; CORONARY RISK-FACTORS; NATIONAL-HEALTH; SECULAR TRENDS; UNITED-STATES; US CHILDREN; BODY-SIZE; HYPERTENSION; PREVALENCE; POPULATION	Context The prevalence of overweight among children and adolescents increased between 1988 and 2000. The change in blood pressure among children and adolescents over that time and the role of overweight is unknown. Objective To examine trends in systolic and diastolic blood pressure among children and adolescents between 1988 and 2000. Design, Setting, and Population Two serially conducted cross-sectional studies using nationally representative samples of children and adolescents, aged 8 to 17 years, from the third National Health and Nutrition Examination Survey (NHANES 111) conducted in 1988-1994 (n=3496) and NHANES 1999-2000 (n=2086). Main Outcome Measures Systolic and diastolic blood pressure levels. Results In 1999-2000, the mean (SE) systolic blood pressure was 106.0 (0.3) mm Hg and diastolic blood pressure was 61.7 (0.5) mm Hg. After adjustment for age, mean systolic blood pressure was 1.6 mm Hg higher among non-Hispanic black girls (P=.11) and 2.9 mm Hg higher among non-Hispanic black boys (P<.001) compared with non-Hispanic whites. Among Mexican Americans, girls' systolic blood pressure was 1.0 mm Hg higher (P=.21) and boys' was 2.7 mm Hg higher (P<.001) compared with non-Hispanic whites (P<.001). With further adjustment for body mass index, these differences were attenuated. After age, race/ethnicity, and sex standardization, systolic blood pressure was 1.4 (95% confidence interval [CI], 0.6-2.2) mm Hg higher (P<.001) and diastolic blood pressure was 3.3 (95% Cl, 2.1-4.5) mm Hg higher in 1999-2000 (P<.001) compared with 1988-1994. With further adjustment for differences in the body mass index distribution in 1988-1994 and 1999-2000, the increase in systolic blood pressure was reduced by 29% and diastolic blood pressure was reduced by 12%. Conclusions Blood pressure has increased over the past decade among children and adolescents. This increase is partially attributable to an increased prevalence of overweight.	Tulane Univ, Sch Med, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Sch Publ Hlth & Trop Med, Dept Med, New Orleans, LA 70112 USA; NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA	Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Muntner, P (corresponding author), Tulane Univ, Sch Med, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave,SL-18, New Orleans, LA 70112 USA.	pmuntner@tulane.edu			NCRR NIH HHS [P2 0 RR017659] Funding Source: Medline; NHLBI NIH HHS [R01 HL68057] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068057] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; Berenson GS, 1996, PUBLIC HEALTH REP, V111, P3; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Daniels SR, 1998, HYPERTENSION, V31, P97, DOI 10.1161/01.HYP.31.1.97; Daniels SR, 1996, J PEDIATR-US, V129, P208, DOI 10.1016/S0022-3476(96)70244-5; Falkner B, 1996, PEDIATRICS, V98, P649; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; GIDDING SS, 1995, J PEDIATR-US, V127, P868, DOI 10.1016/S0022-3476(95)70020-X; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hunt KJ, 2003, AM J EPIDEMIOL, V158, P1048, DOI 10.1093/aje/kwg249; Luepker RV, 1999, J PEDIATR-US, V134, P668, DOI 10.1016/S0022-3476(99)70279-9; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; *NAT CTR HLTH STAT, 1994, PUBL US DEP HHS; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ostchega Y, 2003, J CLIN EPIDEMIOL, V56, P768, DOI 10.1016/S0895-4356(03)00085-4; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rosner B, 2000, AM J EPIDEMIOL, V151, P1007, DOI 10.1093/oxfordjournals.aje.a010129; ROWLAND M, 1982, BLOOD PRESSURE LEVEL; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stary HC, 1989, ARTERIOSCLERIOSIS, V9, P119; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417	24	558	574	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2004	291	17					2107	2113		10.1001/jama.291.17.2107	http://dx.doi.org/10.1001/jama.291.17.2107			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JR	15126439	Bronze			2022-12-01	WOS:000221174300028
J	Chadderton, P; Margrie, TW; Hausser, M				Chadderton, P; Margrie, TW; Hausser, M			Integration of quanta in cerebellar granule cells during sensory processing	NATURE			English	Article							NEURONAL EXCITABILITY; SYNAPTIC CURRENTS; GABA(A) RECEPTORS; DENDRITIC SPINES; CALCIUM-RELEASE; RAT CEREBELLUM; PURKINJE-CELLS; MOSSY FIBERS; CORTEX; INHIBITION	To understand the computations performed by the input layers of cortical structures, it is essential to determine the relationship between sensory-evoked synaptic input and the resulting pattern of output spikes. In the cerebellum, granule cells constitute the input layer, translating mossy fibre signals into parallel fibre input to Purkinje cells(1). Until now, their small size and dense packing(1,2) have precluded recordings from individual granule cells in vivo. Here we use whole-cell patch-clamp recordings to show the relationship between mossy fibre synaptic currents evoked by somatosensory stimulation and the resulting granule cell output patterns. Granule cells exhibited a low ongoing firing rate, due in part to dampening of excitability by a tonic inhibitory conductance mediated by GABA(A) (gamma-aminobutyric acid type A) receptors. Sensory stimulation produced bursts of mossy fibre excitatory postsynaptic currents (EPSCs) that summate to trigger bursts of spikes. Notably, these spike bursts were evoked by only a few quantal EPSCs, and yet spontaneous mossy fibre inputs triggered spikes only when inhibition was reduced. Our results reveal that the input layer of the cerebellum balances exquisite sensitivity with a high signal-to-noise ratio. Granule cell bursts are optimally suited to trigger glutamate receptor activation(3-5) and plasticity(6-8) at parallel fibre synapses, providing a link between input representation and memory storage in the cerebellum.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Chadderton, Paul/0000-0002-6276-1011				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Eccles J. C. M., 1967, CEREBELLUM NEURONAL; ECCLES JC, 1971, EXP BRAIN RES, V13, P15, DOI 10.1007/BF00236428; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LLIMAS R, 1982, CEREBELLUM NEW VISTA, P189; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Morissette J, 1996, EXP BRAIN RES, V109, P240; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Wall MJ, 2003, EUR J NEUROSCI, V18, P869, DOI 10.1046/j.1460-9568.2003.02822.x; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	30	515	519	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					856	860		10.1038/nature02442	http://dx.doi.org/10.1038/nature02442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103377	Green Published			2022-12-01	WOS:000220952300041
J	Singer, JB; Hill, AE; Burrage, L; Olszens, KR; Song, JH; Justice, M; O'Brien, WE; Conti, DV; Witte, JS; Lander, ES; Nadeau, JH				Singer, JB; Hill, AE; Burrage, L; Olszens, KR; Song, JH; Justice, M; O'Brien, WE; Conti, DV; Witte, JS; Lander, ES; Nadeau, JH			Genetic dissection of complex traits with chromosome substitution strains of mice	SCIENCE			English	Article							LABORATORY MICE; SUSCEPTIBILITY; BEHAVIOR; OBESITY; MODELS; LOCUS	Chromosome substitution strains (CSSs) have been proposed as a simple and powerful way to identify quantitative trait loci (QTLs) affecting developmental, physiological, and behavioral processes. Here, we report the construction of a complete CSS panel for a vertebrate species. The CSS panel consists of 22 mouse strains, each of which carries a single chromosome substituted from a donor strain (A/J) onto a common host background (C57BL/6J). A survey of 53 traits revealed evidence for 150 QTLs affecting serum levels of sterols and amino acids, diet-induced obesity, and anxiety. These results demonstrate that CSSs greatly facilitate the detection and identification of genes that control the wide diversity of naturally occurring phenotypic variation in the A/J and C57BL/6J inbred strains.	Broad Inst, Cambridge, MA 02142 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Computat Genom & Syst Biol, Cleveland, OH 44106 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Case Western Reserve University; Case Western Reserve University; Baylor College of Medicine; Case Western Reserve University; Massachusetts Institute of Technology (MIT); University Hospitals of Cleveland	Lander, ES (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	lander@broad.mit.edu; jhn4@cwru.edu			NCRR NIH HHS [RR12305] Funding Source: Medline; NICHD NIH HHS [HD07518] Funding Source: Medline; NIGMS NIH HHS [GM07250] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ASHBURNER M, 1997, GENETICS BIOL DROSOP; Belknap JK, 2003, MAMM GENOME, V14, P723, DOI 10.1007/s00335-003-2264-1; Brockmann GA, 2002, TRENDS GENET, V18, P367, DOI 10.1016/S0168-9525(02)02703-8; Cowley AW, 2001, HYPERTENSION, V37, P456, DOI 10.1161/01.HYP.37.2.456; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE, V2nd; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Festing MFW, 1979, INBRED STRAINS BIOME; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; Gershenfeld HK, 1997, BEHAV GENET, V27, P201, DOI 10.1023/A:1025653812535; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Matin A, 1999, NAT GENET, V23, P237, DOI 10.1038/13874; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Roman RJ, 2002, COLD SPRING HARB SYM, V67, P309, DOI 10.1101/sqb.2002.67.309; Santos J, 2002, ONCOGENE, V21, P6680, DOI 10.1038/sj.onc.1205846; SCRIVER CR, 2001, METABOLIC MOL BASIS, V2; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Turri MG, 2001, GENETICS, V158, P1217; Youngren KK, 2003, HUM MOL GENET, V12, P389, DOI 10.1093/hmg/ddg036; Zhang SM, 2003, OBES RES, V11, P828, DOI 10.1038/oby.2003.114	22	266	281	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					445	448		10.1126/science.1093139	http://dx.doi.org/10.1126/science.1093139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15031436				2022-12-01	WOS:000220845400050
J	Yanega, GM; Rubega, MA				Yanega, GM; Rubega, MA			Feeding mechanisms: Hummingbird jaw bends to aid insect capture - This tiny bird has a neat trick to trap flies in mid-air with its long nectar-seeking beak.	NATURE			English	Editorial Material									Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Yanega, GM (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	gregar.yanega@uconn.edu	Yanega, Gregor/P-5776-2017	Yanega, Gregor/0000-0001-7896-7738				Altshuler DL, 2003, SCIENCE, V300, P588, DOI 10.1126/science.1084477; Baker H.G., 1982, BIOCH ASPECTS EVOL B, V131, P171; BRICE AT, 1991, PHYSIOL ZOOL, V64, P611, DOI 10.1086/physzool.64.2.30158193; Buhler P., 1981, P439; BUHLER PZ, 1970, MORPHOL TIERE, V66, P337; FITZPATRICK JW, 1983, ORNITHOLOGICAL MONOG, P447; STORER RW, 1971, AVIAN BIOL, P150; Zusi Richard L., 1993, P391	8	29	29	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2004	428	6983					615	615		10.1038/428615a	http://dx.doi.org/10.1038/428615a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071586				2022-12-01	WOS:000220697200030
J	Hardy, SE; Gill, TM				Hardy, SE; Gill, TM			Recovery from disability among community-dwelling older persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the American-Geriatrics-Society	MAY 14-18, 2003	BALTIMORE, MD	Amer Geriatr Soc			PHYSICAL PERFORMANCE; FUNCTIONAL DEPENDENCE; RESTRICTED ACTIVITY; RISK-FACTORS; PEOPLE; POPULATION; DECLINE; UNDERESTIMATION; IMPAIRMENTS; IMPACT	Context Previous studies have found that a sizeable minority of newly disabled older persons recover independent function; however, long intervals between assessments have led to difficulty in determining the true incidence and duration of disability, and therefore in accurately characterizing the probability and course of recovery. Objectives To determine the rate of and time to recovery of independent function in community-dwelling older persons who become newly disabled in their activities of daily living (ADLs), to determine the duration of recovery, and to compare the likelihood of recovery among pertinent subgroups of older persons. Design, Setting, and Participants Prospective cohort study, with monthly assessments of ADL function, for 754 initially nondisabled, community-dwelling persons aged 70 years or older, performed in a small urban area from March 1998 to May 2003. Main Outcome Measures Demographic features, chronic conditions, cognitive function, and physical frailty were determined during comprehensive assessments at 18-month intervals. Disability, defined as needing personal assistance with 1 or more key ADLs (bathing, dressing, walking, and transferring), was assessed during monthly telephone interviews. Results A total of 420 participants (56%) experienced disability during a median follow-up of 51 months. Of these participants, 399 (81%) recovered (ie, regained independence in all 4 ADLs) within 12 months of their initial disability episode, and a majority (57%) of these maintained independence for at least 6 months. Among participants who experienced 3 or more consecutive months of disability, a majority (60%) recovered, but only a third of these maintained independence for at least 6 months. Persons who were cognitively impaired, physically frail, or severely disabled (ie, in 3-4 ADLs) at onset were less likely to recover than those who were cognitively intact, non-frail, or mildly disabled, respectively. Nonetheless, a majority of participants within each subgroup recovered. Conclusions Newly disabled older persons recover independent ADL function at rates far exceeding those that have been previously reported. Recovery from disability, however, is often short-lasting, suggesting that additional efforts are warranted to maintain independence in this high-risk group.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Hardy, SE (corresponding author), 20 York St,Tompkins Bsmt 15, New Haven, CT 06504 USA.	susan.hardy@yale.edu	Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368	NIA NIH HHS [R01AG17560, K23AG00759, T32AG1934, K24AG021507] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG021507, K23AG000759, R01AG017560, R01AG001934] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2000, SAS STAT US GUID VER; Beckett LA, 1996, AM J EPIDEMIOL, V143, P766; BRANCH LG, 1984, AM J PUBLIC HEALTH, V74, P266, DOI 10.2105/AJPH.74.3.266; Buchner D M, 1992, Clin Geriatr Med, V8, P1; de Leon CFM, 1999, J GERONTOL B-PSYCHOL, V54, pS162, DOI 10.1093/geronb/54B.3.S162; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR, V2nd; Ferroni MA, 1996, EUR J CLIN PHARMACOL, V51, P23, DOI 10.1007/s002280050155; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GILL TM, 1995, J GERONTOL A-BIOL, V50, pM235, DOI 10.1093/gerona/50A.5.M235; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gill TM, 2003, AM J EPIDEMIOL, V158, P1090, DOI 10.1093/aje/kwg237; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; Gill TM, 2003, ARCH INTERN MED, V163, P1317, DOI 10.1001/archinte.163.11.1317; Gill TM, 2003, J GERONTOL A-BIOL, V58, P70; Gill TM, 1996, J GERONTOL A-BIOL, V51, pM283, DOI 10.1093/gerona/51A.6.M283; Gill TM, 1997, J GEN INTERN MED, V12, P757, DOI 10.1046/j.1525-1497.1997.07161.x; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; GILL TM, IN PRESS ARCH PHYS M; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Guralnik JM, 2002, J AM GERIATR SOC, V50, P1599, DOI 10.1046/j.1532-5415.2002.50421.x; Hansen K, 1999, J AM GERIATR SOC, V47, P360, DOI 10.1111/j.1532-5415.1999.tb03002.x; Hardy SE, 2002, J GEN INTERN MED, V17, P841, DOI 10.1046/j.1525-1497.2002.20105.x; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Kempen GIJM, 1998, AGE AGEING, V27, P595, DOI 10.1093/ageing/27.5.595; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; MANTON KG, 1988, J GERONTOL, V43, pS153, DOI 10.1093/geronj/43.5.S153; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Rodgers W, 1997, J GERONTOL B-PSYCHOL, V52, P21, DOI 10.1093/geronb/52B.Special_Issue.21; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; *US BUR CENS, AM FACTF; VERBRUGGE LM, 1994, J HEALTH SOC BEHAV, V35, P97, DOI 10.2307/2137359; VERBRUGGE LM, 1989, MILBANK Q, V67, P450, DOI 10.2307/3350223	39	256	256	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1596	1602		10.1001/jama.291.13.1596	http://dx.doi.org/10.1001/jama.291.13.1596			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	809PQ	15069047	Bronze			2022-12-01	WOS:000220649000024
J	Mason, C; Givler, A				Mason, C; Givler, A			Name brand medically necessary: Do not substitute	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												drgiv@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1541	1542		10.1001/jama.291.13.1541	http://dx.doi.org/10.1001/jama.291.13.1541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809PQ	15069029				2022-12-01	WOS:000220649000001
J	Roberts, SE; Goldacre, MJ; Neil, HAW				Roberts, SE; Goldacre, MJ; Neil, HAW			Mortality in young people admitted to hospital for diabetes: database study	BRITISH MEDICAL JOURNAL			English	Article							MELLITUS; IDDM		Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Roberts, SE (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.	stephen.roberts@uhcc.ox.ac.uk						KYVIK KO, 1994, DIABETES CARE, V17, P210, DOI 10.2337/diacare.17.3.210; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; MCNALLY PC, 1995, DIABETIC MED, V12, P961, DOI 10.1111/j.1464-5491.1995.tb00406.x; Nishimura R, 1996, DIABETES CARE, V19, P758, DOI 10.2337/diacare.19.7.758; Wibell L, 2001, J INTERN MED, V249, P263, DOI 10.1046/j.1365-2796.2001.00802.x	5	16	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 27	2004	328	7442					741	742		10.1136/bmj.328.7442.741	http://dx.doi.org/10.1136/bmj.328.7442.741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809WH	15044290	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000220666300015
J	Aloy, P; Bottcher, B; Ceulemans, H; Leutwein, C; Mellwig, C; Fischer, S; Gavin, AC; Bork, P; Superti-Furga, G; Serrano, L; Russell, RB				Aloy, P; Bottcher, B; Ceulemans, H; Leutwein, C; Mellwig, C; Fischer, S; Gavin, AC; Bork, P; Superti-Furga, G; Serrano, L; Russell, RB			Structure-based assembly of protein complexes in yeast	SCIENCE			English	Article							RNA-POLYMERASE-II; CRYSTAL-STRUCTURE; CHAPERONIN; TRANSCRIPTION; ORGANIZATION; ARCHITECTURE; INITIATION; RESOLUTION; PHOSDUCIN; NETWORKS	Images of entire cells are preceding atomic structures of the separate molecular machines that they contain. The resulting gap in knowledge can be partly bridged by protein-protein interactions, bioinformatics, and electron microscopy. Here we use interactions of known three-dimensional structure to model a large set of yeast complexes, which we also screen by electron microscopy. For 54 of 102 complexes, we obtain at least partial models of interacting subunits. For 29, including the exosome, the chaperonin containing TCP-1, a 3'-messenger RNA degradation complex, and RNA polymerase II, the process suggests atomic details not easily seen by homology, involving the combination of two or more known structures. We also consider interactions between complexes (cross-talk) and use these to construct a structure-based network of molecular machines in the cell.	European Mol Biol Lab, Struct & Computat Biol Programme, D-69117 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH	Russell, RB (corresponding author), European Mol Biol Lab, Struct & Computat Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	russell@embl.de	Bottcher, Bettina/E-9397-2010; Bork, Peer/F-1813-2013; Russell, Robert/GWU-6389-2022; Russell, Rob/AAH-9145-2019; Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; Aloy, Patrick/AAB-3538-2019; Serrano, Luis/B-3355-2013	Bottcher, Bettina/0000-0002-7962-4849; Bork, Peer/0000-0002-2627-833X; Russell, Robert/0000-0002-7213-1398; Russell, Rob/0000-0002-1905-4717; Superti-Furga, Giulio/0000-0002-0570-1768; Serrano, Luis/0000-0002-5276-1392; Aloy, Patrick/0000-0002-3557-0236; Gavin, Anne-Claude/0000-0003-4917-2340; Ceulemans, Hugo/0000-0002-7059-4399				Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Aloy P, 2002, TRENDS BIOCHEM SCI, V27, P633, DOI 10.1016/S0968-0004(02)02204-1; Aloy P, 2002, EMBO REP, V3, P628, DOI 10.1093/embo-reports/kvf135; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CEULEMANS H, IN PRESS J MOL BIOL; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	31	300	313	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2004	303	5666					2026	2029		10.1126/science.1092645	http://dx.doi.org/10.1126/science.1092645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044803				2022-12-01	WOS:000220429800044
J	King, M				King, M			A novel BRCA2-binding protein and breast and ovarian tumorigenesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BRCA2; COMPLEX; REPAIR		Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	King, M (corresponding author), Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA.			King, Mary-Claire/0000-0001-9426-1743				Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Wang Y, 2000, GENE DEV, V14, P927	4	12	12	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2004	350	12					1252	1253		10.1056/NEJMcibr033528	http://dx.doi.org/10.1056/NEJMcibr033528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803PG	15028830				2022-12-01	WOS:000220242400014
J	Morris, RJ; Lewis, OT; Godfray, HCJ				Morris, RJ; Lewis, OT; Godfray, HCJ			Experimental evidence for apparent competition in a tropical forest food web	NATURE			English	Article							ENEMY-FREE-SPACE; PREY; CONSEQUENCES; COMMUNITY	The herbivorous insects of tropical forests constitute some of the most diverse communities of living organisms(1). For this reason it has been difficult to discover the degree to which these communities are structured, and by what processes. Interspecific competition for resources does occur, but its contemporary importance is limited because most pairs of potentially competing insects feed on different host plants(2). An alternative way in which species can interact is through shared natural enemies, a process called apparent competition(3). Despite extensive theoretical discussion there are few field demonstrations of apparent competition, and none in hyper-diverse tropical communities. Here, we experimentally removed two species of herbivore from a community of leaf-mining insects in a tropical forest. We predicted that other species that share natural enemies with the two removed species would experience lower parasitism and have higher population densities in treatment compared with control sites. In both cases ( on removal of a dipteran and a coleopteran leaf-miner species) we found significantly lower parasitism, and in one case ( removal of the dipteran) we found significantly higher abundance a year after the manipulation. Our results suggest that apparent competition may be important in structuring tropical insect communities.	Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Oxford	Morris, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	r.j.morris@imperial.ac.uk	Lewis, Owen T/B-9531-2011	Lewis, Owen/0000-0001-7935-6111				ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; Abrams P., 1995, FOOD WEBS INTEGRATIO, P371; Abrams PA, 1996, ECOLOGY, V77, P610, DOI 10.2307/2265634; Bonsall MB, 2000, P ROY SOC B-BIOL SCI, V267, P2207, DOI 10.1098/rspb.2000.1270; Bonsall MB, 1999, RES POPUL ECOL, V41, P59, DOI 10.1007/PL00011983; Bonsall MB, 1997, NATURE, V388, P371, DOI 10.1038/41084; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; HESPENHEIDE HA, 1991, ANNU REV ENTOMOL, V36, P535, DOI 10.1146/annurev.en.36.010191.002535; HOLT RD, 1993, AM NAT, V142, P623, DOI 10.1086/285561; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Lewis OT, 2002, J ANIM ECOL, V71, P855, DOI 10.1046/j.1365-2656.2002.00651.x; Memmott J., 1994, P300; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Morris RJ, 2001, J ANIM ECOL, V70, P301, DOI 10.1046/j.1365-2656.2001.00495.x; Muller CB, 1997, J ANIM ECOL, V66, P57, DOI 10.2307/5964; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SCHMITT RJ, 1987, ECOLOGY, V68, P1887, DOI 10.2307/1939880; SETTLE WH, 1990, ECOLOGY, V71, P1461, DOI 10.2307/1938283; Simberloff D., 1992, Selection criteria and ecological consequences of importing natural enemies., P103; STRAUSS SY, 1991, TRENDS ECOL EVOL, V6, P206, DOI 10.1016/0169-5347(91)90023-Q; Strong D.R., 1984, INSECTS PLANTS COMMU; TOMKINS DM, 2000, ECOL LETT, V3, P10; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303	29	208	217	2	144	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					310	313		10.1038/nature02394	http://dx.doi.org/10.1038/nature02394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029194				2022-12-01	WOS:000220250200041
J	Jen, JC; Chan, WM; Bosley, TM; Wan, JJ; Carr, JR; Rub, U; Shattuck, D; Salamon, G; Kudo, LC; Ou, J; Lin, DDM; Salih, MAM; Kansu, T; al Dhalaan, H; al Zayed, Z; MacDonald, DB; Stigsby, B; Plaitakis, A; Dretakis, EK; Gottlob, I; Pieh, C; Traboulsi, EI; Wang, Q; Wang, LJ; Andrews, C; Yamada, K; Demer, JL; Karim, S; Alger, JR; Geschwind, DH; Deller, T; Sicotte, NL; Nelson, SF; Baloh, RW; Engle, EC				Jen, JC; Chan, WM; Bosley, TM; Wan, JJ; Carr, JR; Rub, U; Shattuck, D; Salamon, G; Kudo, LC; Ou, J; Lin, DDM; Salih, MAM; Kansu, T; al Dhalaan, H; al Zayed, Z; MacDonald, DB; Stigsby, B; Plaitakis, A; Dretakis, EK; Gottlob, I; Pieh, C; Traboulsi, EI; Wang, Q; Wang, LJ; Andrews, C; Yamada, K; Demer, JL; Karim, S; Alger, JR; Geschwind, DH; Deller, T; Sicotte, NL; Nelson, SF; Baloh, RW; Engle, EC			Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis	SCIENCE			English	Article							HORIZONTAL GAZE PALSY; PROGRESSIVE SCOLIOSIS; CONGENITAL FIBROSIS; GUIDANCE RECEPTORS; SLIT; EXPRESSION; PARALYSIS; MIDLINE; FAMILY; ORGANIZATION	The mechanisms controlling axon guidance are of fundamental importance in understanding brain development. Growing corticospinal and somatosensory axons cross the midline in the medulla to reach their targets and thus form the basis of contralateral motor control and sensory input. The motor and sensory projections appeared uncrossed in patients with horizontal gaze palsy with progressive scoliosis (HGPPS). In patients affected with HGPPS, we identified mutations in the ROBO3 gene, which shares homology with roundabout genes important in axon guidance in developing Drosophila, zebrafish, and mouse. Like its murine homolog Rig1/Robo3, but unlike other Robo proteins, ROBO3 is required for hindbrain axon midline crossing.	Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA; Childrens Hosp Boston, Dept Neurol, Div Genet, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; King Khalid Eye Specialist Hosp, Neuroophthalmol Div, Riyadh 11462, Saudi Arabia; Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11472, Saudi Arabia; Hacettepe Univ Hosp, Neuroophthalmol Unit, Ankara, Turkey; King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia; Univ Crete, Dept Neurol, Iraklion, Crete, Greece; Univ Crete, Dept Orthopaed Traumatol, Iraklion, Crete, Greece; Univ Leicester, Dept Ophthalmol, Leicester, Leics, England; Univ Freiburg, Univ Eye Clin, Freiburg, Germany; Cleveland Clin Fdn, Cleveland, OH 44195 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; King Khaled Eye Specialist Hospital; Goethe University Frankfurt; Johns Hopkins University; King Saud University; King Khalid University Hospital; Hacettepe University; King Faisal Specialist Hospital & Research Center; University of Crete; University of Crete; University of Leicester; University of Freiburg; Cleveland Clinic Foundation	Jen, JC (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA.	jjen@ucla.edu; engle@enders.tch.harvard.edu	Traboulsi, Elias/AAY-7443-2020; Kansu, Tulay/P-6437-2019; Kansu, Tulay/B-6280-2012; Nelson, Stanley F/D-4771-2009; Salih, Mustafa/C-1222-2014	Kansu, Tulay/0000-0002-1986-4680; Kansu, Tulay/0000-0002-1986-4680; Nelson, Stanley F/0000-0002-2082-3114; Salih, Mustafa/0000-0002-4379-2111; Sicotte, Nancy/0000-0002-5131-3352; Carr-Ascher, Janai/0000-0002-2074-4643	NEI NIH HHS [R01 EY015298, R01 EY008313-14, R01 EY012498, R01 EY013583, EY12498, R01 EY008313, EY15298, EY13583, EY15311] Funding Source: Medline; NHLBI NIH HHS [R01 HL066251] Funding Source: Medline; NICHD NIH HHS [P30 HD018655, P30 HD 18655] Funding Source: Medline; NIDCD NIH HHS [DC05524, DC00162] Funding Source: Medline; NIMH NIH HHS [MH60233] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008313, R01EY015311, R01EY015298, R01EY012498, R01EY013583] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060233, R56MH060233, R37MH060233] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; BOSLEY TM, UNPUB; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Camurri L, 2004, GENE EXPR PATTERNS, V4, P99, DOI 10.1016/S1567-133X(03)00142-X; DEMER JL, UNPUB; DRETAKIS EK, 1974, J BONE JOINT SURG AM, VA 56, P1747, DOI 10.2106/00004623-197456080-00034; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Jen J, 2002, NEUROLOGY, V59, P432, DOI 10.1212/WNL.59.3.432; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KUYPERS HGJ, 1982, BRAIN STEM CONTROL S, P29; KUYPERS HGJM, 1982, PROG BRAIN RES, V57, P381, DOI 10.1016/S0079-6123(08)64138-2; Lanza F, 2002, BRIT J HAEMATOL, V118, P260, DOI 10.1046/j.1365-2141.2002.03544.x; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; LESSER RP, 1987, NEUROLOGY, V37, P82, DOI 10.1212/WNL.37.1.82; Nakano M, 2001, NAT GENET, V29, P315, DOI 10.1038/ng744; Parent A, 1996, CARPENTERS HUMAN NEU; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Pieh C, 2002, NEUROLOGY, V59, P462, DOI 10.1212/WNL.59.3.462; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SHARPE JA, 1975, NEUROLOGY, V25, P1035, DOI 10.1212/WNL.25.11.1035; Steffen H, 1998, NEUROPEDIATRICS, V29, P220, DOI 10.1055/s-2007-973565; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; YEE RD, 1982, ARCH OPHTHALMOL-CHIC, V100, P1449; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141	28	263	268	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2004	304	5676					1509	1513		10.1126/science.1096437	http://dx.doi.org/10.1126/science.1096437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15105459	Green Accepted			2022-12-01	WOS:000221795800047
J	McKinnon, JS; Mori, S; Blackman, BK; David, L; Kingsley, DM; Jamieson, L; Chou, J; Schluter, D				McKinnon, JS; Mori, S; Blackman, BK; David, L; Kingsley, DM; Jamieson, L; Chou, J; Schluter, D			Evidence for ecology's role in speciation	NATURE			English	Article							THREESPINE STICKLEBACKS GASTEROSTEUS; REPRODUCTIVE ISOLATION; NATURAL-SELECTION; PARALLEL SPECIATION; MATE PREFERENCES; ACULEATUS L; EVOLUTION; DIVERGENCE; REINFORCEMENT; POPULATIONS	A principal challenge in testing the role of natural selection in speciation is to connect the build-up of reproductive isolation between populations to divergence of ecologically important traits(1,2). Demonstrations of 'parallel speciation', or assortative mating by selective environment, link ecology and isolation(3-5), but the phenotypic traits mediating isolation have not been confirmed. Here we show that the parallel build-up of mating incompatibilities between stickleback populations can be largely accounted for by assortative mating based on one trait, body size, which evolves predictably according to environment. In addition to documenting the influence of body size on reproductive isolation for stickleback populations spread across the Northern Hemisphere, we have confirmed its importance through a new experimental manipulation. Together, these results suggest that speciation may arise largely as a by-product of ecological differences and divergent selection on a small number of phenotypic traits.	Univ Wisconsin, Whitewater, WI 53190 USA; Gifu Keizai Univ, Biol Lab, Ogaki, Gifu Prefecture 5038550, Japan; HHMI, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Stanford, CA 94305 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Ctr Biodivers, Vancouver, BC V6T 1Z4, Canada	University of Wisconsin System; Howard Hughes Medical Institute; Stanford University; University of British Columbia; University of British Columbia	McKinnon, JS (corresponding author), Univ Wisconsin, Whitewater, WI 53190 USA.	mckinnoj@uww.edu	David, Lior/G-8754-2012	Blackman, Benjamin/0000-0003-4936-6153; Schluter, Dolph/0000-0003-1683-7836; David, Lior/0000-0002-6555-0594				Baker J, 1994, EVOLUTIONARY BIOL TH; Bell MA, 2001, GENETICA, V112, P445; Bell Michael A., 1994, P1; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Buth Donald G., 1994, P61; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; HAY DE, 1975, CAN J ZOOL, V53, P441, DOI 10.1139/z75-057; Hendry AP, 2002, EVOLUTION, V56, P1199; Ishikawa M, 2000, BEHAVIOUR, V137, P1065, DOI 10.1163/156853900502439; Luttbeg B, 2001, ETHOLOGY, V107, P545, DOI 10.1046/j.1439-0310.2001.00694.x; McKinnon JS, 1995, ANIM BEHAV, V50, P1645, DOI 10.1016/0003-3472(95)80018-2; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McPhail J.D., 1994, P399; MCPHAIL JD, 1977, HEREDITY, V38, P53, DOI 10.1038/hdy.1977.7; Mooers AO, 1999, AM NAT, V154, P249, DOI 10.1086/303226; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Servedio MR, 2001, EVOLUTION, V55, P1909, DOI 10.1111/j.0014-3820.2001.tb01309.x; SNYDER RJ, 1989, CAN J ZOOL, V67, P2448, DOI 10.1139/z89-345; Ziuganov VV, 1995, BEHAVIOUR, V132, P1173, DOI 10.1163/156853995X00513	30	355	369	3	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2004	429	6989					294	298		10.1038/nature02556	http://dx.doi.org/10.1038/nature02556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152252				2022-12-01	WOS:000221505900042
J	Wu, DA; Kanai, R; Shimojo, S				Wu, DA; Kanai, R; Shimojo, S			Steady-state misbinding of colour and motion	NATURE			English	Editorial Material							BINDING; VISION		CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Utrecht, Psychonom Div, Helmholtz Res Inst, NL-3584 CS Utrecht, Netherlands; NTT Corp, Commun Sci Labs, Human & Informat Sci Lab, Kanagawa 2430198, Japan	California Institute of Technology; Utrecht University; Nippon Telegraph & Telephone Corporation	Wu, DA (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.	daw-an@caltech.edu	Kanai, Ryota/A-1191-2007	Wu, Daw-An/0000-0003-4296-3369; Kanai, Ryota/0000-0002-0186-2687				LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Moutoussis K, 1997, P ROY SOC B-BIOL SCI, V264, P393, DOI 10.1098/rspb.1997.0056; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wolfe JM, 1999, NEURON, V24, P11, DOI 10.1016/S0896-6273(00)80818-1	5	55	56	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					262	262		10.1038/429262a	http://dx.doi.org/10.1038/429262a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152242	Bronze			2022-12-01	WOS:000221505900031
J	Albillos, A; de-La-Hera, A; Alvarez-Mon, M				Albillos, A; de-La-Hera, A; Alvarez-Mon, M			Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites	LANCET			English	Article								Serum lipopolysaccharide-binding protein is increased in a subset of non-infected ascitic cirrhotic patients, a finding previously related to bacterial passage from the gut to the circulation without overt infection. We prospectively analysed the risk factors associated with a first episode of severe bacterial infection in 84 ascitic cirrhotics, followed up for a median of 46 weeks. The cumulative probability. of such infection in patients with raised and normal lipopolysaccharide-binding protein was 32.4% and 8.0% (p=0.004), respectively. Increased lipopolysaccharide-binding protein was the only factor independently associated with severe bacterial infection in a multivariate analysis (relative risk 4.49, 95% CI 1.42-14.1). Monitoring of serum lipopolysaccharide-binding protein could, therefore, help to target cirrhotic patients with ascites for antibiotic prophylaxis.	Univ Alcala De Henares, Dept Med, CSIC,Unidad I&D Asociada, Lab Enfermedades Sistema Inmune & Oncol, Madrid 28871, Spain; Hosp Univ Ramon y Cajal, Serv Gastroenterol, Madrid, Spain; Hosp Univ Principe Asturias, Serv Enfermedades Sistema Inmune & Oncol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Alcala; Hospital Universitario Ramon y Cajal; Prince of Asturias University Hospital	Albillos, A (corresponding author), Univ Alcala De Henares, Dept Med, CSIC,Unidad I&D Asociada, Lab Enfermedades Sistema Inmune & Oncol, Carretera Madrid Barcelona,KM 33-600, Madrid 28871, Spain.	aalbillosm@meditex.es							0	78	84	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 15	2004	363	9421					1608	1610		10.1016/S0140-6736(04)16206-5	http://dx.doi.org/10.1016/S0140-6736(04)16206-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	820SE	15145636				2022-12-01	WOS:000221408800013
J	van Meurs, JBJ; Dhonukshe-Rutten, RAM; Pluijm, SMF; van der Klift, M; de Jonge, R; Lindemans, J; de Groot, LCPGM; Hofman, A; Witteman, JCM; van Leeuwen, JPTM; Breteler, MMB; Lips, P; Pols, HAP; Uitterlinden, AG				van Meurs, JBJ; Dhonukshe-Rutten, RAM; Pluijm, SMF; van der Klift, M; de Jonge, R; Lindemans, J; de Groot, LCPGM; Hofman, A; Witteman, JCM; van Leeuwen, JPTM; Breteler, MMB; Lips, P; Pols, HAP; Uitterlinden, AG			Homocysteine levels and the risk of osteoporotic fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; PLASMA HOMOCYSTEINE; WOMEN; DETERMINANTS; DISEASE; MEN; HOMOCYSTINURIA; DEMENTIA; ACID; AGE	BACKGROUND: Very high plasma homocysteine levels are characteristic of homocystinuria, a rare autosomal recessive disease accompanied by the early onset of generalized osteoporosis. We therefore hypothesized that mildly elevated homocysteine levels might be related to age-related osteoporotic fractures. METHODS: We studied the association between circulating homocysteine levels and the risk of incident osteoporotic fracture in 2406 subjects, 55 years of age or older, who participated in two separate prospective, population-based studies. In the Rotterdam Study, there were two independent cohorts: 562 subjects in cohort 1, with a mean follow-up period of 8.1 years; and 553 subjects in cohort 2, with a mean follow-up period of 5.7 years. In the Longitudinal Aging Study Amsterdam, there was a single cohort of 1291 subjects, with a mean follow-up period of 2.7 years. Multivariate Cox proportional-hazards regression models were used for analysis of the risk of fracture, with adjustment for age, sex, body-mass index, and other characteristics that may be associated with the risk of fracture or with increased homocysteine levels. RESULTS: During 11,253 person-years of follow-up, osteoporotic fractures occurred in 191 subjects. The overall multivariable-adjusted relative risk of fracture was 1.4 (95 percent confidence interval, 1.2 to 1.6) for each increase of 1 SD in the natural-log-transformed homocysteine level. The risk was similar in all three cohorts studied, and it was also similar in men and women. A homocysteine level in the highest age-specific quartile was associated with an increase by a factor of 1.9 in the risk of fracture (95 percent confidence interval, 1.4 to 2.6). The associations between homocysteine levels and the risk of fracture appeared to be independent of bone mineral density and other potential risk factors for fracture. CONCLUSIONS: An increased homocysteine level appears to be a strong and independent risk factor for osteoporotic fractures in older men and women.	Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Clin Chem, NL-3000 DR Rotterdam, Netherlands; Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; Vrije Univ Amsterdam, Dept Endocrinol, Med Ctr, Amsterdam, Netherlands; Vrije Univ Amsterdam, Inst Res Extramural Med, Med Ctr, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Meurs, JBJ (corresponding author), Erasmus MC, Dept Internal Med, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.vanmeurs@erasmusmc.nl	van Leeuwen, Johannes/D-5015-2014; Breteler, Monique M.B./J-5058-2014	van Leeuwen, Johannes/0000-0002-2282-4006; Breteler, Monique M.B./0000-0002-0626-9305; de Groot, Lisette/0000-0003-2778-2789; van Meurs, Joyce/0000-0001-6245-2123				ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Caliskan S, 2001, CLIN CHIM ACTA, V309, P53, DOI 10.1016/S0009-8981(01)00529-0; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; DEEG DJH, 1998, AUTONOMY WELL BEING, V2, P9; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; HARPEY JP, 1981, J PEDIATR-US, V98, P275, DOI 10.1016/S0022-3476(81)80660-9; HARRIS ED, 1966, LANCET, V2, P707, DOI 10.1016/S0140-6736(66)92976-X; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; JACKSON SH, 1973, CLIN CHIM ACTA, V45, P215, DOI 10.1016/0009-8981(73)90429-4; KANG AH, 1973, J CLIN INVEST, V52, P2571, DOI 10.1172/JCI107449; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lubec B, 1996, BBA-MOL BASIS DIS, V1315, P159, DOI 10.1016/0925-4439(95)00119-0; McKusick V. A., 1966, HERITABLE DISORDERS, P155; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Miyao MK, 2000, J BONE MINER RES, V15, pS459; MUDD SH, 1985, AM J HUM GENET, V37, P1; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Pfeiffer CM, 2000, J NUTR, V130, P2850, DOI 10.1093/jn/130.11.2850; Pluijm SMF, 2001, J BONE MINER RES, V16, P2142, DOI 10.1359/jbmr.2001.16.11.2142; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; van der Klift M, 2002, CALCIFIED TISSUE INT, V70, P443, DOI 10.1007/s00223-001-2076-9; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Zappacosta B, 2002, CLIN CHEM LAB MED, V40, P1139, DOI 10.1515/CCLM.2002.200; 1993, AM J MED S5A, V95, pS1	34	546	561	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2004	350	20					2033	2041		10.1056/NEJMoa032546	http://dx.doi.org/10.1056/NEJMoa032546			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819ZB	15141041	Green Published			2022-12-01	WOS:000221354000004
J	Aharinejad, S; Taghavi, S; Klepetko, W; Abraham, D				Aharinejad, S; Taghavi, S; Klepetko, W; Abraham, D			Prediction of lung-transplant rejection by hepatocyte growth factor	LANCET			English	Article							SERUM; PURIFICATION; GANCICLOVIR; PROPHYLAXIS; PREVENTION; EXPRESSION; GLOBULIN; INJURY; GENE	Background Graft rejection is a major complication of lung transplantation. No serological marker of rejection is in common use. Hepatocyte growth factor (HGF) is highly expressed in the lung and produced after acute lung injury; serum concentrations increase in inflammatory lung diseases. We investigated whether HGF could be an accurate marker for prediction of lung-graft rejection. Methods Serum concentrations of HGF were measured by ELISA in 109 patients who had undergone lung transplantation (65 for chronic obstructive pulmonary disease; 23 for cystic fibrosis; 21 for idiopathic lung fibrosis), comparing those who had no subsequent events and those with episodes of infection or rejection, as well as in 12 healthy controls. Findings The mean baseline serum HGF concentration was 645 ng/L (SD 259) in controls and 1358 ng/L (603) in the patients before transplantation. After transplantation the mean concentration in patients with no events was 1147 ng/L (510) compared with 1559 ng/L (323) in patients with infection (p=0.001 vs controls; change from pretransplant value not significant). Patients with rejection had significantly higher concentrations than all other groups (3972 ng/L [1463], p<0.0001). Logistic regression identified HGF as a predictor for lung graft rejection (p=0.012). After steroid treatment, HGF concentrations returned almost to the preoperative values within 3 days. Interpretation HGF might be a marker for graft rejection in lung transplantation. A potential link between viral infection, mainly cytomegalovirus, and HGF, however, remains to be investigated.	Med Univ Vienna, Dept Anat, Cardiovasc Res Lab, A-1090 Vienna, Austria; Med Univ Vienna, Dept Cardiothorac Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Aharinejad, S (corresponding author), Med Univ Vienna, Dept Anat, Cardiovasc Res Lab, Waehringerstr 13, A-1090 Vienna, Austria.	seyedhossein.aharinejad@meduniwien.ac.at		Abraham, Dietmar/0000-0001-6337-0058				Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; BANDO K, 1995, J THORAC CARDIOV SUR, V109, P49, DOI 10.1016/S0022-5223(95)70419-1; Bewig B, 1999, CLIN TRANSPLANT, V13, P432, DOI 10.1034/j.1399-0012.1999.130510.x; Bewig B, 1999, TRANSPLANT INT, V12, P266, DOI 10.1007/s001470050221; COOPER JD, 1986, NEW ENGL J MED, V314, P1140; DEFRANCES MC, 1992, DEVELOPMENT, V116, P387; El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P828, DOI 10.1016/S1053-2498(99)00047-9; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; GROSSMAN RF, 1990, NEW ENGL J MED, V322, P727, DOI 10.1056/NEJM199003153221104; HALL SM, 1992, AM J RESP CELL MOL, V7, P49, DOI 10.1165/ajrcmb/7.1.49; Hosenpud JD, 1999, J HEART LUNG TRANSPL, V18, P611, DOI 10.1016/S1053-2498(99)00037-6; KHURSHID A, 1998, AM J RESP CRIT CARE, V157, P811; MAEDA J, 1995, AM J RESP CRIT CARE, V152, P1587, DOI 10.1164/ajrccm.152.5.7582299; Mal H, 1998, CHEST, V113, P645, DOI 10.1378/chest.113.3.645; MATSUMOTO K, 1992, P NATL ACAD SCI USA, V89, P3800, DOI 10.1073/pnas.89.9.3800; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; PATTERSON GA, 1995, CURRENT TOPICS GEN T, V3, P363; Ross DJ, 1999, J HEART LUNG TRANSPL, V18, P627, DOI 10.1016/S1053-2498(99)00007-8; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; TSUBOUCHI H, 1991, HEPATOLOGY, V13, P1; Valantine HA, 2001, TRANSPLANTATION, V72, P1647, DOI 10.1097/00007890-200111270-00012; Weill D, 2003, AM J TRANSPLANT, V3, P492, DOI 10.1034/j.1600-6143.2003.00074.x; WILLIAMS TJ, 1995, CURRENT TOPICS GEN T, V3, P501; YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X; YANAGITA K, 1993, J BIOL CHEM, V268, P21212; Yoshimura R, 2000, TRANSPLANT P, V32, P2073, DOI 10.1016/S0041-1345(00)01573-6; Yoshimura R, 2002, TRANSPLANT INT, V15, P156, DOI 10.1007/s00147-002-0391-3; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1	28	24	24	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2004	363	9420					1503	1508		10.1016/S0140-6736(04)16148-5	http://dx.doi.org/10.1016/S0140-6736(04)16148-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GK	15135596				2022-12-01	WOS:000221302700008
J	Samuels, Y; Wang, ZH; Bardelli, A; Silliman, N; Ptak, J; Szabo, S; Yan, H; Gazdar, A; Powell, DM; Riggins, GJ; Willson, JKV; Markowitz, S; Kinzler, KW; Vogelstein, B; Velculescu, VE				Samuels, Y; Wang, ZH; Bardelli, A; Silliman, N; Ptak, J; Szabo, S; Yan, H; Gazdar, A; Powell, DM; Riggins, GJ; Willson, JKV; Markowitz, S; Kinzler, KW; Vogelstein, B; Velculescu, VE			High frequency of mutations of the PIK3CA gene in human cancers	SCIENCE			English	Article									Johns Hopkins Univ, Inst Med, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Virginia Hlth Syst, Div Gastroenterol Hepatol, Charlottesville, VA 22908 USA; Univ Hosp Cleveland, Ireland Canc Ctr, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Virginia; Howard Hughes Medical Institute; University Hospitals of Cleveland; Case Western Reserve University	Velculescu, VE (corresponding author), Johns Hopkins Univ, Inst Med, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	velculescu@jhmi.edu	ravegnini, gloria/K-1330-2016; Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	ravegnini, gloria/0000-0002-7774-402X; Velculescu, Victor/0000-0003-1195-438X; Samuels, Yardena/0000-0002-3349-7266; BARDELLI, Alberto/0000-0003-1647-5070	NCI NIH HHS [CA 88128, CA 67900, CA 62924, CA 57345, CA 43460] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA043460, R01CA057345, R29CA067900, R01CA067900, U01CA088128, R37CA043460, P50CA062924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Phillips WA, 1998, CANCER, V83, P41, DOI 10.1002/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699	4	2697	2934	4	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					554	554		10.1126/science.1096502	http://dx.doi.org/10.1126/science.1096502			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15016963				2022-12-01	WOS:000220975100039
J	Yekta, S; Shih, IH; Bartel, DP				Yekta, S; Shih, IH; Bartel, DP			MicroRNA-directed cleavage of HOXB8 mRNA	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; EXPRESSION; GENES; TRANSLATION; INITIATION; TARGETS; INHIBIT; MIRNA; TIME	MicroRNAs (miRNAs) are endogenous similar to22-nucleotide RNAs, some of which are known to play important regulatory roles in animals by targeting the messages of protein-coding genes for translational repression. We find that miR-196, a miRNA encoded at three paralogous locations in the A, B, and C mammalian HOX clusters, has extensive, evolutionarily conserved complementarity to messages of HOXB8, HOXC8, and HOXD8. RNA fragments diagnostic of miR-196-directed cleavage of HOXB8 were detected in mouse embryos. Cell culture experiments demonstrated down-regulation of HOXB8, HOXC8, HOXD8, and HOXA7 and supported the cleavage mechanism for miR-196-directed repression of HOXB8. These results point to a miRNA-mediated mechanism for the posttranscriptional restriction of HOX gene expression during vertebrate development and demonstrate that metazoan miRNAs can repress expression of their natural targets through mRNA cleavage in addition to inhibiting productive translation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; CHEN X, IN PRESS SCIENC 0731; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	24	1356	1517	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					594	596		10.1126/science.1097434	http://dx.doi.org/10.1126/science.1097434			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105502				2022-12-01	WOS:000220975100051
J	Maitra, A; Sherriff, A; Griffiths, M; Henderson, J				Maitra, A; Sherriff, A; Griffiths, M; Henderson, J		Avon Longitudinal Study Parents Ch	Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN		Univ Bristol, Dept Community Based Med, Avon Longitudinal Study Parents & Children, Bristol BS8 1TQ, Avon, England; St Michaels Hosp, Dept Ear Nose & Throat, Bristol BS2 8EG, Avon, England; Bristol Royal Hosp Children, Dept Resp Med, Bristol BS2 8BJ, Avon, England	University of Bristol; Bristol Royal Hospital For Children		dramaitra@yahoo.co.uk		sherriff, andrea/0000-0002-1016-037X				Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Henderson J, 1999, BRIT MED J, V318, P1173, DOI 10.1136/bmj.318.7192.1173; Kemp T, 1997, EPIDEMIOLOGY, V8, P678, DOI 10.1097/00001648-199710000-00011; Nilsson L, 1998, ARCH PEDIAT ADOL MED, V152, P734; ODENT MR, 1994, JAMA-J AM MED ASSOC, V272, P592, DOI 10.1001/jama.1994.03520080034035	5	28	28	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					925	926		10.1136/bmj.38045.858889.EB	http://dx.doi.org/10.1136/bmj.38045.858889.EB			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15033878	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000220994400018
J	Killworth, PD				Killworth, PD			Comment on "Oceanic Rossby waves acting as a 'hay rake' for ecosystem floating by-products"	SCIENCE			English	Editorial Material							TRAJECTORIES; PROPAGATION; FIELDS		Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton	Killworth, PD (corresponding author), Southampton Oceanog Ctr, Empress Dock, Southampton SO14 3ZH, Hants, England.							Chelton DB, 1996, SCIENCE, V272, P234, DOI 10.1126/science.272.5259.234; Cipollini P, 2001, GEOPHYS RES LETT, V28, P323, DOI 10.1029/1999GL011231; Cipollini P, 1997, GEOPHYS RES LETT, V24, P889, DOI 10.1029/97GL00758; COX SM, 1990, J FLUID MECH, V214, P517, DOI 10.1017/S0022112090000246; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; de Vries P, 2001, J ATMOS OCEAN TECH, V18, P1092; DEWAR WK, 1985, DYNAM ATMOS OCEANS, V9, P215, DOI 10.1016/0377-0265(85)90021-1; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Fu L -L, 2001, SATELLITE ALTIMETRY, P133; Gill A. E., 2016, ATMOSPHERE OCEAN DYN; Killworth PD, 1997, J PHYS OCEANOGR, V27, P1946, DOI 10.1175/1520-0485(1997)027<1946:TSOOAT>2.0.CO;2; Killworth PD, 2003, J PHYS OCEANOGR, V33, P784, DOI 10.1175/1520-0485(2003)33<784:LEPWPI>2.0.CO;2; KILLWORTH PD, UNPUB J GEOPHYS RES; Robinson AR, 1997, P ROY SOC A-MATH PHY, V453, P2295, DOI 10.1098/rspa.1997.0123; Siegel DA, 2001, NATURE, V409, P576, DOI 10.1038/35054659	15	13	13	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087530				2022-12-01	WOS:000220845400025
J	Hauert, C; Doebeli, M				Hauert, C; Doebeli, M			Spatial structure often inhibits the evolution of cooperation in the snowdrift game	NATURE			English	Article							PRISONERS-DILEMMA; POPULATION; ALTRUISM	Understanding the emergence of cooperation is a fundamental problem in evolutionary biology(1). Evolutionary game theory(2,3) has become a powerful framework with which to investigate this problem. Two simple games have attracted most attention in theoretical and experimental studies: the Prisoner's Dilemma(4) and the snowdrift game (also known as the hawk-dove or chicken game)(5). In the Prisoner's Dilemma, the non-cooperative state is evolutionarily stable, which has inspired numerous investigations of suitable extensions that enable cooperative behaviour to persist. In particular, on the basis of spatial extensions of the Prisoner's Dilemma, it is widely accepted that spatial structure promotes the evolution of cooperation(6-8). Here we show that no such general predictions can be made for the effects of spatial structure in the snowdrift game. In unstructured snowdrift games, intermediate levels of cooperation persist. Unexpectedly, spatial structure reduces the proportion of cooperators for a wide range of parameters. In particular, spatial structure eliminates cooperation if the cost-to-benefit ratio of cooperation is high. Our results caution against the common belief that spatial structure is necessarily beneficial for cooperative behaviour.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Hauert, C (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	hauert@zoology.ubc.ca	Doebeli, Michael/D-5391-2012; Hauert, Christoph/E-5369-2011	Hauert, Christoph/0000-0002-1239-281X				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Doebeli M, 1998, P NATL ACAD SCI USA, V95, P8676, DOI 10.1073/pnas.95.15.8676; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hauert C, 2001, P ROY SOC B-BIOL SCI, V268, P761, DOI 10.1098/rspb.2000.1424; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Hofbauer J., 1998, EVOLUTIONARY GAMES P, DOI 10.1017/CBO9781139173179; Killingback T, 1996, P ROY SOC B-BIOL SCI, V263, P1135, DOI 10.1098/rspb.1996.0166; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; MATSUDA H, 1992, PROG THEOR PHYS, V88, P1035, DOI 10.1143/PTP.88.1035; Maynard Smith J., 1982, pi; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Milinski M, 1997, P ROY SOC B-BIOL SCI, V264, P831, DOI 10.1098/rspb.1997.0116; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Mitteldorf J, 2000, J THEOR BIOL, V204, P481, DOI 10.1006/jtbi.2000.2007; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sugden R., 1986, EC RIGHTS COOPERATIO; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILKINSON PF, 1976, ANIM BEHAV, V24, P756, DOI 10.1016/S0003-3472(76)80004-8; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	29	1054	1094	10	231	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					643	646		10.1038/nature02360	http://dx.doi.org/10.1038/nature02360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15074318				2022-12-01	WOS:000220697200041
J	Jancke, D; Chavane, F; Naaman, S; Grinvald, A				Jancke, D; Chavane, F; Naaman, S; Grinvald, A			Imaging cortical correlates of illusion in early visual cortex	NATURE			English	Article							MOTION INDUCTION; LINE-MOTION; ATTENTION; DYNAMICS; FACILITATION; CONNECTIONS; RESPONSES; SPEED; FIELD; AREA	Exploring visual illusions reveals fundamental principles of cortical processing. Illusory motion perception of non-moving stimuli was described almost a century ago by Gestalt psychologists(1,2). However, the underlying neuronal mechanisms remain unknown. To explore cortical mechanisms underlying the 'linemotion' illusion(3), we used real-time optical imaging(4-6), which is highly sensitive to subthreshold activity. We examined, in the visual cortex of the anaesthetized cat, responses to five stimuli: a stationary small square and a long bar; a moving square; a drawnout bar; and the well-known line-motion illusion(3), a stationary square briefly preceding a long stationary bar presentation. Whereas flashing the bar alone evoked the expected localized, short latency and high amplitude activity patterns(7,8), presenting a square 60 - 100 ms before a bar induced the dynamic activity patterns resembling that of fast movement. The preceding square, even though physically non-moving, created gradually propagating subthreshold cortical activity that must contribute to illusory motion, because it was indistinguishable from cortical representations of real motion in this area. These findings demonstrate the effect of spatio-temporal patterns of subthreshold synaptic potentials on cortical processing and the shaping of perception.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Grodetsky Ctr Studies Higher Brain Funct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Jancke, D (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	jancke@neurobiologie.ruhr-uni-bochum.de	GRINVALD, AMIRAM/AAH-9919-2019; Chavane, Frederic/ABB-1487-2021; Jancke, Dirk/A-2961-2015; Jancke, Dirk/A-6721-2015	Chavane, Frederic/0000-0001-7916-2640; Jancke, Dirk/0000-0001-8440-6259; Naaman, Shmuel/0000-0002-5406-6967				ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; CAVANAGH P, 1989, VISION RES, V29, P1197, DOI 10.1016/0042-6989(89)90065-5; Downing PE, 1997, J EXP PSYCHOL HUMAN, V23, P768; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; HIKOSAKA O, 1993, PERCEPTION, V22, P517, DOI 10.1068/p220517; HIKOSAKA O, 1993, VISION RES, V33, P1219, DOI 10.1016/0042-6989(93)90210-N; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Jancke D, 1999, J NEUROSCI, V19, P9016, DOI 10.1523/JNEUROSCI.19-20-09016.1999; KANIZSA G, 1951, ARCH PSICOLOGIA NEUR, V3, P224; Kawahara J, 1996, PERCEPTION, V25, P901, DOI 10.1068/p250901; KENKEL F, 1913, Z PSYCHOL, V67, P358; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; SAGI D, 1986, NATURE, V321, P693, DOI 10.1038/321693a0; Series P, 2002, VISION RES, V42, P2781, DOI 10.1016/S0042-6989(02)00302-4; Shimojo S, 1997, VISION RES, V37, P1575, DOI 10.1016/S0042-6989(96)00313-6; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; STEINMAN BA, 1995, VISION RES, V35, P1859, DOI 10.1016/0042-6989(94)00276-R; Sterkin A, 1998, NEUROSCI LETT, pS41; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405; vonGrunau M, 1996, VISION RES, V36, P2447, DOI 10.1016/0042-6989(95)00330-4; VONGRUNAU M, 1994, PERCEPTION, V23, P913, DOI 10.1068/p230913; vonGrunau M, 1996, VISION RES, V36, P2433, DOI 10.1016/0042-6989(95)00326-6; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161	30	173	174	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					423	426		10.1038/nature02396	http://dx.doi.org/10.1038/nature02396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042090				2022-12-01	WOS:000220404300042
J	Haramis, APG; Begthel, H; van den Born, M; van Es, J; Jonkheer, S; Offerhaus, GJA; Clevers, H				Haramis, APG; Begthel, H; van den Born, M; van Es, J; Jonkheer, S; Offerhaus, GJA; Clevers, H			De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine	SCIENCE			English	Article							MORPHOGENETIC PROTEIN-RECEPTOR; GERMLINE MUTATIONS; EXPRESSION; CANCER; NOGGIN; CELLS; SMAD4; GENE; DPC4; GASTRULATION	Little is known about the signaling mechanisms that determine the highly regular patterning of the intestinal epithelium into crypts and villi. With the use of mouse models, we show that bone morphogenetic protein (BMP)-4 expression occurs exclusively in the intravillus mesenchyme. Villus epithelial cells respond to the BMP signal. Inhibition of BMP signaling by transgenic expression of noggin results in the formation of numerous ectopic crypt units perpendicular to the crypt-villus axis. These changes phenocopy the intestinal histopathology of patients with the cancer predisposition syndrome juvenile polyposis (JP), including the frequent occurrence of intraepithelial neoplasia. Many JP cases are known to harbor mutations in BMP pathway genes. These data indicate that intestinal BMP signaling represses de novo crypt formation and polyp growth.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1100 DD Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	van+Es, Johan/ABD-5411-2021					AALTONEN LA, 2000, PATHOLOGY GENETICS T, P130; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Entius MM, 1999, HEPATO-GASTROENTEROL, V46, P661; GIARDIELLO FM, 1995, EUR J CANCER, V31A, P1085, DOI 10.1016/0959-8049(95)00139-A; HARAMIS APG, UNPUB; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Houlston R, 1998, HUM MOL GENET, V7, P1907, DOI 10.1093/hmg/7.12.1907; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Takaku K, 1999, CANCER RES, V59, P6113; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Woodford-Richens K, 2000, CANCER RES, V60, P2477; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	29	544	576	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1684	1686		10.1126/science.1093587	http://dx.doi.org/10.1126/science.1093587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15017003				2022-12-01	WOS:000220151400048
J	Johnson, J; Canning, J; Kaneko, T; Pru, JK; Tilly, JL				Johnson, J; Canning, J; Kaneko, T; Pru, JK; Tilly, JL			Germline stem cells and follicular renewal in the postnatal mammalian ovary	NATURE			English	Article							MEIOTIC RECOMBINATION; PRIMORDIAL FOLLICLES; HOMING EFFICIENCY; GENE-EXPRESSION; MICE; MOUSE; PROTEIN; TRANSPLANTATION; APOPTOSIS; PROPHASE	A basic doctrine of reproductive biology is that most mammalian females lose the capacity for germ-cell renewal during fetal life, such that a fixed reserve of germ cells (oocytes) enclosed within follicles is endowed at birth. Here we show that juvenile and adult mouse ovaries possess mitotically active germ cells that, based on rates of oocyte degeneration (atresia) and clearance, are needed to continuously replenish the follicle pool. Consistent with this, treatment of prepubertal female mice with the mitotic germ-cell toxicant busulphan eliminates the primordial follicle reserve by early adulthood without inducing atresia. Furthermore, we demonstrate cells expressing the meiotic entry marker synaptonemal complex protein 3 in juvenile and adult mouse ovaries. Wild-type ovaries grafted into transgenic female mice with ubiquitous expression of green fluorescent protein (GFP) become infiltrated with GFP-positive germ cells that form follicles. Collectively, these data establish the existence of proliferative germ cells that sustain oocyte and follicle production in the postnatal mammalian ovary.	Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Vincent Obstet & Gynecol Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tilly, JL (corresponding author), Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Vincent Obstet & Gynecol Serv, Boston, MA 02114 USA.	jtilly@partners.org	Kaneko-Tarui, Tomoko/E-3319-2010; Johnson, Johnson/HDL-9124-2022; Canning, John/R-7421-2019	Kaneko-Tarui, Tomoko/0000-0001-5463-1551; Johnson, Joshua/0000-0002-6016-8089				Anderson L D, 1992, Md Med J, V41, P614; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1; BURSCH W, 1990, CARCINOGENESIS, V11, P847, DOI 10.1093/carcin/11.5.847; Canning J, 2003, ENDOCRINOLOGY, V144, P9, DOI 10.1210/en.2002-220988; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; CRONE M, 1965, EXP CELL RES, V39, P678, DOI 10.1016/0014-4827(65)90071-6; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; FADDY MJ, 1976, J EXP ZOOL, V197, P173, DOI 10.1002/jez.1401970203; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; FADDY MJ, 1987, CELL TISSUE KINET, V20, P551, DOI 10.1111/j.1365-2184.1987.tb01364.x; Foley JGD, 2002, J ANAT, V201, P477, DOI 10.1046/j.1469-7580.2002.00114.x; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; GENEROSO WM, 1971, MUTAT RES, V13, P171, DOI 10.1016/0027-5107(71)90010-8; Gosden R.G., 2003, REPROD MED MOL CELLU, P365; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; IJIRI K, 1983, BRIT J CANCER, V47, P175, DOI 10.1038/bjc.1983.25; Lin HF, 1997, ANNU REV GENET, V31, P455, DOI 10.1146/annurev.genet.31.1.455; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; MATTISON DR, 1980, TOXICOL APPL PHARM, V53, P249, DOI 10.1016/0041-008X(80)90424-X; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; Morita Y, 1999, ENDOCRINOLOGY, V140, P941, DOI 10.1210/en.140.2.941; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pearl R, 1921, J EXP ZOOL, V34, P101; PELLOUX MC, 1988, ACTA ENDOCRINOL-COP, V118, P218, DOI 10.1530/acta.0.1180218; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Russell LB, 2000, MUTAT RES-GEN TOX EN, V464, P201, DOI 10.1016/S1383-5718(99)00185-0; SELDEN JR, 1993, CYTOMETRY, V14, P154, DOI 10.1002/cyto.990140207; SHIROMIZU K, 1984, PEDIATR PHARMACOL, V4, P213; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Szilvassy SJ, 2003, EXP HEMATOL, V31, P331, DOI 10.1016/S0301-472X(03)00005-5; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Torrente Y, 2003, J CELL BIOL, V162, P511, DOI 10.1083/jcb.200210006; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; Walter I, 2000, HISTOCHEM J, V32, P99, DOI 10.1023/A:1004014211408; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	50	849	926	5	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					145	150		10.1038/nature02316	http://dx.doi.org/10.1038/nature02316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014492				2022-12-01	WOS:000220103600039
J	Shorter, J; Lindquist, S				Shorter, J; Lindquist, S			Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers	SCIENCE			English	Article							TERMINAL ATPASE DOMAIN; PROPAGATION; CHAPERONE; COMMUNICATION; DETERMINANT; INHERITANCE; MECHANISM; FIBERS; SYSTEM; PSI+	The protein-remodeling factor Hsp104 governs inheritance of [PSI+], a yeast prion formed by self-perpetuating amyloid conformers of the translation termination factor Sup35. Perplexingly, either excess or insufficient Hsp104 eliminates [PSI+]. In vitro, at low concentrations, Hsp104 catalyzed the formation of oligomeric intermediates that proved critical for the nucleation of Sup35 fibrillization de novo and displayed a conformation common among amyloidogenic polypeptides. At higher Hsp104 concentrations, amyloidogenic oligomerization and contingent fibrillization were abolished. Hsp104 also disassembled mature fibers in a manner that initially exposed new surfaces for conformational replication but eventually exterminated prion conformers. These Hsp104 activities differed in their reaction mechanism and can explain [PSI+] inheritance patterns.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Shorter, James/ABE-7307-2020; Shorter, James/E-8207-2011	Shorter, James/0000-0001-5269-8533; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25874] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Huff ME, 2003, CURR OPIN STRUC BIOL, V13, P674, DOI 10.1016/j.sbi.2003.10.010; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Narayanan S, 2003, P NATL ACAD SCI USA, V100, P9286, DOI 10.1073/pnas.1233535100; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 2002, ADV PROTEIN CHEM, V59, P391; SHORTER J, UNPUB; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001	27	377	382	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1793	1797		10.1126/science.1098007	http://dx.doi.org/10.1126/science.1098007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15155912				2022-12-01	WOS:000222089500043
J	Lanzetti, L; Palamidessi, A; Areces, L; Scita, G; Di Fiore, PP				Lanzetti, L; Palamidessi, A; Areces, L; Scita, G; Di Fiore, PP			Rab5 is a signalling GTPase involved in actin remodelling by receptor tyrosine kinases	NATURE			English	Article							EPIDERMAL-GROWTH-FACTOR; ALPHA-ACTININ; NUCLEOTIDE EXCHANGE; STIMULATED CELLS; RHO GTPASES; RAS; MACROPINOCYTOSIS; ACTIVATION; BINDING; EPS8	Rab5 is a small GTPase involved in the control of intracellular trafficking, both at the level of receptor endocytosis and endosomal dynamics(1). The finding that Rab5 can be activated by receptor tyrosine kinases (RTK)(2) raised the question of whether it also participates in effector pathways emanating from these receptors. Here we show that Rab5 is indispensable for a form of RTK-induced actin remodelling, called circular ruffling. Three independent signals, originating from Rab5, phosphatidylinositol-3-OH kinase and Rac, respectively, are simultaneously required for the induction of circular ruffles. Rab5 signals to the actin cytoskeleton through RN-tre, a previously identified Rab5-specific GTPase-activating protein (GAP)(3). Here we demonstrate that RN-tre has the dual function of Rab(5)-GAP and Rab5 effector. We also show that RN-tre is critical for macropinocytosis, a process previously connected to the formation of circular ruffles(4,5). Finally, RN-tre interacts with both F-actin and actinin-4, an F-actin bundling protein. We propose that RN-tre establishes a three-pronged connection with Rab5, F-actin and actinin-4. This may aid crosslinking of actin fibres into actin networks at the plasma membrane. Thus, we have shown that Rab5 is a signalling GTPase and have elucidated the major molecular elements of its downstream pathway.	Ist Europeo Oncol, I-20141 Milan, Italy; Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Milan	Di Fiore, PP (corresponding author), Ist Europeo Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	difiore@ifom-firc.it	Scita, Giorgio/J-9670-2012; Di Fiore, Pier Paolo/K-2130-2012; Palamidessi, Andrea/F-1203-2018	Di Fiore, Pier Paolo/0000-0002-2252-0950; LANZETTI, Letizia/0000-0001-7541-5524; palamidessi, andrea/0000-0002-7134-7023; Scita, Giorgio/0000-0001-7984-1889				Araki N, 2000, J CELL SCI, V113, P3329; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Benmerah A, 1999, J CELL SCI, V112, P1303; Corgan AM, 2004, BIOCHEM J, V378, P1067, DOI 10.1042/BJ20031124; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Fraley TS, 2003, J BIOL CHEM, V278, P24039, DOI 10.1074/jbc.M213288200; Greenwood JA, 2000, J CELL BIOL, V150, P627, DOI 10.1083/jcb.150.3.627; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Seastone DJ, 2001, J CELL SCI, V114, P2673; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	29	218	232	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					309	314		10.1038/nature02542	http://dx.doi.org/10.1038/nature02542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152255				2022-12-01	WOS:000221505900046
J	Foustoukos, DI; Seyfried, WE				Foustoukos, DI; Seyfried, WE			Hydrocarbons in hydrothermal vent fluids: The role of chromium-bearing catalysts	SCIENCE			English	Article							MID-ATLANTIC RIDGE; ORGANIC-ACIDS; SERPENTINIZATION; GEOCHEMISTRY; CONSTRAINTS; REDUCTION; ROCKS; FIELD; CO2	Fischer-Tropsch type (FTT) synthesis has long been proposed to account for the existence of hydrocarbons in hydrothermal fluids. We show that iron- and chromium-bearing minerals catalyze the abiotic formation of hydrocarbons. In addition to production of methane (CH4aq), we report abiotic generation of ethane (C2H6aq) and propane (C3H8aq) by mineral-catalyzed hydrothermal reactions at 390degreesC and 400 bars. Results suggest that the chromium component in ultramafic rocks could be an important factor for FTT synthesis during water-rock interaction in mid-ocean ridge hydrothermal systems. This in turn could help to support microbial communities now recognized in the subsurface at deep-sea vents.	Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Foustoukos, DI (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.	fous0009@umn.edu						Allen DE, 2003, GEOCHIM COSMOCHIM AC, V67, P1531, DOI 10.1016/S0016-7037(02)01173-0; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; BONATTI E, 1981, SEA, V7, P241; BRADY RC, 1980, J AM CHEM SOC, V102, P6181, DOI 10.1021/ja00539a053; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4321, DOI 10.1016/S0016-7037(03)00209-6; CANNAT M, 1992, EARTH PLANET SC LETT, V109, P87, DOI 10.1016/0012-821X(92)90076-8; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Charlou JL, 2000, CHEM GEOL, V171, P49, DOI 10.1016/S0009-2541(00)00244-8; COLEMAN RG, 1977, MINERALS ROCKS, V12; COLLOM TM, 2003, GEOCHIM COSMOCHIM AC, V67, P3625; Dias RF, 2002, GEOCHIM COSMOCHIM AC, V66, P2755, DOI 10.1016/S0016-7037(02)00871-2; DIAS RF, 2000, THESIS PENNSYLVANIA; DING K, 1992, GEOCHIM COSMOCHIM AC, V56, P3681, DOI 10.1016/0016-7037(92)90161-B; FU Q, 2004, 11 INT S WAT ROCK IN; Holm NG, 2001, EARTH PLANET SC LETT, V191, P1, DOI 10.1016/S0012-821X(01)00397-1; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; McCollom TM, 2003, GEOCHIM COSMOCHIM AC, V67, P3645, DOI 10.1016/S0016-7037(03)00135-2; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; NOVAK S, 1984, IND ENG CHEM FUND, V23, P274, DOI 10.1021/i100015a002; ORBERGER B, 1999, NUCL INSTRUM METH B, V158, P575; ROBIE RA, 1995, US GEOL SURV B, V2131, P462; RONA PA, 1987, J GEOPHYS RES-SOLID, V92, P1417, DOI 10.1029/JB092iB02p01417; SEEWALD J, COMMUNICATION; Seewald JS, 2001, GEOCHIM COSMOCHIM AC, V65, P1641, DOI 10.1016/S0016-7037(01)00544-0; SEYFRIED WE, 1987, HYDROTHERMAL EXPT TE, V9, P216; Stein S, 1998, NIST MASS SPECTRAL S; SUGISAKI R, 1994, GEOCHIM COSMOCHIM AC, V58, P2527, DOI 10.1016/0016-7037(94)90029-9; Taylor K.C., 1969, ADV CATAL, V20, P1; Weckhuysen BM, 1996, CHEM REV, V96, P3327, DOI 10.1021/cr940044o	30	260	279	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					1002	1005		10.1126/science.1096033	http://dx.doi.org/10.1126/science.1096033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15060286				2022-12-01	WOS:000221383300046
J	Ritz, T; Thalau, P; Phillips, JB; Wiltschko, R; Wiltschko, W				Ritz, T; Thalau, P; Phillips, JB; Wiltschko, R; Wiltschko, W			Resonance effects indicate a radical-pair mechanism for avian magnetic compass	NATURE			English	Article							EUROPEAN ROBINS; MIGRATORY BIRDS; FIELD DETECTION; HOMING PIGEONS; ORIENTATION; MODEL; ANIMALS; RECOMBINATION; LIGHT	Migratory birds are known to use the geomagnetic field as a source of compass information(1,2). There are two competing hypotheses for the primary process underlying the avian magnetic compass, one involving magnetite(3-5), the other a magnetically sensitive chemical reaction(6-8). Here we show that oscillating magnetic fields disrupt the magnetic orientation behaviour of migratory birds. Robins were disoriented when exposed to a vertically aligned broadband (0.1 - 10 MHz) or a single-frequency (7-MHz) field in addition to the geomagnetic field. Moreover, in the 7-MHz oscillating field, this effect depended on the angle between the oscillating and the geomagnetic fields. The birds exhibited seasonally appropriate migratory orientation when the oscillating field was parallel to the geomagnetic field, but were disoriented when it was presented at a 24degrees or 48degrees angle. These results are consistent with a resonance effect on singlet - triplet transitions and suggest a magnetic compass based on a radical-pair mechanism(7,8).	Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Univ Frankfurt, Inst Zool, Fachbereich Biol & Informat, D-60054 Frankfurt, Germany; Virginia Tech, Dept Biol, Blacksburg, VA 24061 USA	University of California System; University of California Irvine; Goethe University Frankfurt; Virginia Polytechnic Institute & State University	Ritz, T (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	tritz@uci.edu	Ritz, Thorsten/B-5260-2008	Ritz, Thorsten/0000-0002-2713-539X				BATSCHELET E., 1981, CIRCULAR STAT BIOL M; Beason R.C., 1991, P1813; BEASON RC, 1984, NATURE, V309, P151, DOI 10.1038/309151a0; Beason RC, 1996, J EXP BIOL, V199, P1241; CANFIELD JM, 1994, CHEM PHYS, V182, P1, DOI 10.1016/0301-0104(93)E0442-X; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; Edmonds DT, 1996, P ROY SOC B-BIOL SCI, V263, P295, DOI 10.1098/rspb.1996.0045; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, SOC GEN PHY, V47, P225; Kirschvink JL, 1996, BIOELECTROMAGNETICS, V17, P187, DOI 10.1002/(SICI)1521-186X(1996)17:3<187::AID-BEM4>3.0.CO;2-#; Kobayashi A, 1995, ADV CHEM SER, V250, P367; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; SCHULTEN K, 1982, FESTKOR-ADV SOLID ST, V22, P61, DOI 10.1007/BFb0107935; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Shcherbakov VP, 1999, EUR BIOPHYS J BIOPHY, V28, P380, DOI 10.1007/s002490050222; Timmel CR, 2001, CHEM PHYS LETT, V334, P387, DOI 10.1016/S0009-2614(00)01436-6; Weaver JC, 2000, NATURE, V405, P707, DOI 10.1038/35015128; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Wiltschko W, 1998, J EXP BIOL, V201, P3257; Wiltschko W, 2002, NATURWISSENSCHAFTEN, V89, P445, DOI 10.1007/s00114-002-0356-5; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wiltschko W, 1999, J COMP PHYSIOL A, V184, P295, DOI 10.1007/s003590050327; Wiltschko W, 2001, NATURWISSENSCHAFTEN, V88, P387, DOI 10.1007/s001140100248; Wiltschko W., 1978, ANIMAL MIGRATION NAV, P302, DOI [10.1007/978-3-662-11147-5_29, DOI 10.1007/978-3-662-11147-5_29]	29	390	403	9	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2004	429	6988					177	180		10.1038/nature02534	http://dx.doi.org/10.1038/nature02534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141211				2022-12-01	WOS:000221356300040
J	Fedorka, KM; Mousseau, TA				Fedorka, KM; Mousseau, TA			Female mating bias results in conflicting sex-specific offspring fitness	NATURE			English	Article							MATE CHOICE; GIFTS	Indirect-benefit models of sexual selection assert that females gain heritable offspring advantages through a mating bias for males of superior genetic quality. This has generally been tested by associating a simple morphological quality indicator ( for example, bird tail length) with offspring viability(1). However, selection acts simultaneously on many characters, limiting the ability to detect significant associations, especially if the simple indicator is weakly correlated to male fitness(2,3). Furthermore, recent conceptual developments suggest that the benefits gained from such mating biases may be sex-specific because of sexually antagonistic genes that differentially influence male and female reproductive ability(4). A more suitable test of the indirect-benefit model would examine associations between an aggregate quality indicator(1,3) (such as male mating success) and gender-specific adult fitness components, under the expectation that these components may trade off(1). Here, we show that a father's mating success in the cricket, Allonemobius socius, is positively genetically correlated with his son's mating success but negatively with his daughter's reproductive success. This provides empirical evidence that a female mating bias can result in sexually antagonistic offspring fitness.	Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fedorka, KM (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	fedorka@uga.edu	Mousseau, Timothy A/A-1253-2011	Mousseau, Timothy/0000-0002-2235-4868				BOAKE CRB, 1985, SCIENCE, V227, P1061, DOI 10.1126/science.227.4690.1061; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Fedorka KM, 2002, FLA ENTOMOL, V85, P317, DOI 10.1653/0015-4040(2002)085[0317:TSFIGC]2.0.CO;2; Fedorka KM, 2002, EVOLUTION, V56, P590, DOI 10.1111/j.0014-3820.2002.tb01369.x; HEISLER IL, 1985, HEREDITY, V55, P187, DOI 10.1038/hdy.1985.91; Kokko H, 2001, ECOL LETT, V4, P322, DOI 10.1046/j.1461-0248.2001.00224.x; LYNCH M, 1998, GENETICS ANAL QUANTI, P632; MONTALVO AM, 1994, EVOLUTION, V48, P828, DOI 10.1111/j.1558-5646.1994.tb01365.x; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; MOUSSEAU TA, 1991, UNITY EVOLUTIONARY B, V0002, P00745; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; ROFF DA, 1997, EVOLUTIONARY GENETIC; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; Zar JH., 1999, BIOSTAT ANAL, V4	15	143	143	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2004	429	6987					65	67		10.1038/nature02492	http://dx.doi.org/10.1038/nature02492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129280				2022-12-01	WOS:000221222100044
J	Lindenauer, PK; Pekow, P; Wang, KJ; Gutierrez, B; Benjamin, EM				Lindenauer, PK; Pekow, P; Wang, KJ; Gutierrez, B; Benjamin, EM			Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVES ENDOTHELIAL FUNCTION; VASCULAR-SURGERY; MYOCARDIAL-INFARCTION; CARDIAC RISK; PERIOPERATIVE MORTALITY; REDUCTION; EVENTS; INDEX; PREDICTORS; MORBIDITY	Context Cardiovascular complications following major noncardiac surgery are an important source of perioperative morbidity and mortality. Although lipid-lowering medications are considered a key component in the primary and secondary prevention of cardiovascular disease, their potential benefit during the perioperative period is uncertain. Objective To examine the association between treatment with lipid-lowering medications and in-hospital mortality following major noncardiac surgery. Design, Setting, and Patients A retrospective cohort study based on hospital discharge and pharmacy records of 780591 patients aged 18 years or older who underwent major noncardiac surgery from January 1, 2000, to December 31, 2001, at any 1 of 329 hospitals throughout the United States. Only patients who survived through at least the second hospital day were included. Lipid-lowering therapy was defined as use during the first 2 hospital days. Propensity matching was used to adjust for numerous baseline differences. Main Outcome Measure In-hospital mortality. Results Of the 780 591 patients, 77 082 patients (9.9%) received lipid-lowering therapy perioperatively and 23 100 (2.96%) died during the hospitalization. Treatment with lipid-lowering agents was associated with lower crude mortality (2.13% vs 3.05%, P<.001). In an analysis using matching by propensity score, 1595 patients (2.18%) treated with lipid-lowering medications died compared with 4158 patients (3.15%) who did not receive therapy or in whom treatment was initiated after the second day (P<.001). After adjusting for residual differences in the propensity matched groups using conditional logistic regression, risk of mortality remained lower among treated patients (adjusted odds ratio [OR], 0.62; 95% confidence interval [CI], 0.58-0.67). Based on this adjusted OR, the number needed to treat to prevent a postoperative death in the propensity matched cohort was 85 (95% Cl, 77-98) and varied from 186 among patients at lowest risk to 30 among those with a revised cardiac risk index score of 4 or more. in a further analysis using the entire study cohort and adjusting for quintile of propensity, a significant effect of treatment persisted (adjusted OR, 0.71; 95% Cl, 0.67-0.75). Conclusions Treatment with lipid-lowering agents may reduce risk of death following major noncardiac surgery. Clinical trials are required to confirm this observation.	Baystate Med Ctr, Div Healthcare Qual, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; Premier Corp, Premier Healthcare Informat, Charlotte, NC USA	Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Div Healthcare Qual, 759 Chestnut St,P-5931, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org						Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1435, DOI 10.1001/jama.287.11.1435; Best WR, 2002, J AM COLL SURGEONS, V194, P257, DOI 10.1016/S1072-7515(01)01183-8; Boersma E, 2001, JAMA-J AM MED ASSOC, V285, P1865, DOI 10.1001/jama.285.14.1865; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Dawood MM, 1996, INT J CARDIOL, V57, P37, DOI 10.1016/S0167-5273(96)02769-6; DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; EAGLE KA, 1989, ANN INTERN MED, V110, P859, DOI 10.7326/0003-4819-110-11-859; Farmer J A, 2000, Curr Atheroscler Rep, V2, P208, DOI 10.1007/s11883-000-0022-3; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HALL MJ, 2002, 2000 NATL HOSP DISCH; Huggins GS, 1998, CIRCULATION, V98, P1291, DOI 10.1161/01.CIR.98.13.1291; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lindenauer PK, 2004, ARCH INTERN MED, V164, P762, DOI 10.1001/archinte.164.7.762; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Nettleman MD, 1997, AM J MED, V103, P357, DOI 10.1016/S0002-9343(97)00162-9; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Osamah H, 1997, BRIT J CLIN PHARMACO, V44, P77, DOI 10.1046/j.1365-2125.1997.00625.x; Poldermans D, 2003, CIRCULATION, V107, P1848, DOI 10.1161/01.CIR.0000066286.15621.98; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Ridker PM, 2001, CIRCULATION, V103, P1191; SHOJANIA K, 2001, AHRQ PUBLICATION; Sonksen J, 1998, BMJ-BRIT MED J, V317, P1400, DOI 10.1136/bmj.317.7170.1400	25	302	313	1	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2004	291	17					2092	2099		10.1001/jama.291.17.2092	http://dx.doi.org/10.1001/jama.291.17.2092			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JR	15126437	Bronze			2022-12-01	WOS:000221174300026
J	Egan, ME; Pearson, M; Weiner, SA; Rajendran, V; Rubin, D; Glockner-Pagel, J; Canny, S; Du, K; Lukacs, GL; Caplan, MJ				Egan, ME; Pearson, M; Weiner, SA; Rajendran, V; Rubin, D; Glockner-Pagel, J; Canny, S; Du, K; Lukacs, GL; Caplan, MJ			Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects	SCIENCE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SARCOPLASMIC-RETICULUM; PARTIAL RESTORATION; CHLORIDE CHANNEL; CLINICAL-TRIAL; CFTR FUNCTION; MICE; CA2+; COMPARTMENTS; DEGRADATION	Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator ( CFTR). The most common mutation, DeltaF508, results in the production of a misfolded CFTR protein that is retained in the endoplasmic reticulum and targeted for degradation. Curcumin is a nontoxic Ca-adenosine triphosphatase pump inhibitor that can be administered to humans safely. Oral administration of curcumin to homozygous DeltaF508 CFTR mice in doses comparable, on a weight-per-weight basis, to those well tolerated by humans corrected these animals' characteristic nasal potential difference defect. These effects were not observed in mice homozygous for a complete knockout of the CFTR gene. Curcumin also induced the functional appearance of DeltaF508 CFTR protein in the plasma membranes of transfected baby hamster kidney cells. Thus, curcumin treatment may be able to correct defects associated with the homozygous expression of DeltaF508 CFTR.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Univ Toronto, Hosp Sick Children, Res Inst, Dept Lab Med & Pathol,Program Cell & Lung Biol, Toronto, ON M5G 1X8, Canada	Yale University; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St,POB 208026, New Haven, CT 06520 USA.	michael.caplan@yale.edu		Lukacs, Gergely/0000-0003-0900-0675; Weiner, Scott/0000-0003-4339-6407; Caplan, Michael/0000-0001-5768-4405; Canny, Susan/0000-0002-1762-6718	NIDDK NIH HHS [R01 DK053428, DK17433, DK53428] Funding Source: Medline; NIGMS NIH HHS [GM42136] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053428, P01DK017433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042136] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Brady KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1173, DOI 10.1152/ajplung.2001.281.5.L1173; Cheng AL, 2001, ANTICANCER RES, V21, P2895; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clarke LL, 1996, LAB ANIM SCI, V46, P612; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; Grubb Barbara R, 2002, Methods Mol Med, V70, P525; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Illek B, 2000, AM J PHYSIOL-CELL PH, V279, pC1838, DOI 10.1152/ajpcell.2000.279.6.C1838; Kelley TJ, 1997, P NATL ACAD SCI USA, V94, P2604, DOI 10.1073/pnas.94.6.2604; Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; PIND S, 1994, J BIOL CHEM, V269, P12784; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sumbilla C, 2002, J BIOL CHEM, V277, P13900, DOI 10.1074/jbc.M111155200; TABCHARANI JA, 1992, BIOPHYS J, V62, P1, DOI 10.1016/S0006-3495(92)81759-9; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	27	461	496	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					600	602		10.1126/science.1093941	http://dx.doi.org/10.1126/science.1093941			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105504				2022-12-01	WOS:000220975100053
J	Hampton, T				Hampton, T			New smallpox vaccine shows promise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1825	1825		10.1001/jama.291.15.1825	http://dx.doi.org/10.1001/jama.291.15.1825			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100185				2022-12-01	WOS:000220871200004
J	Muller, U; Exadaktylos, A; Roeder, C; Pisan, M; Eggli, S; Juni, P				Muller, U; Exadaktylos, A; Roeder, C; Pisan, M; Eggli, S; Juni, P			Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem A suspected high proportion of unnecessary blood transfusions occur in patients undergoing total joint replacement. Design Prospective before and after study evaluating the impact of a one page flow chart aimed at reducing the use of blood transfusions. Setting Orthopaedic tertiary care centre in Winterthur, Switzerland. 208 patients underwent primary total joint replacement of hips or knees during the control period (October 1998 to September 1999) and 217 during the intervention period (October 1999 to September 2000). Key measures for improvement Proportion of patients receiving allogencic blood transfusions. Strategies for change A simple one page flow chart, which summarised graphically the perioperative decision pathways for anaemic patients, was placed in all charts of patients undergoing total joint replacement and handed out to medical staff from 4 October 1999 onwards. The implementation of the flow chart focused on its endorsement by chief physicians and the development of a sense of "ownership" among physicians and nurses. Effects of change The proportion of patients receiving allogeneic blood decreased from 35.0% to 19.8% (absolute difference - 15.2%, 95% confidence interval - 23.3 to - 7.0%). The percentage of patients donating and receiving autologous blood also decreased. This led to overall savings of about; pound23 000 ($42 470; E34 441) (pound103.50 per patient undergoing total joint replacement). Differences became more pronounced after adjustment for confounding factors. Lessons learnt Allogeneic blood transfusions in primary hip and knee replacement surgery may be reduced cost effectively by implementing a one page flow chart. Five key elements may have contributed: simplicity; wide distribution; no requirement for major changes; endorsement by local opinion leaders; and development of a sense of ownership. These elements may be used in other contexts to achieve sustained change of clinical practice.	Univ Bristol, UK Med Res Council, Hlth Serv Res Collaborat, Dept Social Med, Bristol BS8 1TH, Avon, England; Univ Bern, Inst Evaluat Res Orthopaed Surg, CH-3001 Bern, Switzerland; Univ Bern, Dept Anaesthesiol, Inselspital, CH-3010 Bern, Switzerland; Kantonsspital Winterthur, Dept Orthopaed Surg, CH-8400 Winterthur, Switzerland; Univ Bern, Dept Orthopaed Surg, CH-3010 Bern, Switzerland	University of Bristol; University of Bern; University of Bern; University of Bern		juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670				AUDET AM, 1992, ANN INTERN MED, V116, P403, DOI 10.7326/0003-4819-116-5-403; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HILL SR, 2002, COCHRANE DB SYST REV, V2; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; MARINO PL, 1998, BLOOD COMPONENT THER; MCCLELLAND B, 1994, TRANSFUS CLIN BIOL, V1, P425, DOI 10.1016/S1246-7820(06)80026-1; PAGE MH, 1984, AUST NZ J SURG, V54, P141, DOI 10.1111/j.1445-2197.1984.tb06705.x; Regan F, 2002, BRIT MED J, V325, P143, DOI 10.1136/bmj.325.7356.143; SIRCHIA G, 1994, TRANSFUSION MED, V4, P251; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; Williamson LM, 1999, BRIT MED J, V319, P16, DOI 10.1136/bmj.319.7201.16; WOHL H, 1977, NEW ENGL J MED, V296, P1044, DOI 10.1056/NEJM197705052961806	13	29	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					934	938		10.1136/bmj.328.7445.934	http://dx.doi.org/10.1136/bmj.328.7445.934			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087341	Green Submitted, Green Published			2022-12-01	WOS:000220994400026
J	Koga, T; Inui, M; Inoue, K; Kim, S; Suematsu, A; Kobayashi, E; Iwata, T; Ohnishi, H; Matozaki, T; Kodama, T; Taniguchi, T; Takayanagi, H; Takai, T				Koga, T; Inui, M; Inoue, K; Kim, S; Suematsu, A; Kobayashi, E; Iwata, T; Ohnishi, H; Matozaki, T; Kodama, T; Taniguchi, T; Takayanagi, H; Takai, T			Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis	NATURE			English	Article							NATURAL-KILLER-CELLS; OSTEOCLAST DIFFERENTIATION; MYELOID CELLS; FC-RECEPTORS; ACTIVATION; MICE; INDUCTION; SYSTEM; GAMMA; BETA	Costimulatory signals are required for activation of immune cells(1), but it is not known whether they contribute to other biological systems. The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption(2,3). Receptor activator of NF-kappaB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF)(4,5). But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis(6). Here we show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)(7)-harbouring adaptors(8-10), Fc receptor common gamma subunit (FcRgamma) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation. In osteoclast precursor cells, FcRgamma and DAP12 associate with multiple immunoreceptors(11-15) and activate calcium signalling through phospholipase Cgamma. Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis. These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.	Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Grad Sch, Bunkyo Ku, Tokyo 1138549, Japan; Tokyo Med & Dent Univ, COE Program Frontier Res Mol Destruct & Reconstru, Bunkyo Ku, Tokyo 1138549, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; JST, CREST, Kawaguchi, Saitama 3320012, Japan; Gunma Univ, Biosignal Res Ctr, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan; Univ Tokyo, Dept Mol Biol & Med, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Gunma University; University of Tokyo	Takayanagi, H (corresponding author), Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	taka.cell@tmd.ac.jp; tostakai@idac.tohoku.ac.jp		Kobayashi, Eiji/0000-0002-7303-2797				Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Olcese L, 1997, J IMMUNOL, V158, P5083; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; PEREZMONTFORT R, 1983, BIOCHEMISTRY-US, V22, P5722, DOI 10.1021/bi00294a007; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:18<2147::AID-IMMU2147>3.3.CO;2-9; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573	30	626	657	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					758	763		10.1038/nature02444	http://dx.doi.org/10.1038/nature02444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085135				2022-12-01	WOS:000220823800042
J	Todd, JJ; Marois, R				Todd, JJ; Marois, R			Capacity limit of visual short-term memory in human posterior parietal cortex	NATURE			English	Article							WORKING-MEMORY; NEURAL SYSTEM; STORAGE; REPRESENTATION; DISSOCIATION; CONSTRAINTS; BINDING; OBJECT	At any instant, our visual system allows us to perceive a rich and detailed visual world. Yet our internal, explicit representation of this visual world is extremely sparse: we can only hold in mind a minute fraction of the visual scene(1,2). These mental representations are stored in visual short-term memory (VSTM). Even though VSTM is essential for the execution of a wide array of perceptual and cognitive functions(3-5), and is supported by an extensive network of brain regions(6-9), its storage capacity is severely limited(10-13). With the use of functional magnetic resonance imaging, we show here that this capacity limit is neurally reflected in one node of this network: activity in the posterior parietal cortex is tightly correlated with the limited amount of scene information that can be stored in VSTM. These results suggest that the posterior parietal cortex is a key neural locus of our impoverished mental representation of the visual world.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Marois, R (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, 530 Wilson Hall, Nashville, TN 37203 USA.	rene.marois@vanderbilt.edu						Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dodwell, 1972, NEW HORIZONS PSYCHOL, P62; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Goldman-Rakic P. S., 1987, HDB PHYSL, V5, P373, DOI DOI 10.1002/CPHY.CP010509; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Jolic&OELIG;ur P., 2001, LIMITS ATTENTION, P82; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rosnow RL, 1996, PSYCHOL SCI, V7, P253, DOI 10.1111/j.1467-9280.1996.tb00369.x; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	30	1046	1076	8	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					751	754		10.1038/nature02466	http://dx.doi.org/10.1038/nature02466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812EW	15085133				2022-12-01	WOS:000220823800040
J	Larson, EB; Shadlen, MF; Wang, L; McCormick, WC; Bowen, JD; Teri, L; Kukull, WA				Larson, EB; Shadlen, MF; Wang, L; McCormick, WC; Bowen, JD; Teri, L; Kukull, WA			Survival after initial diagnosis of Alzheimer disease	ANNALS OF INTERNAL MEDICINE			English	Article							BEHAVIOR PROBLEMS CHECKLIST; MULTIINFARCT DEMENTIA; GENDER-DIFFERENCES; REVISED MEMORY; FOLLOW-UP; PREDICTORS; MORTALITY; DEATH; INSTITUTIONALIZATION; PROGRESSION	Background: Alzheimer disease is an increasingly common condition in older people. Knowledge of life expectancy after the diagnosis of Alzheimer disease and of associations of patient characteristics with survival may help planning for future care. Objective: To investigate the course of Alzheimer disease after initial diagnosis and examine associations hypothesized to correlate with survival among community-dwelling patients with Alzheimer disease. Design: Prospective observational study. Setting: An Alzheimer disease patient registry from a base population of 23 000 persons age 60 years and older in the Group Health Cooperative, Seattle, Washington. Patients: 521 newly recognized persons with Alzheimer disease enrolled from 1987 to 1996 in an Alzheimer disease patient registry. Measurements: Baseline measurements included patient demographic features, Mini-Mental State Examination score, Blessed Dementia Rating Scale score, duration since reported onset of symptoms, associated symptoms, comorbid conditions, and selected signs. Survival was the outcome of interest. Results: The median survival from initial diagnosis was 4.2 years for men and 5.7 years for women with Alzheimer disease. Men had poorer survival across all age groups compared with females. Survival was decreased in all age groups compared with the life expectancy of the U.S. population. Predictors of mortality based on proportional hazards models included a baseline Mini-Mental State Examination score of 17 or less, baseline Blessed Dementia Rating Scale score of 5.0 or greater, presence of frontal lobe release signs, presence of extrapyramidal signs, gait disturbance, history of falls, congestive heart failure, ischemic heart disease, and diabetes at baseline. Limitations: The base population, although typical of the surrounding Seattle community, may not be representative of other, more diverse populations. Conclusions: In this sample of community-dwelling elderly persons who received a diagnosis of Alzheimer disease, survival duration was shorter than predicted on the basis of U.S. population data, especially for persons with onset at relatively younger ages. Features significantly associated with reduced survival at diagnosis were increased severity of cognitive impairment, decreased functional level, history of falls, physical examination findings of frontal release signs, and abnormal gait. The variables most strongly associated with survival were measures of disease severity at the time of diagnosis. These results should be useful to patients and families experiencing Alzheimer disease, other caregivers, clinicians, and policymakers when planning for future care needs.	Univ Washington, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA USA	University of Washington; University of Washington Seattle; Group Health Cooperative	Larson, EB (corresponding author), Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	larson.e@ghz.org		Kukull, Walter/0000-0001-8761-9014	NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER; NIA NIH HHS [AG 06781-13S1, AG 06781] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguero-Torres H, 1998, INT J GERIATR PSYCH, V13, P755, DOI 10.1002/(SICI)1099-1166(1998110)13:11<755::AID-GPS862>3.0.CO;2-Y; BELLONISONZOGNI A, 1989, ARCH GERONTOL GERIAT, V9, P193, DOI 10.1016/0167-4943(89)90039-3; BIANCHETTI A, 1995, DEMENTIA, V6, P108, DOI 10.1159/000106930; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bowen JD, 1996, NEUROLOGY, V47, P433, DOI 10.1212/WNL.47.2.433; Claus JJ, 1998, DEMENT GERIATR COGN, V9, P284, DOI 10.1159/000017073; COX DR, 1972, J R STAT SOC B, V34, P187; Doody RS, 2001, ARCH NEUROL-CHICAGO, V58, P449, DOI 10.1001/archneur.58.3.449; Ewbank DC, 1999, AM J PUBLIC HEALTH, V89, P90, DOI 10.2105/AJPH.89.1.90; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gambassi G, 1999, NEUROLOGY, V53, P508, DOI 10.1212/WNL.53.3.508; Ganguli M, 1999, J AM GERIATR SOC, V47, P842, DOI 10.1111/j.1532-5415.1999.tb03842.x; Geerlings MI, 1997, NEUROLOGY, V49, P798, DOI 10.1212/WNL.49.3.798; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Heyman A, 1996, NEUROLOGY, V46, P656, DOI 10.1212/WNL.46.3.656; HIER DB, 1989, ARCH NEUROL-CHICAGO, V46, P1213, DOI 10.1001/archneur.1989.00520470073030; JAGGER C, 1995, PSYCHOL MED, V25, P171, DOI 10.1017/S0033291700028191; KNOPMAN DS, 1988, J AM GERIATR SOC, V36, P108, DOI 10.1111/j.1532-5415.1988.tb01778.x; Lapane KL, 2001, NEUROLOGY, V56, P650, DOI 10.1212/WNL.56.5.650; Larson E B, 1990, Aging (Milano), V2, P404; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOLSA PK, 1995, ACTA NEUROL SCAND, V91, P159; MOLSA PK, 1986, ACTA NEUROL SCAND, V74, P103; NIELSEN H, 1991, ACTA PSYCHIAT SCAND, V84, P277, DOI 10.1111/j.1600-0447.1991.tb03144.x; Ostbye T, 1999, NEUROLOGY, V53, P521, DOI 10.1212/WNL.53.3.521; Piccininni M, 1998, ALZHEIMERS REP, V1, P321; STERN Y, 1994, NEUROLOGY, V44, P2300, DOI 10.1212/WNL.44.12.2300; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; WALSH JS, 1990, ANN INTERN MED, V113, P429, DOI 10.7326/0003-4819-113-6-429; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Wilson RS, 2002, NEUROLOGY, V58, P1815, DOI 10.1212/WNL.58.12.1815; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501	32	391	398	0	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2004	140	7					501	509		10.7326/0003-4819-140-7-200404060-00008	http://dx.doi.org/10.7326/0003-4819-140-7-200404060-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808OE	15068977				2022-12-01	WOS:000220577600001
J	Dynek, JN; Smith, S				Dynek, JN; Smith, S			Resolution of sister telomere association is required for progression through mitosis	SCIENCE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; MAMMALIAN-CELLS; TANKYRASE; ANAPHASE; COHESIN; SEPARATION; COMPLEXES; TRF1; IDENTIFICATION; CENTROMERES	Cohesins keep sister chromatids associated from the time of their replication in S phase until the onset of anaphase. In vertebrate cells, two distinct pathways dissociate cohesins, one acts on chromosome arms and the other on centromeres. Here, we describe a third pathway that acts on telomeres. Knockdown of tankyrase 1, a telomeric poly(ADP-ribose) polymerase caused mitotic arrest. Chromosomes aligned normally on the metaphase plate but were unable to segregate. Sister chromatids separated at centromeres and arms but remained associated at telomeres, apparently through proteinaceous bridges. Thus, telomeres may require a unique tankyrase 1-dependent mechanism for sister chromatid resolution before anaphase.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Smith, S (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 450 1st Ave, New York, NY 10016 USA.	smithsu@saturn.med.nyu.edu		Smith, Susan/0000-0002-8213-5915	NATIONAL CANCER INSTITUTE [R01CA095099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007238] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095099, R01 CA95099-01] Funding Source: Medline; NIGMS NIH HHS [GM07238-28] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Donaldson MM, 2001, J CELL BIOL, V153, P663, DOI 10.1083/jcb.153.4.663; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; Ofir R, 2002, CHROMOSOMA, V111, P147, DOI 10.1007/s00412-002-0199-z; OHNUKI Y, 1968, CHROMOSOMA, V25, P402, DOI 10.1007/BF02327721; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1999, J CELL SCI, V112, P3649; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X	24	214	229	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					97	100		10.1126/science.1094754	http://dx.doi.org/10.1126/science.1094754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15064417				2022-12-01	WOS:000220567900045
J	Rizzoli, SO; Betz, WJ				Rizzoli, SO; Betz, WJ			The structural organization of the readily releasable pool of synaptic vesicles	SCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; MOTOR-NERVE TERMINALS; TRANSMITTER RELEASE; HIPPOCAMPAL SYNAPSES; EXOCYTOSIS; DEPLETION; ACTIN; KISS; RUN	The defining morphological feature of chemical synapses is the vesicle cluster in the presynaptic nerve terminal. It has generally been assumed that vesicles closest to release sites are recruited first during nerve activity. We tested this by selectively labeling the "readily releasable" pool, those vesicles released first during physiological stimulation. The readily releasable vesicles were not clustered close to the presynaptic membrane but instead were dispersed almost randomly throughout the vesicle cluster. Thus, vesicles are not recruited according to proximity to release sites but are mobilized differently, perhaps by being peeled from the surface of the cluster.	Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Betz, WJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, 4200 E 9th Ave, Denver, CO 80262 USA.	bill.betz@uchsc.edu	Rizzoli, Silvio/ABG-2227-2020	Rizzoli, Silvio/0000-0002-1667-7839	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023466] Funding Source: NIH RePORTER; NINDS NIH HHS [5 RO1 NS023466] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BETZ WJ, 1994, J CELL BIOL, V124, P843, DOI 10.1083/jcb.124.5.843; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; KATZ B, 1979, PROC R SOC SER B-BIO, V205, P369, DOI 10.1098/rspb.1979.0070; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; MOLGO J, 1988, NEUROSCIENCE, V24, P695, DOI 10.1016/0306-4522(88)90362-4; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; SMITH JE, 1980, J EXP BIOL, V89, P19; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003	22	219	222	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2037	2039		10.1126/science.1094682	http://dx.doi.org/10.1126/science.1094682			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044806				2022-12-01	WOS:000220429800047
J	Tanaka, M; Chien, P; Naber, N; Cooke, R; Weissman, JS				Tanaka, M; Chien, P; Naber, N; Cooke, R; Weissman, JS			Conformational variations in an infectious protein determine prion strain differences	NATURE			English	Article							SUP35 PROTEIN; PSI+ PRION; YEAST; PSI(+); GENERATION; INDUCTION; DIVERSITY; VITRO	A remarkable feature of prion biology is the strain phenomenon wherein prion particles apparently composed of the same protein lead to phenotypically distinct transmissible states(1-4). To reconcile the existence of strains with the 'protein-only' hypothesis of prion transmission, it has been proposed that a single protein can misfold into multiple distinct infectious forms, one for each different strain(1-3,5). Several studies have found correlations between strain phenotypes and conformations of prion particles(6-10); however, whether such differences cause or are simply a secondary manifestation of prion strains remains unclear, largely due to the difficulty of creating infectious material from pure protein(3,5). Here we report a high-efficiency protocol for infecting yeast with the [PSI+] prion using amyloids composed of a recombinant Sup35 fragment (Sup-NM). Using thermal stability and electron paramagnetic resonance spectroscopy, we demonstrate that Sup-NM amyloids formed at different temperatures adopt distinct, stably propagating conformations. Infection of yeast with these different amyloid conformations leads to different [PSI+] strains. These results establish that Sup-NM adopts an infectious conformation before entering the cell fulfilling a key prediction of the prion hypothesis(5)-and directly demonstrate that differences in the conformation of the infectious protein determine prion strain variation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	jsw1@itsa.ucsf.edu	Tanaka, Motomasa/N-5064-2015	Tanaka, Motomasa/0000-0002-2994-7703; Weissman, Jonathan/0000-0003-2445-670X				Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; CHIEN P, IN PRESS ANN REV BIO; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Liebman SW, 2002, P NATL ACAD SCI USA, V99, P9098, DOI 10.1073/pnas.152318899; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	30	655	682	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					323	328		10.1038/nature02392	http://dx.doi.org/10.1038/nature02392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029196				2022-12-01	WOS:000220250200045
J	Baas, AF; Kuipers, J; van der Wel, NN; Batlle, E; Koerten, HK; Peters, PJ; Clevers, HC				Baas, AF; Kuipers, J; van der Wel, NN; Batlle, E; Koerten, HK; Peters, PJ; Clevers, HC			Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD	CELL			English	Article							PEUTZ-JEGHERS-SYNDROME; DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; TUMOR-SUPPRESSOR; CYTOPLASMIC LOCALIZATION; TIGHT JUNCTION; PAR GENES; GROWTH; POLARITY; CANCER	The LKB1 gene encodes a serine/threonine kinase that is mutated in the Peutz-Jeghers cancer syndrome. LKB1 is homologous to the Par-4 polarity genes in C. elegans and D. melanogaster. We have previously reported the identification and characterization of an LKB1-specific adaptor protein, STRAD, which activates LKB1 and translocates it from nucleus to cytoplasm. We have now constructed intestinal epithelial cell lines in which inducible STRAD activates LKB1. Upon LKB1 activation, single cells rapidly remodel their actin cytoskeleton to form an apical brush border. The junctional proteins ZO-1 and p120 redistribute in a dotted circle peripheral to the brush border, in the absence of cell-cell contacts. Apical and basolateral markers sort to their respective membrane domains. We conclude that LKB1 can induce complete polarity in intestinal epithelial cells. In contrast to current thinking on polarization of simple epithelia, these cells can fully polarize in the absence of junctional cell-cell contacts.	Ctr Biomed Genet, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RA Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Clevers, HC (corresponding author), Ctr Biomed Genet, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Van Der Wel, Nicole/AAE-7569-2020; Batlle, Eduard/K-8080-2014	Batlle, Eduard/0000-0003-2422-0326; van der Wel, Nicole/0000-0001-6392-3417				ALBERTS B, 2002, MOL BIOL CELL, P609; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Bowerman B, 1997, DEVELOPMENT, V124, P3815; CEREIJIDO M, 1980, J MEMBRANE BIOL, V52, P147, DOI 10.1007/BF01869120; CHENG NN, 1995, GENETICS, V139, P549; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Fleming TP, 2000, SEMIN CELL DEV BIOL, V11, P291, DOI 10.1006/scdb.2000.0179; FRIEDERICH E, 1989, CELL, V59, P461, DOI 10.1016/0092-8674(89)90030-5; FRIEDERICH E, 1990, BIOESSAYS, V12, P403, DOI 10.1002/bies.950120902; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; JEGHERS H, 1949, NEW ENGL J MED, V241, P993, DOI 10.1056/NEJM194912222412501; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KIRBY C, 1990, DEV BIOL, V142, P203, DOI 10.1016/0012-1606(90)90164-E; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Miyoshi H, 2002, CANCER RES, V62, P2261; MORTON DG, 1992, GENETICS, V130, P771; Nakau M, 2002, CANCER RES, V62, P4549; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Peters PJ, 2001, METHOD ENZYMOL, V329, P210; Peutz JL, 1921, NEDERL MAANDSCHR GEN, V10, P134; PINTO M, 1983, BIOL CELL, V47, P323; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Spicer J, 2003, ONCOGENE, V22, P4752, DOI 10.1038/sj.onc.1206669; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; VAN MEER G, 1986, NATURE, V322, P639, DOI 10.1038/322639a0; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	49	404	413	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					457	466		10.1016/S0092-8674(04)00114-X	http://dx.doi.org/10.1016/S0092-8674(04)00114-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016379	Bronze			2022-12-01	WOS:000188825800013
J	Hanayama, R; Tanaka, M; Miyasaka, K; Aozasa, K; Koike, M; Uchiyama, Y; Nagata, S				Hanayama, R; Tanaka, M; Miyasaka, K; Aozasa, K; Koike, M; Uchiyama, Y; Nagata, S			Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice	SCIENCE			English	Article							GERMINAL-CENTERS; MACROPHAGES; CLEARANCE; DEATH; PHOSPHATIDYLSERINE; EXPRESSION; DEFICIENT; EXPOSURE; SURFACE	Apoptotic cells expose phosphatidylserine and are swiftly engulfed by macrophages. Milk fat globule epidermal growth factor (EGF) factor 8 (MFG-E8) is a protein that binds to apoptotic cells by recognizing phosphatidylserine and that enhances the engulfment of apoptotic cells by macrophages. We report that tingible body macrophages in the germinal centers of the spleen and lymph nodes strongly express MFG-E8. Many apoptotic lymphocytes were found on the MFG-E8(-/-) tingible body macrophages, but they were not efficiently engulfed. The MFG-E8(-/-) mice developed splenomegaly, with the formation of numerous germinal centers, and suffered from glomerulonephritis as a result of autoantibody production. These data demonstrate that MFG-E8 has a critical role in removing apoptotic B cells in the germinal centers and that its failure can lead to autoimmune diseases.	Osaka Univ, Sch Med, Dept Genet, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Pathol, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Cell Biol & Neurosci, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Innate Cellular Immun, Kanagawa 2300045, Japan; Osaka Univ, Grad Sch Frontier Biosci, Integrated Biol Labs, Genet Lab, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; RIKEN; Osaka University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamada Oka, Osaka 5650871, Japan.	nagata@genetic.med.osaka-u.ac.jp	Hanayama, Rikinari/D-2940-2011; Koike, Masato/F-9584-2010; Nagata, Shigekazu/AAG-3203-2019; Hanayama, Rikinari/AAO-4959-2021	Koike, Masato/0000-0002-3174-5684; Nagata, Shigekazu/0000-0001-9758-8426; Hanayama, Rikinari/0000-0003-2102-3386				Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; FADOK VA, 1992, J IMMUNOL, V148, P2207; GAUTHIER VJ, 1992, SEMIN NEPHROL, V12, P379; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; HANAYAMA R, UNPUB; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KRAAL G, 1986, IMMUNOLOGY, V58, P665; LEIJH PCJ, 1984, INFECT IMMUN, V46, P448, DOI 10.1128/IAI.46.2.448-452.1984; McKnight AJ, 1998, ADV IMMUNOL, V68, P271, DOI 10.1016/S0065-2776(08)60562-3; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Oshima K, 1999, BIOCHEM BIOPH RES CO, V254, P522, DOI 10.1006/bbrc.1998.0107; Platt N, 2000, J IMMUNOL, V164, P4861, DOI 10.4049/jimmunol.164.9.4861; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; SMITH JP, 1991, ANAT REC, V229, P511, DOI 10.1002/ar.1092290412; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0	25	739	775	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1147	1150		10.1126/science.1094359	http://dx.doi.org/10.1126/science.1094359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155946				2022-12-01	WOS:000221524500040
J	Gonen, T; Sliz, P; Kistler, J; Cheng, YF; Walz, T				Gonen, T; Sliz, P; Kistler, J; Cheng, YF; Walz, T			Aquaporin-0 membrane junctions reveal the structure of a closed water pore	NATURE			English	Article							INTRINSIC PROTEIN MIP; HUMAN LENS MEMBRANE; ELECTRON CRYSTALLOGRAPHY; MAMMALIAN LENS; SELECTIVITY; TRANSPORT; BACTERIORHODOPSIN; PERMEATION; CHANNEL; AQP1	The lens-specific water pore aquaporin-0 (AQP0) is the only aquaporin known to form membrane junctions in vivo(1). We show here that AQP0 from the lens core, containing some carboxy-terminally cleaved AQP0(2,3), forms double-layered crystals that recapitulate in vivo junctions. We present the structure of the AQP0 membrane junction as determined by electron crystallography. The junction is formed by three localized interactions between AQP0 molecules in adjoining membranes, mainly mediated by proline residues conserved in AQP0s from different species but not present in most other aquaporins. Whereas all previously determined aquaporin structures show the pore in an open conformation(4-9), the water pore is closed in AQP0 junctions. The water pathway in AQP0 also contains an additional pore constriction, not seen in other known aquaporin structures(4-9), which may be responsible for pore gating.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Auckland	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	twalz@hms.harvard.edu		Cheng, Yifan/0000-0001-9535-0369; Walz, Thomas/0000-0003-2606-2835				Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Bond PJ, 2002, BIOPHYS J, V83, P763, DOI 10.1016/S0006-3495(02)75207-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandy G, 1997, J MEMBRANE BIOL, V159, P29, DOI 10.1007/s002329900266; COSTELLO MJ, 1989, INVEST OPHTH VIS SCI, V30, P975; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Donaldson P, 2001, NEWS PHYSIOL SCI, V16, P118; Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gonen T, 2000, INVEST OPHTH VIS SCI, V41, P199; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; ROY D, 1979, EXP EYE RES, V28, P353, DOI 10.1016/0014-4835(79)90097-6; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; TAKEMOTO L, 1986, INVEST OPHTH VIS SCI, V27, P443; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Varadaraj K, 1999, J MEMBRANE BIOL, V170, P191, DOI 10.1007/s002329900549	29	284	294	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2004	429	6988					193	197		10.1038/nature02503	http://dx.doi.org/10.1038/nature02503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141214				2022-12-01	WOS:000221356300044
J	Mayr, G				Mayr, G			Old world fossil record of modern-type hummingbirds	SCIENCE			English	Article							BIRD	I report on tiny skeletons of stem-group hummingbirds from the early Oligocene of Germany that are of essentially modern appearance and exhibit morphological specializations toward nectarivory and hovering flight. These are the oldest fossils of modern-type hummingbirds, which had not previously been reported from the Old World. The findings demonstrate that early hummingbird evolution was not restricted to the New World. They further suggest that bird-flower coevolution dates back to the early Oligocene and open another view on the origin of ornithophily in Old World plants.	Forschungsinst Senckenberg, Div Ornithol, D-60325 Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN)	Mayr, G (corresponding author), Forschungsinst Senckenberg, Div Ornithol, Senckenberganlage 25, D-60325 Frankfurt, Germany.	Gerald.Mayr@senckenberg.de						BERNSTEIN LOWELL, 1965, QUART FLORIDA ACAD SCI, V28, P271; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P63, DOI 10.1006/bijl.1998.0241; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; CARPENTER FL, 1979, AM ZOOL, V19, P1105; Ericson PGP, 2003, J AVIAN BIOL, V34, P3, DOI 10.1034/j.1600-048X.2003.03121.x; GRANT V, 1994, P NATL ACAD SCI USA, V91, P10407, DOI 10.1073/pnas.91.22.10407; Johansson US, 2001, J ZOOL SYST EVOL RES, V39, P37; KARHU A. A., 1988, PALEONTOL J, V3, P78; KARHU A. A., 2001, ACHIEVEMENTS PROBLEM, P118; Karhu Alexandr A., 1999, Smithsonian Contributions to Paleobiology, V89, P207; Legendre Serge, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P461; Mayr G, 2003, AUK, V120, P145, DOI 10.1642/0004-8038(2003)120[0145:POETSA]2.0.CO;2; Mayr G, 2003, IBIS, V145, P382, DOI 10.1046/j.1474-919X.2003.00168.x; Micklich N., 1996, Publicaciones Especiales Instituto Espanol de Oceanografia, V21, P129; MOURERCHAUVIRE C, 1989, CR ACAD SCI II, V309, P843; OLSON SL, 1982, SMITHSON CONTRIB PAL, V48, P22; Schuchmann K. L, 1999, HDB BIRDS WORLD, P468; STEGMANN B., 1963, J ORNITHOL, V104, P413, DOI 10.1007/BF01671057; STILES FG, 1981, ANN MO BOT GARD, V68, P323, DOI 10.2307/2398801; STILES FG, 1978, AM ZOOL, V18, P715; Temeles EJ, 2002, BIOTROPICA, V34, P68, DOI 10.1111/j.1744-7429.2002.tb00243.x; Trunko L., 1998, CAROLINEA, V56, P9; WESTERKAMP C, 1990, BOT ACTA, V103, P366, DOI 10.1111/j.1438-8677.1990.tb00176.x; Zusi R.L., 1984, SMITHSONIAN CONTRIBU, V395, P1; [No title captured]	26	88	95	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					861	864		10.1126/science.1096856	http://dx.doi.org/10.1126/science.1096856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131303				2022-12-01	WOS:000221243000041
J	Tomlinson, JM; Wright, D				Tomlinson, JM; Wright, D			Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; IMPOTENCE; LIFE	Objectives To determine the effects of erectile dysfunction and to explore the impact of treatment with sildenafil (Viagra). Design An exploratory qualitative study with semistructured interviews. Setting Men's health clinic in NHS hospital. Participants 40 men who had had erectile dysfunction and had attended the clinic during the year before interview. Main outcome measures Impact of erectile dysfunction on men, their expectations of sildenafil, and impact of treatment on men and their relationships. Issues explored with exploratory qualitative approach. Results Erectile dysfunction caused serious distress to all those men who experienced it, with marked effects on their self esteem and their relationships. Sildenafil, when it worked, caused a great improvement in wellbeing. The expectations raised by media hyperbole with the launch of sildenafil had an adverse effect on the morale of those who found it did not work. When, according to the patient, treatment did not work, the distress was severe and for many confirmed their lack of self worth. Conclusions Further study is needed to explore the feelings of men affected by erectile dysfunction and their perception of treatment. Health professionals should be aware of the extreme distress erectile dysfunction can cause.	Royal Hampshire Cty Hosp, Winchester SO22 5DG, Hants, England; Univ Southampton, Macmillan Res Unit, Southampton SO17 1BJ, Hants, England	University of Southampton	Tomlinson, JM (corresponding author), Clays Farm, E Worldham GU34 3AD, Alton, England.	john@jptomlinson.com						Althof SE, 2002, UROLOGY, V59, P803, DOI 10.1016/S0090-4295(02)01606-0; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; COOPER AJ, 1986, BRIT J HOSP MED, V36, P186; Dunn KM, 2002, J SEX MARITAL THER, V28, P399, DOI 10.1080/00926230290001529; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; FuglMeyer AR, 1997, INT J IMPOT RES, V9, P141, DOI 10.1038/sj.ijir.3900269; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; HAMMERSLEY M, 1989, ETHNOGRAPHY PRINCIPL, P205; Hoddinott P, 1997, FAM PRACT, V14, P307, DOI 10.1093/fampra/14.4.307; *IMP ASS, 1997, SURV 1997; Kaye JA, 2003, BRIT MED J, V326, P424, DOI 10.1136/bmj.326.7386.424; LEE RM, 1993, DOING RES SENSITIVE, P97; MASTERS WH, 1976, AM J PSYCHIAT, V133, P5; McKinlay JB, 2000, INT J IMPOT RES, V12, pS6, DOI 10.1038/sj.ijir.3900567; Melman A, 1999, J UROLOGY, V161, P5, DOI 10.1016/S0022-5347(01)62045-7; Murphy E, 1998, HEALTH TECHNOL ASSES, V2, P112; RILEY AJ, 1994, J SEX HLTH       SUM, pS3; Strauss AL, 2003, QUALITATIVE ANAL SOC, DOI [10.1017/CBO9780511557842, DOI 10.1017/CBO9780511557842]; 1998, SUNDAY TIMES MA 0906, P44; 1998, GAY TIMES        SEP, P18; 1998, INDEPENDENT SUN 0426, P26; 1998, NEWSWEEK        0622	23	96	99	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1037	1039		10.1136/bmj.38044.662176.EE	http://dx.doi.org/10.1136/bmj.38044.662176.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15051618	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000221174500013
J	Nelson, HD				Nelson, HD			Postmenopausal estrogen for treatment of hot flashes - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HORMONE REPLACEMENT THERAPY; PLUS PROGESTIN; BREAST-CANCER; ESTROGEN/PROGESTIN REPLACEMENT; DOUBLE-BLIND; MEDROXYPROGESTERONE ACETATE; CLIMACTERIC SYMPTOMS; MENOPAUSAL SYMPTOMS; DISEASE OUTCOMES; WOMEN	Use of postmenopausal estrogen has changed since the release of the first results from the Women's Health Initiative in 2002. Professional organizations, the US Food and Drug Administration, and the US Preventive Services Task Force have issued new recommendations against use of estrogen and progestin or progesterone for prevention of chronic conditions. This article applies the current state of evidence for postmenopausal estrogen use to management decisions in 2 clinical scenarios: initiating therapy in a peri-menopausal woman with hot flashes and discontinuing estrogen use in a long-term user.	Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Oregon Evidence Based Practice Ctr, Mail Code BICC 504,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu						Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; BacchiModena A, 1997, MATURITAS, V27, P285, DOI 10.1016/S0378-5122(97)00039-X; Barry MJ, 2002, ANN INTERN MED, V136, P127, DOI 10.7326/0003-4819-136-2-200201150-00010; Bech P, 1998, PSYCHOTHER PSYCHOSOM, V67, P259, DOI 10.1159/000012289; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Blumel J E, 1994, Rev Chil Obstet Ginecol, V59, P354; CAMPBELL S, 1976, MANAGEMENT MENOPAUSE; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Connelly MT, 1999, ANN INTERN MED, V131, P265, DOI 10.7326/0003-4819-131-4-199908170-00005; Coope J, 1981, J R Coll Gen Pract, V31, P134; de Vrijer B, 2000, MATURITAS, V34, P47, DOI 10.1016/S0378-5122(99)00085-7; DITKOFF EC, 1991, OBSTET GYNECOL, V78, P991; Good W R, 1999, Climacteric, V2, P29, DOI 10.3109/13697139909025560; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Grady D, 2002, JAMA-J AM MED ASSOC, V287, P2130, DOI 10.1001/jama.287.16.2130; Greendale GA, 1998, OBSTET GYNECOL, V92, P982, DOI 10.1016/S0029-7844(98)00305-6; GRODSTEIN F, 1994, OBSTET GYNECOL, V83, P5; Harris PF, 2002, J PAIN SYMPTOM MANAG, V23, P501, DOI 10.1016/S0885-3924(02)00395-0; HATCHER RA, 1998, CONTRACEPTIVE TECHNO; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hlatky MA, 2002, JAMA-J AM MED ASSOC, V287, P591, DOI 10.1001/jama.287.5.591; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; JENSEN PB, 1987, MATURITAS, V9, P207, DOI 10.1016/0378-5122(87)90003-X; Kam IW, 2002, MENOPAUSE, V9, P72, DOI 10.1097/00042192-200201000-00011; Khoo S K, 1998, Climacteric, V1, P55, DOI 10.3109/13697139809080682; Kronenberg F, 2002, ANN INTERN MED, V137, P805, DOI 10.7326/0003-4819-137-10-200211190-00009; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P52; Lindsay R, 2002, JAMA-J AM MED ASSOC, V287, P2668, DOI 10.1001/jama.287.20.2668; LIVINGSTON WW, 1994, J GEN INTERN MED, V9, P385, DOI 10.1007/BF02629518; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; MacLennan A, 2001, Climacteric, V4, P58, DOI 10.1080/713605036; Maclennan A H, 2004, Cochrane Database Syst Rev, pCD002978, DOI 10.1002/14651858.CD002978.pub2; Mansfield P K, 1997, Health Care Women Int, V18, P55; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; MARSLEW U, 1992, OBSTET GYNECOL, V79, P202; Miller J, 2002, ANN INTERN MED, V136, P680, DOI 10.7326/0003-4819-136-9-200205070-00011; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Pandya KJ, 2000, ANN INTERN MED, V132, P788, DOI 10.7326/0003-4819-132-10-200005160-00004; Polo-Kantola P, 1998, AM J OBSTET GYNECOL, V178, P1002, DOI 10.1016/S0002-9378(98)70539-3; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; ROTHERT M, 1994, EXP GERONTOL, V29, P463, DOI 10.1016/0531-5565(94)90026-4; Rymer J, 2003, BRIT MED J, V326, P322, DOI 10.1136/bmj.326.7384.322; Saure A, 2000, MATURITAS, V34, P133, DOI 10.1016/S0378-5122(99)00103-6; Simon JA, 2001, ANN INTERN MED, V135, P493, DOI 10.7326/0003-4819-135-7-200110020-00008; Soares CD, 2001, ARCH GEN PSYCHIAT, V58, P529; Speroff L, 2001, CLIN GUIDE CONTRACEP; Stearns V, 2000, ANN ONCOL, V11, P17, DOI 10.1023/A:1008382706068; Stephenson J, 2003, JAMA-J AM MED ASSOC, V289, P537, DOI 10.1001/jama.289.5.537; Tice JA, 2003, JAMA-J AM MED ASSOC, V290, P207, DOI 10.1001/jama.290.2.207; UTIAN WH, 1994, MENOPAUSE, V1, P39; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001-5002; Whitney SN, 2004, ANN INTERN MED, V140, P54, DOI 10.7326/0003-4819-140-1-200401060-00012; *WYETH PHARM, 2004, WEB SIT; 2000, CONSUM REP, V65, P17; 2004, WOMENS HLTH INITATIV	63	25	27	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1621	1625		10.1001/jama.291.13.1621	http://dx.doi.org/10.1001/jama.291.13.1621			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809PQ	15069050				2022-12-01	WOS:000220649000027
J	Sharp, D				Sharp, D			Elementary, my dear Mendeleev	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							LEHRER T, ELEMENTS; Oganessian YT, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.021601; SCHEWE PP, 2004, PHYS NEWS UPDAT 0202	3	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 3	2004	363	9415					1092	1092		10.1016/S0140-6736(04)15933-3	http://dx.doi.org/10.1016/S0140-6736(04)15933-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808VB	15064025				2022-12-01	WOS:000220595500006
J	Lee, YS; Nakahara, K; Pham, JW; Kim, K; He, ZY; Sontheimer, EJ; Carthew, RW				Lee, YS; Nakahara, K; Pham, JW; Kim, K; He, ZY; Sontheimer, EJ; Carthew, RW			Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways	CELL			English	Article							NEGATIVE POSTTRANSCRIPTIONAL REGULATION; UTR SEQUENCE MOTIF; RNA-INTERFERENCE; C-ELEGANS; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; DSRNA-BINDING; MICRORNA; INITIATION; MATURATION	The RNase III enzyme Dicer processes RNA into siRNAs and miRNAs, which direct a RNA-induced silencing complex (RISC) to cleave mRNA or block its translation (RNAi). We have characterized mutations in the Drosophila dicer-1 and dicer-2 genes. Mutation in dicer-1 blocks processing of miRNA precursors, whereas dicer-2 mutants are defective for processing siRNA precursors. It has been recently found that Drosophila Dicer-1 and Dicer-2 are also components of siRNA-dependent RISC (siRISC). We find that Dicer-1 and Dicer-2 are required for siRNA-directed mRNA cleavage, though the RNase III activity of Dicer-2 is not required. Dicer-1 and Dicer-2 facilitate distinct steps in the assembly of siRISC. However, Dicer-1 but not Dicer-2 is essential for miRISC-directed translation repression. Thus, siRISCs and miRISCs are different with respect to Dicers in Drosophila.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	r-carthew@northwestern.edu	Nakahara, Kenji/F-5780-2012; He, Zhengying/A-5635-2014	Nakahara, Kenji/0000-0002-9541-3208; Sontheimer, Erik/0000-0002-0881-0310	NIGMS NIH HHS [R01 GM068743, R01 GM077581] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581, R01GM068743] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chou TB, 1996, GENETICS, V144, P1673; Dasgupta S, 1998, MOL MICROBIOL, V28, P629, DOI 10.1046/j.1365-2958.1998.00828.x; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lai EC, 1997, DEVELOPMENT, V124, P4847; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nicholson Allen W., 2003, P149; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Stowers RS, 1999, GENETICS, V152, P1631; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	45	943	1026	3	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					69	81		10.1016/S0092-8674(04)00261-2	http://dx.doi.org/10.1016/S0092-8674(04)00261-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066283	Bronze			2022-12-01	WOS:000221500300009
J	Chung, WH; Hung, SI; Hong, HS; Hsih, MS; Yang, LC; Ho, HC; Wu, JY; Chen, YT				Chung, WH; Hung, SI; Hong, HS; Hsih, MS; Yang, LC; Ho, HC; Wu, JY; Chen, YT			A marker for Stevens-Johnson syndrome	NATURE			English	Editorial Material							TOXIC EPIDERMAL NECROLYSIS; RISK		Chang Gung Mem Hosp, Dept Dermatol, Taipei 10591, Taiwan; Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Duke University	Chung, WH (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	chen0010@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Hung, Shuen-Iu/ABB-2139-2021	Hung, Shuen-Iu/0000-0001-6531-5538				Erlich HA, 2001, IMMUNITY, V14, P347, DOI 10.1016/S1074-7613(01)00115-7; GEER L, 1998, HLA 1998, P327; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Kamaliah MD, 1998, INT J DERMATOL, V37, P520, DOI 10.1046/j.1365-4362.1998.00490.x; KHON AKM, 1996, BURNS, V22, P275; ROUJEAU JC, 1986, TISSUE ANTIGENS, V28, P251; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; ROUJEAU JC, 1994, J INVEST DERMATOL, V102, P28; Rzany B, 1999, LANCET, V353, P2190, DOI 10.1016/S0140-6736(98)05418-X; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Svensson CK, 2001, PHARMACOL REV, V53, P357	11	1168	1272	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					486	486		10.1038/428486a	http://dx.doi.org/10.1038/428486a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15057820	Bronze			2022-12-01	WOS:000220540100029
J	Coutinho, A				Coutinho, A			Pills and promises - a personal account from Uganda	LANCET			English	Editorial Material											Coutinho, A (corresponding author), POB 10443, Kampala, Uganda.	coutinhoa@tasouganda.org							0	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 27	2004	363	9414					1073	1073		10.1016/S0140-6736(04)15848-0	http://dx.doi.org/10.1016/S0140-6736(04)15848-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15065566				2022-12-01	WOS:000220497300027
J	King, CY; Diaz-Avalos, R				King, CY; Diaz-Avalos, R			Protein-only transmission of three yeast prion strains	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROPAGATION; HYPOTHESIS; PSI(+); IDENTIFICATION; REPLICATION; INHERITANCE; DETERMINANT; INDUCTION; REGION	Key questions regarding the molecular nature of prions are how different prion strains can be propagated by the same protein and whether they are only protein(1-3). Here we demonstrate the protein-only nature of prion strains in a yeast model, the [ PSI] genetic element that enhances the read-through of nonsense mutations in the yeast Saccharomyces cerevisiae(4,5). Infectious fibrous aggregates containing a Sup35 prion-determining amino-terminal fragment labelled with green fluorescent protein were purified from yeast harbouring distinctive prion strains. Using the infectious aggregates as 'seeds', elongated fibres were generated in vitro from the bacterially expressed labelled prion protein. De novo generation of strain-specific [ PSI] infectivity was demonstrated by introducing sheared fibres into uninfected yeast hosts. The cross-sectional morphology of the elongated fibres generated in vitro was indistinguishable from that of the short yeast seeds, as visualized by electron microscopy. Electron diffraction of the long fibres showed the 4.7 Angstrom spacing characteristic of the cross-beta structure of amyloids. The fact that the amyloid fibres nucleated in vitro propagate the strain-specific infectivity of the yeast seeds implies that the heritable inforletters mation of distinct prion strains must be encoded by different, self-propagating cross-beta folding patterns of the same prion protein.	Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	King, CY (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	chihyen@sb.fsu.edu	King, Chih-Yen/ABG-2110-2021					Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Derkatch IL, 1996, GENETICS, V144, P1375; DICKINSON AG, 1975, NATURE, V253, P556, DOI 10.1038/253556a0; DICKINSON AG, 1988, CIBA F SYMP, V135, P63; HARASHIMA S, 1984, MOL CELL BIOL, V4, P771, DOI 10.1128/MCB.4.4.771; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Liebman SW, 2002, P NATL ACAD SCI USA, V99, P9098, DOI 10.1073/pnas.152318899; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROSE MD, 1986, MOL CELL BIOL, V6, P3490, DOI 10.1128/MCB.6.10.3490; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884	27	394	400	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					319	323		10.1038/nature02391	http://dx.doi.org/10.1038/nature02391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029195				2022-12-01	WOS:000220250200044
J	Liu, ZF; Yan, HC; Wang, KB; Kuang, TY; Zhang, JP; Gui, LL; An, XM; Chang, WR				Liu, ZF; Yan, HC; Wang, KB; Kuang, TY; Zhang, JP; Gui, LL; An, XM; Chang, WR			Crystal structure of spinach major light-harvesting complex at 2.72 angstrom resolution	NATURE			English	Article							CAROTENOID-BINDING-SITES; 3-DIMENSIONAL STRUCTURE; XANTHOPHYLL CYCLE; ENERGY-TRANSFER; PROTEIN; LHCII; PHOTOPROTECTION; FLUORESCENCE; PROGRAM; PLANTS	The major light-harvesting complex of photosystem II (LHC-II) serves as the principal solar energy collector in the photosynthesis of green plants and presumably also functions in photoprotection under high-light conditions. Here we report the first X-ray structure of LHC-II in icosahedral proteoliposome assembly at atomic detail. One asymmetric unit of a large R32 unit cell contains ten LHC-II monomers. The 14 chlorophylls (Chl) in each monomer can be unambiguously distinguished as eight Chla and six Chlb molecules. Assignment of the orientation of the transition dipole moment of each chlorophyll has been achieved. All Chlb are located around the interface between adjacent monomers, and together with Chla they are the basis for efficient light harvesting. Four carotenoid-binding sites per monomer have been observed. The xanthophyll-cycle carotenoid at the monomer - monomer interface may be involved in the non-radiative dissipation of excessive energy, one of the photoprotective strategies that have evolved in plants.	Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Bot, Lab Photosynth & Environm Mol Physiol, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Chang, WR (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd,Chaoyang Dist, Beijing 100101, Peoples R China.	wrchang@sun5.ibp.ac.cn	Yan, Hanchi/E-3639-2010	Yan, Hanchi/0000-0003-1055-5459; liu, zhen feng/0000-0001-5502-9474				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Bassi R, 1997, PHYSIOL PLANTARUM, V100, P769, DOI 10.1034/j.1399-3054.1997.1000404.x; BEDDARD GS, 1976, CHEM PHYS LETT, V43, P27, DOI 10.1016/0009-2614(76)80749-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2001, BIOPHYS J, V80, P901, DOI 10.1016/S0006-3495(01)76069-9; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; FRANK HA, 1994, PHOTOSYNTH RES, V41, P389, DOI 10.1007/BF02183041; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gilmore AM, 1997, PHYSIOL PLANTARUM, V99, P197, DOI 10.1034/j.1399-3054.1997.990127.x; Gradinaru CC, 1998, BIOPHYS J, V75, P3064, DOI 10.1016/S0006-3495(98)77747-1; Gradinaru CC, 2000, J PHYS CHEM B, V104, P9330, DOI 10.1021/jp001752i; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TA, 1992, MOL REPLACEMENT, P92; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lou Shi-Qing, 1995, Acta Botanica Sinica, V37, P192; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; MASON JG, 1989, NUCLEIC ACIDS RES, V17, P5387, DOI 10.1093/nar/17.13.5387; McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MICHEL H, 1983, TRENDS BIOCHEM SCI, V8, P56, DOI 10.1016/0968-0004(83)90390-0; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Nilsson A, 1997, J BIOL CHEM, V272, P18350, DOI 10.1074/jbc.272.29.18350; NUSSBERGER S, 1993, J MOL BIOL, V234, P347, DOI 10.1006/jmbi.1993.1591; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rossmann MG, 2001, NATO SCI SER I LIFE, V325, P95; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; TONG L, 1990, ACTA CRYSTALLOGR A, V46, P783, DOI 10.1107/S0108767390005530; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	42	1326	1397	25	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					287	292		10.1038/nature02373	http://dx.doi.org/10.1038/nature02373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029188				2022-12-01	WOS:000220250200035
J	Derluyn, I; Broekaert, E; Schuyten, G; De Temmerman, E				Derluyn, I; Broekaert, E; Schuyten, G; De Temmerman, E			Post-traumatic stress in former Ugandan child soldiers	LANCET			English	Article								Worldwide, 300 000 children are currently used as child soldiers in armed conflicts. We interviewed 301 former child soldiers who had been abducted by the northern Ugandan rebellion movement Lord's Resistance Army. All the children were abducted at a young age (mean 12.9 years) and for a long time (mean 744 days). Almost all the children experienced several traumatic events (mean six events); 233 (77%) saw someone being killed, and 118 (39%) had to kill someone themselves. 71 children also filled in the impact of event scale-revised to assess their post-trauma stress reactions. 69 (97%) reported post-traumatic stress reactions of clinical importance. The death of a parent, especially of the mother, led to an important increase in score for avoidance symptoms (mother alive 1.6.4, mother not alive 21.6; p=0.04), with a high increase for girls (from 15.1 to 25.8), but almost no change for boys (from 17.7 to 17.4; p=0.02). Our findings shed light on the nature of severe trauma experienced by this group of children, and show a high rate of post-traumatic stress reactions.	State Univ Ghent, Dept Orthopedag, B-9000 Ghent, Belgium; State Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium; Sponsoring Children Uganda, Nevele, Belgium	Ghent University; Ghent University	Derluyn, I (corresponding author), State Univ Ghent, Dept Orthopedag, Henri Dunantlaan 2, B-9000 Ghent, Belgium.	Ilse.Derluyn@UGent.be	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X; Derluyn, Ilse/0000-0001-5450-1239				Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; BRACKEN PJ, 1995, SOC SCI MED, V40, P1073, DOI 10.1016/0277-9536(94)00181-R; Dyregrov A, 2002, J TRAUMA STRESS, V15, P59, DOI 10.1023/A:1014335312219; Machel G., 2001, IMPACT WAR CHILDREN; Weiss D. S., 1997, ASSESSING	5	196	197	0	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	2004	363	9412					861	863		10.1016/S0140-6736(04)15734-6	http://dx.doi.org/10.1016/S0140-6736(04)15734-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803LB	15031032				2022-12-01	WOS:000220231500013
J	[Anonymous]				[Anonymous]			Running interference on the genome	NATURE			English	Article																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					225	225		10.1038/428225b	http://dx.doi.org/10.1038/428225b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014515	Bronze			2022-12-01	WOS:000220103600064
J	Gandon, Y; Olivie, D; Guyader, D; Aube, C; Oberti, F; Sebille, V; Deugnier, Y				Gandon, Y; Olivie, D; Guyader, D; Aube, C; Oberti, F; Sebille, V; Deugnier, Y			Non-invasive assessment of hepatic iron stores by MRI	LANCET			English	Article							NEEDLE-BIOPSY SPECIMENS; LIVER-IRON; GENETIC HEMOCHROMATOSIS; OVERLOAD; QUANTIFICATION; DIAGNOSIS; FIBROSIS; DISEASE	Background MRI has been proposed for non-invasive detection and quantification of liver iron content, but has not been validated as a reproducible and sensitive method, especially in patients with mild iron overload. We aimed to assess the accuracy of a simple, rapid, and easy to implement MRI procedure to detect and quantify hepatic iron stores. Methods Of 191 patients recruited, 17 were excluded and 174 studied, 139 in a study group and 35 in a validation group. All patients underwent both percutaneous liver biopsy with biochemical assessment of hepatic iron concentration (B-HIC) and MRI of the liver with various gradient-recalled-echo (GRE) sequences obtained with a 1.5 T magnet. Correlation between liver to muscle (L/M) signal intensity ratio and liver iron concentration was calculated. An algorithm to calculate magnetic resonance hepatic iron concentration (MR-HIC) was developed with data from the study group and then applied to the validation group. Findings A highly T2-weighted GRE sequence was most sensitive, with 89% sensitivity and 80% specificity in the validation group, with an L/M ratio below 0.88. This threshold allowed us to detect all clinically relevant liver iron overload greater than 60 mumol/g (normal value <36 &mu;mol/g). With other sequences, an L/M ratio less than I was highly specific (>87%) for raised hepatic iron concentration. With respect to B-HIC range analysed (3-375 mumol/g), mean difference and 95% CI between B-HIC and MR-HIC were quite similar for study and validation groups (0.8 mumol/g [-6.3 to 7.9] and -2.1 mumol/g [-12.9 to 8.9], respectively). Interpretation MRI is a rapid, non-invasive, and cost effective technique that could limit use of liver biopsy to assess liver iron content. Our MR-HIC algorithm is designed to be used on various magnetic resonance machines.	CHU Pontchaillou, Federat Imagerie Med, Rennes, France; CHU Pontchaillou, Serv Malad Foie, Rennes, France; CHU Pontchaillou, Ctr Invest Clin, Rennes, France; CHU Angers, Dept Radiol, Angers, France; CHU Angers, Serv Gastroenterol, Angers, France	CHU Rennes; CHU Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Gandon, Y (corresponding author), Hop Pontchaillou, Federat Imagerie Med, F-35033 Rennes, France.	yves.gandon@chu-rennes.fr	Sebille, Veronique/I-3309-2015	Guyader, Dominique/0000-0001-8912-6950; Sebille, Veronique/0000-0002-0780-7742				ALUSTIZA J, 2000, P RAD SOC N AM NOV 2, P217; BARRY M, 1971, LANCET, V1, P100; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonkovsky HL, 1999, RADIOLOGY, V212, P227, DOI 10.1148/radiology.212.1.r99jl35227; Bonkovsky HL, 1997, HEPATOLOGY, V25, P759, DOI 10.1002/hep.510250345; BRISSOT P, 1999, OXFORD TXB CLIN HEPA, P1379; BRITTENHAM GM, 1982, NEW ENGL J MED, V307, P1671, DOI 10.1056/NEJM198212303072703; de Valk B, 1999, ARCH INTERN MED, V159, P1542, DOI 10.1001/archinte.159.14.1542; Deugnier Y, 2000, B ACAD NAT MED PARIS, V184, P365; Deugnier Yves, 1998, Journal of Hepatology, V28, P21, DOI 10.1016/S0168-8278(98)80371-1; Ernst O, 1997, AM J ROENTGENOL, V168, P1205, DOI 10.2214/ajr.168.5.9129412; Fenzi A, 2003, J MAGN RESON IMAGING, V17, P589, DOI 10.1002/jmri.10306; GANDON Y, 1994, RADIOLOGY, V193, P533, DOI 10.1148/radiology.193.2.7972774; GANDON Y, 1998, P RAD SOC N AM NOV 2, P209; GOMORI JM, 1991, RADIOLOGY, V179, P367, DOI 10.1148/radiology.179.2.2014276; GUYADER D, 1989, GASTROENTEROLOGY, V97, P737, DOI 10.1016/0016-5085(89)90646-X; GUYADER D, 1992, J HEPATOL, V15, P304, DOI 10.1016/0168-8278(92)90060-3; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; HERNANDEZ RJ, 1988, J COMPUT ASSIST TOMO, V12, P91, DOI 10.1097/00004728-198801000-00017; Jensen JH, 2002, MAGNET RESON MED, V47, P1131, DOI 10.1002/mrm.10170; KALTWASSER JP, 1990, BRIT J HAEMATOL, V74, P360, DOI 10.1111/j.1365-2141.1990.tb02596.x; Kreeftenberg HG, 2000, NETH J MED, V56, P133, DOI 10.1016/S0300-2977(00)00003-6; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Outwater EK, 1998, RADIOGRAPHICS, V18, P1465, DOI 10.1148/radiographics.18.6.9821195; Pawlotsky Y, 1999, ARTHRITIS RHEUM, V42, P799; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; ROCCHI E, 1993, HEPATOLOGY, V17, P997, DOI 10.1016/0270-9139(93)90113-2; Siegelman E S, 1997, Magn Reson Imaging Clin N Am, V5, P347; STARK DD, 1991, RADIOLOGY, V179, P333, DOI 10.1148/radiology.179.2.2014271; Villeneuve JP, 1996, J HEPATOL, V25, P172, DOI 10.1016/S0168-8278(96)80070-5	30	474	493	1	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 31	2004	363	9406					357	362		10.1016/S0140-6736(04)15436-6	http://dx.doi.org/10.1016/S0140-6736(04)15436-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070565				2022-12-01	WOS:000188590900010
J	Erwin, DH; Krakauer, DC				Erwin, DH; Krakauer, DC			Insights into innovation	SCIENCE			English	Editorial Material									Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute	Erwin, DH (corresponding author), Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA.	erwin@santafe.edu; krakauer@santafe.edu	Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614				Gould SJ, 2002, STRUCTURE EVOLUTIONA; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Odling-Smee John, 2003, NICHE CONSTRUCTION; Pellmyr O, 2002, P NATL ACAD SCI USA, V99, P5498, DOI 10.1073/pnas.072588699; *SANT FE I, 2004, INN NAT EXP APPL EV; Schumpeter Joseph A., 1926, THEORY EC DEV	6	54	54	4	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2004	304	5674					1117	1119		10.1126/science.1099385	http://dx.doi.org/10.1126/science.1099385			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155937				2022-12-01	WOS:000221524500027
J	Amsen, D; Blander, JM; Lee, GR; Tanigaki, K; Honjo, T; Flavell, RA				Amsen, D; Blander, JM; Lee, GR; Tanigaki, K; Honjo, T; Flavell, RA			Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells	CELL			English	Article							NF-KAPPA-B; DENDRITIC CELLS; IN-VIVO; GENE-EXPRESSION; FUNCTIONAL DIVERSITY; PHYSICAL INTERACTION; NEURAL DEVELOPMENT; CUTTING EDGE; TH2 CELLS; ACTIVATION	Antigen-presenting cells (APC) tailor immune responses to microbial encounters by stimulating differentiation of CD4 T cells into the Th1 and Th2 lineages. We demonstrate that APC use the Notch pathway to instruct T cell differentiation. Strikingly, of the two Notch ligand families, Delta induces Th1, while Jagged induces the alternate Th2 fate. Expression of these different Notch ligands on APC is induced by Th1- or Th2-promoting stimuli. Th2 differentiation has been considered a default process as APC-derived instructive signals are unknown. We demonstrate that Jagged constitutes an instructive signal for Th2 differentiation, which is independent of IL4/STAT6. Th2 differentiation induced by APC is abrogated in T cells lacking the Notch effector RBPJkappa. Notch directs Th2 differentiation by inducing GATA3 and by directly regulating il4 gene transcription through RBPJkappa sites in a 3' enhancer.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan	Yale University; Kyoto University	Amsen, D (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Honjo, Tasuku/N-4470-2016	Blander, Julie Magarian/0000-0001-9207-1700				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Beatus P, 2001, MECH DEVELOP, V104, P3, DOI 10.1016/S0925-4773(01)00373-2; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; Huppert SS, 1997, DEVELOPMENT, V124, P3283; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Lane P, 2000, J EXP MED, V191, P201, DOI 10.1084/jem.191.2.201; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; Murphy KM, 1998, CURR OPIN IMMUNOL, V10, P226, DOI 10.1016/S0952-7915(98)80253-7; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakamura T, 1997, J IMMUNOL, V158, P1085; Newberry RD, 2001, J IMMUNOL, V166, P4465, DOI 10.4049/jimmunol.166.7.4465; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OKA C, 1995, DEVELOPMENT, V121, P3291; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Palmieri M, 1999, NUCLEIC ACIDS RES, V27, P2785, DOI 10.1093/nar/27.13.2785; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872-10880.2003; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	79	702	741	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2004	117	4					515	526		10.1016/S0092-8674(04)00451-9	http://dx.doi.org/10.1016/S0092-8674(04)00451-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137944	Bronze			2022-12-01	WOS:000221458000011
J	D'Amours, D; Stegmeier, F; Amon, A				D'Amours, D; Stegmeier, F; Amon, A			Cdc14 and condensin control the dissolution of cohesin-independent chromosome linkages at repeated DNA	CELL			English	Article							SISTER-CHROMATID SEPARATION; MITOTIC CHROMOSOME; BUDDING YEAST; POLO KINASE; S-PHASE; ANAPHASE; CHECKPOINT; PROTEIN; MITOSIS; SMT4	Chromosome segregation is triggered by the cleavage of cohesins by separase. Here we show that in budding yeast separation of the ribosomal DNA (rDNA) and telomeres also requires Cdc14, a protein phosphatase known for its role in mitotic exit. Cdc14 shares this role with the FEAR network, which activates Cdc14 during early anaphase, but not the mitotic exit network, which promotes Cdc14 activity during late anaphase. We further show that CDC14 is necessary and sufficient to promote condensin enrichment at the rDNA locus and to trigger rDNA segregation in a condensin-dependent manner. We propose that Cdc14 released by the FEAR network mediates the partitioning of rDNA by facilitating the localization of condensin thereto. This dual role of the FEAR network in initiating mitotic exit and promoting chromosome segregation ensures that exit from mitosis is coupled to the completion of chromosome segregation.	MIT, Howard Hughes Med Inst, Canc Res Ctr, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Canc Res Ctr, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56800] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Amon A, 2002, METHOD ENZYMOL, V351, P457; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; GONZALEZ C, 1991, EXP CELL RES, V192, P10, DOI 10.1016/0014-4827(91)90150-S; GRANOT D, 1991, CELL MOTIL CYTOSKEL, V20, P47, DOI 10.1002/cm.970200106; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guillermond A., 1917, ANN I PASTEUR, V3, P107; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; HARTWELL LH, 1985, GENETICS, V110, P381; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; KOSHLAND D, 1987, SCIENCE, V238, P1713, DOI 10.1126/science.3317838; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293, DOI 10.1091/mbc.11.4.1293; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Strunnikov AV, 2001, GENETICS, V158, P95; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; van Heemst D, 1999, CELL, V98, P261, DOI 10.1016/S0092-8674(00)81020-X; VIG BK, 1987, MUTAGENESIS, V2, P155, DOI 10.1093/mutage/2.3.155; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Wai HH, 2000, NUCLEIC ACIDS RES, V28, P3524, DOI 10.1093/nar/28.18.3524; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99	44	236	238	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2004	117	4					455	469		10.1016/S0092-8674(04)00413-1	http://dx.doi.org/10.1016/S0092-8674(04)00413-1			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137939	Bronze			2022-12-01	WOS:000221458000006
J	Sullivan, M; Higuchi, T; Katis, VL; Uhlmann, F				Sullivan, M; Higuchi, T; Katis, VL; Uhlmann, F			Cdc14 phosphatase induces rDNA condensation and resolves cohesin-independent cohesion during budding yeast anaphase	CELL			English	Article							DNA TOPOISOMERASE-II; SISTER-CHROMATID SEPARATION; CHROMOSOME CONDENSATION; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; MITOTIC EXIT; MAMMALIAN-CELLS; FISSION YEAST; EGG EXTRACTS; MITOSIS	At anaphase onset, the protease separase triggers chromosome segregation by cleaving the chromosomal cohesin complex. Here, we show that cohesin destruction in metaphase is sufficient for segregation of much of the budding yeast genome, but not of the long arm of chromosome XII that contains the rDNA repeats. rDNA in metaphase, unlike most other sequences, remains in an undercondensed and topologically entangled state. Separase, concomitantly with cleaving cohesin, activates the phosphatase Cdc14. We find that Cdc14 exerts two effects on rDNA, both mediated by the condensin complex. Lengthwise condensation of rDNA shortens the chromosome XII arm sufficiently for segregation. This condensation depends on the aurora B kinase complex. Independently of condensation, Cdc14 induces condensin-dependent resolution of cohesin-independent rDNA linkage. Cdc14-dependent sister chromatid resolution at the rDNA could introduce a temporal order to chromosome segregation.	Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; Res Inst Mol Pathol, A-1030 Vienna, Austria	Cancer Research UK; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk		Uhlmann, Frank/0000-0002-3527-6619				Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Coelho PA, 2003, J CELL SCI, V116, P4763, DOI 10.1242/jcs.00799; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; DOWNES CS, 1991, P NATL ACAD SCI USA, V88, P8895, DOI 10.1073/pnas.88.20.8895; ELLIOTT SG, 1979, MOL GEN GENET, V169, P237, DOI 10.1007/BF00382269; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GRANOT D, 1991, CELL MOTIL CYTOSKEL, V20, P47, DOI 10.1002/cm.970200106; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; JANNATIPOUR M, 1993, J BIOL CHEM, V268, P18586; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KOSHLAND D, 1987, SCIENCE, V238, P1713, DOI 10.1126/science.3317838; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293, DOI 10.1091/mbc.11.4.1293; Losada A, 2001, BIOESSAYS, V23, P924, DOI 10.1002/bies.1133; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MURRAY AW, 1985, ANNU REV CELL BIOL, V1, P289, DOI 10.1146/annurev.cb.01.110185.001445; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Sumner AT., 2003, CHROMOSOMES ORG FUNC; TAKAO O, 2003, CELL, V115, P109; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; VIG BK, 1981, HUM GENET, V57, P247; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wignall SM, 2003, J CELL BIOL, V161, P1041, DOI 10.1083/jcb.200303185; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	53	208	209	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2004	117	4					471	482		10.1016/S0092-8674(04)00415-5	http://dx.doi.org/10.1016/S0092-8674(04)00415-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137940	Bronze			2022-12-01	WOS:000221458000007
J	Cogle, CR; Yachnis, AT; Laywell, ED; Zander, DS; Wingard, JR; Steindler, DA; Scott, EW				Cogle, CR; Yachnis, AT; Laywell, ED; Zander, DS; Wingard, JR; Steindler, DA; Scott, EW			Bone marrow transdifferentiation in brain after transplantation: a retrospective study	LANCET			English	Article							HEMATOPOIETIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; PURKINJE NEURONS; DENTATE GYRUS; ADULT MICE; NEUROGENESIS; DIFFERENTIATE; ENGRAFTMENT; HIPPOCAMPUS	Background End-organ repair by adult haemopoietic stem cells is under great scrutiny with investigators challenging the notion of these cells' plasticity. Some investigations of animals and short-term human bone marrow transplants suggest that bone marrow can repair brain. We looked for evidence of clinically relevant marrow-derived restorative neurogenesis: long-term, multilineage, neural engraftment that is not the result of cell-fusion events. Methods We examined autopsy brain specimens from three sex-mismatched female bone-marrow-transplantation patients, a female control, and a male control. We did immunohistochemistry, fluorescence in-situ hybridisation, and tissue analysis to look for multilineage, donor-derived neurogenesis. Findings Hippocampal cells containing a Y chromosome were present up to 6 years post-transplant in all three patients. Transgender neurons accounted for 1% of all neurons; there was no evidence of fusion events since only one X chromosome was present. Moreover, transgender astrocytes and microglia made up 1-2% of all glial cells. Interpretation Postnatal human neuropoiesis happens, and human haemopoietic cells can transdifferentiate into neurons, astrocytes, and microglia in a long-term setting without fusing. Transplantable human haemopoietic cells could serve as a therapeutic source for long-term regenerative neuropoiesis.	Univ Florida, Shands Canc Ctr, Program Stem Cell Biol & Regenerat Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Scott, EW (corresponding author), Univ Florida, Shands Canc Ctr, Program Stem Cell Biol & Regenerat Med, 1600 SW Archer Rd,ARB R4-244,POB 100232, Gainesville, FL 32610 USA.	escott@ufl.edu	Steindler, Dennis/AAJ-5811-2020; Zander, Dani/W-1692-2019; Cogle, Christopher/H-1746-2016	Zander, Dani/0000-0002-9243-8354; Cogle, Christopher/0000-0001-5422-6863; Yachnis, Anthony/0000-0002-6971-0698; Wingard, John/0000-0001-7478-5398	NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070143, R01HL070738, R21HL070813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037556] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA09126-25] Funding Source: Medline; NHLBI NIH HHS [HL70813, HL70738, HL70143] Funding Source: Medline; NINDS NIH HHS [NS37556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Krivit W, 1999, Curr Opin Neurol, V12, P167, DOI 10.1097/00019052-199904000-00007; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Liu JL, 1998, J NEUROSCI, V18, P7768; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Parent JM, 1997, J NEUROSCI, V17, P3727; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rajagopal J, 2003, SCIENCE, V299, P363; Reed Ann M, 2003, Curr Rheumatol Rep, V5, P458, DOI 10.1007/s11926-003-0057-x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Steindler DA, 2002, LANCET, V359, P1047, DOI 10.1016/S0140-6736(02)08096-0; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053	39	243	270	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1432	1437		10.1016/S0140-6736(04)16102-3	http://dx.doi.org/10.1016/S0140-6736(04)16102-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121406				2022-12-01	WOS:000221130300010
J	Di Carlo, P; Brune, WH; Martinez, M; Harder, H; Lesher, R; Ren, XR; Thornberry, T; Carroll, MA; Young, V; Shepson, PB; Riemer, D; Apel, E; Campbell, C				Di Carlo, P; Brune, WH; Martinez, M; Harder, H; Lesher, R; Ren, XR; Thornberry, T; Carroll, MA; Young, V; Shepson, PB; Riemer, D; Apel, E; Campbell, C			Missing OH reactivity in a forest: Evidence for unknown reactive biogenic VOCs	SCIENCE			English	Article							ATMOSPHERIC PARTICLES; HYDROXYL RADICALS; AEROSOL FORMATION; DECIDUOUS FOREST; TROPOSPHERIC OH; CHEMISTRY; HYDROCARBONS; OZONE; OZONOLYSIS; EMISSIONS	Forest emissions of biogenic volatile organic compounds (BVOCs), such as isoprene and other terpenes, play a role in the production of tropospheric ozone and aerosols. In a northern Michigan forest, the direct measurement of total OH reactivity, which is the inverse of the OH lifetime, was significantly greater than expected. The difference between measured and expected OH reactivity, called the missing OH reactivity, increased with temperature, as did emission rates for terpenes and other BVOCs. These measurements are consistent with the hypothesis that unknown reactive BVOCs, perhaps terpenes, provide the missing OH reactivity.	Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; Univ Aquila, Dipartimento Fis, CETEMPS, I-67010 Coppito, Laquila, Italy; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Ohio Univ, Dept Chem Engn, Athens, OH 45701 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47301 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Coral Gables, FL 33124 USA; Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of L'Aquila; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Miami; National Center Atmospheric Research (NCAR) - USA	Di Carlo, P (corresponding author), Penn State Univ, Dept Meteorol, 503 Walker Bldg, University Pk, PA 16802 USA.	piero.dicarlo@aquila.infn.it	Thornberry, Troy D/H-7106-2013; Ren, Xinrong/E-7838-2015; Di Carlo, Piero/Q-4450-2016; Harder, Hartwig/AAE-8557-2019; Di Carlo, Piero/C-1657-2016; Ren, Xinrong/B-2229-2010; Shepson, Paul B/E-9955-2012; Harder, Hartwig D/L-2511-2014; Brune, William/U-7661-2017	Ren, Xinrong/0000-0001-9974-1666; Di Carlo, Piero/0000-0003-4971-4509; Harder, Hartwig/0000-0002-6868-714X; Di Carlo, Piero/0000-0003-4971-4509; Harder, Hartwig D/0000-0002-6868-714X; Brune, William/0000-0002-1609-4051				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Aschmann SM, 2002, ATMOS ENVIRON, V36, P4347, DOI 10.1016/S1352-2310(02)00355-2; Atkinson R, 1997, J PHYS CHEM REF DATA, V26, P215, DOI 10.1063/1.556012; Atkinson R, 2003, ATMOS ENVIRON, V37, pS197, DOI 10.1016/S1352-2310(03)00391-1; Carroll MA, 2001, J GEOPHYS RES-ATMOS, V106, P24275, DOI 10.1029/2001JD900189; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Donahue NM, 1998, GEOPHYS RES LETT, V25, P59, DOI 10.1029/97GL53560; Donahue NM, 1996, J PHYS CHEM-US, V100, P5821, DOI 10.1021/jp9525503; Faloona I, 2001, J GEOPHYS RES-ATMOS, V106, P24315, DOI 10.1029/2000JD900691; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Griffin RJ, 1999, J GEOPHYS RES-ATMOS, V104, P3555, DOI 10.1029/1998JD100049; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; KAUFMAN F, 1984, J PHYS CHEM-US, V88, P4909, DOI 10.1021/j150665a024; Kavouras IG, 1998, NATURE, V395, P683, DOI 10.1038/27179; Kleinman LI, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014569; Kovacs TA, 2003, J ENVIRON MONITOR, V5, P68, DOI 10.1039/b204339d; Kovacs TA, 2001, J ATMOS CHEM, V39, P105, DOI 10.1023/A:1010614113786; Kurpius MR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016785; Lewis AC, 2000, NATURE, V405, P778, DOI 10.1038/35015540; Meng Z, 1997, SCIENCE, V277, P116, DOI 10.1126/science.277.5322.116; O'Dowd CD, 2002, NATURE, V416, P497, DOI 10.1038/416497a; Paulson SE, 1997, GEOPHYS RES LETT, V24, P3193, DOI 10.1029/97GL03163; Pfeiffer T, 1998, CHEM PHYS LETT, V298, P351, DOI 10.1016/S0009-2614(98)01208-1; Ren XR, 2003, ATMOS ENVIRON, V37, P3639, DOI 10.1016/S1352-2310(03)00459-X; Ryerson TB, 2001, SCIENCE, V292, P719, DOI 10.1126/science.1058113; Schade GW, 1999, GEOPHYS RES LETT, V26, P2187, DOI 10.1029/1999GL900444; STEVENS PS, 1994, J GEOPHYS RES-ATMOS, V99, P3543, DOI 10.1029/93JD03342; Stockwell WR, 1997, J GEOPHYS RES-ATMOS, V102, P25847, DOI 10.1029/97JD00849; Tan D, 2001, J GEOPHYS RES-ATMOS, V106, P24407, DOI 10.1029/2001JD900016; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0	30	313	315	16	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					722	725		10.1126/science.1094392	http://dx.doi.org/10.1126/science.1094392			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118159				2022-12-01	WOS:000221105300041
J	Osterholm, MT; Norgan, AP				Osterholm, MT; Norgan, AP			The role of irradiation in food safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA.							Andrews L S, 1998, Rev Environ Contam Toxicol, V154, P1; [Anonymous], 1981, World Health Organ Tech Rep Ser, V659, P1; BARNA J, 1979, ACTA ALIMENT HUNG, V8, P205; BURNOUF D, 2002, 3171 INTRREG, P1; Crawford LM, 2001, IRRADIATION FOR FOOD SAFETY AND QUALITY, P9; de Bruyn IN, 2000, RADIAT PHYS CHEM, V57, P223, DOI 10.1016/S0969-806X(99)00385-0; Dickson J.S., 2001, FOOD IRRADIATION PRI, P23; Diehl J. F., 1995, SAFETY IRRADIATED FO; Diehl JF, 2002, RADIAT PHYS CHEM, V63, P211, DOI 10.1016/S0969-806X(01)00622-3; Farkas J, 1998, INT J FOOD MICROBIOL, V44, P189, DOI 10.1016/S0168-1605(98)00132-9; *FOOD AGR ORG UN, 1981, AGR SERV B, V43; Food Safety and Inspection Service, 2003, REC CAS; *FOODB OUTBR RESP, 2000, FOODB DIS OUTBR BACT; FRENZEN PD, 2000, USDA ERS AGR INF B, V757; *GEN ACC OFF, 2000, GAORCED00217; GIDDINGS G, 1996, RADIAT PHYS CHEM, V48, P364; JOSEPHSON ES, 1983, J FOOD SAFETY, V5, P161, DOI 10.1111/j.1745-4565.1983.tb00469.x; Loaharanu P., 2003, IRRADIATED FOODS; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Molins RA, 2001, FOOD CONTROL, V12, P347, DOI 10.1016/S0956-7135(01)00035-4; MOLINS RA, 2001, FOOD IRRADIATION PRI, P131; NARVAIZ P, 1996, RADIAT PHYS CHEM, V48, P360; Raul F, 2002, NUTR CANCER, V44, P188, DOI 10.1207/S15327914NC4402_11; ROYBALL J, 2003, BEEF MAGAZINES  0906; SATIN M, 1996, FOOD IRRADIATON GUID; Sommers CH, 2003, J AGR FOOD CHEM, V51, P6367, DOI 10.1021/jf030348o; Tauxe RV, 2001, EMERG INFECT DIS, V7, P516, DOI 10.3201/eid0707.017706; THAYER DW, 1987, J FOOD PROTECT, V50, P278, DOI 10.4315/0362-028X-50.4.278; Wheeler TL, 1999, J ANIM SCI, V77, P3219; Wood OB, 2000, J AM DIET ASSOC, V100, P246, DOI 10.1016/S0002-8223(00)00075-4; 2003, CONSUMER REPORTS AUG, P34; 1997, FED REG, V62, P64107	32	41	43	7	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1898	1901		10.1056/NEJMsb032657	http://dx.doi.org/10.1056/NEJMsb032657			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115836				2022-12-01	WOS:000221080300015
J	Damy, T; Ratajczak, P; Shah, AM; Camors, E; Marty, I; Hasenfuss, G; Marotte, F; Samuel, JL; Heymes, C				Damy, T; Ratajczak, P; Shah, AM; Camors, E; Marty, I; Hasenfuss, G; Marotte, F; Samuel, JL; Heymes, C			Increased neuronal nitric oxide synthase-derived NO production in the failing human heart	LANCET			English	Article								Experimental data suggest that nitric oxide (NO) generated from neuronal NO synthase (nNOS) modulates the myocardial inotropic state. To assess the contribution of NO, derived from endothelial and neuronal isoforms, to the pathophysiology of congestive heart failure in human beings, we compared expression, localisation, and specific activity of NOS isoforms in myocardium from patients with dilated cardiomyopathy with those in controls who had died from head trauma or intracranial bleeds. Diseased hearts had a significant increase in nNOS mRNA and protein expression, and activity associated with the translocation of nNOS to the sarcolemma through interactions with caveolin 3. Enhanced nNOS activity counteracted a decrease in eNOS expression and activity. Our results provide evidence of increased nNOS-derived NO in the failing human heart. Such altered regulation may be important in the pathophysiology of cardiac dysfunction in human congestive heart failure.	Hop Lariboisiere, INSERM, U572, IFR J Marrey Paris 7, F-75475 Paris 10, France; Kings Coll London, Guys Kings & St Thomass Sch Med, Dept Cardiol, London WC2R 2LS, England; CEA, INSERM, DBMS, Grenoble, France; Univ Gottingen, Dept Cardiol, D-3400 Gottingen, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Gottingen	Heymes, C (corresponding author), Hop Lariboisiere, INSERM, U572, IFR J Marrey Paris 7, 41 Blvd Chapelle, F-75475 Paris 10, France.	Christophe.Heymes@larib.inserm.fr	Marty, Isabelle/N-7114-2017; Heymes, Christophe/Y-9368-2019; Ratajczak, Philippe/H-5398-2012; Marty, Isabelle/ABF-5362-2020	Heymes, Christophe/0000-0002-6666-6193; Marty, Isabelle/0000-0003-3625-913X; Samuel, Jane-Lise/0000-0002-7346-2404; Shah, Ajay/0000-0002-6547-0631				Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Damy T, 2003, FASEB J, V17, P1934, DOI 10.1096/fj.02-1208fje; Hare JM, 1998, CIRCULATION, V97, P161, DOI 10.1161/01.CIR.97.2.161; Ratajczak P, 2003, CARDIOVASC RES, V57, P358, DOI 10.1016/S0008-6363(02)00660-0; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shah AM, 2000, PHARMACOL THERAPEUT, V86, P49, DOI 10.1016/S0163-7258(99)00072-8	7	196	224	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1365	1367		10.1016/S0140-6736(04)16048-0	http://dx.doi.org/10.1016/S0140-6736(04)16048-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110495				2022-12-01	WOS:000220996300012
J	Papadopoulos, MC; Abel, PM; Agranoff, D; Stich, A; Tarelli, E; Bell, BA; Planche, T; Loosemore, A; Saadoun, S; Wilkins, P; Krishna, S				Papadopoulos, MC; Abel, PM; Agranoff, D; Stich, A; Tarelli, E; Bell, BA; Planche, T; Loosemore, A; Saadoun, S; Wilkins, P; Krishna, S			A novel and accurate diagnostic test for human African trypanosomiasis	LANCET			English	Article							SLEEPING SICKNESS; PROSTATE-CANCER; SERUM; ANGOLA	Introduction Human African trypanosomiasis (sleeping sickness) affects up to half a million people every year in sub-Saharan Africa. Because current diagnostic tests for the disease have low accuracy, we sought to develop a novel test that can diagnose human African trypanosomiasis with high sensitivity and specificity. Methods We applied serum samples from 85 patients with African trypanosomiasis and 146 control patients who had other parasitic and non-parasitic infections to a weak cation exchange chip, and analysed with surface-enhanced laser desorption-ionisation time-of-flight mass spectrometry. Mass spectra were then assessed with three powerful data-mining tools: a tree classifier, a neural network, and a genetic algorithm. Findings. Spectra (2-100 kDa) were grouped into training (n=122) and testing (n=109) sets. The training set enabled data-mining software to identify distinct serum proteomic signatures characteristic of human African trypanosomiasis among 206 protein clusters. Sensitivity and specificity, determined with the testing set, were 100% and 98.6%, respectively, when the majority opinion of the three algorithms was considered. This novel approach is much more accurate than any other diagnostic test. Interpretation Our report of the accurate diagnosis of an infection by use of proteomic signature analysis could form the basis for diagnostic tests for the disease, monitoring of response to treatment, and for improving the accuracy of patient recruitment in large-scale epidemiological studies.	St George Hosp, Sch Med, Dept Cellular & Mol Sci, London SW17 0RE, England; St George Hosp, Sch Med, Dept Neurosurg, London, England; St George Hosp, Sch Med, Dept Neuropathol, London, England; St George Hosp, Sch Med, Biom Ctr, London, England; ANGOTRIP, Morro Da Luz, Luanda, Angola; Med Mission Inst, Dept Trop Med, Wurzburg, Germany	St Georges University London; St Georges University London; St Georges University London; St Georges University London	Krishna, S (corresponding author), St George Hosp, Sch Med, Dept Cellular & Mol Sci Infect Dis, London SW17 0RE, England.	s.krishna@sghms.ac.uk		Saadoun, Samira/0000-0002-5480-5678; Krishna, Sanjeev/0000-0003-0066-0634; Planche, Timothy/0000-0002-0263-0888; Papadopoulos, Marios/0000-0001-9174-4176				ABEL P, 2003, IN PRESS TROP MED IN; Adam BL, 2002, CANCER RES, V62, P3609; [Anonymous], [No title captured]; Chen C.H., 1996, FUZZY LOGIC NEURAL N; Clarke W, 2003, ANN SURG, V237, P660, DOI 10.1097/00000658-200305000-00008; DUMAS M, 1999, PROGR HUMAN AFRICAN, P344; Esposito F, 1997, IEEE T PATTERN ANAL, V19, P476, DOI 10.1109/34.589207; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; FUNG ET, 2002, COMPUTATIONAL PROT S, V32, pS34; Li JN, 2002, CLIN CHEM, V48, P1296; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; NOIREAU F, 1988, T ROY SOC TROP MED H, V82, P237, DOI 10.1016/0035-9203(88)90430-0; PAYS E, 1999, PROGR HUMAN AFRICAN, P31; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Poon TCW, 2003, CLIN CHEM, V49, P752, DOI 10.1373/49.5.752; Qu YS, 2002, CLIN CHEM, V48, P1835; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; Stich A, 2002, BRIT MED J, V325, P203, DOI 10.1136/bmj.325.7357.203; STICH AH, 2003, PARASITOL TODAY, V19, P195; *VASS COLL, CLIN CALC 1 OBS SAMP; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	24	103	109	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1358	1363		10.1016/S0140-6736(04)16046-7	http://dx.doi.org/10.1016/S0140-6736(04)16046-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110493				2022-12-01	WOS:000220996300010
J	Abrahamsen, MS; Templeton, TJ; Enomoto, S; Abrahante, JE; Zhu, G; Lancto, CA; Deng, MQ; Liu, C; Widmer, G; Tzipori, S; Buck, GA; Xu, P; Bankier, AT; Dear, PH; Konfortov, BA; Spriggs, HF; Iyer, L; Anantharaman, V; Aravind, L; Kapur, V				Abrahamsen, MS; Templeton, TJ; Enomoto, S; Abrahante, JE; Zhu, G; Lancto, CA; Deng, MQ; Liu, C; Widmer, G; Tzipori, S; Buck, GA; Xu, P; Bankier, AT; Dear, PH; Konfortov, BA; Spriggs, HF; Iyer, L; Anantharaman, V; Aravind, L; Kapur, V			Complete genome sequence of the apicomplexan, Cryptosporidium parvum	SCIENCE			English	Article							PROTEIN	The apicomplexan Cryptosporidium parvum is an intestinal parasite that affects healthy humans and animals, and causes an unrelenting infection in immunocompromised individuals such as AIDS patients. We report the complete genome sequence of C. parvum, type II isolate. Genome analysis identifies extremely streamlined metabolic pathways and a reliance on the host for nutrients. In contrast to Plasmodium and Toxoplasma, the parasite lacks an apicoplast and its genome, and possesses a degenerate mitochondrion that has lost its genome. Several novel classes of cell-surface and secreted proteins with a potential role in host interactions and pathogenesis were also detected. Elucidation of the core metabolism, including enzymes with high similarities to bacterial and plant counterparts, opens new avenues for drug development.	Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; Univ Minnesota, Biomed Genom Ctr, St Paul, MN 55108 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; Tufts Univ, Sch Vet Med, Div Infect Dis, North Grafton, MA 01536 USA; Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23198 USA; Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23198 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Cornell University; Cornell University; Texas A&M University System; Texas A&M University College Station; Tufts University; Virginia Commonwealth University; Virginia Commonwealth University; MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Minnesota System; University of Minnesota Twin Cities	Abrahamsen, MS (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	abe@umn.edu	Anantharaman, Vivek/ABB-9991-2021; Iyer, Lakshminarayan M./H-2996-2019; Kapur, Vivek/F-7610-2013; Zhu, Guan/AFJ-2945-2022; ZHU, GUAN/GQB-0299-2022; Dear, Paul H/A-1162-2012; ZHU, GUAN/D-8147-2011	Anantharaman, Vivek/0000-0001-8395-0009; Zhu, Guan/0000-0003-3888-0659; ZHU, GUAN/0000-0003-3888-0659; Kapur, Vivek/0000-0002-9648-0138; Abrahante, Juan/0000-0002-9074-4307; Aravind, L/0000-0003-0771-253X	NIAID NIH HHS [U01 AI 46397] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046397] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM092504] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Abrahamsen MS, 1999, MOL BIOCHEM PARASIT, V104, P141, DOI 10.1016/S0166-6851(99)00081-X; Bankier AT, 2003, GENOME RES, V13, P1787, DOI 10.1101/gr.1555203; Barnes DA, 1998, MOL BIOCHEM PARASIT, V96, P93, DOI 10.1016/S0166-6851(98)00119-4; Cai XM, 2003, GENE, V321, P39, DOI 10.1016/j.gene.2003.08.008; Cevallos AM, 2000, INFECT IMMUN, V68, P5167, DOI 10.1128/IAI.68.9.5167-5175.2000; Coombs GH, 1999, PARASITOL TODAY, V15, P333, DOI 10.1016/S0169-4758(99)01474-X; Doyle PS, 1998, EXP PARASITOL, V89, P9, DOI 10.1006/expr.1998.4263; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; KORICH DG, 1990, APPL ENVIRON MICROB, V56, P1423, DOI 10.1128/AEM.56.5.1423-1428.1990; KRAMER RA, 1993, MOL BIOCHEM PARASIT, V60, P327, DOI 10.1016/0166-6851(93)90144-M; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; Rosenthal B, 1997, J BACTERIOL, V179, P3736, DOI 10.1128/jb.179.11.3736-3745.1997; Rotte C, 2001, MOL BIOL EVOL, V18, P710, DOI 10.1093/oxfordjournals.molbev.a003853; Schmatz DM, 1997, PARASITOLOGY, V114, pS81; Striepen B, 2002, P NATL ACAD SCI USA, V99, P6304, DOI 10.1073/pnas.092525699; Templeton TJ, 2004, INFECT IMMUN, V72, P980, DOI 10.1128/IAI.72.2.980-987.2004; WILLIAMSON JD, 1995, P NATL ACAD SCI USA, V92, P7148, DOI 10.1073/pnas.92.16.7148; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Zhu G, 2000, MICROBIOL-SGM, V146, P315, DOI 10.1099/00221287-146-2-315; Zhu G, 2000, MOL BIOCHEM PARASIT, V105, P253, DOI 10.1016/S0166-6851(99)00183-8; Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9	27	691	745	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					441	445		10.1126/science.1094786	http://dx.doi.org/10.1126/science.1094786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15044751				2022-12-01	WOS:000220845400049
J	Robinson, GE				Robinson, GE			Beyond nature and nurture	SCIENCE			English	Editorial Material							GENE-EXPRESSION; BEHAVIOR		Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	generobi@life.uiuc.edu						Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Chakravarti A, 2003, NATURE, V421, P412, DOI 10.1038/nature01401; Ferster D, 2004, SCIENCE, V303, P1619, DOI 10.1126/science.1096224; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Schatz BR, 2002, COMPUTER, V35, P54, DOI 10.1109/2.976919; TURNER JRG, 1983, BIOL J LINN SOC, V20, P277, DOI 10.1111/j.1095-8312.1983.tb01877.x; Weaver ICG, 2002, ENDOCR RES, V28, P699, DOI 10.1081/ERC-120016989; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	10	74	76	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					397	399		10.1126/science.1095766	http://dx.doi.org/10.1126/science.1095766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087536				2022-12-01	WOS:000220845400033
J	Hviid, A; Stellfeld, M; Wohlfahrt, J; Melbye, M				Hviid, A; Stellfeld, M; Wohlfahrt, J; Melbye, M			Childhood vaccination and type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNIZATION; RISK; INFECTIONS; VACCINES; IDDM; AUTOIMMUNE; MECHANISMS; MELLITUS; DISEASE	BACKGROUND: A link between childhood vaccinations and the development of type 1 diabetes has been proposed. METHODS: We evaluated a cohort comprising all children born in Denmark from January 1, 1990, through December 31, 2000, for whom detailed information on vaccinations and type 1 diabetes was available. Using Poisson regression models, we estimated rate ratios according to vaccination status, including the trend associated with the number of doses, among all children and in a subgroup of children who had siblings with type 1 diabetes. Given recent claims of clustering of cases of diabetes two to four years after vaccination, we also estimated rate ratios during the period after vaccination. RESULTS: Type 1 diabetes was diagnosed in 681 children during 4,720,517 person-years of follow-up. The rate ratio for type 1 diabetes among children who received at least one dose of vaccine, as compared with unvaccinated children, was 0.91 (95 percent confidence interval, 0.74 to 1.12) for Haemophilus influenzae type b vaccine; 1.02 (95 percent confidence interval, 0.75 to 1.37) for diphtheria, tetanus, and inactivated poliovirus vaccine; 0.96 (95 percent confidence interval, 0.71 to 1.30) for diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine; 1.06 (95 percent confidence interval, 0.80 to 1.40) for whole-cell pertussis vaccine; 1.14 (95 percent confidence interval, 0.90 to 1.45) for measles, mumps, and rubella vaccine; and 1.08 (95 percent confidence interval, 0.74 to 1.57) for oral poliovirus vaccine. The development of type 1 diabetes in genetically predisposed children (defined as those who had siblings with type 1 diabetes) was not significantly associated with vaccination. Furthermore, there was no evidence of any clustering of cases two to four years after vaccination with any vaccine. CONCLUSIONS: These results do not support a causal relation between childhood vaccination and type 1 diabetes.	Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen S, Denmark; Statens Serum Inst, Dept Med, DK-2300 Copenhagen S, Denmark	Aarhus University; Statens Serum Institut; Statens Serum Institut	Hviid, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	aii@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785				Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2000, Diabetologia, V43, P47; [Anonymous], 2002, IMMUNIZATION SAFETY; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BLOM L, 1991, DIABETOLOGIA, V34, P176, DOI 10.1007/BF00418272; Classen DC, 1997, INFECT DIS CLIN PRAC, V6, P449, DOI 10.1097/00019048-199706070-00007; Classen JB, 1999, AUTOIMMUNITY, V31, P43, DOI 10.3109/08916939908993858; Classen JB, 2003, J PEDIATR ENDOCR MET, V16, P495; Classen JB, 2002, AUTOIMMUNITY, V35, P247, DOI 10.1080/08916930290028175; Classen JB, 1996, AUTOIMMUNITY, V24, P137, DOI 10.3109/08916939608995359; Classen JB, 2001, MED HYPOTHESES, V57, P532, DOI 10.1054/mehy.2001.1352; Clayton D., 1993, STAT MODELS EPIDEMIO; DeStefano F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e112; Green A, 2000, LANCET, V355, P873; Halsey NA, 1999, PEDIATR INFECT DIS J, V18, P23, DOI [10.1097/00006454-199901000-00007, 10.1097/00006454-199903000-00002]; Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969; Jefferson T, 1998, J EPIDEMIOL COMMUN H, V52, P674, DOI 10.1136/jech.52.10.674; Knudsen LB, 1998, DAN MED BULL, V45, P320; MALIG C, 1996, 66 IIVRS; Nielsen G L, 1996, J Med Syst, V20, P1, DOI 10.1007/BF02260869; Offit PA, 2003, PEDIATRICS, V111, P653, DOI 10.1542/peds.111.3.653; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; 2000, LANCET, V356, P1690	24	80	84	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1398	1404		10.1056/NEJMoa032665	http://dx.doi.org/10.1056/NEJMoa032665			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070789	Bronze			2022-12-01	WOS:000220562500006
J	Brose, U; Ostling, A; Harrison, K; Martinez, ND				Brose, U; Ostling, A; Harrison, K; Martinez, ND			Unified spatial scaling of species and their trophic interactions	NATURE			English	Article							FOOD-WEB STRUCTURE; AREA; CONNECTANCE; PATTERNS; ENDEMISM	Two largely independent bodies of scaling theory address the quantitative relationships between habitat area, species diversity and trophic interactions. Spatial theory within macroecology addresses how species richness scales with area in landscapes, while typically ignoring interspecific interactions(1-6). Complexity theory within community ecology addresses how trophic links scale with species richness in food webs, while typically ignoring spatial considerations(7-12). Recent studies suggest unifying these theories by demonstrating how spatial patterns influence food-web structure(13-16) and vice versa(17). Here, we follow this suggestion by developing and empirically testing a more unified scaling theory. On the basis of power-law species-area relationships, we develop link-area and non-power-law link-species models that accurately predict how trophic links scale with area and species richness of microcosms, lakes and streams from community to metacommunity levels. In contrast to previous models that assume that species richness alone determines the number of trophic links(7,8), these models include the species' spatial distribution, and hence extend the domain of complexity theory to metacommunity scales. This generality and predictive success shows how complexity theory and spatial theory can be unified into a much more general theory addressing new domains of ecology.	Rocky Mt Biol Labs, Pacific Ecoinformat & Computat Ecol Lab, Crested Butte, CO 81224 USA; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; San Francisco State Univ, Dept Comp Sci, San Francisco, CA 94132 USA	University of California System; University of California Berkeley; California State University System; San Francisco State University	Brose, U (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 3, D-64287 Darmstadt, Germany.	brose@sfsu.edu	Brose, Ulrich/AAT-7547-2020; Brose, Ulrich/I-3488-2014; Martinez, Neo/A-5312-2008	Brose, Ulrich/0000-0001-9156-583X; Martinez, Neo/0000-0002-1130-5550				Bersier LF, 1997, P NATL ACAD SCI USA, V94, P1247, DOI 10.1073/pnas.94.4.1247; Brose U, 2003, SCIENCE, V301; CARTER JL, 2000, 00346 CAL US GEOL SU; CARTER JL, 2000, 0068 CAL US GEOL SUR; COHEN JE, 1984, P NATL ACAD SCI-BIOL, V81, P4105, DOI 10.1073/pnas.81.13.4105; COHEN JE, 1991, AM NAT, V138, P1542, DOI 10.1086/285299; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Green JL, 2003, ECOL LETT, V6, P919, DOI 10.1046/j.1461-0248.2003.00519.x; HARRISON K, 2003, THESIS SAN FRANCISCO; Harte J, 1997, OIKOS, V80, P417, DOI 10.2307/3546614; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Holt RD, 2002, ECOL RES, V17, P261, DOI 10.1046/j.1440-1703.2002.00485.x; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; HUBBELL SP, 1997, UNIFIED THEORY BIOGE; MACARTHUR RH, 1962, THEORY ISLAND BIOGEO; MARTINEZ ND, 1995, OIKOS, V73, P148, DOI 10.2307/3545903; MARTINEZ ND, 1995, LINKING SPECIES & ECOSYSTEMS, P166; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; May RM, 1974, SYST MAN CYBERN, DOI 10.2307/j.ctvs32rq4; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schmid-Araya JM, 2002, J ANIM ECOL, V71, P1056, DOI 10.1046/j.1365-2656.2002.00668.x; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Spencer M, 1996, OIKOS, V75, P419, DOI 10.2307/3545882; SUTHERLAND JW, 1989, FIELD SURVEY BIOTA S; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	30	97	101	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					167	171		10.1038/nature02297	http://dx.doi.org/10.1038/nature02297			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014497				2022-12-01	WOS:000220103600045
J	Sargent, RP; Shepard, RM; Glantz, SA				Sargent, RP; Shepard, RM; Glantz, SA			Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ACUTE CORONARY SYNDROMES; CARDIO2000 CASE-CONTROL; HEALTHY-YOUNG ADULTS; PASSIVE SMOKING; HEART-DISEASE; SECONDHAND SMOKE; ENDOTHELIUM; EXPOSURE; RISK	Objective To determine whether there was a change in hospital admissions for acute myocardial infarction while a local law banning smoking in public and in workplaces was in effect. Design Analysis of admissions front December 1997 through November 2003 using Poisson analysis. Setting Helena, Montana, a geographical]), isolated community with one hospital serving a population of 68140. Participants All patients admitted for acute myocardial infarction. Main outcome measures Number of monthly admissions for acute myocardial infarction for people living in mid outside Helena. Results During the six months the law was enforced the number of admissions fell significantly (-16 admissions, 95% confidence interval -31.7 to -0.3), from an average of 40 admissions during the same 0 months in die years before and after the law to a total of 24 admissions during die six months the law was in effect. There was a non-significant increase of 5.6 (-5.2 to 16.4) in the number of admissions from outside Helena during the same period, from 12.4 in the years before and after the law to 18 while the law was in effect. Conclusions Laws to enforce smoke-free workplaces and public places may be associated with art effect on morbidity from heart disease.	Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; St Peters Community Hosp, HealthCare Qual Performance Council, Helena, MT 59601 USA	University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER; NCI NIH HHS [CA-61021] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; DAVIS JW, 1989, ARCH INTERN MED, V149, P386, DOI 10.1001/archinte.149.2.386; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Glantz SA, 2001, JAMA-J AM MED ASSOC, V286, P462, DOI 10.1001/jama.286.4.462; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; ONG M, IN PRESS AM J MED; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Panagiotakos DB, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-9; Pierce JP, 1994, TOBACCO USE CALIFORN; Pierce JP, 1994, TOB CONTROL, V3, P15, DOI DOI 10.1136/TC.3.1.15; Pitsavos C, 2002, TOB CONTROL, V11, P220, DOI 10.1136/tc.11.3.220; Pope CA, 2001, ENVIRON HEALTH PERSP, V109, P711, DOI 10.2307/3454788; Rosenlund M, 2001, EPIDEMIOLOGY, V12, P558, DOI 10.1097/00001648-200109000-00016; SCHACHINGER V, 2000, CIRCULATION, V100, P2153; Stefanadis C, 1998, ANN INTERN MED, V128, P426, DOI 10.7326/0003-4819-128-6-199803150-00002; Sumida H, 1998, J AM COLL CARDIOL, V31, P811, DOI 10.1016/S0735-1097(98)00010-2; *TOB CONTR SECT, MOD CHANG CAL EXP TO; Valkonen M, 1998, CIRCULATION, V97, P2012, DOI 10.1161/01.CIR.97.20.2012	23	343	349	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2004	328	7446					977	980		10.1136/bmj.38055.715683.55	http://dx.doi.org/10.1136/bmj.38055.715683.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15066887	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000221130100011
J	McManus, JF; Francois, R; Gherardi, JM; Keigwin, LD; Brown-Leger, S				McManus, JF; Francois, R; Gherardi, JM; Keigwin, LD; Brown-Leger, S			Collapse and rapid resumption of Atlantic meridional circulation linked to deglacial climate changes	NATURE			English	Article							OCEAN THERMOHALINE CIRCULATION; SEA-LEVEL RECORD; RADIOCARBON AGE; DISCHARGES; RATES	The Atlantic meridional overturning circulation is widely believed to affect climate. Changes in ocean circulation have been inferred from records of the deep water chemical composition derived from sedimentary nutrient proxies(1), but their impact on climate is difficult to assess because such reconstructions provide insufficient constraints on the rate of overturning(2). Here we report measurements of Pa-231/(230) Th, a kinematic proxy for the meridional overturning circulation, in a sediment core from the subtropical North Atlantic Ocean. We find that the meridional overturning was nearly, or completely, eliminated during the coldest deglacial interval in the North Atlantic region, beginning with the catastrophic iceberg discharge Heinrich event H1, 17,500 yr ago, and declined sharply but briefly into the Younger Dryas cold event, about 12,700 yr ago. Following these cold events, the Pa-231/(230) Th record indicates that rapid accelerations of the meridional overturning circulation were concurrent with the two strongest regional warming events during deglaciation. These results confirm the significance of variations in the rate of the Atlantic meridional overturning circulation for abrupt climate changes.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	McManus, JF (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	jmcmanus@whoi.edu						BACON MP, 1982, J GEOPHYS RES-OCEANS, V87, P2045, DOI 10.1029/JC087iC03p02045; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; BROECKER WS, 1979, J GEOPHYS RES-OC ATM, V84, P3218, DOI 10.1029/JC084iC06p03218; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Chase Z, 2002, EARTH PLANET SC LETT, V204, P215, DOI 10.1016/S0012-821X(02)00984-6; Choi MS, 2001, MAR CHEM, V76, P99, DOI 10.1016/S0304-4203(01)00050-0; Clark PU, 2002, SCIENCE, V295, P2438; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; DUPLESSY JC, 1992, NATURE, V358, P485, DOI 10.1038/358485a0; Elliot M, 2002, QUATERNARY SCI REV, V21, P1153, DOI 10.1016/S0277-3791(01)00137-8; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Hughen KA, 1998, NATURE, V391, P65, DOI 10.1038/34150; LEGRAND P, 1995, PALEOCEANOGRAPHY, V10, P1011, DOI 10.1029/95PA01455; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Marchal O, 2000, PALEOCEANOGRAPHY, V15, P625, DOI 10.1029/2000PA000496; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 1998, EARTH PLANET SC LETT, V155, P29, DOI 10.1016/S0012-821X(97)00201-X; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Ohkouchi N, 2002, SCIENCE, V298, P1224, DOI 10.1126/science.1075287; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Vidal L, 1997, EARTH PLANET SC LETT, V146, P13, DOI 10.1016/S0012-821X(96)00192-6; Waelbroeck C, 1998, PALEOCEANOGRAPHY, V13, P272, DOI 10.1029/98PA00071; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	33	1411	1475	17	447	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					834	837		10.1038/nature02494	http://dx.doi.org/10.1038/nature02494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103371				2022-12-01	WOS:000220952300034
J	Alotaibi, S; Kennedy, J; Tellier, R; Stephens, D; Banwell, B				Alotaibi, S; Kennedy, J; Tellier, R; Stephens, D; Banwell, B			Epstein-Barr virus in pediatric multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHETLAND ISLANDS; ANTIBODY-TITERS; NUCLEAR ANTIGEN; INFECTIONS; CHILDHOOD; HUMAN-HERPESVIRUS-6; DISEASE; ORKNEY	Context Infection with common viruses, particularly Epstein-Barr virus (EBV), has been postulated to contribute to the pathobiology of multiple sclerosis (MS). Detailed virological studies in pediatric MS have not been previously reported. Objective To evaluate whether children with MS are more likely to be seropositive for EBV or other common viruses than their healthy age-matched peers. Design, Setting, and Patients Case-control study of viral samples collected from March 1994 to February 2003 from 30 pediatric MS patients, 90 emergency department controls matched 3:1 with the MS patients by year of birth, and 53 healthy control children. Main Outcome Measures Archived serum samples were analyzed for the presence of IgG antibodies directed against EBV viral capsid antigens, nuclear antigens, and early antigens, cytomegalovirus, parvovirus B19, herpes simplex virus, and varicella zoster. Results Serological evidence for remote EBV infection was present in 83% of pediatric MS patients compared with 42% of emergency department and healthy controls (P<.001). Five pediatric MS patients were negative for all 3 EBV antigens. Pediatric MS patients were less likely than controls to have been exposed to herpes simplex virus (P=.003), while seropositivity for cytomegalovirus, parvovirus 1319, and varicella zoster did not differ between MS patients and controls. Conclusion These results suggest an association between EBV infection and pediatric MS.	Univ Toronto, Hosp Sick Children, Dept Paediat Neurol, Paediat Multiple Sclerosis Clin, Toronto, ON M5G 1X8, Canada; Al Sabah Hosp, Dept Pediat Neurol, Shuwaikh, Kuwait	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Al Sabah Hospital	Banwell, B (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat Neurol, Paediat Multiple Sclerosis Clin, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	brenda.banwell@sickkids.ca						Allen UD, 2001, BONE MARROW TRANSPL, V28, P473, DOI 10.1038/sj.bmt.1703153; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; BRAY PF, 1992, NEUROLOGY, V42, P278, DOI 10.1212/WNL.42.2.278; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; BRAY PF, 1992, NEUROLOGY, V42, P1798, DOI 10.1212/WNL.42.9.1798; CUOMO L, 1995, AIDS RES HUM RETROV, V11, P1241, DOI 10.1089/aid.1995.11.1241; DUQUETTE P, 1987, J PEDIATR-US, V111, P359, DOI 10.1016/S0022-3476(87)80454-7; EVANS AS, 1989, VIRAL INFECT HUMANS, P265; Ghezzi A, 1997, MULT SCLER, V3, P43, DOI 10.1177/135245859700300105; Granieri E, 1997, NEUROLOGY, V49, pS42, DOI 10.1212/WNL.49.2_Suppl_2.S42; Haahr S, 1997, LANCET, V349, P923, DOI 10.1016/S0140-6736(05)62698-0; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; Knox KK, 2000, CLIN INFECT DIS, V31, P894, DOI 10.1086/318141; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; Marrie RA, 2000, NEUROLOGY, V54, P2307, DOI 10.1212/WNL.54.12.2307; MARTIN JR, 1981, LANCET, V2, P777; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSKANZER DC, 1980, J EPIDEMIOL COMMUN H, V34, P265, DOI 10.1136/jech.34.4.265; POSKANZER DC, 1980, J EPIDEMIOL COMMUN H, V34, P258, DOI 10.1136/jech.34.4.258; Swanborg RH, 2003, J NEUROIMMUNOL, V136, P1, DOI 10.1016/S0165-5728(02)00465-4; van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8	24	174	176	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1875	1879		10.1001/jama.291.15.1875	http://dx.doi.org/10.1001/jama.291.15.1875			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100207				2022-12-01	WOS:000220871200029
J	Marshall, T				Marshall, T			When measurements are misleading: modelling the effects of blood pressure misclassification in English population	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	T.P.Marshall@bham.ac.uk		Marshall, Tom/0000-0001-9277-5214				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 1978, J Chronic Dis, V31, P651; *DEP HLTH, HLTH SURV ENGL 1998; Wood D, 1998, HEART, V80, pS1; Wright JM., 2000, 8 INT COCHR C	5	27	28	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					933	933		10.1136/bmj.328.7445.933	http://dx.doi.org/10.1136/bmj.328.7445.933			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087340	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000220994400025
J	Coleman, SW; Patricelli, GL; Borgia, G				Coleman, SW; Patricelli, GL; Borgia, G			Variable female preferences drive complex male displays	NATURE			English	Article							BOWERBIRDS PTILONORHYNCHUS-VIOLACEUS; SATIN BOWERBIRD; MATE-CHOICE; CONSEQUENCES; QUALITY; SIGNALS	Complexity in male sexual displays is widely appreciated(1) but diversity in female mate choice has received little attention. Males of many species have sexual displays composed of multiple display traits, and females are thought to use these different traits in mate choice(1). Models of multiple display trait evolution suggest that these traits provide females with different kinds of information in different stages of the mate choice process(2), or function as redundant signals to improve the accuracy of mate assessment(3),(4). We suggest that complex male displays might also arise because of variation in female preferences for particular male display traits. The causes of female preference variation have received little attention(5-7), and the role of preference variation in shaping complex male displays is unclear. Here we show that in satin bowerbirds (Ptilonorhynchus violaceus) female mate choice is a multistage process, where females of different ages use different male display traits in successive stages. Age- and stage-specific female preferences may contribute to explaining the widespread occurrence of multifaceted male displays.	Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Coleman, SW (corresponding author), Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA.	Coleman@umd.edu	Patricelli, Gail L/L-3730-2017	Borgia, Gerald/0000-0002-2669-9548; Patricelli, Gail/0000-0003-3397-8390				Andersson Malte, 1994; BORGIA G, 1985, ANIM BEHAV, V33, P266, DOI 10.1016/S0003-3472(85)80140-8; BORGIA G, 1995, ANIM BEHAV, V49, P1291, DOI 10.1006/anbe.1995.0161; BORGIA G, 1986, ANIM BEHAV, V34, P727, DOI 10.1016/S0003-3472(86)80056-2; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; Hoglund J, 1995, LEKS, DOI DOI 10.1515/9781400864157; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Moore PJ, 2001, P NATL ACAD SCI USA, V98, P9171, DOI 10.1073/pnas.161154598; Patricelli GL, 2004, BEHAV ECOL, V15, P297, DOI 10.1093/beheco/arh013; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994; Uy JAC, 2001, P ROY SOC B-BIOL SCI, V268, P633, DOI 10.1098/rspb.2000.1413; Uy JAC, 2001, AM NAT, V158, P530, DOI 10.1086/323118; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6	18	183	184	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					742	745		10.1038/nature02419	http://dx.doi.org/10.1038/nature02419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085130				2022-12-01	WOS:000220823800037
J	Olszewski, TD; Erwin, DH				Olszewski, TD; Erwin, DH			Dynamic response of Permian brachiopod communities to long-term environmental change	NATURE			English	Article							SPECIES-ABUNDANCE; NEUTRAL THEORY; MODEL	The fossil record preserves numerous natural experiments that can shed light on the response of ecological communities to environmental change. However, directly observing the community dynamics of extinct organisms is not possible. As an alternative, neutral ecological models(1-3) suggest that species abundance distributions reflect dynamical processes like migration, competition, recruitment, and extinction. Live-dead comparisons suggest that such distributions can be faithfully preserved in the rock record(4). Here we use a maximum-likelihood approach to show that brachiopod (lamp shell) abundance distributions from four temporally distinct ecological landscapes from the Glass Mountains, Texas (of the Permian period), exhibit significant differences. Further, all four are better fitted by zero-sum multinomial distributions, characteristic of Hubbell's neutral model(2), than by log-normal distributions, as predicted by the traditional ecological null hypothesis(5). Using the neutral model as a guide, we suggest that sea level fluctuations spanning about 10 Myr altered the degrees of isolation and exchange among local communities within these ecological landscapes. Neither these long-term environmental changes nor higher-frequency sea level fluctuations resulted in wholesale extinction or major innovation within evolutionary lineages.	Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; Smithsonian Inst, Dept Paleobiol, NMNH, Washington, DC 20013 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Texas A&M University System; Texas A&M University College Station; Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute	Olszewski, TD (corresponding author), Texas A&M Univ, Dept Geol & Geophys, 3115 TAMU, College Stn, TX 77843 USA.	tomo@geo.tamu.edu	Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614; Olszewski, Thomas/0000-0002-0179-6536				Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Carroll M, 2003, PALEOBIOLOGY, V29, P381, DOI 10.1666/0094-8373(2003)029<0381:QEOTIT>2.0.CO;2; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Cooper G.A., 1974, Smithsonian Contributions to Paleobiology, VNo. 15, P233; Cooper G.A., 1972, Smithsonian Contributions to Paleobiology, VNo. 14, P1; Cooper G.A., 1976, Smithsonian Contributions to Paleobiology, VNo. 21, P1923; Cooper G. A, 1977, Smithsonian Contributions to Paleobiology, VNo. 32, P3161; Cooper G.A., 1975, SMITHSONIAN CONTRIBU, V19, P795; COOPER GA, 1976, SMITHSONIAN CONTRIBU, V24, P2609; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; HARRIS MT, 2000, SMITHSONIAN CONTRIBU, V32, P153; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; HUGHES RG, 1984, MAR ECOL PROG SER, V15, P1, DOI 10.3354/meps015001; Jin YG, 1997, EPISODES, V20, P10; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; May R.M., 1975, P81; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McKane AJ, 2004, THEOR POPUL BIOL, V65, P67, DOI 10.1016/j.tpb.2003.08.001; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; ROHR D. M., 2000, SMITHSON CONTRIB EAR, V32, P5; ROUTLEDGE RD, 1980, J THEOR BIOL, V82, P547, DOI 10.1016/0022-5193(80)90177-0; Sarg J., 1999, SEPM SPECIAL PUBLICA, P11, DOI 10.2110/pec.99.11.0011; SARG JF, 1986, LOWER MIDDLE GUADALU, P1; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; WARDLAW BR, 2000, SMITHSONIAN CONTRIBU, V32, P121; Wardlaw Bruce R., 2000, Smithsonian Contributions to the Earth Sciences, V32, P37	30	39	42	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					738	741		10.1038/nature02464	http://dx.doi.org/10.1038/nature02464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085129				2022-12-01	WOS:000220823800036
J	Matsuzaki, M; Misumi, O; Shin-I, T; Maruyama, S; Takahara, M; Miyagishima, SY; Mori, T; Nishida, K; Yagisawa, F; Nishida, K; Yoshida, Y; Nishimura, Y; Nakao, S; Kobayashi, T; Momoyama, Y; Higashiyama, T; Minoda, A; Sano, M; Nomoto, H; Oishi, K; Hayashi, H; Ohta, F; Nishizaka, S; Haga, S; Miura, S; Morishita, T; Kabeya, Y; Terasawa, K; Suzuki, Y; Ishii, Y; Asakawa, S; Takano, H; Ohta, N; Kuroiwa, H; Tanaka, K; Shimizu, N; Sugano, S; Sato, N; Nozaki, H; Ogasawara, N; Kohara, Y; Kuroiwa, T				Matsuzaki, M; Misumi, O; Shin-I, T; Maruyama, S; Takahara, M; Miyagishima, SY; Mori, T; Nishida, K; Yagisawa, F; Nishida, K; Yoshida, Y; Nishimura, Y; Nakao, S; Kobayashi, T; Momoyama, Y; Higashiyama, T; Minoda, A; Sano, M; Nomoto, H; Oishi, K; Hayashi, H; Ohta, F; Nishizaka, S; Haga, S; Miura, S; Morishita, T; Kabeya, Y; Terasawa, K; Suzuki, Y; Ishii, Y; Asakawa, S; Takano, H; Ohta, N; Kuroiwa, H; Tanaka, K; Shimizu, N; Sugano, S; Sato, N; Nozaki, H; Ogasawara, N; Kohara, Y; Kuroiwa, T			Genome sequence of the ultrasmall unicellular red alga Cyanidioschyzon merolae 10D	NATURE			English	Article							CHLOROPLAST DIVISION MACHINERY; MITOCHONDRIA; PLASTIDS; REVEALS; DYNAMIN; PROTEIN; GENES; PROLIFERATION; ENDOSYMBIOSIS; EUKARYOTES	Small, compact genomes of ultrasmall unicellular algae provide information on the basic and essential genes that support the lives of photosynthetic eukaryotes, including higher plants(1,2). Here we report the 16,520,305-base-pair sequence of the 20 chromosomes of the unicellular red alga Cyanidioschyzon merolae 10D as the first complete algal genome. We identified 5,331 genes in total, of which at least 86.3% were expressed. Unique characteristics of this genomic structure include: a lack of introns in all but 26 genes; only three copies of ribosomal DNA units that maintain the nucleolus; and two dynamin genes that are involved only in the division of mitochondria and plastids. The conserved mosaic origin of Calvin cycle enzymes in this red alga and in green plants supports the hypothesis of the existence of single primary plastid endosymbiosis. The lack of a myosin gene, in addition to the unexpressed actin gene, suggests a simpler system of cytokinesis. These results indicate that the C. merolae genome provides a model system with a simple gene composition for studying the origin, evolution and fundamental mechanisms of eukaryotic cells.	Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, Tokyo 1718501, Japan; Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Genet, Ctr Genet Resource Informat, Shizuoka 4118540, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Saitama Univ, Fac Sci, Dept Biochem & Mol Biol, Sakura Ku, Saitama 3388570, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Keio Univ, Sch Med, Dept Mol Biol, Shinjyuku Ku, Tokyo 1608582, Japan; Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; National Agriculture & Food Research Organization - Japan; University of Tokyo; Saitama University; University of Tokyo; Keio University; Kumamoto University; Nara Institute of Science & Technology	Tanaka, K (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, 3-34-1 Nishiikebukuro, Tokyo 1718501, Japan.	mzaki@biol.s.u-tokyo.ac.jp; tsune@rikkyo.ne.jp	Maruyama, Shinichiro/AAO-4764-2021; Higashiyama, Tetsuya/C-2882-2012; Ogasawara, Naotake/B-7971-2011; Mori, Toshiyuki/F-8488-2013; Minoda, Ayumi/GQB-3657-2022; Matsuzaki, Motomichi/D-4043-2016; Tanaka, Kan/E-3724-2015	Higashiyama, Tetsuya/0000-0002-7346-360X; Minoda, Ayumi/0000-0003-1968-7984; Matsuzaki, Motomichi/0000-0001-5811-798X; Tanaka, Kan/0000-0001-7560-7884; Sato, Naoki/0000-0001-6230-0410; Miyagishima, Shin-ya/0000-0002-9111-0832; Nozaki, Hisayoshi/0000-0002-9308-4498; Takano, Hiroyoshi/0000-0003-4720-5057; Nishimura, Yoshiki/0000-0001-8686-9206; Kabeya, Yukihiro/0000-0001-6328-0765				Cavalier-Smith T, 2003, PHILOS T R SOC B, V358, P109, DOI 10.1098/rstb.2002.1194; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kuroiwa H, 2002, PLANTA, V215, P185, DOI 10.1007/s00425-002-0734-4; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; Kuroiwa T, 1998, BIOESSAYS, V20, P344, DOI 10.1002/(SICI)1521-1878(199804)20:4<344::AID-BIES11>3.3.CO;2-L; Kuroiwa Tsuneyoshi, 1994, Cytologia (Tokyo), V59, P149; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; McFadden GI, 2003, P NATL ACAD SCI USA, V100, P3557, DOI 10.1073/pnas.0831049100; Miyagishima M, 1998, PROTOPLASMA, V201, P115, DOI 10.1007/BF01280718; Miyagishima S, 1999, PLANTA, V208, P326, DOI 10.1007/s004250050566; Miyagishima SY, 2003, TRENDS PLANT SCI, V8, P432, DOI 10.1016/S1360-1385(03)00193-6; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Nishida K, 2003, P NATL ACAD SCI USA, V100, P2146, DOI 10.1073/pnas.0436886100; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; Ohta N, 1997, J PLANT RES, V110, P235, DOI 10.1007/BF02509312; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; SURRIDGE D, 2003, NATURE, V422, P275; Takahara M, 2000, MOL GEN GENET, V264, P452, DOI 10.1007/s004380000307; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terui S, 1995, J PHYCOL, V31, P958, DOI 10.1111/j.0022-3646.1995.00958.x; Toda Kyoko, 1995, Cytologia (Tokyo), V60, P183; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zauner S, 2000, P NATL ACAD SCI USA, V97, P200, DOI 10.1073/pnas.97.1.200	31	803	841	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					653	657		10.1038/nature02398	http://dx.doi.org/10.1038/nature02398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071595	hybrid			2022-12-01	WOS:000220697200044
J	Nowak, MA; Sasaki, A; Taylor, C; Fudenberg, D				Nowak, MA; Sasaki, A; Taylor, C; Fudenberg, D			Emergence of cooperation and evolutionary stability in finite populations	NATURE			English	Article							TIT-FOR-TAT; STABLE STRATEGIES; GAMES	To explain the evolution of cooperation by natural selection has been a major goal of biologists since Darwin. Cooperators help others at a cost to themselves, while defectors receive the benefits of altruism without providing any help in return. The standard game dynamical formulation is the 'Prisoner's Dilemma'(1-11), in which two players have a choice between cooperation and defection. In the repeated game, cooperators using direct reciprocity cannot be exploited by defectors, but it is unclear how such cooperators can arise in the first place(12-15). In general, defectors are stable against invasion by cooperators. This understanding is based on traditional concepts of evolutionary stability and dynamics in infinite populations(16-20). Here we study evolutionary game dynamics in finite populations(21-25). We show that a single cooperator using a strategy like 'tit-for-tat' can invade a population of defectors with a probability that corresponds to a net selective advantage. We specify the conditions required for natural selection to favour the emergence of cooperation and define evolutionary stability in finite populations.	Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Math, Cambridge, MA 02138 USA; Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; MIT, Dept Math, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard University; Harvard University; Kyushu University; Massachusetts Institute of Technology (MIT)	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008					AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod Robert K., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Dugatkin LA., 1997, COOPERATION ANIMALS; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; FICCI S, 2000, P 2000 GEN EV COMP C, P927; Fogel GB, 1998, ECOL MODEL, V109, P283, DOI 10.1016/S0304-3800(98)00068-4; FUDENBERG D, 1990, AM ECON REV, V80, P274; FUDENBERG D, 1992, J ECON THEORY, V57, P420, DOI 10.1016/0022-0531(92)90044-I; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hammerstein P, 2003, GENETIC CULTURAL EVO; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J., 1998, EVOLUTIONARY GAMES P, DOI 10.1017/CBO9781139173179; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Killingback T, 1998, J THEOR BIOL, V191, P335, DOI 10.1006/jtbi.1997.0602; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; MAY RM, 1987, NATURE, V327, P15, DOI 10.1038/327015a0; Maynard Smith J., 1982, pi; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Moran PAP., 1962, STAT PROCESSES EVOLU; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; RILEY JG, 1979, J THEOR BIOL, V76, P109, DOI 10.1016/0022-5193(79)90365-5; SCHAFFER ME, 1988, J THEOR BIOL, V132, P469, DOI 10.1016/S0022-5193(88)80085-7; Schreiber SJ, 2001, SIAM J APPL MATH, V61, P2148, DOI 10.1137/S0036139999352857; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	31	886	921	13	298	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					646	650		10.1038/nature02414	http://dx.doi.org/10.1038/nature02414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071593	Green Submitted			2022-12-01	WOS:000220697200042
J	Vitiello, B; Swedo, S				Vitiello, B; Swedo, S			Antidepressant medications in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADOLESCENTS; DEPRESSION; FLUOXETINE; TRIAL		NIMH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Vitiello, B (corresponding author), NIMH, Bethesda, MD 20892 USA.		Vitiello, Benedetto/AAC-1758-2022		NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002666, ZIAMH002666] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P1236, DOI 10.1001/archpsyc.60.12.1236; *PSYCH DRUGS ADV C, 2004, BRIEF INF	5	66	67	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1489	1491		10.1056/NEJMp038248	http://dx.doi.org/10.1056/NEJMp038248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	810CI	15071123				2022-12-01	WOS:000220682000003
J	Dunham, A; Matthews, LH; Burton, J; Ashurst, JL; Howe, KL; Ashcroft, KJ; Beare, DM; Burford, DC; Hunt, SE; Griffiths-Jones, S; Jones, MC; Keenan, SJ; Oliver, K; Scott, CE; Ainscough, R; Almeida, JP; Ambrose, KD; Andrews, DT; Ashwell, RIS; Babbage, AK; Bagguley, CL; Bailey, J; Bannerjee, R; Barlow, KF; Bates, K; Beasley, H; Bird, CP; Bray-Allen, S; Brown, AJ; Brown, JY; Burrill, W; Carder, C; Carter, NP; Chapman, JC; Clamp, ME; Clark, SY; Clarke, G; Clee, CM; Clegg, SCM; Cobley, V; Collins, JE; Corby, N; Coville, GJ; Deloukas, P; Dhami, P; Dunham, I; Dunn, M; Earthrowl, ME; Ellington, AG; Faulkner, L; Frankish, AG; Frankland, J; French, L; Garner, P; Garnett, J; Gilbert, JGR; Gilson, CJ; Ghori, J; Grafham, DV; Gribble, SM; Griffiths, C; Hall, RE; Hammond, S; Harley, JL; Hart, EA; Heath, PD; Howden, PJ; Huckle, EJ; Hunt, PJ; Hunt, AR; Johnson, C; Johnson, D; Kay, M; Kimberley, AM; King, A; Laird, GK; Langford, CJ; Lawlor, S; Leongamornlert, DA; Lloyd, DM; Lloyd, C; Loveland, JE; Lovell, J; Martin, S; Mashreghi-Mohammadi, M; McLaren, SJ; McMurray, A; Milne, S; Moore, MJF; Nickerson, T; Palmer, SA; Pearce, AV; Peck, AI; Pelan, S; Phillimore, B; Porter, KM; Rice, CM; Searle, S; Sehra, HK; Shownkeen, R; Skuce, CD; Smith, M; Steward, CA; Sycamore, N; Tester, J; Thomas, DW; Tracey, A; Tromans, A; Tubby, B; Wall, M; Wallis, JM; West, AP; Whitehead, SL; Willey, DL; Wilming, L; Wray, PW; Wright, MW; Young, L; Coulson, A; Durbin, R; Hubbard, T; Sulston, JE; Beck, S; Bentley, DR; Rogers, J; Ross, MT				Dunham, A; Matthews, LH; Burton, J; Ashurst, JL; Howe, KL; Ashcroft, KJ; Beare, DM; Burford, DC; Hunt, SE; Griffiths-Jones, S; Jones, MC; Keenan, SJ; Oliver, K; Scott, CE; Ainscough, R; Almeida, JP; Ambrose, KD; Andrews, DT; Ashwell, RIS; Babbage, AK; Bagguley, CL; Bailey, J; Bannerjee, R; Barlow, KF; Bates, K; Beasley, H; Bird, CP; Bray-Allen, S; Brown, AJ; Brown, JY; Burrill, W; Carder, C; Carter, NP; Chapman, JC; Clamp, ME; Clark, SY; Clarke, G; Clee, CM; Clegg, SCM; Cobley, V; Collins, JE; Corby, N; Coville, GJ; Deloukas, P; Dhami, P; Dunham, I; Dunn, M; Earthrowl, ME; Ellington, AG; Faulkner, L; Frankish, AG; Frankland, J; French, L; Garner, P; Garnett, J; Gilbert, JGR; Gilson, CJ; Ghori, J; Grafham, DV; Gribble, SM; Griffiths, C; Hall, RE; Hammond, S; Harley, JL; Hart, EA; Heath, PD; Howden, PJ; Huckle, EJ; Hunt, PJ; Hunt, AR; Johnson, C; Johnson, D; Kay, M; Kimberley, AM; King, A; Laird, GK; Langford, CJ; Lawlor, S; Leongamornlert, DA; Lloyd, DM; Lloyd, C; Loveland, JE; Lovell, J; Martin, S; Mashreghi-Mohammadi, M; McLaren, SJ; McMurray, A; Milne, S; Moore, MJF; Nickerson, T; Palmer, SA; Pearce, AV; Peck, AI; Pelan, S; Phillimore, B; Porter, KM; Rice, CM; Searle, S; Sehra, HK; Shownkeen, R; Skuce, CD; Smith, M; Steward, CA; Sycamore, N; Tester, J; Thomas, DW; Tracey, A; Tromans, A; Tubby, B; Wall, M; Wallis, JM; West, AP; Whitehead, SL; Willey, DL; Wilming, L; Wray, PW; Wright, MW; Young, L; Coulson, A; Durbin, R; Hubbard, T; Sulston, JE; Beck, S; Bentley, DR; Rogers, J; Ross, MT			The DNA sequence and analysis of human chromosome 13	NATURE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; HUMAN GENOME SEQUENCE; SEGMENTAL DUPLICATIONS; PHYSICAL MAPS; RNA GENES; DATABASE; FAMILY; POLYMORPHISMS; RECOMBINATION; LOCALIZATION	Chromosome 13 is the largest acrocentric human chromosome. It carries genes involved in cancer including the breast cancer type 2 (BRCA2) and retinoblastoma (RB1) genes, is frequently rearranged in B-cell chronic lymphocytic leukaemia, and contains the DAOA locus associated with bipolar disorder and schizophrenia. We describe completion and analysis of 95.5 megabases (Mb) of sequence from chromosome 13, which contains 633 genes and 296 pseudogenes. We estimate that more than 95.4% of the protein-coding genes of this chromosome have been identified, on the basis of comparison with other vertebrate genome sequences. Additionally, 105 putative non-coding RNA genes were found. Chromosome 13 has one of the lowest gene densities (6.5 genes per Mb) among human chromosomes, and contains a central region of 38 Mb where the gene density drops to only 3.1 genes per Mb.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England	Wellcome Trust Sanger Institute; University of London; University College London	Dunham, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	ad1@sanger.ac.uk	Wright, Mathew/H-5394-2012; Hubbard, Tim J.P./AAT-4571-2020; Johnson, David/A-3907-2011; Hubbard, Tim J/C-2567-2008; Deloukas, Panos/B-2922-2013; Frankish, Adam/G-6545-2011; Durbin, Richard/AAE-7178-2019; Griffiths-Jones, Sam/H-2998-2014	Wright, Mathew/0000-0002-2650-2426; Hubbard, Tim J.P./0000-0002-1767-9318; Johnson, David/0000-0003-0887-3343; Hubbard, Tim J/0000-0002-1767-9318; Deloukas, Panos/0000-0001-9251-070X; Durbin, Richard/0000-0002-9130-1006; Leongamornlert, Daniel/0000-0002-3486-3168; Dunham, Ian/0000-0003-2525-5598; Steward, Charles/0000-0001-8829-5349; Frankish, Adam/0000-0002-4333-628X; Gilbert, James/0000-0001-8079-3159; Fosker, Christine/0000-0002-3799-9474; Hunt, Sarah/0000-0002-8350-1235; Howe, Kevin/0000-0002-1751-9226; Wass, Elizabeth/0000-0002-8605-9921; Wilming, Laurens/0000-0002-4154-7358; Davidson, Claire/0000-0002-4910-8202; Griffiths-Jones, Sam/0000-0001-6043-807X; Keenan, Stephen/0000-0002-9141-7690; Andrews, Dan/0000-0003-3922-6376; Kay, Mike/0000-0002-3282-0834; Hunt, Adrienne/0000-0002-1227-0310; Martin, Sancha/0000-0001-6213-5259; Loveland, Jane/0000-0002-7669-2934				Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Beyer K, 2000, J INVEST DERMATOL, V115, P906, DOI 10.1046/j.1523-1747.2000.00096.x; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Felsenfeld A, 1999, GENOME RES, V9, P1; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guipponi M, 2001, HUM GENET, V109, P569, DOI 10.1007/s004390100607; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kehrer-Sawatzki H, 1998, CHROMOSOME RES, V6, P429, DOI 10.1023/A:1009287223826; Kimura K, 1999, HUM MOL GENET, V8, P1487, DOI 10.1093/hmg/8.8.1487; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Neat MJ, 2001, GENE CHROMOSOME CANC, V32, P236, DOI 10.1002/gcc.1187; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rowntree C, 2002, LEUKEMIA, V16, P1267, DOI 10.1038/sj.leu.2402551; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Stoesser G, 2003, NUCLEIC ACIDS RES, V31, P17, DOI 10.1093/nar/gkg021; Wain HM, 2002, NUCLEIC ACIDS RES, V30, P169, DOI 10.1093/nar/30.1.169; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	50	65	387	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					522	528		10.1038/nature02379	http://dx.doi.org/10.1038/nature02379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15057823	Green Accepted, Bronze			2022-12-01	WOS:000220540100033
J	Lotery, HE; McClure, N; Galask, RP				Lotery, HE; McClure, N; Galask, RP			Vulvoldynia	LANCET			English	Review							VULVAR VESTIBULITIS SYNDROME; CONTACT-DERMATITIS; PAIN-SYNDROME; VULVODYNIA; WOMEN; FEATURES; DYSESTHESIA; INNERVATION; INTERFERON; PREVALENCE	Context Vulvodynia is a term used to describe chronic burning and/or pain in the vulva without objective physical findings to explain the symptoms. The terminology and classification of vulvodynia continue to evolve, and much remains to be understood about the prevalence, pathogenesis, natural history, and management of this distressing condition. Starting point James Aikens and colleagues showed that chronic vulva] pain (vulvodynia or vulvar dysaesthesia) is associated with worse depressive symptoms (Am J Obstet Gynecol 2003; 189: 462-66). However, the increased: scores for depression in this case-control study were attributed to sexual disinterest and experience of chronic pain rather than to features of depressive disorder. These results lend weight to the increasing need for better understanding of the pathogenesis of vulval pain and how to manage it appropriately. Where next? The aetiology of vulvodynia and effectiveness; of treatments need further study. Appraising the available I literature, we have formulated a useful approach to patients with chronic vulval pain. There is a pressing need for further case-control studies of potential causes of vulvodynia and for randomised trials of interventions.	Royal S Hants Hosp, Dept Dermatol, Southampton SO14 0YG, Hants, England; Queens Univ Belfast, Sch Med Obstet & Gynaecol, Belfast, Antrim, North Ireland; Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Univ Iowa Hosp & Clin, Dept Dermatol, Iowa City, IA 52242 USA; Univ Iowa Hosp & Clin, Dept Microbiol, Iowa City, IA 52242 USA	University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital; Queens University Belfast; University of Iowa; University of Iowa; University of Iowa	Lotery, HE (corresponding author), Royal S Hants Hosp, Dept Dermatol, Southampton SO14 0YG, Hants, England.	hlotery@doctors.org.uk						ACOG educational bulletin, 1998, INT J GYNAECOL OBSTE, V60, P181; Aikens JE, 2003, AM J OBSTET GYNECOL, V189, P462, DOI 10.1067/S0002-9378(03)00521-0; Baggish MS, 1997, AM J OBSTET GYNECOL, V177, P507, DOI 10.1016/S0002-9378(97)70137-6; BAZIN S, 1994, OBSTET GYNECOL, V83, P47; BERGERON C, 1994, J REPROD MED, V39, P936; Bergeron S, 2001, OBSTET GYNECOL, V98, P45, DOI 10.1016/S0029-7844(01)01389-8; Bodden-Heidrich R, 1999, J REPROD MED, V44, P411; Bohm-Starke N, 2001, ACTA OBSTET GYN SCAN, V80, P638, DOI 10.1034/j.1600-0412.2001.800709.x; Bohm-Starke N, 1998, GYNECOL OBSTET INVES, V46, P256, DOI 10.1159/000010045; Chadha S, 1998, INT J GYNECOL PATHOL, V17, P7, DOI 10.1097/00004347-199801000-00002; Danielsson I, 2000, ACTA OBSTET GYN SCAN, V79, P872, DOI 10.1034/j.1600-0412.2000.079010872.x; Denbow ML, 1998, INT J STD AIDS, V9, P88, DOI 10.1258/0956462981921738; Eason EL, 1996, CAN MED ASSOC J, V154, P1173; Edwards L, 1997, J REPROD MED, V42, P135; FISCHER G, 1995, BRIT J OBSTET GYNAEC, V102, P773, DOI 10.1111/j.1471-0528.1995.tb10841.x; FRIEDRICH EG, 1987, J REPROD MED, V32, P110; Gerber S, 2002, AM J OBSTET GYNECOL, V186, P361, DOI 10.1067/mob.2002.121091; Gerber S, 2002, AM J OBSTET GYNECOL, V186, P696, DOI 10.1067/mob.2002.121869; Glazer HI, 2000, J REPROD MED, V45, P798; GOETSCH MF, 1991, AM J OBSTET GYNECOL, V164, P1609, DOI 10.1016/0002-9378(91)91444-2; Granot M, 2002, BJOG-INT J OBSTET GY, V109, P863, DOI 10.1111/j.1471-0528.2002.01416.x; Harlow Bernard L, 2003, J Am Med Womens Assoc (1972), V58, P82; Jeremias J, 2000, AM J OBSTET GYNECOL, V182, P283, DOI 10.1016/S0002-9378(00)70212-2; KAUFMAN RH, 1994, BENIGN DIS VULVA VAG; KENT HL, 1990, J REPROD MED, V35, P1138; Lundqvist EN, 1997, ACTA DERM-VENEREOL, V77, P319; Lynch P.J., 1994, GENITAL DERMATOLOGY; MARREN P, 1992, BRIT J DERMATOL, V126, P52, DOI 10.1111/j.1365-2133.1992.tb08403.x; Masterson BJ, 1996, J REPROD MED, V41, P562; MCKAY M, 1988, J REPROD MED, V33, P695; MCKAY M, 1993, J REPROD MED, V38, P9; MCKAY M, 1984, J REPROD MED, V29, P457; Neill SM, 2000, ANN DERMATOL VENER, V127, P368; Nunns D, 2000, BRIT J OBSTET GYNAEC, V107, P1185, DOI 10.1111/j.1471-0528.2000.tb11606.x; PECKHAM BM, 1986, AM J OBSTET GYNECOL, V154, P855, DOI 10.1016/0002-9378(86)90472-2; Powell J, 1999, J ROY SOC MED, V92, P579, DOI 10.1177/014107689909201110; Pukall CF, 2002, PAIN, V96, P163, DOI 10.1016/S0304-3959(01)00442-0; PYKA RE, 1988, INT J GYNECOL PATHOL, V7, P249, DOI 10.1097/00004347-198809000-00005; Reed BD, 2003, J REPROD MED, V48, P409; RIDLEY CM, 1999, VULVA; Scheinfeld N, 2003, INT J DERMATOL, V42, P491, DOI 10.1046/j.1365-4362.2003.01831.x; SOBEL JD, 1992, CLIN INFECT DIS   S1, V14, P148; STEWART DE, 1994, OBSTET GYNECOL, V84, P587; TURNER MLC, 1991, AM J OBSTET GYNECOL, V165, P1233, DOI 10.1016/S0002-9378(12)90733-4; Tympanidis P, 2003, BRIT J DERMATOL, V148, P1021, DOI 10.1046/j.1365-2133.2003.05308.x; Wesselmann U, 1996, SEMIN NEUROL, V16, P63, DOI 10.1055/s-2008-1040961; Westrom LV, 1998, OBSTET GYNECOL, V91, P572, DOI 10.1016/S0029-7844(97)00719-9; Zolnoun DA, 2003, OBSTET GYNECOL, V102, P84, DOI 10.1016/S0029-7844(03)00368-5	48	27	30	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 27	2004	363	9414					1058	1060		10.1016/S0140-6736(04)15842-X	http://dx.doi.org/10.1016/S0140-6736(04)15842-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15065562				2022-12-01	WOS:000220497300021
J	Fernandez, JM; Li, HB				Fernandez, JM; Li, HB			Force-clamp spectroscopy monitors the folding trajectory of a single protein	SCIENCE			English	Article							TITIN IMMUNOGLOBULIN DOMAINS; KINETIC-ANALYSIS; FLEXIBLE COIL; COLLAPSE; MICROSCOPY; UBIQUITIN; MOLECULE; PATHWAY; MODEL; FUNNELS	We used force-clamp atomic force micoscopy to measure the end-to-end length of the small protein ubiquitin during its folding reaction at the single-molecule level. Ubiquitin was first unfolded and extended at a high force, then the stretching force was quenched and protein folding was observed. The folding trajectories were continuous and marked by several distinct stages. The time taken to fold was dependent on the contour length of the unfolded protein and the stretching force applied during folding. The folding collapse was marked by large fluctuations in the end-to-end length of the protein, but these fluctuations vanished upon the final folding contraction. These direct observations of the complete folding trajectory of a protein provide a benchmark to determine the physical basis of the folding reaction.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jfernandez@columbia.edu	Li, Hongbin/G-2949-2012	Li, Hongbin/0000-0001-7813-1332				Buguin A, 1996, CR ACAD SCI II B, V322, P741; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHU B, 1995, MACROMOLECULES, V28, P180, DOI 10.1021/ma00105a024; DEGENNES PG, 1985, J PHYS LETT-PARIS, V46, pL639, DOI 10.1051/jphyslet:019850046014063900; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Frisch T, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041801; Gao M, 2001, BIOPHYS J, V81, P2268, DOI 10.1016/S0006-3495(01)75874-2; GROSBERG AY, 1988, J PHYS-PARIS, V49, P2095, DOI 10.1051/jphys:0198800490120209500; Halperin A, 2000, PHYS REV E, V61, P565, DOI 10.1103/PhysRevE.61.565; Hardin C, 2002, J COMPUT CHEM, V23, P138, DOI 10.1002/jcc.1162; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; Klimov DK, 1997, PHYS REV LETT, V79, P317, DOI 10.1103/PhysRevLett.79.317; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638; NISHIO I, 1982, NATURE, V300, P243, DOI 10.1038/300243a0; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Pande VS, 2000, REV MOD PHYS, V72, P259, DOI 10.1103/RevModPhys.72.259; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WILLIAMS C, 1981, ANNU REV PHYS CHEM, V32, P433, DOI 10.1146/annurev.pc.32.100181.002245; Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43937; Zhou YQ, 1999, J MOL BIOL, V293, P917, DOI 10.1006/jmbi.1999.2936	32	446	459	1	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2004	303	5664					1674	1678		10.1126/science.1092497	http://dx.doi.org/10.1126/science.1092497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15017000				2022-12-01	WOS:000220151400045
J	Wu, CI; Shi, SH; Zhang, YP				Wu, CI; Shi, SH; Zhang, YP			A case for conservation	NATURE			English	Editorial Material									Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; Yunnan Univ, Kunming 650091, Yunnan, Peoples R China	University of Chicago; Sun Yat Sen University; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University	Wu, CI (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.							Normile D, 2003, SCIENCE, V302, P559, DOI 10.1126/science.302.5645.559	1	10	10	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2004	428	6979					213	214		10.1038/428213a	http://dx.doi.org/10.1038/428213a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014510				2022-12-01	WOS:000220103600059
J	Fox, NC; Schott, JM				Fox, NC; Schott, JM			Imaging cerebral atrophy: normal ageing to Alzheimer's disease	LANCET			English	Review							MAGNETIC-RESONANCE IMAGES; HIPPOCAMPAL ATROPHY; COGNITIVE DECLINE; LONGITUDINAL MRI; BRAIN ATROPHY; TEMPORAL-LOBE; GRAY-MATTER; HUMAN LIFE; RATES; HEALTHY	Context With ageing populations, the prevalence of dementia, especially Alzheimer's disease, is set to soar. Alzheimer's disease is associated with progressive cerebral atrophy, which can be seen on MRI with high resolution. Longitudinal MRI could track disease progression and detect neurodegenerative diseases earlier to allow prompt and specific treatment. Such use of MRI requires accurate understanding of how brain changes in normal ageing differ from those in dementia. Starting point Recently, Henry Rusinek and colleagues, in a 6-year longitudinal MRI study of initially healthy elderly subjects, showed that an increased rate of atrophy in the medial temporal lobe predicted future cognitive decline with a specificity of 91% and sensitivity of 89% (Radiology 2003; 229: 691-96). Where next? As understanding of neurodegenerative diseases increases, specific disease-modifying treatments might become available. Serial MRI could help to determine the efficacy of such treatments, which would be expected to slow the rate of atrophy towards that of normal ageing, and might also detect the onset of neurodegeneration. The amount and pattern of excess atrophy might help to predict the underlying pathological process, allowing specific therapies to be started. As the precision of imaging improves, the ability to distinguish healthy ageing from degenerative dementia should improve.	Inst Neurol, Dementia Res Grp, London WC1N 3BG, England	University of London; University College London	Fox, NC (corresponding author), Inst Neurol, Dementia Res Grp, Queen Sq, London WC1N 3BG, England.	nfox@dementia.ion.ucl.ac.uk	Fox, Nick C/B-1319-2009; Schott, Jonathan M/A-9065-2011; Fox, Nick C/AAE-1849-2021	Fox, Nick C/0000-0002-6660-657X; Schott, Jonathan M/0000-0003-2059-024X; Fox, Nick C/0000-0002-6660-657X	Medical Research Council [G116/143] Funding Source: Medline; MRC [G116/143] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Blinkov SM, 1968, HUMAN BRAIN FIGURES; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chan D, 2003, LANCET, V362, P1121, DOI 10.1016/S0140-6736(03)14469-8; COFFEY CE, 1992, NEUROLOGY, V42, P527, DOI 10.1212/WNL.42.3.527; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Du AT, 2003, NEUROLOGY, V60, P481, DOI 10.1212/01.WNL.0000044400.11317.EC; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HO KC, 1980, ARCH PATHOL LAB MED, V104, P635; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P27, DOI 10.1001/archneur.1990.00530010035015; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; MILLER AKH, 1977, ANN HUM BIOL, V4, P253, DOI 10.1080/03014467700007142; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Mueller EA, 1998, NEUROLOGY, V51, P1555, DOI 10.1212/WNL.51.6.1555; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schott JM, 2003, ANN NEUROL, V53, P181, DOI 10.1002/ana.10424; Silbert LC, 2003, NEUROLOGY, V61, P487, DOI 10.1212/01.WNL.0000079053.77227.14; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Thompson PM, 2003, J NEUROSCI, V23, P994	32	281	285	1	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 31	2004	363	9406					392	394		10.1016/S0140-6736(04)15441-X	http://dx.doi.org/10.1016/S0140-6736(04)15441-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15074306				2022-12-01	WOS:000188590900025
J	Mamdani, M; Juurlink, DN; Kopp, A; Naglie, G; Austin, PC; Laupacis, A				Mamdani, M; Juurlink, DN; Kopp, A; Naglie, G; Austin, PC; Laupacis, A			Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study	BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RHEUMATOID-ARTHRITIS; TOXICITY		Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Mamdani, M (corresponding author), Inst Clin Evaluat Sci, 2075 Bayview Ave G106, Toronto, ON M4N 3M5, Canada.	muhammad.mamdani@ices.on.ca		Naglie, Gary/0000-0002-6274-0894; Austin, Peter/0000-0003-3337-233X				Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Mamdani M, 2002, BRIT MED J, V325, P624, DOI 10.1136/bmj.325.7365.624; PINDYCK RS, 1998, ECONOMETRIC MODELS E, pCH15; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Williams J. I., 1996, PATTERNS HLTH CARE O, P339	5	67	71	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 12	2004	328	7453					1415	1416		10.1136/bmj.38068.716262.F7	http://dx.doi.org/10.1136/bmj.38068.716262.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830IB	15138157	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000222114400022
J	Becker, L; Poreda, RJ; Basu, AR; Pope, KO; Harrison, TM; Nicholson, C; Iasky, R				Becker, L; Poreda, RJ; Basu, AR; Pope, KO; Harrison, TM; Nicholson, C; Iasky, R			Bedout: A possible end-Permian impact crater offshore of Northwestern Australia	SCIENCE			English	Article							CRETACEOUS-TERTIARY BOUNDARY; TRIASSIC BOUNDARY; CHICXULUB IMPACT; FLOOD BASALTS; NOBLE-GASES; BASIN; ANTARCTICA; FULLERENES; EXTINCTION; EVOLUTION	The Bedout High, located on the northwestern continental margin of Australia, has emerged as a prime candidate for an end-Permian impact structure. Seismic imaging, gravity data, and the identification of melt rocks and impact breccias from drill cores located on top of Bedout are consistent with the presence of a buried impact crater. The impact breccias contain nearly pure silica glass ( SiO2), fractured and shock-melted plagioclases, and spherulitic glass. The distribution of glass and shocked minerals over hundreds of meters of core material implies that a melt sheet is present. Available gravity and seismic data suggest that the Bedout High represents the central uplift of a crater similar in size to Chicxulub. A plagioclase separate from the Lagrange-1 exploration well has an Ar/Ar age of 250.1 +/- 4.5 million years. The location, size, and age of the Bedout crater can account for reported occurrences of impact debris in Permian-Triassic boundary sediments worldwide.	Univ Calif Santa Barbara, Dept Geol Sci, Inst Crustal Studies, Santa Barbara, CA 93106 USA; Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Geo Eco Arc Res, Aquasco, MD 20608 USA; Australian Natl Univ, Canberra, ACT, Australia; Geol Survey Western Australia, Perth, WA 6004, Australia	University of California System; University of California Santa Barbara; University of Rochester; Australian National University; Geological Survey of Western Australia	Becker, L (corresponding author), Univ Calif Santa Barbara, Dept Geol Sci, Inst Crustal Studies, Santa Barbara, CA 93106 USA.	lbecker@crustal.ucsb.edu	Harrison, Timothy M/E-7443-2012					ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; BASU AR, 1993, SCIENCE, V261, P902, DOI 10.1126/science.261.5123.902; Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; BECKER L, 2002, AM GEOPH UN AGU ABST; Charlton TR, 2001, J ASIAN EARTH SCI, V19, P595, DOI 10.1016/S1367-9120(00)00054-7; Christeson GL, 2001, J GEOPHYS RES-SOL EA, V106, P21751, DOI 10.1029/2001JB000337; Claeys P, 2003, METEORIT PLANET SCI, V38, P1299, DOI 10.1111/j.1945-5100.2003.tb00315.x; COLWELL S, 1994, SEDIMENTARY BASINS W, P757; FRENCH BM, 1998, 594 LPI; Glikson AY, 1999, GEOLOGY, V27, P387, DOI 10.1130/0091-7613(1999)027<0387:OMIACE>2.3.CO;2; GORTER J, 1996, PET EXPLOR SOC AUST, P33; GORTER J, 1998, AUST PET PROD EXPLOR, P159; Graup G, 1999, METEORIT PLANET SCI, V34, P425, DOI 10.1111/j.1945-5100.1999.tb01351.x; *GSWA, 1983, WELL REP GRANG 1 BED; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; HORSTMAN EL, 1984, CANNING BASIN W AUST, P240; IVANOV BA, 2003, LUNAR PLANET SCI, V34, P1338; Izett G. A., 1990, GEOL SOC AM SPEC PAP, V249; JONES AP, 2002, EARTH PLANET SC LETT, V6343, P1; Kaiho K, 2001, GEOLOGY, V29, P815, DOI 10.1130/0091-7613(2001)029<0815:EPCBAB>2.0.CO;2; KRITSKI A, 2000, THESIS U SYDNEY SYDN; KYTE FT, 1995, EARTH PLANET SC LETT, V132, P113, DOI 10.1016/0012-821X(95)00051-D; MELOSH HJ, 2000, CATASTROPHIC EVENTS, P3144; Melosh J, 2001, NATURE, V414, P861, DOI 10.1038/414861a; Miono S, 1996, NUCL INSTRUM METH B, V109, P612, DOI 10.1016/0168-583X(95)00978-7; MIONO S, 1966, NUCL INSTRUM METH B, V150, P516; Morgan J, 1999, GEOLOGY, V27, P407, DOI 10.1130/0091-7613(1999)027<0407:CTTDOA>2.3.CO;2; PETAEV MI, 2004, LUN PLAN SCI C ABSTR, V35, P1216; Pope KO, 2002, GEOLOGY, V30, P99, DOI 10.1130/0091-7613(2002)030<0099:IDNTCO>2.0.CO;2; Poreda RJ, 2003, ASTROBIOLOGY, V3, P75, DOI 10.1089/153110703321632435; PURCELL PG, 1994, SEDIMENTARY BASINS W, P63; PURCELL PG, 1994, SEDIMENTARY BASINS W, P769; Reeckmann S., 1984, CANNING BASIN, P389; Reichow MK, 2002, SCIENCE, V296, P1846, DOI 10.1126/science.1071671; RENNE PR, 1991, SCIENCE, V253, P176, DOI 10.1126/science.253.5016.176; Retallack GJ, 1998, GEOLOGY, V26, P979, DOI 10.1130/0091-7613(1998)026<0979:SFEOIA>2.3.CO;2; SCHURAYTZ BC, 1994, GEOLOGY, V22, P868, DOI 10.1130/0091-7613(1994)022<0868:POIMRA>2.3.CO;2; SHARPTON VL, 1992, NATURE, V359, P819, DOI 10.1038/359819a0; Smit J, 1999, ANNU REV EARTH PL SC, V27, P75, DOI 10.1146/annurev.earth.27.1.75; SMITH SA, 1999, THESIS U ADELAIDE AD; Stu┬ffler D., 1972, FORTSCHRITTE MINERAL, V49, P50; Tsikalas F, 1998, GEOL SOC AM BULL, V110, P537, DOI 10.1130/0016-7606(1998)110<0537:CIAPDA>2.3.CO;2; Tsikalas F, 1998, J GEOPHYS RES-SOL EA, V103, P30469, DOI 10.1029/97JB03389; TSIKALAS F, 1998, J GEOPHYS RES, V103, P30	46	148	174	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1469	1476		10.1126/science.1093925	http://dx.doi.org/10.1126/science.1093925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15143216				2022-12-01	WOS:000221795800034
J	Chung, KKK; Thomas, B; Li, XJ; Pletnikova, O; Troncoso, JC; Marsh, L; Dawson, VL; Dawson, TM				Chung, KKK; Thomas, B; Li, XJ; Pletnikova, O; Troncoso, JC; Marsh, L; Dawson, VL; Dawson, TM			S-nitrosylation of Parkin regulates ubiquitination and compromises Parkin's protective function	SCIENCE			English	Article							NEURONAL NITRIC-OXIDE; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; PROTEIN LIGASE; DISEASE; NEURODEGENERATION; MUTATIONS; COMPLEX; PATHOGENESIS; ASSOCIATION	Parkin is an E3 ubiquitin ligase involved in the ubiquitination of proteins that are important in the survival of dopamine neurons in Parkinson's disease (PD). We show that parkin is S-nitrosylated in vitro, as well as in vivo in a mouse model of PD and in brains of patients with PD and diffuse Lewy body disease. Moreover, S-nitrosylation inhibits parkin's ubiquitin E3 ligase activity and its protective function. The inhibition of parkin's ubiquitin E3 ligase activity by S-nitrosylation could contribute to the degenerative process in these disorders by impairing the ubiquitination of parkin substrates.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38377] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chung KKK, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1304-9; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Feany MB, 2003, NEURON, V38, P13, DOI 10.1016/S0896-6273(03)00201-0; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hattori N, 2003, J NEUROL, V250, P2, DOI 10.1007/s00415-003-1302-y; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Liberatore GT, 1999, NAT MED, V5, P1403; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Przedborski T, 2003, ADV NEUROL, V91, P83; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319	33	605	623	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1328	1331		10.1126/science.1093891	http://dx.doi.org/10.1126/science.1093891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15105460				2022-12-01	WOS:000221669600056
J	Groce, NE; Trasi, R				Groce, NE; Trasi, R			Rape of individuals with disability: AIDS and the folk belief of virgin cleansing	LANCET			English	Editorial Material							SOUTH-AFRICA; ABUSE; WOMEN		Yale Univ, Sch Publ Hlth, Global Hlth Div, New Haven, CT 06520 USA	Yale University	Groce, NE (corresponding author), Yale Univ, Sch Publ Hlth, Global Hlth Div, New Haven, CT 06520 USA.	nora.groce@yale.edu		Groce, Nora/0000-0002-7885-7042				Cambridge P, 1997, DISABIL SOC, V12, P427, DOI 10.1080/09687599727272; DOSSANTOS V, 2004, STATEMENT SEXUAL ABU; Earl-Taylor M, 2002, HIV AIDS STATS VIRGI; Groce NE, 2003, LANCET, V361, P1401, DOI 10.1016/S0140-6736(03)13146-7; Jewkes R, 2002, LANCET, V359, P711, DOI 10.1016/S0140-6736(02)07794-2; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; *MENT DIS RIGHTS I, 2002, NOT AG HUM RIGHTS PE; Nosek MA, 2001, VIOLENCE AGAINST WOM, V7, P477, DOI 10.1177/10778010122182569; Pitcher GJ, 2002, LANCET, V359, P274, DOI 10.1016/S0140-6736(02)07532-3; Saxton M, 2001, VIOLENCE AGAINST WOM, V7, P393, DOI 10.1177/10778010122182523; SMITH C, 2003, IASSCS C SEX SECR JO; SOBSEY D, 1991, VIOLENCE ABUSE LIVES; *UN INT REG INF NE, 2002, FOC VIRG MYTH HIV AI; Womendez C., 1991, SEX DISABIL, V9, P273, DOI DOI 10.1007/BF01102397; *YAL U WORLD BANK, 2004, HIV AIDS DIS GLOB SU	15	84	84	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 22	2004	363	9422					1663	1664		10.1016/S0140-6736(04)16288-0	http://dx.doi.org/10.1016/S0140-6736(04)16288-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822NG	15158626				2022-12-01	WOS:000221546300005
J	Patel, SD; Rajala, MW; Rossetti, L; Scherer, PE; Shapiro, L				Patel, SD; Rajala, MW; Rossetti, L; Scherer, PE; Shapiro, L			Disulfide-dependent multimeric assembly of resistin family hormones	SCIENCE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; PROTEIN ACRP30; ADIPOCYTE; THIAZOLIDINEDIONES; CYSTEINE; MOLECULE; OBESITY; DIFFERENTIATION	Resistin, founding member of the resistin-like molecule (RELM) hormone family, is secreted selectively from adipocytes and induces liver-specific antagonism of insulin action, thus providing a potential molecular link between obesity and diabetes. Crystal structures of resistin and RELMbeta reveal an unusual multimeric structure. Each protomer comprises a carboxy-terminal disulfide-rich beta-sandwich "head" domain and an amino-terminal alpha-helical "tail" segment. The alpha-helical segments associate to form three-stranded coiled coils, and surface-exposed interchain disulfide linkages mediate the formation of tail-to-tail hexamers. Analysis of serum samples shows that resistin circulates in two distinct assembly states, likely corresponding to hexamers and trimers. Infusion of a resistin mutant, lacking the intertrimer disulfide bonds, in pancreatic-insulin clamp studies reveals substantially more potent effects on hepatic insulin sensitivity than those observed with wildtype resistin. This result suggests that processing of the intertrimer disulfide bonds may reflect an obligatory step toward activation.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA; Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University	Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	lss8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019; Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392; Patel, Saurabh/0000-0002-5738-3175				Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Beales PE, 2002, DIABETES-METAB RES, V18, P114, DOI 10.1002/dmrr.262; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/en.143.3.998; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; FUJITA T, 1983, DIABETES, V32, P804, DOI 10.2337/diabetes.32.9.804; FUJIWARA T, 1988, DIABETES, V37, P1549, DOI 10.2337/diabetes.37.11.1549; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Hauner H, 2002, DIABETES-METAB RES, V18, pS10, DOI 10.1002/dmrr.249; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jazet IM, 2003, NETH J MED, V61, P194; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Rajala MW, 2002, MOL ENDOCRINOL, V16, P1920, DOI 10.1210/me.2002-0048; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; *US CENS, BUR CENS 2000 CENS E	32	236	259	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1154	1158		10.1126/science.1093466	http://dx.doi.org/10.1126/science.1093466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155948				2022-12-01	WOS:000221524500042
J	Lawrence, PA				Lawrence, PA			Last hideout of the unknown?	NATURE			English	Editorial Material							SIZE		MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lawrence, PA (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	pal@mrc-lmb.cam.ac.uk		Lawrence, Peter/0000-0002-9554-8268				Coen E, 2004, P NATL ACAD SCI USA, V101, P4728, DOI 10.1073/pnas.0306308101; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Day SJ, 2000, DEVELOPMENT, V127, P2977; Hafen E, 2003, PLOS BIOL, V1, P319, DOI 10.1371/journal.pbio.0000086; Lawrence P. A., 1992, MAKING FLY GENETICS; Thompson D.W., 1945, GROWTH FORM	6	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2004	429	6989					247	247		10.1038/429247a	http://dx.doi.org/10.1038/429247a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152230				2022-12-01	WOS:000221505900021
J	Sijacic, P; Wang, X; Skirpan, AL; Wang, Y; Dowd, PE; McCubbin, AG; Huang, S; Kao, TH				Sijacic, P; Wang, X; Skirpan, AL; Wang, Y; Dowd, PE; McCubbin, AG; Huang, S; Kao, TH			Identification of the pollen determinant of S-RNase-mediated self-incompatibility	NATURE			English	Article							F-BOX GENE; RECEPTOR-LIKE KINASE; PETUNIA-INFLATA; TRANSCRIPTIONAL ANALYSIS; LOCUS; REJECTION; ANTIRRHINUM; PROTEINS; INTERACTS	Many flowering plants have adopted self-incompatibility mechanisms to prevent inbreeding and promote out-crosses(1). In the Solanaceae, Rosaceae and Scrophulariaceae, two separate genes at the highly polymorphic S-locus control self-incompatibility interactions: the S-RNase gene encodes the pistil determinant and the previously unidentified S-gene encodes the pollen determinant(2-4). S-RNases interact with pollen S-allele products to inhibit the growth of self-pollen tubes in the style. Pollen-expressed F-box genes showing allelic sequence polymorphism have recently been identified near to the S-RNase gene in members of the Rosaceae and Scrophulariaceae(5-8); but until now have not been directly shown to encode the pollen determinant. Here we report the identification and characterization of PiSLF, an S-locus F-box gene of Petunia inflata ( Solanaceae). We show that transformation of S1S1, S1S2 and S2S3 plants with the S-2-allele of PiSLF causes breakdown of their pollen function in self-incompatibility. This breakdown of pollen function is consistent with 'competitive interaction', in which pollen carrying two different pollen S-alleles fails to function in self-incompatibility(1,9,10). We conclude that PiSLF encodes the pollen self-incompatibility determinant.	Penn State Univ, Integrat Biosci Grad Degree Program, Althouse Lab 403, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 403, University Pk, PA 16802 USA; Penn State Univ, Intercoll Grad Program Plant Physiol, Althouse Lab 403, University Pk, PA 16802 USA; Monsanto Co, Mystic Res, Mystic, CT 06355 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Monsanto	Kao, TH (corresponding author), Penn State Univ, Integrat Biosci Grad Degree Program, Althouse Lab 403, University Pk, PA 16802 USA.	txk3@psu.edu	McCubbin, Andrew/B-3178-2013					AI YJ, 1990, SEX PLANT REPROD, V3, P130, DOI 10.1007/BF00198857; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Golz JF, 1999, GENETICS, V152, P1123; Golz JF, 2001, P NATL ACAD SCI USA, V98, P15372, DOI 10.1073/pnas.261571598; HUANG S, 1994, PLANT CELL, V6, P1021, DOI 10.1105/tpc.6.7.1021; KAO TH, 2004, PLANT CELL      0309; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; Luu DT, 2001, GENETICS, V159, P329; McCubbin AG, 2000, GENOME, V43, P820, DOI 10.1139/gen-43-5-820; MU JH, 1994, PLANT CELL, V6, P709, DOI 10.1105/tpc.6.5.709; MURFETT J, 1994, NATURE, V367, P563, DOI 10.1038/367563a0; Nettancourt, 2001, INCOMPATIBILITY INCO; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Skirpan AL, 2001, PLANT PHYSIOL, V126, P1480, DOI 10.1104/pp.126.4.1480; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; Wang Y, 2003, PLANT MOL BIOL, V53, P565, DOI 10.1023/B:PLAN.0000019068.00034.09; WANG Y, IN PRESS PLANT MOL; Zhou JL, 2003, SEX PLANT REPROD, V16, P165, DOI 10.1007/s00497-003-0185-5	21	302	344	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					302	305		10.1038/nature02523	http://dx.doi.org/10.1038/nature02523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152253				2022-12-01	WOS:000221505900044
J	Maeda, M; Lu, SJ; Shaulsky, G; Miyazaki, Y; Kuwayama, H; Tanaka, Y; Kuspa, A; Loomis, WF				Maeda, M; Lu, SJ; Shaulsky, G; Miyazaki, Y; Kuwayama, H; Tanaka, Y; Kuspa, A; Loomis, WF			Periodic signaling controlled by an oscillatory circuit that includes protein kinases ERK2 and PKA	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM; CYCLIC-AMP; CAMP-PHOSPHODIESTERASE; MAP KINASE; CELLS; DIFFERENTIATION; AGGREGATION; ACTIVATION; CYCLASE; RAS	Self-regulating systems often use robust oscillatory circuits. One such system controls the chemotactic signaling mechanism of Dictyostelium, where pulses of adenosine 3', 5'-monophosphate (cAMP) are generated with a periodicity of 7 minutes. We have observed spontaneous oscillations in activation of the mitogen-activated protein (MAP) kinase ERK2 that occur in phase with peaks of cAMP, and we show that ERK2 modulates cAMP levels through the phosphodiesterase RegA. Computer modeling and simulations of the underlying circuit faithfully account for the ability of the cells to spontaneously generate periodic pulses during specific stages of development. Similar oscillatory processes may occur in cells of many different species.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan	University of California System; University of California San Diego; Osaka University; Baylor College of Medicine; Baylor College of Medicine; University of Tsukuba	Loomis, WF (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wloomis@ucsd.edu		Shaulsky, Gad/0000-0002-0532-0551; Kuspa, Adam/0000-0002-9156-149X	NIGMS NIH HHS [R01 GM052359, GM62350, GM52359] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052359, R01GM062350] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE K, 1983, DEV BIOL, V95, P200, DOI 10.1016/0012-1606(83)90018-0; Anjard C, 2001, DEVELOPMENT, V128, P3649; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Aubry L, 1997, J BIOL CHEM, V272, P3883, DOI 10.1074/jbc.272.7.3883; Baillie G, 2001, MOL PHARMACOL, V60, P1100, DOI 10.1124/mol.60.5.1100; Baillie GS, 2000, BRIT J PHARMACOL, V131, P811, DOI 10.1038/sj.bjp.0703636; BEHRENS MM, 1986, BIOCHEM INT, V13, P221; GERISCH G, 1979, J EXP BIOL, V81, P33; GERISCH G, 1975, BIOCHEM BIOPH RES CO, V65, P364, DOI 10.1016/S0006-291X(75)80102-1; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Knetsch MLW, 1996, EMBO J, V15, P3361, DOI 10.1002/j.1460-2075.1996.tb00701.x; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Maeda M, 1996, J BIOL CHEM, V271, P3351; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; ROOS W, 1977, NATURE, V266, P259, DOI 10.1038/266259a0; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; Shaulsky G, 1998, DEVELOPMENT, V125, P691; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; Wang B, 1997, SCIENCE, V277, P251, DOI 10.1126/science.277.5323.251; Wessels DJ, 2000, MOL BIOL CELL, V11, P2803, DOI 10.1091/mbc.11.8.2803	24	125	127	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					875	878		10.1126/science.1094647	http://dx.doi.org/10.1126/science.1094647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131307				2022-12-01	WOS:000221243000045
J	Tinel, A; Tschopp, J				Tinel, A; Tschopp, J			The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress	SCIENCE			English	Article							DOMAIN-CONTAINING PROTEIN; CELL-DEATH; INDUCED APOPTOSIS; ADAPTER MOLECULE; MITOCHONDRIA; INDUCTION; ENCODES; BETA; GENE	Apoptosis is triggered by activation of initiator caspases upon complex-mediated clustering of the inactive zymogen, as occurs in the caspase-9 activating apoptosome complex. Likewise, caspase-2, which is involved in stress-induced apoptosis, is recruited into a large protein complex, the molecular composition of which remains elusive. We show that activation of caspase-2 occurs in a complex that contains the death domain - containing protein PIDD, whose expression is induced by p53, and the adaptor protein RAIDD. Increased PIDD expression resulted in spontaneous activation of caspase-2 and sensitization to apoptosis by genotoxic stimuli. Because PIDD functions in p53-mediated apoptosis, the complex assembled by PIDD and caspase-2 is likely to regulate apoptosis induced by genotoxins.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@ib.unil.ch						Ahmad M, 1997, CANCER RES, V57, P615; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; TINEL A, UNPUB; Troy CM, 2000, J NEUROSCI, V20, P1386; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976	21	484	507	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					843	846		10.1126/science.1095432	http://dx.doi.org/10.1126/science.1095432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15073321				2022-12-01	WOS:000221243000035
J	Tocheva, EI; Rosell, FI; Mauk, AG; Murphy, MEP				Tocheva, EI; Rosell, FI; Mauk, AG; Murphy, MEP			Side-on copper-nitrosyl coordination by nitrite reductase	SCIENCE			English	Article							X-RAY-STRUCTURE; ALCALIGENES-FAECALIS S-6; ACHROMOBACTER-CYCLOCLASTES; TYPE-2 COPPER; ACTIVE-SITE; SUBSTRATE-BINDING; DISSIMILATORY NITRITE; OXIDE; COMPLEX; DIOXYGEN	A copper-nitrosyl intermediate forms during the catalytic cycle of nitrite reductase, the enzyme that mediates the committed step in bacterial denitrification. The crystal structure of a type 2 copper-nitrosyl complex of nitrite reductase reveals an unprecedented side-on binding mode in which the nitrogen and oxygen atoms are nearly equidistant from the copper cofactor. Comparison of this structure with a refined nitrite-bound crystal structure explains how coordination can change between copper-oxygen and copper-nitrogen during catalysis. The side-on copper-nitrosyl in nitrite reductase expands the possibilities for nitric oxide interactions in copper proteins such as superoxide dismutase and prions.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	memurphy@interchange.ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014				Aboelella NW, 2002, J AM CHEM SOC, V124, P10660, DOI 10.1021/ja027164v; ADMAN ET, 1995, J BIOL CHEM, V270, P27458, DOI 10.1074/jbc.270.46.27458; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Bange HW, 2000, NATURE, V408, P301, DOI 10.1038/35042656; Boulanger MJ, 2003, PROTEIN SCI, V12, P248, DOI 10.1110/ps.0224503; Boulanger MJ, 2001, BIOCHEMISTRY-US, V40, P9132, DOI 10.1021/bi0107400; Boulanger MJ, 2000, J BIOL CHEM, V275, P23957, DOI 10.1074/jbc.M001859200; Carducci MD, 1997, J AM CHEM SOC, V119, P2669, DOI 10.1021/ja9625743; Chen P, 2003, J AM CHEM SOC, V125, P466, DOI 10.1021/ja020969i; DAWSON JH, 1978, P NATL ACAD SCI USA, V75, P4078, DOI 10.1073/pnas.75.9.4078; Dodd FE, 1998, J MOL BIOL, V282, P369, DOI 10.1006/jmbi.1998.2007; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; FUJISAWA K, 1994, J AM CHEM SOC, V116, P12079, DOI 10.1021/ja00105a069; GODDEN JW, 1991, SCIENCE, V253, P438, DOI 10.1126/science.1862344; HALFEN JA, 1994, J AM CHEM SOC, V116, P5475, DOI 10.1021/ja00091a064; Hauck R. D., 1981, Ecological Bulletins, P551; HOWES BD, 1994, BIOCHEMISTRY-US, V33, P3171, DOI 10.1021/bi00177a005; HULSE CL, 1989, J AM CHEM SOC, V111, P2322, DOI 10.1021/ja00188a067; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA, P3; JACKSON MA, 1991, FEBS LETT, V291, P41, DOI 10.1016/0014-5793(91)81099-T; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kataoka K, 2000, J BIOCHEM-TOKYO, V127, P345, DOI 10.1093/oxfordjournals.jbchem.a022613; KUKIMOTO M, 1994, BIOCHEMISTRY-US, V33, P5246, DOI 10.1021/bi00183a030; Mani K, 2003, J BIOL CHEM, V278, P38956, DOI 10.1074/jbc.M300394200; MARTIN CT, 1981, BIOCHEMISTRY-US, V20, P5147, DOI 10.1021/bi00521a008; MURPHY MEP, 1995, BIOCHEMISTRY-US, V34, P12107, DOI 10.1021/bi00038a003; Murphy MEP, 1997, J BIOL CHEM, V272, P28455, DOI 10.1074/jbc.272.45.28455; PAUL PP, 1990, J AM CHEM SOC, V112, P2430, DOI 10.1021/ja00162a060; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; RUGGIERO CE, 1993, J AM CHEM SOC, V115, P11285, DOI 10.1021/ja00077a030; SILVESTRINI MC, 1990, J BIOL CHEM, V265, P11783; Strange RW, 1999, J MOL BIOL, V287, P1001, DOI 10.1006/jmbi.1999.2648; STRANGE RW, 1995, NAT STRUCT BIOL, V2, P287, DOI 10.1038/nsb0495-287; VANLEEUWEN FX, 1973, BIOCHIM BIOPHYS ACTA, V315, P200, DOI 10.1016/0005-2744(73)90144-7; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Weichsel A, 2000, NAT STRUCT BIOL, V7, P551, DOI 10.1038/76769; Wijma HJ, 2003, BIOCHEMISTRY-US, V42, P4075, DOI 10.1021/bi027270+; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Zhang HM, 2000, J PHYS CHEM B, V104, P10738, DOI 10.1021/jp000745r; Zhao YW, 2002, BIOCHEMISTRY-US, V41, P7464, DOI 10.1021/bi0256274	41	188	192	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					867	870		10.1126/science.1095109	http://dx.doi.org/10.1126/science.1095109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131305				2022-12-01	WOS:000221243000043
J	Lohmann, KJ; Lohmann, CMF; Ehrhart, LM; Bagley, DA; Swing, T				Lohmann, KJ; Lohmann, CMF; Ehrhart, LM; Bagley, DA; Swing, T			Animal behaviour - Geomagnetic map used in sea-turtle navigation	NATURE			English	Editorial Material									Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Central Florida	Lohmann, KJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	klohmann@email.unc.edu						Able KP, 2001, J AVIAN BIOL, V32, P174, DOI 10.1034/j.1600-048X.2001.320211.x; Avens L, 2003, MAR BIOL, V143, P211, DOI 10.1007/s00227-003-1085-9; AVENS L, IN PRESS J EXP BIOL; Gould JL, 1998, CURR BIOL, V8, pR731, DOI 10.1016/S0960-9822(98)70461-0; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Lohmann KJ, 1999, ETHOL ECOL EVOL, V11, P1, DOI 10.1080/08927014.1999.9522838; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; Lohmann KJ., 2003, LOGGERHEAD SEA TURTL, P44; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054	10	197	217	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					909	910		10.1038/428909a	http://dx.doi.org/10.1038/428909a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118716				2022-12-01	WOS:000221083000030
J	Snook, RR; Hosken, DJ				Snook, RR; Hosken, DJ			Sperm death and dumping in Drosophila	NATURE			English	Article							FEMALE; DISPLACEMENT; COMPETITION; STORAGE; MELANOGASTER; MALES; BEHAVIOR	Mating with more than one male is the norm for females of many species. In addition to generating competition between the ejaculates of different males(1,2), multiple mating may allow females to bias sperm use(3,4). In Drosophila melanogaster, the last male to inseminate a female sires approximately 80% of subsequent progeny(5). Both sperm displacement, where resident spermare removed from storage by the incoming ejaculate of the copulating male(6), and sperm incapacitation, where incoming seminal fluids supposedly interfere with resident sperm(7), have been implicated in this pattern of sperm use(5-12). But the idea of incapacitation is problematic because there are no known mechanisms by which an individual could damage rival sperm and not their own. Females also influence the process of sperm use(13,14), but exactly how is unclear. Here we show that seminal fluids do not kill rival sperm and that any 'incapacitation' is probably due to spermageing during spermstorage. We also show that females release stored sperm from the reproductive tract ( sperm dumping) after copulation with a second male and that this requires neither incoming sperm nor seminal fluids. Instead, males may cause stored sperm to be dumped or females may differentially eject sperm from the previous mating.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Zurich, Zool Museum, CH-8703 Zurich, Switzerland	University of Sheffield; University of Zurich	Snook, RR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	r.snook@sheffield.ac.uk	Snook, Rhonda/D-7291-2016	Snook, Rhonda/0000-0003-1852-1448				ALONSOPIMENTEL H, 1994, CELL TISSUE RES, V275, P467, DOI 10.1007/BF00318816; [Anonymous], 1998, SPERM COMPETITION SE; Arthur BI, 1998, P ROY SOC B-BIOL SCI, V265, P1749, DOI 10.1098/rspb.1998.0498; Civetta A, 2000, GENET RES, V75, P143, DOI 10.1017/S0016672399004292; Civetta A, 1999, CURR BIOL, V9, P841, DOI 10.1016/S0960-9822(99)80370-4; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; Cordoba-Aguilar A, 1999, P ROY SOC B-BIOL SCI, V266, P779, DOI 10.1098/rspb.1999.0705; DEVRIES JK, 1964, EVOLUTION, V18, P271, DOI 10.2307/2406401; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; GILCHRIST AS, 1995, J INSECT PHYSIOL, V41, P1087, DOI 10.1016/0022-1910(95)00068-6; Gilchrist AS, 2000, EVOLUTION, V54, P534, DOI 10.1111/j.0014-3820.2000.tb00056.x; Gromko M.H., 1984, P371; GROMKO MH, 1984, EVOLUTION, V38, P1273, DOI 10.1111/j.1558-5646.1984.tb05649.x; HARSHMAN LG, 1994, EVOLUTION, V48, P758, DOI [10.2307/2410484, 10.1111/j.1558-5646.1994.tb01359.x]; HEED WB, 1990, GENETICS SPECIATION, P253; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Janzer B, 2001, MECH DEVELOP, V100, P3, DOI 10.1016/S0925-4773(00)00529-3; LEFEVRE G, 1962, GENETICS, V42, P1719; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Moore HDM, 1999, P ROY SOC B-BIOL SCI, V266, P2343, DOI 10.1098/rspb.1999.0929; OTRONEN M, 1991, BEHAV ECOL SOCIOBIOL, V29, P33, DOI 10.1007/BF00164292; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pitnick S, 2000, EVOLUTION, V54, P1052, DOI 10.1111/j.0014-3820.2000.tb00107.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Price CSC, 1999, NATURE, V400, P449, DOI 10.1038/22755; SCOTT D, 1990, J INSECT PHYSIOL, V36, P451, DOI 10.1016/0022-1910(90)90063-L; Simmons L.W., 1998, P341, DOI 10.1016/B978-012100543-6/50035-0; Simmons L.W., 2001, MG BEH ECOL; Wheeler M. R., 1947, University of Texas Publications no, V4720, P78; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897	30	147	148	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					939	941		10.1038/nature02455	http://dx.doi.org/10.1038/nature02455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118726	Green Accepted			2022-12-01	WOS:000221083000040
J	Ruskin, R				Ruskin, R			The scar	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ronaldruskinmd@aol.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1941	1942		10.1001/jama.291.16.1941	http://dx.doi.org/10.1001/jama.291.16.1941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113791				2022-12-01	WOS:000221062000001
J	Furnes, H; Banerjee, NR; Muehlenbachs, K; Staudigel, H; de Wit, M				Furnes, H; Banerjee, NR; Muehlenbachs, K; Staudigel, H; de Wit, M			Early life recorded in archean pillow lavas	SCIENCE			English	Article							BARBERTON GREENSTONE-BELT; BIOLOGICALLY MEDIATED DISSOLUTION; SOUTH-AFRICA; BASALTIC GLASS; VOLCANIC GLASS; MOUNTAIN LAND; ONVERWACHT; HISTORY; OCEAN; CRUST	Pillow lava rims from the Mesoarchean Barberton Greenstone Belt in South Africa contain micrometer-scale mineralized tubes that provide evidence of submarine microbial activity during the early history of Earth. The tubes formed during microbial etching of glass along fractures, as seen in pillow lavas from recent oceanic crust. The margins of the tubes contain organic carbon, and many of the pillow rims exhibit isotopically light bulk-rock carbonate delta(13)C values, supporting their biogenic origin. Overlapping metamorphic and magmatic dates from the pillow lavas suggest that microbial life colonized these subaqueous volcanic rocks soon after their eruption almost 3.5 billion years ago.	Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Cape Town, Ctr Interact Graph Comp Earth Syst, ZA-7701 Rondebosch, South Africa	University of Bergen; University of Alberta; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Cape Town	Furnes, H (corresponding author), Univ Bergen, Dept Earth Sci, Allegaten 41, N-5007 Bergen, Norway.	Harald.Furnes@geo.uib.no	Banerjee, Neil/G-5358-2015	Banerjee, Neil/0000-0001-7471-766X				Banerjee NR, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000470; Dann JC, 2000, S AFR J GEOL, V103, P47, DOI 10.2113/103.1.47; DERONDE CEJ, 1994, TECTONICS, V13, P983, DOI 10.1029/94TC00353; DEWIT MJ, 1987, J AFR EARTH SCI, V6, P681, DOI 10.1016/0899-5362(87)90007-8; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; Furnes H, 2003, GEOL SOC SPEC PUBL, V218, P415, DOI 10.1144/GSL.SP.2003.218.01.21; Furnes H, 1999, EARTH PLANET SC LETT, V166, P97, DOI 10.1016/S0012-821X(99)00005-9; Furnes H, 2001, GEOCHEM GEOPHY GEOSY, V2; Furnes H, 2001, CHEM GEOL, V173, P313, DOI 10.1016/S0009-2541(00)00285-0; HOFFMAN SE, 1986, NATURE, V321, P55, DOI 10.1038/321055a0; KAMO SL, 1994, TECTONICS, V13, P167, DOI 10.1029/93TC02254; KRUMBEIN WE, 1991, GEOMICROBIOL J, V9, P139, DOI 10.1080/01490459109385995; LOPEZMARTINEZ M, 1992, PRECAMBRIAN RES, V57, P91, DOI 10.1016/0301-9268(92)90095-6; Nakamura K, 2003, GEOCHIM COSMOCHIM AC, V67, pA326; Rasmussen B, 2000, NATURE, V405, P676, DOI 10.1038/35015063; Rogers JR, 2004, CHEM GEOL, V203, P91, DOI 10.1016/j.chemgeo.2003.09.001; ROSS KA, 1986, GEOLOGY, V14, P571, DOI 10.1130/0091-7613(1986)14<571:BGOGS>2.0.CO;2; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Staudigel H, 1998, EARTH PLANET SC LETT, V164, P233, DOI 10.1016/S0012-821X(98)00207-6; Staudigel H, 1995, CHEM GEOL, V126, P147, DOI 10.1016/0009-2541(95)00115-X; THORSETH IH, 1995, CHEM GEOL, V119, P139, DOI 10.1016/0009-2541(94)00098-S; THORSETH IH, 1992, GEOCHIM COSMOCHIM AC, V56, P845, DOI 10.1016/0016-7037(92)90104-Q; Thorseth IH, 1995, CHEM GEOL, V126, P137, DOI 10.1016/0009-2541(95)00114-8; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; Torsvik T, 1998, EARTH PLANET SC LETT, V162, P165, DOI 10.1016/S0012-821X(98)00164-2	25	240	261	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					578	581		10.1126/science.1095858	http://dx.doi.org/10.1126/science.1095858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105498				2022-12-01	WOS:000220975100046
J	Eagleman, DM; Jacobson, JE; Sejnowski, TJ				Eagleman, DM; Jacobson, JE; Sejnowski, TJ			Perceived luminance depends on temporal context	NATURE			English	Article							PRIMARY VISUAL-CORTEX; BRIGHTNESS; SURFACE; REPRESENTATION; CONTRAST	Brightness-the perception of an object's luminance-arises from complex and poorly understood interactions at several levels of processing(1). It is well known that the brightness of an object depends on its spatial context(2), which can include perceptual organization(3), scene interpretation(4), three-dimensional interpretation(5), shadows(6), and other high-level percepts. Here we present a new class of illusion in which temporal relations with spatially neighbouring objects can modulate a target object's brightness. When compared with a nearby patch of constant luminance, a brief flash appears brighter with increasing onset asynchrony. Simultaneous contrast, retinal effects, masking, apparent motion and attentional effects cannot account for this illusory enhancement of brightness. This temporal context effect indicates that two parallel streams-one adapting and one non-adapting-encode brightness in the visual cortex.	Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Philosophy, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Eagleman, DM (corresponding author), Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, 6431 Fannin St,Suite 7-046, Houston, TX 77030 USA.	david.eagleman@uth.tmc.edu	Sejnowski, Terrence/AAV-5558-2021		NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; BOWEN RW, 1989, VISION RES, V29, P1501, DOI 10.1016/0042-6989(89)90134-X; COWEY A, 1974, EXP BRAIN RES, V21, P447; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; GILCHRIST AL, 1988, PERCEPT PSYCHOPHYS, V43, P415, DOI 10.3758/BF03207877; GILCHRIST AL, 1994, LIGHTNESS BRIGHTNESS; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; Koffka K, 1935, PRINCIPLES GESTALT P; MacEvoy SP, 1998, NAT NEUROSCI, V1, P616, DOI 10.1038/2849; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Sulzer, 1902, J PHYSIOL PATHOL GEN, P632; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124	16	31	35	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					854	856		10.1038/nature02467	http://dx.doi.org/10.1038/nature02467			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15085147	Green Accepted			2022-12-01	WOS:000220952300040
J	Lello, J; Boag, B; Fenton, A; Stevenson, IR; Hudson, PJ				Lello, J; Boag, B; Fenton, A; Stevenson, IR; Hudson, PJ			Competition and mutualism among the gut helminths of a mammalian host	NATURE			English	Article							VOLE CLETHRIONOMYS-GLAREOLUS; ANOPLOCEPHALINE CESTODES; TRICHINELLA-SPIRALIS; HAEMONCHUS-CONTORTUS; INFECTIONS; PATTERNS; COEXISTENCE; POPULATION; CONCURRENT; PARASITES	Most animal species are infected with multiple parasite species; however, the role of interspecific parasite interactions in influencing parasite dynamics and shaping parasite communities has been unclear. Although laboratory studies have found evidence of cross-immunity, immunosuppression and competition(1-6), analyses of hosts in the field have generally concluded that parasite communities are little more than random assemblages(7-14). Here we present evidence of consistent interspecific interactions in a natural mammalian system, revealed through the analysis of parasite intensity data collected from a free-ranging rabbit (Oryctolagus cuniculus) population, sampled monthly for a period of 23 yr. The wild rabbit plays host to a diverse gut helminth community(15-17) that reflects the communities seen in other economically important domestic herbivores(18,19). These findings suggest that parasite interactions could have profound implications for the dynamics of parasite communities. The efficacy of parasite control programmes could be jeopardized if such interactions are not taken into account. In contrast, a clear understanding of such interactions may provide the basis for the development of more environmentally acceptable methods of parasite control.	CSIRO, Livestock Ind, FD McMaster Labs, Armidale, NSW 2350, Australia; Univ Stirling, Dept Biol Sci, Stirling FK9 4LA, Scotland; Penn State Univ, Dept Biol, Mueller Lab 513, University Pk, PA 16802 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Stirling; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lello, J (corresponding author), CSIRO, Livestock Ind, FD McMaster Labs, Locked Bag 1,PO Armidale, Armidale, NSW 2350, Australia.	Joanne.Lello@csiro.au	Lello, Joanne/AAG-7838-2021; Fenton, Andy/B-5972-2009; Hudson, Peter/AAB-8080-2020; Lello, Joanne/A-5261-2010	Fenton, Andy/0000-0002-7676-917X; Hudson, Peter/0000-0003-0468-3403; Lello, Joanne/0000-0002-2640-1027				ADAMS DB, 1989, INT J PARASITOL, V19, P717, DOI 10.1016/0020-7519(89)90056-8; Behnke JM, 2001, PARASITOLOGY, V122, pS39, DOI 10.1017/S0031182000016796; Behnke JM, 2001, PARASITOLOGY, V123, P401, DOI 10.1017/S0031182001008605; BEHNKE JM, 1978, EXP PARASITOL, V46, P121, DOI 10.1016/0014-4894(78)90162-5; Boag B., 1999, Aspects of Applied Biology, V53, P119; BOAG B, 1989, P HELM SOC WASH, V56, P116; Boag B, 2001, INT J PARASITOL, V31, P1421, DOI 10.1016/S0020-7519(01)00270-3; BUSH AO, 1986, CAN J ZOOL, V64, P142, DOI 10.1139/z86-023; Christensen CM, 1997, PARASITOLOGY, V114, P273, DOI 10.1017/S003118209600844X; CHRISTENSEN NO, 1987, PARASITOL RES, V73, P387, DOI 10.1007/BF00538196; Cornell SJ, 2003, P NATL ACAD SCI USA, V100, P7401, DOI 10.1073/pnas.0832206100; COWAN DP, 1983, THESIS U LONDON; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; CROFTON HD, 1954, PARASITOLOGY, V44, P313, DOI 10.1017/S0031182000018953; Dalton JP, 2003, INT J PARASITOL, V33, P621, DOI 10.1016/S0020-7519(03)00057-2; DOBSON A, 1994, PARASITOLOGY, V109, pS97, DOI 10.1017/S0031182000085115; DOBSON RJ, 1995, INT J PARASITOL, V25, P495, DOI 10.1016/0020-7519(94)00157-J; FORBES M, 1994, OECOLOGIA, V97, P520, DOI 10.1007/BF00325891; Forbes MR, 1999, OECOLOGIA, V120, P613, DOI 10.1007/s004420050897; FORD GE, 1971, IMMUNOLOGY, V21, P1073; HAUKISALMI V, 1993, J ANIM ECOL, V62, P221, DOI 10.2307/5353; HAUKISALMI V, 1993, J ANIM ECOL, V62, P230, DOI 10.2307/5354; MEADBRIGGS AR, 1973, PARASITOLOGY, V67, P351, DOI 10.1017/S0031182000046576; MEADBRIGGS AR, 1975, J HELMINTHOL, V49, P49; MICHEL JF, 1953, NATURE, V172, P312, DOI 10.1038/172312a0; Nilssen AC, 1998, PARASITOLOGY, V117, P273, DOI 10.1017/S0031182098003060; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Poulin R, 1996, OECOLOGIA, V105, P545, DOI 10.1007/BF00330018; Poulin R, 2001, PARASITOLOGY, V122, pS3, DOI 10.1017/S0031182000016991; SILVER BB, 1980, J PARASITOL, V66, P786, DOI 10.2307/3280669	30	234	240	1	112	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					840	844		10.1038/nature02490	http://dx.doi.org/10.1038/nature02490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103373	Bronze			2022-12-01	WOS:000220952300036
J	Berns, A				Berns, A			Good news for gene therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.							Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207	5	27	30	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1679	1680		10.1056/NEJMcibr040341	http://dx.doi.org/10.1056/NEJMcibr040341			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084702				2022-12-01	WOS:000220819800015
J	Oliver, D; Lien, CC; Soom, M; Baukrowitz, T; Jonas, P; Fakler, B				Oliver, D; Lien, CC; Soom, M; Baukrowitz, T; Jonas, P; Fakler, B			Functional conversion between A-type and delayed rectifier K+ channels by membrane lipids	SCIENCE			English	Article							ARACHIDONIC-ACID; POTASSIUM CHANNELS; ACTION-POTENTIALS; INACTIVATION; TRANSIENT; ION; PHOSPHORYLATION; SENSITIVITY; INHIBITION; MODULATION	Voltage-gated potassium (Kv) channels control action potential repolarization, interspike membrane potential, and action potential frequency in excitable cells. It is thought that the combinatorial association between distinct alpha and beta subunits determines whether Kv channels function as non-inactivating delayed rectifiers or as rapidly inactivating A-type channels. We show that membrane lipids can convert A-type channels into delayed rectifiers and vice versa. Phosphoinositides remove N-type inactivation from A-type channels by immobilizing the inactivation domains. Conversely, arachidonic acid and its amide anandamide endow delayed rectifiers with rapid voltage-dependent inactivation. The bidirectional control of Kv channel gating by lipids may provide a mechanism for the dynamic regulation of electrical signaling in the nervous system.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Univ Jena, Inst Physiol 2, D-07744 Jena, Germany	University of Freiburg; Friedrich Schiller University of Jena	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de; bernd.fakler@physiologie.uni-freiburg.de	Lien, Cheng-Chang/AAO-6249-2020; Oliver, Dominik/F-5845-2013	Lien, Cheng-Chang/0000-0002-6692-9942; Oliver, Dominik/0000-0002-8368-0923; Baukrowitz, Thomas/0000-0003-4562-0505; Jonas, Peter/0000-0001-5001-4804				Antz C, 1999, NAT STRUCT BIOL, V6, P146; Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; CHANDY KG, 1995, HDB RECEPTORS CHANNE, V2; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Colbert CM, 1999, J NEUROSCI, V19, P8163; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hille B., 2001, ION CHANNELS EXCITAB, V3; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HONORE E, 1994, P NATL ACAD SCI USA, V91, P1937, DOI 10.1073/pnas.91.5.1937; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Keros S, 1997, J NEUROSCI, V17, P3476; Krauter T, 2001, MOL PHARMACOL, V59, P1086, DOI 10.1124/mol.59.5.1086; Lien CC, 2003, J NEUROSCI, V23, P2058; Lien CC, 2002, J PHYSIOL-LONDON, V538, P405, DOI 10.1113/jphysiol.2001.013066; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; OLIVER D, UNPUB; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Villarroel A, 1996, J NEUROSCI, V16, P1016; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022	41	268	278	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					265	270		10.1126/science.1094113	http://dx.doi.org/10.1126/science.1094113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15031437				2022-12-01	WOS:000220719400039
J	Bibring, JP; Langevin, Y; Poulet, F; Gendrin, A; Gondet, B; Berthe, M; Soufflot, A; Drossart, P; Combes, M; Bellucci, G; Moroz, V; Mangold, N; Schmitt, B				Bibring, JP; Langevin, Y; Poulet, F; Gendrin, A; Gondet, B; Berthe, M; Soufflot, A; Drossart, P; Combes, M; Bellucci, G; Moroz, V; Mangold, N; Schmitt, B		OMEGA Team	Perennial water ice identified in the south polar cap of Mars	NATURE			English	Article							SURFACE; TOPOGRAPHY	The inventory of water and carbon dioxide reservoirs on Mars are important clues for understanding the geological, climatic and potentially exobiological evolution of the planet(1). From the early mapping observation of the permanent ice caps on the martian poles(2,3), the northern cap was believed to be mainly composed of water ice, whereas the southern cap was thought to be constituted of carbon dioxide ice. However, recent missions ( NASA missions Mars Global Surveyor and Odyssey) have revealed surface structures(4), altimetry profiles(5), underlying buried hydrogen(6), and temperatures of the south polar regions that are thermodynamically consistent with a mixture of surface water ice and carbon dioxide(7). Here we present the first direct identification and mapping of both carbon dioxide and water ice in the martian high southern latitudes, at a resolution of 2 km, during the local summer, when the extent of the polar ice is at its minimum. We observe that this south polar cap contains perennial water ice in extended areas: as a small admixture to carbon dioxide in the bright regions; associated with dust, without carbon dioxide, at the edges of this bright cap; and, unexpectedly, in large areas tens of kilometres away from the bright cap.	Inst Astrophys Spatiale, F-91405 Orsay, France; Observ Paris, LESIA, F-92195 Meudon, France; INAF, IFSI, Rome, Italy; IKI, Moscow, Russia; OrsayTerre, F-91405 Orsay, France; Lab Planetol Grenoble, F-38400 Grenoble, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Istituto Nazionale Astrofisica (INAF); Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Bibring, JP (corresponding author), Inst Astrophys Spatiale, Orsay Campus, F-91405 Orsay, France.	bibring@ias.u-psud.fr	Drossart, Pierre/H-8670-2013; Schmitt, Bernard/A-1064-2009; Bellucci, Giancarlo/ABA-9201-2020; Fouchet, Thierry/C-6374-2017	Schmitt, Bernard/0000-0002-1230-6627; Bellucci, Giancarlo/0000-0003-0867-8679; Erard, Stephane/0000-0002-9099-8366; Altieri, Francesca/0000-0002-6338-8300; Forni, Olivier/0000-0001-6772-9689; Ignatiev, Nikolay/0000-0002-6358-7094; Capaccioni, Fabrizio/0000-0003-1631-4314; Cerroni, Priscilla/0000-0003-0239-2741; Fouchet, Thierry/0000-0001-9040-8285				BIBRING JP, IN PRESS ESA; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; Clifford SM, 2000, ICARUS, V144, P210, DOI 10.1006/icar.1999.6290; HERKENHOFF KE, 2001, USGS GEOLOGIC INVE I, V2686; Kieffer H. H., 1992, MARS, P1180; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; Nye JF, 2000, ICARUS, V144, P449, DOI 10.1006/icar.1999.6306; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; Poulet F, 2002, ICARUS, V160, P313, DOI 10.1006/icar.2002.6970; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Thomas PC, 2000, NATURE, V404, P161, DOI 10.1038/35004528; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; 2003, ESA B, V115, P10	15	235	245	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					627	630		10.1038/nature02461	http://dx.doi.org/10.1038/nature02461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15024393				2022-12-01	WOS:000220697200036
J	Sil, AK; Maeda, S; Sano, Y; Roop, DR; Karin, M				Sil, AK; Maeda, S; Sano, Y; Roop, DR; Karin, M			IkB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis	NATURE			English	Article							NF-KAPPA-B; VERTEBRATE LIMB; MICE LACKING; PHOSPHORYLATION; EXPRESSION; ACTIVATION; GENE; REQUIREMENT; ANTAGONISM; RECEPTOR	IkappaB kinase-alpha (IKK-alpha)(1) exhibits protein-kinase-dependent and -independent functions. Its kinase activity is required for lymphoid organogenesis(2) and mammary gland development(3), whereas a kinase-independent activity is required for epidermal keratinocyte differentiation(4). In addition to failed epidermal differentiation, IKK-alpha-deficient mice exhibit abnormal skeletal and craniofacial morphogenesis(4-6). As similar defects are not exhibited by mice that experience systemic inhibition of NF-kappaB(7), we postulated that the morphogenetic defects in IKK-alpha-deficient mice are not caused by reduced NF-kappaB activity but instead are due to failed epidermal differentiation that disrupts proper epidermal-mesodermal interactions. We tested this hypothesis by introducing an epidermal-specific Ikka (also known as Chuk) transgene into IKK-alpha-deficient mice. Mice lacking IKK-alpha in all cell types including bone and cartilage, but not in basal epidermal keratinocytes, exhibit normal epidermal differentiation and skeletal morphology. Thus, epidermal differentiation is required for proper morphogenesis of mesodermally derived skeletal elements. One way by which IKK-alpha controls skeletal and craniofacial morphogenesis is by repressing expression of fibroblast growth factor (FGF) family members, such as FGF8, whose expression is specifically elevated in the limb bud ectoderm of IKK-alpha-deficient mice.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA	University of California System; University of California San Diego; Baylor College of Medicine; Baylor College of Medicine	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu						Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dudley AT, 2000, CURR OPIN GENET DEV, V10, P387, DOI 10.1016/S0959-437X(00)00101-5; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.0.CO;2-8; TAKAHASHI H, 1995, HISTOPATHOLOGY, V26, P45, DOI 10.1111/j.1365-2559.1995.tb00619.x; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; TORREY TW, 1970, MORPHOGENESIS VERTEB, P275; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; WESSELLS NK, 1997, TISSUE INTERACTIONS; WILKINSON DG, 1993, IN SITU HYBRIDIZATIO; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yi SE, 2000, DEVELOPMENT, V127, P621; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	172	181	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					660	664		10.1038/nature02421	http://dx.doi.org/10.1038/nature02421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071597				2022-12-01	WOS:000220697200046
J	Moreno, E; Basler, K				Moreno, E; Basler, K			dMyc transforms cells into super-competitors	CELL			English	Article							LONG-RANGE ACTION; DEVELOPING DROSOPHILA EYE; C-MYC; MORPHOGEN GRADIENT; ENDOCYTIC PATHWAY; TYROSINE KINASE; CELLULAR GROWTH; APOPTOSIS; CANCER; GENES	Overexpression of myc protooncogenes has been implicated in the genesis of many human tumors. Myc proteins seem to regulate diverse biological processes, but their role in tumorigenesis remains enigmatic. Here we use Drosophila imaginal discs to mimic situations in which cells with unequal levels of Myc protein are apposed and show that this invariably elicits a win/lose situation reminiscent of cell competition; cells with lower levels of dMyc are eliminated by apoptosis whereas cells with higher levels of dMyc over-proliferate. We find that this competitive behavior correlates with, and can be corrected by, the activation of the BMP/Dpp survival signaling pathway. Hence the heritable increase in dMyc levels causes cells to behave as "super-competitors" and reveals a novel mode of clonal expansion that causes, but also relies on, the killing of surrounding cells.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.unizh.ch	Moreno, Eduardo/D-7262-2011	moreno, eduardo/0000-0001-5040-452X; Basler, Konrad/0000-0003-3534-1529				Abrams JM, 2002, CELL, V110, P403, DOI 10.1016/S0092-8674(02)00904-2; Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Baker NE, 2001, CELL, V104, P699, DOI 10.1016/S0092-8674(02)06076-2; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Braakhuis BJM, 2003, CANCER RES, V63, P1727; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burke R, 1996, DEVELOPMENT, V122, P2261; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Guo QM, 2000, CANCER RES, V60, P5922; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lawrence P., 1992, MAKING FLY GENETICS; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Milan M, 2002, EMBO REP, V3, P724, DOI 10.1093/embo-reports/kvf151; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; RUBERTE E, 1995, CELL, V80, P890; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Yu SY, 2002, DEVELOPMENT, V129, P3269; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	61	420	428	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2004	117	1					117	129		10.1016/S0092-8674(04)00262-4	http://dx.doi.org/10.1016/S0092-8674(04)00262-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066287	Green Accepted, Bronze			2022-12-01	WOS:000221500300013
J	Rudolf, PM; Bernstein, IBG				Rudolf, PM; Bernstein, IBG			Counterfeit drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Rudolf, PM (corresponding author), US FDA, Rockville, MD 20857 USA.							*FOOD DRUG ADM, 2004, COMB COUNT DRUGS REP	1	47	47	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1384	1386		10.1056/NEJMp038231	http://dx.doi.org/10.1056/NEJMp038231			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070787				2022-12-01	WOS:000220562500004
J	Tu, JV; Willison, DJ; Silver, FL; Fang, J; Richards, JA; Laupacis, A; Kapral, MK				Tu, JV; Willison, DJ; Silver, FL; Fang, J; Richards, JA; Laupacis, A; Kapral, MK		Investigators Registry Canadian St	Impracticability of informed consent in the Registry of the Canadian Stroke Network	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; ACUTE MYOCARDIAL-INFARCTION; MEDICAL-RECORDS; HEALTH; PRIVACY; THREAT	BACKGROUND: Government legislators and research ethics boards in some jurisdictions require all patients to give written informed consent before enrollment in clinical registries. However, the effect of such a requirement on the use of clinical registries and the extent to which registry data can be generalized remain uncertain. METHODS: We examined the effectiveness of a comprehensive attempt to obtain informed consent between June 2001 and December 2002 on the overall participation rate and the characteristics of participating patients in the Registry of the Canadian Stroke Network, a prospective registry based at 20 major stroke centers across Canada. RESULTS: The overall participation rate (i.e., the consent rate among all potential participants) was 39.3 percent of 4285 eligible patients during phase 1 of the project (June 2001 through February 2002) and 50.6 percent of 2823 eligible patients during phase 2 (June 2002 through December 2002), despite the presence of neurologic research nurse coordinators at each site. Many patients died or left the hospital before they could be approached for consent. Major selection biases were found; the in-hospital mortality rate was much lower among patients who were enrolled (6.9 percent) than among those who were not enrolled (21.7 percent) (relative risk of in-hospital death, 3.13; 95 percent confidence interval, 2.65 to 3.70; P<0.001). We estimate that approximately $500,000 (Canadian dollars) was spent on consent-related issues during the first two years of the registry. CONCLUSIONS: Obtaining written informed consent for participation in a stroke registry led to important selection biases, such that registry patients were not representative of the typical patient with stroke at each center. These findings highlight the need for legislation on privacy and policies permitting waivers of informed consent for minimal-risk observational research.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada; St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Hlth Network, Div Neurol, Toronto, ON, Canada; Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tu, JV (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	tu@ices.on.ca	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Tu, Jack/0000-0003-0111-722X				Al-Shahi R, 2000, BMJ-BRIT MED J, V321, P1031, DOI 10.1136/bmj.321.7268.1031; Brown P, 2000, BRIT MED J, V321, P849, DOI 10.1136/bmj.321.7265.849; *CAN I HLTH RES, 2001, REC INT APPL PERS IN; Hill MD, 2001, CAN J NEUROL SCI, V28, P232, DOI 10.1017/S0317167100001384; HILL MD, 2002, CAN J NEUROL SCI, V29, P103; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; Kulynych J, 2002, NEW ENGL J MED, V346, P201, DOI 10.1056/NEJM200201173460312; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McCarthy DB, 1999, HEALTH SERV RES, V34, P417; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; Tu JV, 2003, ARCH INTERN MED, V163, P293, DOI 10.1001/archinte.163.3.293; Upshur REG, 2001, CAN MED ASSOC J, V165, P888; Vandenbroucke JP, 1998, BRIT MED J, V316, P1331, DOI 10.1136/bmj.316.7141.1331; Verity C, 2002, BRIT MED J, V324, P1210, DOI 10.1136/bmj.324.7347.1210; Woolf SH, 2000, ARCH FAM MED, V9, P1111, DOI 10.1001/archfami.9.10.1111	19	305	307	0	17	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1414	1421		10.1056/NEJMsa031697	http://dx.doi.org/10.1056/NEJMsa031697			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070791	Bronze			2022-12-01	WOS:000220562500008
J	Berns, K; Hijmans, EM; Mullenders, J; Brummelkamp, TR; Velds, A; Heimerikx, M; Kerkhoven, RM; Madiredjo, M; Nijkamp, W; Weigelt, B; Agami, R; Ge, W; Cavet, G; Linsley, PS; Beijersbergen, RL; Bernards, R				Berns, K; Hijmans, EM; Mullenders, J; Brummelkamp, TR; Velds, A; Heimerikx, M; Kerkhoven, RM; Madiredjo, M; Nijkamp, W; Weigelt, B; Agami, R; Ge, W; Cavet, G; Linsley, PS; Beijersbergen, RL; Bernards, R			A large-scale RNAi screen in human cells identifies new components of the p53 pathway	NATURE			English	Article							MAMMALIAN-CELLS; TUMOR SUPPRESSION; GENE; EXPRESSION; INTERFERENCE; SENESCENCE; FIBROBLASTS; P19(ARF); ARREST; MDM2	RNA interference (RNAi) is a powerful new tool with which to perform loss-of-function genetic screens in lower organisms and can greatly facilitate the identification of components of cellular signalling pathways(1-3). In mammalian cells, such screens have been hampered by a lack of suitable tools that can be used on a large scale. We and others have recently developed expression vectors to direct the synthesis of short hairpin RNAs (shRNAs) that act as short interfering RNA (siRNA)-like molecules to stably suppress gene expression(4,5). Here we report the construction of a set of retroviral vectors encoding 23,742 distinct shRNAs, which target 7,914 different human genes for suppression. We use this RNAi library in human cells to identify one known and five new modulators of p53-dependent proliferation arrest. Suppression of these genes confers resistance to both p53-dependent and p19(ARF)-dependent proliferation arrest, and abolishes a DNA-damage-induced G1 cell-cycle arrest. Furthermore, we describe siRNA bar-code screens to rapidly identify individual siRNA vectors associated with a specific phenotype. These new tools will greatly facilitate large-scale loss-of-function genetic screens in mammalian cells.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Rosetta Inpharmat Inc, Kirkland, WA 98034 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Beijersbergen, RL (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.beijersbergen@nki.nl; r.bernards@nki.nl	agami, reuven/GOG-8289-2022; Mullenders, Jasper/J-2398-2015	Mullenders, Jasper/0000-0003-3737-6901; Beijersbergen, Roderick/0000-0003-0116-4130; Agami, Reuven/0000-0002-2848-2473; Hijmans, Marielle/0000-0003-4847-9412; Velds, Arno/0000-0003-4333-8872; Bernards, Rene/0000-0001-8677-3423				Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brummelkamp TR, 2003, NAT REV CANCER, V3, P781, DOI 10.1038/nrc1191; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heetebrij RJ, 2003, CHEMBIOCHEM, V4, P573, DOI 10.1002/cbic.200200498; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; MIYASHITA T, 1995, CELL, V80, P293; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang AH, 1999, MOL CELL BIOL, V19, P7816	30	864	953	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					431	437		10.1038/nature02371	http://dx.doi.org/10.1038/nature02371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042092	Green Published			2022-12-01	WOS:000220404300044
J	Proudman, C; Pinchbeck, G; Clegg, P; French, N				Proudman, C; Pinchbeck, G; Clegg, P; French, N			Equine welfare: Risk of horses falling in the Grand National	NATURE			English	Editorial Material							FATALITIES		Univ Liverpool, Fac Vet Sci, Epidemiol Grp, Wirral CH64 7TE, Merseyside, England	University of Liverpool	Proudman, C (corresponding author), Univ Liverpool, Fac Vet Sci, Epidemiol Grp, Wirral CH64 7TE, Merseyside, England.	c.j.proudman@liverpool.ac.uk	French, Nigel/F-5725-2011	French, Nigel/0000-0002-6334-0657				McKee S. L., 1995, Equine Veterinary Education, V7, P202, DOI 10.1111/j.2042-3292.1995.tb01225.x; TUNER M, 2002, BRIT J SPORT MED, V36, P430; Williams RB, 2001, EQUINE VET J, V33, P478, DOI 10.2746/042516401776254808	3	16	16	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2004	428	6981					385	386		10.1038/428385a	http://dx.doi.org/10.1038/428385a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042079				2022-12-01	WOS:000220404300029
J	Lazzaro, BP; Sceurman, BK; Clark, AG				Lazzaro, BP; Sceurman, BK; Clark, AG			Genetic basis of natural variation in D-melanogaster antibacterial immunity	SCIENCE			English	Article							GENOTYPE-ENVIRONMENT INTERACTION; GENOME-WIDE ANALYSIS; EVOLUTION; EXPRESSION; PEPTIDE; RESISTANCE; PROTEINS; FAMILY	Many genes involved in Drosophila melanogaster innate immune processes have been identified, but whether naturally occurring polymorphism in these genes leads to variation in immune competence among wild flies has not been tested. We report here substantial variability among wild-derived D. melanogaster in the ability to suppress infection by a Gram-negative entomopathogen, Serratia marcescens. Variability in immune competence was significantly associated with nucleotide polymorphism in 16 innate immunity genes, corresponding primarily to pathogen recognition and intracellular signaling loci, and substantial epistasis was detected between intracellular signaling and antimicrobial peptide genes. Variation in these genes, therefore, seems to drive variability in immunocompetence among wild Drosophila.	Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cornell University	Lazzaro, BP (corresponding author), Cornell Univ, Dept Entomol, 4138 Comstock Hall, Ithaca, NY 14853 USA.	bl89@cornell.edu		Clark, Andrew/0000-0001-7159-8511	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046402] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46402] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASLING B, 1995, INSECT BIOCHEM MOLEC, V25, P511, DOI 10.1016/0965-1748(94)00091-C; Begun DJ, 2000, GENETICS, V154, P1231; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; Fry JD, 1998, GENET RES, V71, P133, DOI 10.1017/S0016672398003176; Gurganus MC, 1998, GENETICS, V149, P1883; Hedengren M, 2000, BIOCHEM BIOPH RES CO, V279, P574, DOI 10.1006/bbrc.2000.3988; Hoffmann R, 2002, GENOME BIOL, V3; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lazzaro BP, 2003, MOL BIOL EVOL, V20, P914, DOI 10.1093/molbev/msg109; Lazzaro BP, 2001, GENETICS, V159, P659; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Lewis SE, 2002, GENOME BIOL, V3; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Schlenke TA, 2003, GENETICS, V164, P1471; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Vieira C, 2000, GENETICS, V154, P213; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Williams MJ, 2001, ADV IMMUNOL, V79, P225, DOI 10.1016/S0065-2776(01)79005-0	24	186	190	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2004	303	5665					1873	1876		10.1126/science.1092447	http://dx.doi.org/10.1126/science.1092447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	15031506				2022-12-01	WOS:000220281600057
J	Wan, PTC; Garnett, MJ; Roe, SM; Lee, S; Niculescu-Duvaz, D; Good, VM; Jones, CM; Marshall, CJ; Springer, CJ; Barford, D; Marais, R				Wan, PTC; Garnett, MJ; Roe, SM; Lee, S; Niculescu-Duvaz, D; Good, VM; Jones, CM; Marshall, CJ; Springer, CJ; Barford, D; Marais, R		Cancer Genome Project	Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF	CELL			English	Article							KINASE DOMAIN; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; MAP KINASE; BRAF; INHIBITION; DISCOVERY; COMPLEX	Over 30 mutations of the B-RAF gene associated with human cancers have been identified, the majority of which are located within the kinase domain. Here we show that of 22 B-RAF mutants analyzed, 18 have elevated kinase activity and signal to ERK in vivo. Surprisingly, three mutants have reduced kinase activity towards MEK in vitro but, by activating C-RAF in vivo, signal to ERK in cells. The structures of wild type and oncogenic (VB)-B-599E-RAF kinase domains in complex with the RAF inhibitor BAY43-9006 show that the activation segment is held in an inactive conformation by association with the P loop. The clustering of most mutations to these two regions suggests that disruption of this interaction converts B-RAF into its active conformation. The high activity mutants signal to ERK by directly phosphorylating MEK, whereas the impaired activity mutants stimulate MEK by activating endogenous C-RAF, possibly via an allosteric or transphosphorylation mechanism.	Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, London SW3 6JB, England; Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; Wellcome Trust Sanger Institute	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk; richard.marais@icr.ac.uk		Springer, Caroline/0000-0002-0650-4002; Marais, Richard/0000-0001-7484-4183; Roe, Mark/0000-0002-7371-9855				Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bankston D, 2002, ORG PROCESS RES DEV, V6, P777, DOI 10.1021/op020205n; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Brose MS, 2002, CANCER RES, V62, P6997; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCP4, 1991, ACTA CRYSTALLOGR D, V50, P760; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Cohen Y, 2003, INVEST OPHTH VIS SCI, V44, P2876, DOI 10.1167/iovs.02-1329; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DENT JA, 1989, DEVELOPMENT, V105, P61; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; GLOVER HR, 1995, ONCOGENE, V11, P1347; Grant BD, 1998, BIOCHEMISTRY-US, V37, P7708, DOI 10.1021/bi972987w; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Ikenoue T, 2003, CANCER RES, V63, P8132; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jones CM, 1996, DEVELOPMENT, V122, P1545; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Lowinger TB, 2002, CURR PHARM DESIGN, V8, P2269, DOI 10.2174/1381612023393125; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; MacNicol MC, 2000, J BIOL CHEM, V275, P3803, DOI 10.1074/jbc.275.6.3803; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Morrison DK, 2001, J CELL SCI, V114, P1609; Nagar B, 2002, CANCER RES, V62, P4236; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; REIDL B, 2000, Patent No. 200041698; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Weber CK, 2001, CANCER RES, V61, P3595; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yuen ST, 2002, CANCER RES, V62, P6451; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	48	2087	2223	3	193	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					855	867		10.1016/S0092-8674(04)00215-6	http://dx.doi.org/10.1016/S0092-8674(04)00215-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035987	Bronze			2022-12-01	WOS:000221499900011
J	Giannone, G; Dubin-Thaler, BJ; Dobereiner, HG; Kieffer, N; Bresnick, AR; Sheetz, MP				Giannone, G; Dubin-Thaler, BJ; Dobereiner, HG; Kieffer, N; Bresnick, AR; Sheetz, MP			Periodic lamellipodial contractions correlate with rearward actin waves	CELL			English	Article							DEPOLYMERIZING FACTOR COFILIN; FILAMENT TURNOVER; ARP2/3 COMPLEX; MYOSIN-II; MOTILITY; FORCE; LOCALIZATION; PHOSPHORYLATION; RAC; PROTRUSION	Cellular lamellipodia bind to the matrix and probe its rigidity through forces generated by rearward F-actin transport. Cells respond to matrix rigidity by moving toward more rigid matrices using an unknown mechanism. In spreading and migrating cells we find local periodic contractions of lamellipodia that depend on matrix rigidity, fibronectin binding and myosin light chain kinase (MLCK). These contractions leave periodic rows of matrix bound beta3-integrin and paxillin while generating waves of rearward moving actin bound alpha-actinin and MLCK. The period between contractions corresponds to the time for F-actin to move across the lamellipodia. Shortening lamellipodial width by activating cofilin decreased this period proportionally. Increasing lamellipodial width by Rac signaling activation increased this period. We propose that an actin bound, contraction-activated signaling complex is transported locally from the tip to the base of the lamellipodium, activating the next contraction/extension cycle.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Ctr, CNRS, CRP Sante, Lab Franco Luxembourgeois Rech Biomed, L-1511 Luxembourg, Luxembourg; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Columbia University; Luxembourg Institute of Health; Yeshiva University; Albert Einstein College of Medicine	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	Döbereiner, Hans-Günther/F-7302-2012	Döbereiner, Hans-Günther/0000-0003-1691-634X; Giannone, Gregory/0000-0002-0932-1690	NIGMS NIH HHS [GM362] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dobereiner HG, 1997, PHYS REV E, V55, P4458, DOI 10.1103/PhysRevE.55.4458; DUBINTHALER BJ, 2004, IN PRESS BIOPHYS J; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Jin YJ, 2001, J BIOL CHEM, V276, P30342, DOI 10.1074/jbc.M102404200; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Munevar S, 2001, MOL BIOL CELL, V12, P3947, DOI 10.1091/mbc.12.12.3947; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Plancon S, 2001, BIOCHEM J, V357, P529, DOI 10.1042/0264-6021:3570529; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	47	456	461	3	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					431	443		10.1016/S0092-8674(04)00058-3	http://dx.doi.org/10.1016/S0092-8674(04)00058-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016377	Bronze			2022-12-01	WOS:000188825800011
J	Dyer, O				Dyer, O			Journal rejects article after objections from marketing department	BRITISH MEDICAL JOURNAL			English	News Item																			0	13	14	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 31	2004	328	7434					244	244		10.1136/bmj.328.7434.244-b	http://dx.doi.org/10.1136/bmj.328.7434.244-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771LC	15133870				2022-12-01	WOS:000188786000009
J	Stoneburner, RL; Low-Beer, D				Stoneburner, RL; Low-Beer, D			Population-level HIV declines and behavioral risk avoidance in Uganda	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SEXUAL-BEHAVIOR; PREGNANT-WOMEN; PREVALENCE; AIDS; TRANSMISSION; DYNAMICS; HIV/AIDS; COHORT; TRENDS	Uganda provides the clearest example that human immunodeficiency virus (HIV) is preventable if populations are mobilized to avoid risk. Despite limited resources, Uganda has shown a 70% decline in HIV prevalence since the early 1990s, linked to a 60% reduction in casual sex. The response in Uganda appears to be distinctively associated with communication about acquired immunodeficiency syndrome (AIDS) through social networks. Despite substantial condom use and promotion of biomedical approaches, other African countries have shown neither similar behavioral responses nor HIV prevalence declines of the same scale. The Ugandan success is equivalent to a vaccine of 80% effectiveness. Its replication will require changes in global HIV/AIDS intervention policies and their evaluation.	Univ Cambridge, Populat Hlth Evaluat Unit, Cambridge, England	University of Cambridge	Stoneburner, RL (corresponding author), Univ Cambridge, Populat Hlth Evaluat Unit, Cambridge, England.	randstoneburner@netzero.net						AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; ASIIMWEOKIROR G, 1996, 11 INT C AIDS VANC B; BESSINGER R, 2003, TRENDS SEXUAL FERTIL; *CENTR BOARD HLTH, 2004, ANC SENT SURV HIV SY; Fennema JSA, 1998, AIDS, V12, P931, DOI 10.1097/00002030-199808000-00016; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; HESSOL NA, 1989, AM J EPIDEMIOL, V130, P1167, DOI 10.1093/oxfordjournals.aje.a115445; HOGLE JA, 2002, WHAT HAPPENED UGANDA; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Konde-Lule J K, 1995, Health Transit Rev, V5 Suppl, P27; Korenromp EL, 2002, AIDS, V16, P2209, DOI 10.1097/00002030-200211080-00014; Kwesigabo G, 2000, J ACQ IMMUN DEF SYND, V23, P410; Low-Beer D, 2002, LANCET, V360, P1788, DOI 10.1016/S0140-6736(02)11701-6; MARTIN JL, 1987, AM J PUBLIC HEALTH, V77, P578, DOI 10.2105/AJPH.77.5.578; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; MCKUSICK L, 1985, AM J PUBLIC HEALTH, V75, P493, DOI 10.2105/AJPH.75.5.493; MERTENS T, 1994, AIDS, V8, P1359, DOI 10.1097/00002030-199410000-00002; MOODI R, 1991, EVALUATION STUDY UGA; MUGYENYI P, COMMUNICATION; MUSINGUZI J, 1996, REPORT RESULTS POPUL; *N MAND CHILDR FUN, 2002, S AFR NAT HIV PREV B; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Nunn AJ, 1997, BRIT MED J, V315, P767, DOI 10.1136/bmj.315.7111.767; Okware S, 2001, B WORLD HEALTH ORGAN, V79, P1113; Parkhurst JO, 2002, LANCET, V360, P78, DOI 10.1016/S0140-6736(02)09340-6; Rose G., 1992, STRATEGY PREVENTIVE; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Stoneburner R, 1998, AIDS, V12, P226; STONEBURNER R, 2000, 13 INT C AIDS DURB S; Stoneburner RL, 1996, AM J EPIDEMIOL, V144, P682, DOI 10.1093/oxfordjournals.aje.a008981; STONEBURNER RL, 1993, AM J EPIDEMIOL, V138, P1093, DOI 10.1093/oxfordjournals.aje.a116827; STONEBURNER RL, 1997, ASSESSMENT EMERGING; STONEBURNER RL, IN PRESS INT J EPIDE; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Susser M, 1996, AM J PUBLIC HEALTH, V86, P1713, DOI 10.2105/AJPH.86.12.1713; Tarantola D, 1997, AIDS, V11 Suppl B, pS5; *UNAIDS, 1998, MEAS SUCC UG; UNAIDS, 1999, TRENDS HIV INC PREV; UNAIDS, 2003, AIDS EP UPD; Wawer MJ, 1997, AIDS, V11, P1023, DOI 10.1097/00002030-199708000-00011; Weidle PJ, 2002, LANCET, V359, P2261, DOI 10.1016/S0140-6736(02)09297-8; *WHO, 1991, STESASERA119 WHO; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506	44	327	330	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					714	718		10.1126/science.1093166	http://dx.doi.org/10.1126/science.1093166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816JD	15118157				2022-12-01	WOS:000221105300039
J	Hachet, O; Ephrussi, A				Hachet, O; Ephrussi, A			Splicing of oskar RNA in the nucleus is coupled to its cytoplasmic localization	NATURE			English	Article							BICOID MESSENGER-RNA; EXON-EXON JUNCTIONS; MAGO NASHI; RIBONUCLEOPROTEIN-PARTICLES; DROSOPHILA OOCYTE; BINDING PROTEIN; GERM PLASM; POSTERIOR; POLE; COMPLEX	oskar messenger RNA localization at the posterior pole of the Drosophila oocyte is essential for germline and abdomen formation in the future embryo(1,2). The nuclear shuttling proteins Y14/Tsunagi and Mago nashi are required for oskar mRNA localization, and they co-localize with oskar mRNA at the posterior pole of the oocyte(3-5). Their human homologues, Y14/ RBM8 and Magoh, are core components of the exon - exon junction complex (EJC)(6-9). The EJC is deposited on mRNAs in a splicing-dependent manner, 20 - 24 nucleotides upstream of exon - exon junctions, independently of the RNA sequence(6-8). This indicates a possible role of splicing in oskar mRNA localization, challenging the established notion that the oskar 3 0 untranslated region (3' UTR) is sufficient for this process. Here we show that splicing at the first exon - exon junction of oskar RNA is essential for oskar mRNA localization at the posterior pole. We revisit the issue of sufficiency of the oskar 3' UTR for posterior localization and show that the localization of unrelated transcripts bearing the oskar 3' UTR is mediated by endogenous oskar mRNA. Our results reveal an important new function for splicing: regulation of messenger ribonucleoprotein complex assembly and organization for mRNA cytoplasmic localization.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Ephrussi, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1,Postfach 10-2209, D-69117 Heidelberg, Germany.	ephrussi@embl-heidelberg.de	Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021	Ephrussi, Anne/0000-0002-5061-4620				AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V1; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HORTON RM, 1991, BIOTECHNIQUES, V5, P528; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kim-Ha Jeongsil, 1993, Development (Cambridge), V119, P169; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Macchi P, 2003, J NEUROSCI, V23, P5778; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Mohr SE, 2001, GENE DEV, V15, P2886; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; RONGO C, 1995, DEVELOPMENT, V121, P2737; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; Wagner C, 2001, J MOL BIOL, V313, P511, DOI 10.1006/jmbi.2001.5057; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0	30	252	257	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					959	963		10.1038/nature02521	http://dx.doi.org/10.1038/nature02521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118729				2022-12-01	WOS:000221083000045
J	Sollner, C; Rauch, GJ; Siemens, J; Geisler, R; Schuster, SC; Muller, U; Nicolson, T				Sollner, C; Rauch, GJ; Siemens, J; Geisler, R; Schuster, SC; Muller, U; Nicolson, T		Tubingen 2000 Screen Consortium	Mutations in cadherin 23 affect tip links in zebrafish sensory hair cells	NATURE			English	Article							CALCIUM CHELATION; MYOSIN VIIA; SURFACE; CDH23; WALTZER; ANTIGEN; GENE; STEREOCILIA; HARMONIN; BUNDLES	Hair cells have highly organized bundles of apical projections, or stereocilia, that are deflected by sound and movement. Displacement of stereocilia stretches linkages at the tips of stereocilia that are thought to gate mechanosensory channels(1). To identify the molecular machinery that mediates mechanotransduction in hair cells, zebrafish mutants were identified with defects in balance and hearing(2). In sputnik mutants, stereociliary bundles are splayed to various degrees, with individuals displaying reduced or absent mechanotransduction(3,4). Here we show that the defects in sputnik mutants are caused by mutations in cadherin 23 (cdh23). Mutations in Cdh23 also cause deafness and vestibular defects in mice and humans(5-9), and the protein is present in hair bundles(10,11). We show that zebrafish Cdh23 protein is concentrated near the tips of hair bundles, and that tip links are absent in homozygous sputnik(tc317e) larvae. Moreover, tip links are absent in larvae carrying weak alleles of cdh23 that affect mechanotransduction but not hair bundle integrity. We conclude that Cdh23 is an essential tip link component required for hair-cell mechanotransduction.	Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany; Max Planck Inst Entwicklungsbiol, AG Gen & Signal Transduct, D-72076 Tubingen, Germany; Scripps Res Inst, La Jolla, CA 92037 USA; Oregon Hearing Res Ctr, Portland, OR 97239 USA; Vollum Inst, Portland, OR 97239 USA; Artemis Pharmaceut GmbH, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society; Scripps Research Institute	Nicolson, T (corresponding author), Max Planck Inst Entwicklungsbiol, Genet Abt, Spemannstr 35, D-72076 Tubingen, Germany.	nicolson@ohsu.edu	Geisler, Robert/K-6201-2013	Geisler, Robert/0000-0002-3909-8311; Dahm, Ralf/0000-0001-5203-8578; Maderspacher, Florian/0000-0003-4324-8455; Siemens, Jan/0000-0001-9051-9217				ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Goodyear R, 1999, J NEUROSCI, V19, P3761; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Goodyear RJ, 2003, J NEUROSCI, V23, P4878; Granato M, 1996, DEVELOPMENT, V123, P399; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Katori Y, 1996, J ELECTRON MICROSC, V45, P207, DOI 10.1093/oxfordjournals.jmicro.a023434; Leckband D, 2000, CURR OPIN CELL BIOL, V12, P587, DOI 10.1016/S0955-0674(00)00136-8; NEUGEBAUER DC, 1987, CELL TISSUE RES, V249, P199, DOI 10.1007/BF00215434; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; PICKLES JO, 1992, TRENDS NEUROSCI, V15, P254, DOI 10.1016/0166-2236(92)90066-H; PICKLES JO, 1989, HEARING RES, V41, P31, DOI 10.1016/0378-5955(89)90176-7; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; SIEMENS J, 2004, NATURE          0331, DOI DOI 10.1038/NATURE02483; Sivasankar S, 2001, BIOPHYS J, V80, P1758, DOI 10.1016/S0006-3495(01)76146-2; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Wada T, 2001, BIOCHEM BIOPH RES CO, V283, P113, DOI 10.1006/bbrc.2001.4724; Westerfield M., 1995, ZEBRAFISH BOOK; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554	31	247	254	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					955	959		10.1038/nature02484	http://dx.doi.org/10.1038/nature02484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15057246				2022-12-01	WOS:000221083000044
J	Wilson, JF				Wilson, JF			Cheaper drugs in foreign markets increase the focus on domestic drug prices	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				CALFEE JE, 2003, HLTH POLICY OUTL NOV; DANZON PM, HLTH AFFAIRS; WAGNER JL, ANN REV PUBLIC HLTH	3	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					677	680		10.7326/0003-4819-140-8-200404200-00044	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00044			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096358				2022-12-01	WOS:000220851700034
J	Lowdon, D				Lowdon, D			Interactive case report - A 66 year old woman with breathlessness: case outcome - Commentary: Patient's view	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Victoria Hosp, Dundee DD2 1SP, Scotland			douglas.lowdon@tpct.scot.nhs.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					944	945		10.1136/bmj.328.7445.944	http://dx.doi.org/10.1136/bmj.328.7445.944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087344	Green Published			2022-12-01	WOS:000220994400029
J	Hagoort, P; Hald, L; Bastiaansen, M; Petersson, KM				Hagoort, P; Hald, L; Bastiaansen, M; Petersson, KM			Integration of word meaning and world knowledge in language comprehension	SCIENCE			English	Article							SENTENCES; POTENTIALS; HUMANS; N400	Although the sentences that we hear or read have meaning, this does not necessarily mean that they are also true. Relatively little is known about the critical brain structures for, and the relative time course of, establishing the meaning and truth of linguistic expressions. We present electroencephalogram data that show the rapid parallel integration of both semantic and world knowledge during the interpretation of a sentence. Data from functional magnetic resonance imaging revealed that the left inferior prefrontal cortex is involved in the integration of both meaning and world knowledge. Finally, oscillatory brain responses indicate that the brain keeps a record of what makes a sentence hard to interpret.	Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands; Univ Nijmegen, Nijmegen Inst Cognit & Informat, Nijmegen, Netherlands; Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Max Planck Society	Hagoort, P (corresponding author), Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands.	peter.hagoort@fcdonders.kun.nl	GNC, GNC/B-5716-2013; Petersson, Karl Magnus/HDO-0143-2022; Bastiaansen, Marcel C.M./D-2507-2010; Petersson, Karl Magnus/E-8188-2012; Hald, Lea A/J-3405-2012; Hagoort, Peter/B-7417-2012	Petersson, Karl Magnus/0000-0002-8245-0392; Petersson, Karl Magnus/0000-0002-8245-0392; Hald, Lea A/0000-0001-7641-8049; Bastiaansen, Marcel/0000-0003-2865-7859				Bastiaansen M, 2003, CORTEX, V39, P967, DOI 10.1016/S0010-9452(08)70873-6; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Chomsky N., 1975, REFLECTIONS LANGUAGE; Clark H.H., 1996, USING LANGUAGE; Clifton C., 1999, ARCHITECTURES MECH L, P213; FORSTER KI, 1989, SENTENCE PROCESSING, P27; Frege G., 1892, Z F UR PHILOSOPHIE P, V100, P25; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; JACKENDOFF R, 2003, FDN LANGUAGE BRAIN G; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Katz J.J., 1972, SEMANTIC THEORY; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Marslen-Wilson WD., 1988, LANG COGN PROCESS, V3, P1; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Seuren Pieter A. M, 1985, DISCOURSE SEMANTICS; Seuren Pieter A.M., 1998, W LINGUISTICS HIST I; Sperber Dan, 1986, RELEVANCE; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; ZOLA-MORGAN S, 1990, P434	25	764	783	11	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					438	441		10.1126/science.1095455	http://dx.doi.org/10.1126/science.1095455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15031438	Green Published			2022-12-01	WOS:000220845400048
J	Mori, MX; Erickson, MG; Yue, DT				Mori, MX; Erickson, MG; Yue, DT			Functional stoichiometry and local enrichment of calmodulin interacting with Ca2+ channels	SCIENCE			English	Article							CALCIUM-CHANNELS; CA2+-DEPENDENT INACTIVATION; CREB PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; NUCLEUS; CA2+/CALMODULIN; PREASSOCIATION; FACILITATION; SUPPORTS; MEDIATE	Calmodulin (CaM) interactions with Ca2+ channels mediate both Ca2+ regulation of channels and local Ca2+ triggering of transcription factors implicated in neuronal memory. Crucial to these functions are the number of CaM molecules (CaMs) regulating each channel, and the number of CaMs privy to the local Ca2+ signal from each channel. To resolve these parameters, we fused L-type Ca2+ channels to single CaM molecules. These chimeric molecules revealed that a single CaM directs L-type channel regulation. Similar fusion molecules were used to estimate the local CaM concentration near Ca2+ channels. This estimate indicates marked enrichment of local CaM, as if a "school" of nearby CaMs were poised to enhance the transduction of local Ca2+ entry into diverse signaling pathways.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ca2 Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Ca2 Signals Lab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ca2 Signals Lab, 720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu						Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Ikeda SR, 2001, SCIENCE, V294, P318, DOI 10.1126/science.1066160; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Maier LS, 2000, J MOL CELL CARDIOL, V32, P2249, DOI 10.1006/jmcc.2000.1252; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Soong TW, 2002, J NEUROSCI, V22, P10142; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	30	156	159	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					432	435		10.1126/science.1093490	http://dx.doi.org/10.1126/science.1093490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087548				2022-12-01	WOS:000220845400046
J	Holmes, W				Holmes, W			3 by 5, but at what cost?	LANCET			English	Editorial Material									Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3004, Australia	Burnet Institute	Holmes, W (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3004, Australia.	holmes@burnet.edu.au						*AS PAC NETW PEOPL, DOC AIDS REL DISCR A; FREEDMAN LP, BACKGROUND PAPER TAS; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Ogden J, 2003, SOC SCI MED, V57, P179, DOI 10.1016/S0277-9536(02)00373-8	4	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 27	2004	363	9414					1072	1073		10.1016/S0140-6736(04)15847-9	http://dx.doi.org/10.1016/S0140-6736(04)15847-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15065565				2022-12-01	WOS:000220497300026
J	MacCoss, M; Baillie, TA				MacCoss, M; Baillie, TA			Organic chemistry in drug discovery	SCIENCE			English	Article							ANTAGONIST; RECEPTOR; POTENT	The role played by organic chemistry in the pharmaceutical industry continues to be one of the main drivers in the drug discovery process. However, the precise nature of that role is undergoing a visible change, not only because of the new synthetic methods and technologies now available to the synthetic and medicinal chemist, but also in several key areas, particularly in drug metabolism and chemical toxicology, as chemists deal with the ever more rapid turnaround of testing data that influences their day-to-day decisions.	Merck Res Labs, Dept Basic Chem, Rahway, NJ 07065 USA; Merck Res Labs, Dept Drug Metab, W Point, PA 19486 USA	Merck & Company; Merck & Company	MacCoss, M (corresponding author), Merck Res Labs, Dept Basic Chem, 126 E Lincoln Ave, Rahway, NJ 07065 USA.	malcolm_maccoss@merck.com						DEPALMA A, 2003, DRUG DISCOV DEV, V6, P51; DEPALMA A, 2002, DRUG DISCOV DEV, V5, P50; Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Hale JJ, 1998, J MED CHEM, V41, P4607, DOI 10.1021/jm980299k; KOPPAL T, 2003, DRUG DISCOV DEV, V6, P59; KOPPAL T, 2003, DRUG DISCOV DEV, V6, P22; Korfmacher WA, 2001, RAPID COMMUN MASS SP, V15, P335, DOI 10.1002/rcm.235; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McCoy M, 2003, CHEM ENG NEWS, V81, P15; Netzer R, 2001, DRUG DISCOV TODAY, V6, P78, DOI 10.1016/S1359-6446(00)01602-0; Rouhi AM, 2003, CHEM ENG NEWS, V81, P75; SNIDER RM, 1991, SCIENCE, V251, P435, DOI 10.1126/science.1703323; Uetrecht J, 2003, DRUG DISCOV TODAY, V8, P832, DOI 10.1016/S1359-6446(03)02816-2; 2003, DRUG DISCOV DEV, V6, P30	14	98	101	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2004	303	5665					1810	1813		10.1126/science.1096800	http://dx.doi.org/10.1126/science.1096800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	15031494				2022-12-01	WOS:000220281600042
J	Vulliet, PR; Greeley, M; Halloran, SM; MacDonald, KA; Kittleson, MD				Vulliet, PR; Greeley, M; Halloran, SM; MacDonald, KA; Kittleson, MD			Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs	LANCET			English	Article							MYOCARDIAL-INFARCTION	Mesenchymal stromal cells (MSCs) have the potential to treat many myocardial diseases. We investigated whether these multipotent stem cells derived from bone marrow could be administered safely into the coronary circulation of healthy dogs. We injected about 0.5 million cells per kg bodyweight of early passage autologous MSCs into the left circumflex coronary artery of anaesthetised dogs. During administration, we noted ST segment elevation and T wave changes characteristic of acute myocardial ischaemia. 7 days later, macroscopic and microscopic evidence of myocardial infarction was noted. Histological sections of myocardium showed several scattered regions of dense fibroplasia accompanied by macrophage infiltrates only in areas where the MSCs were observed. We also noted raised plasma concentrations of cardiac troponin I and collagen fibril deposition in the lesions. These findings show acute myocardial ischaemia and subacute myocardial microinfarction after intracoronary arterial injection of MSCs into dogs.	Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Vulliet, PR (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	prvulliet@ucdavis.edu	Kittleson, Mark D/ABD-6706-2021	Kittleson, Mark D/0000-0002-1113-8369				Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; KITTLESON MD, 1987, AM HEART J, V114, P70, DOI 10.1016/0002-8703(87)90309-7; MOORE PF, 1990, TISSUE ANTIGENS, V36, P211, DOI 10.1111/j.1399-0039.1990.tb01831.x; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C	5	351	432	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 6	2004	363	9411					783	784		10.1016/S0140-6736(04)15695-X	http://dx.doi.org/10.1016/S0140-6736(04)15695-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801JK	15016490				2022-12-01	WOS:000220092000010
J	Mitchell, P; Hope, T; Gregson, BA; Mendelow, AD				Mitchell, P; Hope, T; Gregson, BA; Mendelow, AD			Regional differences in outcome from subarachnoid haemorrhage: comparative audit	BRITISH MEDICAL JOURNAL			English	Article							SCALE		Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Queens Med Ctr, Dept Neurosurg, Nottingham NG7 2UH, England	Newcastle General Hospital; Newcastle University - UK; University of Nottingham	Mitchell, P (corresponding author), Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	Patrick.Mitchell@ncl.ac.uk	Mendelow, Alexander/AAW-2878-2021	Gregson, Barbara/0000-0003-4868-9137				DRAKE CG, 1988, J NEUROSURG, V68, P985; JENNETT B, 1975, LANCET, V1, P480; NELSON MJ, 1999, SAFE NEUROSURGERY 20; SAHS AL, 1981, ANEURYSMAL SUBARACHN	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 22	2004	328	7450					1234	1235		10.1136/bmj.38084.592639.AE	http://dx.doi.org/10.1136/bmj.38084.592639.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15105285	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000221677200020
J	Han, JS; Szak, ST; Boeke, JD				Han, JS; Szak, ST; Boeke, JD			Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes	NATURE			English	Article							REVERSE TRANSCRIPTION; ALLELIC VARIATION; ORF1 PROTEIN; LINE-1; RNA; IDENTIFICATION; EXPRESSION; GENE; DNA; SPECIFICITY	LINE-1 (L1) elements are the most abundant autonomous retrotransposons in the human genome, accounting for about 17% of human DNA. The L1 retrotransposon encodes two proteins, open reading frame (ORF)1 and the ORF2 endonuclease/reverse transcriptase. L1 RNA and ORF2 protein are difficult to detect in mammalian cells, even in the context of overexpression systems. Here we show that inserting L1 sequences on a transcript significantly decreases RNA expression and therefore protein expression. This decreased RNA concentration does not result from major effects on the transcription initiation rate or RNA stability. Rather, the poor L1 expression is primarily due to inadequate transcriptional elongation. Because L1 is an abundant and broadly distributed mobile element, the inhibition of transcriptional elongation by L1 might profoundly affect expression of endogenous human genes. We propose a model in which L1 affects gene expression genome-wide by acting as a 'molecular rheostat' of target genes. Bioinformatic data are consistent with the hypothesis that L1 can serve as an evolutionary fine-tuner of the human transcriptome.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; Biogen Inc, Cambridge, MA 02142 USA	Johns Hopkins University; Johns Hopkins University; Biogen	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jboeke@jhmi.edu		Boeke, Jef/0000-0001-5322-4946				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Clements AP, 1998, NUCLEIC ACIDS RES, V26, P3528, DOI 10.1093/nar/26.15.3528; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Cuello P, 1999, EMBO J, V18, P2867, DOI 10.1093/emboj/18.10.2867; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dieckmann T, 1997, J MOL BIOL, V273, P467, DOI 10.1006/jmbi.1997.1329; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; FENG Q, 1996, THESIS J HOPKINS U; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; HICKEY DA, 1982, GENETICS, V101, P519; Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3139, DOI 10.1093/nar/20.12.3139; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oliver JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Szak ST, 2002, GENOME BIOL, V3; Tang W, 2000, P NATL ACAD SCI USA, V97, P6025, DOI 10.1073/pnas.110139897; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; XU QH, 1994, J BIOL CHEM, V269, P3100; Yajima I, 1999, HUM MOL GENET, V8, P1431, DOI 10.1093/hmg/8.8.1431; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; Zarudnaya MI, 2003, NUCLEIC ACIDS RES, V31, P1375, DOI 10.1093/nar/gkg241	50	363	372	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					268	274		10.1038/nature02536	http://dx.doi.org/10.1038/nature02536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152245				2022-12-01	WOS:000221505900035
J	Han, JS; Boeke, JD				Han, JS; Boeke, JD			A highly active synthetic mammalian retrotransposon	NATURE			English	Article							HUMAN L1 RETROTRANSPOSITION; LINE-1 RETROTRANSPOSITION; MOUSE LINE-1; IN-VITRO; ENDONUCLEASE; ELEMENT; CELLS	LINE-1 (L1) elements are retrotransposons that comprise large fractions of mammalian genomes(1). Transcription through L1 open reading frames is inefficient owing to an elongation defect(2), inhibiting the robust expression of L1 RNA and proteins, the substrate and enzyme(s) for retrotransposition(3-5). This elongation defect probably controls L1 transposition frequency in mammalian cells. Here we report bypassing this transcriptional defect by synthesizing the open reading frames of L1 from synthetic oligonucleotides, altering 24% of the nucleic acid sequence without changing the amino acid sequence. Such resynthesis led to greatly enhanced steady-state L1 RNA and protein levels. Remarkably, when the synthetic open reading frames were substituted for the wild-type open reading frames in an established retrotransposition assay(4), transposition levels increased more than 200-fold. This indicates that there are probably no large, rigidly conserved cis-acting nucleic acid sequences required for retrotransposition within L1 coding regions. These synthetic retrotransposons are also the most highly active L1 elements known so far and have potential as practical tools for manipulating mammalian genomes.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jboeke@jhmi.edu		Boeke, Jef/0000-0001-5322-4946				Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hamer L, 2001, CURR OPIN CHEM BIOL, V5, P67, DOI 10.1016/S1367-5931(00)00162-9; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARTIN SL, 1995, GENE, V153, P261, DOI 10.1016/0378-1119(94)00785-Q; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	23	133	139	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2004	429	6989					314	318		10.1038/nature02535	http://dx.doi.org/10.1038/nature02535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152256				2022-12-01	WOS:000221505900047
J	Blander, JM; Medzhitov, R				Blander, JM; Medzhitov, R			Regulation of phagosome maturation by signals from Toll-like receptors	SCIENCE			English	Article							LYSOSOMAL MEMBRANE GLYCOPROTEIN; PHAGOCYTOSIS; IDENTIFICATION; MECHANISMS	In higher metazoans, phagocytosis is essential in host defense against microbial pathogens and in clearance of apoptotic cells. Both microbial and apoptotic cells are delivered on a common route from phagosomes to lysosomes for degradation. Here, we found that activation of the Toll-like receptor (TLR) signaling pathway by bacteria, but not apoptotic cells, regulated phagocytosis at multiple steps including internalization and phagosome maturation. Phagocytosis of bacteria was impaired in the absence of TLR signaling. Two modes of phagosome maturation were observed, constitutive and inducible; their differential engagement depended on the ability of the cargo to trigger TLR signaling.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Blander, Julie Magarian/0000-0001-9207-1700	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46688] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BLANDER JM, UNPUB; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; HOWE CL, 1988, P NATL ACAD SCI USA, V85, P7577, DOI 10.1073/pnas.85.20.7577; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Metchnikoff E., 1905, IMMUNITY INFECT DIS; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Storrie Brian, 1996, Bioessays, V18, P895, DOI 10.1002/bies.950181108; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Via LE, 1998, J CELL SCI, V111, P897; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	22	782	814	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					1014	1018		10.1126/science.1096158	http://dx.doi.org/10.1126/science.1096158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143282				2022-12-01	WOS:000221383300050
J	He, WH; Miao, FJP; Lin, DCH; Schwandner, RT; Wang, ZL; Gao, JH; Chen, JL; Tian, H; Ling, L				He, WH; Miao, FJP; Lin, DCH; Schwandner, RT; Wang, ZL; Gao, JH; Chen, JL; Tian, H; Ling, L			Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors	NATURE			English	Article							RENIN-ANGIOTENSIN SYSTEM; PROXIMAL TUBULE; BLOOD-PRESSURE; HYPERTENSION; ACTIVATION; TRANSPORT; DISCOVERY; ASSAY; ALPHA; MICE	The citric acid cycle is central to the regulation of energy homeostasis and cell metabolism(1). Mutations in enzymes that catalyse steps in the citric acid cycle result in human diseases with various clinical presentations(2). The intermediates of the citric acid cycle are present at micromolar concentration in blood and are regulated by respiration, metabolism and renal reabsorption/ extrusion. Here we show that GPR91 (ref. 3), a previously orphan G-protein-coupled receptor (GPCR), functions as a receptor for the citric acid cycle intermediate succinate. We also report that GPR99 (ref. 4), a close relative of GPR91, responds to alpha-ketoglutarate, another intermediate in the citric acid cycle. Thus by acting as ligands for GPCRs, succinate and alpha-ketoglutarate are found to have unexpected signalling functions beyond their traditional roles. Furthermore, we show that succinate increases blood pressure in animals. The succinate-induced hypertensive effect involves the renin - angiotensin system and is abolished in GPR91-deficient mice. Our results indicate a possible role for GPR91 in renovascular hypertension, a disease closely linked to atherosclerosis, diabetes and renal failure(5,6).	Tularik Inc, San Francisco, CA 94080 USA; Tularik GmbH, D-93053 Regensburg, Germany		Ling, L (corresponding author), Tularik Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA.	ling@tularik.com						An SZ, 2001, P NATL ACAD SCI USA, V98, P7576, DOI 10.1073/pnas.131200698; BAUMBACH L, 1976, J PHYSIOL-LONDON, V258, P243, DOI 10.1113/jphysiol.1976.sp011417; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028, DOI 10.1152/ajprenal.0148.2001; Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; GULLANS SR, 1984, AM J PHYSIOL, V246, pF859, DOI 10.1152/ajprenal.1984.246.6.F859; GULLANS SR, 1988, AM J PHYSIOL, V255, pF1170, DOI 10.1152/ajprenal.1988.255.6.F1170; Gurley SB, 2002, COLD SPRING HARB SYM, V67, P451, DOI 10.1101/sqb.2002.67.451; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1067, DOI 10.1152/physrev.1990.70.4.1067; HEMS DA, 1970, BIOCHEM J, V120, P105, DOI 10.1042/bj1200105; Jandeleit-Dahm K, 2002, CURR OPIN NEPHROL HY, V11, P221, DOI 10.1097/00041552-200203000-00014; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; KREBS HA, 1970, PERSPECT BIOL MED, V14, P154; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Kushnir MM, 2001, CLIN CHEM, V47, P1993; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; MARTIN M, 1989, PFLUG ARCH EUR J PHY, V413, P217, DOI 10.1007/BF00583533; Olin Jeffrey W., 2002, Cardiology Clinics, V20, P547, DOI 10.1016/S0733-8651(02)00091-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; Silva APT, 2002, RENAL FAILURE, V24, P275, DOI 10.1081/JDI-120005361; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Sugiyama F, 2002, PHYSIOL GENOMICS, V10, P5, DOI 10.1152/physiolgenomics.00002.2002; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; Wittenberger T, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-17; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866	30	604	667	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					188	193		10.1038/nature02488	http://dx.doi.org/10.1038/nature02488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141213	Bronze			2022-12-01	WOS:000221356300043
J	Gillison, ML; Lowy, DR				Gillison, ML; Lowy, DR			A causal role for human papillomavirus in head and neck cancer	LANCET			English	Editorial Material							SQUAMOUS-CELL CARCINOMAS; ORAL-CANCER; INFECTION; P53; OVEREXPRESSION; P16(INK4A); CAVITY; SUBSET; RISK; DNA		Johns Hopkins Med Inst, Baltimore, MD 21231 USA; NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gillison, ML (corresponding author), Johns Hopkins Med Inst, Baltimore, MD 21231 USA.	gillima@jhmi.edu			NATIONAL CANCER INSTITUTE [Z01BC010579, ZIABC010579] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERGUM S, 2003, CLIN CANCER RES, V9, P6469; Fregonesi PAG, 2003, J HISTOCHEM CYTOCHEM, V51, P1291; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg107, 10.1093/jnci/djg/107]; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Kutler DI, 2003, J NATL CANCER I, V95, P1718, DOI 10.1093/jnci/djg091; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Rajkumar T, 2003, EUR J CANCER PREV, V12, P135, DOI 10.1097/00008469-200304000-00007; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; Smith EM, 2004, JNCI-J NATL CANCER I, V96, P449, DOI 10.1093/jnci/djh074; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Summersgill KF, 2000, ORAL SURG ORAL MED O, V90, P334, DOI 10.1067/moe.2000.107359	15	168	173	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2004	363	9420					1488	1489		10.1016/S0140-6736(04)16194-1	http://dx.doi.org/10.1016/S0140-6736(04)16194-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GK	15135592				2022-12-01	WOS:000221302700004
J	Hay, AD; Schroeder, K; Fahey, T				Hay, AD; Schroeder, K; Fahey, T			10-minute consultation - Acute cough in children	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Dundee, Tayside Ctr Gen Practic, Dundee DD2 4AD, Scotland	University of Bristol; University of Dundee	Hay, AD (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.	alastair.hay@bristol.ac.uk	Fahey, Tom/C-9367-2012; Hay, Alastair/L-1818-2019	Fahey, Tom/0000-0002-5896-5783; Hay, Alastair/0000-0003-3012-375X					0	8	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 1	2004	328	7447					1062	1062		10.1136/bmj.328.7447.1062	http://dx.doi.org/10.1136/bmj.328.7447.1062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117793	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000221174500022
J	Yang, XG; Matsuda, K; Bialek, P; Jacquot, S; Masuoka, HC; Schinke, T; Li, LZ; Brancorsini, S; Sassone-Corsi, P; Townes, TM; Hanauer, A; Karsenty, G				Yang, XG; Matsuda, K; Bialek, P; Jacquot, S; Masuoka, HC; Schinke, T; Li, LZ; Brancorsini, S; Sassone-Corsi, P; Townes, TM; Hanauer, A; Karsenty, G			ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry syndrome	CELL			English	Article							MENTAL-RETARDATION SYNDROME; UNFOLDED PROTEIN RESPONSE; C-FOS GENE; TRANSCRIPTION FACTOR; CLEIDOCRANIAL DYSPLASIA; TRANSLATIONAL CONTROL; TARGETED DISRUPTION; BONE-FORMATION; CELL-SURVIVAL; MAPK PATHWAY	Coffin-Lowry Syndrome (CLS) is an X-linked mental retardation condition associated with skeletal abnormalities. The gene mutated in CLS, RSK2, encodes a growth factor-regulated kinase. However, the cellular and molecular bases of the skeletal abnormalities associated with CLS remain unknown. Here, we show that RSK2 is required for osteoblast differentiation and function. We identify the transcription factor ATF4 as a critical substrate of RSK2 that is required for the timely onset of osteoblast differentiation, for terminal differentiation of osteoblasts, and for osteoblast-specific gene expression. Additionally, RSK2 and ATF4 posttranscriptionally regulate the synthesis of Type I collagen, the main constituent of the bone matrix. Accordingly, Atf4-deficiency results in delayed bone formation during embryonic development and low bone mass throughout postnatal life. These findings identify ATF4 as a critical regulator of osteoblast differentiation and function, and indicate that lack of ATF4 phosphorylation by RSK2 may contribute to the skeletal phenotype of CLS.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Bone Dis Program, Houston, TX 77030 USA; CU Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Baylor College of Medicine; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Alabama System; University of Alabama Birmingham	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	karsenty@bcm.tmc.edu	Sassone-Corsi, Paolo/H-6182-2011; Brancorsini, Stefano/L-8770-2015; Matsuda, Koichi/D-4597-2011	Brancorsini, Stefano/0000-0002-8410-7248; Matsuda, Koichi/0000-0001-7292-2686				AUBIN JE, 2002, MESSENCHYMAL STEM CE, V1; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; COFFIN R, 1966, J PEDIATR-US, V69, P198, DOI 10.1016/S0022-3476(66)80320-7; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; LOWRY B, 1971, AM J DIS CHILD, V121, P496, DOI 10.1001/archpedi.1971.02100170078009; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MCKNIGHT SL, 1992, CCAAT ENHANCER BINDI, V2; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Merienne K, 2000, ONCOGENE, V19, P4221, DOI 10.1038/sj.onc.1203712; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; PARFITT AM, 1987, J BONE MINER RES, V2, P427; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; TEMTAMY SA, 1975, J PEDIATR-US, V86, P724, DOI 10.1016/S0022-3476(75)80357-X; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YOUNG ID, 1988, J MED GENET, V25, P344, DOI 10.1136/jmg.25.5.344; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	43	599	635	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					387	398		10.1016/S0092-8674(04)00344-7	http://dx.doi.org/10.1016/S0092-8674(04)00344-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109498	Bronze			2022-12-01	WOS:000221176400012
J	Koike, N; Fukumura, D; Gralla, O; Au, P; Schechner, JS; Jain, RK				Koike, N; Fukumura, D; Gralla, O; Au, P; Schechner, JS; Jain, RK			Creation of long-lasting blood vessels	NATURE			English	Editorial Material							IN-VIVO; CELLS		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University	Koike, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA.	jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548	NCI NIH HHS [P01 CA080124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655	10	538	574	6	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					138	139		10.1038/428138a	http://dx.doi.org/10.1038/428138a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014486				2022-12-01	WOS:000220103600033
J	Wei, W; Ayad, NG; Wan, Y; Zhang, GJ; Kirschner, MW; Kaelin, WG				Wei, W; Ayad, NG; Wan, Y; Zhang, GJ; Kirschner, MW; Kaelin, WG			Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex	NATURE			English	Article							BOX PROTEIN SKP2; DNA-REPLICATION; S-PHASE; MITOSIS; PROTEOLYSIS; RECOGNITION; EXPRESSION; P27(KIP1); BINDING; DESTRUCTION	Cell-cycle transitions are driven by waves of ubiquitin-dependent degradation of key cell-cycle regulators. SCF (Skp1/Cullin/F-box protein) complexes and anaphase-promoting complexes (APC) represent two major classes of ubiquitin ligases whose activities are thought to regulate primarily the G1/S and metaphase/anaphase cell-cycle transitions, respectively(1,2). The major target of the Skp1/Cul1/Skp2 (SCFSKP2) complex is thought to be the Cdk inhibitor p27 during S phase, whereas the principal targets for the APC are thought to be involved in chromatid separation (securin) and exit from mitosis (cyclin B). Although the role of the APC in mitosis is relatively clear, there is mounting evidence that APCs containing Cdh1 (APC(CDH1)) also have a function in the G1 phase of the cell cycle(2,3). Here, we show that the F-box protein Skp2 is polyubiquitinated, and hence earmarked for destruction, by APC(CDH1). As a result, accumulation of SCFSKP2 requires prior inactivation of APC(CDH1). These findings provide an insight into the orchestration of SCF and APC activities during cell-cycle progression, and into the involvement of the APC in G1.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	marc@hms.harvard.edu; william_kaelin@dfci.harvard.edu	Zhang, Guo-Jun/H-3890-2015	Zhang, Guo-Jun/0000-0001-5182-5887				Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Imaki H, 2003, CANCER RES, V63, P4607; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Nelsen CJ, 2001, ONCOGENE, V20, P1825, DOI 10.1038/sj.onc.1204248; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	30	385	397	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					194	198		10.1038/nature02381	http://dx.doi.org/10.1038/nature02381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014503				2022-12-01	WOS:000220103600052
J	Karoshi, MA				Karoshi, MA			Urine pregnancy test and intrauterine inseminations	LANCET			English	Editorial Material									N Middlesex Univ Hosp, Dept Obstet & Gynaecol, London N18 1QX, England		Karoshi, MA (corresponding author), N Middlesex Univ Hosp, Dept Obstet & Gynaecol, London N18 1QX, England.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 31	2004	363	9406					362	362		10.1016/S0140-6736(04)15437-8	http://dx.doi.org/10.1016/S0140-6736(04)15437-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070566				2022-12-01	WOS:000188590900011
J	Christensen, K; Juel, K; Herskind, M; Murray, JC				Christensen, K; Juel, K; Herskind, M; Murray, JC			Long term follow up study of survival associated with cleft lip and palate at birth	BRITISH MEDICAL JOURNAL			English	Article							CONGENITAL-MALFORMATIONS; CHILDHOOD-CANCER; RECORD-LINKAGE; RISK; DEFECTS; POPULATION; CHILDREN; INFANTS	Objective To assess the overall and cause specific mortality of people from birth to 55 years with cleft lip and palate. Design Long term follow up study. Setting Danish register of deaths. Participants People born with cleft lip and palate between 1943 and 1987, followed to 1998. Main outcome measures Observed and expected numbers of deaths, summarised as overall and cause specific standardised mortality ratios. Results 5331 people with cleft lip and palate were followed for 170 421 person years. The expected number of deaths was 259, but 402 occurred, corresponding to a standardised mortality ratio of 1.4 (95% confidence interval 1.3 to 1.6) for males and 1.8 (1.5 to 2.1) for females. The increased risk of mortality was nearly constant for the three intervals at follow up: first year of life, 1-17 years, and 18-55 years. The participants had an increased risk of all major causes of death. Conclusions People with cleft lip and palate have increased mortality up to age 55. Children born with cleft lip and palate and possibly other congenital malformations may benefit from specific preventive health measures into and throughout adulthood.	Univ So Denmark, Inst Publ Hlth, Ctr Prevent Congenital Malformat, DK-5000 Odense, Denmark; Natl Inst Publ Hlth, DK-2100 Copenhagen, Denmark; Odense Univ Hosp, Dept Pediat, DK-5000 Odense, Denmark; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Iowa	Christensen, K (corresponding author), Univ So Denmark, Inst Publ Hlth, Ctr Prevent Congenital Malformat, DK-5000 Odense, Denmark.	kchristensen@health.sdu.dk	Christensen, Kaare/C-2360-2009; Juel, Knud/C-8916-2013	Christensen, Kaare/0000-0002-5429-5292; Juel, Knud/0000-0002-4134-1173	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011948] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 11948] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Christensen K, 1999, CLEFT PALATE-CRAN J, V36, P96, DOI 10.1597/1545-1569(1999)036<0096:TCDFCP>2.3.CO;2; CHRISTENSEN K, 1995, NEW ENGL J MED, V333, P161, DOI 10.1056/NEJM199507203330305; Christensen K, 2002, CLEFT PALATE-CRAN J, V39, P392, DOI 10.1597/1545-1569(2002)039<0392:FCAPDA>2.0.CO;2; CHRISTENSEN K, 1994, CLIN GENET, V46, P329; Fogh-Andersen, 1942, INHERITANCE HARELIP; MILI F, 1993, AM J EPIDEMIOL, V137, P629, DOI 10.1093/oxfordjournals.aje.a116720; MILI F, 1993, AM J EPIDEMIOL, V137, P639, DOI 10.1093/oxfordjournals.aje.a116721; Nopoulos P, 2002, GENET MED, V4, P1, DOI 10.1097/00125817-200201000-00001; Ramstad T, 1995, SCAND J PLAST RECONS, V29, P329, DOI 10.3109/02844319509008968; WINDHAM GC, 1985, AM J EPIDEMIOL, V121, P49, DOI 10.1093/oxfordjournals.aje.a113982; ZACK M, 1991, CANCER RES, V51, P3696; Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488	12	150	155	2	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 12	2004	328	7453					1405	1406		10.1136/bmj.38106.559120.7C	http://dx.doi.org/10.1136/bmj.38106.559120.7C			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830IB	15145797	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000222114400016
J	Castle, LA; Siehl, DL; Gorton, R; Patten, PA; Chen, YH; Bertain, S; Cho, HJ; Duck, N; Wong, J; Liu, DL; Lassner, MW				Castle, LA; Siehl, DL; Gorton, R; Patten, PA; Chen, YH; Bertain, S; Cho, HJ; Duck, N; Wong, J; Liu, DL; Lassner, MW			Discovery and directed evolution of a glyphosate tolerance gene	SCIENCE			English	Article							SEROTONIN N-ACETYLTRANSFERASE; HERBICIDE-RESISTANCE; PROTEIN; PLANTS; MECHANISM; RESIDUES	The herbicide glyphosate is effectively detoxified by N-acetylation. We screened a collection of microbial isolates and discovered enzymes exhibiting glyphosate N-acetyltransferase (GAT) activity. Kinetic properties of the discovered enzymes were insufficient to confer glyphosate tolerance to transgenic organisms. Eleven iterations of DNA shuffling improved enzyme efficiency by nearly four orders of magnitude from 0.87 mM(-1) min(-1) to 8320 mM(-1) min(-1). From the fifth iteration and beyond, GAT enzymes conferred increasing glyphosate tolerance to Escherichia coli, Arabidopsis, tobacco, and maize. Glyphosate acetylation provides an alternative strategy for supporting glyphosate use on crops.	Verdia Inc, Redwood City, CA 94063 USA; Maxygen Inc, Redwood City, CA 94063 USA; Pioneer HiBred Int Inc, Johnston, IA 50131 USA	DuPont	Castle, LA (corresponding author), Verdia Inc, Redwood City, CA 94063 USA.	linda.castle@verdiainc.com						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barry G, 1992, CURR TOP PLANT PHYSL, P139; CASTLE L, UNPUB; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x; Draker KA, 2004, BIOCHEMISTRY-US, V43, P446, DOI 10.1021/bi035667n; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Franz J., 1997, GLYPHOSATE UNIQUE GL; GOUGLER JA, 1981, PLANT PHYSIOL, V68, P668, DOI 10.1104/pp.68.3.668; JAMES C, 2003, ISAA BRIEFS, V29; Khalil EM, 1998, J BIOL CHEM, V273, P30321, DOI 10.1074/jbc.273.46.30321; KINSKY SC, 1960, J BIOL CHEM, V235, P94; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Padgette Stephen R., 1996, P53; Pline WA, 2002, J AGR FOOD CHEM, V50, P506, DOI 10.1021/jf0110699; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; STALKER DM, 1988, SCIENCE, V242, P419, DOI 10.1126/science.242.4877.419; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; THOMPSON CJ, 1987, EMBO J, V6, P2519, DOI 10.1002/j.1460-2075.1987.tb02538.x; ZHAO ZY, 2004, Patent No. 5981840	21	220	318	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2004	304	5674					1151	1154		10.1126/science.1096770	http://dx.doi.org/10.1126/science.1096770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155947				2022-12-01	WOS:000221524500041
J	Goldman, DP; Joyce, GF; Escarce, JJ; Pace, JE; Solomon, MD; Laouri, M; Landsman, PB; Teutsch, SM				Goldman, DP; Joyce, GF; Escarce, JJ; Pace, JE; Solomon, MD; Laouri, M; Landsman, PB; Teutsch, SM			Pharmacy benefits and the use of drugs by the chronically ill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST; IMPACT	Context Many health plans have instituted more cost sharing to discourage use of more expensive pharmaceuticals and to reduce drug spending. Objective To determine how changes in cost sharing affect use of the most commonly used drug classes among the privately insured and the chronically ill. Design, Setting, and Participants Retrospective US study conducted from 1997 to 2000, examining linked pharmacy claims data with health plan benefit designs from 30 employers and 52 health plans. Participants were 528969 privately insured beneficiaries aged 18 to 64 years and enrolled from 1 to 4 years (960791 person-years). Main Outcome Measure Relative change in drug days supplied (per member, per year) when co-payments doubled in a prototypical drug benefit plan. Results Doubling co-payments was associated with reductions in use of 8 therapeutic classes. The largest decreases occurred for nonsteroidal anti-inflammatory drugs (NSAIDs) (45%) and antihistamines (44%). Reductions in overall days supplied of antihyperlipidemics (34%), antiulcerants (33%), antiasthmatics (32%), antihypertensives (26%), antidepressants (26%), and antidiabetics (25%) were also observed. Among patients diagnosed as having a chronic illness and receiving ongoing care, use was less responsive to co-payment changes. Use of antidepressants by depressed patients declined by 8%; use of anti hypertensives by hypertensive patients decreased by 10%. Larger reductions were observed for arthritis patients taking NSAIDs (27%) and allergy patients taking antihistamines (31%). Patients with diabetes reduced their use of antidiabetes drugs by 23%. Conclusions The use of medications such as antihistamines and NSAIDs, which are taken intermittently to treat symptoms, was sensitive to co-payment changes. Other medications-antihypertensive, antiasthmatic, antidepressant, antihyperlipidemic, antiulcerant, and antidiabetic agents-also demonstrated significant price responsiveness. The reduction in use of medications for individuals in ongoing care was more modest. Still, significant increases in co-payments raise concern about adverse health consequences because of the large price effects, especially among diabetic patients.	RAND Corp, Santa Monica, CA 90407 USA; Merck, W Point, PA USA; Calif Healthcare Fdn, Oakland, CA USA	RAND Corporation	Goldman, DP (corresponding author), RAND Corp, 1700 Main St, Santa Monica, CA 90407 USA.	dgoldman@rand.org; gjoyce@rand.org	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396				Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; HARRIS BL, 1990, MED CARE, V28, P907, DOI 10.1097/00005650-199010000-00005; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Johnson RE, 1997, HEALTH SERV RES, V32, P103; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; LOHR KN, 1986, MED CARE S, V24, pS39; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; *MED EC CO, 2000, 2000 DRUG TOP RED BO; Motheral B, 2001, MED CARE, V39, P1293, DOI 10.1097/00005650-200112000-00005; Rector TS, 2003, MED CARE, V41, P398, DOI 10.1097/00005650-200303000-00008; REEDER CE, 1985, INQUIRY-J HEALTH CAR, V22, P396; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421	15	419	423	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2004	291	19					2344	2350		10.1001/jama.291.19.2344	http://dx.doi.org/10.1001/jama.291.19.2344			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821JD	15150206	Bronze			2022-12-01	WOS:000221455400022
J	Charap, M				Charap, M			Reducing resident work hours: Unproven assumptions and unforeseen outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Sch Med, Dept Med, New York, NY 10016 USA	New York University	Charap, M (corresponding author), NYU, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.							*ACCR COUNC GRAD M, 2002, REP ACGME WORK GROUP; Kohn L, 2000, ERR IS HUMAN BUILDIN; LUDMERER K, 1999, TIME HEAL, P320; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Steinbrook R, 2002, NEW ENGL J MED, V347, P1296, DOI 10.1056/NEJMhpr022383; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116; Weinger MB, 2002, JAMA-J AM MED ASSOC, V287, P955, DOI 10.1001/jama.287.8.955	8	91	91	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2004	140	10					814	815		10.7326/0003-4819-140-10-200405180-00011	http://dx.doi.org/10.7326/0003-4819-140-10-200405180-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822EX	15148068				2022-12-01	WOS:000221520900006
J	Cooper, CP; Williams, KN; Carey, KA; Fowler, CS; Frank, M; Gelb, CA				Cooper, CP; Williams, KN; Carey, KA; Fowler, CS; Frank, M; Gelb, CA			Advertising campaign on a major internet search engine to promote colorectal cancer screening	BRITISH MEDICAL JOURNAL			English	Article									Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Yahoo, Atlanta, GA 30327 USA; Ogilvy Publ Relat Worldwide, Washington, DC 20036 USA	Centers for Disease Control & Prevention - USA	Cooper, CP (corresponding author), Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE,MS K-55, Atlanta, GA 30341 USA.	ccooper@cdc.gov						Bannan K. J., 2003, BtoB, V88; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P196; Jorgensen CM, 2001, J WOMEN HEALTH GEN-B, V10, P417, DOI 10.1089/152460901300233876; Krishnamurthy S, 2000, MARK MANAG, V9, P34	4	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 15	2004	328	7449					1179	1180		10.1136/bmj.328.7449.1179	http://dx.doi.org/10.1136/bmj.328.7449.1179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821XU	15142926	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000221497500027
J	Billker, O; Dechamps, S; Tewari, R; Wenig, G; Franke-Fayard, B; Brinkmann, V				Billker, O; Dechamps, S; Tewari, R; Wenig, G; Franke-Fayard, B; Brinkmann, V			Calcium and a calcium-dependent protein kinase regulate gamete formation and mosquito transmission in a malaria parasite	CELL			English	Article							PLASMODIUM-FALCIPARUM; TOXOPLASMA-GONDII; MONOCLONAL-ANTIBODIES; SEXUAL DEVELOPMENT; XANTHURENIC ACID; GENOME SEQUENCE; HOST-CELLS; BERGHEI; EXFLAGELLATION; GAMETOGENESIS	Transmission of malaria parasites to mosquitoes is initiated by the obligatory sexual reproduction of the parasite within the mosquito bloodmeal. Differentiation of specialized transmission stages, the gametocytes, into male and female gametes is induced by a small mosquito molecule, xanthurenic acid (XA). Using a Plasmodium berghei strain expressing a bioluminescent calcium sensor, we show that XA triggers a rapid rise in cytosolic calcium specifically in gametocytes that is essential for their differentiation into gametes. A member of a family of plant-like calcium dependent protein kinases, CDPK4, is identified as the molecular switch that translates the XA-induced calcium signal into a cellular response by regulating cell cycle progression in the male gametocyte. CDPK4 is shown to be essential for the sexual reproduction and mosquito transmission of P. berghei. This study reveals an unexpected function for a plant-like signaling pathway in cell cycle regulation and life cycle progression of a malaria parasite.	Univ London Imperial Coll Sci Technol & Med, Dept Sci Biol, London SW7 2AZ, England; Leiden Univ, Med Ctr, Parasitol Lab, NL-2300 RC Leiden, Netherlands; Max Planck Inst Infekt Biol, D-10117 Berlin, Germany	Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society	Billker, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Sci Biol, London SW7 2AZ, England.	o.billker@imperial.ac.uk	Brinkmann, Volker/A-6015-2009; Tewari, Rita/M-5698-2014	, Blandine/0000-0001-6041-4182; Tewari, Rita/0000-0003-3943-1847; Billker, Oliver/0000-0003-1716-168X	MRC [G120/746] Funding Source: UKRI; Medical Research Council [G120/746] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alleva LM, 2001, MOL BIOCHEM PARASIT, V117, P121, DOI 10.1016/S0166-6851(01)00338-3; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; BILKER O, 1997, PARSSITOLOGY, V115, P1; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; DOERIG C, 1995, MOL BIOCHEM PARASIT, V70, P167, DOI 10.1016/0166-6851(95)00033-W; Farber PM, 1997, MOL BIOCHEM PARASIT, V87, P211, DOI 10.1016/S0166-6851(97)00052-2; Farmer PK, 1999, BBA-PROTEIN STRUCT M, V1434, P6, DOI 10.1016/S0167-4838(99)00166-1; FRANKEFAYARD B, 2004, IN PRESS MOL BIOCH P; Gantt S, 2000, INFECT IMMUN, V68, P3667, DOI 10.1128/IAI.68.6.3667-3673.2000; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; JANSE CJ, 1986, MOL BIOCHEM PARASIT, V20, P173, DOI 10.1016/0166-6851(86)90029-0; KAWAMOTO F, 1990, MOL BIOCHEM PARASIT, V42, P101, DOI 10.1016/0166-6851(90)90117-5; KAWAMOTO F, 1993, EUR J CELL BIOL, V60, P101; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Li JL, 2000, BBA-GENE STRUCT EXPR, V1491, P341, DOI 10.1016/S0167-4781(00)00032-4; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; LUDWIG AA, 2003, J EXP BOT, V55, P1; MARTIN SK, 1994, J PARASITOL, V80, P371, DOI 10.2307/3283406; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Muhia DK, 2001, MOL MICROBIOL, V42, P553, DOI 10.1046/j.1365-2958.2001.02665.x; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; SINDEN RE, 1976, PROC R SOC SER B-BIO, V193, P55, DOI 10.1098/rspb.1976.0031; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; THOMPSON J, 1994, MOL BIOCHEM PARASIT, V68, P189, DOI 10.1016/0166-6851(94)90164-3; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; Tucker WC, 2002, BIOCHEM J, V366, P1, DOI 10.1042/BJ20020776; van Spaendonk RML, 2001, J BIOL CHEM, V276, P22638, DOI 10.1074/jbc.M101234200; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; WOODS A, 1989, J CELL SCI, V93, P491; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031; ZHAO Y, 1993, J BIOL CHEM, V268, P4347; [No title captured]	41	346	358	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 14	2004	117	4					503	514		10.1016/S0092-8674(04)00449-0	http://dx.doi.org/10.1016/S0092-8674(04)00449-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137943	Bronze			2022-12-01	WOS:000221458000010
J	MacDonald, IR; Bohrmann, G; Escobar, E; Abegg, F; Blanchon, P; Blinova, V; Bruckmann, W; Drews, M; Eisenhauer, A; Han, X; Heeschen, K; Meier, F; Mortera, C; Naehr, T; Orcutt, B; Bernard, B; Brooks, J; de Farago, M				MacDonald, IR; Bohrmann, G; Escobar, E; Abegg, F; Blanchon, P; Blinova, V; Bruckmann, W; Drews, M; Eisenhauer, A; Han, X; Heeschen, K; Meier, F; Mortera, C; Naehr, T; Orcutt, B; Bernard, B; Brooks, J; de Farago, M			Asphalt volcanism and chemosynthetic life in the Campeche Knolls, Gulf of Mexico	SCIENCE			English	Article							OIL; SEEPS	In the Campeche Knolls, in the southern Gulf of Mexico, lava-like flows of solidified asphalt cover more than 1 square kilometer of the rim of a dissected salt dome at a depth of 3000 meters below sea level. Chemosynthetic tubeworms and bivalves colonize the sea floor near the asphalt, which chilled and contracted after discharge. The site also includes oil seeps, gas hydrate deposits, locally anoxic sediments, and slabs of authigenic carbonate. Asphalt volcanism creates a habitat for chemosynthetic life that may be widespread at great depth in the Gulf of Mexico.	Texas A&M Univ, Phys & Life Sci Dept, Corpus Christi, TX 78412 USA; Univ Bremen, Fachbereich Geowissensch 5, D-28334 Bremen, Germany; Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City 045510, DF, Mexico; Inst Ciencias Mar & Limnol, Cancun, DF, Mexico; Leibniz Inst Meereswissensch, IFM, GEOMAR, D-24148 Kiel, Germany; State Ocean Adm, Inst Oceanog 2, Zhejiang 310012, Peoples R China; Univ Nacl Autonoma Mexico, Inst Geofis, Mexico City 04510, DF, Mexico; Univ Georgia, Athens, GA 30602 USA; TDI Brooks Int Inc, College Stn, TX 77845 USA; Aurensis SA, Madrid 28003, Spain	Texas A&M University System; University of Bremen; Universidad Nacional Autonoma de Mexico; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; State Oceanic Administration; Universidad Nacional Autonoma de Mexico; University System of Georgia; University of Georgia	MacDonald, IR (corresponding author), Texas A&M Univ, Phys & Life Sci Dept, 6300 Ocean Dr, Corpus Christi, TX 78412 USA.	imacdonald@falcon.tamucc.edu	Eisenhauer, Anton/K-6454-2012; Han, Xiqiu/AIB-2819-2022; Orcutt, Beth N/A-4051-2011; Bohrmann, Gerhard/D-4474-2017; Naehr, Thomas/C-2958-2008; Blanchon, Paul/B-7720-2009	Han, Xiqiu/0000-0001-9285-0915; Orcutt, Beth N/0000-0002-6233-3578; Bohrmann, Gerhard/0000-0001-9976-4948; Mortera Gutierrez, Carlos Angel Quintil/0000-0002-8522-004X; Brueckmann, Warner/0000-0001-6636-8148; Blanchon, Paul/0000-0002-7792-5808; Escobar Briones, Elva/0000-0002-8485-7495				Aharon P, 2000, GEOCHIM COSMOCHIM AC, V64, P233, DOI 10.1016/S0016-7037(99)00292-6; Bergquist DC, 2003, MAR ECOL-P S Z N I, V24, P31, DOI 10.1046/j.1439-0485.2003.03800.x; BOUMA AH, 1969, T GULF COAST ASS GEO, V19, P115; Bryant W. R., 1991, GULF MEXICO BASIN, P13; COLE GA, 2001, WORLD OIL, P69; Ewing T.E., 1991, STRUCTURAL FRAMEWORK, VJ, P31, DOI [10.1130/DNAG-GNA-J.31, DOI 10.1130/DNAG-GNA-J.31]; Grajales-Nishimura JM, 2000, GEOLOGY, V28, P307, DOI 10.1130/0091-7613(2000)028<0307:CITOOR>2.3.CO;2; Homafius J.S., 1999, J GEOPHYS RES, V20, P20; JOYE SB, IN PRESS CHEM GEOL; MacDonald IR, 2003, MAR GEOL, V198, P133, DOI 10.1016/S0025-3227(03)00098-7; MACDONALD IR, 1993, J GEOPHYS RES-OCEANS, V98, P16351, DOI 10.1029/93JC01289; MACGREGOR DS, 1993, MAR PETROL GEOL, V10, P606, DOI 10.1016/0264-8172(93)90063-X; PEQUEGNAT WE, 1978, CONRIB MAR SCI, V22, P63; Sloan E.D., 1998, CLATHRATE HYDRATES N, P705; *TDI BROOKS INT, 2001, 01698 TDI BROOKS INT	15	106	114	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2004	304	5673					999	1002		10.1126/science.1097154	http://dx.doi.org/10.1126/science.1097154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143278				2022-12-01	WOS:000221383300045
J	Banks, E; Beral, V; Reeves, G; Balkwill, A; Barnes, I				Banks, E; Beral, V; Reeves, G; Balkwill, A; Barnes, I		Million Women Study Collaborators	Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN PLUS PROGESTIN; INITIATIVE RANDOMIZED-TRIAL; BONE-MINERAL DENSITY; REPLACEMENT THERAPY; HIP FRACTURE; RISK; METAANALYSIS; FOREARM; BREAST; CANCER	Context Evidence is limited on the effects of different patterns of use of postmenopausal hormone therapy on fracture incidence and particularly on the effects of ceasing use. Objective To investigate the effect of different patterns of hormone therapy use on fracture incidence. Design, Setting, and Participants Prospective study of 138737 postmenopausal women aged 50 to 69 years recruited from the UK general population in 19961998 (the Million Women Study) and followed up for 1.9 to 3.9 years (average, 2.8 years) for fracture incidence. Main Outcome Measure Adjusted relative risk (RR) for incident fracture (except fracture of the fingers, toes, and ribs) in hormone therapy users compared with never users at baseline. Results A total of 5197 women (3.7%) reported 1 or more fractures, 79% resulting from falls. Current users of hormone therapy at baseline had a significantly reduced incidence of fracture (RR, 0.62; 95% confidence interval [CI], 0.58-0.66; P<.001). This protection was evident soon after hormone therapy began, and the RR decreased with increasing duration of use (P=.001). Among current users at baseline the RR of fracture did not vary significantly according to whether estrogen-only, estrogen-progestin, or other types of hormones were used (RR [95% CI], 0.64 [0.58-0.71], 0.58 [0.53-0.64], and 0.67 [0.56-0.80], respectively; P=19), nor did it vary significantly according to estrogen dose or estrogen or progestin constituents. The RR associated with current use of hormone therapy did not vary significantly according to 11 personal characteristics of study participants, including their age at menopause, body mass index, and physical activity. Past users of hormone therapy at baseline experienced no significant protection against fractures (RR, 1.07; 95% CI, 0.99-1.15); incidence rates returned to those of never-users within about a year of ceasing use. Conclusions All types of hormone therapy studied confer substantial protection against fracture while they are used. This protection appears rapidly after use commences and wears off rapidly after use ceases. The older women are, the greater is their absolute reduction in fracture incidence while using hormone therapy.	Radcliffe Infirm, Epidemiol Unit, Canc Res UK, Oxford OX2 6HE, England; Univ Reading, Sch Appl Stat, Reading, Berks, England	Cancer Research UK; Radcliffe Infirmary; University of Reading	Banks, E (corresponding author), Radcliffe Infirm, Epidemiol Unit, Canc Res UK, Oxford OX2 6HE, England.	emily.banks@anu.edu.au		Balkwill, Angela/0000-0002-6327-6245; Banks, Emily/0000-0002-4617-1302				Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Honkanen K, 1999, AM J EPIDEMIOL, V150, P511; Keegan THM, 2003, OSTEOPOROSIS INT, V14, P469, DOI 10.1007/s00198-003-1379-2; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; MEHTA D, 1999, BRIT NATL FORMULARY; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; *STAT CORP, 2003, STAT STAT SOFTW REL; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; Townsend P, 1988, HLTH DEPRIVATION INE; Tremollieres FA, 2001, OSTEOPOROSIS INT, V12, P385, DOI 10.1007/s001980170107; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WEISS NS, 1980, NEW ENGL J MED, V303, P1195, DOI 10.1056/NEJM198011203032102; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001-5002	22	91	95	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2004	291	18					2212	2220		10.1001/jama.291.18.2212	http://dx.doi.org/10.1001/jama.291.18.2212			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GR	15138243	Bronze			2022-12-01	WOS:000221303500023
J	Hovind, P; Tarnow, L; Rossing, P; Jensen, BR; Graae, M; Torp, I; Binder, C; Parving, HH				Hovind, P; Tarnow, L; Rossing, P; Jensen, BR; Graae, M; Torp, I; Binder, C; Parving, HH			Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study	BRITISH MEDICAL JOURNAL			English	Article							INSULIN-DEPENDENT DIABETICS; URINARY ALBUMIN EXCRETION; BLOOD-GLUCOSE CONTROL; INTENSIVE TREATMENT; RISK-FACTORS; NEPHROPATHY; MELLITUS; PROGRESSION; HYPERTENSION; PRESSURE	Objective To evaluate baseline predictors for the development of persistent microalbuminuria and macroalbuminuria prospectively in patients with type 1 diabetes. Design Prospective observational study of an inception cohort. Setting Outpatient diabetic clinic in a tertiary referral centre, Gentofte, Denmark. Participants 286 patients (216 adults) newly diagnosed with type 1 diabetes consecutively admitted to the clinic between 1 September 1979 and 31 August 1984. Main outcome measures Persistent microalbuminuria and persistent macroalbuminuria. Results During the median follow up of 18.0 years (range 1.0-21.5 years), total of 4706 patient years of follow up, 79 of 277 patients developed persistent microalbuminuria. 27 progressed further to persistent macroalbuminuria. The cumulative incidence of persistent microalbuminuria and persistent macroalbuminuria was 33.6% (95% confidence interval 27.2% to 40.0%) and 14.6% (8.9% to 20.3%), respectively. Significant predictors (95% confidence intervals) for the development of persistent microalbuminuria were a 10-fold increase in urinary albumin excretion rate (relative risk 3.78, 1.57 to 9.13), being male (2.41, 1.43 to 4.06), a 10 mm Hg increase in mean arterial blood pressure (1.38, 1.20 to 1.57), a 1% increase in haemoglobin A(1c) (1.18, 1.04 to 1.32), and a 1 cm increase in height (0.96, 0.95 to 0.98). 28 patients with microalbuminuria (35%) regressed to normoalbuminuria either transiently (n=15) or permanently (n=13). Conclusions Around one third of patients newly diagnosed with type 1 diabetes develop persistent microalbuminuria. within the first 20 years of diabetes. Several potentially modifiable risk factors predict the development of persistent microalbuminuria and persistent macroalbuminuria.	Steno Diabet Ctr, DK-2820 Gentofte, Denmark	Steno Diabetes Center	Hovind, P (corresponding author), Steno Diabet Ctr, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.	phovind@dadlnet.dk	rossing, peter/AAH-7879-2021; rossing, peter/AAZ-3415-2021	rossing, peter/0000-0002-1531-4294; Tarnow, Lise/0000-0002-8735-966X				BANGSTAD HJ, 1993, DIABETOLOGIA, V36, P523, DOI 10.1007/BF02743268; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Close CF, 1999, DIABETIC MED, V16, P918; COONROD BA, 1993, DIABETES CARE, V16, P1376, DOI 10.2337/diacare.16.10.1376; Cordonnier DJ, 1999, J AM SOC NEPHROL, V10, P1253; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; FABER OK, 1977, DIABETOLOGIA, V13, P263, DOI 10.1007/BF01219710; Fagerudd JA, 1998, DIABETES, V47, P439, DOI 10.2337/diabetes.47.3.439; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; HOSTETTER TH, 1982, AM J MED, V72, P375, DOI 10.1016/0002-9343(82)90490-9; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MATHIESEN ER, 1990, DIABETES, V39, P245, DOI 10.2337/diabetes.39.2.245; MOGENSEN CE, 1995, LANCET, V346, P1080, DOI 10.1016/S0140-6736(95)91747-0; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Parving HH., 2000, KIDNEY, V6, P1731; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Rossing P, 2002, DIABETES CARE, V25, P859, DOI 10.2337/diacare.25.5.859; ROSSING P, 1995, BRIT MED J, V310, P296, DOI 10.1136/bmj.310.6975.296; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; VIBERTI GC, 1982, LANCET, V1, P1430; VIBERTI GC, 1987, BRIT MED J, V295, P515, DOI 10.1136/bmj.295.6597.515; WANG PH, 1993, LANCET, V341, P1306, DOI 10.1016/0140-6736(93)90816-Y; WILLIAMSON JR, 1986, DIABETES, V35, P20, DOI 10.2337/diabetes.35.1.20	30	266	275	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 8	2004	328	7448					1105	1108		10.1136/bmj.38070.450891.FE	http://dx.doi.org/10.1136/bmj.38070.450891.FE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818YS	15096438	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000221281000019
J	Coleman, CN; Stone, HB; Moulder, JE; Pellmar, TC				Coleman, CN; Stone, HB; Moulder, JE; Pellmar, TC			Modulation of radiation injury	SCIENCE			English	Editorial Material							PULMONARY FIBROSIS; NORMAL TISSUE		NCI, Radiat Res Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical College of Wisconsin; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Coleman, CN (corresponding author), NCI, Radiat Res Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA.	pellmar@afrri.usuhs.mil	Moulder, John E/E-6799-2012					Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Coleman C. Norman, 2003, Radiation Research, V160, P729, DOI 10.1667/RR3096; Delanian S, 2003, J CLIN ONCOL, V21, P2545, DOI 10.1200/JCO.2003.06.064; Haston CK, 2002, CANCER RES, V62, P3782; Hong JH, 1999, INT J RADIAT BIOL, V75, P1421, DOI 10.1080/095530099139287; Jinaratana V., 2002, RADIOLOGIC ACCIDENT, V1st; Landauer MR, 2003, J APPL TOXICOL, V23, P379, DOI 10.1002/jat.904; Moulder JE, 2004, INT J RADIAT BIOL, V80, P3, DOI 10.1080/09553000310001642920; National Council on Radiation Protection and Measurements (NCRP), 2001, 138 NCRP; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; STICKNEY DR, 2001, BLOOD, V102; Stone HB, 2002, RADIAT RES, V157, P204, DOI 10.1667/0033-7587(2002)157[0204:MNTDP]2.0.CO;2; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Trotti A, 2002, SEMIN RADIAT ONCOL, V12, P1, DOI 10.1053/srao.2002.31353	14	103	111	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					693	694		10.1126/science.1095956	http://dx.doi.org/10.1126/science.1095956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118152				2022-12-01	WOS:000221105300032
J	Michailov, GV; Sereda, MW; Brinkmann, BG; Fischer, TM; Haug, B; Birchmeier, C; Role, L; Lai, C; Schwab, MH; Nave, KA				Michailov, GV; Sereda, MW; Brinkmann, BG; Fischer, TM; Haug, B; Birchmeier, C; Role, L; Lai, C; Schwab, MH; Nave, KA			Axonal neuregulin-1 regulates myelin sheath thickness	SCIENCE			English	Article							SCHWANN-CELLS; GROWTH; NERVE; MAINTENANCE; EXPRESSION; RECEPTORS; ISOFORMS; NEURONS; CALIBER; SIZE	In the nervous system of vertebrates, myelination is essential for rapid and accurate impulse conduction. Myelin thickness depends on axon fiber size. We use mutant and transgenic mouse lines to show that axonal Neuregulin-1 (Nrg1) signals information about axon size to Schwann cells. Reduced Nrg1 expression causes hypomyelination and reduced nerve conduction velocity. Neuronal overexpression of Nrg1 induces hypermyelination and demonstrates that Nrg1 type III is the responsible isoform. We suggest a model by which myelin-forming Schwann cells integrate axonal Nrg1 signals as a biochemical measure of axon size.	Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Univ Gottingen, Dept Clin Neurophysiol, D-37075 Gottingen, Germany; Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Columbia Univ, New York, NY 10032 USA; Hertie Inst Multiple Sclerosis Res, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; Scripps Research Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Columbia University	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany.	nave@em.mpg.de	Role, LW/Q-7371-2018; Nave, Klaus-Armin/C-8883-2011	Role, LW/0000-0001-5851-212X; 				Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Bermingham-McDonogh O, 1997, MOL CELL NEUROSCI, V10, P184, DOI 10.1006/mcne.1997.0654; BRINKMANN BG, UNPUB; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; DEWEBSTER FH, 1971, NEUROSCI RES PROGRAM, V9, P470; Donaldson HH, 1905, J COMP NEUROL PSYCHO, V15, P1, DOI 10.1002/cne.920150102; Elder GA, 2001, J NEUROSCI RES, V65, P493, DOI 10.1002/jnr.1179; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FRAHER JP, 1990, ACTA NEUROPATHOL, V79, P364, DOI 10.1007/BF00308712; FRIEDE RL, 1986, EXP NEUROL, V92, P234, DOI 10.1016/0014-4886(86)90137-8; FRIEDE RL, 1982, BRAIN RES, V235, P335, DOI 10.1016/0006-8993(82)91012-5; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.3.CO;2-X; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Meyer D, 1997, DEVELOPMENT, V124, P3575; MICHAILOV GV, UNPUB; ONEILL JH, 1984, ACTA NEUROPATHOL, V63, P313, DOI 10.1007/BF00687339; PANNESE E, 1987, ANAT EMBRYOL, V175, P423, DOI 10.1007/BF00309678; Rosenbaum C, 1997, EXP NEUROL, V148, P604, DOI 10.1006/exnr.1997.6696; SALZER J, COMMUNICATION; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Waxman SG, 1997, CURR BIOL, V7, pR406, DOI 10.1016/S0960-9822(06)00203-X; WILLIAMS PL, 1971, J ANAT, V109, P505; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	38	697	718	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					700	703		10.1126/science.1095862	http://dx.doi.org/10.1126/science.1095862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15044753				2022-12-01	WOS:000221105300035
J	Seoane, J; Le, HV; Shen, LJ; Anderson, SA; Massague, J				Seoane, J; Le, HV; Shen, LJ; Anderson, SA; Massague, J			Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation	CELL			English	Article							GROWTH-FACTOR-BETA; C-ELEGANS DAF-16; TGF-BETA; TRANSCRIPTIONAL REPRESSION; NEOCORTICAL NEURONS; CRYSTAL-STRUCTURE; RADIAL GLIA; DNA-BINDING; LIFE-SPAN; MYC	FoxO Forkhead transcription factors are shown here to act as signal transducers at the confluence of Smad, PI3K, and FoxG1 pathways. Smad proteins activated by TGF-beta form a complex with FoxO proteins to turn on the growth inhibitory gene p21Cip1. This process is negatively controlled by the PI3K pathway, a known inhibitor of FoxO localization in the nucleus, and by the telencephalic development factor FoxG1, which we show binds to FoxO-Smad complexes and blocks p21Cip1 expression. We suggest that the activity of this network confers resistance to TGF-beta-mediated cytostasis during the development of the telencephalic neuroepithelium and in glioblastoma brain tumor cells.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Cornell University	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Seoane, Joan/AAG-9173-2019	Seoane, Joan/0000-0002-6541-5974; Massague, Joan/0000-0001-9324-8408	NATIONAL CANCER INSTITUTE [R37CA034610, R01CA034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044819] Funding Source: NIH RePORTER; NCI NIH HHS [CA34610] Funding Source: Medline; NINDS NIH HHS [NS44819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Czech MP, 2003, P NATL ACAD SCI USA, V100, P11198, DOI 10.1073/pnas.2135308100; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dou CL, 2000, MOL CELL BIOL, V20, P6201, DOI 10.1128/MCB.20.17.6201-6211.2000; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Jennings MT, 1998, J NEURO-ONCOL, V36, P123, DOI 10.1023/A:1005863419880; Jennings MT, 1997, J NEURO-ONCOL, V31, P233, DOI 10.1023/A:1005767616500; Kaestner KH, 2000, GENE DEV, V14, P142; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lopes SMCD, 2003, GENE EXPR PATTERNS, V3, P355, DOI 10.1016/S1567-133X(03)00029-2; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miller MW, 2003, J COMP NEUROL, V460, P410, DOI 10.1002/cne.10658; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Rodriguez C, 2001, J BIOL CHEM, V276, P30224, DOI 10.1074/jbc.M102759200; Samatar AA, 2002, J BIOL CHEM, V277, P28118, DOI 10.1074/jbc.M203686200; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, J BIOL CHEM, V278, P35444, DOI 10.1074/jbc.M301413200; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Takahashi T, 1996, J NEUROSCI, V16, P5762; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	83	772	815	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					211	223		10.1016/S0092-8674(04)00298-3	http://dx.doi.org/10.1016/S0092-8674(04)00298-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084259	Bronze			2022-12-01	WOS:000220913400009
J	Cleary, P; Shorvon, S; Tallis, R				Cleary, P; Shorvon, S; Tallis, R			Late-onset seizures as a predictor of subsequent stroke	LANCET			English	Article							SILENT STROKE; EPILEPTIC SEIZURES; ISCHEMIC STROKE; INFARCTION; PREVALENCE; FREQUENCY; RISK	Background Cerebrovascular disease is thought to be a major cause of epilepsy in late life. We investigated the hypothesis that the onset of seizures after the age of 60 years in people with no history of overt stroke might be associated with an increased risk of subsequent stroke. Methods Data were obtained from the UK General Practice Research Database on 4709 individuals who had seizures beginning at or after the age of 60 years, and on 4709 randomly selected controls with no history of seizures, matched for age, sex, and general practice. Individuals with a history of cerebrovascular disease, other acquired brain injury, brain tumour, drug or alcohol misuse, or dementia were not eligible for inclusion. Computerised patients' records were searched for subsequent diagnoses of stroke. Findings Log-rank testing, adjusted for matching, showed a highly significant difference in stroke-free survival between the two groups (p<0.0001). With a Cox's model, we estimated that the relative hazard of stroke at any point for people with seizures compared with the control group was 2.89 (95% Cl 2.45-3.41). Interpretation Our findings show that the onset of seizures in late life is associated with a striking increase in the risk of stroke. Further research is warranted to assess the benefit of specific interventions to prevent stroke in patients with seizures.	Gartnavel Royal Hosp, Brownlee Ctr, Glasgow, Lanark, Scotland; UCL Natl Hosp Neurol & Neurosurg, London, England; Univ Manchester, Div Geriatr Med, Manchester M13 9PL, Lancs, England	Gartnavel Royal Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Manchester	Tallis, R (corresponding author), Hope Hosp, Div Geriatr Med, Clin Sci Bldg, Salford M6 8HD, Lancs, England.	rtallis@fs1.ho.man.ac.uk	Shorvon, Simon D/A-2019-2009	Cleary, Paul/0000-0001-9335-5422				Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; CHODOSH EH, 1988, NEUROLOGY, V38, P1674, DOI 10.1212/WNL.38.11.1674; COCITO L, 1989, J NEUROL NEUROSUR PS, V52, P292, DOI 10.1136/jnnp.52.2.292; EBRAHIM S, 2003, BROCKLEHURSTS TXB GE; GIROUD M, 1994, EPILEPSIA, V35, P959, DOI 10.1111/j.1528-1157.1994.tb02540.x; HERDERSCHEE D, 1992, STROKE, V23, P1220, DOI 10.1161/01.STR.23.9.1220; HERDERSCHEE D, 1994, CLIN NEUROL NEUROSUR, V96, P219, DOI 10.1016/0303-8467(94)90071-X; HOLLOWELL J, 1994, GEN PRACTICE RES DAT; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; KASE CS, 1989, STROKE, V20, P850, DOI 10.1161/01.STR.20.7.850; McCarron P, 2001, PUBLIC HEALTH, V115, P12, DOI 10.1016/S0033-3506(01)00408-5; RICCI S, 1994, STROKE, V25, P2293, DOI 10.1161/01.STR.25.11.2293; ROBERTS RC, 1988, EPILEPSIA, V29, P190, DOI 10.1111/j.1528-1157.1988.tb04418.x; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; SHINTON RA, 1987, LANCET, V1, P11; SHORVON SD, 1984, J NEUROL NEUROSUR PS, V47, P225, DOI 10.1136/jnnp.47.3.225; vanLatum JC, 1996, NEUROLOGY, V46, P159; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Wannamethee SG, 2000, STROKE, V31, P1882, DOI 10.1161/01.STR.31.8.1882	19	160	162	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1184	1186		10.1016/S0140-6736(04)15946-1	http://dx.doi.org/10.1016/S0140-6736(04)15946-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081649				2022-12-01	WOS:000220748100007
J	Kansagra, S; List, J				Kansagra, S; List, J			The clinical relevance of genomic variation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK; MEDICINE; GENE; PHARMACOGENETICS; POLYMORPHISMS; ASSOCIATION; DISEASE		Duke Univ, Sch Med, Durham, NC 27706 USA; Yale Univ, Sch Divin, New Haven, CT 06520 USA	Duke University; Yale University	Kansagra, S (corresponding author), Duke Univ, Sch Med, Durham, NC 27706 USA.							Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Wolf CR, 2000, BRIT MED J, V320, P987, DOI 10.1136/bmj.320.7240.987	12	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1641	1641		10.1001/jama.291.13.1641	http://dx.doi.org/10.1001/jama.291.13.1641			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809PQ	15069054				2022-12-01	WOS:000220649000031
J	Boyd, PW; Law, CS; Wong, CS; Nojiri, Y; Tsuda, A; Levasseur, M; Takeda, S; Rivkin, R; Harrison, PJ; Strzepek, R; Gower, J; McKay, RM; Abraham, E; Arychuk, M; Barwell-Clarke, J; Crawford, W; Crawford, D; Hale, M; Harada, K; Johnson, K; Kiyosawa, H; Kudo, I; Marchetti, A; Miller, W; Needoba, J; Nishioka, J; Ogawa, H; Page, J; Robert, M; Saito, H; Sastri, A; Sherry, N; Soutar, T; Sutherland, N; Taira, Y; Whitney, F; Wong, SKE; Yoshimura, T				Boyd, PW; Law, CS; Wong, CS; Nojiri, Y; Tsuda, A; Levasseur, M; Takeda, S; Rivkin, R; Harrison, PJ; Strzepek, R; Gower, J; McKay, RM; Abraham, E; Arychuk, M; Barwell-Clarke, J; Crawford, W; Crawford, D; Hale, M; Harada, K; Johnson, K; Kiyosawa, H; Kudo, I; Marchetti, A; Miller, W; Needoba, J; Nishioka, J; Ogawa, H; Page, J; Robert, M; Saito, H; Sastri, A; Sherry, N; Soutar, T; Sutherland, N; Taira, Y; Whitney, F; Wong, SKE; Yoshimura, T			The decline and fate of an iron-induced subarctic phytoplankton bloom	NATURE			English	Article							PACIFIC-OCEAN; NORTH PACIFIC; FERTILIZATION; SINKING; COPEPOD; FLUXES	Iron supply has a key role in stimulating phytoplankton blooms in high-nitrate low-chlorophyll oceanic waters(1-5). However, the fate of the carbon fixed by these blooms, and how efficiently it is exported into the ocean's interior, remains largely unknown(1-5). Here we report on the decline and fate of an iron-stimulated diatom bloom in the Gulf of Alaska. The bloom terminated on day 18, following the depletion of iron and then silicic acid, after which mixed-layer particulate organic carbon (POC) concentrations declined over six days. Increased particulate silica export via sinking diatoms was recorded in sediment traps at depths between 50 and 125 m from day 21, yet increased POC export was not evident until day 24. Only a small proportion of the mixed-layer POC was intercepted by the traps, with more than half of the mixed-layer POC deficit attributable to bacterial remineralization and mesozooplankton grazing. The depletion of silicic acid and the inefficient transfer of iron-increased POC below the permanent thermocline have major implications both for the biogeochemical interpretation of times of greater iron supply in the geological past(6,7), and also for proposed geo-engineering schemes to increase oceanic carbon sequestration(3,8).	Univ Otago, NIWA Ctr Chem & Phys Oceanog, Dept Chem, Dunedin 9003, New Zealand; Natl Inst Water & Atmospher Res, Wellington, New Zealand; Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; Univ Tokyo, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF A1C 5S7, Canada; Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China; Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; Natl Inst Adv Ind Sci & Technol, Chiyoda Ku, Tokyo 1008921, Japan; Marine Biol Res Inst Japan, Shinagawa Ku, Tokyo 1420042, Japan; Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; Cent Res Inst Elect Power Ind, Chiba 2701194, Japan; Univ Tokyo, Ocean Res Inst, Marine Biogeochem Lab, Nakano Ku, Tokyo 1648639, Japan; Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi 9850001, Japan; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3N5, Canada	University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Fisheries & Oceans Canada; National Institute for Environmental Studies - Japan; University of Tokyo; Laval University; University of Tokyo; Memorial University Newfoundland; University of British Columbia; Hong Kong University of Science & Technology; University System of Ohio; Bowling Green State University; National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University; University of British Columbia; Dalhousie University; Central Research Institute of Electric Power Industry - Japan; University of Tokyo; Fisheries Research Agency - Japan; University of Victoria	Boyd, PW (corresponding author), Univ Otago, NIWA Ctr Chem & Phys Oceanog, Dept Chem, POB 56, Dunedin 9003, New Zealand.	p.boyd@niwa.co.nz	SAITO, HIROAKI/J-6948-2017; Boyd, Philip W/J-7624-2014; McKay, Robert Michael/P-3759-2017; Nishioka, Jun/F-5314-2011; Strzepek, Robert Francis/A-1216-2011; Sastri, Akash/D-7798-2013; Strzepek, Robert/GQH-8703-2022; Crawford, David W/B-5679-2012; 毅, 芳村/M-1778-2017; Nojiri, Yukihiro/D-1999-2010; Abraham, Edward R/D-7422-2011; Crawford, David W./AAS-9927-2020	SAITO, HIROAKI/0000-0002-5502-9076; Boyd, Philip W/0000-0001-7850-1911; McKay, Robert Michael/0000-0003-2723-5371; Nishioka, Jun/0000-0003-1723-9344; Strzepek, Robert Francis/0000-0002-6442-7121; Sastri, Akash/0000-0001-8075-0917; Crawford, David W/0000-0003-2948-1007; 毅, 芳村/0000-0001-5700-2590; Nojiri, Yukihiro/0000-0001-9885-9195; Abraham, Edward R/0000-0003-4490-6704; Crawford, David W./0000-0003-2948-1007; Marchetti, Adrian/0000-0003-4608-4775; Takeda, Shigenobu/0000-0002-4997-1583; Law, Cliff/0000-0002-7669-2475				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Bidle KD, 2002, SCIENCE, V298, P1980, DOI 10.1126/science.1076076; Bishop JKB, 1999, DEEP-SEA RES PT I, V46, P353, DOI 10.1016/S0967-0637(98)00069-7; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 1998, GLOBAL BIOGEOCHEM CY, V12, P297, DOI 10.1029/97GB03366; BUESSELER KO, 1994, GLOBAL BIOGEOCHEM CY, V8, P179, DOI 10.1029/94GB00207; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; CULLEN JJ, 1991, LIMNOL OCEANOGR, V36, P1578, DOI 10.4319/lo.1991.36.8.1578; DAGG M, 1993, DEEP-SEA RES PT I, V40, P1431, DOI 10.1016/0967-0637(93)90121-I; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Harrison KG, 2000, PALEOCEANOGRAPHY, V15, P292, DOI 10.1029/1999PA000427; Honda MC, 2002, DEEP-SEA RES PT II, V49, P5595, DOI 10.1016/S0967-0645(02)00201-1; KOMAR PD, 1981, LIMNOL OCEANOGR, V26, P172, DOI 10.4319/lo.1981.26.1.0172; LaRoche J, 1996, NATURE, V382, P802; Law CS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001604; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; Nishioka J, 2001, MAR CHEM, V74, P157, DOI 10.1016/S0304-4203(01)00013-5; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rivkin RB, 2001, SCIENCE, V291, P2398, DOI 10.1126/science.291.5512.2398; SIEGEL DA, 1990, J GEOPHYS RES-OCEANS, V95, P5305, DOI 10.1029/JC095iC04p05305; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Tabata S., 1975, ATMOSPHERE, V13, P133; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; TSUDA A, 1994, MAR BIOL, V120, P203, DOI 10.1007/BF00349680	30	368	387	3	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					549	553		10.1038/nature02437	http://dx.doi.org/10.1038/nature02437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15058302				2022-12-01	WOS:000220540100039
J	Yang, ZY; Kong, WP; Huang, Y; Roberts, A; Murphy, BR; Subbarao, K; Nabel, GJ				Yang, ZY; Kong, WP; Huang, Y; Roberts, A; Murphy, BR; Subbarao, K; Nabel, GJ			A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice	NATURE			English	Article							ACUTE RESPIRATORY SYNDROME; HONG-KONG; VIRUS; IDENTIFICATION; CHALLENGE; INFECTION; PROTEINS; GENOME; PIGS	Public health measures have successfully identified and contained outbreaks of the severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV)(1-5), but concerns remain over the possibility of future recurrences. Finding a vaccine for this virus therefore remains a high priority. Here, we show that a DNA vaccine encoding the spike (S) glycoprotein of the SARS-CoV induces T cell and neutralizing antibody responses, as well as protective immunity, in a mouse model. Alternative forms of S were analysed by DNA immunization. These expression vectors induced robust immune responses mediated by CD4 and CD8 cells, as well as significant antibody titres, measured by enzyme-linked immunosorbent assay. Moreover, antibody responses in mice vaccinated with an expression vector encoding a form of S that includes its transmembrane domain elicited neutralizing antibodies. Viral replication was reduced by more than six orders of magnitude in the lungs of mice vaccinated with these S plasmid DNA expression vectors, and protection was mediated by a humoral but not a T-cell-dependent immune mechanism. Gene-based vaccination for the SARS-CoV elicits effective immune responses that generate protective immunity in an animal model.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC-3005,40 Convent Dr, Bethesda, MD 20892 USA.	gnabel@nih.gov		Subbarao, Kanta/0000-0003-1713-3056	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005056, Z01AI000934, ZIAAI000934] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2013, WHOCDSCSRGAR2003; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Knipe D, 2001, FIELDS VIROLOGY, P1187; Kong WP, 2003, J VIROL, V77, P12764, DOI 10.1128/JVI.77.23.12764-12772.2003; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lai M.M., 2001, FIELDS VIROLOGY; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Park SK, 1998, AM J VET RES, V59, P1002; Perlman S, 1998, ADV EXP MED BIOL, V440, P503; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SAIF LJ, 1993, VET MICROBIOL, V37, P285, DOI 10.1016/0378-1135(93)90030-B; Sestak K, 1999, VET IMMUNOL IMMUNOP, V70, P203, DOI 10.1016/S0165-2427(99)00074-4; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; YANG ZY, IN PRESS J VIROL	23	506	561	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					561	564		10.1038/nature02463	http://dx.doi.org/10.1038/nature02463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15024391	Bronze, Green Published			2022-12-01	WOS:000220540100042
J	Piao, XH; Hill, RS; Bodell, A; Chang, BS; Basel-Vanagaite, L; Straussberg, R; Dobyns, WB; Qasrawi, B; Winter, RM; Innes, AM; Voit, T; Ross, ME; Michaud, JL; Descarle, JC; Barkovich, AJ; Walsh, CA				Piao, XH; Hill, RS; Bodell, A; Chang, BS; Basel-Vanagaite, L; Straussberg, R; Dobyns, WB; Qasrawi, B; Winter, RM; Innes, AM; Voit, T; Ross, ME; Michaud, JL; Descarle, JC; Barkovich, AJ; Walsh, CA			G protein-coupled receptor-dependent development of human frontal cortex	SCIENCE			English	Article							BILATERAL FRONTOPARIETAL POLYMICROGYRIA; CEREBRAL-CORTEX; PERISYLVIAN POLYMICROGYRIA; CORTICAL AREAS; NEOCORTEX; MIGRATION; EPILEPSY; IDENTITY; NEURONS; GENES	The mammalian cerebral cortex is characterized by complex patterns of anatomical and functional areas that differ markedly between species, but the molecular basis for this functional subdivision is largely unknown. Here, we show that mutations in GPR56, which encodes an orphan G protein - coupled receptor (GPCR) with a large extracellular domain, cause a human brain cortical malformation called bilateral frontoparietal polymicrogyria (BFPP). BFPP is characterized by disorganized cortical lamination that is most severe in frontal cortex. Our data suggest that GPCR signaling plays an essential role in regional development of human cerebral cortex.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Newborn Med,Dept Med, Boston, MA 02115 USA; Rabin Med Ctr, Dept Med Genet, IL-49100 Petah Tiqwa, Israel; Schneider Childrens Med Ctr, Dept Child Neurol, Neurogenet Clin, IL-49202 Petah Tiqwa, Israel; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Minist Social Affairs & Labor, Social Welf Inst, Kuwait 13006, Kuwait; Inst Child Hlth, Clin Genet Unit, London WC1N 1EH, England; Univ Calgary, Alberta Childrens Hosp, Dept Med Genet, Calgary, AB T2T 5C7, Canada; Univ Essen Gesamthsch, Dept Pediat, D-45122 Essen, Germany; Cornell Univ, Dept Neurol & Neurosci, New York, NY 10021 USA; Hop St Justine, Div Med Genet, Montreal, PQ H3T 1C5, Canada; Hop St Justine, Dept Med Imaging, Montreal, PQ H3T 1C5, Canada; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Rabin Medical Center; University of Chicago; University of London; University College London; Alberta Childrens Hospital; University of Calgary; University of Duisburg Essen; Cornell University; Universite de Montreal; Universite de Montreal; University of California System; University of California San Francisco	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	innes, allan micheil/A-9955-2017; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020	Dobyns, William/0000-0002-7681-2844; Innes, Micheil/0000-0001-9881-5467; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Walsh, Christopher/0000-0002-0156-2238; Piao, Xianhua/0000-0001-7540-6767	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035129, K08NS045762] Funding Source: NIH RePORTER; NICHD NIH HHS [HD07466] Funding Source: Medline; NINDS NIH HHS [R37 NS35129, K08 NS045762-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Chang BS, 2003, ANN NEUROL, V53, P596, DOI 10.1002/ana.10520; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; FERRER I, 1991, ANAT EMBRYOL, V184, P517, DOI 10.1007/BF01236058; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Guerreiro MM, 2000, ANN NEUROL, V48, P39, DOI 10.1002/1531-8249(200007)48:1<39::AID-ANA7>3.3.CO;2-O; Guerrini R, 1997, ANN NEUROL, V41, P65, DOI 10.1002/ana.410410112; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; KUZNIECKY R, 1993, LANCET, V341, P608, DOI 10.1016/0140-6736(93)90363-L; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Liu M, 1999, GENOMICS, V55, P296, DOI 10.1006/geno.1998.5644; Liu Q, 2000, J NEUROSCI, V20, P7682; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Piao XH, 2002, AM J HUM GENET, V70, P1028, DOI 10.1086/339552; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; Sztriha L, 2000, PEDIATR NEUROL, V22, P240, DOI 10.1016/S0887-8994(99)00142-3; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Villard L, 2002, AM J HUM GENET, V70, P1003, DOI 10.1086/339433; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131	30	398	404	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2033	2036		10.1126/science.1092780	http://dx.doi.org/10.1126/science.1092780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044805				2022-12-01	WOS:000220429800046
J	Gallione, CJ; Repetto, GM; Legius, E; Rustgi, AK; Schelley, SL; Tejpar, S; Mitchell, G; Drouin, E; Westermann, CJJ; Marchuk, DA				Gallione, CJ; Repetto, GM; Legius, E; Rustgi, AK; Schelley, SL; Tejpar, S; Mitchell, G; Drouin, E; Westermann, CJJ; Marchuk, DA			A combined syndrome of juvenile polyposis and hereditary haemorrhagic telanglectasia associated with mutations in MADH4 (SMAD4)	LANCET			English	Article							PULMONARY ARTERIOVENOUS-MALFORMATIONS; HYPERTROPHIC OSTEOARTHROPATHY; TELANGIECTASIA; GENE; PROTEIN; ENDOGLIN; PATHWAY; CELLS	Background Juvenile polyposis and hereditary haemorrhagic telangiectasia are autosomal dominant disorders with distinct and non-overlapping clinical features. The former, an inherited gastrointestinal malignancy predisposition, is caused by mutations in MADH4 (encoding SMAD4) or BMPR1A, and the latter is a vascular malformation disorder caused by mutations in ENG (endoglin) or ACVRL1 (ALK1). All four genes encode proteins involved in the transforming-growth-factor-beta signalling pathway. Although there are reports of patients and families with phenotypes of both disorders combined, the genetic aetiology of this association is unknown. Methods Blood samples were collected from seven unrelated families segregating both phenotypes. DNA from the proband of each family was sequenced for the ACVRL1, ENG, and MADH4 genes. Mutations were examined for familial cosegregation with phenotype and presence or absence in population controls. Findings No patient had mutations in the ENG or ACVRL1 genes; all had MADH4 mutations. Three cases of de-novo MADH4 mutations were found. In one, the mutation was passed on to a similarly affected child. Each mutation cosegregated with the syndromic phenotype in other affected family members. Interpretation Mutations in MADH4 can cause a syndrome consisting of both juvenile polyposis and hereditary haemorrhagic telangiectasia phenotypes. Since patients with these disorders are generally ascertained through distinct medical specialties, genetic testing is recommended for patients presenting with either phenotype to identify those at risk of this syndrome. Patients with juvenile polyposis who have an MADH4 mutation should be screened for the vascular lesions associated with hereditary haemorrhagic telangiectasia, especially occult arteriovenous malformations in visceral organs that may otherwise present suddenly with serious medical consequences.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Univ Desarrollo Clin Alemana, Fac Ciencias Salud, Santiago, Chile; Hosp Padre Hurtado, Santiago, Chile; Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium; Univ Penn, Dept Genet, Div Gastroenterol, Philadelphia, PA 19104 USA; Abramson Family Canc Res Inst & Canc Ctr, Philadelphia, PA USA; Stanford Univ, Dept Pediat Genet, Stanford, CA 94305 USA; Hop St Justine, Div Genet, Montreal, PQ H3T 1C5, Canada; Hop St Justine, Div Gastroenterol, Montreal, PQ H3T 1C5, Canada; St Antonius Hosp, Dept Pulm Dis, Nieuwegein, Netherlands	Duke University; Clinica Alemana; Universidad de Chile; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of Pennsylvania; Stanford University; Universite de Montreal; Universite de Montreal; St. Antonius Hospital Utrecht	Marchuk, DA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Box 3175, Durham, NC 27710 USA.	march004@mc.duke.edu	Legius, Eric/H-1735-2011; Repetto, Gabriela/C-7833-2012	Repetto, Gabriela/0000-0003-0120-5684; Marchuk, Douglas/0000-0002-3110-6671	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049171] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49171] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAERT AL, 1983, AM J ROENTGENOL, V141, P661, DOI 10.2214/ajr.141.4.661; Ballauff A, 1999, Z GASTROENTEROL, V37, P385; Begbie ME, 2003, POSTGRAD MED J, V79, P18, DOI 10.1136/pmj.79.927.18; Berg J, 2003, J MED GENET, V40, P585, DOI 10.1136/jmg.40.8.585; Burger B, 2002, AM J MED GENET, V110, P289, DOI 10.1002/ajmg.10411; Coffin CM, 1996, ARCH PATHOL LAB MED, V120, P1032; CONTE WJ, 1982, CLIN RES, V30, pA93; COX KL, 1980, GASTROENTEROLOGY, V78, P1566; Desai DC, 1998, J MED GENET, V35, P476, DOI 10.1136/jmg.35.6.476; ERKUL PE, 1994, PEDIATR RADIOL, V24, P145, DOI 10.1007/BF02020177; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Inoue S, 1999, AM J MED SCI, V317, P59, DOI 10.1097/00000441-199901000-00010; JASS JR, 1988, HISTOPATHOLOGY, V13, P619; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; PRIETO G, 1990, J PEDIATR GASTR NUTR, V11, P133, DOI 10.1097/00005176-199007000-00026; RADIN DR, 1994, ABDOM IMAGING, V19, P140, DOI 10.1007/BF00203488; Roth S, 1999, GENE CHROMOSOME CANC, V26, P54, DOI 10.1002/(SICI)1098-2264(199909)26:1<54::AID-GCC8>3.0.CO;2-D; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; SCHUMACHER B, 1994, Z GASTROENTEROL, V32, P105; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; SIMPSON EL, 1985, AM J ROENTGENOL, V144, P983, DOI 10.2214/ajr.144.5.983; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178	31	489	513	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2004	363	9412					852	859		10.1016/S0140-6736(04)15732-2	http://dx.doi.org/10.1016/S0140-6736(04)15732-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803LB	15031030				2022-12-01	WOS:000220231500011
J	Woo, PCY; Lau, SKP; Tsoi, HW; Chan, KH; Wong, BHL; Che, XY; Tam, VKP; Tam, SCF; Cheng, VCC; Hung, IFN; Wong, SSY; Zheng, BJ; Guan, Y; Yuen, KY				Woo, PCY; Lau, SKP; Tsoi, HW; Chan, KH; Wong, BHL; Che, XY; Tam, VKP; Tam, SCF; Cheng, VCC; Hung, IFN; Wong, SSY; Zheng, BJ; Guan, Y; Yuen, KY			Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia	LANCET			English	Article							ACUTE RESPIRATORY SYNDROME; RECOMBINANT NUCLEOCAPSID PROTEIN; ANTIBODIES; ENCODES; IDENTIFICATION; SERODIAGNOSIS; MANNOPROTEIN; DIAGNOSIS; OUTBREAK; ELISA	Background Although the genome of severe acute respiratory syndrome coronavirus (SARS-CoV) has been sequenced and a possible animal reservoir identified, seroprevalence studies and mass screening for detection of subclinical and non-pneumonic infections are still lacking. Methods We cloned and purified the nucleocapsid protein and spike polypeptide of SARS-CoV and examined their immunogenicity with serum from patients with SARS-CoV pneumonia. An ELISA based on recombinant nucleocapsid protein for IgG detection was tested with serum from 149 healthy blood donors who donated 3 years previously and with serum positive for antibodies against SARS-CoV (by indirect immunofluorescence assay) from 106 patients with SARS-CoV pneumonia. The seroprevalence of SARS-CoV was studied with the ELISA in healthy blood donors who donated during the SARS outbreak in Hong Kong, non-pneumonic hospital inpatients, and symptom-free health-care workers. All positive samples were confirmed by two separate western-blot assays (with recombinant nucleocapsid protein and recombinant spike polypeptide). Findings Western-blot analysis showed that the nucleocapsid protein and spike polypeptide of SARS-CoV are highly immunogenic. The specificity of the IgG antibody test (ELISA with positive samples confirmed by the two western-blot assays) was 100%, and the sensitivity was 94.3%. Three of 400 healthy blood donors who donated during the SARS outbreak and one of 131 non-pneumonic paediatric inpatients were positive for IgG antibodies, confirmed by the two western-blot assays (total, 0.48% of our study population). Interpretation Our findings support the existence of subclinical or non-pneumonic SARS-CoV infections. Such infections are more common than SARS-CoV pneumonia in our locality.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; First Mil Med Univ, Zhujiang Hosp, Cent Lab, Guangzhou, Peoples R China; Queen Mary Hosp, Dept Clin Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Southern Medical University - China; University of Hong Kong	Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pathol Bldg, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Hung, Ivan FN/ABD-5916-2021; Tsoi, Hoi Wah/C-4428-2009; Yuen, Kwok Yung/C-4465-2009; Wong, Samson/C-4446-2009; Chan, Kwok Hung/ABD-5399-2021; Lau, Susanna/C-4321-2009; Woo, Patrick Chiu Yat/C-4449-2009	Hung, Ivan FN/0000-0002-1556-2538; Yuen, Kwok-yung/0000-0002-2083-1552; Guan, Yi/0000-0001-6057-9243; Woo, Patrick Chiu Yat/0000-0001-9401-1832; CHENG, Vincent Chi-Chung/0000-0003-1765-7706				BRIESE T, 1995, J CLIN MICROBIOL, V33, P348, DOI 10.1128/JCM.33.2.348-351.1995; Cao L, 1998, INFECT IMMUN, V66, P966, DOI 10.1128/IAI.66.3.966-973.1998; Cao L, 1998, J CLIN MICROBIOL, V36, P3028, DOI 10.1128/JCM.36.10.3028-3031.1998; Chan CM, 2002, J CLIN MICROBIOL, V40, P2041, DOI 10.1128/JCM.40.6.2041-2045.2002; Chan PKS, 2003, EMERG INFECT DIS, V9, P1453, DOI 10.3201/eid0911.030421; Denac H, 1997, J VIROL METHODS, V65, P169, DOI 10.1016/S0166-0934(97)02186-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Ndifuna A, 1998, J VIROL METHODS, V70, P37, DOI 10.1016/S0166-0934(97)00170-5; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; POHLKOPPE A, 1995, J VIROL METHODS, V55, P175, DOI 10.1016/0166-0934(95)00041-R; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Seah JN, 2000, VET MICROBIOL, V75, P11, DOI 10.1016/S0378-1135(00)00202-9; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Wang CH, 2002, VET MICROBIOL, V85, P333, DOI 10.1016/S0378-1135(01)00525-9; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Woo PCY, 2003, J CLIN MICROBIOL, V41, P845, DOI 10.1128/JCM.41.2.845-850.2003; Woo PCY, 2001, CLIN DIAGN LAB IMMUN, V8, P832, DOI 10.1128/CDLI.8.4.832-836.2001; Woo PCY, 2001, J MED MICROBIOL, V50, P330, DOI 10.1099/0022-1317-50-4-330; Yuen KY, 2001, J CLIN MICROBIOL, V39, P3830, DOI 10.1128/JCM.39.11.3830-3837.2001	27	108	115	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2004	363	9412					841	845		10.1016/S0140-6736(04)15729-2	http://dx.doi.org/10.1016/S0140-6736(04)15729-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803LB	15031027	Green Published, Bronze			2022-12-01	WOS:000220231500008
J	Wiegman, A; de Groot, E; Hutten, BA; Rodenburg, J; Gort, J; Bakker, HD; Sijbrands, EJG; Kastelein, JJP				Wiegman, A; de Groot, E; Hutten, BA; Rodenburg, J; Gort, J; Bakker, HD; Sijbrands, EJG; Kastelein, JJP			Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia	LANCET			English	Article								Patients with familial hypercholesterolaemia have severe coronary-artery disease early in adult life. Whether lipid-lowering treatment should be started in childhood remains to be established. We therefore assessed 201 children heterozygous for familial hypercholesterolaemia and 80 unaffected siblings (both age ranges 8-18 years) with B-mode ultrasound to measure carotid wall intima-media thickness. Mean combined carotid intima-media thickness of heterozygotes was significantly greater than that of unaffected siblings (0.494 mm [SD 0.051] vs 0.472 [SD 0.049], p=0.002). A significant deviation in intima-media thickness was noted from age 12 years in children with familial hypercholesterolaemia. Findings on multivariate analysis showed LDL cholesterol, age, and sex to be strong and independent predictors of intima-media thickness. Since raised LDL cholesterol concentrations can be lowered efficiently, clinical studies are needed to investigate long-term safety and effectiveness of statin treatment in children with familial hypercholesterolaemia.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Paediat, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Epidemiol & Biostat, NL-1100 DD Amsterdam, Netherlands; Univ Rotterdam, Erasmus Med Ctr, Dept Internal Med, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands.	e.vandongen@amc.uva.nl	Kastelein, John/AAF-7950-2020; Sijbrands, Eric/A-1065-2009	Sijbrands, Eric/0000-0001-8857-7389; Wiegman, Albert/0000-0001-6223-5671				MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; Wiegman A, 2003, CIRCULATION, V107, P1473, DOI 10.1161/01.CIR.0000058166.99182.54	4	222	231	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2004	363	9406					369	370		10.1016/S0140-6736(04)15467-6	http://dx.doi.org/10.1016/S0140-6736(04)15467-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070569				2022-12-01	WOS:000188590900014
J	Ferriman, A				Ferriman, A			Novartis breached code after doctors say it "invented" a disease	BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1379	1379		10.1136/bmj.325.7377.1379	http://dx.doi.org/10.1136/bmj.325.7377.1379			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	15083812	Green Published			2022-12-01	WOS:000179975000010
J	Van Petegem, F; Clark, KA; Chatelain, FC; Minor, DL				Van Petegem, F; Clark, KA; Chatelain, FC; Minor, DL			Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain	NATURE			English	Article							G-PROTEIN MODULATION; I-II LINKER; MOLECULAR DETERMINANTS; CA2+ CHANNELS; INACTIVATION; BINDING; GAMMA; INHIBITION; CONTAINS; LOOP	Voltage-gated calcium channels (CaVs) govern muscle contraction, hormone and neurotransmitter release, neuronal migration, activation of calcium-dependent signalling cascades, and synaptic input integration(1). An essential Ca-V intracellular protein, the beta-subunit (Ca(V)beta)(1,2), binds a conserved domain ( the alpha-interaction domain, AID) between transmembrane domains I and II of the pore-forming alpha(1) subunit(3) and profoundly affects multiple channel properties such as voltage-dependent activation(2), inactivation rates(2), G-protein modulation(4), drug sensitivity(5) and cell surface expression(6,7). Here, we report the high-resolution crystal structures of the Ca(V)beta(2a) conserved core, alone and in complex with the AID. Previous work suggested that a conserved region, the beta-interaction domain (BID), formed the AID-binding site(3,8); however, this region is largely buried in the Ca(V)beta core and is unavailable for protein - protein interactions. The structure of the AID - Ca(V)beta(2a) complex shows instead that Ca(V)beta(2a) engages the AID through an extensive, conserved hydrophobic cleft ( named the alpha-binding pocket, ABP). The ABP - AID interaction positions one end of the Ca(V)beta near the intracellular end of a pore-lining segment, called IS6, that has a critical role in Ca-V inactivation(9,10). Together, these data suggest that Ca(V)betas influence Ca-V gating by direct modulation of IS6 movement within the channel pore.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 513 Parnassus Ave,Box 0130, San Francisco, CA 94143 USA.	minor@itsa.ucsf.edu	Tuluc, Petronel/C-2527-2011; Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537; CHATELAIN, Franck C./0000-0002-8426-8893	NHLBI NIH HHS [R01 HL080050, R01 HL080050-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080050] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Hering S, 2002, TRENDS PHARMACOL SCI, V23, P509, DOI 10.1016/S0165-6147(02)02104-1; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kochegarov AA, 2003, CELL CALCIUM, V33, P145, DOI 10.1016/S0143-4160(02)00239-7; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Paarmann I, 2002, J BIOL CHEM, V277, P40832, DOI 10.1074/jbc.M205618200; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Restituito S, 2000, J NEUROSCI, V20, P9046; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Walker D, 1999, J BIOL CHEM, V274, P12383, DOI 10.1074/jbc.274.18.12383; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9	30	316	323	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2004	429	6992					671	675		10.1038/nature02588	http://dx.doi.org/10.1038/nature02588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827PJ	15141227	Green Accepted			2022-12-01	WOS:000221912600044
J	Paez, JG; Janne, PA; Lee, JC; Tracy, S; Greulich, H; Gabriel, S; Herman, P; Kaye, FJ; Lindeman, N; Boggon, TJ; Naoki, K; Sasaki, H; Fujii, Y; Eck, MJ; Sellers, WR; Johnson, BE; Meyerson, M				Paez, JG; Janne, PA; Lee, JC; Tracy, S; Greulich, H; Gabriel, S; Herman, P; Kaye, FJ; Lindeman, N; Boggon, TJ; Naoki, K; Sasaki, H; Fujii, Y; Eck, MJ; Sellers, WR; Johnson, BE; Meyerson, M			EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy	SCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; BRAF GENE; INHIBITOR; SENSITIVITY; TRIAL; AMPLIFICATION; COMBINATION; PACLITAXEL; EFFICACY	Receptor tyrosine kinase genes were sequenced in non - small cell lung cancer (NSCLC) and matched normal tissue. Somatic mutations of the epidermal growth factor receptor gene EGFR were found in 15 of 58 unselected tumors from Japan and 1 of 61 from the United States. Treatment with the EGFR kinase inhibitor gefitinib (Iressa) causes tumor regression in some patients with NSCLC, more frequently in Japan. EGFR mutations were found in additional lung cancer samples from U. S. patients who responded to gefitinib therapy and in a lung adenocarcinoma cell line that was hypersensitive to growth inhibition by gefitinib, but not in gefitinib-insensitive tumors or cell lines. These results suggest that EGFR mutations may predict sensitivity to gefitinib.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; Natl Naval Med Res Inst, Genet Branch, NCI, Bethesda, MD 20889 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Naval Medical Research Center (NMRC); Harvard University; Brigham & Women's Hospital; Nagoya City University	Sellers, WR (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	William_Sellers@dfci.harvard.edu; Bruce_Johnson@dfci.harvard.edu; Matthew_Meyerson@dfci.harvard.edu	Naoki, Katsuhiko/J-5937-2019; kaye, frederic/E-2437-2011; Meyerson, Matthew L/E-7123-2012	Naoki, Katsuhiko/0000-0002-9637-1388; 	NATIONAL CANCER INSTITUTE [Z01SC007256, ZIASC007256] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey R, 2003, LUNG CANCER, V41, pS71, DOI DOI 10.1016/S0169-5002(03)91900-3; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Breathnach OS, 2001, J CLIN ONCOL, V19, P1734, DOI 10.1200/JCO.2001.19.6.1734; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Fujishita T, 2003, ONCOLOGY-BASEL, V64, P399, DOI 10.1159/000070299; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Janne PA, 2004, LUNG CANCER-J IASLC, V44, P221, DOI 10.1016/j.lungcan.2003.12.014; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Naoki K, 2002, CANCER RES, V62, P7001; Ono M, 2004, MOL CANCER THER, V3, P465; RUSCH V, 1993, CANCER RES, V53, P2379; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; YAMAZAKI H, 1988, MOL CELL BIOL, V8, P1816, DOI 10.1128/MCB.8.4.1816	26	7560	8139	28	929	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2004	304	5676					1497	1500		10.1126/science.1099314	http://dx.doi.org/10.1126/science.1099314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15118125				2022-12-01	WOS:000221795800043
J	Ramos, JD; Rai-Chaudhuri, A; Neill, RW				Ramos, JD; Rai-Chaudhuri, A; Neill, RW			International online discussion lists on chronic myelogenous leukaemia	BRITISH MEDICAL JOURNAL			English	Article									Canc Resources & Advocacy, Seattle, WA 98115 USA		Ramos, JD (corresponding author), Canc Resources & Advocacy, 7303 23rd Ave NE, Seattle, WA 98115 USA.	jdramos3@comcast.net						BOUDREAU D, PATIENT POWER; HOU CH, 2003, COMPUTER TIMES  0108; *PEW INT AM LIF PR, 2002, VIT DEC INT US DEC W; STROM S, 2003, NY TIMES A      0605, V1, pC11	4	8	9	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 15	2004	328	7449					1177	1178		10.1136/bmj.328.7449.1177	http://dx.doi.org/10.1136/bmj.328.7449.1177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821XU	15142925	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000221497500026
J	Bieganowski, P; Brenner, C				Bieganowski, P; Brenner, C			Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD(+) in fungi and humans	CELL			English	Article							BIOCHEMICAL GENOMICS APPROACH; COLONY-ENHANCING FACTOR; BINDING-PROTEIN MIBP; LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; NMN ADENYLYLTRANSFERASE; HAEMOPHILUS-INFLUENZAE; CALORIE RESTRICTION; DIPHOSPHOPYRIDINE NUCLEOTIDE; HETEROLOGOUS EXPRESSION	NAD(+) is essential for life in all organisms, both as a coenzyme for oxidoreductases and as a source of ADPribosyl groups used in various reactions, including those that retard aging in experimental systems. Nicotinic acid and nicotinamide were defined as the vitamin precursors of NAD(+) in Elvehjem's classic discoveries of the 1930s. The accepted view of eukaryotic NAD(+) biosynthesis, that all anabolism flows through nicotinic acid mononucleotide, was challenged experimentally and revealed that nicotinamide riboside is an unanticipated NAD(+) precursor in yeast. Nicotinamide riboside kinases from yeast and humans essential for this pathway were identified and found to be highly specific for phosphorylation of nicotinamide riboside and the cancer drug tiazofurin. Nicotinamide riboside was discovered as a nutrient in milk, suggesting that nicotinamide riboside is a useful compound for elevation of NAD(+) levels in humans.	Dartmouth Coll Sch Med, Dept Genet, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Dept Biochem, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Brenner, C (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Rubin 733-HB7937, Lebanon, NH 03756 USA.	charles.brenner@dartmouth.edu	Bieganowski, Pawel/ABC-8554-2021; Brenner, Charles/D-6339-2014	Bieganowski, Pawel/0000-0002-1169-4517; Brenner, Charles/0000-0002-4955-3226	NATIONAL CANCER INSTITUTE [P01CA077738] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA077738-040003, P01 CA077738, CA77738] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brachmann CB, 1998, YEAST, V14, P115; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Capuzzi D M, 2000, Curr Atheroscler Rep, V2, P64, DOI 10.1007/s11883-000-0096-y; COONEY DA, 1983, ADV ENZYME REGUL, V21, P271, DOI 10.1016/0065-2571(83)90019-5; Elvehjem CA, 1938, J BIOL CHEM, V123, P137; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Emanuelli M, 2003, PROTEIN EXPRES PURIF, V27, P357, DOI 10.1016/S1046-5928(02)00645-9; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRIDLAND A, 1986, CANCER RES, V46, P532; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Ghosh S, 1996, GENE, V176, P249, DOI 10.1016/0378-1119(96)00260-0; Gingrich W, 1944, J BACTERIOL, V47, P535, DOI 10.1128/JB.47.6.535-550.1944; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KERN L, 1990, NUCLEIC ACIDS RES, V18, P5279, DOI 10.1093/nar/18.17.5279; KORNBERG A, 1950, J BIOL CHEM, V182, P779; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; KROHN K, 1992, J MED CHEM, V35, P511, DOI 10.1021/jm00081a012; KUMASOV OV, 2002, J BACTERIOL, V184, P6906; Kurtz JE, 1999, CURR GENET, V36, P130, DOI 10.1007/s002940050482; Lecoq K, 2001, YEAST, V18, P335, DOI 10.1002/1097-0061(20010315)18:4<335::AID-YEA674>3.0.CO;2-X; LEDER IG, 1951, J BIOL CHEM, V189, P889; Li J, 2003, DEV BIOL, V261, P209, DOI 10.1016/S0012-1606(03)00304-X; Li J, 1999, J CELL BIOL, V147, P1391, DOI 10.1083/jcb.147.7.1391; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MAAYAN ML, 1964, NATURE, V204, P1169, DOI 10.1038/2041169a0; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUNSON M, 1994, GENE, V144, P59, DOI 10.1016/0378-1119(94)90203-8; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Pasternak RC, 1996, ANN INTERN MED, V125, P529, DOI 10.7326/0003-4819-125-7-199610010-00001; PETRACK B, 1965, J BIOL CHEM, V240, P1725; Phizicky EM, 2002, METHOD ENZYMOL, V350, P546; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sandmeier JJ, 2002, GENETICS, V160, P877; Sasiak K, 1996, ARCH BIOCHEM BIOPHYS, V333, P414, DOI 10.1006/abbi.1996.0409; SAUNDERS PP, 1990, CANCER RES, V50, P5269; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; SCHUTZ G, 1972, J BIOL CHEM, V247, P5327; SHIFRINE M, 1960, NATURE, V187, P623, DOI 10.1038/187623a0; Singh SK, 2002, J BIOL CHEM, V277, P33291, DOI 10.1074/jbc.M204368200; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; THIERRY A, 1990, YEAST, V6, P521, DOI 10.1002/yea.320060609; Yun M, 2000, J BIOL CHEM, V275, P28093; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	58	456	495	6	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2004	117	4					495	502		10.1016/S0092-8674(04)00416-7	http://dx.doi.org/10.1016/S0092-8674(04)00416-7			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137942	Bronze			2022-12-01	WOS:000221458000009
J	Holtzendorff, J; Hung, D; Brende, P; Reisenauer, A; Viollier, PH; McAdams, HH; Shapiro, L				Holtzendorff, J; Hung, D; Brende, P; Reisenauer, A; Viollier, PH; McAdams, HH; Shapiro, L			Oscillating global regulators control the genetic circuit driving a bacterial cell cycle	SCIENCE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; CAULOBACTER-CRESCENTUS; HISTIDINE KINASE; DNA-REPLICATION; LOCALIZATION; DIVISION; IDENTIFICATION; PROGRESSION; CTRA	A newly identified cell-cycle master regulator protein, GcrA, together with the CtrA master regulator, are key components of a genetic circuit that drives cell-cycle progression and asymmetric polar morphogenesis in Caulobacter crescentus. The circuit drives out-of-phase temporal and spatial oscillation of GcrA and CtrA concentrations, producing time- and space-dependent transcriptional regulation of modular functions that implement cell-cycle processes. The CtrA/GcrA regulatory circuit controls expression of polar differentiation factors and the timing of DNA replication. CtrA functions as a silencer of the replication origin and GcrA as an activator of components of the replisome and the segregation machinery.	Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Engn, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Shapiro, L (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	shapiro@stanford.edu	Viollier, Patrick/AAD-9405-2021	Viollier, Patrick/0000-0002-5249-9910	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032506, R37GM032506] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32506, GM1426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jenal U, 2002, CURR OPIN MICROBIOL, V5, P558, DOI 10.1016/S1369-5274(02)00378-8; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jensen RB, 2000, TRENDS CELL BIOL, V10, P483, DOI 10.1016/S0962-8924(00)01840-7; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Marques MDV, 1997, J BACTERIOL, V179, P5502, DOI 10.1128/jb.179.17.5502-5510.1997; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Reisenauer A, 2002, EMBO J, V21, P4969, DOI 10.1093/emboj/cdf490; Ryan KR, 2003, ANNU REV BIOCHEM, V72, P367, DOI 10.1146/annurev.biochem.72.121801.161824; SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630	27	147	150	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					983	987		10.1126/science.1095191	http://dx.doi.org/10.1126/science.1095191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15087506				2022-12-01	WOS:000221383300040
J	Flannery, B; Schrag, S; Bennett, NA; Lynfield, R; Harrison, LH; Reingold, A; Cieslak, PR; Hadler, J; Farley, MM; Facklam, RR; Zell, ER; Whitney, CG				Flannery, B; Schrag, S; Bennett, NA; Lynfield, R; Harrison, LH; Reingold, A; Cieslak, PR; Hadler, J; Farley, MM; Facklam, RR; Zell, ER; Whitney, CG		Active Bacterial Core Surveillance	Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCOCCAL DISEASE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINE	Context Historically, incidence of pneumococcal disease in the United States has been higher among blacks than among whites. Following recommendation of a new 7-valent pneumococcal conjugate vaccine for children in October 2000, the incidence of invasive pneumococcal disease has declined dramatically, but the impact of vaccination on racial disparities in incidence of pneumococcal disease is unknown. Objective To assess the effect of conjugate vaccine introduction on rates of pneumococcal disease among whites and blacks in the United States. Design, Setting, and Patients Analysis of data from the Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, an active, population-based surveillance system in 7 states. Patients were 15923 persons with invasive pneumococcal disease occurring between January 1, 1998, and December 31, 2002, Main Outcome Measures Age- and race-specific pneumococcal disease incidence rates (cases per 100000 persons), rate ratios, and rate differences. Results Between 1998 and 2002, annual incidence rates for invasive pneumococcal disease decreased from 19.0 to 12.1 cases per 100000 among whites and from 54.9 to 26.5 among blacks. Due to these declines, 14730 fewer cases occurred among whites and 8780 fewer cases occurred among blacks in the United States in 2002, compared with 2 prevaccine years, 1998 and 1999. Before vaccine introduction, incidence among blacks was 2.9 times higher than among whites (95% confidence interval [CI], 2.73.0); in 2002, the black-white rate ratio had been reduced to 2.2 (95% CI, 2.0-2.4). Incidence among black children younger than 2 years went from being 3.3 times higher (95% CI, 3.0-3.7) than among white children in the prevaccine period to 1.6 times higher (95% CI, 1.1-2.2) in 2002. By 2002, 74% of white children and 68% of black children aged 19 to 35 months in the 7 states had received at least 1 dose of pneumococcal conjugate vaccine; 43% of white and 39% of black children received 3 or more doses. Conclusion Although blacks remain at higher risk of invasive pneumococcal disease, introduction of childhood pneumococcal vaccination has reduced the racial disparity in incidence of pneumococcal disease.	CDCP, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Monroe Cty Dept Hlth, Rochester, NY USA; Univ Rochester, Rochester, NY USA; Minnesota Dept Hlth, Minneapolis, MN USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Oregon Dept Human Serv, Off Dis Prevent & Epidemiol, Portland, OR USA; Connecticut Dept Publ Hlth, Hartford, CT USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA	Centers for Disease Control & Prevention - USA; University of Rochester; Minnesota Department of Health (MHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Flannery, B (corresponding author), CDCP, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, MS C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	bflannery@cdc.gov						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P783; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P987; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1140; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P446; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Harrison LH, 2000, ARCH INTERN MED, V160, P89, DOI 10.1001/archinte.160.1.89; Ingram DD., 2003, VITAL HLTH STAT SERI, V2; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; *RES TRIANGL I, 2001, SUDAAN US MAN REL 8; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Sisk JE, 2003, ANN INTERN MED, V138, P960, DOI 10.7326/0003-4819-138-12-200306170-00007; *US DEP HHS, 2002, 2001 NAT IMM SURV; *US DEP HHS, 2000, HLTH PEOPL 2010 UND; *US DEP HHS, 2003, 2002 NAT IMM SURV; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	21	136	142	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2004	291	18					2197	2203		10.1001/jama.291.18.2197	http://dx.doi.org/10.1001/jama.291.18.2197			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GR	15138241	Bronze			2022-12-01	WOS:000221303500021
J	Clarke, HF; Dalley, JW; Crofts, HS; Robbins, TW; Roberts, AC				Clarke, HF; Dalley, JW; Crofts, HS; Robbins, TW; Roberts, AC			Cognitive inflexibility after prefrontal serotonin depletion	SCIENCE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ORBITOFRONTAL CORTEX; TRYPTOPHAN DEPLETION; FRONTAL-CORTEX; EXCITOTOXIC LESIONS; DECISION-MAKING; BASAL FOREBRAIN; REWARD; REVERSAL; METHYLPHENIDATE	Serotonergic dysregulation within the prefrontal cortex (PFC) is implicated in many neuropsychiatric disorders, but the precise role of serotonin within the PFC is poorly understood. Using a serial discrimination reversal paradigm, we showed that upon reversal, selective serotonin depletion of the marmoset PFC produced perseverative responding to the previously rewarded stimulus without any significant effects on either retention of a discrimination learned preoperatively or acquisition of a novel discrimination postoperatively. These results highlight the importance of prefrontal serotonin in behavioral flexibility and are highly relevant to obsessive-compulsive disorder, schizophrenia, and the cognitive sequelae of drug abuse in which perseveration is prominent.	Univ Cambridge, Dept Anat, Cambridge, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge	Roberts, AC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge, England.	acr4@cam.ac.uk	Roberts, Angela C/C-1313-2012; Robbins, Trevor W/A-7551-2008	Roberts, Angela C/0000-0003-2873-157X; Dalley, Jeffrey/0000-0002-2282-3660; Robbins, Trevor/0000-0003-0642-5977				Baare WFC, 1999, BIOL PSYCHIAT, V45, P1597, DOI 10.1016/S0006-3223(98)00266-2; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; HANDLEY GW, 1978, PSYCHOPHARMACOLOGY, V57, P115, DOI 10.1007/BF00426967; HARDIN H, 1994, MOL BRAIN RES, V26, P1, DOI 10.1016/0169-328X(94)90067-1; Hermesh H, 2003, EUR NEUROPSYCHOPHARM, V13, P87, DOI 10.1016/S0924-977X(02)00128-1; HIRANO H, 1995, J NEUROCHEM, V65, P1139; INSEL TR, 1992, PSYCHIAT CLIN N AM, V15, P813; Jentsch JD, 2002, NEUROPSYCHOPHARMACOL, V26, P183, DOI 10.1016/S0893-133X(01)00355-4; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; McCann UD, 2000, NEUROPSYCHOBIOLOGY, V42, P11, DOI 10.1159/000026665; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P390, DOI 10.1007/s002130000542; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Pantelis C, 1999, SCHIZOPHR RES, V37, P251, DOI 10.1016/S0920-9964(98)00156-X; PARK SB, 1994, NEUROPHARMACOLOGY, V33, P575, DOI 10.1016/0028-3908(94)90089-2; RIDLEY RM, 1981, PHARMACOL BIOCHEM BE, V14, P849, DOI 10.1016/0091-3057(81)90373-7; ROBERTS AC, 1992, NEUROSCIENCE, V47, P251, DOI 10.1016/0306-4522(92)90241-S; ROBERTS AC, 1990, NEUROSCIENCE, V34, P311, DOI 10.1016/0306-4522(90)90142-Q; Rogers RD, 1999, PSYCHOPHARMACOLOGY, V146, P482, DOI 10.1007/PL00005494; Rogers RD, 2003, NEUROPSYCHOPHARMACOL, V28, P153, DOI 10.1038/sj.npp.1300001; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Zohar J, 1996, BRIT J PSYCHIAT, V169, P468, DOI 10.1192/bjp.169.4.468	28	461	467	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					878	880		10.1126/science.1094987	http://dx.doi.org/10.1126/science.1094987			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131308	Green Submitted			2022-12-01	WOS:000221243000046
J	Kers, JA; Wach, MJ; Krasnoff, SB; Widom, J; Cameron, KD; Bukhalid, RA; Gibson, DM; Crane, BR; Loria, R				Kers, JA; Wach, MJ; Krasnoff, SB; Widom, J; Cameron, KD; Bukhalid, RA; Gibson, DM; Crane, BR; Loria, R			Nitration of a peptide phytotoxin by bacterial nitric oxide synthase	NATURE			English	Article							PROTEIN; THAXTOMIN; BIOSYNTHESIS; EXPRESSION; GENES	Nitric oxide ( NO) is a potent intercellular signal in mammals that mediates key aspects of blood pressure, hormone release, nerve transmission and the immune response of higher organisms(1-4). Proteins homologous to full-length mammalian nitric oxide synthases (NOSs) are found in lower multicellular organisms(5). Recently, genome sequencing has shown that some bacteria contain genes coding for truncated NOS proteins; this is consistent with reports of NOS-like activities in bacterial extracts(6,7). Biological functions for bacterial NOSs are unknown, but have been presumed to be analogous to their role in mammals. Here we describe a gene in the plant pathogen Streptomyces turgidiscabies that encodes a NOS homologue, and we reveal its role in nitrating a dipeptide phytotoxin required for plant pathogenicity(8). High similarity between bacterial NOSs indicates a general function in biosynthetic nitration; thus, bacterial NOSs constitute a new class of enzymes(9-11). Here we show that the primary function of Streptomyces NOS is radically different from that of mammalian NOS. Surprisingly, mammalian NO signalling and bacterial biosynthetic nitration share an evolutionary origin.	Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA; ARS, USDA, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA); Cornell University	Loria, R (corresponding author), Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA.	rl21@cornell.edu						Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; CARTER GT, 1989, J CHEM SOC CHEM COMM, P1271, DOI 10.1039/c39890001271; CHEN YJ, 1995, J BACTERIOL, V177, P5122, DOI 10.1128/jb.177.17.5122-5128.1995; Choi WS, 1997, BIOCHEM BIOPH RES CO, V237, P554, DOI 10.1006/bbrc.1997.7189; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Goyer C, 1998, PHYTOPATHOLOGY, V88, P442, DOI 10.1094/PHYTO.1998.88.5.442; Healy FG, 2000, MOL MICROBIOL, V38, P794, DOI 10.1046/j.1365-2958.2000.02170.x; Healy FG, 2002, J BACTERIOL, V184, P2019, DOI 10.1128/JB.184.7.2019-2029.2002; Hughes MN, 1999, BBA-BIOENERGETICS, V1411, P263, DOI 10.1016/S0005-2728(99)00019-5; ISCHIROPOULOS H, 2002, FREE RADICAL BIOL ME, V33; JALAL MAF, 1986, ACTA CRYSTALLOGR C, V42, P733, DOI 10.1107/S010827018609474X; Kieser T, 2000, PRACTICAL STREPTOMYC; Koppenol WH, 1998, FREE RADICAL BIO MED, V25, P385, DOI 10.1016/S0891-5849(98)00093-8; Lipton SA, 2001, NATURE, V413, P118, DOI 10.1038/35093186; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Martin GE, 2000, J NAT PROD, V63, P543, DOI 10.1021/np9903191; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; OHBA K, 1987, J ANTIBIOT, V40, P709, DOI 10.7164/antibiotics.40.709; Packer L., 1996, METHODS ENZYMOL, P268; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Ridd JH, 1998, ACTA CHEM SCAND, V52, P11, DOI 10.3891/acta.chem.scand.52-0011; Southan GJ, 1996, BIOCHEM PHARMACOL, V51, P383, DOI 10.1016/0006-2952(95)02099-3; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Torreilles J, 2001, FRONT BIOSCI-LANDMRK, V6, pD1161, DOI 10.2741/Torreill	30	202	209	4	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					79	82		10.1038/nature02504	http://dx.doi.org/10.1038/nature02504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129284				2022-12-01	WOS:000221222100048
J	Tschumperlin, DJ; Dai, GH; Maly, IV; Kikuchi, T; Laiho, LH; McVittie, AK; Haley, KJ; Lilly, CM; So, PTC; Lauffenburger, DA; Kamm, RD; Drazen, JM				Tschumperlin, DJ; Dai, GH; Maly, IV; Kikuchi, T; Laiho, LH; McVittie, AK; Haley, KJ; Lilly, CM; So, PTC; Lauffenburger, DA; Kamm, RD; Drazen, JM			Mechanotransduction through growth-factor shedding into the extracellular space	NATURE			English	Article							IN-THE-LUNG; MECHANICAL-STRESS; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; BRONCHIAL EPITHELIUM; AUTOCRINE LOOPS; FACTOR RECEPTOR; SHEAR-STRESS; G-PROTEINS; RELEASE	Physical forces elicit biochemical signalling in a diverse array of cells, tissues and organisms(1-3), helping to govern fundamental biological processes. Several hypotheses have been advanced that link physical forces to intracellular signalling pathways, but in many cases the molecular mechanisms of mechanotransduction remain elusive(1-9). Here we find that compressive stress shrinks the lateral intercellular space surrounding epithelial cells, and triggers cellular signalling via autocrine binding of epidermal growth factor family ligands to the epidermal growth factor receptor. Mathematical analysis predicts that constant rate shedding of autocrine ligands into a collapsing lateral intercellular space leads to increased local ligand concentrations that are sufficient to account for the observed receptor signalling; direct experimental comparison of signalling stimulated by compressive stress versus exogenous soluble ligand supports this prediction. These findings establish a mechanism by which mechanotransduction arises from an autocrine ligand - receptor circuit operating in a dynamically regulated extracellular volume, not requiring induction of force-dependent biochemical processes within the cell or cell membrane.	Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Physiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pulm & Crit Care, Boston, MA 02115 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Drazen, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Physiol Program, Boston, MA 02115 USA.	jdrazen@nejm.org	Drazen, Jeffrey M/E-5841-2012; Kamm, Roger D/I-7630-2012	Dai, Guohao/0000-0001-7346-2685; /0000-0002-7232-304X	NIBIB NIH HHS [P41 EB015871] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015871] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Ali MH, 2002, CRIT CARE MED, V30, pS198, DOI 10.1097/00003246-200205001-00005; Blount P, 2003, NEURON, V37, P731, DOI 10.1016/S0896-6273(03)00122-3; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; DULL RO, 1992, J VASC RES, V29, P410, DOI 10.1159/000158959; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Gudi SRP, 1996, CIRC RES, V79, P834, DOI 10.1161/01.RES.79.4.834; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Han OH, 1998, AM J PHYSIOL-GASTR L, V275, pG534, DOI 10.1152/ajpgi.1998.275.3.G534; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; KONDO M, 1992, AM J PHYSIOL, V262, P176; Lauffenburger DA, 1998, P NATL ACAD SCI USA, V95, P15368, DOI 10.1073/pnas.95.26.15368; Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338; MARTINS MA, 1990, J CLIN INVEST, V85, P170, DOI 10.1172/JCI114408; OHASHI Y, 1992, AM REV RESPIR DIS, V145, P1469, DOI 10.1164/ajrccm/145.6.1469; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; SPRING KR, 1978, SCIENCE, V200, P54, DOI 10.1126/science.635571; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Torday JS, 2003, CELL BIOCHEM BIOPHYS, V37, P235; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Tschumperlin DJ, 2002, AM J PHYSIOL-LUNG C, V282, pL904, DOI 10.1152/ajplung.00270.2001; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wiggs BR, 1997, J APPL PHYSIOL, V83, P1814, DOI 10.1152/jappl.1997.83.6.1814; Yamamoto K, 2003, AM J PHYSIOL-HEART C, V285, pH793, DOI 10.1152/ajpheart.01155.2002	30	249	258	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					83	86		10.1038/nature02543	http://dx.doi.org/10.1038/nature02543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15103386	Green Accepted, Bronze			2022-12-01	WOS:000221222100049
J	Budanov, AV; Sablina, AA; Feinstein, E; Koonin, EV; Chumakov, PM				Budanov, AV; Sablina, AA; Feinstein, E; Koonin, EV; Chumakov, PM			Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD	SCIENCE			English	Article							CYSTEINE-SULFINIC ACID; TUBERCULOSIS ALKYLHYDROPEROXIDASE AHPD; ALKYL HYDROPEROXIDE REDUCTASE; OXIDATIVE STRESS; NITROSATIVE STRESS; HYDROGEN-PEROXIDE; DEFENSE; IDENTIFICATION; OVEROXIDATION; INACTIVATION	Acting as a signal, hydrogen peroxide circumvents antioxidant defense by over-oxidizing peroxiredoxins (Prxs), the enzymes that metabolize peroxides. We show that sestrins, a family of proteins whose expression is modulated by p53, are required for regeneration of Prxs containing Cys-SO2H, thus reestablishing the antioxidant firewall. Sestrins contain a predicted redox-active domain homologous to AhpD, the enzyme catalyzing the reduction of a bacterial Prx, AhpC. Purified Hi95 (sestrin 2) protein supports adenosine triphosphate-dependent reduction of over-oxidized Prxl in vitro, indicating that unlike AhpD, which is a disulfide reductase, sestrins are cysteine sulfinyl reductases. As modulators of peroxide signaling and antioxidant defense, sestrins constitute potential therapeutic targets.	Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; Canc Res Ctr, Moscow 1154785, Russia; Quark Biotech Inc, IL-70400 Ness Ziona, Israel; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Cleveland Clinic Foundation; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Chumakov, PM (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	chumakp@ccf.org	Sablina, Anna/P-2818-2019; Chumakov, Peter M/E-7731-2014; Sablina, Anna/B-2217-2017	Sablina, Anna/0000-0001-9526-4014; Sablina, Anna/0000-0001-9526-4014; Budanov, Andrei/0000-0002-7943-1000; Chumakov, Peter/0000-0002-8078-2908	NATIONAL LIBRARY OF MEDICINE [Z01LM000061, ZIALM000061] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; BUDANOV AV, UNPUB; BYRK R, 2002, SCIENCE, V295, P1073, DOI DOI 10.1126/SCIENCE.1067798; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Koshkin A, 2003, J BIOL CHEM, V278, P29502, DOI 10.1074/jbc.M303747200; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; Nunn CM, 2002, J BIOL CHEM, V277, P20033, DOI 10.1074/jbc.M200864200; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	30	591	621	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					596	600		10.1126/science.1095569	http://dx.doi.org/10.1126/science.1095569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105503				2022-12-01	WOS:000220975100052
J	Parker, LH; Schmidt, M; Jin, SW; Gray, AM; Beis, D; Pham, T; Frantz, G; Palmieri, S; Hillan, K; Stainier, DYR; de Sauvage, FJ; Ye, WL				Parker, LH; Schmidt, M; Jin, SW; Gray, AM; Beis, D; Pham, T; Frantz, G; Palmieri, S; Hillan, K; Stainier, DYR; de Sauvage, FJ; Ye, WL			The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation	NATURE			English	Article							ZEBRAFISH GENE; MUTANT EMBRYOS; EXPRESSION; ANGIOGENESIS; NOTOCHORD; DOMAIN; MORPHOGENESIS; PROTEIN; HOMOLOG; CLOCHE	Vascular development is a complex but orderly process that is tightly regulated. A number of secreted factors produced by surrounding cells regulate endothelial cell (EC) differentiation, proliferation, migration and coalescence into cord-like structures(1,2). Vascular cords then undergo tubulogenesis to form vessels with a central lumen(3,4). But little is known about how tubulogenesis is regulated in vivo. Here we report the identification and characterization of a new EC-derived secreted factor, EGF-like domain 7 (Egfl7). Egfl7 is expressed at high levels in the vasculature associated with tissue proliferation, and is downregulated in most of the mature vessels in normal adult tissues. Loss of Egfl7 function in zebrafish embryos specifically blocks vascular tubulogenesis. We uncover a dynamic process during which gradual separation and proper spatial arrangement of the angioblasts allow subsequent assembly of vascular tubes. This process fails to take place in Egfl7 knockdown embryos, leading to the failure of vascular tube formation. Our study defines a regulator that controls a specific and important step in vasculogenesis.	Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ye, WL (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	loni@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Schmidt, Maike/0000-0001-9062-1828; Ye, Weilan/0000-0002-6219-3982; Stainier, Didier/0000-0002-0382-0026; Beis, Dimitris/0000-0003-2579-7848; Dichgans, Martin/0000-0002-0654-387X				Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Childs S, 2002, DEVELOPMENT, V129, P973; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Folkman J, 1997, EXS, V79, P1; Fong GH, 1999, DEVELOPMENT, V126, P3015; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Liao W, 1997, DEVELOPMENT, V124, P381; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Lyons MS, 1998, DEV DYNAM, V212, P133, DOI 10.1002/(SICI)1097-0177(199805)212:1<133::AID-AJA12>3.0.CO;2-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Parker LH, 1999, METHOD CELL BIOL, V59, P313; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Sumoy L, 1997, MECH DEVELOP, V63, P15, DOI 10.1016/S0925-4773(97)00671-0; Vokes SA, 2002, DEVELOPMENT, V129, P775; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	27	290	331	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					754	758		10.1038/nature02416	http://dx.doi.org/10.1038/nature02416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085134				2022-12-01	WOS:000220823800041
J	Leitzmann, MF; Platz, EA; Stampfer, MJ; Willett, WC; Giovannucci, E				Leitzmann, MF; Platz, EA; Stampfer, MJ; Willett, WC; Giovannucci, E			Ejaculation frequency and subsequent risk of prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUAL-BEHAVIOR; SEMINAL PLASMA; INTRALUMINAL CRYSTALLOIDS; ERECTILE DYSFUNCTION; CIGARETTE-SMOKING; MEN; CARCINOMA; EPIDEMIOLOGY; QUESTIONNAIRE; METAANALYSIS	Context Sexual activity has been hypothesized to play a role in the development of prostate cancer, but epidemiological data are virtually limited to case-control studies, which may be prone to bias because recall among individuals with prostate cancer could be distorted as a consequence of prostate malignancy or ongoing therapy. Objective To examine the association between ejaculation frequency, which includes sexual intercourse, nocturnal emission, and masturbation and risk of prostate cancer. Design, Setting, and Participants Prospective study using follow-up data from the Health Professionals Follow-up Study (February 1, 1992, through January 31, 2000) of 29342 US men aged 46 to 81 years, who provided information on history of ejaculation frequency on a self-administered questionnaire in 1992 and responded to follow-up questionnaires every 2 years to 2000. Ejaculation frequency was assessed by asking participants to report the average number of ejaculations they had per month during the ages of 20 to 29 years, 40 to 49 years, and during the past year (1991). Main Outcome Measure Incidence of total prostate cancer. Results During 222426 person-years of follow-up, there were 1449 new cases of total prostate cancer, 953 organ-confined cases, and 147 advanced cases of prostate cancer. Most categories of ejaculation frequency were unrelated to risk of prostate cancer. However, high ejaculation frequency was related to decreased risk of total prostate cancer. The multivariate relative risks for men reporting 21 or more ejaculations per month compared with men reporting 4 to 7 ejaculations per month at ages 20 to 29 years were 0.89 (95% confidence interval [CI], 0.73-1.10); ages 40 to 49 years, 0.68 (95% CI, 0.53-0.86); previous year, 0.49 (95% CI, 0.27-0.88); and averaged across a lifetime, 0.67(95% CI, 051-0.89). Similar associations were observed for organ-confined prostate cancer. Ejaculation frequency was not statistically significantly associated with risk of advanced prostate cancer. Conclusions Our results suggest that ejaculation frequency is not related to increased risk of prostate cancer.	NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Johns Hopkins Bloomerg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Leitzmann, MF (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, EPS-MSC 7232,6120 Execut Blvd, Bethesda, MD 20892 USA.	leitzmann@mail.nih.gov			NCI NIH HHS [5T32 CA09001-26, CA055075] Funding Source: Medline; NHLBI NIH HHS [HL035464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009001, Z01CP010127] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn HS, 2002, BJU INT, V89, P526, DOI 10.1046/j.1464-410X.2002.02650.x; Anton RC, 1998, AM J SURG PATHOL, V22, P446, DOI 10.1097/00000478-199804000-00009; AUMULLER G, 1991, Bulletin de l'Association des Anatomistes, V75, P39; BAKER LH, 1981, J UROLOGY, V125, P370, DOI 10.1016/S0022-5347(17)55039-9; BANERJEE AK, 1986, UROLOGY, V28, P159, DOI 10.1016/0090-4295(86)90112-3; Binks S, 1999, IMMUNOL INVEST, V28, P353, DOI 10.3109/08820139909062269; Bortz WM, 1999, J GERONTOL A-BIOL, V54, pM237, DOI 10.1093/gerona/54.5.M237; CHAKLIN AV, 1984, UROL NEFROL MOSK, V4, P46; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; COX DR, 1972, J R STAT SOC B, V34, P187; DELROSARIO AD, 1993, HUM PATHOL, V24, P1159, DOI 10.1016/0046-8177(93)90210-8; Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012; DJAKIEW D, 1992, J ANDROL, V13, P476; Du S F, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P343; Feldman HA, 2000, PREV MED, V30, P328, DOI 10.1006/pmed.2000.0643; Giles GG, 2003, BJU INT, V92, P211, DOI 10.1046/j.1464-410X.2003.04319.x; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Hayes R B, 1992, Eur J Cancer Prev, V1, P239, DOI 10.1097/00008469-199204000-00005; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; HOLMES EJ, 1977, CANCER, V39, P2073, DOI 10.1002/1097-0142(197705)39:5<2073::AID-CNCR2820390525>3.0.CO;2-C; HONDA GD, 1988, BRIT J CANCER, V57, P326, DOI 10.1038/bjc.1988.74; Hsieh CC, 1999, INT J CANCER, V80, P699, DOI 10.1002/(SICI)1097-0215(19990301)80:5<699::AID-IJC12>3.3.CO;2-Z; Ilic M, 1996, BRIT J CANCER, V74, P1682, DOI 10.1038/bjc.1996.610; ISAACS JT, 1983, PROSTATE, V4, P351, DOI 10.1002/pros.2990040405; Jackson M A, 1981, Prog Clin Biol Res, V53, P111; Jakobsson L, 2001, J CLIN NURS, V10, P573, DOI 10.1046/j.1365-2702.2001.00499.x; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; KELLY RW, 1997, HUMAN REPROD, V12, P220; KRAIN LS, 1974, PREV MED, V3, P154, DOI 10.1016/0091-7435(74)90070-X; LAVECCHIA C, 1993, J EPIDEMIOL COMMUN H, V47, P450, DOI 10.1136/jech.47.6.450; LEIGH BC, 1993, AM J PUBLIC HEALTH, V83, P1400, DOI 10.2105/AJPH.83.10.1400; MANDEL JS, 1987, J GERONTOL, V42, P259, DOI 10.1093/geronj/42.3.259; MANTZOROS CS, 1995, BRIT MED J, V310, P1289, DOI 10.1136/bmj.310.6990.1289; MARSIGLIO W, 1991, J GERONTOL, V46, P338; Matthias RE, 1997, GERONTOLOGIST, V37, P6, DOI 10.1093/geront/37.1.6; MCVARY KT, 1994, BIOL REPROD, V51, P99, DOI 10.1095/biolreprod51.1.99; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; Mirone V, 2002, EUR UROL, V41, P294, DOI 10.1016/S0302-2838(02)00005-2; MISHINA T, 1985, PROSTATE, V6, P423, DOI 10.1002/pros.2990060411; NEWMAN HF, 1982, UROLOGY, V19, P341, DOI 10.1016/0090-4295(82)90186-8; OISHI K, 1990, PROSTATE, V17, P269, DOI 10.1002/pros.2990170403; Okamoto M, 2002, AIDS RES HUM RETROV, V18, P797, DOI 10.1089/08892220260139549; PICHINI S, 1994, CLIN PHARMACOKINET, V26, P356, DOI 10.2165/00003088-199426050-00004; RO JY, 1986, CANCER, V57, P2397, DOI 10.1002/1097-0142(19860615)57:12<2397::AID-CNCR2820571226>3.0.CO;2-1; Rosenblatt KA, 2001, AM J EPIDEMIOL, V153, P1152, DOI 10.1093/aje/153.12.1152; ROSS RK, 1987, JNCI-J NATL CANCER I, V78, P869; ROSS RK, 1983, PROSTATE, V4, P333, DOI 10.1002/pros.2990040403; ROTKIN ID, 1977, CANCER TREAT REP, V61, P173; SCHIAVI RC, 1990, AM J PSYCHIAT, V147, P766; SEVERSON RK, 1989, CANCER RES, V49, P1857; Shaneyfelt T, 2000, J CLIN ONCOL, V18, P847, DOI 10.1200/JCO.2000.18.4.847; Smith E R, 1981, Prog Clin Biol Res, V75B, P131; STEELE R, 1971, J CHRON DIS, V24, P29, DOI 10.1016/0021-9681(71)90056-7; Strickler HD, 2001, EPIDEMIOL REV, V23, P144, DOI 10.1093/oxfordjournals.epirev.a000781; TARTER TH, 1992, J INVEST ALLERG CLIN, V2, P106; WHITE JR, 1990, ARCH SEX BEHAV, V19, P193, DOI 10.1007/BF01541546	56	72	73	6	34	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1578	1586		10.1001/jama.291.13.1578	http://dx.doi.org/10.1001/jama.291.13.1578			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809PQ	15069045	Bronze			2022-12-01	WOS:000220649000022
J	Shubin, NH; Daeschler, EB; Coates, MI				Shubin, NH; Daeschler, EB; Coates, MI			The early evolution of the tetrapod humerus	SCIENCE			English	Article							DEVONIAN TETRAPOD; MORPHOLOGY; FINS	A tetrapod humerus from the Late Devonian of Pennsylvania has a novel mix of primitive and derived characters. A comparative analysis of this fossil and other relevant humeri from the Devonian shows that the role of the limb in propping the body arose first in fish fins, not tetrapod limbs. The functional diversity of the earliest known limbs includes several different kinds of appendage design. This functional diversity was achieved with a humeral architecture that was remarkably conserved during the Devonian.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA	University of Chicago; Drexel University	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu	Coates, Michael/AAO-3810-2020	Coates, Michael/0000-0003-2843-1075				AHLBERG PE, 1991, NATURE, V354, P298, DOI 10.1038/354298a0; Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Carroll RL., 1988, VERTEBRATE PALEONTOL; Clack J. A., 2012, GAINING GROUND ORIGI; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; DAESCHLER EB, 1994, SCIENCE, V265, P639, DOI 10.1126/science.265.5172.639; Goto T, 1999, ICHTHYOL RES, V46, P281, DOI 10.1007/BF02678514; Gregory W. K., 1941, Annals of the New York Academy of Sciences, V42, P273; Jarvik Erik, 1996, Fossils and Strata, V40, P1; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; ROMER AS, 1958, EVOLUTION, V12, P365, DOI 10.2307/2405858; Traverse A, 2002, COUR FOR SEKENBG, V241, P19; VOROBYEVA E, 1992, FOSSIL FISHES LIVING; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; Wilga CD, 2001, J MORPHOL, V249, P195, DOI 10.1002/jmor.1049	18	79	80	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					90	93		10.1126/science.1094295	http://dx.doi.org/10.1126/science.1094295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15064415				2022-12-01	WOS:000220567900043
J	Murphy, SM; Murray, D; Smith, S; Orr, DJA				Murphy, SM; Murray, D; Smith, S; Orr, DJA			Lesson of the week - Burns caused by steam inhalation for respiratory tract infections in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Our Ladys Hosp Sick Children, Dept Plast & Reconstruct Surg, Dublin 12, Ireland; Univ Dublin Trinity Coll, Dept Community Hlth & Gen Practice, Dublin 2, Ireland	Our Ladys Children Hospital Crumlin; Trinity College Dublin	Murphy, SM (corresponding author), Our Ladys Hosp Sick Children, Dept Plast & Reconstruct Surg, Dublin 12, Ireland.	siunm@hotmail.com	Smith, Susan/D-1872-2012; Orr, David/T-1779-2019	Smith, Susan/0000-0001-6027-2727; Orr, David/0000-0002-1935-1412				BALSLEV T, 1990, Ugeskrift for Laeger, V152, P1384; Jeffery SLA, 2000, BRIT MED J, V320, P235, DOI 10.1136/bmj.320.7229.235; MODELL M, 1996, PAEDIAT PROBLEMS GEN, P199; SINGH M, 2001, COCHRANE DB SYST REV, P1728	4	9	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2004	328	7442					757	757		10.1136/bmj.328.7442.757	http://dx.doi.org/10.1136/bmj.328.7442.757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809WH	15044293	Green Published			2022-12-01	WOS:000220666300021
J	Ungless, MA; Magill, PJ; Bolam, JP				Ungless, MA; Magill, PJ; Bolam, JP			Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli	SCIENCE			English	Article							SUBSTANTIA NIGRA; DISCHARGE RATE; RELEASE; RAT; MODULATION; ACTIVATION; RESPONSES; SYSTEM; REWARD; STRESS	Dopamine neurons play a key role in reward-related behaviors. Reward coding theories predict that dopamine neurons will be inhibited by or will not respond to aversive stimuli. Paradoxically, between 3 and 49% of presumed dopamine neurons are excited by aversive stimuli. We found that, in the ventral tegmental area of anesthetized rats, the population of presumed dopamine neurons that are excited by aversive stimuli is actually not dopaminergic. The identified dopamine neurons were inhibited by the aversive stimulus. These findings suggest that dopamine neurons are specifically excited by reward and that a population of nondopamine neurons is excited by aversive stimuli.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Ungless, MA (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	mark.ungless@zoo.ox.ac.uk	Ungless, Mark/A-1985-2009	Magill, Peter/0000-0001-7141-7071; Bolam, J Paul/0000-0002-5008-8405; Ungless, Mark/0000-0002-1730-3353				Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; CHIODO LA, 1980, BRAIN RES, V189, P544, DOI 10.1016/0006-8993(80)90366-2; Fa M, 2003, SYNAPSE, V48, P1, DOI 10.1002/syn.10177; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; FREEMAN AS, 1987, BRAIN RES, V405, P46, DOI 10.1016/0006-8993(87)90988-7; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; JEDEMA HP, 1994, J NEUROCHEM, V63, P785, DOI 10.1046/j.1471-4159.1994.63020785.x; KEEFE KA, 1993, J NEUROCHEM, V61, P1943, DOI 10.1111/j.1471-4159.1993.tb09837.x; MAEDA H, 1982, BRAIN RES BULL, V8, P7, DOI 10.1016/0361-9230(82)90021-1; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; PALIJ P, 1990, BRAIN RES, V509, P172, DOI 10.1016/0006-8993(90)90329-A; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Steffensen SC, 1998, J NEUROSCI, V18, P8003	25	571	577	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2004	303	5666					2040	2042		10.1126/science.1093360	http://dx.doi.org/10.1126/science.1093360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044807	Green Submitted			2022-12-01	WOS:000220429800048
J	Sourjik, V; Berg, HC				Sourjik, V; Berg, HC			Functional interactions between receptors in bacterial chemotaxis	NATURE			English	Article							ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; COVALENT MODIFICATION; MODEL; CHEMORECEPTOR; SENSITIVITY; COMPLEX; BINDING; METHYLATION; COMPONENTS	Bacterial chemotaxis is a model system for signal transduction, noted for its relative simplicity, high sensitivity, wide dynamic range and robustness. Changes in ligand concentrations are sensed by a protein assembly consisting of transmembrane receptors, a coupling protein ( CheW) and a histidine kinase (CheA)(1-4). In Escherichia coli, these components are organized at the cell poles in tight clusters that contain several thousand copies of each protein(1,4-6). Here we studied the effects of variation in the composition of clusters on the activity of the kinase and its sensitivity to attractant stimuli, monitoring responses in vivo using fluorescence resonance energy transfer. Our results indicate that assemblies of bacterial chemoreceptors work in a highly cooperative manner, mimicking the behaviour of allosteric proteins. Conditions that favour steep responses to attractants in mutants with homogeneous receptor populations also enhance the sensitivity of the response in wild-type cells. This is consistent with a number of models(7-11) that assume long-range cooperative interactions between receptors as a general mechanism for signal integration and amplification.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA	Harvard University; Harvard University	Berg, HC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	hberg@biosun.harvard.edu						Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; AMES P, 1994, J BACTERIOL, V176, P6340, DOI 10.1128/jb.176.20.6340-6348.1994; ASAKURA S, 1984, J MOL BIOL, V176, P349, DOI 10.1016/0022-2836(84)90494-7; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; Bornhorst JA, 2000, BIOCHEMISTRY-US, V39, P9486, DOI 10.1021/bi0002737; Boukhvalova MS, 2002, J BIOL CHEM, V277, P22251, DOI 10.1074/jbc.M110908200; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; Levit MN, 2002, J BIOL CHEM, V277, P36748, DOI 10.1074/jbc.M204317200; Levit MN, 2002, J BIOL CHEM, V277, P36760, DOI 10.1074/jbc.M204325200; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mello BA, 2003, P NATL ACAD SCI USA, V100, P8223, DOI 10.1073/pnas.1330839100; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; NINFA EG, 1991, J BIOL CHEM, V266, P9764; Shi Y, 1998, PHYS REV E, V58, P6399, DOI 10.1103/PhysRevE.58.6399; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; Shimizu TS, 2003, J MOL BIOL, V329, P291, DOI 10.1016/S0022-2836(03)00437-6; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x	28	350	358	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					437	441		10.1038/nature02406	http://dx.doi.org/10.1038/nature02406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042093				2022-12-01	WOS:000220404300045
J	Fung, JC; Rockmill, B; Odell, M; Roeder, GS				Fung, JC; Rockmill, B; Odell, M; Roeder, GS			Imposition of crossover interference through the nonrandom distribution of synapsis initiation complexes	CELL			English	Article							MEIOTIC RECIPROCAL RECOMBINATION; SIZE-DEPENDENT CONTROL; CHROMOSOME SYNAPSIS; SACCHAROMYCES-CEREVISIAE; SYNAPTONEMAL COMPLEX; BUDDING YEAST; CROSSING-OVER; CHIASMA INTERFERENCE; FISSION YEAST; MUTS HOMOLOG	Meiotic crossovers (COs) are nonrandomly distributed along chromosomes such that two COs seldom occur close together, a phenomenon known as CO interference. We have used genetic and cytological methods to investigate interference mechanisms in budding yeast. Assembly of the synaptonemal complex (SC) initiates at a few sites along each chromosome, triggered by a complex of proteins (including Zip2 and Zip3) called the synapsis initiation complex (SIC). We found that SICs, like COs, display interference, supporting the hypothesis that COs occur at synapsis initiation sites. Unexpectedly, we found that SICs show interference in mutants in which CO interference is abolished; one explanation is that these same mutations eliminate the subset of COs that normally occur at SICs. Since SICs are assembled in advance of SC and they are properly positioned even in the absence of SC formation, these data clearly demonstrate an aspect of interference that is independent of synapsis.	Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Roeder, GS (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA.	shirleen.roeder@yale.edu						Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; BAHLER J, 1993, J CELL BIOL, V121, P241, DOI 10.1083/jcb.121.2.241; Carpenter ATC, 1988, GENETIC RECOMBINATIO, P529, DOI [10.1038/ng1287, DOI 10.1038/NG1287]; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; EGELMITANI M, 1982, HEREDITAS, V97, P179, DOI 10.1111/j.1601-5223.1982.tb00870.x; FOSS E, 1993, GENETICS, V133, P681; Havekes FWJ, 1994, CHROMOSOME RES, V2, P315, DOI 10.1007/BF01552725; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; KABACK DB, 1989, P NATL ACAD SCI USA, V86, P3694, DOI 10.1073/pnas.86.10.3694; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kaback DB, 1999, GENETICS, V152, P1475; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; LAMBIE EJ, 1988, CELL, V52, P863, DOI 10.1016/0092-8674(88)90428-X; LAMBIE EJ, 1986, GENETICS, V114, P769; LOIDL J, 1990, GENOME, V33, P759, DOI 10.1139/g90-115; MAGUIRE MP, 1988, J THEOR BIOL, V134, P565, DOI 10.1016/S0022-5193(88)80058-4; MOENS PB, 1969, CAN J GENET CYTOL, V11, P857, DOI 10.1139/g69-101; Mortimer R.R., 1974, MECH RECOMBINATION, P263, DOI [10.1007/978-1-4684-2133-0_23, DOI 10.1007/978-1-4684-2133-0_23]; MUNZ P, 1994, GENETICS, V137, P701; Novak JE, 2001, GENETICS, V158, P1013; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1995, J CELL BIOL, V128, P455, DOI 10.1083/jcb.128.4.455; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tung KS, 1998, GENETICS, V149, P817; Zar JH., 1999, BIOSTAT ANAL	38	163	166	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					795	802		10.1016/S0092-8674(04)00249-1	http://dx.doi.org/10.1016/S0092-8674(04)00249-1			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035982	Bronze			2022-12-01	WOS:000221499900006
J	Yu, L; Alva, A; Su, H; Dutt, P; Freundt, E; Welsh, S; Baehrecke, EH; Lenardo, MJ				Yu, L; Alva, A; Su, H; Dutt, P; Freundt, E; Welsh, S; Baehrecke, EH; Lenardo, MJ			Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8	SCIENCE			English	Article							DOMAIN KINASE RIP; INDUCED APOPTOSIS; NECROSIS; PROTEIN; MECHANISMS; BECLIN-1; TUMORIGENESIS; DEGRADATION; APG7P/CVT2P; INHIBITION	Caspases play a central role in apoptosis, a well-studied pathway of programmed cell death. Other programs of death potentially involving necrosis and autophagy may exist, but their relation to apoptosis and mechanisms of regulation remains unclear. We de. ne a new molecular pathway in which activation of the receptor-interacting protein (a serine-threonine kinase) and Jun amino-terminal kinase induced cell death with the morphology of autophagy. Autophagic death required the genes ATG7 and beclin 1 and was induced by caspase-8 inhibition. Clinical therapies involving caspase inhibitors may arrest apoptosis but also have the unanticipated effect of promoting autophagic cell death.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; Univ Oxford, Weatherall Inst Mol Med, Oxford OX39D, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; University of Oxford	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.	lenardo@nih.gov	Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110	NIGMS NIH HHS [GM59136] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM059136, R01GM059136] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; HENGARTNER MO, 1994, CURR OPIN GENET DEV, V4, P581, DOI 10.1016/0959-437X(94)90076-F; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jia L, 1997, BRIT J HAEMATOL, V98, P673, DOI 10.1046/j.1365-2141.1997.2623081.x; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Nicholson DW, 2003, SCIENCE, V299, P214, DOI 10.1126/science.1081274; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Yu Lili, UNPUB; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	28	1044	1100	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2004	304	5676					1500	1502		10.1126/science.1096645	http://dx.doi.org/10.1126/science.1096645			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15131264				2022-12-01	WOS:000221795800044
J	Taylor-Robinson, A				Taylor-Robinson, A			In-vitro model offers insight into the pathophysiology of severe malaria	LANCET			English	Editorial Material							RED-BLOOD-CELL; PLASMODIUM-FALCIPARUM; FLOW		Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Taylor-Robinson, A (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.	a.w.taylor-robinson@leeds.ac.uk	Taylor-Robinson, Andrew/R-2805-2019	Taylor-Robinson, Andrew/0000-0001-7342-8348				Clark IA, 2003, PHARMACOL THERAPEUT, V99, P221, DOI 10.1016/S0163-7258(03)00060-3; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Cooke Brian M, 2002, Methods Mol Med, V72, P561, DOI 10.1385/1-59259-271-6:561; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Gifford SC, 2003, BIOPHYS J, V84, P623, DOI 10.1016/S0006-3495(03)74882-6; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Shelby JP, 2003, P NATL ACAD SCI USA, V100, P14618, DOI 10.1073/pnas.2433968100; Shelby JP, 2003, ANAL CHEM, V75, P1387, DOI 10.1021/ac026275+; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5	10	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 22	2004	363	9422					1661	1663		10.1016/S0140-6736(04)16286-7	http://dx.doi.org/10.1016/S0140-6736(04)16286-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822NG	15158624				2022-12-01	WOS:000221546300003
J	Ma, JB; Ye, KQ; Patel, DJ				Ma, JB; Ye, KQ; Patel, DJ			Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain	NATURE			English	Article							HUMAN-CELLS; SIRNAS; INITIATION; SYSTEM	Short RNAs mediate gene silencing, a process associated with virus resistance, developmental control and heterochromatin formation in eukaryotes(1-5). RNA silencing is initiated through Dicer-mediated processing of double-stranded RNA into small interfering RNA (siRNA)(6,7). The siRNA guide strand associates with the Argonaute protein in silencing effector complexes, recognizes complementary sequences and targets them for silencing(8-11). The PAZ domain is an RNA-binding module found in Argonaute and some Dicer proteins and its structure has been determined in the free state(12-14). Here, we report the 2.6 Angstrom crystal structure of the PAZ domain from human Argonaute eIF2c1 bound to both ends of a 9-mer siRNA-like duplex. In a sequence-independent manner, PAZ anchors the 2-nucleotide 3' overhang of the siRNA-like duplex within a highly conserved binding pocket, and secures the duplex by binding the 7-nucleotide phosphodiester backbone of the overhang-containing strand and capping the 5'-terminal residue of the complementary strand. On the basis of the structure and on binding assays, we propose that PAZ might serve as an siRNA-end-binding module for siRNA transfer in the RNA silencing pathway, and as an anchoring site for the 3' end of guide RNA within silencing effector complexes.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org			NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIAID NIH HHS [R01 AI068776] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Hohjoh H, 2002, FEBS LETT, V521, P195, DOI 10.1016/S0014-5793(02)02860-0; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SONG JJ, 1932, NAT STRUCT BIOL, V10, P1026; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129	30	525	592	4	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					318	322		10.1038/nature02519	http://dx.doi.org/10.1038/nature02519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152257	Green Accepted			2022-12-01	WOS:000221505900048
J	Singhal, A; Lucas, A				Singhal, A; Lucas, A			Early origins of cardiovascular disease: is there a unifying hypothesis?	LANCET			English	Editorial Material							CATCH-UP GROWTH; DEPENDENT DIABETES-MELLITUS; GESTATIONAL-AGE INFANTS; CORONARY-HEART-DISEASE; LOW-BIRTH-WEIGHT; INSULIN-RESISTANCE; CHILDHOOD GROWTH; EARLY NUTRITION; BLOOD-PRESSURE; CHOLESTEROL		Inst Child Hlth, MRC, Childhood Nutr Res Ctr, London WC1N 1EH, England	University of London; University College London	Singhal, A (corresponding author), Inst Child Hlth, MRC, Childhood Nutr Res Ctr, 30 Guilford St, London WC1N 1EH, England.	a.singhal@ich.ucl.ac.uk						BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Cianfarani S, 1999, ARCH DIS CHILD-FETAL, V81, pF71, DOI 10.1136/fn.81.1.F71; COLLE E, 1976, PEDIATRICS, V57, P363; DEIBER M, 1989, J CLIN ENDOCR METAB, V68, P232, DOI 10.1210/jcem-68-1-232; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Finken MJJ, 2003, PEDIATR RES, V53, p32A; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; HAHN P, 1984, J NUTR, V114, P1231, DOI 10.1093/jn/114.7.1231; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Law CM, 2002, ARCH DIS CHILD-FETAL, V86, pF7, DOI 10.1136/fn.86.1.F7; LUCAS A, 1991, CIBA F SYMP, V156, P38; Martin RM, 2003, AM J CLIN NUTR, V77, P1489, DOI 10.1093/ajcn/77.6.1489; MCCANCE RA, 1962, LANCET, V2, P671; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/01.PDR.0000036602.81878.6D; OUNSTED MK, 1985, ARCH DIS CHILD, V60, P631, DOI 10.1136/adc.60.7.631; Owen CG, 2002, PEDIATRICS, V110, P597, DOI 10.1542/peds.110.3.597; Pettitt DJ, 1997, LANCET, V350, P166, DOI 10.1016/S0140-6736(96)12103-6; PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P154, DOI 10.1055/s-0029-1211159; Plagemann A, 2002, DIABETES CARE, V25, P16, DOI 10.2337/diacare.25.1.16; Roth GS, 2000, EUR J CLIN NUTR, V54, pS15, DOI 10.1038/sj.ejcn.1601020; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Singhal A, 2002, AM J CLIN NUTR, V75, P993, DOI 10.1093/ajcn/75.6.993; Singhal A, 2001, LANCET, V358, P1159, DOI 10.1016/S0140-6736(01)06276-6; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Singhal A, 2004, LANCET, V363, P1571, DOI 10.1016/S0140-6736(04)16198-9; Stern MP, 1996, ANN INTERN MED, V124, P110, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00006; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21	35	547	570	0	35	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 15	2004	363	9421					1642	1645		10.1016/S0140-6736(04)16210-7	http://dx.doi.org/10.1016/S0140-6736(04)16210-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	820SE	15145640				2022-12-01	WOS:000221408800026
J	DeLoache, JS; Uttal, D; Rosengren, KS				DeLoache, JS; Uttal, D; Rosengren, KS			Scale errors offer evidence for a perception-action dissociation early in life	SCIENCE			English	Article							SYSTEMS; OBJECTS; INFANCY	We report a perception-action dissociation in the behavior of normally developing young children. In adults and older children, the perception of an object and the organization of actions on it are seamlessly integrated. However, as documented here, 18- to 30-month-old children sometimes fail to use information about object size and make serious attempts to perform impossible actions on miniature objects. They try, for example, to sit in a dollhouse chair or to get into a small toy car. We interpret scale errors as reflecting problems with inhibitory control and with the integration of visual information for perception and action.	Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA; Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; Univ Illinois, Dept Psychol, Champaign, IL 61820 USA	University of Virginia; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign	DeLoache, JS (corresponding author), Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA.	jdeloache@virginia.edu		Rosengren, Karl/0000-0003-1448-1282	NICHD NIH HHS [HD-25271, 5 T32 HD007323-18] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007323, R37HD025271, R01HD025271] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Bertenthal BI, 1996, ANNU REV PSYCHOL, V47, P431, DOI 10.1146/annurev.psych.47.1.431; Creem SH, 2001, ACTA PSYCHOL, V107, P43, DOI 10.1016/S0001-6918(01)00021-X; David Milner A, 1995, MAG VISUAL BRAIN ACT; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI [/10.1093/acprof:oso/9780195134971.003.0029, DOI 10.1093/ACPROF:OSO/9780195134971.003.0029, 10.1093/acprof:oso/9780195134971.003.0029]; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Glover S, 2002, TRENDS COGN SCI, V6, P288, DOI 10.1016/S1364-6613(02)01920-4; GLOVER S, IN PRESS BEHAV BRAIN; GOODALE MA, 2000, NEW COGNITIVE NEUROS, P365; Leslie AM, 1998, TRENDS COGN SCI, V2, P10, DOI 10.1016/S1364-6613(97)01113-3; Mareschal D, 2003, COGNITION, V88, P259, DOI 10.1016/S0010-0277(03)00039-8; Newman C, 2001, DEV PSYCHOL, V37, P561, DOI 10.1037//0012-1649.37.4.561; Thelen E, 2000, INFANCY, V1, P3, DOI 10.1207/S15327078IN0101_02; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; VISHTON PM, 2003, BIENN M SOC RES CHIL; von Hofsten C, 1998, COGNITION, V67, P255, DOI 10.1016/S0010-0277(98)00029-8; Zelazo PD, 1998, CURR DIR PSYCHOL SCI, V7, P121, DOI 10.1111/1467-8721.ep10774761	17	104	105	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2004	304	5673					1027	1029		10.1126/science.1093567	http://dx.doi.org/10.1126/science.1093567			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	820IV	15143286				2022-12-01	WOS:000221383300054
J	Wilken, C; Kitzing, K; Kurzbauer, R; Ehrmann, M; Clausen, T				Wilken, C; Kitzing, K; Kurzbauer, R; Ehrmann, M; Clausen, T			Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease	CELL			English	Article							ESCHERICHIA-COLI SIGMA(E); HEAT-SHOCK RESPONSE; SERINE-PROTEASE; EXTRACYTOPLASMIC STRESS; HTRA FAMILY; TRANSCRIPTION-FACTOR; QUALITY-CONTROL; RSEA; MITOCHONDRIAL; APOPTOSIS	Gram-negative bacteria respond to misfolded proteins in the cell envelope with the sigmaE-driven expression of periplasmic proteases/chaperones. Activation of sigmaE is controlled by a proteolytic cascade that is initiated by the DegS protease. DegS senses misfolded protein in the periplasm, undergoes autoactivation, and cleaves the antisigma factor RseA. Here, we present the crystal structures of three distinct states of DegS from E. coli. DegS alone exists in a catalytically inactive form. Binding of stress-signaling peptides to its PDZ domain induces a series of conformational changes that activates protease function. Backsoaking of crystals containing the DegS-activator complex revealed the presence of an active/inactive hybrid structure and demonstrated the reversibility of activation. Taken together, the structural data illustrate in molecular detail how DegS acts as a periplasmic stress sensor. Our results suggest a novel regulatory role for PDZ domains and unveil novel mechanism of reversible protease activation.	Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria; Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Cardiff University	Clausen, T (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Ehrmann, Michael/A-7307-2012	Ehrmann, Michael/0000-0002-1927-260X; Clausen, Tim/0000-0003-1582-6924				Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Collaborative Comuptational Project 4, 2002, ACTA CRYSTALLOGR D, V58, P1897; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Harris BZ, 2001, J CELL SCI, V114, P3219; HARRIS BZ, 1996, J CELL SCI, V863, P341; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hengge R, 2003, MOL MICROBIOL, V49, P1451, DOI 10.1046/j.1365-2958.2003.03693.x; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jones CH, 2002, J BACTERIOL, V184, P5762, DOI 10.1128/JB.184.20.5762-5771.2002; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kim DY, 2003, J BIOL CHEM, V278, P6543, DOI 10.1074/jbc.M208148200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Shridhar V, 2002, CANCER RES, V62, P262; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yamaguchi H, 2003, CANCER RES, V63, P1483; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; Young JC, 2003, CELL, V113, P1, DOI 10.1016/S0092-8674(03)00192-2	51	229	234	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2004	117	4					483	494		10.1016/S0092-8674(04)00454-4	http://dx.doi.org/10.1016/S0092-8674(04)00454-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137941	Bronze			2022-12-01	WOS:000221458000008
J	Eubank, S; Guclu, H; Kumar, VSA; Marathe, MV; Srinivasan, A; Toroczkai, Z; Wang, N				Eubank, S; Guclu, H; Kumar, VSA; Marathe, MV; Srinivasan, A; Toroczkai, Z; Wang, N			Modelling disease outbreaks in realistic urban social networks	NATURE			English	Article							SMALLPOX; TRANSMISSION; SPREAD; ATTACK	Most mathematical models for the spread of disease use differential equations based on uniformmixing assumptions(1) or ad hoc models for the contact process(2-4). Here we explore the use of dynamic bipartite graphs to model the physical contact patterns that result from movements of individuals between specific locations. The graphs are generated by large-scale individual-based urban traffic simulations built on actual census, land-use and population-mobility data. We find that the contact network among people is a strongly connected small-world-like(5) graph with a well-defined scale for the degree distribution. However, the locations graph is scale-free(6), which allows highly efficient outbreak detection by placing sensors in the hubs of the locations network. Within this large-scale simulation framework, we then analyse the relative merits of several proposed mitigation strategies for smallpox spread. Our results suggest that outbreaks can be contained by a strategy of targeted vaccination combined with early detection without resorting to mass vaccination of a population.	Los Alamos Natl Lab, Basic & Appl Simulat Sci Grp, Los Alamos, NM 87545 USA; Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA; Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Complex Syst Grp, Los Alamos, NM 87545 USA; Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Rensselaer Polytechnic Institute; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Maryland; University of Maryland College Park	Eubank, S (corresponding author), Los Alamos Natl Lab, Basic & Appl Simulat Sci Grp, MS M997, Los Alamos, NM 87545 USA.	eubank@lanl.gov	Guclu, Hasan/B-7080-2008; Toroczkai, Zoltan/AAC-8446-2019; Eubank, Stephen/AAD-5089-2021; Toroczkai, Zoltan/A-3421-2008; Eubank, Stephen/D-7497-2011	Guclu, Hasan/0000-0003-3582-9460; Toroczkai, Zoltan/0000-0002-6602-2849; Toroczkai, Zoltan/0000-0002-6602-2849; Eubank, Stephen/0000-0002-7177-309X; Vullikanti, Anil Kumar/0000-0002-8597-6197				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; BARRETT CL, 2000, LAUR001725 LOS AL NA; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Dall J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016121; Dorogovtsev SN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066122; Eichner M, 2003, AM J EPIDEMIOL, V158, P110, DOI 10.1093/aje/kwg103; EUBANK S, 2002, P 2002 ACM S APPL CO, P139; EUBANK S, 2004, P 15 ACM SIAM S DISC, P711; Fenner F., 1988, SMALLPOX ITS ERADICA; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Jin EM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046132; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Keeling MJ, 2000, J THEOR BIOL, V203, P51, DOI 10.1006/jtbi.1999.1064; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026121; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Szabo G, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056102; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ZWINGLE E, 2002, NATL GEOGR, V202, P70	28	1223	1272	11	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					180	184		10.1038/nature02541	http://dx.doi.org/10.1038/nature02541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141212				2022-12-01	WOS:000221356300041
J	Frankland, PW; Bontempi, B; Talton, LE; Kaczmarek, L; Silva, AJ				Frankland, PW; Bontempi, B; Talton, LE; Kaczmarek, L; Silva, AJ			The involvement of the anterior cingulate cortex in remote contextual fear memory	SCIENCE			English	Article							TIME-DEPENDENT REORGANIZATION; RETROGRADE-AMNESIA; ZIF268 EXPRESSION; PREFRONTAL CORTEX; HIPPOCAMPUS; PLASTICITY; NEOCORTEX; STORAGE; COGNITION; RETRIEVAL	Although the molecular, cellular, and systems mechanisms required for initial memory processing have been intensively investigated, those underlying permanent memory storage remain elusive. We present neuroanatomical, pharmacological, and genetic results demonstrating that the anterior cingulate cortex plays a critical role in remote memory for contextual fear conditioning. Imaging of activity-dependent genes shows that the anterior cingulate is activated by remote memory and that this activation is impaired by a null alpha-CaMKII mutation that blocks remote memory. Accordingly, reversible inactivation of this structure in normal mice disrupts remote memory without affecting recent memory.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Hosp Sick Children, Dept Integrat Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Cognit Neurosci Lab, CNRS, UMR 5106, F-33405 Talence, France; M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Centre National de la Recherche Scientifique (CNRS); Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Charles Young Dr, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021; Kaczmarek, Leszek/B-6171-2008; Kaczmarek, Leszek/AHA-0076-2022	Silva, Alcino/0000-0002-1587-4558; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; Silva, Alcino/0000-0001-5525-0494				Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; KACZMAREK L, 2002, HDB CHEM NEUROANATOM, P370; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Robbins TW, 2000, PROG BRAIN RES, V126, P469; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Takehara K, 2003, J NEUROSCI, V23, P9897; Thomas KL, 2002, EUR J NEUROSCI, V16, P1789, DOI 10.1046/j.1460-9568.2002.02247.x; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	28	672	685	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					881	883		10.1126/science.1094804	http://dx.doi.org/10.1126/science.1094804			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131309				2022-12-01	WOS:000221243000047
J	Harvey, RJ; Depner, UB; Wassle, H; Ahmadi, S; Heindl, C; Reinold, H; Smart, TG; Harvey, K; Schutz, B; Abo-Salem, OM; Zimmer, A; Poisbeau, P; Welzl, H; Wolfer, DP; Betz, H; Zeilhofer, HU; Muller, U				Harvey, RJ; Depner, UB; Wassle, H; Ahmadi, S; Heindl, C; Reinold, H; Smart, TG; Harvey, K; Schutz, B; Abo-Salem, OM; Zimmer, A; Poisbeau, P; Welzl, H; Wolfer, DP; Betz, H; Zeilhofer, HU; Muller, U			GlyR alpha 3: An essential target for spinal PGE(2)-mediated inflammatory pain sensitization	SCIENCE			English	Article							INHIBITORY GLYCINE RECEPTOR; DORSAL HORN NEURONS; PROSTAGLANDIN E-2; SUBUNIT; MOUSE; RAT; CORD; LOCALIZATION; HYPERALGESIA; MUTATION	Prostaglandin E-2 (PGE(2)) is a crucial mediator of inflammatory pain sensitization. Here, we demonstrate that inhibition of a specific glycine receptor subtype (GlyR alpha3) by PGE(2)-induced receptor phosphorylation underlies central inflammatory pain sensitization. We show that GlyR alpha3 is distinctly expressed in superficial layers of the spinal cord dorsal horn. Mice deficient in GlyR alpha3 not only lack the inhibition of glycinergic neurotransmission by PGE(2) seen in wildtype mice but also show a reduction in pain sensitization induced by spinal PGE(2) injection or peripheral inflammation. Thus, GlyR alpha3 may provide a previously unrecognized molecular target in pain therapy.	Max Planck Inst Hirnforsch, Neurochem Abt, D-60528 Frankfurt, Germany; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; Max Planck Inst Hirnforsch, Abt Neuroanat, D-60528 Frankfurt, Germany; UCL, Dept Pharmacol, London WC1E 6BT, England; Univ Klinikum Bonn, Inst Mol Neurobiol, D-53105 Bonn, Germany; Univ Strasbourg 1, Lab Neurophysiol Cellulaire & Integree, CNRS, UMR 7519, F-67084 Strasbourg, France; Univ Zurich Irchel, Inst Anat, Abt Neuroanat & Verhalten, CH-8057 Zurich, Switzerland	Max Planck Society; University of London; University College London; University of London School of Pharmacy; University of Erlangen Nuremberg; Max Planck Society; University of London; University College London; University of Bonn; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Zurich	Betz, H (corresponding author), Max Planck Inst Hirnforsch, Neurochem Abt, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de; umueller@mpih-frankfurt.mpg.de	Heindl-Erdmann, Cornelia/F-4809-2018; Abo-Salem, Prof, Dr. Osama Mohamed/AAA-8284-2022; Schütz, Burkhard/AAA-8078-2019; Wolfer, David P/B-3293-2016; Harvey, Robert J/D-3994-2016; Zimmer, Andreas/B-8357-2009; Zeilhofer, Hanns Ulrich/A-4600-2008	Abo-Salem, Prof, Dr. Osama Mohamed/0000-0002-6087-5867; Schütz, Burkhard/0000-0003-4473-1959; Wolfer, David P/0000-0002-5957-1401; Harvey, Robert J/0000-0001-5956-6664; Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Poisbeau, Pierrick/0000-0002-6089-9201				Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Baba H, 2001, J NEUROSCI, V21, P1750, DOI 10.1523/JNEUROSCI.21-05-01750.2001; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Beiche F, 1996, FEBS LETT, V390, P165, DOI 10.1016/0014-5793(96)00604-7; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; DOHERTY NS, 1987, BRIT J PHARMACOL, V91, P39, DOI 10.1111/j.1476-5381.1987.tb08981.x; Doubell TP, 1999, TXB PAIN, V4, P165; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Guhring H, 2000, J NEUROSCI, V20, P6714, DOI 10.1523/JNEUROSCI.20-17-06714.2000; Haverkamp S, 2003, J COMP NEUROL, V465, P524, DOI 10.1002/cne.10852; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; KUHSE J, 1990, J BIOL CHEM, V265, P22317; Maihofner C, 2000, NEUROSCIENCE, V101, P1093, DOI 10.1016/S0306-4522(00)00361-4; MALMBERG AB, 1992, SCIENCE, V257, P1276, DOI 10.1126/science.1381521; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Samad TA, 2002, TRENDS MOL MED, V8, P390, DOI 10.1016/S1471-4914(02)02383-3; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; SCHRODER S, 1991, BIOCHEMISTRY-US, V30, P42, DOI 10.1021/bi00215a007; Turnbach ME, 2002, PAIN, V97, P127, DOI 10.1016/S0304-3959(02)00012-X; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	26	456	473	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					884	887		10.1126/science.1094925	http://dx.doi.org/10.1126/science.1094925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131310	Green Accepted			2022-12-01	WOS:000221243000048
J	Higashi, T; Shekelle, PG; Solomon, DH; Knight, EL; Roth, C; Chang, JT; Kamberg, CJ; MaClean, CH; Young, RT; Adams, J; Reuben, DB; Avorn, J; Wenger, NS				Higashi, T; Shekelle, PG; Solomon, DH; Knight, EL; Roth, C; Chang, JT; Kamberg, CJ; MaClean, CH; Young, RT; Adams, J; Reuben, DB; Avorn, J; Wenger, NS			The quality of pharmacologic care for vulnerable older patients	ANNALS OF INTERNAL MEDICINE			English	Article							INAPPROPRIATE MEDICATION USE; ACUTE MYOCARDIAL-INFARCTION; ADVERSE DRUG-REACTIONS; EXPLICIT CRITERIA; ELDERLY-PATIENTS; CLINICAL-TRIALS; BEERS CRITERIA; HEART-FAILURE; HEALTH-CARE; COMMUNITY	Background: Although pharmacotherapy is critical to the medical care of older patients, medications can have considerable toxicity in this age group. To date, research has focused on inappropriate prescribing and policy efforts have aimed at access, but no comprehensive measurement of the quality of pharmacologic management using explicit criteria has been performed. Objective: To evaluate the broad range of pharmacologic care processes for vulnerable older patients. Design: Observational cohort study. Setting: 2 managed care organizations enrolling older persons. Patients: community-dwelling high-risk patients 65 years of age or older continuously enrolled in the managed care organizations from 1 July 1998 to 31 July 1999. Measurements: Patients' receipt of care as specified in 43 quality indicators covering 4 domains of pharmacologic care: 1) prescribing indicated medications; 2) avoiding inappropriate medications; 3) education, continuity, and documentation; and 4) medication monitoring. Results: Of 475 vulnerable older patients, 372 (78%) consented to participate and had medical records that could be abstracted.The percentage of appropriate pharmacologic management ranged from 10% for documentation of risks of nonsteroidal anti-inflammatory drugs to 100% for avoiding short-acting calcium-channel blockers in patients with heart failure and avoiding beta-blockers in patients with asthma. Pass rates for quality indicators in the "avoiding inappropriate medications" domain (97% [95% Cl, 96% to 98%]) were significantly higher than pass rates for "prescribing indicated medications" (50% [Cl, 45% to 55%]); "education, continuity, and documentation" (81% [Cl, 79% to 84%]); and "medication monitoring" (64% [Cl, 60% to 68%]). Limitations: Fewer than 10 patients were eligible for many of the quality indicators measured, and the generalizabiIity of these findings in 2 managed care organizations to the general geriatric population is uncertain. Conclusions: Failures to prescribe indicated medications, monitor medications appropriately, document necessary information, educate patients, and maintain continuity are more common prescribing problems than use of inappropriate drugs in older patients.	Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA 90095 USA; Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA 90095 USA; RAND Hlth, Washington, DC USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Higashi, T (corresponding author), Univ Calif Los Angeles, Div Gen Internal Med, 911 Broxton Plaza, Los Angeles, CA 90095 USA.		Chang, John T./L-7840-2019		BHP HRSA HHS [PE-19001] Funding Source: Medline	BHP HRSA HHS		*AG HEALTHC RES QU, 1996, HLTH CAR US AM 1996; [Anonymous], 2001, ANN INTERN MED, V135, P653, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00004; [Anonymous], 2000, MED EXP PAN SURV 200; Aparasu RR, 2000, ANN PHARMACOTHER, V34, P338, DOI 10.1345/aph.19006; Aparasu RR, 1997, ANN PHARMACOTHER, V31, P823, DOI 10.1177/106002809703100702; Aparasu RR, 1999, AM J HEALTH-SYST PH, V56, P433, DOI 10.1093/ajhp/56.5.433; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; CHRISCHILLES EA, 1992, ANN INTERN MED, V117, P634, DOI 10.7326/0003-4819-117-8-634; *CTR MED MED SERV, 2002, MED CURR BEN SURV; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; FINK A, 1987, JAMA-J AM MED ASSOC, V258, P1905, DOI 10.1001/jama.258.14.1905; Fitzgerald LS, 1997, ANN PHARMACOTHER, V31, P543, DOI 10.1177/106002809703100503; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.268.11.1417; Hanlon JT, 2000, PHARMACOTHERAPY, V20, P575, DOI 10.1592/phco.20.6.575.35163; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Havranek EP, 1998, ARCH INTERN MED, V158, P2024, DOI 10.1001/archinte.158.18.2024; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hunt D, 2001, ANN INTERN MED, V134, P931, DOI 10.7326/0003-4819-134-10-200105150-00007; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; KANE RL, 1994, ESSENTIALS CLIN GERI; Kuperman G J, 2001, Jt Comm J Qual Improv, V27, P509; LASCHOBER MA, 2002, HLTH AFF MILWOOD; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Luck J, 2000, AM J MED, V108, P642, DOI 10.1016/S0002-9343(00)00363-6; MILLER DK, 1995, J AM GERIATR SOC, V43, P60, DOI 10.1111/j.1532-5415.1995.tb06244.x; Monane M, 1998, JAMA-J AM MED ASSOC, V280, P1249, DOI 10.1001/jama.280.14.1249; Primatesta P, 2000, BMJ-BRIT MED J, V321, P1322, DOI 10.1136/bmj.321.7272.1322; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; RATNER J, 1995, PUBLICATION US GAO; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 1999, JAMA-J AM MED ASSOC, V282, P113, DOI 10.1001/jama.282.2.113; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; SCHNEIDER JK, 1992, AM J HOSP PHARM, V49, P90, DOI 10.1093/ajhp/49.1.90; Sloss EM, 2000, J AM GERIATR SOC, V48, P363, DOI 10.1111/j.1532-5415.2000.tb04691.x; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; TAMBLYN RM, 1994, CAN MED ASSOC J, V150, P1801; Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741; Tseng CW, 2003, JAMA-J AM MED ASSOC, V290, P222, DOI 10.1001/jama.290.2.222; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	45	151	155	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2004	140	9					714	720		10.7326/0003-4819-140-9-200405040-00011	http://dx.doi.org/10.7326/0003-4819-140-9-200405040-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816XR	15126255				2022-12-01	WOS:000221143100005
J	Anderson, HR; Ruggles, R; Strachan, DP; Austin, JB; Burr, M; Jeffs, D; Standring, P; Steriu, A; Goulding, R				Anderson, HR; Ruggles, R; Strachan, DP; Austin, JB; Burr, M; Jeffs, D; Standring, P; Steriu, A; Goulding, R			Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12-14 year olds in the British Isles, 1995-2002: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							CHILDHOOD; ALLERGIES; ISAAC		St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England; Univ Aberdeen, Highlands & Isl Hlth Res Inst, Inverness IV2 3ED, Scotland; Univ Wales Coll Med, Dept Epidemiol State & PUbl Hlth, Cardiff CF14 4XN, S Glam, Wales; Board Hlth, St Martins GY4 6UU, Guernsey, England; Dept Hlth & Social Secur, Douglas IM1 3QA, Isle Of Man, England; Harvey Educ Ctr, St Helier JE1 3QZ, Jersey, England	St Georges University London; UHI Millennium Institute; University of Aberdeen; Cardiff University	Anderson, HR (corresponding author), St George Hosp, Sch Med, Dept Community Hlth Sci, London SW17 0RE, England.	r.anderson@sghms.ac.uk	Steriu, Andreea/AAQ-5127-2021; Anderson, Hugh R/A-7417-2016	Steriu, Andreea/0000-0002-2998-8644; 				ANDERSON HR, 2002, EFFECTIVE MANAGEMENT; Asher MI, 1998, EUR RESPIR J, V12, P315; Jeffs D, 2000, J R SOC PROMO HEALTH, V120, P236, DOI 10.1177/146642400012000411; Kaur B, 1998, BRIT MED J, V316, P118; MAN KGN, 2001, THORAX, V56, P312	5	136	139	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 1	2004	328	7447					1052	1053		10.1136/bmj.38057.583727.47	http://dx.doi.org/10.1136/bmj.38057.583727.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15028634	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000221174500018
J	Gloyn, AL; Pearson, ER; Antcliff, JF; Proks, P; Bruining, GJ; Slingerland, AS; Howard, N; Srinivasan, S; Silva, JMCL; Molnes, J; Edghill, EL; Frayling, TM; Temple, IK; Mackay, D; Shield, JPH; Sumnik, Z; van Rhijn, A; Wales, JKH; Clark, P; Gorman, S; Aisenberg, J; Ellard, S; Njolstad, PR; Ashcroft, FM; Hattersley, AT				Gloyn, AL; Pearson, ER; Antcliff, JF; Proks, P; Bruining, GJ; Slingerland, AS; Howard, N; Srinivasan, S; Silva, JMCL; Molnes, J; Edghill, EL; Frayling, TM; Temple, IK; Mackay, D; Shield, JPH; Sumnik, Z; van Rhijn, A; Wales, JKH; Clark, P; Gorman, S; Aisenberg, J; Ellard, S; Njolstad, PR; Ashcroft, FM; Hattersley, AT			Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLETE GLUCOKINASE DEFICIENCY; K-ATP; SULFONYLUREA RECEPTOR; E23K VARIANT; COMMON-CAUSE; IDENTIFICATION; OVERACTIVITY; ASSOCIATION; INHIBITION; SEQUENCE	BACKGROUND Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K-ATP) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K ATP channels was greatly reduced. CONCLUSIONS Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5AX, Devon, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Sophia Childrens Univ Hosp, Rotterdam, Netherlands; Childrens Hosp Westmead, Inst Endocrinol & Diabet, Westmead, NSW, Australia; Piaui State Univ, Sch Med, Teresina, Piaui, Brazil; Univ Bergen, Inst Clin Med & Mol Med, Bergen, Norway; Southampton Univ & Hosp, Wessex Clin Genet Serv, Natl Hlth Serv Trust, Southampton, Hants, England; Southampton Univ & Hosp, Div Human Genet, Natl Hlth Serv Trust, Southampton, Hants, England; Salisbury Dist Hosp, Wessex Reg Genet Labs, Salisbury, England; Royal Hosp Children, Bristol, Avon, England; Charles Univ, Dept Pediat 2, Prague, Czech Republic; Charles Univ, Fac Med 2, Prague, Czech Republic; Meander Med Ctr, Amersfoort, Netherlands; Sheffield Childrens Hosp, Acad Unit Child Hlth, Sheffield, S Yorkshire, England; Reg Endocrine Lab, Birmingham, W Midlands, England; St Lukes Hosp, Bradford BD5 0NA, W Yorkshire, England; Hackensack Univ, Med Ctr, Div Pediat Endocrinol & Diabet, Hackensack, NJ USA	University of Exeter; University of Oxford; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; University of Sydney; Universidade Estadual do Piaui (UESPI); University of Bergen; University of Southampton; University of Southampton; Salisbury District Hospital; Bristol Royal Hospital For Children; Charles University Prague; Charles University Prague; Meander Medisch Centrum; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Hackensack University Medical Center	Hattersley, AT (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Barrack Rd, Exeter EX2 5AX, Devon, England.	a.t.hattersley@ex.ac.uk	temple, isabel K/K-2391-2015; Shield, Julian PH/D-6297-2014; Mackay, Deborah JG/B-2879-2015; Wales, Jerry/A-6797-2011	Shield, Julian PH/0000-0003-2601-7575; Gloyn, Anna/0000-0003-1205-1844; Pearson, Ewan/0000-0001-9237-8585; Sumnik, Zdenek/0000-0002-6462-6462; Mackay, Deborah JG/0000-0003-3088-4401; Wales, Jerry/0000-0002-8769-648X; Hattersley, Andrew/0000-0001-5620-473X; Temple, Isabel Karen/0000-0002-6045-1781; Ellard, Sian/0000-0002-7620-5526; Proks, Peter/0000-0001-6097-3646				Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Frayling TM, 2003, DIABETES, V52, P872, DOI 10.2337/diabetes.52.3.872; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gloyn AL, 2002, DIABETOLOGIA, V45, P290, DOI 10.1007/s00125-001-0746-9; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hernandez-Sanchez C, 2001, P NATL ACAD SCI USA, V98, P3549, DOI 10.1073/pnas.051012898; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inoue H, 1997, DIABETES, V46, P502, DOI 10.2337/diabetes.46.3.502; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Nichols CG, 2002, AM J PHYSIOL-ENDOC M, V283, pE403, DOI 10.1152/ajpendo.00168.2002; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Njolstad PR, 2003, DIABETES, V52, P2854, DOI 10.2337/diabetes.52.11.2854; Novelli G, 2003, TRENDS MOL MED, V9, P370, DOI 10.1016/S1471-4914(03)00162-X; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Ribalet B, 2003, BIOPHYS J, V84, P266, DOI 10.1016/S0006-3495(03)74847-4; Riedel MJ, 2003, DIABETES, V52, P2630, DOI 10.2337/diabetes.52.10.2630; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Shield JPH, 2000, HORM RES, V53, P7, DOI 10.1159/000053198; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Temple IK, 2000, DIABETES, V49, P1359, DOI 10.2337/diabetes.49.8.1359; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Vaxillaire M, 2002, DIABETOLOGIA, V45, P454; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829	35	827	876	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1838	1849		10.1056/NEJMoa032922	http://dx.doi.org/10.1056/NEJMoa032922			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115830	Bronze, Green Accepted			2022-12-01	WOS:000221080300007
J	Wang, KLC; Yoshida, H; Lurin, C; Ecker, JR				Wang, KLC; Yoshida, H; Lurin, C; Ecker, JR			Regulation of ethylene gas biosynthesis by the Arabidopsis ETO1 protein	NATURE			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; UBIQUITIN LIGASES; RESPONSE PATHWAY; GENE FAMILY; KEY ENZYME; PHOSPHORYLATION; MUTATIONS; ADAPTERS; BTB/POZ; MUTANTS	Ethylene gas is used as a hormone by plants, in which it acts as a critical growth regulator. Its synthesis is also rapidly evoked in response to a variety of biotic and abiotic stresses(1,2). The Arabidopsis ethylene-overproducer mutants eto2 and eto3 have previously been identified as having mutations in two genes, ACS5 and ACS9, respectively; these encode isozymes of 1-aminocyclopropane-1- carboxylic acid synthase (ACS), which catalyse the rate-limiting step in ethylene biosynthesis(3,4). Here we report that another ethylene-overproducer mutation, eto1, is in a gene that negatively regulates ACS activity and ethylene production. The ETO1 protein directly interacts with and inhibits the enzyme activity of full-length ACS5 but not of a truncated form of the enzyme, resulting in a marked accumulation of ACS5 protein and ethylene. Overexpression of ETO1 inhibited induction of ethylene production by the plant growth regulator cytokinin, and promoted ACS5 degradation by a proteasome-dependent pathway. ETO1 also interacts with CUL3, a constituent of ubiquitin ligase complexes in which we propose that ETO1 serves as a substrate-specific adaptor protein. ETO1 thus has a dual mechanism, inhibiting ACS enzyme activity and targeting it for protein degradation. This permits rapid modulation of the concentration of ethylene.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	Salk Institute; University of Pennsylvania	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	/AAD-1735-2020; Ecker, Joseph R/B-9144-2008	/0000-0003-3516-4438; Ecker, Joseph R/0000-0001-5799-5895				Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Capitani G, 1999, J MOL BIOL, V294, P745, DOI 10.1006/jmbi.1999.3255; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kobe B, 1999, NATURE, V402, P373, DOI 10.1038/46478; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; ROMAN G, 1995, GENETICS, V139, P1393; SPANU P, 1994, PLANT PHYSIOL, V106, P529, DOI 10.1104/pp.106.2.529; Tarun AS, 1998, J BIOL CHEM, V273, P12509, DOI 10.1074/jbc.273.20.12509; Tarun AS, 1998, P NATL ACAD SCI USA, V95, P9796, DOI 10.1073/pnas.95.17.9796; Tatsuki M, 2001, J BIOL CHEM, V276, P28051, DOI 10.1074/jbc.M101543200; Tsuchisaka A, 2004, P NATL ACAD SCI USA, V101, P2275, DOI 10.1073/pnas.0308515101; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103	30	294	326	8	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					945	950		10.1038/nature02516	http://dx.doi.org/10.1038/nature02516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118728				2022-12-01	WOS:000221083000042
J	Worobey, M; Santiago, ML; Keele, BF; Ndjango, JBN; Joy, JB; Labamall, BL; Dhed'a, BD; Rambaut, A; Sharp, PM; Shaw, GM; Hahn, BH				Worobey, M; Santiago, ML; Keele, BF; Ndjango, JBN; Joy, JB; Labamall, BL; Dhed'a, BD; Rambaut, A; Sharp, PM; Shaw, GM; Hahn, BH			Origin of AIDS - Contaminated polio vaccine theory refuted	NATURE			English	Editorial Material									Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; Univ Kisangani, Fac Med, Kisangani, DEM REP CONGO; Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1A6, Canada; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England	University of Arizona; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Simon Fraser University; University of Oxford; University of Nottingham	Worobey, M (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.	worobey@email.arizona.edu	Sharp, Paul/Y-3787-2019; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010; Rambaut, Andrew/B-2481-2009	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Rambaut, Andrew/0000-0003-4337-3707; Santiago, Mario L./0000-0001-7792-2706; Hahn, Beatrice/0000-0002-9400-9887; Joy, Jeffrey/0000-0002-7013-1482				Berry N, 2001, NATURE, V410, P1046, DOI 10.1038/35074176; Blancou P, 2001, NATURE, V410, P1045, DOI 10.1038/35074171; Butler D, 2004, NATURE, V428, P109, DOI 10.1038/428109b; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Hooper E., 1999, RIVER JOURNEY BACK S; Hooper E, 2003, ATTI CONVEGNI LINCEI, V187, P27; KORHER B, 2000, SCIENCE, V288, P1789; Plotkin SA, 2001, PHILOS T R SOC B, V356, P815, DOI 10.1098/rstb.2001.0861; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Santiago ML, 2003, J VIROL, V77, P2233, DOI 10.1128/JVI.77.3.2233-2242.2003; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Sharp PM, 2001, PHILOS T R SOC B, V356, P867, DOI 10.1098/rstb.2001.0863; Trivers R, 2000, NATURE, V404, P828, DOI 10.1038/35009190	13	60	64	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					820	820		10.1038/428820a	http://dx.doi.org/10.1038/428820a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103367	Bronze			2022-12-01	WOS:000220952300030
J	Choi, HK; Atkinson, K; Karlson, EW; Willett, W; Curhan, G				Choi, HK; Atkinson, K; Karlson, EW; Willett, W; Curhan, G			Alcohol intake and risk of incident gout in men: a prospective study	LANCET			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ADENINE-NUCLEOTIDE TURNOVER; CORONARY-HEART-DISEASE; URIC-ACID; CONSUMPTION; WOMEN; REPRODUCIBILITY; HYPERURICEMIA; ACTIVATION; METABOLISM		Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Rheumatol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Choi, HK (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Rheumatol Unit, Bulfinch 165,55 Fruit St, Boston, MA 02114 USA.	hchoi@partners.org			NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NIDDK NIH HHS [DK58573] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; Becker C, 2001, EUR J NUTR, V40, P1, DOI 10.1007/PL00007380; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Curhan GC, 1998, ANN INTERN MED, V128, P534, DOI 10.7326/0003-4819-128-7-199804010-00003; Djousse L, 2002, STROKE, V33, P907, DOI 10.1161/hs0402.105245; DRUM DE, 1981, ARCH INTERN MED, V141, P477, DOI 10.1001/archinte.141.4.477; EASTMOND CJ, 1995, BRIT J RHEUMATOL, V34, P756; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Fam AG, 2002, J RHEUMATOL, V29, P1350; GIBSON T, 1984, BRIT J RHEUMATOL, V23, P203; Gibson T, 1977, Adv Exp Med Biol, V76B, P46; GIBSON T, 1983, ANN RHEUM DIS, V42, P123, DOI 10.1136/ard.42.2.123; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; MACHLACHLAN MJ, 1967, AM J MED, V42, P38; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; *NUTR DAT LAB, 1999, USDA NUTR DAT STAND; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Shadick NA, 2000, J RHEUMATOL, V27, P1708; SHARPE CR, 1984, CAN MED ASSOC J, V131, P563; VANDENBERG MK, 1994, J RHEUMATOL, V21, P700; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WHITEHEAD TP, 1978, LANCET, V1, P978; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; YU TF, 1957, P SOC EXP BIOL MED, V96, P809	30	448	494	4	66	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 17	2004	363	9417					1277	1281		10.1016/S0140-6736(04)16000-5	http://dx.doi.org/10.1016/S0140-6736(04)16000-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094272				2022-12-01	WOS:000220904900009
J	Agashe, VR; Guha, S; Chang, HC; Genevaux, P; Hayer-Hartl, M; Stemp, M; Georgopoulos, C; Hartl, FU; Barral, JM				Agashe, VR; Guha, S; Chang, HC; Genevaux, P; Hayer-Hartl, M; Stemp, M; Georgopoulos, C; Hartl, FU; Barral, JM			Function of trigger factor and DnaK in multidomain protein folding: Increase in yield at the expense of folding speed	CELL			English	Article							NASCENT POLYPEPTIDE-CHAINS; NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; BETA-GALACTOSIDASE; FIREFLY LUCIFERASE; LIVING CELLS; IN-VIVO; HSP70; RIBOSOME	Trigger factor and DnaK protect nascent protein chains from misfolding and aggregation in the E. coli cytosol, but how these chaperones affect the mechanism of de novo protein folding is not yet understood. Upon expression under chaperone-depleted conditions, multidomain proteins such as bacterial beta-galactosidase (beta-gal) and eukaryotic luciferase fold by a rapid but inefficient default pathway, tightly coupled to translation. Trigger factor and DnaK improve the folding yield of these proteins but markedly delay the folding process both in vivo and in vitro. This effect requires the dynamic recruitment of additional trigger factor molecules to translating ribosomes. While beta-galactosidase uses this chaperone mechanism effectively, luciferase folding in E. coli remains inefficient. The efficient co-translational domain folding of luciferase observed in the eukaryotic system is not compatible with the bacterial chaperone system. These findings suggest important differences in the coupling of translation and folding between bacterial and eukaryotic cells.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Ctr Med Univ Geneva, Dept Biochim Med, CH-1211 Geneva, Switzerland	Max Planck Society; University of Geneva	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Genevaux, Pierre/A-4851-2015; Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; GENEVAUX, Pierre/0000-0001-7539-3126; zhang, hong jun/0000-0003-0030-8323				Ausubel F.M., 2003, CURRENT PROTOCOLS MO; Ayling A, 1996, PROTEIN SCI, V5, P478; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bremer H, 1996, ESCHERICHIA COLI SAL, P1553; Buchberger A, 1996, J MOL BIOL, V261, P328, DOI 10.1006/jmbi.1996.0465; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Castanie HP, 1997, ANAL BIOCHEM, V254, P150, DOI 10.1006/abio.1997.2423; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Herbst R, 1997, J BIOL CHEM, V272, P7099, DOI 10.1074/jbc.272.11.7099; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; KOLB VA, 1994, EMBO J, V13, P3631, DOI 10.1002/j.1460-2075.1994.tb06670.x; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Nichtl A, 1998, J MOL BIOL, V282, P1083, DOI 10.1006/jmbi.1998.2075; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; SANCHEZ IE, 2004, IN PRESS J MOL BIOL; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x	38	165	170	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					199	209		10.1016/S0092-8674(04)00299-5	http://dx.doi.org/10.1016/S0092-8674(04)00299-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084258	hybrid			2022-12-01	WOS:000220913400008
J	Stephenson, J; Obasi, A				Stephenson, J; Obasi, A			HIV risk-reduction in adolescents	LANCET			English	Editorial Material							RURAL UGANDA; SEXUAL RISK; PREVENTION; INTERVENTIONS; BEHAVIOR; TRANSMISSION; TRIALS		UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England; London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; UCL Medical School; University of London; London School of Hygiene & Tropical Medicine	Stephenson, J (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England.	jstephen@gum.ucl.ac.uk	Obasi, Angela/AAK-4395-2021	Obasi, Angela/0000-0001-6801-8889				Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chesney MA, 2003, AM J PUBLIC HEALTH, V93, P933, DOI 10.2105/AJPH.93.6.933; Cowan FM, 2002, AIDS, V16, P1673, DOI 10.1097/00002030-200208160-00013; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; GRUNSEIT A, 1997, UNAIDS 97 GEN UNAIDS; Hawkes S, 2000, TROP MED INT HEALTH, V5, pA37, DOI 10.1046/j.1365-3156.2000.00594.x; Johnson BT, 2003, ARCH PEDIAT ADOL MED, V157, P381, DOI 10.1001/archpedi.157.4.381; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Mullen PD, 2002, J ACQ IMMUN DEF SYND, V30, pS94, DOI 10.1097/01.QAI.0000019980.12814.DF; OBASI A, 1997, 12 M INT SOC SEX TRA, pS44; Stephenson JM, 2000, AIDS, V14, pS115; *UNAIDS, 2000, UNAIDS0013E	13	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1177	1178		10.1016/S0140-6736(04)15983-7	http://dx.doi.org/10.1016/S0140-6736(04)15983-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811BT	15081646				2022-12-01	WOS:000220748100004
J	Laitinen, T; Polvi, A; Rydman, P; Vendelin, J; Pulkkinen, V; Salmikangas, P; Makela, S; Rehn, M; Pirskanen, A; Rautanen, A; Zucchelli, M; Gullsten, H; Leino, M; Alenius, H; Petays, T; Haahtela, T; Laitinen, A; Laprise, C; Hudson, TJ; Laitinen, LA; Kere, J				Laitinen, T; Polvi, A; Rydman, P; Vendelin, J; Pulkkinen, V; Salmikangas, P; Makela, S; Rehn, M; Pirskanen, A; Rautanen, A; Zucchelli, M; Gullsten, H; Leino, M; Alenius, H; Petays, T; Haahtela, T; Laitinen, A; Laprise, C; Hudson, TJ; Laitinen, LA; Kere, J			Characterization of a common susceptibility locus for asthma-related traits	SCIENCE			English	Article							BRONCHIAL HYPERRESPONSIVENESS; LINKAGE DISEQUILIBRIUM; POSITIONAL CLONING; GENE	Susceptibility to asthma depends on variation at an unknown number of genetic loci. To identify susceptibility genes on chromosome 7p, we adopted a hierarchical genotyping design, leading to the identification of a 133-kilobase risk-conferring segment containing two genes. One of these coded for an orphan G protein coupled receptor named GPRA ( G protein - coupled receptor for asthma susceptibility), which showed distinct distribution of protein isoforms between bronchial biopsies from healthy and asthmatic individuals. In three cohorts from Finland and Canada, single nucleotide polymorphism - tagged haplotypes associated with high serum immunoglobulin E or asthma. The murine ortholog of GPRA was up-regulated in a mouse model of ovalbumin-induced inflammation. Together, these data implicate GPRA in the pathogenesis of atopy and asthma.	Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; GeneOS Ltd, Helsinki 00251, Finland; Univ Helsinki, Biomedicum, Dept Anat, FIN-00014 Helsinki, Finland; Univ Helsinki, Finnish Genome Ctr, FIN-00014 Helsinki, Finland; Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden; Karolinska Inst, Clin Res Ctr, S-14157 Huddinge, Sweden; Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Helsinki 00251, Finland; Univ Helsinki, Cent Hosp, Dept Allergol Dis, Helsinki 00029, Finland; Univ Helsinki, Cent Hosp, Dept Med, Helsinki 00029, Finland; Univ Quebec, Community Gen Med Ctr, Chicoutimi, PQ G7H 2B1, Canada; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada	University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Quebec; University of Quebec Chicoutimi; McGill University	Kere, J (corresponding author), Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland.	juha.kere@biosci.ki.se	Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Alenius, Harri/0000-0003-0106-8923; Laprise, Catherine/0000-0001-5526-9945				Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Illig Thomas, 2002, Paediatr Respir Rev, V3, P47, DOI 10.1053/prrv.2002.0185; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/ng0501-87; Leaves NI, 2002, EUR J HUM GENET, V10, P177, DOI 10.1038/sj.ejhg.5200787; Norio R, 2003, HUM GENET, V112, P441, DOI 10.1007/s00439-002-0875-3; PULKKINEN V, UNPUB; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	14	341	365	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					300	304		10.1126/science.1090010	http://dx.doi.org/10.1126/science.1090010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073379				2022-12-01	WOS:000220719400050
J	Muller, UK; Kranenbarg, S				Muller, UK; Kranenbarg, S			Power at the tip of the tongue	SCIENCE			English	Editorial Material									Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands	Wageningen University & Research	Muller, UK (corresponding author), Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	ulrike.muller@wur.nl						Askew GN, 2001, J EXP BIOL, V204, P3587; BIEWENER AA, 1988, J EXP BIOL, V140, P243; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; de Groot JH, 2004, P ROY SOC B-BIOL SCI, V271, P761, DOI 10.1098/rspb.2003.2637; Deban SM, 1997, NATURE, V389, P27, DOI 10.1038/37898	5	23	23	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					217	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073361				2022-12-01	WOS:000220719400027
J	Loizou, JI; El-Khamisy, SF; Zlatanou, A; Moore, DJ; Chan, DW; Qin, J; Sarno, S; Meggio, F; Pinna, LA; Caldecott, KW				Loizou, JI; El-Khamisy, SF; Zlatanou, A; Moore, DJ; Chan, DW; Qin, J; Sarno, S; Meggio, F; Pinna, LA; Caldecott, KW			The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks	CELL			English	Article							FHA DOMAIN; POLY(ADP-RIBOSE) POLYMERASE; XRCC1; PHOSPHORYLATION; DAMAGE; BETA; ATP; 4,5,6,7-TETRABROMOBENZOTRIAZOLE; REQUIREMENT; DISRUPTION	CK2 was the first protein kinase identified and is required for the proliferation and survival of mammalian cells. Here, we have identified an unanticipated role for CK2. We show that this essential protein kinase phosphorylates the scaffold protein XRCC1 and thereby enables the assembly and activity of DNA single-strand break repair protein complexes in vitro and at sites of chromosomal breakage. Moreover, we show that inhibiting XRCC1 phosphorylation by mutation of the CK2 phosphorylation sites or preventing CK2 activity using a highly specific inhibitor ablates the rapid repair of cellular DNA single-strand breaks by XRCC1. These data identify a direct role for CK2 in the repair of chromosomal DNA strand breaks and in maintaining genetic integrity.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Baylor Coll Med, Houston, TX 77030 USA; Univ Padua, I-35121 Padua, Italy; Venetian Inst Mol Med, I-35129 Padua, Italy	University of Sussex; Baylor College of Medicine; University of Padua; Veneto Institute Molecular Medicine	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd,Falmer, Brighton BN1 9RQ, E Sussex, England.	k.w.caldecott@sussex.ac.uk	Caldecott, Keith/S-4245-2019	Caldecott, Keith/0000-0003-4255-9016; Loizou, Joanna/0000-0003-1853-0424; , Sherif/0000-0003-2721-7763	Medical Research Council [G0001259] Funding Source: Medline; MRC [G0001259] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Barz T, 2003, J CELL SCI, V116, P1563, DOI 10.1242/jcs.00352; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Kadkhodayan S, 1996, SOMAT CELL MOLEC GEN, V22, P453, DOI 10.1007/BF02369437; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1976, ANAL BIOCHEM, V71, P583, DOI 10.1016/S0003-2697(76)80028-0; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Sarno S, 2002, PHARMACOL THERAPEUT, V93, P159, DOI 10.1016/S0163-7258(02)00185-7; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Thomas M C, 2000, BMC Nephrol, V1, P1, DOI 10.1186/1471-2369-1-1; THOMPSON LH, 1982, MUTAT RES, V95, P427, DOI 10.1016/0027-5107(82)90276-7; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Zhang XL, 1998, ANAL CHEM, V70, P2050, DOI 10.1021/ac971207m	45	267	281	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					17	28		10.1016/S0092-8674(04)00206-5	http://dx.doi.org/10.1016/S0092-8674(04)00206-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066279	Bronze			2022-12-01	WOS:000221500300005
J	Minokoshi, Y; Alquier, T; Furukawa, N; Kim, YB; Lee, A; Xue, BZ; Mu, J; Foufelle, F; Ferre, P; Birnbaum, MJ; Stuck, BJ; Kahn, BB				Minokoshi, Y; Alquier, T; Furukawa, N; Kim, YB; Lee, A; Xue, BZ; Mu, J; Foufelle, F; Ferre, P; Birnbaum, MJ; Stuck, BJ; Kahn, BB			AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; BODY-WEIGHT; GLUCOSE-PRODUCTION; GENE-EXPRESSION; MALONYL-COA; IN-VITRO; LEPTIN; NEURONS; INHIBITION	Obesity is an epidemic in Western society, and causes rapidly accelerating rates of type 2 diabetes and cardiovascular disease. The evolutionarily conserved serine/threonine kinase, AMP-activated protein kinase (AMPK), functions as a 'fuel gauge' to monitor cellular energy status(1). We investigated the potential role of AMPK in the hypothalamus in the regulation of food intake. Here we report that AMPK activity is inhibited in arcuate and paraventricular hypothalamus (PVH) by the anorexigenic hormone leptin, and in multiple hypothalamic regions by insulin, high glucose and refeeding. A melanocortin receptor agonist, a potent anorexigen(2), decreases AMPK activity in PVH, whereas agouti-related protein, an orexigen(2), increases AMPK activity. Melanocortin receptor signalling is required for leptin and refeeding effects on AMPK in PVH. Dominant negative AMPK expression in the hypothalamus is sufficient to reduce food intake and body weight, whereas constitutively active AMPK increases both. Alterations of hypothalamic AMPK activity augment changes in arcuate neuropeptide expression induced by fasting and feeding. Furthermore, inhibition of hypothalamic AMPK is necessary for leptin's effects on food intake and body weight, as constitutively active AMPK blocks these effects. Thus, hypothalamic AMPK plays a critical role in hormonal and nutrient-derived anorexigenic and orexigenic signals and in energy balance.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Cox Inst, Philadelphia, PA 19104 USA; Ctr REch Biomed Cordeliers, INSERM, U465, F-75270 Paris 6, France	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Alquier, Thierry/Z-1917-2019; Ferré, Pascal/K-1250-2013	Alquier, Thierry/0000-0001-8171-802X; Ferré, Pascal/0000-0003-0115-7045; Birnbaum, Morris/0000-0001-9972-8680; Minokoshi, Yasuhiko/0000-0002-7119-4805; FOUFELLE, Fabienne/0000-0002-0752-622X; Mu, James/0000-0001-8081-2401				Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Levin BE, 2001, INT J OBESITY, V25, pS68, DOI 10.1038/sj.ijo.0801916; Light PE, 2003, CIRCULATION, V107, P1962, DOI 10.1161/01.CIR.0000069269.60167.02; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Xavier GD, 2003, BIOCHEM J, V371, P761; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885	31	1246	1304	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					569	574		10.1038/nature02440	http://dx.doi.org/10.1038/nature02440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15058305				2022-12-01	WOS:000220540100044
J	Webster, MA; Kaping, D; Mizokami, Y; Duhamel, P				Webster, MA; Kaping, D; Mizokami, Y; Duhamel, P			Adaptation to natural facial categories	NATURE			English	Article							FACE RECOGNITION; PERCEPTION; EXPRESSIONS; MECHANISMS; RACE	Face perception is fundamentally important for judging the characteristics of individuals, such as identification of their gender, age, ethnicity or expression. We asked how the perception of these characteristics is influenced by the set of faces that observers are exposed to. Previous studies have shown that the appearance of a face can be biased strongly after viewing an altered image of the face, and have suggested that these aftereffects reflect response changes in the neural mechanisms underlying object or face perception(1-5). Here we show that these adaptation effects are pronounced for natural variations in faces and for natural categorical judgements about faces. This suggests that adaptation may routinely influence face perception in normal viewing, and could have an important role in calibrating properties of face perception according to the subset of faces populating an individual's environment.	Univ Nevada, Dept Psychol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Webster, MA (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.	mwebster@unr.nevada.edu	Mizokami, Yoko/R-6982-2016	Mizokami, Yoko/0000-0001-7678-5463; Webster, Michael/0000-0001-8262-7525	NATIONAL EYE INSTITUTE [R01EY010834] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010834] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037/0033-2909.115.2.268; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Furl N, 2002, COGNITIVE SCI, V26, P797, DOI 10.1016/S0364-0213(02)00084-8; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Matsumoto D., 1988, JAPANESE CAUCASIAN F; McKone E, 2001, J EXP PSYCHOL HUMAN, V27, P573, DOI 10.1037/0096-1523.27.3.573; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6; Zhao L, 2001, VISION RES, V41, P2979, DOI 10.1016/S0042-6989(01)00202-4	18	485	491	1	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2004	428	6982					557	561		10.1038/nature02420	http://dx.doi.org/10.1038/nature02420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	807ZT	15058304				2022-12-01	WOS:000220540100041
J	Tomari, Y; Du, TT; Haley, B; Schwarz, DS; Bennett, R; Cook, HA; Koppetsch, BS; Theurkauf, WE; Zamore, PD				Tomari, Y; Du, TT; Haley, B; Schwarz, DS; Bennett, R; Cook, HA; Koppetsch, BS; Theurkauf, WE; Zamore, PD			RISC assembly defects in the Drosophila RNAi mutant armitage	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; GENETIC INTERFERENCE; MEIOTIC DRIVE; GERM-LINE; C-ELEGANS; TRANSGENE; HELICASE; INITIATION; EXPRESSION	The putative RNA helicase, Armitage (Armi), is required to repress oskar translation in Drosophila oocytes; armi mutant females are sterile and armi mutations disrupt anteroposterior and dorsoventral patterning. Here, we show that armi is required for FINAL armi mutant male germ cells fail to silence Stellate, a gene regulated endogenously by RNAi, and lysates from armi mutant ovaries are defective for RNAi in vitro. Native gel analysis of protein-siRNA complexes in wild-type and armi mutant ovary lysates suggests that armi mutants support early steps in the RNAi pathway but are defective in the production of active RNA-induced silencing complex (RISC), which mediates target RNA destruction in RNAi. Our results suggest that armi is required for RISC maturation.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	william.theurkauf@umassmed.edu; phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Tomari, Yukihide/A-8009-2009	Tomari, Yukihide/0000-0001-8442-0851; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862, R01GM065236] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62862-01, GM65236-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Belloni M, 2002, GENETICS, V161, P1551; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Boutla A, 2001, CURR BIOL, V11, P1776, DOI 10.1016/S0960-9822(01)00541-3; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Celotto AM, 2002, RNA, V8, P718, DOI 10.1017/S1355838202021064; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gvozdev VA, 2003, GENETICA, V117, P239, DOI 10.1023/A:1022952315467; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jorgensen Richard A., 2003, P5; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Schmidt A, 1999, GENETICS, V151, P749; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	68	302	333	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					831	841		10.1016/S0092-8674(04)00218-1	http://dx.doi.org/10.1016/S0092-8674(04)00218-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035985	Bronze			2022-12-01	WOS:000221499900009
J	Murakami, A; Miyashita, H; Iseki, M; Adachi, K; Mimuro, M				Murakami, A; Miyashita, H; Iseki, M; Adachi, K; Mimuro, M			Chlorophyll d in an epiphytic cyanobacterium of red algae	SCIENCE			English	Article									Kobe Univ, Res Ctr Inland Seas, Awaji, Hyogo 6562401, Japan; Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; Kyoto Univ, Dept Technol & Ecol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Marine Biotechnol Inst, Kamaishi, Iwate 0260001, Japan	Kobe University; Kobe University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Murakami, A (corresponding author), Kobe Univ, Res Ctr Inland Seas, Awaji, Hyogo 6562401, Japan.	akiomura@kobe-u.ac.jp						[Anonymous], 2002, PHOTOSYNTHETICA; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; ESTIGNEEV VB, 1970, BIOCHEMISTRY-US, V35, P48; HOLT A. STANLEY, 1961, CANADIAN JOUR BOT, V39, P327; HOLT AS, 1959, CAN J CHEM, V37, P507, DOI 10.1139/v59-069; LEY RE, 1999, PHYCOLOGY; Manning WM, 1943, J BIOL CHEM, V151, P1; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Strain HH, 1958, CHLOROPLAST PIGMENTS	9	121	129	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1633	1633		10.1126/science.1095459	http://dx.doi.org/10.1126/science.1095459			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15016990				2022-12-01	WOS:000220151400033
J	Bashir, T; Dorrello, NV; Amador, V; Guardavaccaro, D; Pagano, M				Bashir, T; Dorrello, NV; Amador, V; Guardavaccaro, D; Pagano, M			Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/C-Cdh1 ubiquitin ligase	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; BOX PROTEIN SKP2; CELL-CYCLE; DEGRADATION; BINDING; UBIQUITYLATION; PROGRESSION; MITOSIS	Skp2 and its cofactor Cks1 are the substrate-targeting subunits of the SCFSkp2-Cks1 (Skp1/Cul1/F-box protein) ubiquitin ligase complex that regulates entry into S phase by inducing the degradation of the cyclin-dependent kinase inhibitors p21 and p27 (ref. 1). Skp2 is an oncoprotein that often shows increased expression in human cancers(2); however, the mechanism that regulates its cellular abundance is not well understood. Here we show that both Skp2 and Cks1 proteins are unstable in G1 and that their degradation is mediated by the ubiquitin ligase APC/C-Cdh1 (anaphase-promoting complex/cyclosome and its activator Cdh1). Silencing of Cdh1 by RNA interference in G1 cells stabilizes Skp2 and Cks1, with a consequent increase in p21 and p27 proteolysis. Depletion of Cdh1 also increases the percentage of cells in S phase, whereas concomitant downregulation of Skp2 reverses this effect, showing that Skp2 is an essential target of APC/C-Cdh1. Expression of a stable Skp2 mutant that cannot bind APC/C-Cdh1 induces premature entry into S phase. Thus, the induction of Skp2 and Cks1 degradation in G1 represents a principal mechanism by which APC/C-Cdh1 prevents the unscheduled degradation of SCFSkp2-Cks1 substrates and maintains the G1 state.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Inst Canc, New York, NY 10016 USA	New York University; New York University	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, MSB 599,550 1st Ave, New York, NY 10016 USA.	michele.pagano@med.nyu.edu		pagano, michele/0000-0003-3210-2442; Guardavaccaro, Daniele/0000-0002-4517-1765				Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Sudakin V, 1997, J BIOL CHEM, V272, P18051, DOI 10.1074/jbc.272.29.18051; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362	12	395	408	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					190	193		10.1038/nature02330	http://dx.doi.org/10.1038/nature02330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014502				2022-12-01	WOS:000220103600051
J	Bejerano, G; Pheasant, M; Makunin, I; Stephen, S; Kent, WJ; Mattick, JS; Haussler, D				Bejerano, G; Pheasant, M; Makunin, I; Stephen, S; Kent, WJ; Mattick, JS; Haussler, D			Ultraconserved elements in the human genome	SCIENCE			English	Article							CONSERVED SEQUENCES; REGULATORY ELEMENTS; NONCODING SEQUENCES; GENE; MOUSE; HUMAN-CHROMOSOME-21; IDENTIFICATION; EVOLUTION; RNA; INTRONS	There are 481 segments longer than 200 base pairs (bp) that are absolutely conserved (100% identity with no insertions or deletions) between orthologous regions of the human, rat, and mouse genomes. Nearly all of these segments are also conserved in the chicken and dog genomes, with an average of 95 and 99% identity, respectively. Many are also significantly conserved in fish. These ultraconserved elements of the human genome are most often located either overlapping exons in genes involved in RNA processing or in introns or nearby genes involved in the regulation of transcription and development. Along with more than 5000 sequences of over 100 bp that are absolutely conserved among the three sequenced mammals, these represent a class of genetic elements whose functions and evolutionary origins are yet to be determined, but which are more highly conserved between these species than are proteins and appear to be essential for the ontogeny of mammals and other vertebrates.	Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Queensland, Inst Mol Biosci, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of Queensland	Bejerano, G (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	jill@soe.ucsc.edu; haussler@soe.ucsc.edu	Pheasant, Michael/A-7564-2008; Mattick, John S/I-7789-2012; Makunin, Igor V/A-1306-2008; Stuart, Stephen/I-3380-2012; Mattick, John/ABH-6130-2020	Pheasant, Michael/0000-0001-9781-7655; Mattick, John S/0000-0002-7680-7527; Stuart, Stephen/0000-0001-5141-640X; Mattick, John/0000-0002-7680-7527	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG002371] Funding Source: NIH RePORTER; NHGRI NIH HHS [1P41HG02371] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEJERANO G, IN PRESS BIOINFORM S; BOFFELI D, IN PRESS NATURE REV; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Frazer KA, 2004, GENOME RES, V14, P367, DOI 10.1101/gr.1961204; Frazer KA, 2001, GENOME RES, V11, P1651, DOI 10.1101/gr.198201; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; PLAZA S, 1995, MOL CELL BIOL, V15, P892; Rahman L, 2004, GENOMICS, V83, P76, DOI 10.1016/S0888-7543(03)00207-6; ROSKIN KM, 2003, P 7 ANN INT C RES CO, P257, DOI DOI 10.1145/640075.640109; SABARINADH C, 2003, GENOME BIOL, V4; Sherr EH, 2003, CURR OPIN PEDIATR, V15, P567, DOI 10.1097/00008480-200312000-00004; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0	37	1169	1262	1	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1321	1325		10.1126/science.1098119	http://dx.doi.org/10.1126/science.1098119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15131266	Green Submitted			2022-12-01	WOS:000221669600054
J	Ingelfinger, JR				Ingelfinger, JR			Pediatric antecedents of adult cardiovascular disease - Awareness and intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 1987, PEDIATRICS, V79, P1; BLUMENTHAL S, 1977, PEDIATRICS, V59, P797; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Falkner B, 1996, PEDIATRICS, V98, P649	4	51	54	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2004	350	21					2123	2126		10.1056/NEJMp048069	http://dx.doi.org/10.1056/NEJMp048069			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821XM	15152057				2022-12-01	WOS:000221496700003
J	Heymann, DL; Aylward, RB; Wolff, C				Heymann, DL; Aylward, RB; Wolff, C			Dangerous pathogens in the laboratory: from smallpox to today's SARS setbacks and tomorrow's polio-free world	LANCET			English	Editorial Material							CERTIFICATION		WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	World Health Organization	Heymann, DL (corresponding author), WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland.	heymannd@who.int						DOWDLE W, 2003, B WORLD HEALTH ORGAN, V82, P59; Fenner F., 1988, SMALLPOX ITS ERADICA; Fine PEM, 2004, B WORLD HEALTH ORGAN, V82, P47; Mulders MN, 1997, J INFECT DIS, V176, P617, DOI 10.1086/514081; *SARS, 2003, SARS SING UPD, V2; Sutter RW, 2004, B WORLD HEALTH ORGAN, V82, P31; *WHO, 2003, SEV AC RESP SYNDR TA; *WHO, WHOVB0311; *WHO, 2004, SARS CHIN UPD, V6; *WHO, 2003, REP INF CONS ID MAN; *WHO, CHIN CONF SARS INF P; World Health Organization, 2003, WHO POST BIOS GUID H; World Health Organization, 2003, WHO BIOS GUID HANDL; World Health Organization, 2003, GUID SAF PROD QUAL C	14	28	28	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 15	2004	363	9421					1566	1568		10.1016/S0140-6736(04)16234-X	http://dx.doi.org/10.1016/S0140-6736(04)16234-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	820SE	15145625	Bronze, Green Published			2022-12-01	WOS:000221408800002
J	Ferguson, NM; Fraser, C; Donnelly, CA; Ghani, AC; Anderson, RM				Ferguson, NM; Fraser, C; Donnelly, CA; Ghani, AC; Anderson, RM			Public health risk from the avian H5N1 influenza epidemic	SCIENCE			English	Editorial Material							EMERGENCE		Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Ghani, Azra/0000-0002-0007-4910; Anderson, Roy/0000-0002-9528-3175; Donnelly, Christl/0000-0002-0195-2463				Abbott A, 2004, NATURE, V427, P472, DOI 10.1038/427472a; ANDERSON R M, 1991; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P350; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Cox NJ, 2003, VACCINE, V21, P1801, DOI 10.1016/S0264-410X(03)00076-8; De Serres G, 2000, AM J EPIDEMIOL, V151, P1039, DOI 10.1093/oxfordjournals.aje.a010145; Farrington CP, 2003, BIOSTATISTICS, V4, P279, DOI 10.1093/biostatistics/4.2.279; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997	14	122	130	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					968	969		10.1126/science.1096898	http://dx.doi.org/10.1126/science.1096898			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143265				2022-12-01	WOS:000221383300030
J	Prigge, ST; Eipper, BA; Mains, RE; Amzel, LM				Prigge, ST; Eipper, BA; Mains, RE; Amzel, LM			Dioxygen binds end-on to mononuclear copper in a precatalytic enzyme complex	SCIENCE			English	Article							ALPHA-HYDROXYLATING MONOOXYGENASE; ACTIVE-SITE COPPER; PEPTIDYLGLYCINE MONOOXYGENASE; PEPTIDE AMIDATION; ELECTRON-TRANSFER; OXYGEN ACTIVATION; MECHANISM; REACTIVITY; SUBSTRATE; BIOACTIVITY	Copper active sites play a major role in enzymatic activation of dioxygen. We trapped the copper-dioxygen complex in the enzyme peptidylglycine-alpha-hydroxylating monooxygenase (PHM) by freezing protein crystals that had been soaked with a slow substrate and ascorbate in the presence of oxygen. The x-ray crystal structure of this precatalytic complex, determined to 1.85-angstrom resolution, shows that oxygen binds to one of the coppers in the enzyme with an end-on geometry. Given this structure, it is likely that dioxygen is directly involved in the electron transfer and hydrogen abstraction steps of the PHM reaction. These insights may apply to other copper oxygen-activating enzymes, such as dopamine beta-monooxygenase, and to the design of biomimetic complexes.	Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21218 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Connecticut	Amzel, LM (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21218 USA.	Mario@neruda.med.jhmi.edu	Prigge, Sean/GVS-9197-2022	Prigge, Sean/0000-0001-9684-1733; Amzel, L. Mario/0000-0002-0129-9572	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032949, R01DK032949, R56DK032949] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32949] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aboelella NW, 2002, J AM CHEM SOC, V124, P10660, DOI 10.1021/ja027164v; Bell J, 2003, BIOCHEMISTRY-US, V42, P7133, DOI 10.1021/bi034247v; Berreau LM, 1996, INORG CHEM, V35, P6339, DOI 10.1021/ic960340e; Blackburn NJ, 2000, J BIOL INORG CHEM, V5, P341, DOI 10.1007/PL00010663; Boswell JS, 1996, BIOCHEMISTRY-US, V35, P12241, DOI 10.1021/bi960742y; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; Chaudhuri P, 1999, ANGEW CHEM INT EDIT, V38, P1095, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1095::AID-ANIE1095>3.0.CO;2-I; Chen P, 2003, J AM CHEM SOC, V125, P466, DOI 10.1021/ja020969i; Croft AK, 2003, J AM CHEM SOC, V125, P4119, DOI 10.1021/ja029674v; CUTTITTA F, 1993, ANAT REC, V236, P87, DOI 10.1002/ar.1092360112; EIPPER BA, 1995, BIOCHEMISTRY-US, V34, P2857, DOI 10.1021/bi00009a016; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Evans JP, 2003, J BIOL CHEM, V278, P49691, DOI 10.1074/jbc.M300797200; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Francisco WA, 2002, J AM CHEM SOC, V124, P8194, DOI 10.1021/ja025758s; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P8244, DOI 10.1021/bi973004y; Francisco WA, 2003, BIOCHEMISTRY-US, V42, P1813, DOI 10.1021/bi020592t; FREEMAN JC, 1993, J AM CHEM SOC, V115, P4923, DOI 10.1021/ja00064a077; FUJISAWA K, 1994, J AM CHEM SOC, V116, P12079, DOI 10.1021/ja00105a069; GUBELMANN MH, 1983, STRUCT BOND, V55, P1; HARATA M, 1994, J AM CHEM SOC, V116, P10817, DOI 10.1021/ja00102a070; Jaron S, 2001, BIOCHEMISTRY-US, V40, P6867, DOI 10.1021/bi002849y; Jaron S, 1999, BIOCHEMISTRY-US, V38, P15086, DOI 10.1021/bi991341w; Karlin KD, 1997, ACCOUNTS CHEM RES, V30, P139, DOI 10.1021/ar950257f; KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141; LANDYMORELIM AEN, 1983, BIOCHEM BIOPH RES CO, V117, P289, DOI 10.1016/0006-291X(83)91573-5; MERKLER DJ, 1994, ENZYME MICROB TECH, V16, P450, DOI 10.1016/0141-0229(94)90014-0; Ponce A, 2000, J AM CHEM SOC, V122, P8187, DOI 10.1021/ja000017h; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; PRIGGE ST, UNPUB; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Takahashi K, 1998, BIOCHEM J, V336, P131, DOI 10.1042/bj3360131; Tezcan FA, 2001, P NATL ACAD SCI USA, V98, P5002, DOI 10.1073/pnas.081072898; Tolman WB, 2001, CURR OPIN CHEM BIOL, V5, P188, DOI 10.1016/S1367-5931(00)00189-7; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Wilmot CM, 2003, BIOCHEM SOC T, V31, P493, DOI 10.1042/bst0310493	41	335	336	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					864	867		10.1126/science.1094583	http://dx.doi.org/10.1126/science.1094583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131304				2022-12-01	WOS:000221243000042
J	Ghosh, M; Song, XY; Mouneimne, G; Sidani, M; Lawrence, DS; Condeelis, JS				Ghosh, M; Song, XY; Mouneimne, G; Sidani, M; Lawrence, DS; Condeelis, JS			Cofilin promotes actin polymerization and defines the direction of cell motility	SCIENCE			English	Article							DEPOLYMERIZING FACTOR; ARP2/3 COMPLEX; LEADING-EDGE; LIM-KINASE; PHOSPHORYLATION; FILAMENTS; PROTEINS; OVEREXPRESSION; DICTYOSTELIUM; LOCALIZATION	A general caging method for proteins that are regulated by phosphorylation was used to study the in vivo biochemical action of cofilin and the subsequent cellular response. By acute and local activation of a chemically engineered, light-sensitive phosphocofilin mimic, we demonstrate that cofilin polymerizes actin, generates protrusions, and determines the direction of cell migration. We propose a role for cofilin that is distinct from its role as an actin-depolymerizing factor.	Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Condeelis, JS (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	condeeli@aecom.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061034, R01GM038511] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61034, GM38511] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE H, 1993, EXP CELL RES, V206, P1, DOI 10.1006/excr.1993.1113; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Aizawa H, 1996, J CELL BIOL, V132, P335, DOI 10.1083/jcb.132.3.335; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; CONDEELIS J, 2003, CELL MOTILITY MOL OR, P175; COX D, 1992, J CELL BIOL, V116, P943, DOI 10.1083/jcb.116.4.943; Cox D, 1996, MOL BIOL CELL, V7, P803, DOI 10.1091/mbc.7.5.803; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Ghosh M, 2002, J AM CHEM SOC, V124, P2440, DOI 10.1021/ja017592l; GHOSH M, UNPUB; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; MCKIM KS, 1994, MOL GEN GENET, V242, P346, DOI 10.1007/BF00280425; Meberg PJ, 2000, J NEUROSCI, V20, P2459; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; ONO S, 1993, J MUSCLE RES CELL M, V14, P195, DOI 10.1007/BF00115454; Roy P, 2001, J CELL BIOL, V153, P1035, DOI 10.1083/jcb.153.5.1035; Samstag Y, 1996, J IMMUNOL, V156, P4167; Shestakova EA, 1999, CANCER RES, V59, P1202; Soll DR, 1995, INT REV CYTOL, V163, P43; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	27	526	553	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					743	746		10.1126/science.1094561	http://dx.doi.org/10.1126/science.1094561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118165				2022-12-01	WOS:000221105300048
J	Plotkin, JB; Dushoff, J; Fraser, HB				Plotkin, JB; Dushoff, J; Fraser, HB			Detecting selection using a single genome sequence of M-tuberculosis and P-falciparum	NATURE			English	Article							NUCLEOTIDE SUBSTITUTION; EXPRESSION; EVOLUTION; PROTEINS; PATTERNS	Selective pressures on proteins are usually measured by comparing nucleotide sequences(1). Here we introduce a method to detect selection on the basis of a single genome sequence. We catalogue the relative strength of selection on each gene in the entire genomes of Mycobacterium tuberculosis and Plasmodium falciparum. Our analysis confirms that most antigens are under strong selection for amino-acid substitutions, particularly the PE/PPE family(2) of putative surface proteins in M. tuberculosis and the EMP1 family(3) of cytoadhering surface proteins in P. falciparum. We also identify many uncharacterized proteins that are under strong selection in each pathogen. We provide a genome-wide analysis of natural selection acting on different stages of an organism's life cycle: genes expressed in the ring stage(4) of P. falciparum are under stronger positive selection than those expressed in other stages of the parasite's life cycle. Our method of estimating selective pressures requires far fewer data than comparative sequence analysis, and it measures selection across an entire genome; the method can readily be applied to a large range of sequenced organisms.	Harvard Soc Fellows, Cambridge, MA 02138 USA; Bauer Ctr Gen Res, Cambridge, MA 02138 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California Berkeley	Plotkin, JB (corresponding author), Harvard Soc Fellows, 7 Divin Ave, Cambridge, MA 02138 USA.	jplotkin@fas.harvard.edu	Plotkin, Joshua B/E-6947-2013					Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Escalante AA, 1998, GENETICS, V149, P189; FELSENSTEIN J, 1981, BIOL J LINN SOC, V16, P183, DOI 10.1111/j.1095-8312.1981.tb01847.x; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gould SJ, 2002, STRUCTURE EVOLUTIONA; HUDSON RR, 1987, GENETICS, V116, P153; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lobry JR, 2002, GENOME BIOL, V3; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Skeiky YAW, 2000, J IMMUNOL, V165, P7140, DOI 10.4049/jimmunol.165.12.7140; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TAJIMA F, 1989, GENETICS, V123, P585; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745; Zuckerkandl E., 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477	30	73	76	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					942	945		10.1038/nature02458	http://dx.doi.org/10.1038/nature02458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118727	hybrid			2022-12-01	WOS:000221083000041
J	Siemens, J; Lillo, C; Dumont, RA; Reynolds, A; Williams, DS; Gillespie, PG; Muller, U				Siemens, J; Lillo, C; Dumont, RA; Reynolds, A; Williams, DS; Gillespie, PG; Muller, U			Cadherin 23 is a component of the tip link in hair-cell stereocilia	NATURE			English	Article							SYNDROME TYPE 1D; MECHANICAL TRANSDUCTION; CALCIUM CHELATION; INNER-EAR; ADAPTATION; CDH23; MUTATIONS; HARMONIN; ADHESION; ANTIGEN	Mechanoelectrical transduction, the conversion of mechanical force into electrochemical signals, underlies a range of sensory phenomena, including touch, hearing and balance. Hair cells of the vertebrate inner ear are specialized mechanosensors that transduce mechanical forces arising from sound waves and head movement to provide our senses of hearing and balance(1,2); however, the mechanotransduction channel of hair cells and the molecules that regulate channel activity have remained elusive. One molecule that might participate in mechanoelectrical transduction is cadherin 23 (CDH23), as mutations in its gene cause deafness and age-related hearing loss(3-6). Furthermore, CDH23 is large enough to be the tip link, the extracellular filament proposed to gate the mechanotransduction channel(7). Here we show that antibodies against CDH23 label the tip link, and that CDH23 has biochemical properties similar to those of the tip link. Moreover, CDH23 forms a complex with myosin-1c, the only known component of the mechanotransduction apparatus(8), suggesting that CDH23 and myosin-1c cooperate to regulate the activity of mechanically gated ion channels in hair cells.	Scripps Res Inst, Dept Cell Biol, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol & Neurosci, La Jolla, CA 92093 USA; Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Scripps Research Institute; University of California System; University of California San Diego; Oregon Health & Science University; Oregon Health & Science University	Muller, U (corresponding author), Scripps Res Inst, Dept Cell Biol, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA.	umueller@scripps.edu	Lillo, Concepcion/A-6321-2009	Lillo, Concepcion/0000-0001-5814-9826; Siemens, Jan/0000-0001-9051-9217; Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL EYE INSTITUTE [R01EY007042] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY007042, R01 EY007042-18] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; COREY DP, 1983, J NEUROSCI, V3, P962; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Furness DN, 2002, HEARING RES, V173, P10, DOI 10.1016/S0378-5955(02)00584-1; Garcia JA, 1998, J NEUROSCI, V18, P8637; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goodyear R, 1999, J NEUROSCI, V19, P3761; Goodyear RJ, 2003, J NEUROSCI, V23, P4878; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; LITTLE KF, 1985, CELL TISSUE RES, V242, P427; Muller U, 2001, TRENDS CELL BIOL, V11, P334, DOI 10.1016/S0962-8924(01)02046-3; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; OSBORNE MP, 1990, ACTA OTO-LARYNGOL, V110, P37, DOI 10.3109/00016489009122513; PICKLES JO, 1991, SCANNING MICROSCOPY, V5, P1115; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; SHEPHERD GMG, 1991, J GEN PHYSIOL, V98, pA25; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; SOLLNER C, 2004, NATURE          0331; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	29	330	349	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					950	955		10.1038/nature02483	http://dx.doi.org/10.1038/nature02483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15057245				2022-12-01	WOS:000221083000043
J	Han, X; Wang, CT; Bai, JH; Chapman, ER; Jackson, MB				Han, X; Wang, CT; Bai, JH; Chapman, ER; Jackson, MB			Transmembrane segments of syntaxin line the fusion pore of Ca2+-triggered exocytosis	SCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; KISS-AND-RUN; MEMBRANE-FUSION; VESICLE; SYNAPTOTAGMIN; HPC-1/SYNTAXIN; CONDUCTANCE; MODULATION; MECHANISMS; SECRETION	The fusion pore of regulated exocytosis is a channel that connects and spans the vesicle and plasma membranes. The molecular composition of this important intermediate structure of exocytosis is unknown. Here, we found that mutations of some residues within the transmembrane segment of syntaxin (Syx), a plasma membrane protein essential for exocytosis, altered neurotransmitter flux through fusion pores and altered pore conductance. The residues that influenced fusion-pore flux lay along one face of an alpha-helical model. Thus, the fusion pore is formed at least in part by a circular arrangement of 5 to 8 Syx transmembrane segments in the plasma membrane.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	mjackson@physiology.wisc.edu	Wang, Chih-Tien/GRE-8232-2022	Wang, Chih-Tien/0000-0001-7639-7508; Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030016, R01NS030016, R01NS044057] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56827] Funding Source: Medline; NIMH NIH HHS [MH61876] Funding Source: Medline; NINDS NIH HHS [NS44057, NS30016] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ALVAREZ DT, 1993, NATURE, V363, P554, DOI DOI 10.1038/363554A0; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colliver TL, 2000, J NEUROCHEM, V74, P1086; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hille B., 1992, ION CHANNELS EXCITAB; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; NEHER E, 1988, NEUROSCIENCE, V26, P727, DOI 10.1016/0306-4522(88)90094-2; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Suga K, 2003, J BIOCHEM, V133, P325, DOI 10.1093/jb/mvg044; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xia ZP, 2001, J BIOL CHEM, V276, P1766, DOI 10.1074/jbc.M008741200	30	253	260	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					289	292		10.1126/science.1095801	http://dx.doi.org/10.1126/science.1095801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15016962				2022-12-01	WOS:000220719400047
J	Wallace, GL; Treffert, DA				Wallace, GL; Treffert, DA			Head size and autism	LANCET			English	Editorial Material							CIRCUMFERENCE; DISORDER; CHILDREN; GROWTH; LIFE; AGE		NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; St Agnes Hosp, Fond Du Lac, WI USA; Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Wisconsin System; University of Wisconsin Madison	Wallace, GL (corresponding author), NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA.	gregwallace@mail.nih.gov	Wallace, Gregory/H-2158-2018; Wallace, Gregory/A-4789-2008	Wallace, Gregory/0000-0003-0329-5054; 				Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; BAILEY A, 1993, LANCET, V341, P1225, DOI 10.1016/0140-6736(93)91065-T; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Conciatori M, 2004, BIOL PSYCHIAT, V55, P413, DOI 10.1016/j.biopsych.2003.10.005; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; DeLong GR, 1999, NEUROLOGY, V52, P911, DOI 10.1212/WNL.52.5.911; Deutsch CK, 2003, J AUTISM DEV DISORD, V33, P209, DOI 10.1023/A:1022903913547; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Kanner L, 1943, NERV CHILD, V2, P217; Lainhart JE, 2003, JAMA-J AM MED ASSOC, V290, P393, DOI 10.1001/jama.290.3.393; Miles JH, 2000, AM J MED GENET, V95, P339, DOI 10.1002/1096-8628(20001211)95:4<339::AID-AJMG9>3.3.CO;2-2; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Stevenson RE, 1997, LANCET, V349, P1744, DOI 10.1016/S0140-6736(05)62956-X	14	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 27	2004	363	9414					1003	1004		10.1016/S0140-6736(04)15877-7	http://dx.doi.org/10.1016/S0140-6736(04)15877-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15051277				2022-12-01	WOS:000220497300003
J	Myers, RA; Levin, SA; Lande, R; James, FC; Murdoch, WW; Paine, RT				Myers, RA; Levin, SA; Lande, R; James, FC; Murdoch, WW; Paine, RT			Hatcheries and endangered salmon	SCIENCE			English	Editorial Material									Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA	Dalhousie University; Princeton University; University of California System; University of California San Diego; State University System of Florida; Florida State University; University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle	Myers, RA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	ransom.myers@dal.ca; slevin@princeton.edu; rlande@ucsd.edu; james@bio.fsu.edu; murdoch@lifesci.ucsb.edu; painert@u.washington.edu	Ebersole, Joseph L/A-8371-2009; Levin, Simon A/J-1218-2014	Levin, Simon A/0000-0002-8216-5639				Allendorf Fred W., 1996, P238; Einum Sigurd, 2001, Nordic Journal of Freshwater Research, V75, P56; Gibson A. J. F., 2003, 1123 FISH AQ SCI; HILBORN R, 1993, CAN J FISH AQUAT SCI, V50, P2043, DOI 10.1139/f93-228; LENT R, 2002, FED REGISTER, V67, P6215; LICHATWICH J, 1999, SALMON RIVERS; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; *NAT RES COUNC, 1996, UPSTR SALM SOC PAC; REISENBICHLER R, 2003, ASSESSING EXTINCTION, P147; Waples R.S., 1991, MAR FISH REV, V53, P11; Waples RS, 1999, FISHERIES, V24, P12, DOI 10.1577/1548-8446(1999)024<0012:DSMAH>2.0.CO;2	11	64	68	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2004	303	5666					1980	1980		10.1126/science.1095410	http://dx.doi.org/10.1126/science.1095410			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044790				2022-12-01	WOS:000220429800025
J	Niethammer, P; Bastiaens, P; Karsenti, E				Niethammer, P; Bastiaens, P; Karsenti, E			Stathmin-tubulin interaction gradients in motile and mitotic cells	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; SMALL G-PROTEINS; MICROTUBULE DYNAMICS; IN-VITRO; PHOSPHORYLATION; IDENTIFICATION; CHROMATIN; FAMILY; KINASE; RHO	The spatial organization of the microtubule cytoskeleton is thought to be directed by steady-state activity gradients of diffusible regulatory molecules. We visualized such intracellular gradients by monitoring the interaction between tubulin and a regulator of microtubule dynamics, stathmin, using a fluorescence resonance energy transfer (FRET) biosensor. These gradients were observed both during interphase in motile membrane protrusions and during mitosis around chromosomes, which suggests that a similar mechanism may contribute to the creation of polarized microtubule structures. These interaction patterns are likely to reflect phosphorylation of stathmin in these areas.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Bastiaens, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bastiaen@embl-heidelberg.de; karsenti@embl-heidelberg.de						Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; CHNEIWEISS H, 1992, J NEUROCHEM, V58, P282, DOI 10.1111/j.1471-4159.1992.tb09308.x; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; Drouva SV, 1998, ENDOCRINOLOGY, V139, P2235, DOI 10.1210/en.139.5.2235; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kuntziger T, 2001, J BIOL CHEM, V276, P22979, DOI 10.1074/jbc.M101466200; LEIGHTON IA, 1993, MOL CELL BIOCHEM, V128, P151, DOI 10.1007/BF01076766; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; SOBEL A, 1989, J BIOL CHEM, V264, P3765; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Stukenberg PT, 2003, CURR BIOL, V13, pR848, DOI 10.1016/j.cub.2003.10.020; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082	30	168	172	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2004	303	5665					1862	1866		10.1126/science.1094108	http://dx.doi.org/10.1126/science.1094108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	15031504				2022-12-01	WOS:000220281600054
J	Macpherson, AJ; Uhr, T				Macpherson, AJ; Uhr, T			Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria	SCIENCE			English	Article							RESPONSES; PHAGOCYTOSIS	The enormous number of commensal bacteria in the lower intestine of vertebrates share abundant molecular patterns used for innate immune recognition of pathogenic bacteria. We show that, even though commensals are rapidly killed by macrophages, intestinal dendritic cells (DCs) can retain small numbers of live commensals for several days. This allows DCs to selectively induce IgA, which helps protect against mucosal penetration by commensals. The commensal-loaded DCs are restricted to the mucosal immune compartment by the mesenteric lymph nodes, which ensures that immune responses to commensal bacteria are induced locally, without potentially damaging systemic immune responses.	Univ Spital Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Macpherson, AJ (corresponding author), Univ Spital Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland.	amacpher@pathol.unizh.ch	Eckhardt, Erik/G-1567-2010					Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2001, MICROBES INFECT, V3, P1021, DOI 10.1016/S1286-4579(01)01460-5; MACPHERSON AJ, UNPUB; Nagl M, 2002, CLIN DIAGN LAB IMMUN, V9, P1165, DOI 10.1128/CDLI.9.6.1165-1168.2002; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; POST LE, 1980, J BIOL CHEM, V255, P4653; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sansonetti P, 2001, SEMIN IMMUNOL, V13, P381, DOI 10.1006/smim.2001.0335; WELLS CL, 1988, REV INFECT DIS, V10, P958	15	1059	1156	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1662	1665		10.1126/science.1091334	http://dx.doi.org/10.1126/science.1091334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15016999				2022-12-01	WOS:000220151400042
J	Kirke, PN; Mills, JI; Molloy, AM; Brody, LC; O'Leary, VB; Daly, L; Murray, S; Conley, M; Mayne, PD; Smith, O; Scott, JM				Kirke, PN; Mills, JI; Molloy, AM; Brody, LC; O'Leary, VB; Daly, L; Murray, S; Conley, M; Mayne, PD; Smith, O; Scott, JM			Impact of the MHFR C677T polymorphism on risk of neural tube defects: case-control study	BRITISH MEDICAL JOURNAL			English	Article							5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; HOMOCYSTEINE		Hlth Res Board, Child Hlth Epidemiol Div, Dublin 2, Ireland; NICHHD, Div Epidemiol Stat & Prevent Res, NIH, Epidemiol Sect, Bethesda, MD 20892 USA; Univ Ireland Trinity Coll, St James Hosp, Dept Clin Med, Dublin 8, Ireland; NHGRI, Mol Pathogenesis Sect, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Natl Univ Ireland Univ Coll Dublin, Dept Epidemiol & Publ Hlth Med, Dublin 2, Ireland; Childrens Univ Hosp, Dublin 1, Ireland; Natl Ctr Hereditary Coagulat Disorders, Dublin 8, Ireland	Health Research Board - Ireland; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Trinity College Dublin; University College Dublin; Childrens University Hospital - Temple Street	Kirke, PN (corresponding author), Hlth Res Board, Child Hlth Epidemiol Div, Dublin 2, Ireland.	pkirke@hrb.ie	Smith, Owen/AAU-8929-2020	Mills, James/0000-0003-4496-332X; Molloy, Anne/0000-0002-1688-9049; O'Leary, Valerie/0000-0003-1171-9830	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023163, Z01HD002502] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000167] Funding Source: NIH RePORTER; NICHD NIH HHS [N0IHD 23163] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Johanning GL, 2000, J MED GENET, V37, P949, DOI 10.1136/jmg.37.12.949; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202	5	99	104	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 26	2004	328	7455					1535	1536		10.1136/bmj.38036.646030.EE	http://dx.doi.org/10.1136/bmj.38036.646030.EE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DV	15155469	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000222392700019
J	Luman, ET; Fiore, AE; Strine, TW; Barker, LE				Luman, ET; Fiore, AE; Strine, TW; Barker, LE			Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; IMMUNIZATION; CHILDREN; MERCURY; AGE	Context In July 1999, the longstanding preference to begin hepatitis B vaccination of all US infants at birth was temporarily suspended because of concerns about exposure to mercury contained in the vaccine preservative thimerosal. The suspension was lifted in September 1999 when preservative-free hepatitis B vaccine became available. Objective To determine the effects of changes in recommendations regarding administration of a hepatitis B birth dose on vaccination coverage. Design, Setting, and Participants Cohort analysis of vaccination status of 41589 US children born before, during, and after the recommendation to suspend the birth dose. Main Outcome Measures Association between birth cohort and age at receipt of hepatitis B vaccine dose 1, and receipt by 19 months of age of all recommended vaccines. Results The proportion of US infants who received dose 1 of hepatitis B vaccine at birth declined from 47% among those born 7 to 12 months before the suspension to 11% among those born during the suspension. Birth-dose coverage remained significantly lower in the year after the suspension was lifted (23% in the first 6 months and 33% in months 7-12). Coverage with 3 doses of hepatitis B vaccine by 19 months of age declined from 88% among those born 7 to 12 months before the suspension to 81% among those born during the suspension and 85% among those born in the 6 months after the suspension, but returned to baseline levels for those born 7 to 12 months after the suspension was lifted. These reductions represent 750000 fewer newborns vaccinated during 2000 compared with 1998, and an excess 182000 children undervaccinated for hepatitis B at 19 months of age compared with 1998 coverage levels. Coverage with other recommended vaccinations did not decline over this time. Conclusions' Reductions in hepatitis B vaccine birth-dose coverage persisted after recommendations were made to resume previous newborn vaccination practices. Although the recommendation to complete the series by 19 months of age was never changed, infants born between July and December 1999 were less likely to have completed the series by 19 months, compared with infants born during the previous year. The lack of impact on other vaccinations suggests that public confidence in immunization remained strong.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Univ, Sch Publ Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Luman, ET (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, 1600 Clifton Rd NE,Mail Stop E-62, Atlanta, GA 30333 USA.	ECL7@cdc.gov	Fiore, Anthony/AAO-8956-2020					[Anonymous], 1991, MMWR-MORBID MORTAL W, V40, P1; [Anonymous], [No title captured]; Armstrong GL, 2001, PEDIATRICS, V108, P1123, DOI 10.1542/peds.108.5.1123; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Barker L, 2002, MMWR Morb Mortal Wkly Rep, V51, P664; Beasley R.P., 1984, VIRAL HEPATITIS LIVE, P209; Biroscak BJ, 2003, PEDIATRICS, V111, pE645, DOI 10.1542/peds.111.6.e645; Brayden RM, 2001, J PEDIATR-US, V138, P752, DOI 10.1067/mpd.2001.112896; Cabana MD, 2002, AMBUL PEDIATR, V2, P367, DOI 10.1367/1539-4409(2002)002<0367:EOSVFS>2.0.CO;2; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P94; *CDCP, 2002, GUID VIR HEP SURV CA; *CDCP, 1996, MMWR-MORBID MORTAL W, V44, P940; *CDCP, 2001, VIT STAT US 1999, V1; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P563; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P19; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1007; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P829; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P963; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P996; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P780; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P203; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P637; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P585; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P547; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P176; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P893; Clark SJ, 2001, ARCH PEDIAT ADOL MED, V155, P915, DOI 10.1001/archpedi.155.8.915; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Cooper A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e98; DALAKER J., 1998, CURRENT POPULATION R, VP60-201; DeStefano Frank, 2004, Expert Rev Vaccines, V3, P19, DOI 10.1586/14760584.3.1.19; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; Frankel MR, 2003, STAT MED, V22, P1611, DOI 10.1002/sim.1515; Freed GL, 2002, PEDIATRICS, V109, P1153, DOI 10.1542/peds.109.6.1153; Hurie MB, 2001, PEDIATRICS, V107, P755, DOI 10.1542/peds.107.4.755; Lauderdale DS, 1999, JAMA-J AM MED ASSOC, V282, P1725, DOI 10.1001/jama.282.18.1725; Madsen KM, 2003, PEDIATRICS, V112, P604, DOI 10.1542/peds.112.3.604; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; Oram RJ, 2001, JAMA-J AM MED ASSOC, V285, P1874, DOI 10.1001/jama.285.14.1874; Pichichero ME, 2002, LANCET, V360, P1737, DOI 10.1016/S0140-6736(02)11682-5; *RES TRIANGL I, 2001, SUDAAN US MAN REL 8; Smith PJ, 2001, AM J PREV MED, V20, P17, DOI 10.1016/S0749-3797(01)00285-9; SMITH PJ, 2001, VITAL HLTH STAT SERI, V2; Stokley S, 2001, AM J PREV MED, V20, P55, DOI 10.1016/S0749-3797(01)00280-X; Stratton K, 2001, IMMUNIZATION SAFETY; US Census Bureau, 2002, CENS 2000 BAS; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; Verstraeten T, 2003, PEDIATRICS, V112, P1039, DOI 10.1542/peds.112.2.e98; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Yusuf HR, 2000, JAMA-J AM MED ASSOC, V284, P978, DOI 10.1001/jama.284.8.978; Zell ER, 2000, PUBLIC HEALTH REP, V115, P65, DOI 10.1093/phr/115.1.65; 1995, MMWR MORB MORTAL WKL, V44, P613; 1995, MMWR MORB MORTAL WKL, V44, P621; 1995, MMWR MORB MORTAL WKL, V44, P619	57	24	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2004	291	19					2351	2358		10.1001/jama.291.19.2351	http://dx.doi.org/10.1001/jama.291.19.2351			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821JD	15150207	Bronze			2022-12-01	WOS:000221455400023
J	Miller, WC; Ford, CA; Morris, M; Handcock, MS; Schmitz, JL; Hobbs, MM; Cohen, MS; Harris, KM; Udry, JR				Miller, WC; Ford, CA; Morris, M; Handcock, MS; Schmitz, JL; Hobbs, MM; Cohen, MS; Harris, KM; Udry, JR			Prevalence of chlamydial and gonococcal infections among young adults in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRACHOMATIS INFECTION; RISK BEHAVIORS; CARE; EPIDEMIOLOGY; ADOLESCENTS; POLICY; WOMEN; BLACK; CITY	Context Chlamydial and gonococcal infections are important causes of pelvic inflammatory disease, ectopic pregnancy, and infertility. Although screening for Chlamydia trachomatis is widely recommended among young adult women, little information is available regarding the prevalence of chlamydial and gonococcal infections in the general young adult population. Objective To determine the prevalence of chlamydial and gonoccoccal infections in a nationally representative sample of young adults living in the United States. Design, Setting, and Participants Cross-sectional analyses of a prospective cohort study of a nationally representative sample of 14322 young adults aged 18 to 26 years. In-home interviews were conducted across the United States for Wave III of The National Longitudinal Study of Adolescent Health (Add Health) from April 2, 2001, to May 9, 2002. This study sample represented 66.3% of the original 18924 participants in Wave I of Add Health. First-void urine specimens using ligase chain reaction assay were available for 12548 (87.6%) of the Wave III participants. Main Outcome Measures Prevalences of chlamydial and gonococcal infections in the general young adult population, and by age, self-reported race/ethnicity, and geographic region of current residence. Results Overall prevalence of chlamydial infection was 4.19% (95% confidence interval [CI], 3.48%-4.90%). Women (4.74%; 95% CI, 3.93%-5.71%) were more likely to be infected than men (3.67%; 95% CI, 2.93%-4.58%; prevalence ratio, 1.29; 95% CI 1.03-1.63). The prevalence of chlamydial infection was highest among black women (13.95%; 95% CI, 11.25%-17.18%) and black men (11.12%; 95% CI, 8.51%14.42%); lowest prevalences were among Asian men (1.14%; 95% CI, 0.40%-3.21%), white men (1.38%; 95% CI, 0.93%-2.03%), and white women (2.52%; 95% CI, 1.90%-3.34%). Prevalence of chlamydial infection was highest in the south (5.39%; 95% CI, 4.24%-6.83%) and lowest in the northeast (2.39%; 95% CI, 1.56%-3.65%). Overall prevalence of gonorrhea was 0.43% (95% CI, 0.29%-0.63%). Among black men and women, the prevalence was 2.13% (95% CI, 1.46%-3.10%) and among white young adults, 0.10% (95% CI, 0.03%-0.27%). Prevalence of coinfection with both chlamydial and gonococcal infections was 0.030% (95% CI, 0.18%-0.49%). Conclusions The prevalence of chlamydial infection is high among young adults in the United States. Substantial racial/ethnic disparities are present in the prevalence of both chlamydial and gonococcal infections.	Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA; Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; Univ Washington, Dept Sociol, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, WC (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, CB 7435,2105F Mcgavran Greenburg, Chapel Hill, NC 27599 USA.	bill_miller@unc.edu	Miller, William C/H-4800-2014; Handcock, Mark S./AAY-3318-2021; Schmitz, John/AAF-9053-2019	Miller, William C/0000-0002-1934-7827; Handcock, Mark S./0000-0002-9985-2785; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828, P01HD031921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038210, R01HD041877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012831] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		*ADD HLTH BIOM TEA, BIOM WAV 3 ADD HLTH; *AM AC FAM PHYS, SUMM POL REC PER HLT; American Academy of Pediatrics, 2000, PEDIATRICS, V105, P645; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; BEARMAN PS, NATL LONGITUDINAL ST; Brookmeyer R., 1994, AIDS EPIDEMIOLOGY QU; BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; *CDCP, 2002, SEX TRANSM DIS SURV; Centers of Disease Control and Prevention, 2000, SEX TRANSM DIS SURV; Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1; Cook RL, 2001, J ADOLESCENT HEALTH, V28, P204, DOI 10.1016/S1054-139X(00)00152-X; Fang J, 2000, J URBAN HEALTH, V77, P735, DOI 10.1007/BF02344034; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Hollblad-Fadiman K, 2003, AM J PREV MED, V24, P287, DOI 10.1016/S0749-3797(02)00636-0; Hook E. W., 1999, SEXU LLY TRANSMITTED, P451; Johnson Robert E, 2002, MMWR Recomm Rep, V51, P1; Klausner JD, 2001, J INFECT DIS, V183, P1087, DOI 10.1086/319276; Ku L, 2002, AM J PUBLIC HEALTH, V92, P1140, DOI 10.2105/AJPH.92.7.1140; Mangione-Smith R, 2000, ARCH PEDIAT ADOL MED, V154, P1108, DOI 10.1001/archpedi.154.11.1108; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Miller WC, 2000, AM J PREV MED, V18, P115, DOI 10.1016/S0749-3797(99)00146-4; *NAT COMM QUAL ASS, 2001, STAT MAN CAR QUAL; Nelson HD, 2001, AM J PREV MED, V20, P95, DOI 10.1016/S0749-3797(01)00253-7; ODONNELL L, 1994, SEX TRANSM DIS, V21, P137, DOI 10.1097/00007435-199405000-00003; QUINN K, THEIR OWN YOUNG ADUL; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Sandman D, OUT TOUCH AM MEN HLT; Saraiya M, 1999, AM J EPIDEMIOL, V149, P1025; St Lawrence JS, 2002, AM J PUBLIC HEALTH, V92, P1784, DOI 10.2105/AJPH.92.11.1784; TILSON EC, 2001, PREV MED 2001 SCI SY; Torkko KC, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e32; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; Udry JR, 2003, SOC SCI RES, V32, P294, DOI 10.1016/S0049-089X(02)00060-1; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; Watson EJ, 2002, J MED MICROBIOL, V51, P1021, DOI 10.1099/0022-1317-51-12-1021; WESTROM L, 1999, SEXUALLY TRANSMITTED, P783	38	429	442	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2004	291	18					2229	2236		10.1001/jama.291.18.2229	http://dx.doi.org/10.1001/jama.291.18.2229			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GR	15138245	Green Submitted, Bronze			2022-12-01	WOS:000221303500025
J	Ryan, J; Piercy, J; James, P				Ryan, J; Piercy, J; James, P			Assessment of NICE guidance on two surgical procedures	LANCET			English	Article								The National Institute of Excellence (NICE) released its first guidance in 2000 on clinical procedures and technologies in England and Wales. Using hospital activity data, we looked at the effect of NICE guidance on wisdom tooth extraction and primary total hip replacement in the UK National Health Service. We selected hospitals that submitted their activity continuously between 1997 and 2002. Analysis of wisdom tooth extraction showed that NICE guidance was not the primary reason for the downward trend in extractions (p=0.8287); this trend was more likely to be attributable to previous guidance. For total hip replacement there was no significant change in behaviour away from use of non-cemented hip prostheses. Therefore, NICE guidance has had little effect on behaviour for these two procedures.	Mapi Values Ltd, Bollington SK10 5JB, Cheshire, England; Thames Valley Univ, London, England; CHKS Ltd, Alcester, Warwick, England; Univ York, York YO10 5DD, N Yorkshire, England	University of West London; University of York - UK	Ryan, J (corresponding author), Mapi Values Ltd, Bollington SK10 5JB, Cheshire, England.	james.ryan@mapivalues.com						*FAC DENT SURG, 1997, NAT CLIN GUID 1997; Maddala GS, 2001, INTRO ECONOMETRICS; *NAT I CLIN EXC, 2000, 2 NAT I CLIN EXC; *NAT I CLIN EXC, 2000, 1 NAT I CLINE XC; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Thwaites R, 2004, ACTA PAEDIATR, V93, P23, DOI 10.1080/08035320310021011	6	23	23	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 8	2004	363	9420					1525	1526		10.1016/S0140-6736(04)16180-1	http://dx.doi.org/10.1016/S0140-6736(04)16180-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GK	15135602				2022-12-01	WOS:000221302700014
J	Hetzel, M; Hetzel, J; Arslandemir, C; Nussle, K; Schirrmeister, H				Hetzel, M; Hetzel, J; Arslandemir, C; Nussle, K; Schirrmeister, H			Reliability of symptoms to determine use of bone scans to identify bone metastases in lung cancer: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany; Univ Ulm, Dept Nucl Med, D-89069 Ulm, Germany; Univ Ulm, Dept Diagnost Radiol, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Hetzel, M (corresponding author), Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany.	martin.hetzel@medizin.uni-ulm.de						[Anonymous], 1997, AM J RESP CRIT CARE, V156, P320; DEYO RA, 1987, SPINE, V12, P264, DOI 10.1097/00007632-198704000-00013; MICHEL F, 1991, THORAX, V46, P469, DOI 10.1136/thx.46.7.469; Silvestri GA, 2003, CHEST, V123, p147S, DOI 10.1378/chest.123.1_suppl.147S	4	16	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1051	1052		10.1136/bmj.328.7447.1051	http://dx.doi.org/10.1136/bmj.328.7447.1051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117792	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000221174500017
J	Foote, AD; Osborne, RW; Hoelzel, AR				Foote, AD; Osborne, RW; Hoelzel, AR			Environment - Whale-call response to masking boat noise	NATURE			English	Editorial Material							KILLER WHALES		Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; Whale Museum, Friday Harbor, WA 98250 USA	Durham University	Foote, AD (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	a.r.hoelzel@dur.ac.uk		Foote, Andrew/0000-0001-7384-1634				Bain David E., 1994, P243; Bigg M.A., 1990, REP INT WHALING COMM, V12, P384; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Heil P, 2003, P NATL ACAD SCI USA, V100, P6151, DOI 10.1073/pnas.1030017100; HOELZEL AR, 1993, ANIM BEHAV, V45, P581, DOI 10.1006/anbe.1993.1068; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; [No title captured]	8	181	190	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					910	910		10.1038/428910a	http://dx.doi.org/10.1038/428910a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118717	Bronze			2022-12-01	WOS:000221083000031
J	Damste, JSS; Muyzer, G; Abbas, B; Rampen, SW; Masse, G; Allard, WG; Belt, ST; Robert, JM; Rowland, SJ; Moldowan, JM; Barbanti, SM; Fago, FJ; Denisevich, P; Dahl, J; Trindade, LAF; Schouten, S				Damste, JSS; Muyzer, G; Abbas, B; Rampen, SW; Masse, G; Allard, WG; Belt, ST; Robert, JM; Rowland, SJ; Moldowan, JM; Barbanti, SM; Fago, FJ; Denisevich, P; Dahl, J; Trindade, LAF; Schouten, S			The rise of the rhizosolenid diatoms	SCIENCE			English	Article							HASLEA-OSTREARIA SIMONSEN; ORGANIC-CARBON BURIAL; ISOPRENOID ALKENES; FOSSIL RECORD; IDENTIFICATION; C-25; SETIGERA; SILICA; SEDIMENTS; PENTAENE	The 18S ribosomal DNA molecular phylogeny and lipid composition of over 120 marine diatoms showed that the capability to biosynthesize highly branched isoprenoid (HBI) alkenes is restricted to two specific phylogenetic clusters, which independently evolved in centric and pennate diatoms. The molecular record of C-25 HBI chemical fossils in a large suite of well-dated marine sediments and petroleum revealed that the older cluster, composed of rhizosolenid diatoms, evolved 91.5+/-1.5 million years ago (Upper Turonian), enabling an accurate dating of the pace of diatom evolution that is unprecedented. The rapid rise of the rhizosolenid diatoms probably resulted from a major reorganization of the nutrient budget in the mid-Cretaceous oceans, triggered by plate tectonics.	Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Delft Univ Technol, Dept Biotechnol, Environm Biotechnol Grp, NL-2628 BC Delft, Netherlands; Univ Plymouth, Sch Earth Ocean & Environm Sci, Petr & Environm Geochem Grp, Plymouth PL4 8AA, Devon, England; Univ Nantes, ISOmer, UPRESEA 2663, Fac Sci, F-44322 Nantes 3, France; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Petrobras Res Ctr, CENPES, BR-20132970 Rio De Janeiro, Brazil	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Delft University of Technology; University of Plymouth; Nantes Universite; Stanford University; Petrobras	Damste, JSS (corresponding author), Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, POB 59, NL-1790 AB Den Burg, Netherlands.	damste@nioz.nl	Muyzer, Gerard/ABE-5834-2020; Damste, Jaap S Sinninghe/F-6128-2011; Muyzer, Gerard/A-3161-2013	Muyzer, Gerard/0000-0002-2422-0732; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Rampen, Sebastiaan/0000-0002-1092-6363; Barbanti, Silvana/0000-0001-5682-9764				ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Belt ST, 2000, GEOCHIM COSMOCHIM AC, V64, P3839, DOI 10.1016/S0016-7037(00)00464-6; Belt ST, 2002, PHYTOCHEMISTRY, V59, P141, DOI 10.1016/S0031-9422(01)00444-7; Belt ST, 2001, ORG GEOCHEM, V32, P1169, DOI 10.1016/S0146-6380(01)00102-4; Belt ST, 1996, TETRAHEDRON LETT, V37, P4755, DOI 10.1016/0040-4039(96)00926-4; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; COOLEN MJL, UNPUB; Damste JSS, 2002, J LIPID RES, V43, P1641, DOI 10.1194/jlr.M200148-JLR200; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; Damste JSS, 1999, ORG GEOCHEM, V30, P1581; Dixit S, 2001, MAR CHEM, V73, P333, DOI 10.1016/S0304-4203(00)00118-3; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Kemp AES, 1999, NATURE, V398, P57, DOI 10.1038/18001; Kooistra WHCF, 1996, MOL PHYLOGENET EVOL, V6, P391, DOI 10.1006/mpev.1996.0088; Kuypers MMM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000569; KUYPERS MMM, 2001, GEOL ULTRAIECTINA; Masse G, 2004, P NATL ACAD SCI USA, V101, P4413, DOI 10.1073/pnas.0400902101; MOLDOWAN JM, 1994, SCIENCE, V265, P768, DOI 10.1126/science.265.5173.768; Pike J, 1999, GEOLOGY, V27, P311, DOI 10.1130/0091-7613(1999)027<0311:DMIGOC>2.3.CO;2; ROBSON JN, 1986, NATURE, V324, P561, DOI 10.1038/324561a0; Round F.E., 1990, DIATOMS BIOL MORPHOL; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; VOLKMAN JK, 1994, ORG GEOCHEM, V21, P407, DOI 10.1016/0146-6380(94)90202-X; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0	26	196	208	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					584	587		10.1126/science.1096806	http://dx.doi.org/10.1126/science.1096806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105500				2022-12-01	WOS:000220975100048
J	Ikegaya, Y; Aaron, G; Cossart, R; Aronov, D; Lampl, I; Ferster, D; Yuste, R				Ikegaya, Y; Aaron, G; Cossart, R; Aronov, D; Lampl, I; Ferster, D; Yuste, R			Synfire chains and cortical songs: Temporal modules of cortical activity	SCIENCE			English	Article							SEQUENCES; NEURONS; REPLAY; DYNAMICS; PATTERNS	How can neural activity propagate through cortical networks built with weak, stochastic synapses? We find precise repetitions of spontaneous patterns of synaptic inputs in neocortical neurons in vivo and in vitro. These patterns repeat after minutes, maintaining millisecond accuracy. Calcium imaging of slices reveals reactivation of sequences of cells during the occurrence of repeated intracellular synaptic patterns. The spontaneous activity drifts with time, engaging different cells. Sequences of active neurons have distinct spatial structures and are repeated in the same order over tens of seconds, revealing modular temporal dynamics. Higher order sequences are replayed with compressed timing.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Columbia University; Northwestern University	Yuste, R (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	rmy5@columbia.edu	Cossart, Rosa/E-7674-2014; Cossart, Rosa/AAT-7934-2020	Cossart, Rosa/0000-0003-2111-6638; Cossart, Rosa/0000-0003-2111-6638; Ikegaya, Yuji/0000-0003-2260-8191; Lampl, Ilan/0000-0002-9380-0730				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Abeles M., 1991, CORTICONICS; BIENENSTOCK E, 1995, NETWORK-COMP NEURAL, V6, P179, DOI 10.1088/0954-898X/6/2/004; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grinvald A, 2003, BIOPOLYMERS, V68, P422, DOI 10.1002/bip.10273; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Llinas R. R., 2002, 1 VORTEX NEURONS SEL; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; NOTTEBOHM F, 1990, PHILOS T R SOC B, V329, P115, DOI 10.1098/rstb.1990.0156; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SILBERBERG G, 2004, J PHYSL, P19; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; STEVENS CF, 1994, CURR BIOL, V4, P268, DOI 10.1016/S0960-9822(00)00062-2; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	31	603	612	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					559	564		10.1126/science.1093173	http://dx.doi.org/10.1126/science.1093173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105494				2022-12-01	WOS:000220975100041
J	Wright, IJ; Reich, PB; Westoby, M; Ackerly, DD; Baruch, Z; Bongers, F; Cavender-Bares, J; Chapin, T; Cornelissen, JHC; Diemer, M; Flexas, J; Garnier, E; Groom, PK; Gulias, J; Hikosaka, K; Lamont, BB; Lee, T; Lee, W; Lusk, C; Midgley, JJ; Navas, ML; Niinemets, U; Oleksyn, J; Osada, N; Poorter, H; Poot, P; Prior, L; Pyankov, VI; Roumet, C; Thomas, SC; Tjoelker, MG; Veneklaas, EJ; Villar, R				Wright, IJ; Reich, PB; Westoby, M; Ackerly, DD; Baruch, Z; Bongers, F; Cavender-Bares, J; Chapin, T; Cornelissen, JHC; Diemer, M; Flexas, J; Garnier, E; Groom, PK; Gulias, J; Hikosaka, K; Lamont, BB; Lee, T; Lee, W; Lusk, C; Midgley, JJ; Navas, ML; Niinemets, U; Oleksyn, J; Osada, N; Poorter, H; Poot, P; Prior, L; Pyankov, VI; Roumet, C; Thomas, SC; Tjoelker, MG; Veneklaas, EJ; Villar, R			The worldwide leaf economics spectrum	NATURE			English	Article							PHOTOSYNTHESIS-NITROGEN RELATIONS; LIFE-SPAN; USE EFFICIENCY; HIGH-RAINFALL; DRY MASS; AREA; NUTRIENT; PLANT; LEAVES; CARBON	Bringing together leaf trait data spanning 2,548 species and 175 sites we describe, for the first time at global scale, a universal spectrum of leaf economics consisting of key chemical, structural and physiological properties. The spectrum runs from quick to slow return on investments of nutrients and dry mass in leaves, and operates largely independently of growth form, plant functional type or biome. Categories along the spectrum would, in general, describe leaf economic variation at the global scale better than plant functional types, because functional types overlap substantially in their leaf traits. Overall, modulation of leaf traits and trait relationships by climate is surprisingly modest, although some striking and significant patterns can be seen. Reliable quantification of the leaf economics spectrum and its interaction with climate will prove valuable for modelling nutrient fluxes and vegetation boundaries under changing land-use and climate.	Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Simon Bolivar, Dept Estudios Ambientales, Caracas 1080, Venezuela; Wageningen Univ, Forest Ecol & Forest Management Grp, Dept Environm Sci, NL-6700 AH Wageningen, Netherlands; Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Vrije Univ Amsterdam, Inst Ecol Sci, Dept Syst Ecol, NL-1081 HV Amsterdam, Netherlands; Univ Zurich, Inst Umwelwissensch, Zurich, Switzerland; Univ Illes Balears, Dept Biol, Lab Fisiol Vegetal, Palma de Mallorca 07122, Illes Balears, Spain; Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, F-34293 Montpellier 5, France; Curtin Univ Technol, Dept Environm Biol, Perth, WA 6845, Australia; Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Univ Wisconsin, Dept Biol, Eau Claire, WI 54702 USA; Landcare Res, Dunedin, New Zealand; Univ Concepcion, Dept Bot, Concepcion, Chile; Univ Cape Town, Dept Bot, ZA-7701 Rondebosch, South Africa; Univ Tartu, Dept Plant Physiol, EE-51011 Tartu, Estonia; Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; Univ Tokyo, Nikko Bot Garden, Grad Sch Sci, Nikko, Tochigi 3211435, Japan; Univ Utrecht, NL-3508 TB Utrecht, Netherlands; Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; Charles Darwin Univ, Key Ctr Wildlife Management, Darwin, NT 0909, Australia; Ural State Univ, Ekaterinburg, Russia; Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada; Texas A&M Univ, Dept Forest Sci, College Stn, TX 77843 USA; Univ Cordoba, Area Ecol, E-14071 Cordoba, Spain	Macquarie University; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Simon Bolivar University; Wageningen University & Research; Smithsonian Institution; Smithsonian Environmental Research Center; University of Alaska System; University of Alaska Fairbanks; Vrije Universiteit Amsterdam; University of Zurich; Universitat de les Illes Balears; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Curtin University; Tohoku University; University of Wisconsin System; Landcare Research - New Zealand; Universidad de Concepcion; University of Cape Town; University of Tartu; Polish Academy of Sciences; University of Tokyo; Utrecht University; University of Western Australia; Charles Darwin University; Ural Federal University; University of Toronto; Texas A&M University System; Texas A&M University College Station; Universidad de Cordoba	Wright, IJ (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia.	iwright@rna.bio.mq.edu.au	Poorter, Hendrik/B-8062-2010; Poorter, Hendrik/Y-2542-2019; Hikosaka, Kouki/A-5415-2013; Ackerly, David/A-1247-2009; Gulías, Javier/N-7240-2013; Hikosaka, Kouki/AAH-4214-2019; Oleksyn, Jacek/I-4539-2012; Prior, Lynda/A-7460-2012; Cavender-Bares, Jeannine/K-5716-2013; Garnier, Eric/D-1650-2012; Oleksyn, Jacek/AAR-2351-2020; Poot, Pieter/B-3457-2011; THOMAS, Sean C./B-6089-2008; Osada, Noriyuki/K-2946-2012; Flexas, Jaume/C-1898-2012; Tjoelker, Mark G/M-2413-2016; Veneklaas, Erik J/C-8907-2009; Niinemets, Ülo/A-3816-2008; Villar, Rafael/F-7507-2010; Wright, Ian J/G-4979-2012	Poorter, Hendrik/0000-0001-9900-2433; Poorter, Hendrik/0000-0001-9900-2433; Hikosaka, Kouki/0000-0003-1744-3775; Ackerly, David/0000-0002-1847-7398; Hikosaka, Kouki/0000-0003-1744-3775; Prior, Lynda/0000-0002-5511-2320; Garnier, Eric/0000-0002-9392-5154; THOMAS, Sean C./0000-0002-0686-2483; Flexas, Jaume/0000-0002-3069-175X; Tjoelker, Mark G/0000-0003-4607-5238; Veneklaas, Erik J/0000-0002-7030-4056; Niinemets, Ülo/0000-0002-3078-2192; Villar, Rafael/0000-0002-3895-9984; Wright, Ian J/0000-0001-8338-9143; Poot, Pieter/0000-0001-7721-0696; Lamont, Byron/0000-0001-9279-7149; Gulias, Javier/0000-0002-6685-4231; Westoby, Mark/0000-0001-7690-4530; Reich, Peter/0000-0003-4424-662X; Lee, Tali/0000-0002-3933-6607; Oleksyn, Jacek/0000-0002-6576-3258; Cavender-Bares, Jeannine/0000-0003-3375-9630				ACKERLY DD, 1995, OECOLOGIA, V101, P289, DOI 10.1007/BF00328814; BARRY RG, 1981, MOUNTAIN WEATHER CLI, P24; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bonan GB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001360; Campbell G. S., 1998, INTRO ENV BIOPHYSICS; Cannell MGR, 2000, ANN BOT-LONDON, V85, P45, DOI 10.1006/anbo.1999.0996; Choudhury BJ, 1997, REMOTE SENS ENVIRON, V61, P64, DOI 10.1016/S0034-4257(96)00241-6; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Evans JR, 2000, PHOTOSYNTHESIS PHYSL, P321, DOI DOI 10.1007/0-306-48137-5_14; Farquhar GD, 2002, SILVA FENN, V36, P625, DOI 10.14214/sf.530; Field C., 1986, EC PLANT FORM FUNCTI, P25; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; GOVNISH TJ, 1986, EC PLANT FORM FUNCTI; Green DS, 2001, TREE PHYSIOL, V21, P1341, DOI 10.1093/treephys/21.18.1341; Grime J. P., 1994, EXPLOITATION ENV HET, P1; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; HARPER JL, 1989, OECOLOGIA, V80, P53, DOI 10.1007/BF00789931; Hikosaka K, 1998, FUNCT ECOL, V12, P896, DOI 10.1046/j.1365-2435.1998.00272.x; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; KORNER C, 1999, ALPINE PLANT LIFE FU, pCH3; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambers H., 2008, PLANT PHYSL ECOLOGY, V2, DOI [10.1007/978-0-387-78341-3, DOI 10.1007/978-0-387-78341-3]; Maximov NA., 1929, PLANT RELATION WATER; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; ORIANS GH, 1977, AM NAT, V111, P677, DOI 10.1086/283199; PARKHURST DF, 1994, NEW PHYTOL, V126, P449, DOI 10.1111/j.1469-8137.1994.tb04244.x; Peterson AG, 1999, OECOLOGIA, V118, P144, DOI 10.1007/s004420050712; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reich PB, 1998, OECOLOGIA, V114, P471, DOI 10.1007/s004420050471; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; REICH PB, 1994, OECOLOGIA, V97, P73, DOI 10.1007/BF00317910; Reich PB, 1998, FUNCT ECOL, V12, P948, DOI 10.1046/j.1365-2435.1998.00274.x; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Sokal RR, 2012, BIOMETRY, V4th; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, DOI 10.1515/9781400885695; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Walters MB, 2000, ECOLOGY, V81, P1887, DOI 10.1890/0012-9658(2000)081[1887:SSNSAG]2.0.CO;2; Westoby M, 2000, AM NAT, V155, P649, DOI 10.1086/303346; Whittaker R.H., 1975, COMMUNITIES ECOSYSTE, P167; Wright IJ, 2003, AM NAT, V161, P98, DOI 10.1086/344920; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x	50	5308	5960	226	3403	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					821	827		10.1038/nature02403	http://dx.doi.org/10.1038/nature02403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103368	Green Published			2022-12-01	WOS:000220952300031
J	Beer, MA; Tavazoie, S				Beer, MA; Tavazoie, S			Predicting gene expression from sequence	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; C-ELEGANS; BAYESIAN NETWORKS; CHROMOSOMAL DOMAINS; REGULATORY NETWORKS; PROMOTER ELEMENTS; STRESS-RESPONSE; TRANSCRIPTION; SKN-1; YEAST	We describe a systematic genome-wide approach for learning the complex combinatorial code underlying gene expression. Our probabilistic approach identifies local DNA-sequence elements and the positional and combinatorial constraints that determine their context-dependent role in transcriptional regulation. The inferred regulatory rules correctly predict expression patterns for 73% of genes in Saccharomyces cerevisiae, utilizing microarray expression data and sequences in the 800 bp upstream of genes. Application to Caenorhabditis elegans identifies predictive regulatory elements and combinatorial rules that control the phased temporal expression of transcription factors, histones, and germline specific genes. Successful prediction requires diverse and complex rules utilizing AND, OR, and NOT logic, with significant constraints on motif strength, orientation, and relative position. This system generates a large number of mechanistic hypotheses for focused experimental validation, and establishes a predictive dynamical framework for understanding cellular behavior from genomic sequence.	Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Tavazoie, S (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tavazoie@molbio.princeton.edu	Beer, Michael/AFV-4282-2022; Rosa, Bruce/F-6393-2010	Beer, Michael A/0000-0001-9955-3809				An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; Davidson GS, 2001, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2001, PROCEEDINGS, P23, DOI 10.1109/INFVIS.2001.963275; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman N, 1998, NATO ADV SCI I D-BEH, V89, P421; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hartigan J.A., 1975, CLUSTERING ALGORITHM; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1023/A:1022623210503; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KLASS M, 1988, J MOL BIOL, V199, P15, DOI 10.1016/0022-2836(88)90375-0; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LHERNAULT S, 1997, SPERMATOGENESIS, P271; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Pearl J., 1988, PROBABILISTIC REASON, DOI [10.1016/C2009-0-27609-4, DOI 10.1016/C2009-0-27609-4, 10.1016/B978-0-08-051489-5.50008-4]; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; RISANNEN J, 1989, STOCHASTIC COMPLEXIT; ROBERTS SB, 1989, J MOL BIOL, V206, P567, DOI 10.1016/0022-2836(89)90566-4; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; WOUDT LP, 1986, EMBO J, V5, P1037, DOI 10.1002/j.1460-2075.1986.tb04319.x	50	441	452	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					185	198		10.1016/S0092-8674(04)00304-6	http://dx.doi.org/10.1016/S0092-8674(04)00304-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084257	Bronze			2022-12-01	WOS:000220913400007
J	Worrall, A; O'Herlihy, A; Banerjee, S; Jaffa, T; Lelliott, P; Hill, P; Scott, A; Brook, H				Worrall, A; O'Herlihy, A; Banerjee, S; Jaffa, T; Lelliott, P; Hill, P; Scott, A; Brook, H			Inappropriate admission of young people with mental disorder to adult psychiatric wards and paediatric wards: cross sectional study of six months' activity	BRITISH MEDICAL JOURNAL			English	Article									Royal Coll Psychiatrists, Res Unit, London SW1H 0HW, England; Univ London Kings Coll, Inst Psychiat, Hlth Serv Res Dept, London, England; Fulbourne Hosp, Phoenix Ctr, Cambridge, England; Great Ormond St Hosp Children, Dept Psychol Med, London, England	University of London; King's College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Worrall, A (corresponding author), Royal Coll Psychiatrists, Res Unit, 6th Floor,83 Victoria St, London SW1H 0HW, England.	aworrall@cru.rcpsych.ac.uk	Banerjee, Sube/E-3757-2010	Banerjee, Sube/0000-0002-8083-7649				Barker S, 2000, ENV UNFRIENDLY PATIE; *MILMIS PROJ GROUP, 1995, PSYCHIAT B, V19, P276; OHERLIHY A, 2001, UNPUB NATL IN PATIEN; Scott D., 2001, MENTAL HLTH LEARNING, V4, P305; Worrall A., 2001, PSYCHIAT B, V25, P219, DOI [10.1192/pb.25.6.219, DOI 10.1192/PB.25.6.219]	5	19	19	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					867	868		10.1136/bmj.38058.605787.AE	http://dx.doi.org/10.1136/bmj.38058.605787.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15066888	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000220871400016
J	Friedrich, MJ				Friedrich, MJ			Institute probes music's therapeutic potential	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Coleman J., 1997, INT J ARTS MED, V5, P4; 2003, PAIN MANAG NURS, V4, P54	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1554	1555		10.1001/jama.291.13.1554	http://dx.doi.org/10.1001/jama.291.13.1554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809PQ	15069033				2022-12-01	WOS:000220649000005
J	de la Cova, C; Abril, M; Bellosta, P; Gallant, P; Johnston, LA				de la Cova, C; Abril, M; Bellosta, P; Gallant, P; Johnston, LA			Drosophila Myc regulates organ size by inducing cell competition	CELL			English	Article							WING DEVELOPMENT; TNF SUPERFAMILY; GROWTH; PROLIFERATION; COMPARTMENTS; DIVISION; SURVIVAL; PROTEIN; APOPTOSIS; ENCODES	Experiments in both vertebrates and invertebrates have illustrated the competitive nature of growth and led to the idea that competition is a mechanism of regulating organ and tissue size. We have assessed competitive interactions between cells in a developing organ and examined their effect on its final size. We show that local expression of the Drosophila growth regulator dMyc, a homolog of the c-myc protooncogene, induces cell competition and leads to the death of nearby wildtype cells in developing wings. We demonstrate that cell competition is executed via induction of the proapoptotic gene hid and that both competition and hid function are required for the wing to reach an appropriate size when dMyc is expressed. Moreover, we provide evidence that reproducible wing size during normal development requires apoptosis. Modulating dmyc levels to create cell competition and hid-dependent cell death may be a mechanism used during normal development to control organ size.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	Columbia University; University of Zurich	Johnston, LA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St,Room 704, New York, NY 10032 USA.	lj180@columbia.edu	Johnston, Laura A/ABC-1945-2021; Bellosta, Paola/AAA-3413-2020	Bellosta, Paola/0000-0003-1913-5661; de la Cova, Claire/0000-0001-8719-6883; JOHNSTON, LAURA A/0000-0001-9477-7897	NICHD NIH HHS [R01 HD042770, R01 HD042770-02, R01 HD042770-05, R01 HD042770-03, R01 HD042770-04, R01 HD042770-01A1] Funding Source: Medline; NIGMS NIH HHS [R01 GM078464-04, R01 GM078464-02, R01 GM078464-03, R01 GM078464, R01 GM078464-01, T32 GM007088] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078464, T32GM007088] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0; Burke R, 1996, DEVELOPMENT, V122, P2261; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; HAY BA, 1994, DEVELOPMENT, V120, P2121; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 2003, NAT CELL BIOL, V5, P827, DOI 10.1038/ncb1041; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; SaeboeLarssen S, 1997, MOL GEN GENET, V255, P141, DOI 10.1007/s004380050482; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; Simpson P, 1980, Basic Life Sci, V16, P129; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Stern DL, 1999, DEVELOPMENT, V126, P1091; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Weigmann K, 1999, DEVELOPMENT, V126, P3823; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZECCA M, 1995, DEVELOPMENT, V121, P2265	39	431	437	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					107	116		10.1016/S0092-8674(04)00214-4	http://dx.doi.org/10.1016/S0092-8674(04)00214-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066286	Bronze			2022-12-01	WOS:000221500300012
J	Lo, MC; Gay, F; Odom, R; Shi, Y; Lin, F				Lo, MC; Gay, F; Odom, R; Shi, Y; Lin, F			Phosphorylation by the beta-catenin/MAPK complex promotes 14-3-3-mediated nuclear export of TCF/POP-1 in signal-responsive cells in C-elegans	CELL			English	Article							C-ELEGANS; POLARITY SIGNALS; 14-3-3 PROTEINS; MAP KINASE; POP-1; EMBRYOS; GENE; TRANSCRIPTION; ENDODERM; PATHWAY	In C. elegans embryos, a Wnt/MAPK signaling pathway downregulates the TCF/LEF transcription factor POP-1, resulting in a lower nuclear level in signal-responsive cells compared to their sisters. Although the beta-catenin WRM-1 is required for POP-1 down-regulation, a direct interaction between these two proteins does not seem to be required, as the beta-catenin-interacting domain of POP-1 is dispensable for both POP-1 downregulation and function in early embryos. We show here that WRM-1 downregulates POP-1 by promoting its phosphorylation by the MAP kinase LIT-1 and subsequent nuclear export via a 14-3-3 protein, PAR-5. In signal-responsive cells, we also detect a concurrent upregulation of nuclear LIT-1 that is dependent on Wnt/MAPK signaling. Our results suggest a model whereby Wnt/MAPK signaling downregulates POP-1 levels in responsive cells, in part by increasing nuclear LIT-1 levels, thereby increasing POP-1 phosphorylation and PAR-5-mediated nuclear export.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School	Lin, F (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	rueyling.lin@utsouthwestern.edu			NICHD NIH HHS [HD37933] Funding Source: Medline; NIGMS NIH HHS [GM58012] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058012] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Bullions Linda C., 1998, Current Opinion in Oncology, V10, P81, DOI 10.1097/00001622-199801000-00013; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gay F, 2003, GENE DEV, V17, P717, DOI 10.1101/gad.1042403; Gay F, 2002, MOL ENDOCRINOL, V16, P1332, DOI 10.1210/me.16.6.1332; GOLDSTEIN B, 1992, NATURE, V357, P255, DOI 10.1038/357255a0; Herman MA, 2001, DEVELOPMENT, V128, P581; Hermann GJ, 2000, DEVELOPMENT, V127, P3429; Hyodo-Miura J, 2002, GENES CELLS, V7, P487, DOI 10.1046/j.1365-2443.2002.00536.x; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pandur P, 2001, BIOESSAYS, V23, P207, DOI 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0; Polakis P, 2000, GENE DEV, V14, P1837; Praitis V, 2001, GENETICS, V157, P1217; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Schroeder DF, 1998, DEVELOPMENT, V125, P4877; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002	38	109	138	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					95	106		10.1016/S0092-8674(04)00203-X	http://dx.doi.org/10.1016/S0092-8674(04)00203-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066285	Bronze			2022-12-01	WOS:000221500300011
J	Cook, HA; Koppetsch, BS; Wu, J; Theurkauf, WE				Cook, HA; Koppetsch, BS; Wu, J; Theurkauf, WE			The Drosophila SDE3 homolog armitage is required for oskar mRNA silencing and embryonic axis specification	CELL			English	Review							RESTRICTS POLE PLASM; DOUBLE-STRANDED-RNA; BINDING-PROTEIN; CAENORHABDITIS-ELEGANS; POSTERIOR LOCALIZATION; GERM PLASM; KINESIN-I; TRANSLATIONAL REGULATION; ANTERIOR-POSTERIOR; PATTERN-FORMATION	Polarization of the microtubule cytoskeleton during early oogenesis is required to specify the posterior of the Drosophila oocyte, which is essential for asymmetric mRNA localization during mid-oogenesis and for embryonic axis specification. The posterior determinant oskar mRNA is translationally silent until mid-oogenesis. We show that mutations in armitage and three components of the RNAi pathway disrupt oskar mRNA translational silencing, polarization of the microtubule cytoskeleton, and posterior localization of oskar mRNA. armitage encodes a homolog of SDE3, a presumptive RNA helicase involved in posttranscriptional gene silencing (RNAi) in Arabidopsis, and is required for RNAi in Drosophila ovaries. Armitage forms an asymmetric network associated with the polarized microtubule cytoskeleton and is concentrated with translationally silent oskar mRNA in the oocyte. We conclude that RNA silencing is essential for establishment of the cytoskeletal polarity that initiates embryonic axis specification and for translational control of oskar mRNA.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	William.Theurkauf@umassmed.edu		Theurkauf, William/0000-0001-7342-1912	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007312] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD 07312] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; BERIETH T, 1988, EMBO J, V7, P1749; Bernstein E, 2001, RNA, V7, P1509; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Castagnetti S, 2003, DEVELOPMENT, V130, P835, DOI 10.1242/dev.00309; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Celotto AM, 2002, RNA, V8, P718, DOI 10.1017/S1355838202021064; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chou TB, 1996, GENETICS, V144, P1673; Clegg NJ, 1997, DEVELOPMENT, V124, P4661; Clegg NJ, 2001, DEV GENES EVOL, V211, P44, DOI 10.1007/s004270000114; CONSORTIUM TF, 2003, NUCLEIC ACIDS RES, V31, P172; Cooperstock RL, 2001, INT REV CYTOL, V203, P541; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EDDY EM, 1975, INT REV CYTOL, V43, P229; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Gonzalez-Reyes A, 1997, DEVELOPMENT, V124, P4927; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HAMILTON BA, 1994, METHOD CELL BIOL, V44, P81, DOI 10.1016/S0091-679X(08)60907-3; HARLOW E, 1999, USING ANTIBODIES LAB, P70; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ikenishi K, 1998, DEV GROWTH DIFFER, V40, P1; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim-Ha Jeongsil, 1993, Development (Cambridge), V119, P169; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kolonin MG, 2000, DEV BIOL, V227, P661, DOI 10.1006/dbio.2000.9916; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lieberfarb ME, 1996, DEVELOPMENT, V122, P579; LIN HF, 1994, DEVELOPMENT, V120, P947; Linder P, 2000, NAT STRUCT BIOL, V7, P97, DOI 10.1038/72464; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mohr E, 2001, INT J BIOCHEM CELL B, V33, P669, DOI 10.1016/S1357-2725(01)00047-4; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; O'Connor Mark, 1993, V18, P75; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; RONGO C, 1995, DEVELOPMENT, V121, P2737; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Saffman EE, 1998, MOL CELL BIOL, V18, P4855, DOI 10.1128/MCB.18.8.4855; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Schmidt A, 1999, GENETICS, V151, P749; SCHUPBACH T, 1991, GENETICS, V129, P1119; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; STARK A, 2003, PLOS BIOL, V1, pE61, DOI DOI 10.1371/JOURNAL.PBIO.0000061; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tracey WD, 2000, GENETICS, V154, P273; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Weng YM, 1996, MOL CELL BIOL, V16, P5477; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Willmann MR, 2001, TRENDS PLANT SCI, V6, P450, DOI 10.1016/S1360-1385(01)02147-1; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zaccai M, 1996, DEV GENET, V19, P249, DOI 10.1002/(SICI)1520-6408(1996)19:3<249::AID-DVG8>3.0.CO;2-9	101	188	200	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					817	829		10.1016/S0092-8674(04)00250-8	http://dx.doi.org/10.1016/S0092-8674(04)00250-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035984	Bronze			2022-12-01	WOS:000221499900008
J	Turelli, P; Mangeat, B; Jost, S; Vianin, S; Trono, D				Turelli, P; Mangeat, B; Jost, S; Vianin, S; Trono, D			Inhibition of hepatitis B virus replication by APOBEC3G	SCIENCE			English	Article									Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland; Univ Geneva, Frontiers Genet Res Program, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Trono, D (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland.	Didier.Trono@medecine.unige.ch		Mangeat, Bastien/0000-0003-2592-0236				Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; KewalRamani VN, 2003, SCIENCE, V301, P923, DOI 10.1126/science.1088965; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Ngui SL, 1999, REV MED VIROL, V9, P183, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;183::AID-RMV248&gt;3.0.CO;2-P; OON CJ, 1995, VACCINE, V13, P699, DOI 10.1016/0264-410X(94)00080-7; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	7	359	395	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2004	303	5665					1829	1829		10.1126/science.1092066	http://dx.doi.org/10.1126/science.1092066			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	15031497				2022-12-01	WOS:000220281600045
J	Halme, A; Bumgarner, S; Styles, C; Fink, GR				Halme, A; Bumgarner, S; Styles, C; Fink, GR			Genetic and epigenetic regulation of the FLO gene family generates cell-surface variation in yeast	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; ANTIGENIC VARIATION; INVASIVE GROWTH; SIR PROTEINS; EXPRESSION; MUTATIONS; KINASE; GLYCOPROTEIN; INFORMATION	The FLO gene family of Saccharomyces cerevisiae includes an expressed gene, FLO11, and a set of silent, telomere-adjacent FLO genes. This gene family encodes cell-wall glycoproteins that regulate cell-cell and cell-surface adhesion. Epigenetic silencing of FLO11 regulates a key developmental switch: when FLO11 is expressed, diploid cells form pseudohyphal filaments; when FLO11 is silent, the cells grow in yeast form. The epigenetic state of FLO11 is heritable for many generations and regulated by the histone deacetylase (HDAC) Hda1p. The silent FLO10 gene is activated by high-frequency loss-of-function mutations at either IRA1 or IRA2. FLO10 is regulated by the same transcription factors that control FLO11: Sfl1p and Flo8p, but is silenced by a distinct set of HDACs: Hst1p and Hst2p. These sources of epigenetic and genetic variation explain the observed heterogeneity of cell-surface protein expression within a population of cells derived from a single clone.	Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Fink, GR (corresponding author), Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	gfink@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035010, R01GM040266, R01GM035010] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNARDS A, 1981, CELL, V27, P497, DOI 10.1016/0092-8674(81)90391-3; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BRANDRISS MC, 1979, J BACTERIOL, V140, P504, DOI 10.1128/JB.140.2.504-507.1979; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; HABER JE, 1979, GENETICS, V93, P13; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kumar A, 2002, METHOD ENZYMOL, V350, P219, DOI 10.1016/S0076-6879(02)50965-4; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; MICHELS PAM, 1984, EMBO J, V3, P1345, DOI 10.1002/j.1460-2075.1984.tb01975.x; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Otto SP, 2002, ADV GENET, V46, P451; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; PAYS E, 1994, ANNU REV MICROBIOL, V48, P25, DOI 10.1146/annurev.mi.48.100194.000325; PAYS E, 1983, CELL, V35, P721, DOI 10.1016/0092-8674(83)90105-8; PAYS E, 1983, CELL, V34, P371, DOI 10.1016/0092-8674(83)90371-9; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; RINE J, 1979, GENETICS, V93, P877; RINE J, 1987, GENETICS, V116, P9; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; ROSE MD, 1990, METHODS YEAST GENETI; RUDENKO G, 1995, CELL, V83, P547, DOI 10.1016/0092-8674(95)90094-2; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; RUSSELL M, 1993, MOL BIOL CELL, V4, P757, DOI 10.1091/mbc.4.7.757; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; SIDDIQUI AH, 1988, MOL CELL BIOL, V8, P4634, DOI 10.1128/MCB.8.11.4634; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; WEIDEN M, 1991, MOL CELL BIOL, V11, P3823, DOI 10.1128/MCB.11.8.3823; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	50	273	286	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					405	415		10.1016/S0092-8674(04)00118-7	http://dx.doi.org/10.1016/S0092-8674(04)00118-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016375	Bronze			2022-12-01	WOS:000188825800009
J	Cascales, E; Christie, PJ				Cascales, E; Christie, PJ			Definition of a bacterial type IV secretion pathway for a DNA substrate	SCIENCE			English	Article							AGROBACTERIUM-TUMEFACIENS VIRB7; COMPLEX TRANSPORT APPARATUS; PLANT-CELLS; PROTEIN; CONJUGATION; SYSTEM; ATPASE; TRWB	Bacteria use conjugation systems, a subfamily of the type IV secretion systems, to transfer DNA to recipient cells. Despite 50 years of research, the architecture and mechanism of action of the channel mediating DNA transfer across the bacterial cell envelope remains obscure. By use of a sensitive, quanti. able assay termed transfer DNA immunoprecipitation (TrIP), we identify contacts between a DNA substrate (T-DNA) and 6 of 12 components of the VirB/D4 conjugation system of the phytopathogen Agrobacterium tumefaciens. Our results de. ne the translocation pathway for a DNA substrate through a bacterial conjugation machine, specifying the contributions of each subunit of the secretory apparatus to substrate passage.	Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System	Christie, PJ (corresponding author), Univ Texas, Sch Med, Dept Microbiol & Mol Genet, 6431 Fannin,JFB1-765, Houston, TX 77030 USA.	peter.j.christie@uth.tmc.edu	CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179	NIGMS NIH HHS [GM48746, R01 GM048746] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048746, R29GM048746] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LB, 1996, P NATL ACAD SCI USA, V93, P8889, DOI 10.1073/pnas.93.17.8889; Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x; Beaupre CE, 1997, J BACTERIOL, V179, P78, DOI 10.1128/jb.179.1.78-89.1997; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Dang TA, 1999, MOL MICROBIOL, V32, P1239, DOI 10.1046/j.1365-2958.1999.01436.x; Ding ZY, 2003, TRENDS MICROBIOL, V11, P527, DOI 10.1016/j.tim.2003.09.004; Fernandez D, 1996, J BACTERIOL, V178, P3168, DOI 10.1128/jb.178.11.3168-3176.1996; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gilmour MW, 2003, MOL MICROBIOL, V49, P105, DOI 10.1046/j.1365-2958.2003.03551.x; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Hormaeche I, 2002, J BIOL CHEM, V277, P46456, DOI 10.1074/jbc.M207250200; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; LESSL M, 1994, CELL, V77, P321, DOI 10.1016/0092-8674(94)90146-5; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100; Pantoja M, 2002, MOL MICROBIOL, V45, P1325, DOI 10.1046/j.1365-2958.2002.03098.x; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Spudich GM, 1996, P NATL ACAD SCI USA, V93, P7512, DOI 10.1073/pnas.93.15.7512; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8	25	268	280	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1170	1173		10.1126/science.1095211	http://dx.doi.org/10.1126/science.1095211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155952	Green Accepted			2022-12-01	WOS:000221524500047
J	Cordaux, R; Deepa, E; Vishwanathan, H; Stoneking, M				Cordaux, R; Deepa, E; Vishwanathan, H; Stoneking, M			Genetic evidence for the demic diffusion of agriculture to India	SCIENCE			English	Article									Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Louisiana State Univ, Baton Rouge, LA 70803 USA; Bharathiar Univ, Dept Environm Sci, Coimbatore 641046, Tamil Nadu, India	Max Planck Society; Louisiana State University System; Louisiana State University; Bharathiar University	Cordaux, R (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	cordaux@lsu.edu	Hucthagowder, Vishwanathan/C-9831-2009					Ammerman AJ, 1984, NEOLITHIC TRANSITION; Misra VN, 2001, J BIOSCIENCES, V26, P491, DOI 10.1007/BF02704749; SINGH KS, 1998, PEOPLE INDIA INDIA C; Whittle A., 1996, EUROPE NEOLITHIC	4	29	32	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2004	304	5674					1125	1125		10.1126/science.1095819	http://dx.doi.org/10.1126/science.1095819			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155941				2022-12-01	WOS:000221524500032
J	Munoz, J; Felicisimo, AM; Cabezas, F; Burgaz, AR; Martinez, I				Munoz, J; Felicisimo, AM; Cabezas, F; Burgaz, AR; Martinez, I			Wind as a long-distance dispersal vehicle in the Southern Hemisphere	SCIENCE			English	Article							NEW-ZEALAND; BIOGEOGRAPHY; ENVIRONMENT	Anisotropic (direction-dependent) long-distance dispersal (LDD) by wind has been invoked to explain the strong floristic affinities shared among landmasses in the Southern Hemisphere. Its contribution has not yet been systematically tested because of the previous lack of global data on winds. We used global winds coverage from the National Aeronautics and Space Administration SeaWinds scatterometer to test whether floristic similarities of Southern Hemisphere moss, liverwort, lichen, and pteridophyte floras conform better with (i) the anisotropic LDD hypothesis, which predicts that connection by "wind highways" increases floristic similarities, or (ii) a direction-independent LDD hypothesis, which predicts that floristic similarities among sites increase with geographic proximity. We found a stronger correlation of floristic similarities with wind connectivity than with geographic proximities, which supports the idea that wind is a dispersal vehicle for many organisms in the Southern Hemisphere.	Real Jardin Bot, Madrid 28014, Spain; Univ Extremadura, Escuela Politecn, Caceres 10071, Spain; Univ Complutense, Dept Biol Vegetal 1, E-28040 Madrid, Spain; Univ Rey Juan Carlos, Mostoles 28933, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Universidad de Extremadura; Complutense University of Madrid; Universidad Rey Juan Carlos	Munoz, J (corresponding author), Real Jardin Bot, Plaza Murillo 2, Madrid 28014, Spain.	jmunoz@ma-rjb.csic.es	Munoz, Jesus/B-7809-2008; Cabezas, Francisco José/A-8859-2016; Cabezas, Francisco J./ABG-3403-2020; Cabezas, Francisco J./ABG-2629-2020; Martinez, Isabel/K-8800-2014; Felicisimo, Angel/B-4138-2008	Cabezas, Francisco J./0000-0003-0614-0445; Cabezas, Francisco J./0000-0003-0614-0445; Martinez, Isabel/0000-0002-5924-1648; Felicisimo, Angel/0000-0002-9953-8614; Munoz, Jesus/0000-0002-9266-2268				Brodo I. M., 2001, LICHENS N AM; CLOSE RC, 1978, INT J BIOMETEOROL, V22, P1, DOI 10.1007/BF01553136; FREEMAN JA, 1945, J ANIM ECOL, V14, P128, DOI 10.2307/1389; Greenslade P, 1999, J BIOGEOGR, V26, P1161, DOI 10.1046/j.1365-2699.1999.00356.x; Hooker JD., 1845, BOT ANTARCTIC VOYAGE, V1; Hubbell Stephen P., 2001, V32, pi; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Jet Propulsion Laboratory, 2001, SEAWINDS QUIKSCAT LE; Legendre P., 1998, NUMERICAL ECOLOGY, V2nd; Marshall WA, 1996, NATURE, V383, P680, DOI 10.1038/383680a0; MILLER N. G., 1985, MONOGRAPHS SYSTEMATI, V11, P71; MILLER NG, 1976, BRYOLOGIST, V79, P55, DOI 10.2307/3241866; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Oliver WRB, 1925, J LINN SOC LOND BOT, V47, P99, DOI DOI 10.1111/J.1095-8339.1925.TB01794.X; RAVEN P H, 1973, New Zealand Journal of Botany, V11, P177; Sassen K, 2003, J ATMOS SCI, V60, P873, DOI 10.1175/1520-0469(2003)060<0873:MCCDFH>2.0.CO;2; Shigesada N, 2002, DISPERSAL ECOLOGY, P350; TRYON R, 1986, BOT REV, V52, P117, DOI 10.1007/BF02860999; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; van Zanten B. O., 1976, J HATTORI BOT LAB, V41, P133; van Zanten BO, 1981, ADV BRYOLOGY, V1, P479; van Zanten BO., 1978, J HATTORI BOT LAB, V44, P455, DOI DOI 10.1639/0007-2745(1997)100[380:OMDBIG]2.0.CO;2; Winkworth RC, 2002, TRENDS ECOL EVOL, V17, P514, DOI 10.1016/S0169-5347(02)02590-9	24	405	422	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1144	1147		10.1126/science.1095210	http://dx.doi.org/10.1126/science.1095210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155945				2022-12-01	WOS:000221524500039
J	Liu, LD; Wong, TP; Pozza, MF; Lingenhoehl, K; Wang, YS; Sheng, M; Auberson, YP; Wang, YT				Liu, LD; Wong, TP; Pozza, MF; Lingenhoehl, K; Wang, YS; Sheng, M; Auberson, YP; Wang, YT			Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity	SCIENCE			English	Article							LONG-TERM DEPRESSION; SUBUNIT COMPOSITION; RAT-BRAIN; FUNCTIONAL-PROPERTIES; CRITICAL PERIOD; VISUAL-CORTEX; IN-VITRO; LTP; POTENTIATION; DEPENDENCE	Activation of N-methyl-D-aspartate subtype glutamate receptors (NMDARs) is required for long-term potentiation (LTP) and long-term depression (LTD) of excitatory synaptic transmission at hippocampal CA1 synapses, the proposed cellular substrates of learning and memory. However, little is known about how activation of NMDARs leads to these two opposing forms of synaptic plasticity. Using hippocampal slice preparations, we showed that selectively blocking NMDARs that contain the NR2B subunit abolishes the induction of LTD but not LTP. In contrast, preferential inhibition of NR2A-containing NMDARs prevents the induction of LTP without affecting LTD production. These results demonstrate that distinct NMDAR subunits are critical factors that determine the polarity of synaptic plasticity.	Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; MIT, Picower Ctr Learning & Memory, RIKE MIT Neurosci Res Ctr, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of British Columbia; Novartis; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Wang, YT (corresponding author), Univ British Columbia, Brain Res Ctr, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	ytwang@interchange.ubc.ca	Auberson, Yves/AAF-6538-2019; Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008	Auberson, Yves/0000-0001-5800-4811; Wong, Tak Pan/0000-0001-8611-4911; Liu, Lidong/0000-0002-7026-690X				Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BULLER AL, 1994, J NEUROSCI, V14, P5471; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Erisir A, 2003, J NEUROSCI, V23, P5208; ERRINGTON ML, 1995, J NEUROPHYSIOL, V74, P1793, DOI 10.1152/jn.1995.74.4.1793; Hendricson AW, 2002, J PHARMACOL EXP THER, V301, P938, DOI 10.1124/jpet.301.3.938; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kohr G, 2003, J NEUROSCI, V23, P10791; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; Mockett B, 2002, EUR J NEUROSCI, V15, P1819, DOI 10.1046/j.1460-9568.2002.02008.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mutel V, 1998, J NEUROCHEM, V70, P2147; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tovar KR, 1999, J NEUROSCI, V19, P4180; Wenzel A, 1997, J NEUROCHEM, V68, P469; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	36	857	902	0	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					1021	1024		10.1126/science.1096615	http://dx.doi.org/10.1126/science.1096615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143284				2022-12-01	WOS:000221383300052
J	Brown, EJ				Brown, EJ			The molecular basis of streptococcal toxic shock syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FIBRINOGEN		Univ Calif San Francisco, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Brown, EJ (corresponding author), Univ Calif San Francisco, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA.							Harlan JM, 2002, CRIT CARE MED, V30, pS214, DOI 10.1097/00003246-200205001-00007; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; LAUDANO AP, 1980, BIOCHEMISTRY-US, V19, P1013, DOI 10.1021/bi00546a028; Lolis E, 2003, NAT REV DRUG DISCOV, V2, P635, DOI 10.1038/nrd1153	4	19	21	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2004	350	20					2093	2094		10.1056/NEJMcibr040657	http://dx.doi.org/10.1056/NEJMcibr040657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819ZB	15141050				2022-12-01	WOS:000221354000014
J	Bottle, A; Jarman, B; Aylin, P; Taylor, R				Bottle, A; Jarman, B; Aylin, P; Taylor, R			Dr Foster's case notes - Some way to go for consistent implementation of guidance on hip fracture	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Bottle, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743					0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 8	2004	328	7448					1097	1097		10.1136/bmj.328.7448.1097	http://dx.doi.org/10.1136/bmj.328.7448.1097			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818YS	15130976	Green Published			2022-12-01	WOS:000221281000014
J	Fagerlin, A; Rovner, D; Stableford, S; Jentoft, C; Wei, JT; Holmes-Rovner, M				Fagerlin, A; Rovner, D; Stableford, S; Jentoft, C; Wei, JT; Holmes-Rovner, M			Patient education materials about the treatment of early-stage prostate cancer: A critical review	ANNALS OF INTERNAL MEDICINE			English	Review							NUMERACY; INFORMATION; DECISIONS; CHOICE	Background: To ensure that patients make informed medical decisions, patient education materials must communicate treatment risks and benefits. Objective: To survey publicly available patient education materials and assess their suitability to support informed decision making in early-stage prostate cancer. Design: Cross-sectional review of Internet, print, and multimedia sources. Setting: University data analysis laboratory. Measurements: The content of 44 materials that described all standard treatment options was reviewed. Top-rated documents underwent plain-language review. Total score on 54 content items and accuracy, balance, and plain-language evaluation was measured. Results: 502 of 546 patient education materials did not describe all standard treatments (watchful waiting, surgery, radiation, and hormone therapy). Eighty percent of the 44 materials that addressed standard treatments and underwent content review described anatomy, physiology, stage, and grade of cancer. Half of the materials fully described radical prostatectomy and radiation therapy. One third of the materials included risks and benefits of each treatment; none explicitly compared outcomes of all treatments in a single summary. Information was accurate and balanced but did not include key content for informed consent. Limitations: The search was restricted to publicly available materials and did not include books or materials written in languages other than English. The accuracy, balance, and plain-language reviews were evaluated by 1 reviewer. The criteria reflect the authors' focus on informed decision making. Other aspects of health education may require a different evaluation template. Conclusions: Currently available patient education materials on early-stage prostate cancer treatment do not contain comprehensive information about the risks and benefits of each treatment. To assist patients and physicians in choosing among prostate cancer treatment options, a new generation of materials is needed.	Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA; Vet Adm Ctr Practice Management & Outcomes Res, Vet Adm Healthcare Syst, Program Improving Hlth Care Decis, Ann Arbor, MI 48109 USA; Michigan State Univ, E Lansing, MI 48824 USA; Univ New England, Maine Area Hlth Educ Ctr, Hlth Literacy Ctr, Biddeford, ME USA	University of Michigan System; University of Michigan; Michigan State University; University of New England - Maine	Fagerlin, A (corresponding author), Univ Michigan, Div Gen Med, 300 N Ingalls Bldg,Room 7C27, Ann Arbor, MI 48109 USA.	fagerlin@umich.edu	Wei, John T/E-8967-2012; lei, cao/ABA-7520-2021					Adelsward V, 1996, SOC SCI MED, V43, P1179, DOI 10.1016/0277-9536(95)00366-5; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Centers for Disease Control and Prevention, 1999, SCI TECHN INF SIMPL; COULTER A, 1998, INFORMING PATIENTS A; Doak CC, 1996, TEACHING PATIENTS LO; Feldman-Stewart D, 2000, MED DECIS MAKING, V20, P228, DOI 10.1177/0272989X0002000208; Fischhoff Baruch, 1999, Journal of the National Cancer Institute Monographs, P7; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Holmes-Rovner M, 1999, MED CARE, V37, P270, DOI 10.1097/00005650-199903000-00007; Holmes-Rovner M, 2000, J EVAL CLIN PRACT, V6, P263, DOI 10.1046/j.1365-2753.2000.00258.x; Holmes-Rovner M, 2001, BMJ-BRIT MED J, V322, P664, DOI 10.1136/bmj.322.7287.664; Kirsch I. S., 1993, 93275 NCES US DEP ED; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; MAZUR DJ, 1993, MED DECIS MAKING, V13, P59, DOI 10.1177/0272989X9301300108; McBean A M, 1994, Health Care Financ Rev, V15, P77; O'Connor A M, 1999, J Natl Cancer Inst Monogr, P67; O'Connor AM, 1998, PATIENT EDUC COUNS, V33, P267, DOI 10.1016/S0738-3991(98)00026-3; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; O'Connor AM, 2003, COCHRANE LIB, P2; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; SELDEN CR, 2000, HLTH LIT CURRENT BIB; TAUB D, 2002, N CENTR SECT M AM UR	23	81	82	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2004	140	9					721	728		10.7326/0003-4819-140-9-200405040-00012	http://dx.doi.org/10.7326/0003-4819-140-9-200405040-00012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816XR	15126256				2022-12-01	WOS:000221143100006
J	Jung, GY; Stephanopoulos, G				Jung, GY; Stephanopoulos, G			A functional protein chip for pathway optimization and in vitro metabolic engineering	SCIENCE			English	Article							TREHALOSE; YEAST; GLYCOLYSIS	Pathway optimization is difficult to achieve owing to complex, nonlinear, and largely unknown interactions of enzymes, regulators, and metabolites. We report a pathway reconstruction using RNA display - derived messenger RNA - enzyme fusion molecules. These chimeras are immobilized by hybridization of their messenger RNA end with homologous capture DNA spotted on a substrate surface. Enzymes thus immobilized retain activity proportional to the amount of capture DNA, allowing modulation of the relative activity of pathway enzymes. Entire pathways can thus be reconstructed and optimized in vitro from genomic information. We provide concept validation with the sequential reactions catalyzed by luciferase and nucleoside diphosphate kinase and further illustrate this method with the optimization of the five-step pathway for trehalose synthesis.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Room 56-469, Cambridge, MA 02139 USA.	gregstep@mit.edu	Jung, Gyoo Yeol/R-7194-2019					BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Chi ZM, 2003, J BIOTECHNOL, V102, P135, DOI 10.1016/S0168-1656(03)00021-X; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Hugenholtz J, 2002, ANTON LEEUW INT J G, V82, P217, DOI 10.1023/A:1020608304886; Jorgensen H, 2002, APPL MICROBIOL BIOT, V59, P310, DOI 10.1007/s00253-002-1017-5; KACSER H, 1993, EUR J BIOCHEM, V216, P361, DOI 10.1111/j.1432-1033.1993.tb18153.x; Karamohamed S, 1999, BIOTECHNIQUES, V26, P728, DOI 10.2144/99264rr02; KIENLE I, 1993, YEAST, V9, P907; Klapa MI, 2003, EUR J BIOCHEM, V270, P3525, DOI 10.1046/j.1432-1033.2003.03732.x; Koffas MAG, 2003, METAB ENG, V5, P32, DOI 10.1016/S1096-7176(03)00002-8; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Pitts WJ, 2000, J MED CHEM, V43, P27, DOI 10.1021/jm9900321; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; Stafford DE, 2002, P NATL ACAD SCI USA, V99, P1801, DOI 10.1073/pnas.032681699; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Stephanopoulos G. N., 1998, METAB ENG, P115, DOI [10.1016/b978-012666260-3/50005-4, DOI 10.1016/B978-012666260-3/50005-4]; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Weng S, 2002, PROTEOMICS, V2, P48, DOI 10.1002/1615-9861(200201)2:1<48::AID-PROT48>3.0.CO;2-I	20	50	60	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					428	431		10.1126/science.1096920	http://dx.doi.org/10.1126/science.1096920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087547				2022-12-01	WOS:000220845400045
J	Bullinger, L; Dohner, K; Bair, E; Frohling, S; Schlenk, RF; Tibshirani, R; Dohner, H; Pollack, JR				Bullinger, L; Dohner, K; Bair, E; Frohling, S; Schlenk, RF; Tibshirani, R; Dohner, H; Pollack, JR			Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL LYMPHOMA; STUDY-GROUP ULM; NORMAL CYTOGENETICS; NORMAL HEMATOPOIESIS; PREDICT SURVIVAL; IN-VIVO; AML 10; MLL; TUMORS; CANCER	Background: In patients with acute myeloid leukemia (AML), the presence or absence of recurrent cytogenetic aberrations is used to identify the appropriate therapy. However, the current classification system does not fully reflect the molecular heterogeneity of the disease, and treatment stratification is difficult, especially for patients with intermediate-risk AML with a normal karyotype. Methods: We used complementary-DNA microarrays to determine the levels of gene expression in peripheral-blood samples or bone marrow samples from 116 adults with AML (including 45 with a normal karyotype). We used unsupervised hierarchical clustering analysis to identify molecular subgroups with distinct gene-expression signatures. Using a training set of samples from 59 patients, we applied a novel supervised learning algorithm to devise a gene-expression-based clinical-outcome predictor, which we then tested using an independent validation group comprising the 57 remaining patients. Results: Unsupervised analysis identified new molecular subtypes of AML, including two prognostically relevant subgroups in AML with a normal karyotype. Using the supervised learning algorithm, we constructed an optimal 133-gene clinical-outcome predictor, which accurately predicted overall survival among patients in the independent validation group (P=0.006), including the subgroup of patients with AML with a normal karyotype (P=0.046). In multivariate analysis, the gene-expression predictor was a strong independent prognostic factor (odds ratio, 8.8; 95 percent confidence interval, 2.6 to 29.3; P<0.001). Conclusions: The use of gene-expression profiling improves the molecular classification of adult AML.	Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany	Stanford University; Stanford University; Stanford University; Ulm University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, 269 Campus Dr,CCSR 3245A, Stanford, CA 94305 USA.	pollack1@stanford.edu	Schlenk, Richard/AAG-3218-2019; Bullinger, Lars/AAL-7965-2020; Döhner, Hartmut/C-8933-2016	Döhner, Hartmut/0000-0003-2116-5536; Bullinger, Lars/0000-0002-5890-5510; Bair, Eric/0000-0001-8733-7869				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bloomfield CD, 1998, CANCER RES, V58, P4173; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Caligiuri MA, 1998, CANCER RES, V58, P55; Dohner K, 2002, J CLIN ONCOL, V20, P3254, DOI 10.1200/JCO.2002.09.088; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Frohling S, 2002, J CLIN ONCOL, V20, P2480, DOI 10.1200/JCO.2002.08.155; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; GILES FJ, 2002, ACUTE MYELOID LEUKEM, P73; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Lowenberg B, 2001, BEST PRACT RES CL HA, V14, P65, DOI 10.1053/beha.2000.0116; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Mrozek K, 2001, BEST PRACT RES CL HA, V14, P19, DOI 10.1053/beha.2000.0114; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tanabe S, 1996, GENE CHROMOSOME CANC, V15, P206, DOI 10.1002/(SICI)1098-2264(199604)15:4<206::AID-GCC2>3.0.CO;2-5; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	45	766	826	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1605	1616		10.1056/NEJMoa031046	http://dx.doi.org/10.1056/NEJMoa031046			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084693				2022-12-01	WOS:000220819800005
J	Shapiro, MD; Marks, ME; Peichel, CL; Blackman, BK; Nereng, KS; Jonsson, B; Schluter, D; Kingsley, DM				Shapiro, MD; Marks, ME; Peichel, CL; Blackman, BK; Nereng, KS; Jonsson, B; Schluter, D; Kingsley, DM			Genetic and developmental basis of evolutionary pelvic reduction in threespine sticklebacks	NATURE			English	Article							GASTEROSTEUS-ACULEATUS; T-BOX; PUNGITIUS-PUNGITIUS; BROOK STICKLEBACK; CULAEA-INCONSTANS; HINDLIMB; LIMB; POPULATIONS; DROSOPHILA; IDENTITY	Hindlimb loss has evolved repeatedly in many different animals by means of molecular mechanisms that are still unknown. To determine the number and type of genetic changes underlying pelvic reduction in natural populations, we carried out genetic crosses between threespine stickleback fish with complete or missing pelvic structures. Genome-wide linkage mapping shows that pelvic reduction is controlled by one major and four minor chromosome regions. Pitx1 maps to the major chromosome region controlling most of the variation in pelvic size. Pelvic-reduced fish show the same left-right asymmetry seen in Pitx1 knockout mice, but do not show changes in Pitx1 protein sequence. Instead, pelvic-reduced sticklebacks show site-specific regulatory changes in Pitx1 expression, with reduced or absent expression in pelvic and caudal fin precursors. Regulatory mutations in major developmental control genes may provide a mechanism for generating rapid skeletal changes in natural populations, while preserving the essential roles of these genes in other processes.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Holar Agr Coll, Inst Freshwater Fisheries, IS-551 Saudarkrokur, Iceland; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; Fred Hutchinson Cancer Center; University of British Columbia	Kingsley, DM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu	Marks, Melissa/V-6587-2019	Marks, Melissa/0000-0003-2625-6322; Peichel, Catherine/0000-0002-7731-8944; Schluter, Dolph/0000-0003-1683-7836; Blackman, Benjamin/0000-0003-4936-6153				Bejder L, 2002, EVOL DEV, V4, P445, DOI 10.1046/j.1525-142X.2002.02033.x; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; BELL MA, 1987, BIOL J LINN SOC, V31, P347, DOI 10.1111/j.1095-8312.1987.tb01998.x; BELL MA, 1985, COPEIA, P437; BELL MA, 1993, EVOLUTION, V47, P906, DOI 10.1111/j.1558-5646.1993.tb01243.x; BELL MA, 1985, PALEOBIOLOGY, V11, P258, DOI 10.1017/S0094837300011581; Bell MA, 1974, NAT HIST MUS ANGEL C, V257, P1; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; CAMPBELL RN, 1979, P ROY SOC EDINB B, V77, P377, DOI 10.1017/S026972700001280X; Campione M, 1999, DEVELOPMENT, V126, P1225; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Darwin C.R., 1859, ORIGIN SPECIES MEANS, P450; EDGE TA, 1983, CAN FIELD NAT, V97, P334; Garrity DM, 2002, DEVELOPMENT, V129, P4635; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; GILES N, 1983, J ZOOL, V199, P535; Hoogland R., 1957, Behaviour, V10, P205; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lanctot C, 1999, DEVELOPMENT, V126, P1805; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 1998, DEVELOPMENT, V125, P2825; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; MOODIE GEE, 1976, SYST ZOOL, V25, P49, DOI 10.2307/2412778; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; NELSON JS, 1971, COPEIA, P707; NELSON JS, 1977, J FISH RES BOARD CAN, V34, P1314, DOI 10.1139/f77-193; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; REIST JD, 1980, CAN J ZOOL, V58, P1253, DOI 10.1139/z80-175; Ross M.T., 1999, CURRENT PROTOCOLS HU; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shang J, 1997, DEV DYNAM, V209, P242, DOI 10.1002/(SICI)1097-0177(199706)209:2<242::AID-AJA10>3.0.CO;2-0; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Struthers J., 1881, J ANATOMY PHYSL, V15, P141; STRUTHERS J, 1881, J ANAT PHYSL, V15, P302; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; SWARUP H, 1958, J EMBRYOL EXP MORPH, V6, P373; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Wilkinson D.G., 1993, ESSENTIAL DEV BIOL P, P257; Ziuganov VV, 1995, BEHAVIOUR, V132, P1095, DOI 10.1163/156853995X00478; [No title captured]	51	637	655	4	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					717	723		10.1038/nature02415	http://dx.doi.org/10.1038/nature02415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085123				2022-12-01	WOS:000220823800030
J	Field, J; Brace, S				Field, J; Brace, S			Pre-social benefits of extended parental care	NATURE			English	Article							SUBSOCIAL INTERTIDAL BEETLE; BLEDIUS-SPECTABILIS; SOLITARY WASP; PARASITISM; EVOLUTION; EUSOCIALITY; HYMENOPTERA; ADVANTAGE; BEES	The evolution of helping, in which some individuals forfeit their own reproduction and help others to reproduce, is a central problem in evolutionary biology. Recently proposed insurance-based mechanisms rely on a pre-existing life history with a long period of offspring dependency relative to the short life expectancies of adult carers(1-4): a lone mother's offspring are doomed if she dies young, whereas after a helper dies, other group members can finish rearing the offspring(5,6). A critical question, however, is how this life history could evolve in ancestral non-social populations, as offspring survival would then depend on a single, short-lived carer. Here, we resolve this paradox by focusing on the extended parental care inherent in prolonged dependency. We show experimentally that in non-social wasps, extended care can significantly reduce the impact of interspecific parasites. Under extended care, offspring are less vulnerable by the time they are exposed to parasites, and costs of parasitism are reduced because mothers have the option to terminate investment in failing offspring. By experimentally simulating aspects of extended care in a species where it is lacking, we demonstrate that neither benefit requires specialized behaviour. Such benefits could therefore offset the disadvantage of prolonged dependency in non-social species, thereby facilitating the evolution of helping.	UCL, Dept Biol, London NW1 2HE, England	University of London; University College London	Field, J (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	jeremy.field@ucl.ac.uk						[Anonymous], 2000, BEES WORLD; Baerends G. P., 1941, Tijdschrift voor Entomologie Amsterdam, V84, P68; Beekman M, 2003, TRENDS ECOL EVOL, V18, P277, DOI 10.1016/S0169-5347(03)00068-5; Bohart R. M., 1976, SPHECID WASPS WORLD; Carpenter J.M., 1991, P7; Cowan D.P., 1991, P33; Evans H.E., 1966, COMP ETHOLOGY EVOLUT; EVANS HOWARD E., 1959, AMER MIDLAND NAT, V62, P449, DOI 10.2307/2422538; Fabre J.-H., 1916, HUNTING WASPS; FIELD J, 1989, BEHAVIOUR, V110, P219, DOI 10.1163/156853989X00475; FIELD J, 1989, BEHAVIOUR, V110, P23, DOI 10.1163/156853989X00367; Field J, 2000, NATURE, V404, P869, DOI 10.1038/35009097; GADAGKAR R, 1990, PHILOS T ROY SOC B, V329, P17, DOI 10.1098/rstb.1990.0146; GODFRAY HCJ, 1994, PARASITOIDS; HAGER BJ, 1985, PSYCHE-STUTTGART, V92, P7451; Hunt James H., 1994, P211; Hunt JH, 1999, EVOLUTION, V53, P225, DOI 10.1111/j.1558-5646.1999.tb05348.x; O'Neill K. M., 2001, SOLITARY WASPS; Queller David C., 1996, P218; QUELLER DC, 1994, P ROY SOC B-BIOL SCI, V256, P105, DOI 10.1098/rspb.1994.0056; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reeve H.K., 1991, P99; ROSENHEIM JA, 1987, ANN ENTOMOL SOC AM, V80, P739, DOI 10.1093/aesa/80.6.739; SAMUEL CT, 1987, FACTORS AFFECTING CO; Schwarz MP, 2003, SYST BIOL, V52, P1, DOI 10.1080/10635150390132632; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; Wcislo WT, 1996, J INSECT BEHAV, V9, P643, DOI 10.1007/BF02213885; WYATT TD, 1989, ANIM BEHAV, V38, P778, DOI 10.1016/S0003-3472(89)80110-1; WYATT TD, 1989, BEHAVIOUR, V110, P76, DOI 10.1163/156853989X00394; [No title captured]	30	48	49	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2004	428	6983					650	652		10.1038/nature02427	http://dx.doi.org/10.1038/nature02427			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071594				2022-12-01	WOS:000220697200043
J	Hasan, RK; Wulfkuhle, JD; Liotta, LA; Petricoin, EF				Hasan, RK; Wulfkuhle, JD; Liotta, LA; Petricoin, EF			Molecular technologies for personalized cancer management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHASE PROTEIN MICROARRAYS; BREAST-CANCER; OVARIAN-CANCER; CHEMOTHERAPY; SURVIVAL; PROGRESSION; MUTATIONS; DNA		Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; NCI, Bethesda, MD 20892 USA; US FDA, Bethesda, MD 20014 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Hasan, RK (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.							*AM CANC SOC, 2003, CANC FACTS FIG; Baak JPA, 2003, EUR J CANCER, V39, P1199, DOI 10.1016/S0959-8049(03)00265-X; Cheng L, 1999, CANCER, V85, P2455, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2455::AID-CNCR22>3.0.CO;2-C; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Haber D, 2002, NEW ENGL J MED, V346, P1660, DOI 10.1056/NEJMed020044; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; LU ZH, 1993, CANCER RES, V53, P5433; Mariadason JM, 2003, HEMATOL ONCOL CLIN N, V17, P377, DOI 10.1016/S0889-8588(03)00006-6; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Shirota Y, 2001, J CLIN ONCOL, V19, P4298, DOI 10.1200/JCO.2001.19.23.4298; Sotiriou C, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr433; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Workman P, 2001, Expert Opin Pharmacother, V2, P911; Wulfkuhle JD, 2003, PROTEOMICS, V3, P2085, DOI 10.1002/pmic.200300591; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043	20	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1644	1645		10.1001/jama.291.13.1644	http://dx.doi.org/10.1001/jama.291.13.1644			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809PQ	15069056				2022-12-01	WOS:000220649000033
J	Korobkova, E; Emonet, T; Vilar, JMG; Shimizu, TS; Cluzel, P				Korobkova, E; Emonet, T; Vilar, JMG; Shimizu, TS; Cluzel, P			From molecular noise to behavioural variability in a single bacterium	NATURE			English	Article							ESCHERICHIA-COLI; CHEMOTAXIS; ADAPTATION; METHYLATION; ROBUSTNESS; PROTEINS; MODEL; MOTOR; CELLS	The chemotaxis network that governs the motion of Escherichia coli has long been studied to gain a general understanding of signal transduction. Although this pathway is composed of just a few components, it exhibits some essential characteristics of biological complexity, such as adaptation and response to environmental signals(1). In studying intracellular networks, most experiments and mathematical models(2-5) have assumed that network properties can be inferred from population measurements. However, this approach masks underlying temporal fluctuations of intracellular signalling events. We have inferred fundamental properties of the chemotaxis network from a noise analysis of behavioural variations in individual bacteria. Here we show that certain properties established by population measurements, such as adapted states, are not conserved at the single-cell level: for timescales ranging from seconds to several minutes, the behaviour of non-stimulated cells exhibit temporal variations much larger than the expected statistical fluctuations. We find that the signalling network itself causes this noise and identify the molecular events that produce it. Small changes in the concentration of one key network component suppress temporal behavioural variability, suggesting that such variability is a selected property of this adaptive system.	Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Rockefeller Univ, New York, NY 10021 USA; Keio Univ, Inst Adv Biosci, Lab Bioinformat, Fujisawa, Kanagawa 2528520, Japan	University of Chicago; University of Chicago; Rockefeller University; Keio University	Cluzel, P (corresponding author), Univ Chicago, Inst Biophys Dynam, 5640 S Ellis Ave, Chicago, IL 60637 USA.	cluzel@uchicago.edu	Emonet, Thierry/AAI-3740-2020; Vilar, Jose MG/A-9069-2013	Vilar, Jose MG/0000-0003-4037-0746				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; ASAKURA S, 1984, J MOL BIOL, V176, P349, DOI 10.1016/0022-2836(84)90494-7; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; FAHRNER KA, 1995, THESIS HARVARD U; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; KHAN S, 1980, J MOL BIOL, V138, P563, DOI 10.1016/S0022-2836(80)80018-0; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Levit MN, 2002, J BIOL CHEM, V277, P36760, DOI 10.1074/jbc.M204325200; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Morton-Firth CJ, 1998, J THEOR BIOL, V192, P117, DOI 10.1006/jtbi.1997.0651; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; SAMUEL ADT, 1995, P NATL ACAD SCI USA, V92, P3502, DOI 10.1073/pnas.92.8.3502; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	24	343	354	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					574	578		10.1038/nature02404	http://dx.doi.org/10.1038/nature02404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15058306				2022-12-01	WOS:000220540100045
J	Schneider, H; Schuettpelz, E; Pryer, KM; Cranfill, R; Magallon, S; Lupia, R				Schneider, H; Schuettpelz, E; Pryer, KM; Cranfill, R; Magallon, S; Lupia, R			Ferns diversified in the shadow of angiosperms	NATURE			English	Article							DIVERGENCE TIMES; EVOLUTION; SEQUENCES; ABUNDANCE; PLANTS; LIGHT; RATES; RBCL	The rise of angiosperms during the Cretaceous period is often portrayed as coincident with a dramatic drop in the diversity and abundance of many seed-free vascular plant lineages, including ferns(1-5). This has led to the widespread belief that ferns, once a principal component of terrestrial ecosystems(6), succumbed to the ecological predominance of angiosperms and are mostly evolutionary holdovers from the late Palaeozoic/early Mesozoic era. The first appearance of many modern fern genera in the early Tertiary fossil record implies another evolutionary scenario; that is, that the majority of living ferns resulted from a more recent diversification(7-10). But a full understanding of trends in fern diversification and evolution using only palaeobotanical evidence is hindered by the poor taxonomic resolution of the fern fossil record in the Cretaceous(11). Here we report divergence time estimates for ferns and angiosperms based on molecular data, with constraints from a reassessment of the fossil record. We show that polypod ferns (>80% of living fern species) diversified in the Cretaceous, after angiosperms, suggesting perhaps an ecological opportunistic response to the diversification of angiosperms, as angiosperms came to dominate terrestrial ecosystems.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Univ Gottingen, Albert von Haller Inst Pflanzenwissensch, Abt Systemat Bot, D-37073 Gottingen, Germany; Univ Calif Berkeley, Univ Herbarium, Berkeley, CA 94720 USA; Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City 04510, DF, Mexico; Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73072 USA; Univ Oklahoma, Sch Geol & Geophys, Norman, OK 73072 USA	Duke University; University of Gottingen; University of California System; University of California Berkeley; Universidad Nacional Autonoma de Mexico; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Pryer, KM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	pryer@duke.edu	Pryer, Kathleen/X-4635-2019; Schuettpelz, Eric/A-4881-2008; Schneider, Harald/B-6681-2008; Pryer, Kathleen M./ABF-4908-2020	Schneider, Harald/0000-0002-4548-7268; Pryer, Kathleen M./0000-0002-9776-6736; Schuettpelz, Eric/0000-0003-3891-9904; Magallon, Susana/0000-0002-6838-7497				Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Collinson M. E., 1996, PTERIDOLOGY PERSPECT, P349; Crane P.R., 1987, ORIGINS ANGIOSPERMS, P107; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Deng SH, 2002, REV PALAEOBOT PALYNO, V119, P93, DOI 10.1016/S0034-6667(01)00131-2; Dilcher DL, 2001, TAXON, V50, P697, DOI 10.2307/1223702; Friis EM, 2001, NATURE, V410, P357, DOI 10.1038/35066557; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kawai H, 2003, NATURE, V421, P287, DOI 10.1038/nature01310; LIDGARD S, 1990, PALEOBIOLOGY, V16, P77, DOI 10.1017/S009483730000974X; Lovis J.D., 1978, ADV BOT RES, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Nagalingum NS, 2002, REV PALAEOBOT PALYNO, V119, P69, DOI 10.1016/S0034-6667(01)00130-0; NIKLAS KJ, 1983, NATURE, V303, P614, DOI 10.1038/303614a0; PAGEL M, 2002, BIOL EVOLUTION STAT, P148; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rothwell G. W., 1996, PTERIDOLOGY PERSPECT, P395; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sandler HM, 2002, CANCER J, V8, P301, DOI 10.1097/00130404-200207000-00005; Schneider H, 2001, REV PALAEOBOT PALYNO, V115, P33, DOI 10.1016/S0034-6667(01)00048-3; Skog JE, 2001, BRITTONIA, V53, P236, DOI 10.1007/BF02812701; SMITH A R, 1972, Biotropica, V4, P4, DOI 10.2307/2989639; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI [10.1111/j.1095-8339.2000.tb01588.x, 10.1006/bojl.2000.0380]; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wikstrom N, 2001, MOL PHYLOGENET EVOL, V19, P177, DOI 10.1006/mpev.2001.0936	30	545	609	5	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					553	557		10.1038/nature02361	http://dx.doi.org/10.1038/nature02361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15058303				2022-12-01	WOS:000220540100040
J	Reynolds, SJ; Shepherd, ME; Risbud, AR; Gangakhedkar, RR; Brookmeyer, RS; Divekar, AD; Mehendale, SM; Bollinger, RC				Reynolds, SJ; Shepherd, ME; Risbud, AR; Gangakhedkar, RR; Brookmeyer, RS; Divekar, AD; Mehendale, SM; Bollinger, RC			Male circumcision and risk of HIV-1 and other sexually transmitted infections in India	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COHORT	Circumcised men have a lower risk of HIV-1 infection than uncircumcised men. Laboratory findings suggest that the foreskin is enriched with HIV-1 target cells. However, some data suggest that circumcision could simply be a marker for low-risk behaviours. In a prospective study of 2298 HIV-uninfected men attending sexually transmitted infection clinics in India, we noted that circumcision was strongly protective against HIV-1 infection (adjusted relative risk 0.15; 95% Cl 0.04-0.62; p=0.0089); however, we noted no protective effect against herpes simplex virus type 2, syphilis, or gonorrhoea. The specificity of this relation suggests a biological rather than behavioural explanation for the protective effect of male circumcision against HIV-1.	Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; Natl AIDS Res Inst, Pune, Maharashtra, India	Johns Hopkins University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Bollinger, RC (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Ross 1150,720 Rutland Ave, Baltimore, MD 21205 USA.	rcb@jhmi.edu		Bollinger, Robert/0000-0002-6798-6834; Reynolds, Steven/0000-0002-5403-2759	FIC NIH HHS [TW000010] Funding Source: Medline; NIAID NIH HHS [R21-AI3387901, N01-AI35173, R01-AI41369] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041369, N01AI035173, R21AI033879] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; MEHENDALE SM, 1995, J INFECT DIS, V172, P1486, DOI 10.1093/infdis/172.6.1486; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018	5	126	127	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 27	2004	363	9414					1039	1040		10.1016/S0140-6736(04)15840-6	http://dx.doi.org/10.1016/S0140-6736(04)15840-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15051285				2022-12-01	WOS:000220497300011
J	McNutt, R; Abrams, R; Hasler, S				McNutt, R; Abrams, R; Hasler, S			Why blame systems for unsafe care?	LANCET			English	Editorial Material							ERRORS		Rush Univ, Med Ctr, Dept Med, Chicago, IL 60621 USA	Rush University	McNutt, R (corresponding author), Rush Univ, Med Ctr, Dept Med, Chicago, IL 60621 USA.	Robert_McNutt@rush.edu						Berwick DM, 2003, NEW ENGL J MED, V348, P2570, DOI 10.1056/NEJMe030044; Berwick DM, 2001, BMJ-BRIT MED J, V322, P247, DOI 10.1136/bmj.322.7281.247; Cleghorn GD, 1996, JOINT COMM J QUAL IM, V22, P206, DOI 10.1016/S1070-3241(16)30223-1; McNutt RA, 2002, JAMA-J AM MED ASSOC, V287, P1997, DOI 10.1001/jama.287.15.1997; Pande P.S., 2000, 6 SIGMA WAY GE MOTOR; SCHRIEBER J, 2003, MANAGEMENT DIABETIC	6	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 20	2004	363	9413					913	914		10.1016/S0140-6736(04)15821-2	http://dx.doi.org/10.1016/S0140-6736(04)15821-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804OS	15043956				2022-12-01	WOS:000220308600005
J	Whicker, FW; Hinton, TG; MacDonell, MM; Pinder, JE; Habegger, LJ				Whicker, FW; Hinton, TG; MacDonell, MM; Pinder, JE; Habegger, LJ			Environment - Avoiding destructive remediation at DOE sites	SCIENCE			English	Editorial Material							GRASSLAND; PLUTONIUM		Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA; Argonne Natl Lab, Environm Assessment Div, Argonne, IL 60439 USA	Colorado State University; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Argonne National Laboratory	Whicker, FW (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	ward.whicker@colostate.edu						Breshears DD, 2003, EARTH SURF PROC LAND, V28, P1189, DOI 10.1002/esp.1034; Church BW, 2001, ENVIRON SCI POLLUT R, P9, DOI 10.1065/espr2001.11.099.4; DOE, 1997, DOEEM0319; HEBERT HJ, 2003, ASSOCIATED PRES 0717; Johansen MP, 2003, J ENVIRON QUAL, V32, P2150, DOI 10.2134/jeq2003.2150; LITTLE CA, 1978, HEALTH PHYS, V34, P451, DOI 10.1097/00004032-197805000-00005; LITTLE CA, 1980, J ENVIRON QUAL, V9, P350, DOI 10.2134/jeq1980.00472425000900030004x; MARCY BC, 1994, 19 ANN C P NEW ORL L; NELSON RH, 2001, WASTE WILDERNESS MAI; PASTERNAK D, 1992, US NEWS WORLD R 1214, P34; *US DOE, 2003, 4551 US DOE; US DoE, 2002, DOESTD11532002; *US DOE, 2002, REV ENV MAN PROGR; *US DOE, 2003, GUID DEV SIT SPEC RI; Whicker FW, 1995, INT AEAPS 2, P561; WHICKER FW, 1990, ECOL MONOGR, V60, P471, DOI 10.2307/1943017; WHICKER FW, 1997, FRESHWATER ESTUARINE; WHICKER FW, 1993, ENV HLTH PHYSICS, P473; ROCKY FLATS CLEANUP; 1993, FED REG         0325, V58, P16268	20	77	86	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1615	1616		10.1126/science.1093187	http://dx.doi.org/10.1126/science.1093187			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15016982				2022-12-01	WOS:000220151400025
J	Laurance, WF; Oliveira, AA; Laurance, SG; Condit, R; Nascimento, HEM; Sanchez-Thorin, AC; Lovejoy, TE; Andrade, A; D'Angelo, S; Ribeiro, JE; Dick, CW				Laurance, WF; Oliveira, AA; Laurance, SG; Condit, R; Nascimento, HEM; Sanchez-Thorin, AC; Lovejoy, TE; Andrade, A; D'Angelo, S; Ribeiro, JE; Dick, CW			Pervasive alteration of tree communities in undisturbed Amazonian forests	NATURE			English	Article							TROPICAL RAIN-FOREST; EL-NINO; GROWTH; VARIABILITY; SEEDLINGS	Amazonian rainforests are some of the most species-rich tree communities on earth(1). Here we show that, over the past two decades, forests in a central Amazonian landscape have experienced highly nonrandom changes in dynamics and composition. Our analyses are based on a network of 18 permanent plots unaffected by any detectable disturbance. Within these plots, rates of tree mortality, recruitment and growth have increased over time. Of 115 relatively abundant tree genera, 27 changed significantly in population density or basal area-a value nearly 14 times greater than that expected by chance. An independent, eight-year study in nearby forests corroborates these shifts in composition. Contrary to recent predictions(2-5), we observed no increase in pioneer trees. However, genera of faster-growing trees, including many canopy and emergent species, are increasing in dominance or density, whereas genera of slower-growing trees, including many subcanopy species, are declining. Rising atmospheric CO2 concentrations(6) may explain these changes, although the effects of this and other large-scale environmental alterations remain uncertain. These compositional changes could have important impacts on the carbon storage, dynamics and biota of Amazonian forests.	Smithsonian Trop Res Inst, Balboa, Panama; INPA, Dept Bot, BR-69011970 Manaus, Amazonas, Brazil; INPA, Biol Dynam Forest Fragments Project, BR-69011970 Manaus, Amazonas, Brazil; Univ Sao Paulo, Dept Biol, BR-14040901 Sao Paulo, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Universidade de Sao Paulo	Laurance, WF (corresponding author), Smithsonian Trop Res Inst, Apartado 2072, Balboa, Panama.	laurancew@tivoli.si.edu	Ribeiro, Jose Eduardo L. S./A-8574-2013; Nascimento, Henrique E/F-8612-2012; Laurance, William F/B-2709-2012; Laurance, Susan/G-6021-2011; Oliveira, Alexandre/ABH-1255-2020; de Oliveira, Alexandre Adalardo/G-8830-2012	Ribeiro, Jose Eduardo L. S./0000-0002-2389-5631; Laurance, William F/0000-0003-4430-9408; Laurance, Susan/0000-0002-2831-2933; Oliveira, Alexandre/0000-0001-5526-8109; de Oliveira, Alexandre Adalardo/0000-0001-5526-8109				ARTAXO P, 2003, INT GLOB ATMOS CHEM, V27, P12; BAKER TR, IN PRESS PHIL T R B; CASPER BB, 1992, OECOLOGIA, V90, P212, DOI 10.1007/BF00317178; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; CLARK DA, 1994, J ECOL, V82, P865, DOI 10.2307/2261450; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; Dunbar RB, 2000, NATURE, V407, P956, DOI 10.1038/35039661; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Korner C, 1998, CLIMATIC CHANGE, V39, P297, DOI 10.1023/A:1005325204713; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; LEWIS SL, IN PRESS PHIL T R B; Malhi Y, 1998, J GEOPHYS RES-ATMOS, V103, P31593, DOI 10.1029/98JD02647; MALHI Y, IN PRESS PHIL T R B; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; PHILLIPS OL, IN PRESS PHIL T R B; Piperno DR, 1996, QUATERNARY RES, V45, P202, DOI 10.1006/qres.1996.0020; REEKIE EG, 1989, OECOLOGIA, V79, P212, DOI 10.1007/BF00388481; Ter Steege H, 2001, ECOLOGY, V82, P3197, DOI 10.1890/0012-9658(2001)082[3197:CCDADI]2.0.CO;2; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; Winter K, 1999, FLORA, V194, P221, DOI 10.1016/S0367-2530(17)30900-3; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.1890/0012-9658(1999)080[1632:TENOSO]2.0.CO;2	29	195	215	2	61	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					171	175		10.1038/nature02383	http://dx.doi.org/10.1038/nature02383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014498	Green Published			2022-12-01	WOS:000220103600046
J	Shulman, AI; Larson, C; Mangelsdorf, DJ; Ranganathan, R				Shulman, AI; Larson, C; Mangelsdorf, DJ; Ranganathan, R			Structural determinants of allosteric ligand activation in RXR heterodimers	CELL			English	Article							RETINOID-X-RECEPTORS; VITAMIN-D-RECEPTOR; NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; PROTEIN FAMILIES; MOLECULAR-BASIS; BINDING DOMAIN; LXR-ALPHA; ACID; IDENTIFICATION	Allosteric communication underlies ligand-dependent transcriptional responses mediated by nuclear receptors. While studies have elucidated many of the components involved in this process, the energetic architecture within the receptor protein that mediates allostery remains unknown. Using a sequence-based method designed to detect coevolution of amino acids in a protein, termed the statistical coupling analysis (SCA), we identify a network of energetically coupled residues that link the functional surfaces of nuclear receptor ligand binding domains. Functional analysis of these predicted residues demonstrates their participation in an allosteric network that governs the ability of heterodimeric receptors to activate transcription in response to ligand binding by either partner. Interestingly, mutation of a single network residue can discriminate between receptor activation by endocrine dietary, and synthetic agonists. These results reveal a structural network required for RXR heterodimer allosteric communication and suggest that the specificity of ligand response and permissivity coevolved to enable signal discrimination.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu		Mangelsdorf, David/0000-0002-4355-0796				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; Doolittle R. F, 1996, COMPUTER METHODS MAC; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; HARMON MA, 1995, P NATL ACAD SCI USA, V92, P6157, DOI 10.1073/pnas.92.13.6157; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson PD, 1998, J BIOL CHEM, V273, P8483, DOI 10.1074/jbc.273.14.8483; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	34	265	270	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					417	429		10.1016/S0092-8674(04)00119-9	http://dx.doi.org/10.1016/S0092-8674(04)00119-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016376	Bronze			2022-12-01	WOS:000188825800010
J	Fremeau, RT; Kam, K; Qureshi, T; Johnson, J; Copenhagen, DR; Storm-Mathisen, J; Chaudhry, FA; Nicoll, RA; Edwards, RH				Fremeau, RT; Kam, K; Qureshi, T; Johnson, J; Copenhagen, DR; Storm-Mathisen, J; Chaudhry, FA; Nicoll, RA; Edwards, RH			Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites	SCIENCE			English	Article							INORGANIC-PHOSPHATE COTRANSPORTER; MOLECULAR-CLONING; SYNAPSIN-I; BRAIN; IDENTIFICATION; VESICLES; NEURONS; EXPRESSION; TRANSMISSION; PROBABILITY	Vesicular glutamate transporters (VGLUTs) 1 and 2 show a mutually exclusive distribution in the adult brain that suggests specialization for synapses with different properties of release. Consistent with this distribution, inactivation of the VGLUT1 gene silenced a subset of excitatory neurons in the adult. However, the same cell populations exhibited VGLUT1-independent transmission early in life. Developing hippocampal neurons transiently coexpressed VGLUT2 and VGLUT1 at distinct synaptic sites with different short-term plasticity. The loss of VGLUT1 also reduced the reserve pool of synaptic vesicles. Thus, VGLUT1 plays an unanticipated role in membrane trafficking at the nerve terminal.	Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, Grad Program Cell Biol, San Francisco, CA 94143 USA; Univ Oslo, Inst Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oslo; University of Oslo	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu; edwards@itsa.ucsf.edu		Storm-Mathisen, Jon/0000-0002-2930-3262	NEI NIH HHS [R01 EY001869] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001869] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; CARLSON MD, 1989, J BIOL CHEM, V264, P7369; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Gras C, 2002, J NEUROSCI, V22, P5442; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	27	365	376	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1815	1819		10.1126/science.1097468	http://dx.doi.org/10.1126/science.1097468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15118123				2022-12-01	WOS:000222089500049
J	Birchall, M				Birchall, M			Tongue transplantation	LANCET			English	Editorial Material							REPLANTATION		Univ Hosp Aintree, Head & Neck Canc Ctr, Liverpool L7AL, Merseyside, England		Birchall, M (corresponding author), Univ Hosp Aintree, Head & Neck Canc Ctr, Liverpool L7AL, Merseyside, England.	martinbirchall@btinternet.com						Buntic RF, 1998, PLAST RECONSTR SURG, V101, P1604, DOI 10.1097/00006534-199805000-00026; Day TA, 2000, MICROSURG, V20, P105, DOI 10.1002/(SICI)1098-2752(2000)20:3<105::AID-MICR2>3.0.CO;2-3; Dubernard JM, 2003, ANN SURG, V238, P128, DOI 10.1097/01.SLA.0000078945.70869.82; Hettiaratchy S, 2002, LANCET, V360, P5, DOI 10.1016/S0140-6736(02)09361-3; Klotzko AJ, 1999, NEW SCI, V162, P51; Marcen R, 2003, TRANSPL P, V35, P1714, DOI 10.1016/S0041-1345(03)00669-9; Mihalov ML, 1996, CLIN TRANSPLANT, V10, P248; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; Zuydam AC, 2000, BRIT J ORAL MAX SURG, V38, P513, DOI 10.1054/bjom.2000.0482; 2003, CDS REV, V96, P44; 2003, BBC NEWS        0722	11	30	33	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 22	2004	363	9422					1663	1663		10.1016/S0140-6736(04)16287-9	http://dx.doi.org/10.1016/S0140-6736(04)16287-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822NG	15158625				2022-12-01	WOS:000221546300004
J	Yamashita, S; Miyagi, C; Fukada, T; Kagara, N; Che, YS; Hirano, T				Yamashita, S; Miyagi, C; Fukada, T; Kagara, N; Che, YS; Hirano, T			Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer	NATURE			English	Article							TRANSCRIPTION FACTOR SNAIL; BREAST-CANCER; MUTANT EMBRYOS; CELL MOVEMENTS; WILD-TYPE; EXPRESSION; STAT3; GENE; MORPHOGENESIS; INVOLVEMENT	Vertebrate gastrulation is a critical step in the establishment of body plan. During gastrulation, epithelial-mesenchymal transition (EMT) occurs(1). EMT is one of the central events of embryonic development, organ and tissue regeneration, and cancer metastasis(1,2). Signal transducers and activators of transcription (STATs) mediate biological actions such as cell proliferation, differentiation and survival in response to cytokines and growth factors, in a variety of biological processes(3-6). STATs are also important in EMT during gastrulation, organogenesis, wound healing and cancer progression(7-9). We previously showed that STAT3 is activated in the organizer during zebrafish gastrulation and its activity is essential for gastrulation movements. The requirement for STAT3 is cell-autonomous for the anterior migration of gastrula organizer cells, and non-cell-autonomous for the convergence of neighbouring cells(10). The molecular mechanisms of STAT's action in EMT, however, are unknown. Here we identify LIV1, a breast-cancer-associated zinc transporter protein(11-13), as a downstream target of STAT3 that is essential and sufficient for STAT3's cell-autonomous role in the EMT of zebrafish gastrula organizer cells. Furthermore, we demonstrate that LIV1 is essential for the nuclear localization of zinc-finger protein Snail, a master regulator of EMT1,2,14,15. These results establish a molecular link between STAT3, LIV1 and Snail in EMT.	Osaka Univ, Grad Sch Frontier Biosci, Lab Dev Immunol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Sci, Dept Mol Oncol, Suita, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Kanagawa 2300045, Japan	Osaka University; Osaka University; RIKEN	Hirano, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Dev Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hirano@molonc.med.osaka-u.ac.jp	Hirano, Toshio/C-8194-2009					Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; KAMIMURA D, 2003, SIGNAL TRANSDUCERS A, P155; Kozlowski DJ, 2000, METH MOL B, V135, P349; MANNING DL, 1994, EUR J CANCER, V30A, P675, DOI 10.1016/0959-8049(94)90543-6; MANNING DL, 1988, MOL CELL ENDOCRINOL, V59, P205, DOI 10.1016/0303-7207(88)90105-0; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; SOLNICAKREZEL L, 1995, BIOESSAYS, V17, P931, DOI 10.1002/bies.950171106; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; THISSE C, 1995, DEV BIOL, V172, P86, DOI 10.1006/dbio.1995.0007; THISSE C, 1993, DEVELOPMENT, V119, P1203; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; YAMASHITA S, 2003, SIGNAL TRANSDUCERS A, P595	28	291	306	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					298	302		10.1038/nature02545	http://dx.doi.org/10.1038/nature02545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15129296				2022-12-01	WOS:000221505900043
J	Klausmeier, CA; Litchman, E; Daufresne, T; Levin, SA				Klausmeier, CA; Litchman, E; Daufresne, T; Levin, SA			Optimal nitrogen-to-phosphorus stoichiometry of phytoplankton	NATURE			English	Article							N-P; RATIOS; PRODUCTIVITY	Redfield noted the similarity between the average nitrogen-to-phosphorus ratio in plankton (N: P = 16 by atoms) and in deep oceanic waters (N: P = 15; refs 1, 2). He argued that this was neither a coincidence, nor the result of the plankton adapting to the oceanic stoichiometry, but rather that phytoplankton adjust the N: P stoichiometry of the ocean to meet their requirements through nitrogen fixation, an idea supported by recent modelling studies(3,4). But what determines the N: P requirements of phytoplankton? Here we use a stoichiometrically explicit model of phytoplankton physiology and resource competition to derive from first principles the optimal phytoplankton stoichiometry under diverse ecological scenarios. Competitive equilibrium favours greater allocation to P-poor resource-acquisition machinery and therefore a higher N: P ratio; exponential growth favours greater allocation to P-rich assembly machinery and therefore a lower N: P ratio. P-limited environments favour slightly less allocation to assembly than N-limited or light-limited environments. The model predicts that optimal N: P ratios will vary from 8.2 to 45.0, depending on the ecological conditions. Our results show that the canonical Redfield N: P ratio of 16 is not a universal biochemical optimum, but instead represents an average of species-specific N: P ratios.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	Princeton University; University System of Georgia; Georgia Institute of Technology; Rutgers State University New Brunswick	Klausmeier, CA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	christopher.klausmeier@biology.gatech.edu	Klausmeier, Christopher A/J-9339-2012; Levin, Simon A/J-1218-2014	Levin, Simon A/0000-0002-8216-5639; Litchman, Elena/0000-0001-7736-6332; Klausmeier, Christopher/0000-0002-6987-5871				AKSNES DL, 1991, MAR ECOL PROG SER, V70, P65, DOI 10.3354/meps070065; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; COPINMONTEGUT C, 1983, DEEP-SEA RES, V30, P31, DOI 10.1016/0198-0149(83)90031-6; DROOP MR, 1974, J MAR BIOL ASSOC UK, V54, P825, DOI 10.1017/S002531540005760X; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; KIRK JTO, 1967, PLASTIDS THEIR CHEM, P6; KLAUSMEIER CA, IN PRESS LIMNOL OCEA; Kooijman S.A.L.M, 2000, DYNAMIC ENERGY MASS, DOI DOI 10.1017/CBO9780511565403; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; Letelier RM, 1996, MAR ECOL PROG SER, V133, P263, DOI 10.3354/meps133263; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; Pahlow M, 2000, SCIENCE, V287, P831, DOI 10.1126/science.287.5454.831; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; RAVEN JA, 1980, AD MICROB PHYSL, V21, P147; REDFIELD AC, 1958, AM SCI, V46, P205; RHEE GY, 1980, J PHYCOL, V16, P486, DOI 10.1111/j.1529-8817.1980.tb03065.x; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Schneider B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001871; SHUTER B, 1979, J THEOR BIOL, V78, P519, DOI 10.1016/0022-5193(79)90189-9; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, DOI 10.1515/9781400885695; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941	30	636	684	16	464	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					171	174		10.1038/nature02454	http://dx.doi.org/10.1038/nature02454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141209				2022-12-01	WOS:000221356300038
J	Lossos, IS; Czerwinski, DK; Alizadeh, AA; Wechser, MA; Tibshirani, R; Botstein, D; Levy, R				Lossos, IS; Czerwinski, DK; Alizadeh, AA; Wechser, MA; Tibshirani, R; Botstein, D; Levy, R			Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BCL-2 PROTEIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; P53; DIFFERENTIATION; OLIGONUCLEOTIDE; TRANSLOCATIONS; REARRANGEMENT; MICROARRAYS; REVEALS; DISEASE	BACKGROUND Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.	Stanford Univ, Sch Med, Div Oncol,Dept Med, Med Ctr, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Stat, Stanford, CA 94305 USA; Univ Miami, Dept Med, Div Hematol Oncol, Miami, FL USA; Appl Biosyst Inc, Foster City, CA 94404 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Miami; Thermo Fisher Scientific; Applied Biosystems	Levy, R (corresponding author), Stanford Univ, Sch Med, Div Oncol,Dept Med, Med Ctr, Rm 1105, Stanford, CA 94305 USA.	levy@stanford.edu	Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Levy, Ronald/0000-0003-2061-0650	NCI NIH HHS [CA33399, CA34233] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033399, P01CA034233, R37CA033399] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adida C, 2000, BLOOD, V96, P1921; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Barrans SL, 2002, BLOOD, V99, P1136, DOI 10.1182/blood.V99.4.1136; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Clark EA, 2001, NATURE, V411, P974, DOI 10.1038/35082119; Colomo L, 2003, BLOOD, V101, P78, DOI 10.1182/blood-2002-04-1286; COX DR, 1972, J R STAT SOC B, V34, P187; DELMER A, 1995, BLOOD, V85, P2870, DOI 10.1182/blood.V85.10.2870.bloodjournal85102870; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Drillenburg P, 1999, LEUKEMIA, V13, P1448, DOI 10.1038/sj.leu.2401490; HARRIS NL, 1994, BLOOD, V84, P1361; Hermine O, 1996, BLOOD, V87, P265, DOI 10.1182/blood.V87.1.265.bloodjournal871265; Ichikawa A, 1997, NEW ENGL J MED, V337, P529, DOI 10.1056/NEJM199708213370804; JAFFE ES, 1998, LYMPHOMAS, P77; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Koduru PRK, 1997, BLOOD, V90, P4078, DOI 10.1182/blood.V90.10.4078; Kramer MHH, 1996, J CLIN ONCOL, V14, P2131, DOI 10.1200/JCO.1996.14.7.2131; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Krenacs L, 1998, BLOOD, V92, P1308, DOI 10.1182/blood.V92.4.1308.416k32_1308_1316; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Lossos IS, 2003, BLOOD, V101, P433, DOI 10.1182/blood-2002-06-1931; Lossos IS, 2001, BLOOD, V98, P945, DOI 10.1182/blood.V98.4.945; Moller MB, 2000, LEUKEMIA, V14, P898, DOI 10.1038/sj.leu.2401761; Mosher DF, 2001, NAT MED, V7, P290, DOI 10.1038/85426; Proost P, 1996, INT J CLIN LAB RES, V26, P211, DOI 10.1007/BF02602952; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Simon R, 2003, J NATL CANCER I, V95, P14, DOI 10.1093/jnci/95.1.14; Thorstenson YR, 2001, AM J HUM GENET, V69, P396, DOI 10.1086/321296; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vose UM, 1998, SEMIN ONCOL, V25, P483; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang AM, 1999, PATHOL INT, V49, P1043, DOI 10.1046/j.1440-1827.1999.00980.x	51	698	734	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1828	1837		10.1056/NEJMoa032520	http://dx.doi.org/10.1056/NEJMoa032520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115829	Bronze			2022-12-01	WOS:000221080300006
J	Meyer, A				Meyer, A			Learning from the Altmeister	NATURE			English	Editorial Material									Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Meyer, A (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.		Meyer, Axel/C-9826-2009	Meyer, Axel/0000-0002-0888-8193					0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2004	428	6986					897	897		10.1038/428897a	http://dx.doi.org/10.1038/428897a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118706				2022-12-01	WOS:000221083000022
J	Hill, SE; Blakely, TA; Kawachi, I; Woodward, A				Hill, SE; Blakely, TA; Kawachi, I; Woodward, A			Mortality among "never smokers" living with smokers: two cohort studies, 1981-4 and 1996-9	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PASSIVE SMOKING		Wellington Sch Med & Hlth Sci, Dept Publ Hlth, Wellington, New Zealand; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA	University of Otago; Harvard University; Harvard T.H. Chan School of Public Health	Blakely, TA (corresponding author), Wellington Sch Med & Hlth Sci, Dept Publ Hlth, POB 7343, Wellington, New Zealand.	tblakely@wnmeds.ac.nz		Woodward, Alistair/0000-0001-5425-6018; Hill, Sarah/0000-0003-3555-433X				Blakely T, 2000, AUST NZ J PUBL HEAL, V24, P92, DOI 10.1111/j.1467-842X.2000.tb00732.x; HOLE DJ, 1989, BRIT MED J, V299, P423, DOI 10.1136/bmj.299.6696.423; HUMBLE C, 1990, AM J PUBLIC HEALTH, V80, P599, DOI 10.2105/AJPH.80.5.599; SANDLER DP, 1989, AM J PUBLIC HEALTH, V79, P163, DOI 10.2105/AJPH.79.2.163; SVENDSEN KH, 1987, AM J EPIDEMIOL, V126, P783, DOI 10.1093/oxfordjournals.aje.a114715	5	33	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2004	328	7446					988	989		10.1136/bmj.38070.503009.EE	http://dx.doi.org/10.1136/bmj.38070.503009.EE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816SR	15066889	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000221130100015
J	Kim, HC; Nam, CM; Jee, SH; Han, KH; Oh, DK; Suh, I				Kim, HC; Nam, CM; Jee, SH; Han, KH; Oh, DK; Suh, I			Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CLINICAL-TRIALS; EPIDERMAL NERVE-FIBERS; CHRONIC HEPATITIS-C; TOPICAL CAPSAICIN; ALANINE AMINOTRANSFERASE; DOUBLE-BLIND; NEUROPATHIC PAIN; ALT LEVELS; QUALITY; VALUES	Objective To examine the relation between the normal nano-e of serum aminotransferase 0 concentration and mortality from liver disease. Design Prospective cohort study. Setting Korea Medical Insurance Corporation study with eight years' follow up. Participants 94 533 men and 47 522 women aged 35-59 years. Main outcome measure Mortality from liver diseases according, to death certificate. Results There was a positive association between the aminotransferase concentration, even within normal range (35-40 IU/I), and mortality from liver disease. Compared with the concentration < 20 IU/I, the adjusted relative risks for an aspartate aminotransferase concentration of 20-29 IU/I and 30-39 IU/I were 2.5 (95% confidence interval 2.0 to 3.0) and 8.0 (6.6 to 9.8) in men and 3.3 (1.7 to 6.4) and 18.2 (8.1 to 40.4) in women, respectively, The corresponding risks for alanine aminotransferase were 2.9 (2.4 to 3.5) and 9.5 (7.9 to 11.5) in men and 3.8 (1.9 to 7.7) and 6.6 (1.5 to 25.6) in women, respectively According to receiver operating characteristic curves the best cut-off values for the prediction of liver disease in men were 31 IU/I for aspartate aminotransferase and 30 IU/I for alanine aminotransferase. Conclusion People with slightly increased aminotransferase activity, but still within the normal range, should be closely observed and further investigated for liver diseases.	Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul 120752, South Korea; Yonsei Univ, Grad Sch Hlth Sci & Management, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System	Suh, I (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, 134 Shinchon Dong, Seoul 120752, South Korea.	isuh@yumc.yonsei.ac.kr	Kim, Hyeon Chang/F-8796-2019	Kim, Hyeon Chang/0000-0001-7867-1240; Nam, Chung Mo/0000-0003-0985-0928; Suh, Il/0000-0002-9689-7849; Jee, Sun Ha/0000-0001-9519-3068				AHN YO, 1999, JAMA KOREA S E ASIA, P382; Altman Roy D., 1994, Seminars in Arthritis and Rheumatism, V23, P25, DOI 10.1016/S0049-0172(10)80023-X; BERNSTEIN JE, 1989, J AM ACAD DERMATOL, V21, P265, DOI 10.1016/S0190-9622(89)70171-7; BIESBROECK R, 1995, ADV THER, V12, P111; *BRIT MED ASS ROYA, 2003, BRIT NAT FORM; CHAD DA, 1990, PAIN, V42, P387, DOI 10.1016/0304-3959(90)91153-A; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chun BY, 1992, KOREAN J EPIDEMIOL, V14, P54; COOK D, 1992, ANN INTERN MED, V117, pA16; DEAL CL, 1991, CLIN THER, V13, P383; *DEP HLTH, 2003, PRESCR COST AN ENGL; DONOFRIO P, 1991, ARCH INTERN MED, V151, P2225; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ellison N, 1997, J CLIN ONCOL, V15, P2974, DOI 10.1200/JCO.1997.15.8.2974; Espinosa M, 2000, CLIN NEPHROL, V54, P151; Gholson CF, 1997, AM J GASTROENTEROL, V92, P1788; Gotzsche PC, 2001, ANN RHEUM DIS, V60, P349, DOI 10.1136/ard.60.4.349; Guzzaloni G, 2000, INT J OBESITY, V24, P772, DOI 10.1038/sj.ijo.0801224; HULTCRANTZ R, 1986, SCAND J GASTROENTERO, V21, P109, DOI 10.3109/00365528609034632; Hung KY, 1997, NEPHROL DIAL TRANSPL, V12, P180, DOI 10.1093/ndt/12.1.180; Jadad AR, 1996, PAIN, V66, P239, DOI 10.1016/0304-3959(96)03033-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jamal MM, 1999, HEPATOLOGY, V30, P1307, DOI 10.1002/hep.510300526; JENSEN DM, 1987, ARCH INTERN MED, V147, P1734, DOI 10.1001/archinte.147.10.1734; Kalso E, 2000, EUR J PAIN-LONDON, V4, P321, DOI 10.1053/eujp.2000.0191; Kaplan MM, 2002, ANN INTERN MED, V137, P49, DOI 10.7326/0003-4819-137-1-200207020-00012; Keitel WG, 2001, ARZNEIMITTELFORSCH, V51, P896; KIRN YK, 1993, J CLIN PATHOL QUAL C, V15, P1; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; LOW PA, 1995, PAIN, V62, P163, DOI 10.1016/0304-3959(94)00261-C; Mason L, 2004, BMJ-BRIT MED J, V328, P995, DOI 10.1136/bmj.38040.607141.EE; Mathiesen UL, 1999, SCAND J GASTROENTERO, V34, P85; McCleane G, 2000, BRIT J CLIN PHARMACO, V49, P574, DOI 10.1046/j.1365-2125.2000.00200.x; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOORE R, 2003, BANDOLIERS LITTLE BO, P238; Moore RA, 1998, BRIT MED J, V316, P333, DOI 10.1136/bmj.316.7128.333; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; MORRIS JA, 1995, STAT CONFIDENCE CONF, P50; *NAT STAT OFF, 2002, ANN REP CAUS DEATH S; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; Paice JA, 2000, J PAIN SYMPTOM MANAG, V19, P45, DOI 10.1016/S0885-3924(99)00139-6; Persico M, 2000, GASTROENTEROLOGY, V118, P760, DOI 10.1016/S0016-5085(00)70145-4; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Pradat P, 2002, HEPATOLOGY, V36, P973, DOI 10.1053/jhep.2002.35530; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; RAINS C, 1995, DRUG AGING, V7, P317, DOI 10.2165/00002512-199507040-00007; REYNOLDS JEF, 1999, MARTINDALE EXTRA PHA; SALVAGGIO A, 1991, CLIN CHEM, V37, P720; Schnitzer T J, 1995, J Clin Rheumatol, V1, P268; Schnitzer Thomas, 1994, Seminars in Arthritis and Rheumatism, V23, P34, DOI 10.1016/S0049-0172(10)80024-1; SHERMAN KE, 1991, ARCH INTERN MED, V151, P260, DOI 10.1001/archinte.151.2.260; SIEST G, 1975, CLIN CHEM, V21, P1077; Simone DA, 1998, J NEUROSCI, V18, P8947; Smith LA, 2000, PAIN, V86, P119, DOI 10.1016/S0304-3959(00)00234-7; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Tsai JF, 1997, LIVER, V17, P24; WATSON CPN, 1993, CLIN THER, V15, P510; WATSON CPN, 1992, PAIN, V51, P375, DOI 10.1016/0304-3959(92)90223-X; Winocur E, 2000, J OROFAC PAIN, V14, P31; ZHANG WY, 1994, EUR J CLIN PHARMACOL, V46, P517	63	398	424	2	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2004	328	7446					983	986C		10.1136/bmj.38050.593634.63	http://dx.doi.org/10.1136/bmj.38050.593634.63			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15028636	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000221130100013
J	Yu, ITS; Li, YG; Wong, TW; Tam, W; Chan, AT; Lee, JHW; Leung, DYC; Ho, T				Yu, ITS; Li, YG; Wong, TW; Tam, W; Chan, AT; Lee, JHW; Leung, DYC; Ho, T			Evidence of airborne transmission of the severe acute respiratory syndrome virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HONG-KONG; SARS; OUTBREAK; AGENT	Background: There is uncertainty about the mode of transmission of the severe acute respiratory syndrome (SARS) virus. We analyzed the temporal and spatial distributions of cases in a large community outbreak of SARS in Hong Kong and examined the correlation of these data with the three-dimensional spread of a virus-laden aerosol plume that was modeled using studies of airflow dynamics. Methods: We determined the distribution of the initial 187 cases of SARS in the Amoy Gardens housing complex in 2003 according to the date of onset and location of residence. We then studied the association between the location (building, floor, and direction the apartment unit faced) and the probability of infection using logistic regression. The spread of the airborne, virus-laden aerosols generated by the index patient was modeled with the use of airflow-dynamics studies, including studies performed with the use of computational fluid-dynamics and multizone modeling. Results: The curves of the epidemic suggested a common source of the outbreak. All but 5 patients lived in seven buildings (A to G), and the index patient and more than half the other patients with SARS (99 patients) lived in building E. Residents of the floors at the middle and upper levels in building E were at a significantly higher risk than residents on lower floors; this finding is consistent with a rising plume of contaminated warm air in the air shaft generated from a middle-level apartment unit. The risks for the different units matched the virus concentrations predicted with the use of multizone modeling. The distribution of risk in buildings B, C, and D corresponded well with the three-dimensional spread of virus-laden aerosols predicted with the use of computational fluid-dynamics modeling. Conclusions: Airborne spread of the virus appears to explain this large community outbreak of SARS, and future efforts at prevention and control must take into consideration the potential for airborne spread of this virus.	Chinese Univ Hong Kong, Dept Community & Family Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong	Yu, ITS (corresponding author), Prince Wales Hosp, Sch Publ Hlth, Dept Community & Family Med, 4th Fl, Shatin, Hong Kong, Peoples R China.	iyu@cuhk.edu.hk	Lee, Joseph/C-1806-2009; Chan, Andy/D-3361-2013; Tam, Wilson/K-1664-2019; Yu, Ignatius Tak Sun/A-9936-2008; Wong, Tze Wai/K-5344-2013; TAM, Wilson W.S./H-5890-2019; Leung, Dennis Y.C./C-1892-2009; Li, Yuguo/A-9469-2010	TAM, Wilson W.S./0000-0003-0641-3060; Leung, Dennis Y.C./0000-0002-8917-0916; Li, Yuguo/0000-0002-2281-4529; Chan, Andy/0000-0003-2267-4949				Ash A, 1999, STAT MED, V18, P375, DOI 10.1002/(SICI)1097-0258(19990228)18:4<375::AID-SIM20>3.0.CO;2-J; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Collett D., 2002, MODELLING BINARY DAT; Donnelly CA, 2003, LANCET, V361, P1832; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Ferziger J.H., 2001, COMPUTATIONAL METHOD; *HONG KONG SPEC AD, 2003, OUTBR SEV AC RESP SY; *HONG KONG SPEC AD, 2004, LAT FIG 2003 SEV AC; LEBANON NH, 2004, FLUENT; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li Y., 2003, INT J VENT, V1, P3, DOI [10.1080/14733315.2003.11683640, DOI 10.1080/14733315.2003.11683640]; Li YG, 2000, BUILD ENVIRON, V35, P191, DOI 10.1016/S0360-1323(99)00011-6; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ng SKC, 2003, LANCET, V362, P570, DOI 10.1016/S0140-6736(03)14121-9; Orme M, 1998, 44 AIVC INT EN AG; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; SAS Institute, 1999, SAS STAT US GUID; Sorensen JH, 2001, PHYS CHEM EARTH PT B, V26, P93, DOI 10.1016/S1464-1909(00)00223-9; Tomlinson B, 2003, LANCET, V361, P1486, DOI 10.1016/S0140-6736(03)13218-7; Varia M, 2003, CAN MED ASSOC J, V169, P285; *WHO REG OFF W PAC, 2003, ENV HLTH TEAM REP AM; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; 2003, MMWR MORB MORTAL WKL, V52, P284; 2003, MMWR MORB MORTAL WKL, V52, P241	26	773	807	18	176	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1731	1739		10.1056/NEJMoa032867	http://dx.doi.org/10.1056/NEJMoa032867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102999	Bronze			2022-12-01	WOS:000220947300007
J	Sasso, FC; Carbonara, O; Nasti, R; Campana, B; Marfella, R; Torella, M; Nappi, G; Torella, R; Cozzolino, D				Sasso, FC; Carbonara, O; Nasti, R; Campana, B; Marfella, R; Torella, M; Nappi, G; Torella, R; Cozzolino, D			Glucose metabolism and coronary heart disease in patients with normal glucose tolerance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCATION END-PRODUCTS; CARDIOVASCULAR MORTALITY; OXIDATIVE STRESS; PLASMA-GLUCOSE; RISK-FACTOR; FOLLOW-UP; MEN; INSULIN; HYPERGLYCEMIA; ENDPRODUCTS	Context Several investigations as well as prospective studies have shown a significant correlation between glucose metabolism and atherosclerosis in patients without diabetes, but differences in parameters of glucose metabolism among the various degrees of coronary disease in such patients have not been specifically evaluated. Objective To investigate glucose metabolism in patients with normal glucose tolerance (NGT) and coronary heart disease (CHD). Design, Setting, and Participants Cross-sectional study of 234 men (mean [SDI age, 56.2 [6.1] years) with NGT and suspected CHD who were admitted from January 1 through June 30, 2001, to an academic medical center in Italy for coronary angiography. Main Outcome Measures Correlation of glucose metabolic factors and extent of atherosclerosis determined by coronary angiography. Factors included levels of fasting and postload glucose and insulin, glycosylated hemoglobin (HbA(1c)), and lipids, as well as insulin resistance measured by homeostasis model assessment (HOMA-IR). Results Patients were divided into 4 groups based on coronary angiography: no significant stenosis (n=42), 1-vessel disease (n=72), 2-vessel disease (n=64), and 3-vessel disease (n =56). Simple correlation analysis showed that the factors correlated with the extent of atherosclerosis were levels of postload glucose (r=0.667), HbA(1c) (r=0.561), postload insulin (r=0.221), and fasting insulin (r=0.297), as well as HOMA-IR (r=0.278) (P<.001 for all). Multiple stepwise regression analysis suggested that the factors independently associated with the number of stenosed coronary arteries were levels of postload plasma glucose (r=0.572), HbA(1c) (r=0.413), postload insulin (r=0.267), and fasting insulin (r=0.174), as well as HOMA-IR (r=0.250) (P<.001 for all). Similar results were obtained after grouping patients by Duke Myocardial Jeopardy Score. Conclusions For patients with NGT and different extents of atherosclerotic disease, postload glycemia and HbA(1c) level are not equally distributed but are significantly higher in those with more severe disease. This suggests that the glycemic milieu correlates with the cardiovascular risk according to a linear model.	Univ Naples 2, Inst Internal Med, Fac Med, Via F Petrarca 64, I-80122 Naples, Italy; Univ Naples 2, Fac Med, Inst Cardiovasc Surg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Sasso, FC (corresponding author), Univ Naples 2, Inst Internal Med, Fac Med, Via F Petrarca 64, I-80122 Naples, Italy.	ferdinando.sasso@unina2.it	Sasso, Ferdinando Carlo/AAE-5665-2019; Marfella, Raffaele/C-6899-2012; Sasso, Ferdinando Carlo/AAA-8423-2020	Sasso, Ferdinando Carlo/0000-0002-9142-7848; Marfella, Raffaele/0000-0003-3960-9270; torella, michele/0000-0003-3853-3171				*AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS74, DOI DOI 10.2337/DIACARE.25.2007.S74; Austen WG, 1975, CIRCULATION S4, V51, P5; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Borch-Johnsen K, 1999, LANCET, V354, P617; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055, DOI 10.1016/S0735-1097(85)80005-X; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DONAHUE RP, 1987, DIABETES, V36, P689, DOI 10.2337/diabetes.36.6.689; FARRER M, 1995, METABOLISM, V44, P1016, DOI 10.1016/0026-0495(95)90099-3; FUJIWARA R, 1995, AM J CARDIOL, V75, P122, DOI 10.1016/S0002-9149(00)80059-4; Gavin JR, 1999, DIABETES CARE, V22, pS5; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Graham MM, 2001, AM HEART J, V142, P254, DOI 10.1067/mhj.2001.116481; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Howard G, 1998, ANN EPIDEMIOL, V8, P358, DOI 10.1016/S1047-2797(98)00002-7; Kanauchi M, 2001, DIABETES CARE, V24, P1620, DOI 10.2337/diacare.24.9.1620; KANNEL WB, 1978, JAMA-J AM MED ASSOC, V38, P46; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Kilhovd BK, 1999, DIABETES CARE, V22, P1543, DOI 10.2337/diacare.22.9.1543; Kowalska I, 2001, DIABETES CARE, V24, P897, DOI 10.2337/diacare.24.5.897; KUME S, 1995, AM J PATHOL, V147, P654; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; NAKAMURA Y, 1993, AM J PATHOL, V143, P1649; PAN WH, 1986, AM J EPIDEMIOL, V123, P504, DOI 10.1093/oxfordjournals.aje.a114266; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727	34	80	82	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1857	1863		10.1001/jama.291.15.1857	http://dx.doi.org/10.1001/jama.291.15.1857			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100204	Bronze			2022-12-01	WOS:000220871200026
J	Rainer, TH; Chan, PKS; Ip, M; Lee, N; Hui, DS; Smit, D; Wu, A; Ahuja, AT; Tam, JS; Sung, JJY; Cameron, P				Rainer, TH; Chan, PKS; Ip, M; Lee, N; Hui, DS; Smit, D; Wu, A; Ahuja, AT; Tam, JS; Sung, JJY; Cameron, P			The spectrum of severe acute respiratory syndrome-associated coronavirus infection	ANNALS OF INTERNAL MEDICINE			English	Article							HONG-KONG; OUTBREAK; SARS; IDENTIFICATION	Background: Whether subclinical or atypical presentations of severe acute respiratory syndrome (SARS) occur and whether clinical judgment is accurate in detecting SARS are unknown. Objectives: To describe the spectrum of SARS coronavirus infection in a large outbreak and to compare diagnoses based on clinical judgment with the SARS coronavirus test. Design: Secondary analysis of prospectively collected clinical data and archived serum. Setting: A SARS screening clinic of a university hospital in the New Territories of Hong Kong. Patients: 1221 patients attending the clinic between 12 March 2003 and 12 May 2003. Measurements: SARS coronavirus serology. Results: 145 of 553 (26%) patients had serologic evidence of SARS coronavirus infection. Of 910 patients who were managed without hospitalization, only 6 had serologic evidence of SARS. Five of the six patients had normal chest radiographs, and four had symptoms such as myalgia, chills, coughing, and feeling feverish. With the SARS coronavirus serologic test as the gold standard, the clinical diagnosis of probable SARS at hospitalization had a sensitivity of 0.96 (95% Cl, 0.91 to 0.98) and a specificity of 0.96 (Cl, 0.92 to 0.97). Limitations: Follow-up serologic samples were not obtained from almost half of the patients because they declined further testing. Some people living in the community who were infected but who had minor or no symptoms might not have visited the clinic. Conclusions: There is little evidence of widespread subclinical or mild forms of SARS coronavirus infection. Clinical diagnoses during the outbreak were reasonable and resulted in appropriate triaging.	Chinese Univ Hong Kong, Prince Wales Hosp, Trauma & Emergency Ctr, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Trauma & Emergency Ctr, Accid & Emergency Med Acad Unit, Rooms 107-113,30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	rainer1091@cuhk.edu.hk	Rainer, Timothy/I-2591-2013; Hui, David Shu-Cheong/O-2754-2015; Ip, Margaret/K-1096-2013; Chan, Paul KS/J-9360-2013; Lee, Nelson/B-6418-2008; Sung, Joseph J. Y./R-3203-2018; Ahuja, Anil T/H-4031-2017	Rainer, Timothy/0000-0003-3355-3237; Hui, David Shu-Cheong/0000-0003-4382-2445; Ip, Margaret/0000-0003-1291-6537; Chan, Paul KS/0000-0002-6360-4608; Lee, Nelson/0000-0002-0783-6607; Sung, Joseph J. Y./0000-0003-3125-5199; Ahuja, Anil T/0000-0002-0726-5402; Cameron, Peter/0000-0002-1443-557X				[Anonymous], 2003, Wkly Epidemiol Rec, V78, P97; [Anonymous], 2003, UPD INT US CAS DEF S; CHAN PK, 2004, EMERG INFECT DIS, P10; Chan PKS, 2003, EMERG INFECT DIS, V9, P1453, DOI 10.3201/eid0911.030421; Chan-Yeung M, 2003, BRIT MED J, V326, P850, DOI 10.1136/bmj.326.7394.850; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ho W, 2003, LANCET, V361, P1313, DOI 10.1016/S0140-6736(03)13085-1; Hui DSC, 2003, CHEST, V124, P12, DOI 10.1378/chest.124.1.12; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; WHO, 2003, US LAB METH SARS DIA; World Health Organization, 2003, CAS DEF SURV SEV AC; World Health Organization, 2003, CUM NUMB REP PROB CA	21	26	26	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					614	619		10.7326/0003-4819-140-8-200404200-00008	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096332				2022-12-01	WOS:000220851700004
J	Coale, KH; Johnson, KS; Chavez, FP; Buesseler, KO; Barber, RT; Brzezinski, MA; Cochlan, WP; Millero, FJ; Falkowski, PG; Bauer, JE; Wanninkhof, RH; Kudela, RM; Altabet, MA; Hales, BE; Takahashi, T; Landry, MR; Bidigare, RR; Wang, XJ; Chase, Z; Strutton, PG; Friederich, GE; Gorbunov, MY; Lance, VP; Hilting, AK; Hiscock, MR; Demarest, M; Hiscock, WT; Sullivan, KF; Tanner, SJ; Gordon, RM; Hunter, CN; Elrod, VA; Fitzwater, SE; Jones, JL; Tozzi, S; Koblizek, M; Roberts, AE; Herndon, J; Brewster, J; Ladizinsky, N; Smith, G; Cooper, D; Timothy, D; Brown, SL; Selph, KE; Sheridan, CC; Twining, BS; Johnson, ZI				Coale, KH; Johnson, KS; Chavez, FP; Buesseler, KO; Barber, RT; Brzezinski, MA; Cochlan, WP; Millero, FJ; Falkowski, PG; Bauer, JE; Wanninkhof, RH; Kudela, RM; Altabet, MA; Hales, BE; Takahashi, T; Landry, MR; Bidigare, RR; Wang, XJ; Chase, Z; Strutton, PG; Friederich, GE; Gorbunov, MY; Lance, VP; Hilting, AK; Hiscock, MR; Demarest, M; Hiscock, WT; Sullivan, KF; Tanner, SJ; Gordon, RM; Hunter, CN; Elrod, VA; Fitzwater, SE; Jones, JL; Tozzi, S; Koblizek, M; Roberts, AE; Herndon, J; Brewster, J; Ladizinsky, N; Smith, G; Cooper, D; Timothy, D; Brown, SL; Selph, KE; Sheridan, CC; Twining, BS; Johnson, ZI			Southern ocean iron enrichment experiment: Carbon cycling in high- and low-Si waters	SCIENCE			English	Article							EQUATORIAL PACIFIC-OCEAN; LAST GLACIAL MAXIMUM; POLAR FRONTAL ZONE; ROSS SEA; PHYTOPLANKTON GROWTH; PRIMARY PRODUCTIVITY; BIOLOGICAL RESPONSE; SILICA PRODUCTION; FERTILIZATION; BLOOM	The availability of iron is known to exert a controlling influence on biological productivity in surface waters over large areas of the ocean and may have been an important factor in the variation of the concentration of atmospheric carbon dioxide over glacial cycles. The effect of iron in the Southern Ocean is particularly important because of its large area and abundant nitrate, yet iron-enhanced growth of phytoplankton may be differentially expressed between waters with high silicic acid in the south and low silicic acid in the north, where diatom growth may be limited by both silicic acid and iron. Twomesoscaleexperiments, designed to investigate the effects of iron enrichment in regions with high and low concentrations of silicic acid, were performed in the Southern Ocean. These experiments demonstrate iron's pivotal role in controlling carbon uptake and regulating atmospheric partial pressure of carbon dioxide.	Moss Landing Marine Labs, Moss Landing, CA 95039 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Duke Univ, Nicholas Sch Environm & Earth Sci, Beaufort, NC 28516 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Tiburon, CA 94920 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol, New Brunswick, NJ 08901 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Univ Massachusetts, Sch Marine Sci & Technol, New Bedford, MA 02744 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; MIT, Cambridge, MA 02139 USA	Moss Landing Marine Laboratories; Monterey Bay Aquarium Research Institute; Woods Hole Oceanographic Institution; Duke University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; California State University System; San Francisco State University; University of Miami; Rutgers State University New Brunswick; Rutgers State University New Brunswick; William & Mary; Virginia Institute of Marine Science; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of California System; University of California Santa Cruz; University of Massachusetts System; Oregon State University; Columbia University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Massachusetts Institute of Technology (MIT)	Coale, KH (corresponding author), Moss Landing Marine Labs, 8272 Moss Landing Rd, Moss Landing, CA 95039 USA.	coale@mlml.calstate.edu	Koblizek, Michal/H-2851-2014; Johnson, Zackary I/E-4601-2011; Wang, Xiujun/F-2641-2010; Johnson, Kenneth S/F-9742-2011; Strutton, Peter G/C-4466-2011; Tozzi, Sasha/B-2111-2009; Chase, Zanna/E-9232-2013	Johnson, Zackary I/0000-0003-0793-8512; Wang, Xiujun/0000-0002-2859-8011; Johnson, Kenneth S/0000-0001-5513-5584; Strutton, Peter G/0000-0002-2395-9471; Chase, Zanna/0000-0001-5060-779X; Twining, Benjamin/0000-0002-1365-9192; Selph, Karen/0000-0001-7281-4706				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; ARMSTRONG RA, 2002, DEEP SEA RES 2, V49, P2265; BEHRENFELD M, 1996, NATURE, V371, P508; BIDIGARE RR, 2002, EOS S, V83, pF798; Bishop JKB, 2004, SCIENCE, V304, P417, DOI 10.1126/science.1087717; Boyd PW, 2002, DEEP-SEA RES PT II, V49, P1803, DOI 10.1016/S0967-0645(02)00013-9; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; Brzezinski MA, 1997, LIMNOL OCEANOGR, V42, P856, DOI 10.4319/lo.1997.42.5.0856; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2003, DEEP-SEA RES PT II, V50, P635, DOI 10.1016/S0967-0645(02)00588-X; Coale KH, 1998, DEEP-SEA RES PT II, V45, P919, DOI 10.1016/S0967-0645(98)00019-8; Cochlan WP, 2002, DEEP-SEA RES PT II, V49, P3365, DOI 10.1016/S0967-0645(02)00088-7; Daly KL, 2001, J GEOPHYS RES-OCEANS, V106, P7107, DOI 10.1029/1999JC000090; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Fitzwater SE, 2000, DEEP-SEA RES PT II, V47, P3159, DOI 10.1016/S0967-0645(00)00063-1; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2571, DOI 10.1016/S0967-0645(01)00009-1; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Hales B, 2002, J ATMOS OCEAN TECH, V19, P1096, DOI 10.1175/1520-0426(2002)019<1096:TPSAHR>2.0.CO;2; Hiscock MR, 2003, DEEP-SEA RES PT II, V50, P533, DOI 10.1016/S0967-0645(02)00583-0; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; JOHNSON K, 2002, EOS S, V83, pF799; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; LEVITUS S, 1998, US WORLD OCEAN ATLAS; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Moore JK, 2000, GLOBAL BIOGEOCHEM CY, V14, P455, DOI 10.1029/1999GB900051; Olson RJ, 2000, DEEP-SEA RES PT II, V47, P3181, DOI 10.1016/S0967-0645(00)00064-3; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Schlitzer R., 2000, EOS T AM GEOPHYS UN, V81, P45, DOI [DOI 10.1029/00E000028, 10.1029/00EO00028, DOI 10.1029/00EO00028]; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smith WO, 2000, DEEP-SEA RES PT II, V47, P3073, DOI 10.1016/S0967-0645(00)00059-X; Sweeney C, 2000, DEEP-SEA RES PT II, V47, P3395, DOI 10.1016/S0967-0645(00)00073-4; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Timmermans KR, 1998, MAR ECOL PROG SER, V166, P27, DOI 10.3354/meps166027; Trull T, 2001, DEEP-SEA RES PT II, V48, P2439, DOI 10.1016/S0967-0645(01)00003-0; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561	48	471	483	3	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					408	414		10.1126/science.1089778	http://dx.doi.org/10.1126/science.1089778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087542				2022-12-01	WOS:000220845400039
J	Cochran, WW; Mouritsen, H; Wikelski, M				Cochran, WW; Mouritsen, H; Wikelski, M			Migrating songbirds recalibrate their magnetic compass daily from twilight cues	SCIENCE			English	Article							CELESTIAL CUES; ORIENTATION; BIRD; INFORMATION; CALIBRATION; PATTERNS; SUNSET; THRUSH; LIGHT; DUSK	Night migratory songbirds can use stars, sun, geomagnetic field, and polarized light for orientation when tested in captivity. We studied the interaction of magnetic, stellar, and twilight orientation cues in free-flying songbirds. We exposed Catharus thrushes to eastward-turned magnetic fields during the twilight period before takeoff and then followed them for up to 1100 kilometers. Instead of heading north, experimental birds flew westward. On subsequent nights, the same individuals migrated northward again. We suggest that birds orient with a magnetic compass calibrated daily from twilight cues. This could explain how birds cross the magnetic equator and deal with declination.	Illinois Nat Hist Survey, Champaign, IL 61820 USA; Carl von Ossietzky Univ Oldenburg, Inst Biol, Volkswagen Nachwuchsgrp Anim Nav, D-26111 Oldenburg, Germany; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Illinois Natural History Survey; Carl von Ossietzky Universitat Oldenburg; Volkswagen; Princeton University	Cochran, WW (corresponding author), 1204 W Union St, Champaign, IL 61821 USA.	Sparrow@springnet1.com; Henrik.mouritsen@uni-oldenburg.de; Wikelski@princeton.edu	Mouritsen, Henrik/A-5401-2010	Mouritsen, Henrik/0000-0001-7082-4839				ABLE KP, 1993, NATURE, V364, P523, DOI 10.1038/364523a0; ABLE KP, 1982, NATURE, V299, P550, DOI 10.1038/299550a0; ABLE KP, 1995, J COMP PHYSIOL A, V177, P351; AKESSON S, 1994, ANIM BEHAV, V48, P1379, DOI 10.1006/anbe.1994.1374; ALERSTAM T, 1987, J EXP BIOL, V130, P63; BATSCHELET E., 1981, CIRCULAR STAT BIOL M; BEASON RC, 1992, ETHOLOGY, V91, P75; BINGMAN VP, 1988, ETHOLOGY, V77, P1; COCHRAN W. W., 1967, LIVING BIRD, V6, P213; Cochran W.W., 1985, Illinois Natural History Survey Bulletin, V33, P297; COCHRAN WW, 1987, ANIM BEHAV, V35, P927, DOI 10.1016/S0003-3472(87)80132-X; COCHRAN WW, 2004, IN PRESS BIRDS 2 WOR; Cochran WW, 1972, ANIMAL ORIENTATION N, P39; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; EMLEN ST, 1970, ANIM BEHAV, V18, P215, DOI 10.1016/S0003-3472(70)80031-8; EMLEN ST, 1967, AUK, V84, P309, DOI 10.2307/4083084; ENGELS WL, 1962, BIOL BULL, V123, P94, DOI 10.2307/1539506; HELBIG AJ, 1990, EXPERIENTIA, V46, P755, DOI 10.1007/BF01939958; HELBIG JA, 1991, ORIENTATION BIRDS, P270; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Mettke-Hofmann C, 2003, P NATL ACAD SCI USA, V100, P5863, DOI 10.1073/pnas.1037505100; MOORE FR, 1987, BIOL REV, V62, P65, DOI 10.1111/j.1469-185X.1987.tb00626.x; Mouritsen H, 1998, ANIM BEHAV, V55, P1311, DOI 10.1006/anbe.1997.0696; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2001, J EXP BIOL, V204, P3855; Outlaw DC, 2003, AUK, V120, P299, DOI 10.1642/0004-8038(2003)120[0299:EOLMIA]2.0.CO;2; PHILLIPS JB, 1992, BEHAV ECOL SOCIOBIOL, V31, P189; Pulido F, 2003, AVIAN MIGRATION, P53; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Sandberg R, 2000, ANIM BEHAV, V60, P453, DOI 10.1006/anbe.2000.1582; Sandberg R, 2002, AUK, V119, P201, DOI 10.1642/0004-8038(2002)119[0201:OONMSS]2.0.CO;2; Sauer F., 1957, Zeitschrift fuer Tierpsychologie, V14, P29; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W., 1975, Zeitschrift Tierpsychol, V39, P265; WILTSCHKO W, 1975, Zeitschrift fuer Tierpsychologie, V37, P337; Wiltschko W, 1996, J EXP BIOL, V199, P29; Wiltschko W, 1998, J COMP PHYSIOL A, V182, P521, DOI 10.1007/s003590050199; WILTSCHKO W, 1995, J COMP PHYSIOL A, V177, P363	41	272	283	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					405	408		10.1126/science.1095844	http://dx.doi.org/10.1126/science.1095844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087541				2022-12-01	WOS:000220845400038
J	Lustbader, JW; Cirilli, M; Lin, C; Xu, HW; Takuma, K; Wang, N; Caspersen, C; Chen, X; Pollak, S; Chaney, M; Trinchese, F; Liu, SM; Gunn-Moore, F; Lue, LF; Walker, DG; Kuppusamy, P; Zewier, ZL; Arancio, O; Stern, D; Yan, SSD; Wu, H				Lustbader, JW; Cirilli, M; Lin, C; Xu, HW; Takuma, K; Wang, N; Caspersen, C; Chen, X; Pollak, S; Chaney, M; Trinchese, F; Liu, SM; Gunn-Moore, F; Lue, LF; Walker, DG; Kuppusamy, P; Zewier, ZL; Arancio, O; Stern, D; Yan, SSD; Wu, H			ABAD directly links A beta to mitochondrial toxicity in Alzheimer's disease	SCIENCE			English	Article							BINDING ALCOHOL-DEHYDROGENASE; AMYLOID-BETA; TRANSGENIC MICE; PEPTIDE; PROTEIN; PATHOGENESIS; DYSFUNCTION; APOPTOSIS; MODEL	Mitochondrial dysfunction is a hallmark of beta-amyloid (Abeta) -induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Abeta-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Abeta to mitochondrial toxicity. Abeta interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Abeta-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Abeta interaction and suppresses Abeta-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Abeta-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Abeta interaction may be a therapeutic target in AD.	Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Reprod Sci, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Harbin Med Univ, Dept Immunol, Harbin 150086, Peoples R China; NYU, Dept Neurol, New York, NY 10003 USA; NYU, Nathan Kline Inst, Dementia Res Ctr, New York, NY 10016 USA; NYU, Dept Psychiat Physiol & Neurosci, New York, NY 10016 USA; Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland; Sun Hlth Res Inst, Sun City, AZ 85351 USA; Ohio State Univ, David Heart & Lung Res Inst, Columbus, OH 43210 USA; Med Coll Georgia, Deans Off, Augusta, GA 30912 USA	Columbia University; Columbia University; Columbia University; Columbia University; Cornell University; Harbin Medical University; New York University; Nathan Kline Institute for Psychiatric Research; New York University; New York University; University of St Andrews; Banner Research; Banner Health; Banner Sun Health Research Institute; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Yan, SSD (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.	sdy1@columbia.edu; haowu@med.cornell.edu	Pollak, Seth D/G-2345-2011; arancio, ottavio/AAB-7959-2019	Xu, Hongwei/0000-0001-5763-3894; arancio, ottavio/0000-0001-6335-164X; Gunn-Moore, Francis James/0000-0003-3422-3387	NIA NIH HHS [AG17490, 1K07AG00959, P50AG08702, AG16736] Funding Source: Medline; NINDS NIH HHS [NS42855] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017490, R01AG016736, K07AG000959, P50AG008702] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; ABREO MA, 2002, Patent No. 931186; Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Beyreuther K, 1997, NATURE, V389, P677, DOI 10.1038/39479; Blass JP, 2003, NEUROL RES, V25, P556, DOI 10.1179/016164103101201995; Blass JP, 2002, INT REV NEUROBIOL, V51, P325, DOI 10.1016/S0074-7742(02)51010-2; Cash AD, 2002, NEUROSCIENTIST, V8, P489, DOI 10.1177/107385802236968; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Di Rosa G, 2002, J MOL NEUROSCI, V19, P135, DOI 10.1007/s12031-002-0024-4; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; GRILL HP, 1992, J AM COLL CARDIOL, V20, P1604, DOI 10.1016/0735-1097(92)90457-X; Mattson MP, 2002, INT REV NEUROBIOL, V53, P387; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oppermann UCT, 1999, FEBS LETT, V451, P238, DOI 10.1016/S0014-5793(99)00586-4; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Swerdlow RH, 2002, INT REV NEUROBIOL, V53, P341; Torroja L, 1998, J CELL BIOL, V141, P1009, DOI 10.1083/jcb.141.4.1009; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2000, J BIOL CHEM, V275, P27100	22	1018	1083	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					448	452		10.1126/science.1091230	http://dx.doi.org/10.1126/science.1091230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087549				2022-12-01	WOS:000220845400051
J	Borges, Z				Borges, Z			It is within ourselves that we start to overcome prejudice	LANCET			English	Article											Borges, Z (corresponding author), Ave Rio Branco,613 Vila Mamona, BR-79304020 Corumba, MS, Brazil.	zildaidea@terra.com.br							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1220	1220		10.1016/S0140-6736(04)15953-9	http://dx.doi.org/10.1016/S0140-6736(04)15953-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081656				2022-12-01	WOS:000220748100023
J	Kamena, F; Spang, A				Kamena, F; Spang, A			Tip20p prohibits back-fusion of COPII vesicles with the endoplasmic reticulum	SCIENCE			English	Article							RETROGRADE TRANSPORT; NUCLEOTIDE EXCHANGE; MEMBRANE-FUSION; SNARE PROTEINS; ER; GOLGI; YEAST; INTERACTS; RETRIEVAL; COATOMER	Directionality in intracellular trafficking is essential to ensure the correct localization of proteins along the secretory pathway. Here, we found evidence for an active mechanism that prohibited back-fusion of de novo - generated vesicles with their donor compartment. Tip20p is a peripheral membrane protein implicated in consumption of COPI vesicles at the endoplasmic reticulum. However, a specific mutant of TIP20 did not interfere with COPII vesicle generation but allowed these vesicles to fuse back to the endoplasmic reticulum, a process that does not occur normally in the cell.	Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Spang, A (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 39, D-72076 Tubingen, Germany.	anne.spang@tuebingen.mpg.de	Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203				Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Cosson P, 1997, EUR J CELL BIOL, V73, P93; Frigerio G, 1998, YEAST, V14, P633, DOI 10.1002/(SICI)1097-0061(199805)14:7<633::AID-YEA267>3.0.CO;2-3; LATTERICH M, 1994, CELL, V78, P87, DOI 10.1016/0092-8674(94)90575-4; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x	18	26	28	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					286	289		10.1126/science.1095049	http://dx.doi.org/10.1126/science.1095049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073376				2022-12-01	WOS:000220719400046
J	Padayatty, SJ; Sun, H; Wang, YH; Riordan, HD; Hewitt, SM; Katz, A; Wesley, RA; Levine, M				Padayatty, SJ; Sun, H; Wang, YH; Riordan, HD; Hewitt, SM; Katz, A; Wesley, RA; Levine, M			Vitamin C pharmacokinetics: Implications for oral and intravenous use	ANNALS OF INTERNAL MEDICINE			English	Article							RECOMMENDED DIETARY ALLOWANCE; ASCORBIC-ACID; DISEASE PREVENTION; ADVANCED CANCER; CYTOTOXICITY; VOLUNTEERS; TRIAL	Background: Vitamin C at high concentrations is toxic to cancer cells in vitro. Early clinical studies of vitamin C in patients with terminal cancer suggested clinical benefit, but 2 double-blind, placebo-controlled trials showed none. However, these studies used different routes of administration. Objective: To determine whether plasma vitamin C concentrations vary substantially with the route of administration. Design: Dose concentratior. studies and pharmacokinetic modeling. Setting: Academic medical center. Participants: 17 healthy hospitalized volunteers. Measurements: Vitamin C plasma and urine concentrations were measured after administration of oral and intravenous doses at a dose range of 0.015 to 1.25 g, and plasma concentrations were calculated for a dose range of 1 to 100 g. Results: Peak plasma vitamin C concentrations were higher after administration of intravenous doses than after administration of oral doses (P < 0.001), and the difference increased according to dose. Vitamin C at a dose of 1.25 g administered orally produced mean ( +/- SD) peak plasma concentrations of 134.8 +/- 20.6 mumol/L compared with 885 +/- 201.2 mumol/L for intravenous administration. For the maximum tolerated oral dose of 3 g every 4 hours, pharmacokinetic modeling predicted peak plasma vitamin C concentrations of 220 mumol/L and 13 400 mumol/L for a 50-g intravenous dose. Peak predicted urine concentrations of vitamin C from intravenous administration were 140-fold higher than those from maximum oral doses. Limitations: Patient data are not available to confirm pharmacokinetic modeling at high doses and in patients with cancer. Conclusions: oral vitamin C produces plasma concentrations that are tightly controlled. Only intravenous administration of vitamin C produces high plasma and urine concentrations that might have antitumor activity. Because efficacy of vitamin C treatment cannot be judged from clinical trials that use only oral dosing, the role of vitamin C in cancer treatment should be re-evaluated.	NIH, Mol & Clin Nutr Sect, Bethesda, MD 20892 USA; NCI, NIDDKD, Bethesda, MD 20892 USA; NIH, Clin Ctr, Bethesda, MD 20892 USA; Food & Drug Adm, Rockville, MD USA; Biocommun Res Inst, Wichita, KS USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); US Food & Drug Administration (FDA)	Levine, M (corresponding author), NIH, Mol & Clin Nutr Sect, Bldg 10,Room 4D52-MSC 1372, Bethesda, MD 20892 USA.		Padayatty, Sebastian J/A-8581-2012	Padayatty, Sebastian J/0000-0001-8758-3170; Hewitt, Stephen/0000-0001-8283-1788	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK054506] Funding Source: NIH RePORTER; NIDDK NIH HHS [Z01 DK 54506] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMERON E, 1974, CHEM-BIOL INTERACT, V9, P285, DOI 10.1016/0009-2797(74)90019-2; CAMERON E, 1993, CANC VITAMIN C; Clement MV, 2001, ANTIOXID REDOX SIGN, V3, P157, DOI 10.1089/152308601750100687; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; Fairfield KM, 2002, JAMA-J AM MED ASSOC, V287, P3116, DOI 10.1001/jama.287.23.3116; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Graumlich JF, 1997, PHARMACEUT RES, V14, P1133, DOI 10.1023/A:1012186203165; LEUNG PY, 1993, ANTICANCER RES, V13, P475; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; McCORMICK W J, 1959, Arch Pediatr, V76, P166; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272; Padayatty SJ, 2001, CAN MED ASSOC J, V164, P353; RIORDAN NH, 1995, MED HYPOTHESES, V44, P207, DOI 10.1016/0306-9877(95)90137-X; Sakagami H, 2000, CELL MOL BIOL, V46, P129; WANG XY, 1992, FREE RADICAL BIO MED, V12, P121, DOI 10.1016/0891-5849(92)90005-2; WASHKO PW, 1992, ANAL BIOCHEM, V204, P1, DOI 10.1016/0003-2697(92)90131-P; WITTES RE, 1985, NEW ENGL J MED, V312, P178, DOI 10.1056/NEJM198501173120310	20	555	581	2	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2004	140	7					533	537		10.7326/0003-4819-140-7-200404060-00010	http://dx.doi.org/10.7326/0003-4819-140-7-200404060-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808OE	15068981				2022-12-01	WOS:000220577600005
J	Borner, GV; Kleckner, N; Hunter, N				Borner, GV; Kleckner, N; Hunter, N			Crossover/noncrossover differentiation, synaptonemal complex formation, and regulatory surveillance at the leptotene/zygotene transition of meiosis	CELL			English	Article							MEIOTIC CHROMOSOME SYNAPSIS; DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; CROSSING-OVER; RECIPROCAL RECOMBINATION; FUNCTIONAL INTERACTIONS; CROSSOVER INTERFERENCE; BUDDING YEAST; RECA HOMOLOGS	Yeast mutants lacking meiotic proteins Zip1, Zip2, Zip3, Mer3, and/or Msh5 (ZMMs) were analyzed for recombination, synaptonemal complex (SC), and meiotic progression. At 33degreesC, recombination-initiating double-strand breaks (DSBs) and noncrossover products (NCRs) form normally while formation of single-end invasion strand exchange intermediates (SEIs), double Holliday junctions, crossover products (CRs), and SC are coordinately defective. Thus, during wildtype meiosis, recombinational interactions are differentiated into CR and NCR types very early, prior to onset of stable strand exchange and independent of SC. By implication, crossover interference does not require SC formation. We suggest that SC formation may require interference. Subsequently, CR-designated DSBs undergo a tightly coupled, ZMM-promoted transition that yields SEI-containing recombination complexes embedded in patches of SC. zmm mutant phenotypes differ strikingly at 33degreesC and 23degreesC implicating higher temperature as a positive effector of recombination and identifying a checkpoint that monitors local CR-specific events, not SC formation, at late leptotene.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Calif Davis, Microbiol Sect, Ctr Genet & Dev, Davis, CA 95616 USA	Harvard University; University of California System; University of California Davis	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu			NIGMS NIH HHS [GM44794] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; BYERS B, 1975, P NATL ACAD SCI USA, V72, P5056, DOI 10.1073/pnas.72.12.5056; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Copenhaver GP, 2002, GENETICS, V160, P1631; Darlington C. D., 1937, RECENT ADV CYTOLOGY; de los Santos T, 2003, GENETICS, V164, P81; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; ENGEBRECHT J, 1990, CELL, V62, P927, DOI 10.1016/0092-8674(90)90267-I; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; HENDERSON KA, 2004, IN PRESS P NATL ACAD; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 2003, MOL CELL, V12, P533, DOI 10.1016/S1097-2765(03)00361-7; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kee K, 2002, GENETICS, V160, P111; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kelly KO, 2000, GENETICS, V156, P617; Lichten M, 2001, CURR BIOL, V11, pR253, DOI 10.1016/S0960-9822(01)00131-2; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; MAGUIRE MP, 1966, GENETICS, V53, P1071; Moens PB, 2002, J CELL SCI, V115, P1611; MOENS PB, 1978, CAN J GENET CYTOL, V20, P567, DOI 10.1139/g78-066; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Novak JE, 2001, GENETICS, V158, P1013; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; ROSE MD, 1990, METHODS YEAST GENETI; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SODMORIA.UA, 1974, J REPROD FERTIL, V37, P263, DOI 10.1530/jrf.0.0370263; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Webber HA, 2004, J CELL BIOL, V164, P819, DOI 10.1083/jcb.200310077; ZICKLER D, 1977, CHROMOSOMA, V61, P289, DOI 10.1007/BF00288615; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	57	485	502	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					29	45		10.1016/S0092-8674(04)00292-2	http://dx.doi.org/10.1016/S0092-8674(04)00292-2			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066280	Bronze			2022-12-01	WOS:000221500300006
J	Bouret, SG; Draper, SJ; Simerly, RB				Bouret, SG; Draper, SJ; Simerly, RB			Trophic action of leptin on hypothalamic neurons that regulate feeding	SCIENCE			English	Article							BODY-WEIGHT; BRAIN-DEVELOPMENT; THYROID-HORMONE; NERVOUS-SYSTEM; ENERGY-BALANCE; OBESITY	In adult mammals, the adipocyte-derived hormone leptin acts on the brain to reduce food intake by regulating the activity of neurons in the arcuate nucleus of the hypothalamus (ARH). Here, we report that neural projection pathways from the ARH are permanently disrupted in leptin-deficient (Lep(ob)/Lep(ob)) mice and leptin treatment in adulthood does not reverse these neuroanatomical defects. However, treatment of Lep(ob)/Lep(ob) neonates with exogenous leptin rescues the development of ARH projections, and leptin promotes neurite outgrowth from ARH neurons in vitro. These results suggest that leptin plays a neurotrophic role during the development of the hypothalamus and that this activity is restricted to a neonatal critical period that precedes leptin's acute regulation of food intake in adults.	Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Simerly, RB (corresponding author), Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA.	simerlyr@ohsu.edu	Bouret, Sebastien/AAG-7120-2021; Lee, shin/C-1393-2016	Bouret, Sebastien/0000-0002-4174-9769	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055819, R01DK065900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037952] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00163] Funding Source: Medline; NIDDK NIH HHS [DK55819, DK65900] Funding Source: Medline; NINDS NIH HHS [NS37952] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Elias CF, 2000, J COMP NEUROL, V423, P261; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; MADEIRA MD, 1995, PROG NEUROBIOL, V45, P275, DOI 10.1016/0301-0082(94)00052-J; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; Mistry AM, 1999, AM J PHYSIOL-REG I, V277, pR742, DOI 10.1152/ajpregu.1999.277.3.R742; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; QIU K, 2001, 31 ANN M SOC NEUR SA; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steppan CM, 1999, BIOCHEM BIOPH RES CO, V256, P600, DOI 10.1006/bbrc.1999.0382; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	22	911	936	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					108	110		10.1126/science.1095004	http://dx.doi.org/10.1126/science.1095004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15064420				2022-12-01	WOS:000220567900048
J	Mills, MM; Ridame, C; Davey, M; La Roche, J; Geider, RJ				Mills, MM; Ridame, C; Davey, M; La Roche, J; Geider, RJ			Iron and phosphorus co-limit nitrogen fixation in the eastern tropical North Atlantic	NATURE			English	Article							OCEANIC PRIMARY PRODUCTION; WESTERN MEDITERRANEAN SEA; MARINE CYANOBACTERIUM; TRICHODESMIUM SPP.; PACIFIC-OCEAN; PHYTOPLANKTON; GROWTH; PHOSPHATE; N-2	The role of iron in enhancing phytoplankton productivity in high nutrient, low chlorophyll oceanic regions was demonstrated first through iron-addition bioassay experiments(1) and subsequently confirmed by large-scale iron fertilization experiments(2). Iron supply has been hypothesized to limit nitrogen fixation and hence oceanic primary productivity on geological timescales(3), providing an alternative to phosphorus as the ultimate limiting nutrient(4). Oceanographic observations have been interpreted both to confirm and refute this hypothesis(5,6), but direct experimental evidence is lacking(7). We conducted experiments to test this hypothesis during the Meteor 55 cruise to the tropical North Atlantic. This region is rich in diazotrophs(8) and strongly impacted by Saharan dust input(9). Here we show that community primary productivity was nitrogen-limited, and that nitrogen fixation was co-limited by iron and phosphorus. Saharan dust addition stimulated nitrogen fixation, presumably by supplying both iron and phosphorus(10,11). Our results support the hypothesis that aeolian mineral dust deposition promotes nitrogen fixation in the eastern tropical North Atlantic.	Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; IFM GEOMAR Leibniz Inst Meereswissensch, D-24105 Kiel, Germany; Marine Biol Assoc UK, Plymouth PL1 2PB, Devon, England	University of Essex; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Marine Biological Association United Kingdom	Geider, RJ (corresponding author), Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England.	geider@essex.ac.uk	LaRoche, Julie/A-1109-2010	LaRoche, Julie/0000-0003-4809-6411; Geider, Richard/0000-0003-3276-047X				Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, DOI 10.1029/2003-O180001]; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Gao Y, 2001, GEOPHYS RES LETT, V28, P29, DOI 10.1029/2000GL011926; GLIBERT PM, 1994, APPL ENVIRON MICROB, V60, P3996, DOI 10.1128/AEM.60.11.3996-4000.1994; Graziano LM, 1996, AQUAT MICROB ECOL, V11, P53, DOI 10.3354/ame011053; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Guieu C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000582; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Kustka A, 2003, J PHYCOL, V39, P12, DOI 10.1046/j.1529-8817.2003.01156.x; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; LOHRENZ SE, 1992, J PLANKTON RES, V14, P201, DOI 10.1093/plankt/14.2.201; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Palinska KA, 2002, MICROBIOL-SGM, V148, P2405, DOI 10.1099/00221287-148-8-2405; REDFIELD AC, 1958, AM SCI, V46, P205; Ridame C, 2002, LIMNOL OCEANOGR, V47, P856, DOI 10.4319/lo.2002.47.3.0856; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Tyrrell T, 2003, J PLANKTON RES, V25, P405, DOI 10.1093/plankt/25.4.405; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; WELSCHMEYER N, 1994, LIMNOL OCEANOGR, V38, P1985; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Wu JF, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001924; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	30	683	707	8	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					292	294		10.1038/nature02550	http://dx.doi.org/10.1038/nature02550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152251				2022-12-01	WOS:000221505900041
J	Somers, CM; McCarry, BE; Malek, F; Quinn, JS				Somers, CM; McCarry, BE; Malek, F; Quinn, JS			Reduction of particulate air pollution lowers the risk of heritable mutations in mice	SCIENCE			English	Article							AMBIENT AIR; MOUSE; CANCER; ADMISSIONS; RADIATION; INDUCTION; MORTALITY; EXPOSURE; DAMAGE; LOCI	Urban and industrial air pollution can cause elevated heritable mutation rates in birds and rodents. The relative importance of airborne particulate matter versus gas-phase substances in causing these genetic effects under ambient conditions has been unclear. Here we show that high-efficiency particulate-air (HEPA) filtration of ambient air significantly reduced heritable mutation rates at repetitive DNA loci in laboratory mice housed outdoors near a major highway and two integrated steel mills. These findings implicate exposure to airborne particulate matter as a principal factor contributing to elevated mutation rates in sentinel mice and add to accumulating evidence that air pollution may pose genetic risks to humans and wildlife.	McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; McMaster Univ, Dept Chem, Hamilton, ON L8S 4K1, Canada; Lakeland Coll, Sch Environm Sci, Vermilion, AB T9X 1K5, Canada	McMaster University; McMaster University	Quinn, JS (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	quinn@mcmaster.ca	Malek, Fairouz/E-4410-2018; Somers, Christopher/AAE-6390-2019	Malek, Fairouz/0000-0002-0948-5775; 				Bobak M, 2000, ENVIRON HEALTH PERSP, V108, P173, DOI 10.2307/3454517; Bois P, 1998, GENOMICS, V49, P122, DOI 10.1006/geno.1998.5228; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Burgaz S, 2002, CHEMOSPHERE, V47, P57, DOI 10.1016/S0045-6535(01)00185-0; BURNETT RT, 1995, AM J EPIDEMIOL, V142, P15, DOI 10.1093/oxfordjournals.aje.a117540; DELFINO RJ, 1994, ENVIRON RES, V67, P1, DOI 10.1006/enrs.1994.1061; Dubrova YE, 1998, P NATL ACAD SCI USA, V95, P6251, DOI 10.1073/pnas.95.11.6251; Dubrova YE, 2002, MUTAT RES-FUND MOL M, V499, P143, DOI 10.1016/S0027-5107(01)00284-6; ETTINGER HJ, 1969, AM IND HYG ASSOC J, V30, P20, DOI 10.1080/0002889698506002; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; Krewski D, 2003, J TOXICOL ENV HEAL A, V66, P1507, DOI 10.1080/15287390306424; LEGZDINS AE, 1994, POLYCYCL AROMAT COMP, V5, P157, DOI 10.1080/10406639408015167; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Palli D, 2001, INT J CANCER, V94, P121, DOI 10.1002/ijc.1433; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Ritz B, 2002, AM J EPIDEMIOL, V155, P17, DOI 10.1093/aje/155.1.17; Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P887, DOI 10.2307/3434998; Soares SRC, 2003, ENVIRON RES, V92, P191, DOI 10.1016/S0013-9351(02)00061-0; Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499; Sorensen M, 2003, CANCER EPIDEM BIOMAR, V12, P191; Vilarino-Guell C, 2003, MUTAT RES-FUND MOL M, V526, P63, DOI 10.1016/S0027-5107(03)00016-2; YAMADA Y, 1984, HEALTH PHYS, V46, P543, DOI 10.1097/00004032-198403000-00005; Yauk CL, 2000, MUTAT RES-FUND MOL M, V452, P211, DOI 10.1016/S0027-5107(00)00093-2; Yauk CL, 1996, P NATL ACAD SCI USA, V93, P12137, DOI 10.1073/pnas.93.22.12137	25	236	251	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					1008	1010		10.1126/science.1095815	http://dx.doi.org/10.1126/science.1095815			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143280				2022-12-01	WOS:000221383300048
J	Schmidt-Hieber, C; Jonas, P; Bischofberger, J				Schmidt-Hieber, C; Jonas, P; Bischofberger, J			Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; RAT DENTATE GYRUS; MEMBRANE-PROPERTIES; NEURONS; NEUROGENESIS; DEPRESSION; INDUCTION; SEQUENCES; CURRENTS; CHANNELS	Neural stem cells in various regions of the vertebrate brain continuously generate neurons throughout life(1-4). In the mammalian hippocampus, a region important for spatial and episodic memory(5,6), thousands of new granule cells are produced per day(7), with the exact number depending on environmental conditions and physical exercise(1,8). The survival of these neurons is improved by learning and conversely learning may be promoted by neurogenesis(8-10). Although it has been suggested that newly generated neurons may have specific properties to facilitate learning(2,10,11), the cellular and synaptic mechanisms of plasticity in these neurons are largely unknown. Here we show that young granule cells in the adult hippocampus differ substantially from mature granule cells in both active and passive membrane properties. In young neurons, T-type Ca2+ channels can generate isolated Ca2+ spikes and boost fast Na+ action potentials, contributing to the induction of synaptic plasticity. Associative long-term potentiation can be induced more easily in young neurons than in mature neurons under identical conditions. Thus, newly generated neurons express unique mechanisms to facilitate synaptic plasticity, which may be important for the formation of new memories.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Bischofberger, J (corresponding author), Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany.	josef.bischofberger@uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804; Schmidt-Hieber, Christoph/0000-0002-5328-9704; Bischofberger, Josef/0000-0002-4006-1663				BLAXTER TJ, 1989, J PHYSIOL-LONDON, V412, P93, DOI 10.1113/jphysiol.1989.sp017605; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; ELIOT LS, 1994, J NEUROPHYSIOL, V72, P762, DOI 10.1152/jn.1994.72.2.762; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Liu SH, 2003, J NEUROSCI, V23, P732; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; LUBBERS K, 1988, ANAT EMBRYOL, V178, P119, DOI 10.1007/BF02463645; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Normann C, 2000, J NEUROSCI, V20, P8290, DOI 10.1523/JNEUROSCI.20-22-08290.2000; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; RIHN LL, 1990, DEV BRAIN RES, V54, P115, DOI 10.1016/0165-3806(90)90071-6; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seki T, 2002, J NEUROSCI RES, V69, P772, DOI 10.1002/jnr.10366; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a	30	918	953	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					184	187		10.1038/nature02553	http://dx.doi.org/10.1038/nature02553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15107864				2022-12-01	WOS:000221356300042
J	Sadler, L; Saftlas, A; Wang, WQ; Exeter, M; Whittaker, J; McCowan, L				Sadler, L; Saftlas, A; Wang, WQ; Exeter, M; Whittaker, J; McCowan, L			Treatment for cervical intraepithelial neoplasia and risk of preterm delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LARGE LOOP EXCISION; 2001 CONSENSUS GUIDELINES; TRANSFORMATION ZONE; UTERINE CERVIX; LASER-SURGERY; CONE BIOPSY; PREGNANCY; CONIZATION; WOMEN; MANAGEMENT	Context It is unclear whether treatments for cervical intraepithelial neoplasia (CIN) increase the subsequent risk of preterm delivery. Most studies have lacked sufficient sample size, mixed heterogeneous subtypes of preterm delivery, and failed to control for confounding factors. Objective To determine whether cervical laser and loop electrosurgical excision procedure (LEEP) treatments increase risk of preterm delivery and its subtypes. Design, Setting, and Participants Retrospective cohort study conducted among women evaluated at a colposcopy clinic serving Auckland, New Zealand (1988-2000), comparing delivery outcomes of untreated women (n =426) and those treated (n = 652) with laser conization, laser ablation, or LEEP. Record linkage using unique health identifiers identified women who had subsequent deliveries. Main Outcome Measures Total preterm delivery and its subtypes, spontaneous labor and premature rupture of membranes before 37 weeks' gestation (pPROM). Results The overall rate of preterm delivery was 13.8%. The rate of pPROM was 6.2 % and the rate of spontaneous preterm delivery was 3.8 %. Analyses showed no significant increase in risk of total preterm delivery (adjusted relative risk [aRR], 1.1; 95% confidence interval [CI], 0.8-1.5) or spontaneous preterm delivery (aRR, 1.3; 95% Cl, 0.7-2.6) for any treatment. Risk of pPROM was significantly increased following treatment with laser conization (aRR, 2.7; 95% Cl, 1.3-5.6) or LEEP (aRR, 1.9; 95% Cl, 1.0-3.8), but not laser ablation (aRR, 1.1; 95% Cl, 0.5-2.4). Moreover, risk of pPROM and total preterm delivery increased significantly with increasing height of tissue removed from the cervix in conization. Women in the highest tertile of cone height (greater than or equal to1.7 cm) had a greater than 3-fold increase in risk of pPROM compared with untreated women (aRR, 3.6; 95% Cl, 1.8-7.5). Conclusions LEEP and laser cone treatments were associated with significantly increased risk of pPROM. Careful consideration should be given to treatment of CIN in women of reproductive age, especially when treatment might reasonably be delayed or targeted to high-risk cases.	Univ Auckland, Natl Womens Hosp, Dept Obstet & Gynaecol, Auckland 1, New Zealand; Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA	University of Auckland; University of Iowa	Sadler, L (corresponding author), Univ Auckland, Natl Womens Hosp, Dept Obstet & Gynaecol, Private Bag 92-189, Auckland 1, New Zealand.	l.sadler@auckland.ac.nz	McCowan, Lesley/C-2215-2009	McCowan, Lesley/0000-0001-9915-7873	NICHD NIH HHS [R01 HD37924] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037924] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Althuisius SM, 2001, AM J OBSTET GYNECOL, V185, P1106, DOI 10.1067/mob.2001.118655; BLOMFIELD PI, 1993, AM J OBSTET GYNECOL, V169, P620, DOI 10.1016/0002-9378(93)90633-T; Braet P. G., 1994, Journal of Obstetrics and Gynaecology (Abingdon), V14, P79, DOI 10.3109/01443619409030016; BULLER RE, 1982, AM J OBSTET GYNECOL, V142, P506, DOI 10.1016/0002-9378(82)90752-9; Coppell K, 2000, NEW ZEAL MED J, V113, P48; CRAMPTON P, 1998, NZ PUBLIC HLTH REPOR, V5, P81; CRUICKSHANK ME, 1995, BRIT J OBSTET GYNAEC, V102, P467, DOI 10.1111/j.1471-0528.1995.tb11319.x; Drakeley AJ, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003253, DOI 10.1002/14651858.CD003253]; El-Bastawissi AY, 1999, OBSTET GYNECOL, V93, P207, DOI 10.1016/S0029-7844(98)00386-X; Forsmo S, 1996, ACTA OBSTET GYN SCAN, V75, P139, DOI 10.3109/00016349609033306; Gunasekera P. C., 1992, Journal of Obstetrics and Gynaecology (Abingdon), V12, P291, DOI 10.3109/01443619209015508; HAFFENDEN DK, 1993, BRIT J OBSTET GYNAEC, V100, P1059, DOI 10.1111/j.1471-0528.1993.tb15153.x; HAGEN B, 1993, BRIT J OBSTET GYNAEC, V100, P717, DOI 10.1111/j.1471-0528.1993.tb14261.x; JONES JM, 1979, BRIT J OBSTET GYNAEC, V86, P913, DOI 10.1111/j.1471-0528.1979.tb11237.x; KRISTENSEN J, 1993, OBSTET GYNECOL, V81, P1005; LARSSON G, 1982, ACTA OBSTET GYN SCAN, V61, P461, DOI 10.3109/00016348209156591; LEIMAN G, 1980, AM J OBSTET GYNECOL, V136, P14, DOI 10.1016/0002-9378(80)90556-6; LUDVIKSSON K, 1982, EUR J OBSTET GYN R B, V14, P135, DOI 10.1016/0028-2243(82)90088-0; MATHEVET P, 1994, GYNECOL ONCOL, V54, P175, DOI 10.1006/gyno.1994.1189; MOINIAN M, 1982, EUR J OBSTET GYN R B, V14, P135; Paraskevaidis E, 2002, GYNECOL ONCOL, V86, P10, DOI 10.1006/gyno.2002.6650; RAOI L, 1997, OBSTET GYNECOL, V90, P978; RICCIOTTI HA, 1995, INT J GYNECOL OBSTET, V50, P175, DOI 10.1016/0020-7292(95)02432-C; SAGOT P, 1995, EUR J OBSTET GYN R B, V58, P53, DOI 10.1016/0028-2243(94)01986-H; SAUNDERS N, 1986, REPROD PERINAT MED, V6, P121; SAVITZ DA, 1991, AM J OBSTET GYNECOL, V164, P467, DOI 10.1016/S0002-9378(11)80001-3; SOUTTER WP, 1986, COLP GYNECOL LAS SUR, V2, P35; SPITZER M, 1995, OBSTET GYNECOL, V86, P504, DOI 10.1016/0029-7844(95)00237-L; SVARE JA, 1992, EUR J OBSTET GYN R B, V47, P41, DOI 10.1016/0028-2243(92)90212-H; WEBER T, 1979, ACTA OBSTET GYN SCAN, V58, P347, DOI 10.3109/00016347909154594; Wright TC, 2003, AM J OBSTET GYNECOL, V189, P295, DOI 10.1067/mob.2003.633; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	32	284	309	1	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2004	291	17					2100	2106		10.1001/jama.291.17.2100	http://dx.doi.org/10.1001/jama.291.17.2100			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JR	15126438	Bronze			2022-12-01	WOS:000221174300027
J	Goren-Inbar, N; Alperson, N; Kislev, ME; Simchoni, O; Melamed, Y; Ben-Nun, A; Werker, E				Goren-Inbar, N; Alperson, N; Kislev, ME; Simchoni, O; Melamed, Y; Ben-Nun, A; Werker, E			Evidence of hominin control of fire at Gesher Benot Ya'aqov, Israel	SCIENCE			English	Article							MIDDLE PLEISTOCENE; SEDIMENTS; MINERALS; AFRICA; KENYA	The presence of burned seeds, wood, and flint at the Acheulian site of Gesher Benot Ya'aqov in Israel is suggestive of the control of. re by humans nearly 790,000 years ago. The distribution of the site's small burned flint fragments suggests that burning occurred in specific spots, possibly indicating hearth locations. Wood of six taxa was burned at the site, at least three of which are edible-olive, wild barley, and wild grape.	Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel; Bar Ilan Univ, Dept Life Sci, IL-52900 Ramat Gan, Israel; Hebrew Univ Jerusalem, Dept Bot, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, GIS Ctr, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Bar Ilan University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Goren-Inbar, N (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Mt Scopus, IL-91905 Jerusalem, Israel.	goren@cc.huji.ac.il						[Anonymous], 1997, FOREST ECOLOGY; Belitzky S, 2002, QUATERNARY RES, V58, P372, DOI 10.1006/qres.2002.2347; BELLOMO RV, 1994, J HUM EVOL, V27, P173, DOI 10.1006/jhev.1994.1041; Bird MI, 1998, NATURE, V394, P767, DOI 10.1038/29507; CALLOW P, 1986, COTTE BRELADE 1961; Clark J.D., 1985, AFR ARCHAEOL REV, V3, P3, DOI [10.1007/BF01117453, DOI 10.1007/BF01117453]; FAHN A, 1986, ANATOMY IDENTIFICATI; Garrod DAE, 1937, STONE AGE MOUNT CARM, V1; GERAADS D, 1983, ANTHROPOLOGIE, V87, P138; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N, 2002, ACHEULIAN SITE GESHE; GOWLETT JAJ, 1981, NATURE, V294, P125, DOI 10.1038/294125a0; JAMES SR, 1989, CURR ANTHROPOL, V30, P1, DOI 10.1086/203705; Karkanas P, 2002, J ARCHAEOL SCI, V29, P721, DOI 10.1006/jasc.2001.0742; Kislev Mordechai, 1997, Lagascalia, V19, P289; KLEIN RG, 1999, HUMAN CAREER HUMAN B; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Meignen L., 2000, PALEORIENT, V26, P9; MERCIER N, 1995, J ARCHAEOL SCI, V22, P495, DOI 10.1006/jasc.1995.0048; OAKLEY KP, 1961, SOCIAL LIFE EARLY MA, P176; Olive M., 1989, NATURE FONCTION FOYE; Purdy B. A, 1975, LITHIC TECHNOLOGY MA, P133; Rightmire, 1990, EVOLUTION HOMO ERECT; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; TURVILLE-PETRE F, 1927, RES PREHISTORIC GALI; Weiner S, 1998, SCIENCE, V281, P251, DOI 10.1126/science.281.5374.251; Weiner S, 2002, J ARCHAEOL SCI, V29, P1289, DOI 10.1006/jasc.2001.0790; Whelan R.J, 1995, ECOLOGY FIRE	30	306	321	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					725	727		10.1126/science.1095443	http://dx.doi.org/10.1126/science.1095443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118160				2022-12-01	WOS:000221105300042
J	Paushkin, SV; Patel, M; Furia, BS; Peltz, SW; Trotta, CR				Paushkin, SV; Patel, M; Furia, BS; Peltz, SW; Trotta, CR			Identification of a human endonuclease complex reveals a link between tRNA splicing and Pre-mRNA 3 ' end formation	CELL			English	Article							CANCER SUSCEPTIBILITY GENE; SACCHAROMYCES-CEREVISIAE; INTERVENING SEQUENCES; PROTEIN INTERACTIONS; RIBONUCLEASE-P; XENOPUS-LAEVIS; YEAST; CLEAVAGE; POLYADENYLATION; TRANSCRIPTION	tRNA splicing is a fundamental process required for cell growth and division. The first step in tRNA splicing is the removal of introns catalyzed in yeast by the tRNA splicing endonuclease. The enzyme responsible for intron removal in mammalian cells is unknown. We present the identification and characterization of the human tRNA splicing endonuclease. This enzyme consists of HsSen2, HsSen34, HsSen15, and HsSen54, homologs of the yeast tRNA endonuclease subunits. Additionally, we identified an alternatively spliced isoform of SEN2 that is part of a complex with unique RNA endonuclease activity. Surprisingly, both human endonuclease complexes are associated with pre-mRNA3' end processing factors. Furthermore, siRNA-mediated depletion of SEN2 exhibited defects in maturation of both pre-tRNA and pre-mRNA. These findings demonstrate a link between pre-tRNA splicing and pre-mRNA 3' end formation, suggesting that the endonuclease subunits function in multiple RNA-processing events.	PTC Therapeut, S Plainfield, NJ 07080 USA		Trotta, CR (corresponding author), PTC Therapeut, 100 Corp Court, S Plainfield, NJ 07080 USA.	ctrotta@ptcbio.com						Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; BALDI MI, 1986, CELL, V47, P965, DOI 10.1016/0092-8674(86)90811-1; Belfort M, 1997, CELL, V89, P1003, DOI 10.1016/S0092-8674(00)80287-1; Bujnicki JM, 2000, FEBS LETT, V486, P328, DOI 10.1016/S0014-5793(00)02322-X; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; CLARK MW, 1987, J CELL BIOL, V105, P1515, DOI 10.1083/jcb.105.4.1515; Culver GM, 1997, J BIOL CHEM, V272, P13203, DOI 10.1074/jbc.272.20.13203; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; DEROBERTIS EM, 1979, NATURE, V278, P137, DOI 10.1038/278137a0; Fabbri S, 1998, SCIENCE, V280, P284, DOI 10.1126/science.280.5361.284; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; GANDINIATTARDI D, 1990, METHOD ENZYMOL, V181, P510; HO CK, 1990, EMBO J, V9, P1245, DOI 10.1002/j.1460-2075.1990.tb08232.x; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacobson MR, 1997, J CELL SCI, V110, P829; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; MATTOCCIA E, 1979, CELL, V18, P643, DOI 10.1016/0092-8674(79)90119-3; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0; OCONNOR JP, 1992, MOL CELL BIOL, V12, P3843, DOI 10.1128/MCB.12.9.3843; OGDEN RC, 1984, NUCLEIC ACIDS RES, V12, P9367, DOI 10.1093/nar/12.24.9367; OTSUKA A, 1981, MOL CELL BIOL, V1, P269, DOI 10.1128/MCB.1.3.269; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Preker PJ, 1997, EMBO J, V16, P4727, DOI 10.1093/emboj/16.15.4727; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; Simard J, 2002, ENDOCRINOLOGY, V143, P2029, DOI 10.1210/en.143.6.2029; STANDRING DN, 1981, P NATL ACAD SCI-BIOL, V78, P5963, DOI 10.1073/pnas.78.10.5963; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; TROTTA CR, 1998, RNA WORLD, V2, P561; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Wallace AM, 1999, P NATL ACAD SCI USA, V96, P6763, DOI 10.1073/pnas.96.12.6763; WESTAWAY SK, 1988, J BIOL CHEM, V263, P3171; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.e02-11-0757; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao J, 1999, MOL CELL BIOL, V19, P7733	45	164	179	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					311	321		10.1016/S0092-8674(04)00342-3	http://dx.doi.org/10.1016/S0092-8674(04)00342-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109492	Bronze			2022-12-01	WOS:000221176400006
J	Rutter, M; Caspi, A; Fergusson, D; Horwood, LJ; Goodman, R; Maughan, B; Moffitt, TE; Meltzer, H; Carroll, J				Rutter, M; Caspi, A; Fergusson, D; Horwood, LJ; Goodman, R; Maughan, B; Moffitt, TE; Meltzer, H; Carroll, J			Sex differences in developmental reading disability - New findings from 4 epidemiological studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; POPULATION	Context An influential article published in 1990 claimed that the increased rate of reading disability in boys was a consequence of referral bias. Objectives To summarize the history of research on sex differences in reading disability and to provide new evidence from 4 independent epidemiological studies about the nature, extent, and significance of sex differences in reading disability. Design, Setting, and Participants The Dunedin Multidisciplinary Health and Development Study comprised 989 individuals (52.1% male) in a cohort born between April 1972 and March 1973 in Dunedin, New Zealand, and followed up from age 3 years; reading performance and IQ were assessed at ages 7, 9, and 11 years using the Burt Word Reading Test and the Wechsler Intelligence Scale for Children-Revised (WISC-R), respectively. The Christchurch Health and Development Study comprised 895 individuals (50% male) in a prospectively studied cohort born in the Christchurch, New Zealand, region during a 4-month period in 1977; reading performance and IQ were assessed at ages 8 to 10 years using the Burt Word Reading Test and the WISC-R. The Office for National Statistics (ONS) Study comprised a UK nationally representative sample of 5752 children (50.1% male) aged 9 to 15 years in 1999; reading was assessed on the British Ability Scales II and IQ on the British Picture Vocabulary Scales II. The Environmental Risk Longitudinal Twin Study (E-Risk) comprised 2163 twin children from England and Wales (49.1% male) identified at birth in 1994 and 1995 and included administration of the Test of Word Reading Efficiency at age 7 years and the Wechsler Preschool and Primary Scale of Intelligence-Revised as a test of IQ at age 5 years. Main Outcome Measure Reading performance by sex in the lowest 15% of the distribution for all 4 studies, with and without taking IQ into account. Results In all 4 studies, the rates of reading disability were significantly higher in boys. For non-IQ-referenced reading disability: Dunedin study, 21.6% in boys vs 7.9% in girls (odds ratio [OR], 3.19; 95% confidence interval [Cl], 2.15-4.17); Christchurch study, 20.6% in boys vs 9.8% in girls (OR, 2.38; 95% Cl, 1.62-3.50); ONS study, 17.6% in boys vs 13.0% in girls (OR, 1.43; 95% Cl, 1.23-1.65); and E-Risk, 18.0% in boys vs 13.0% in girls (OR, 1.39; 95% Cl, 1.04-1.86). The rates for IQ-referenced reading disabilities were similar. Conclusion Reading disabilities are clearly more frequent in boys than in girls.	Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; Christchurch Sch Med, Christchurch, New Zealand; Off Natl Stat, London, England; Univ Warwick, Coventry CV4 7AL, W Midlands, England	University of London; King's College London; University of London; King's College London; University of Otago; University of Warwick	Rutter, M (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, Box P080,De Crespigny Pk, London SE5 8AF, England.	j.wickham@iop.kcl.ac.uk	Rutter, Michael/C-8570-2013; Carroll, Julia/D-6259-2011; Moffitt, Terrie E/D-5295-2011; Meltzer, Herbert Y/E-8131-2013; caspi, avshalom/AAJ-5874-2020; caspi, avshalom/D-5294-2011	Carroll, Julia/0000-0002-3614-6883; Moffitt, Terrie E/0000-0002-8589-6760; caspi, avshalom/0000-0003-0082-4600; caspi, avshalom/0000-0003-0082-4600; Rutter, Michael Llewellyn/0000-0003-1577-7405; Horwood, L./0000-0003-4881-1956; Goodman, Robert/0000-0001-5596-1667; Fergusson, David/0000-0002-8117-017X	NIMH NIH HHS [MH49414, MH45070] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049414, R29MH049414, R01MH045070] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERGER M, 1975, BRIT J PSYCHIAT, V126, P510, DOI 10.1192/bjp.126.6.510; DUNN LM, 1997, BRIT PICTURE VOCABUL, V2; Fergusson D M, 1989, Paediatr Perinat Epidemiol, V3, P302; Fergusson DM, 2001, AUST NZ J PSYCHIAT, V35, P287, DOI 10.1046/j.1440-1614.2001.00902.x; Fergusson DM, 1996, DEV PSYCHOL, V32, P132, DOI 10.1037/0012-1649.32.1.132; Flannery KA, 2000, J INT NEUROPSYCH SOC, V6, P433, DOI 10.1017/S1355617700644016; Gould W, 1999, MAXIMUM LIKELIHOOD E; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; McCullouch K., 1996, BRIT ABILITY SCALES; Meltzer H., 2000, MENTAL HLTH CHILDREN; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Reid, 1981, BURT WORD READING TE; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; SATTLER JM, 1992, ASSESSMENT CHILDRE S; *SCOTT COUNC RES E, 1976, BURT WORD READING TE; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; SNOWLING MJ, 2002, CHILD ADOLESCENT PSY, P682; *STATA CORP, 2001, STATA REL 7 0 COMP P; Torgesen J., 2011, TEST WORD READING EF; *UNESCO ORG EC COO, 2003, KNOWL SKILLS LIF 1 R; Wechsler D., 1974, MANUAL WECHSLER INTE; WECHSLER D, 1990, WECHSLER PRESCHOOL P; YULE W, 1974, BRIT J EDUC PSYCHOL, V44, P1, DOI 10.1111/j.2044-8279.1974.tb00760.x; [No title captured]	24	293	301	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					2007	2012		10.1001/jama.291.16.2007	http://dx.doi.org/10.1001/jama.291.16.2007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815SM	15113820				2022-12-01	WOS:000221062000033
J	You, LC; Cox, RS; Weiss, R; Arnold, FH				You, LC; Cox, RS; Weiss, R; Arnold, FH			Programmed population control by cell-cell communication and regulated killing	NATURE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; VIBRIO-FISCHERI; TOGGLE SWITCH; BACTERIA; NETWORKS; DEATH; CONSTRUCTION; EVOLUTION; ELEMENTS	De novo engineering of gene circuits inside cells is extremely difficult(1-9), and efforts to realize predictable and robust performance must deal with noise in gene expression and variation in phenotypes between cells(10-12). Here we demonstrate that by coupling gene expression to cell survival and death using cell-cell communication, we can programme the dynamics of a population despite variability in the behaviour of individual cells. Specifically, we have built and characterized a 'population control' circuit that autonomously regulates the density of an Escherichia coli population. The cell density is broadcasted and detected by elements from a bacterial quorum-sensing system(13,14), which in turn regulate the death rate. As predicted by a simple mathematical model, the circuit can set a stable steady state in terms of cell density and gene expression that is easily tunable by varying the stability of the cell-cell communication signal. This circuit incorporates a mechanism for programmed death in response to changes in the environment, and allows us to probe the design principles of its more complex natural counterparts.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	California Institute of Technology; California Institute of Technology; Princeton University; Princeton University	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu		Arnold, Frances H./0000-0002-4027-364X				Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; CHEN W, 1993, GENE, V130, P15, DOI 10.1016/0378-1119(93)90341-Y; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; Egland KA, 2001, J BACTERIOL, V183, P382, DOI 10.1128/JB.183.1.382-386.2001; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerchman Y, 2004, P NATL ACAD SCI USA, V101, P2221, DOI 10.1073/pnas.0400473101; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Weiss R., 2003, Natural Computing, V2, P47, DOI 10.1023/A:1023307812034; Weiss R, 2000, 6 INT M DNA BAS COMP, V2054, P1; WEISS R, 1999, DIM WORKSH EV COMP, P275; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; You LC, 2003, BIOINFORMATICS, V19, P435, DOI 10.1093/bioinformatics/btg009; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832	32	484	512	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					868	871		10.1038/nature02491	http://dx.doi.org/10.1038/nature02491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15064770				2022-12-01	WOS:000220952300044
J	Zufall, RA; Rausher, MD				Zufall, RA; Rausher, MD			Genetic changes associated with floral adaptation restrict future evolutionary potential	NATURE			English	Article							DIHYDROFLAVONOL 4-REDUCTASE; SUBSTRATE-SPECIFICITY; IPOMOEA; FLOWERS; GLYCOSIDES	A commonly accepted evolutionary principle is that adaptive change constrains the potential directions of future evolutionary change(1-3). One manifestation of this is Dollo's law, which states that character elimination is irreversible(4,5). Although the common occurrence of irreversibility has been documented by phylogenetic analyses of phenotypic transitions, little is known about the underlying causes of this phenomenon(4). One explanation for evolutionary irreversibility relies on the fact that many characteristics result from interactions between multiple gene products(4,6). Such characteristics may often be eliminated by inactivation of just one gene in the network. If they serve no other functions, other genes of the network are then free to accumulate mutations or evolve new functions. Evolutionary change after character loss results in the accumulation of redundant loss-of-function mutations. Such pathway degeneration makes it very unlikely that the characteristic will re-evolve, because multiple simultaneous mutations would be required(4). Here we describe what appear to be the initial stages of such degeneration in the anthyocyanin pigment pathway associated with an adaptive change from blue to red flowers in the morning glory Ipomoea quamoclit.	Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Zufall, RA (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.	bzufall@smith.edu						AN G, 1988, PLANT MOL BIOL MAN A, V3, P1; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; BULL JJ, 1985, EVOLUTION, V39, P1149, DOI [10.2307/2408742, 10.1111/j.1558-5646.1985.tb00455.x]; Clegg MT, 2003, NAT REV GENET, V4, P206, DOI 10.1038/nrg1023; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dobzhansky T., 1970, GENETICS EVOLUTIONAR; Dong XY, 2001, PLANT PHYSIOL, V127, P46, DOI 10.1104/pp.127.1.46; FAEGRI DT, 1966, PRINCIPLES POLLINATI; FORKMANN G, 1987, Z NATURFORSCH C, V42, P1146; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Grant V., 1977, ORGANISMIC EVOLUTION; Harbourne J. B., 1967, COMP BIOCH FLAVONOID; Hoshino A, 2003, PLANT CELL PHYSIOL, V44, P990, DOI 10.1093/pcp/pcg143; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; LAVA C, 2001, OECOLOGIA, V128, P263; MACHADO I C S, 1987, Revista Brasileira de Biologia, V47, P425; Manos PS, 2001, SYST BOT, V26, P585; MCDONALD A, 1991, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V62, P65; Miller RE, 1999, SYST BOT, V24, P209, DOI 10.2307/2419549; MILLER RE, IN PRESS AM J BOT; SAITO N, 1995, PHYTOCHEMISTRY, V40, P1283, DOI 10.1016/0031-9422(95)00369-I; Saito N, 1996, PHYTOCHEMISTRY, V43, P1365, DOI 10.1016/S0031-9422(96)00501-8; STAFFORD HA, 1982, PLANT PHYSIOL, V70, P695, DOI 10.1104/pp.70.3.695; Swofford D, 2000, PAUP PHYLOGENETIC AN; WAGNER GP, 1982, J THEOR BIOL, V96, P337, DOI 10.1016/0022-5193(82)90114-X; Zufall RA, 2003, J HERED, V94, P442, DOI 10.1093/jhered/esg098; ZUFALL RA, 2003, THESIS DUKE U	29	125	142	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					847	850		10.1038/nature02489	http://dx.doi.org/10.1038/nature02489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103375				2022-12-01	WOS:000220952300038
J	Buesseler, KO; Andrews, JE; Pike, SM; Charette, MA				Buesseler, KO; Andrews, JE; Pike, SM; Charette, MA			The effects of iron fertilization on carbon sequestration in the Southern Ocean	SCIENCE			English	Article							PARTICULATE ORGANIC-CARBON; EXPORT; BLOOM; PHYTOPLANKTON; ENRICHMENT; TH-234	An unresolved issue in ocean and climate sciences is whether changes to the surface ocean input of the micronutrient iron can alter the flux of carbon to the deep ocean. During the Southern Ocean Iron Experiment, we measured an increase in the flux of particulate carbon from the surface mixed layer, as well as changes in particle cycling below the iron-fertilized patch. The flux of carbon was similar in magnitude to that of natural blooms in the Southern Ocean and thus small relative to global carbon budgets and proposed geoengineering plans to sequester atmospheric carbon dioxide in the deep sea.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu	Charette, Matthew/I-9495-2012					Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bidigare RR, 1999, PALEOCEANOGRAPHY, V14, P589, DOI 10.1029/1999PA900026; Bishop JKB, 2004, SCIENCE, V304, P417, DOI 10.1126/science.1087717; BOYD P, 1995, DEEP-SEA RES PT I, V42, P619, DOI 10.1016/0967-0637(95)00017-Z; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BRZEZINSKI MA, 2002, AM GEOPH SOC FALL M; BUESSELER KO, 1992, DEEP-SEA RES, V39, P1115, DOI 10.1016/0198-0149(92)90060-7; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2003, DEEP-SEA RES PT II, V50, P579, DOI 10.1016/S0967-0645(02)00585-4; Buesseler KO, 1998, GLOBAL BIOGEOCHEM CY, V12, P297, DOI 10.1029/97GB03366; Buesseler KO, 2001, DEEP-SEA RES PT II, V48, P4275, DOI 10.1016/S0967-0645(01)00089-3; Buesseler KO, 2001, MAR CHEM, V74, P15, DOI 10.1016/S0304-4203(00)00092-X; BUESSELER KO, UNPUB; Charette MA, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000069; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; COALE KH, 1985, LIMNOL OCEANOGR, V30, P22, DOI 10.4319/lo.1985.30.1.0022; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; Morrison JM, 2001, DEEP-SEA RES PT II, V48, P3943, DOI 10.1016/S0967-0645(01)00075-3; Nodder SD, 2001, GEOPHYS RES LETT, V28, P2409, DOI 10.1029/2001GL013008; RIEBESELL U, COMMUNICATION; Smetacek V, 1998, NATURE, V391, P224, DOI 10.1038/34528; Smetacek V., 2001, US JGOFS NEWS, V11, P11; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000	30	176	188	7	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					414	417		10.1126/science.1086895	http://dx.doi.org/10.1126/science.1086895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087543				2022-12-01	WOS:000220845400040
J	O'Doherty, J; Dayan, P; Schultz, J; Deichmann, R; Friston, KJ; Dolan, RJ				O'Doherty, J; Dayan, P; Schultz, J; Deichmann, R; Friston, KJ; Dolan, RJ			Dissociable roles of ventral and dorsal striatum in instrumental conditioning	SCIENCE			English	Article							BASAL GANGLIA; DOPAMINE NEURONS; TEMPORAL PREDICTION; PREFRONTAL CORTEX; REWARD; ORGANIZATION; MOTIVATION; RESPONSES; PATHWAYS; MODELS	Instrumental conditioning studies how animals and humans choose actions appropriate to the affective structure of an environment. According to recent reinforcement learning models, two distinct components are involved: a "critic," which learns to predict future reward, and an " actor," which maintains information about the rewarding outcomes of actions to enable better ones to be chosen more frequently. We scanned human participants with functional magnetic resonance imaging while they engaged in instrumental conditioning. Our results suggest partly dissociable contributions of the ventral and dorsal striatum, with the former corresponding to the critic and the latter corresponding to the actor.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Gatsby Computat Neurosci Unit, London WC1N 3BG, England	University of London; University College London; University of London; University College London	O'Doherty, J (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England.	j.odoherty@fil.ion.ucl.ac.uk	Friston, Karl/D-9230-2011; anand, amit/A-7222-2009; O'Doherty, John P/F-1204-2013; Schultz, Johannes/B-8613-2012	Friston, Karl/0000-0001-7984-8909; Schultz, Johannes/0000-0003-4117-232X; Dayan, Peter/0000-0003-3476-1839; Dolan, Ray/0000-0001-9356-761X				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baird III L. C., 1993, WLTR931146; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barto A, 1998, REINFORCEMENT LEARNI, V1st; BARTO AG, 1996, MODELS INFORMATION P, pCH11; Brown J, 1999, J NEUROSCI, V19, P10502; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Dayan P, 2002, ADV NEUR IN, V14, P11; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HOUK JC, 1996, MODELS INFORMATION P, P249; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; MACKINTOSH NJ, 1983, CONDITINING ASS LEAR; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Skinner B.F., 1938, BEHAV ORGAN EXP ANAL; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Thorndike EL, 1911, ANIMAL INTELLIGENCE; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9	32	1480	1482	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					452	454		10.1126/science.1094285	http://dx.doi.org/10.1126/science.1094285			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087550	Green Submitted			2022-12-01	WOS:000220845400052
J	Ely, EW; Shintani, A; Truman, B; Speroff, T; Gordon, SM; Harrell, FE; Inouye, SK; Bernard, GR; Dittus, RS				Ely, EW; Shintani, A; Truman, B; Speroff, T; Gordon, SM; Harrell, FE; Inouye, SK; Bernard, GR; Dittus, RS			Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONFUSION ASSESSMENT METHOD; MINI-MENTAL-STATE; AGITATION-SEDATION SCALE; CRITICALLY-ILL PATIENTS; RISK-FACTORS; SEPTIC ENCEPHALOPATHY; OLDER PERSONS; SEVERE SEPSIS; SOFA SCORE; INFLAMMATION	Context In the intensive care unit (ICU), delirium is a common yet underdiagnosed form of organ dysfunction, and its contribution to patient outcomes is unclear. Objective To determine if delirium is an independent predictor of clinical outcomes, including 6-month mortality and length of stay among ICU patients receiving mechanical ventilation. Design, Setting, and Participants Prospective cohort study enrolling 275 consecutive mechanically ventilated patients admitted to adult medical and coronary ICUs of a US university-based medical center between February 2000 and May 2001. Patients were followed up for development of delirium over 2158 ICU days using the Confusion Assessment Method for the ICU and the Richmond Agitation-Sedation Scale. Main Outcome Measures Primary outcomes included 6-month mortality, overall hospital length of stay, and length of stay in the post-ICU period. Secondary outcomes were ventilator-free days and cognitive impairment at hospital discharge. Results Of 275 patients, 51 (18.5%) had persistent coma and died in the hospital. Among the remaining 224 patients, 183 (81.7%) developed delirium at some point during the ICU stay. Baseline demographics including age, comorbidity scores, dementia scores, activities of daily living, severity of illness, and admission diagnoses were similar between those with and without delirium (P>.05 for all). Patients who developed delirium had higher 6-month mortality rates (34% vs 15%, P=.03) and spent 10 days longer in the hospital than those who never developed delirium (P<.001). After adjusting for covariates (including age, severity of illness, comorbid conditions, coma, and use of sedatives or analgesic medications), delirium was independently associated with higher 6-month mortality (adjusted hazard ratio [HR], 3.2; 95% confidence interval [CI], 1.4-7.7; P=.008), and longer hospital stay (adjusted HR, 2.0; 95% Cl, 1.4-3.0; P<.001). Delirium in the ICU was also independently associated with a longer post-ICU stay (adjusted HR, 1.6; 95% Cl, 1.2-2.3; P=.009), fewer median days alive and without. mechanical ventilation (19 [interquartile range, 4-23] vs 24 [19261; adjusted P=.03), and a higher incidence of cognitive impairment at hospital discharge (adjusted HR, 9.1; 95% Cl, 2.3-35.3; P=.002). Conclusion Delirium was an independent predictor of higher 6-month mortality and longer hospital stay even after adjusting for relevant covariates including coma, sedatives, and analgesics in patients receiving mechanical ventilation.	Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Div Allergy Pulm Crit Care Med,Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Vet Affairs Tennessee Valley Geriatr Res Educ & C, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; Vanderbilt University; Vanderbilt University; Vanderbilt University; Yale University	Ely, EW (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Div Allergy Pulm Crit Care Med,Sch Med, 6th Floor,Med Ctr E 6109, Nashville, TN 37232 USA.	wes.ely@vanderbilt.edu	Inouye, Sharon/R-7216-2019; Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172	NIA NIH HHS [K23 AG01023-01A1, K24AG00949] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG000949, K23AG001023] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aldemir M, 2001, CRIT CARE, V5, P265, DOI 10.1186/cc1044; *AM PSYCH ASS, WHAT IS DELIRIUM; AM. PSYCHIATRIC ASS'N, 1994, DIAGN STAT MAN MENT, P123; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 1999, Am J Psychiatry, V156, P1; Axell AIRG, 2002, ACTA ANAESTH SCAND, V46, P726, DOI 10.1034/j.1399-6576.2002.460616.x; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; CAMMARANO WB, 1998, PRINCIPLES CRITICAL, P90; Camus V, 2000, INT J GERIATR PSYCH, V15, P313, DOI 10.1002/(SICI)1099-1166(200004)15:4<313::AID-GPS115>3.0.CO;2-M; COX DR, 1972, J R STAT SOC B, V34, P187; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Eilers H, 2001, ANESTH ANALG, V93, P213, DOI 10.1097/00000539-200107000-00042; Elie M, 1998, J GEN INTERN MED, V13, P204, DOI 10.1046/j.1525-1497.1998.00047.x; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2004, CRIT CARE MED, V32, P106, DOI 10.1097/01.CCM.0000098033.94737.84; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2003, CLIN INFECT DIS, V37, P187, DOI 10.1086/375775; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Ely EW, 2001, SEMIN RESP CRIT CARE, V22, P115, DOI 10.1055/s-2001-13826; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; Geary S M, 1994, Crit Care Nurs Q, V17, P51; GUSTAFSON Y, 1991, J AM GERIATR SOC, V39, P760, DOI 10.1111/j.1532-5415.1991.tb02697.x; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Inouye SK, 1999, AM J MED, V106, P565, DOI 10.1016/S0002-9343(99)00070-4; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1994, AM J MED, V97, P278, DOI 10.1016/0002-9343(94)90011-6; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kiely DK, 2003, J GERONTOL A-BIOL, V58, P441, DOI 10.1093/gerona/58.5.M441; Kleinbaum David G., 1988, APPL REGRESSION ANAL, V2a, P210; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; LIPOWSKI ZJ, 1989, NEW ENGL J MED, V320, P578; Litaker D, 2001, GEN HOSP PSYCHIAT, V23, P84, DOI 10.1016/S0163-8343(01)00117-7; Lorentz WJ, 2002, CAN J PSYCHIAT, V47, P723, DOI 10.1177/070674370204700803; Luhr OR, 2000, INTENS CARE MED, V26, P508, DOI 10.1007/s001340051197; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457; McGuire BE, 2000, ARCH INTERN MED, V160, P906, DOI 10.1001/archinte.160.7.906; McNicoll L, 2003, J AM GERIATR SOC, V51, P591, DOI 10.1034/j.1600-0579.2003.00201.x; Meagher DJ, 2001, BMJ-BRIT MED J, V322, P144, DOI 10.1136/bmj.322.7279.144; Meagher DJ, 2000, J NEUROPSYCH CLIN N, V12, P51, DOI 10.1176/jnp.12.1.51; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Nicholson TE, 2002, DRUG METAB DISPOS, V30, P42, DOI 10.1124/dmd.30.1.42; OCONNOR DW, 1989, J PSYCHIAT RES, V23, P87, DOI 10.1016/0022-3956(89)90021-6; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Peterson JF, 2003, J AM GERIATR SOC, V51, pS174; PETO R, 1972, J BIOMETRICS, V26, P579; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; Rahkonen T, 2001, INT J GERIATR PSYCH, V16, P415, DOI 10.1002/gps.356; Renton KW, 2000, J PHARMACOL EXP THER, V294, P524; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rockwood K, 1999, AGE AGEING, V28, P551, DOI 10.1093/ageing/28.6.551; Rolfson DB, 1999, CAN J CARDIOL, V15, P771; Rothwell NJ, 1996, PHARMACOL THERAPEUT, V69, P85, DOI 10.1016/0163-7258(95)02033-0; Sanders AB, 2002, ANN EMERG MED, V39, P338, DOI 10.1067/mem.2002.122273; Schmitz R., 1998, FUTURE NEEDS PULMONA; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; SCHOR JD, 1992, JAMA-J AM MED ASSOC, V267, P827, DOI 10.1001/jama.267.6.827; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021; Shimamoto Y, 1999, ARCH TOXICOL, V73, P41, DOI 10.1007/s002040050584; Shimamoto Y, 1998, ARCH TOXICOL, V72, P492, DOI 10.1007/s002040050533; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; Tangalos EG, 1996, MAYO CLIN PROC, V71, P829, DOI 10.4065/71.9.829; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; TRUJILLO KA, 1991, NEW BIOL, V3, P915; TRUMAN B, 2003, AM J RESP CRIT CARE, V167, pA969; Truman Brenda, 2003, Crit Care Nurse, V23, P25; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vincent JL, 2002, CRIT CARE, V6, pS1, DOI 10.1186/cc1860; Vinik HR, 1998, ANESTH ANALG, V86, P1307, DOI 10.1097/00000539-199806000-00033; WIJDICKS EFM, 2002, NEUROLOGIC COMPLICAT; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woiciechowsky C, 1999, BRAIN RES, V816, P563, DOI 10.1016/S0006-8993(98)01238-4; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016	101	1836	1942	4	82	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1753	1762		10.1001/jama.291.14.1753	http://dx.doi.org/10.1001/jama.291.14.1753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811RJ	15082703	Bronze, Green Published			2022-12-01	WOS:000220788700033
J	Westerlund, H; Ferrie, J; Hagberg, J; Jeding, K; Oxenstierna, G; Theorell, T				Westerlund, H; Ferrie, J; Hagberg, J; Jeding, K; Oxenstierna, G; Theorell, T			Workplace expansion, long-term sickness absence, and hospital admission	LANCET			English	Article							FACTORY CLOSURE; HEALTH; EMPLOYEES; JOB; UNEMPLOYMENT; DISEASE; DEATH; WOMEN	Background Downsizing has in previous studies, as well as in public debate, been associated with increased sickness absence. No studies have, however, looked at the long-term relation between workplace expansion and morbidity. Methods We investigated exposure to personnel change during 1991-96 in relation to long-term (90 days or longer) medically certified sickness absence and hospital admission for specified diagnoses during 1997-99 in 24 036 participants with a complete employment record in the biennial national Swedish Work Environment Surveys from 1989 to the end of 1999. Findings Accumulated exposure to large expansion (greater than or equal to18% per year) was related to an increased risk of long-term sickness absence (odds ratio 1.07 [95% Cl 1.01-1.13], p=0.013) and hospital admission (1.09 [1.02-1.16], p=0.017). In this context, odds ratio signifies the change in odds for each additional year of exposure, varying from 0 to 6. Moderate expansion (greater than or equal to8% and <18% per year), was associated with a decreased risk of admission (0.91 [0.84-0.98], p=0.012). Moderate downsizing (>= 8% and <18% per year) was associated with an increased risk of sickness absence (1.07 (1.02-1.12], p=0.003). The strongest association between large expansion and sickness absence was in women in the public sector (1.18 [1.08-1.30], p=0.0002), corresponding to an odds ratio of 2.77 [1.62-4.74] between full exposure (all 6 years) and no exposure. Interpretation This study confirms earlier findings that downsizing is associated with health risks. It also shows that repeated exposure to rapid personnel expansion, possibly connected with centralisation of functions, statistically predicts long-term sickness absence and hospital admission. Although no conclusions about causal pathways can be drawn from our results, this exposure should be considered in future studies, policy making, and occupational health care practice.	Natl Inst Psychosocial Med, Stockholm, Sweden; UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Stockholm, Dept Stat, S-10691 Stockholm, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	University of London; University College London; Stockholm University; Karolinska Institutet	Westerlund, H (corresponding author), Natl Inst Psychosocial Med, Mosseberg Res Stn, Mossebergspk 2, S-52132 Falkoping, Sweden.	hugo.westerlund@ipm.ki.se	Ferrie, Jane/AAZ-2009-2020; Westerlund, Hugo/A-3049-2012	Westerlund, Hugo/0000-0002-8806-5698; Hagberg, Jan/0000-0001-6851-265X				Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; BEALE N, 1985, J ROY COLL GEN PRACT, V35, P510; Bjorkelund C, 2001, Lakartidningen, V98, P3314; EYER J, 1977, INT J HEALTH SERV, V7, P625, DOI 10.2190/15F1-N58K-D38Y-2X0P; EYER J, 1977, INT J HEALTH SERV, V7, P125, DOI 10.2190/9WA2-RVL3-MT9D-EL9D; Ferrie JE, 1998, SOC SCI MED, V46, P243, DOI 10.1016/S0277-9536(97)00158-5; Ferrie JE, 2001, BMJ-BRIT MED J, V322, P647, DOI 10.1136/bmj.322.7287.647; Ferrie JE, 1998, AM J PUBLIC HEALTH, V88, P1030, DOI 10.2105/AJPH.88.7.1030; Grunberg L, 2001, J Occup Health Psychol, V6, P15, DOI 10.1037/1076-8998.6.1.15; IVERSEN L, 1989, BRIT MED J, V299, P1073, DOI 10.1136/bmj.299.6707.1073; KASL SV, 1975, PSYCHOSOM MED, V37, P106, DOI 10.1097/00006842-197503000-00002; Kivimaki M, 2001, OCCUP ENVIRON MED, V58, P811, DOI 10.1136/oem.58.12.811; Kuper H, 2002, OCCUP ENVIRON MED, V59, P777, DOI 10.1136/oem.59.11.777; Landsbergis P A, 1999, J Occup Health Psychol, V4, P108, DOI 10.1037/1076-8998.4.2.108; MORRIS JK, 1991, BRIT J IND MED, V48, P1; PLATT S, 1998, CHANGING LABOUR MARK; Theorell T, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e9; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; WESTERLUND H, IN PRESS EUR J PUBLI; WESTIN S, 1989, J CLIN EPIDEMIOL, V42, P435, DOI 10.1016/0895-4356(89)90133-9; Witte, 1999, EUR WORK ORG PSYCHOL, V8, P155, DOI DOI 10.1080/135943299398302	21	77	79	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1193	1197		10.1016/S0140-6736(04)15949-7	http://dx.doi.org/10.1016/S0140-6736(04)15949-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081652				2022-12-01	WOS:000220748100010
J	Mount, AS; Wheeler, AP; Paradkar, RP; Snider, D				Mount, AS; Wheeler, AP; Paradkar, RP; Snider, D			Hemocyte-mediated shell mineralization in the eastern oyster	SCIENCE			English	Article							NUCLEATION; CALCITE; APLACOPHORA; MORPHOLOGY; GROWTH	The growth of molluscan shell crystals is usually thought to be initiated from solution by extracellular organic matrix. We report a class of granulocytic hemocytes that may be directly involved in shell crystal production for oysters. On the basis of scanning electron microscopy (SEM) and x-ray microanalysis, these granulocytes contain calcium carbonate crystals, and they increase in abundance relative to other hemocytes following experimentally induced shell regeneration. Hemocytes are observed at the mineralization front using vital fluorescent staining and SEM. Some cells are observed releasing crystals that are subsequently remodeled, thereby at least augmenting matrix-mediated crystal-forming processes in this system.	Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; Clemson Univ, Ctr Adv Engn Fibers & Films, Clemson, SC 29634 USA	Clemson University; Clemson University	Mount, AS (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	mount@clemson.edu		Mount, Andrew/0000-0002-3376-1135				ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; CARRIKER M R, 1980, Proceedings National Shellfisheries Association, V70, P139; Carriker Melbourne R., 1996, P75; Cheng T.C., 1981, INVERTEBRATE BLOOD C, P233; Cheng Thomas C., 1996, P299; CRENSHAW MA, 1972, BIOL BULL, V143, P506, DOI 10.2307/1540180; Eble Albert F., 1996, P271; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; FORD SE, 1993, J INVERTEBR PATHOL, V61, P49, DOI 10.1006/jipa.1993.1009; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P219, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Gosling E., 2003, BIVALVE MOLLUSCS BIO; GREENFIELD EM, 1984, AM ZOOL, V24, P925; Hine PM, 1999, FISH SHELLFISH IMMUN, V9, P367, DOI 10.1006/fsim.1998.0205; JODREY LH, 1953, BIOL BULL, V104, P398, DOI 10.2307/1538493; JUSTUS M, 2002, 6 INT C SHELLF REST; KINGSLEY RJ, 1984, AM ZOOL, V24, P833; MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0; MCCORMICKRAY MG, 1991, J INVERTEBR PATHOL, V58, P219, DOI 10.1016/0022-2011(91)90066-Y; MOUNT AS, 1999, THESIS CLEMSON U; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2000, BIOL BULL, V198, P121, DOI 10.2307/1542810; Sikes CS, 2000, BIOL BULL, V198, P50, DOI 10.2307/1542803; Simkiss K., 1989, BIOMINERALIZATION CE; WATABE N, 1983, MOLLUSCA 1, V4, P289; Wheeler A.P., 1992, P179; WHEELER AP, 1975, BIOL BULL, V148, P472, DOI 10.2307/1540523; Wilbur K. M., 1983, MOLLUSCA 1, P236; WILBUR KM, 1952, BIOL BULL, V103, P269, DOI 10.2307/1538451; WILBUR KM, 1964, PHYSL MOLLUSCA, V1, P242; [No title captured]	32	323	344	8	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					297	300		10.1126/science.1090506	http://dx.doi.org/10.1126/science.1090506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073378				2022-12-01	WOS:000220719400049
J	Pham, JW; Pellino, JL; Lee, YS; Carthew, RW; Sontheimer, EJ				Pham, JW; Pellino, JL; Lee, YS; Carthew, RW; Sontheimer, EJ			A Dicer-2-dependent 80S complex cleaves targeted mRNAs during RNAi in Drosophila	CELL			English	Article							INITIATION; PROTEIN; MATURATION; SIRNAS	We use native gel electrophoresis to characterize complexes that mediate RNA interference (RNAi) in Drosophila. Our data reveal three distinct complexes (R1, R2, and R3) that assemble on short interfering RNAs (siRNAs) in vitro. To form, all three complexes require Dicer-2 (Dcr-2), which directly contacts siRNAs in the ATP-independent R1 complex. R1 serves as a precursor to both the R2 and R3 complexes. R3 is a large (80S), ATP-enhanced complex that contains unwound siRNAs, cofractionates with known RNAi factors, and binds and cleaves targeted mRNAs in a cognate-siRNA-dependent manner. Our results establish an ordered biochemical pathway for RISC assembly and indicate that siRNAs must first interact with Dcr-2 to reach the R3 "holo-RISC" complex. Dcr-2 does not simply transfer siRNAs to a distinct effector complex, but rather assembles into RISC along with the siRNAs, indicating that its role extends beyond the initiation phase of RNAi.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Sontheimer, EJ (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM068743-01, R01 GM068743] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Djikeng A, 2003, RNA, V9, P802, DOI 10.1261/rna.5270203; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nadano D, 2001, BIOCHEMISTRY-US, V40, P15184, DOI 10.1021/bi0108397; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	27	329	362	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					83	94		10.1016/S0092-8674(04)00258-2	http://dx.doi.org/10.1016/S0092-8674(04)00258-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066284	Bronze			2022-12-01	WOS:000221500300010
J	Higashida, C; Miyoshi, T; Fujita, A; OcegueraYanez, F; Monypenny, J; Andou, Y; Narumiya, S; Watanabe, N				Higashida, C; Miyoshi, T; Fujita, A; OcegueraYanez, F; Monypenny, J; Andou, Y; Narumiya, S; Watanabe, N			Actin polymerization-driven molecular movement of mDia1 in living cells	SCIENCE			English	Article							CAPPING PROTEIN; FISSION YEAST; FORMIN MDIA1; PROFILIN; NUCLEATION; CYTOKINESIS; FILAMENTS; DYNAMICS; CYTOSKELETON; ELONGATION	mDia1, a Rho effector, belongs to the Formin family of proteins, which shares the conserved tandem FH1-FH2 unit structure. Formins including mDia1 accelerate actin nucleation while interacting with actin. lament fast-growing ends. Here our single-molecule imaging revealed fast directional movement of mDia1 FH1-FH2 for tens of microns in living cells. The movement of mDia1 FH1-FH2 was blocked by actin-perturbing drugs, and the speed of mDia1 FH1-FH2 movement appeared to correlate with actin elongation rates. In vitro, mDia1 FH1-FH2 associated persistently with the growing actin barbed end. mDia1 probably moves processively along the growing end of actin. laments in cells, and Formins may be a molecular motility machinery that is independent from motor proteins.	Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 606, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Watanabe, N (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 606, Japan.	naoki-w@mfour.med.kyoto-u.ac.jp						Adam T, 1996, EMBO J, V15, P3315, DOI 10.1002/j.1460-2075.1996.tb00696.x; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SOUTHWICK FS, 1990, J CELL BIOL, V110, P1965, DOI 10.1083/jcb.110.6.1965; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	29	238	246	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2007	2010		10.1126/science.1093923	http://dx.doi.org/10.1126/science.1093923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044801	Green Submitted			2022-12-01	WOS:000220429800039
J	Liu, SW; Xiao, GF; Chen, YB; He, YX; Niu, JK; Escalante, CR; Xiong, HB; Farmar, J; Debnath, AK; Tien, P; Jiang, SB				Liu, SW; Xiao, GF; Chen, YB; He, YX; Niu, JK; Escalante, CR; Xiong, HB; Farmar, J; Debnath, AK; Tien, P; Jiang, SB			Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors	LANCET			English	Article							ACUTE RESPIRATORY SYNDROME; GP41 CORE STRUCTURE; INFECTION IN-VITRO; HIV-1 GP41; POTENT INHIBITORS; COILED-COIL; ENVELOPE GLYCOPROTEIN; SYNTHETIC PEPTIDES; MEMBRANE-FUSION; TYPE-1 GP41	Background Studies on the fusion-inhibitory peptides derived from the heptad repeat 1 and 2 (HR1 and HR2) regions of the HIV-1 envelope glycoprotein gp41 provided crucial information on the viral fusogenic mechanism. We used a similar approach to study the fusogenic mechanism of severe-acute-respiratory-syndrome-associated coronavirus (SARS-CoV). Methods We tested the inhibitory activity against infection of two sets of peptides corresponding to sequences of SARS-CoV spike protein HR1 and HR2 regions and investigated the interactions between the HR1 and HR2 peptides by surface plasmon resonance, sedimentation equilibration analysis, circular dichroism, native polyacrylamide-gel electrophoresis, size exclusion high-performance liquid chromatography, and computer-aided homology modelling and molecule docking analysis. Findings One peptide, CP-1, derived from the HR2 region, inhibited SARS-CoV infection in the micromolar range. CP-1 bound with high affinity to a peptide from the HR1 region, NP-1. CIPA alone had low alpha-helicity and self-associated to form a trimer in phosphate buffer (pH 7.2). CP-1 and NP-1 mixed in equimolar concentrations formed a six-helix bundle, similar to the fusogenic core structure of HIV-1 gp41. Interpretation After binding to the target cell, the transmembrane spike protein might change conformation by association between the HR1 and HR2 regions to form an oligomeric structure, leading to fusion between the viral and target-cell membranes. At the prefusion intermediate state, CP-1 could bind to the HR1 region and interfere with the conformational changes, resulting in inhibition of SARS-CoV fusion with the target cells. CP-1 might be modifiable to increase its anti-SARS-CoV activity and could be further developed as an antiviral agent for treatment or prophylaxis of SARS-CoV infection.	New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; Wuhan Univ, Modern Virol Res Ctr, Wuhan 430072, Peoples R China; Mt Sinai Sch Med, New York, NY USA	New York Blood Center; Wuhan University; Icahn School of Medicine at Mount Sinai	Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, 310 E 67th St, New York, NY 10021 USA.	SJiang@DNYBloodcenter.org	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; Liu, Shuwen/0000-0001-6346-5006				BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Cavanagh D, 1995, CORONAVIRIDAE, P73; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Debnath AK, 1999, J MED CHEM, V42, P3203, DOI 10.1021/jm990154t; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Dwyer JJ, 2003, BIOCHEMISTRY-US, V42, P4945, DOI 10.1021/bi027283n; Gallagher TM, 1997, J VIROL, V71, P3129, DOI 10.1128/JVI.71.4.3129-3137.1997; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; JIANG SB, 1993, BIOCHEM BIOPH RES CO, V195, P533, DOI 10.1006/bbrc.1993.2078; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2002, CURR PHARM DESIGN, V8, P563; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Jones DK, 1998, BIOCHEM J, V330, P983; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Krueger DK, 2001, J VIROL, V75, P2792, DOI 10.1128/JVI.75.6.2792-2802.2001; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Lombardi S, 1996, VIROLOGY, V220, P274, DOI 10.1006/viro.1996.0315; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Luo ZL, 1999, J VIROL, V73, P8152, DOI 10.1128/JVI.73.10.8152-8159.1999; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Qin E, 2003, CHINESE SCI BULL, V48, P941, DOI [10.1360/03wc0186, 10.1007/BF03184203]; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rost B, 1996, METHOD ENZYMOL, V266, P525; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; Watanabe S, 2000, J VIROL, V74, P10194, DOI 10.1128/JVI.74.21.10194-10201.2000; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; WHO, 2003, WHO M REPORT; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yao QZ, 1996, VIROLOGY, V223, P103, DOI 10.1006/viro.1996.0459; Yu M, 2002, J GEN VIROL, V83, P623, DOI 10.1099/0022-1317-83-3-623; Zhao Q, 2002, AIDS RES HUM RETROV, V18, P989, DOI 10.1089/08892220260235353	50	367	405	4	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2004	363	9413					938	947		10.1016/S0140-6736(04)15788-7	http://dx.doi.org/10.1016/S0140-6736(04)15788-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804OS	15043961	Green Published, Bronze			2022-12-01	WOS:000220308600010
J	Cheng, CL; Flamarique, IN				Cheng, CL; Flamarique, IN			Opsin expression: New mechanism for modulating colour vision - Single cones start making a different opsin as young salmon move to deeper waters	NATURE			English	Editorial Material							VISUAL PIGMENT COEXPRESSION; RETINA		Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Cheng, CL (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	inigo@sfu.ca						Fein A, 1982, PHOTORECEPTORS THEIR; Forsell J, 2001, J EXP BIOL, V204, P2517; Groot C., 1991, PACIFIC SALMON LIFE; KUNZ YW, 1994, VISION RES, V34, P1375, DOI 10.1016/0042-6989(94)90136-8; Lukats A, 2002, INVEST OPHTH VIS SCI, V43, P2468; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; Parry JWL, 2002, INVEST OPHTH VIS SCI, V43, P1662; SZEL A, 1994, NATURE, V370, P336, DOI 10.1038/370336a0; 1986, RETINA MODEL CELL 1, P297	9	90	93	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					279	279		10.1038/428279a	http://dx.doi.org/10.1038/428279a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029185	Bronze			2022-12-01	WOS:000220250200030
J	Chan, CS; De Stasio, G; Welch, SA; Girasole, M; Frazer, BH; Nesterova, MV; Fakra, S; Banfield, JF				Chan, CS; De Stasio, G; Welch, SA; Girasole, M; Frazer, BH; Nesterova, MV; Fakra, S; Banfield, JF			Microbial polysaccharides template assembly of nanocrystal fibers	SCIENCE			English	Article							ELECTRON-MICROSCOPY; IRON; BIOFILMS; ZNS	Biological systems can produce extraordinary inorganic structures and morphologies. The mechanisms of synthesis are poorly understood but are of great interest for engineering novel materials. We use spectromicroscopy to show that microbially generated submicrometer-diameter iron oxyhydroxide (FeOOH). laments contain polysaccharides, providing an explanation for the formation of akaganeite pseudo-single crystals with aspect ratios of similar to1000:1. We infer that the cells extrude the polysaccharide strands to localize FeOOH precipitation in proximity to the cell membrane to harness the proton gradient for energy generation. Characterization of organic compounds with high spatial resolution, correlated with mineralogical information, should improve our understanding of biomineralization mechanisms.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; Univ Wisconsin, Ctr Synchrotron Radiat, Stoughton, WI 53589 USA; CNR, Ist Struttura Mat, I-00044 Frascati, Italy; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; Consiglio Nazionale delle Ricerche (CNR); Istituto di Struttura della Materia (ISM-CNR); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	De Stasio, G (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	pupa@src.wisc.edu; jill@eps.berkeley.edu	Gilbert, Pupa/A-6299-2010; Chan, Clara S/B-6420-2011; GIRASOLE, MARCO/I-6861-2013	Gilbert, Pupa/0000-0002-0139-2099; Chan, Clara S/0000-0003-1810-4994; GIRASOLE, MARCO/0000-0001-6146-2979; Banfield, Jill/0000-0001-8203-8771; Welch, Susan/0000-0002-2890-0065				Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; COMBES JM, 1989, PHYSICA B, V158, P419, DOI 10.1016/0921-4526(89)90333-5; Cornell RM., 1997, IRON OXIDES STRUCTUR, V39, P1499, DOI [10.1016/S0010-938X(97)00096-6, DOI 10.1016/S0010-938X(97)00096-6]; Debon SJJ, 2001, FOOD CHEM, V73, P401, DOI 10.1016/S0308-8146(00)00312-5; Druschel GK, 2002, ECON GEOL BULL SOC, V97, P1319, DOI 10.2113/97.6.1319; Ehrlich H.L., 1996, GEOMICROBIOLOGY; FRAZER BH, IN PRESS ULTRAMICROS; ISHII I, 1987, J CHEM PHYS, V87, P830, DOI 10.1063/1.453290; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; Lawrence JR, 2003, APPL ENVIRON MICROB, V69, P5543, DOI 10.1128/AEM.69.9.5543-5554.2003; Mann S., 2001, BIOMINERALIZATION PR; Mavrocordatos D, 2002, AM MINERAL, V87, P940; Nicholls D., 2002, BIOENERGETICS; PARKHURST DL, 1999, SPECIATION MODELED U; Sogaard EG, 2000, WATER RES, V34, P2675, DOI 10.1016/S0043-1354(00)00002-6; Stohr J, 2013, SPRINGE SER SURF SCI; Ueshima M, 2001, CLAY CLAY MINER, V49, P292, DOI 10.1346/CCMN.2001.0490403; Wehrli B., 1990, AQUATIC CHEM KINETIC, P311	18	321	344	7	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1656	1658		10.1126/science.1092098	http://dx.doi.org/10.1126/science.1092098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15016997				2022-12-01	WOS:000220151400040
J	Riedel, M; Hausleiter, J; Martinoff, S				Riedel, M; Hausleiter, J; Martinoff, S			Scimitar syndrome	LANCET			English	Editorial Material									Tech Univ Munich, German Heart Ctr, Dept Cardiol, D-80636 Munich, Germany; Tech Univ Munich, German Heart Ctr, Dept Radiol, D-80636 Munich, Germany	German Heart Centre Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich	Riedel, M (corresponding author), Tech Univ Munich, German Heart Ctr, Dept Cardiol, D-80636 Munich, Germany.		hasanzad, maryam/G-4362-2017; Hausleiter, Jörg/V-4206-2019; Latib, Azeem/B-4165-2008	hasanzad, maryam/0000-0001-7164-0599; Latib, Azeem/0000-0001-9035-343X					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 31	2004	363	9406					356	356		10.1016/S0140-6736(04)15435-4	http://dx.doi.org/10.1016/S0140-6736(04)15435-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070564	Bronze			2022-12-01	WOS:000188590900009
J	Benenson, Y; Gil, B; Ben-Dor, U; Adar, R; Shapiro, E				Benenson, Y; Gil, B; Ben-Dor, U; Adar, R; Shapiro, E			An autonomous molecular computer for logical control of gene expression	NATURE			English	Article							CELL LUNG-CANCER; DNA SOLUTION; COMPUTATION; ANTISENSE; MACHINE; APOPTOSIS; DESIGN	Early biomolecular computer research focused on laboratory-scale, human-operated computers for complex computational problems(1-7). Recently, simple molecular-scale autonomous programmable computers were demonstrated(8-15) allowing both input and output information to be in molecular form. Such computers, using biological molecules as input data and biologically active molecules as outputs, could produce a system for 'logical' control of biological processes. Here we describe an autonomous biomolecular computer that, at least in vitro, logically analyses the levels of messenger RNA species, and in response produces a molecule capable of affecting levels of gene expression. The computer operates at a concentration of close to a trillion computers per microlitre and consists of three programmable modules: a computation module, that is, a stochastic molecular automaton(12-17); an input module, by which specific mRNA levels or point mutations regulate software molecule concentrations, and hence automaton transition probabilities; and an output module, capable of controlled release of a short single-stranded DNA molecule. This approach might be applied in vivo to biochemical sensing, genetic engineering and even medical diagnosis and treatment. As a proof of principle we programmed the computer to identify and analyse mRNA of disease-related genes(18-22) associated with models of small-cell lung cancer and prostate cancer, and to produce a single-stranded DNA molecule modelled after an anticancer drug.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shapiro, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	Ehud.Shapiro@weizmann.ac.il	Benenson, Yaakov/B-1433-2009		European Research Council [233047] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		ADAR R, UNPUB P NATL ACAD SC; ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Balzani V, 2003, CHEMPHYSCHEM, V4, P49, DOI 10.1002/cphc.200390007; Bar-Ziv R, 2002, P NATL ACAD SCI USA, V99, P11589, DOI 10.1073/pnas.162369099; Benenson Y, 2003, P NATL ACAD SCI USA, V100, P2191, DOI 10.1073/pnas.0535624100; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; BENENSON Y, 2004, DEKKER ENCY NANOSCIE, P2043; Capoulade C, 2001, BLOOD, V97, P1043, DOI 10.1182/blood.V97.4.1043; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Holmlund JT, 2003, ANN NY ACAD SCI, V1002, P244, DOI 10.1196/annals.1281.027; Holzer S, 2000, J AM MED INFORM ASSN, P364; Khodor J, 1999, BIOSYSTEMS, V52, P93, DOI 10.1016/S0303-2647(99)00036-2; Klasa RJ, 2002, ANTISENSE NUCLEIC A, V12, P193, DOI 10.1089/108729002760220798; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Pedersen N, 2003, CANCER RES, V63, P1943; RABIN MO, 1963, INFORM CONTROL, V6, P230, DOI 10.1016/S0019-9958(63)90290-0; Ruben AJ, 2000, NAT REV MOL CELL BIO, V1, P69, DOI 10.1038/35036086; Sakamoto K, 1999, BIOSYSTEMS, V52, P81, DOI 10.1016/S0303-2647(99)00035-0; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; TAKAHASHI T, 1991, ONCOGENE, V6, P1775; Thorns C, 2002, PATHOL INT, V52, P578, DOI 10.1046/j.1320-5463.2002.01400.x; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	30	578	636	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					423	429		10.1038/nature02551	http://dx.doi.org/10.1038/nature02551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15116117	Green Accepted			2022-12-01	WOS:000221644600041
J	Riordan, DC				Riordan, DC			Interaction strategies of lesbian, gay, and bisexual healthcare practitioners in the clinical examination of patients: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-STUDENTS; DOCTORS; NEED; SEX; PHYSICIANS; CHAPERONES; WOMEN	Objective To explore how lesbian, gay, and bisexual healthcare practitioners manage their identity in the clinical examination of patients. Design Qualitative study using grounded theory. Setting Hospital and primary health care. Participants 16 healthcare professionals who identified themselves as lesbian, gay, or bisexual, and who are involved in the clinical examination of patients. Results Healthcare professionals engage in a complex interplay of identity management strategies to avoid homophobic abuse; as a signal of safety from homophobia and understanding for their lesbian, gay, and bisexual patients and as a desexualisation strategy principally for gay men and their women patients. Their training has not helped them deal with ethical and medicolegal anxieties. Conclusion In the light of new legislation, published guidelines will help training and governing bodies understand and help ameliorate the added pressures on their lesbian, gay, and bisexual students and medical staff.	St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England	St Georges University London	Riordan, DC (corresponding author), St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England.	driordan@sghms.ac.uk						Acker J, 1990, GENDER SOC, V4, P139, DOI 10.1177/089124390004002002; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA; Bignell CJ, 1999, BMJ-BRIT MED J, V319, P137, DOI 10.1136/bmj.319.7203.137; *BRIT MED ASS, 1997, TRUST DOCT PAT REL G; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Brogan DJ, 1999, JAMA-J AM MED ASSOC, V282, P1290, DOI 10.1001/jama.282.13.1290; Burke BP, 2001, BRIT MED J, V322, P422, DOI 10.1136/bmj.322.7283.422; CHALLACOMBE CB, 1983, PRACTITIONER, V227, P848; Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; DOYAL L, 2003, BRIT MED J, V327, P939; *GAY LESB ASS DOCT, 2002, IMPR WORK LIV; *GEN MED COUNC, 2001, INT EX; Giuffre PA, 2000, GENDER SOC, V14, P457, DOI 10.1177/089124300014003006; Goffman Erving., 1990, STIGMA NOTES MANAGEM; HAERN J, 1990, SEXUALITY ORG; Hughes C, 2003, BMJ-BRIT MED J, V327, P939, DOI 10.1136/bmj.327.7421.939; Jackson S., 2003, SEXUALITIES SOC READ, P69; KNOWLES R, 1999, BRIT MED J, V319, P137; Lewis RJ, 2001, J HOMOSEXUAL, V42, P63, DOI 10.1300/J082v42n01_04; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Moynihan C, 1998, BRIT MED J, V317, P1072; O'Flynn N, 2002, BRIT MED J, V325, P683, DOI 10.1136/bmj.325.7366.683; Plummer K., 1975, SEXUAL STIGMA INTERA; Risdon C, 2000, CAN MED ASSOC J, V162, P331; Selby M, 1999, BRIT MED J, V318, P1129; Strauss A., 1998, BASICS QUALITATIVE R; Torrance CJ, 1999, BRIT MED J, V319, P159, DOI 10.1136/bmj.319.7203.159	28	15	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2004	328	7450					1227	1229		10.1136/bmj.38071.774525.EB	http://dx.doi.org/10.1136/bmj.38071.774525.EB			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	824HL	15113753	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000221677200017
J	Nebeker, JR; Barach, P; Samore, MH				Nebeker, JR; Barach, P; Samore, MH			Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICATION ERRORS; DEPARTMENTS; MEDICINE; SAFETY; CARE	Adverse drug events cause substantial morbidity and mortality, yet they remain underappreciated and misunderstood. The terminology to describe errors and patient harm associated with medications causes much confusion. This article uses the case study of a patient with multiple adverse drug events to clarify key terms, such as adverse event, adverse drug reaction, adverse drug event, medication error, and side effect. The case discussion illustrates clinical approaches to analyzing the causal connection between a suspect drug and an adverse event. Examples and rationale for meaningful documentation of adverse drug events are provided, along with an outline of the types of events that should be reported to regulatory agencies.	Salt Lake IDEAS Ctr, Salt Lake City, UT 84148 USA		Nebeker, JR (corresponding author), Salt Lake IDEAS Ctr, GRECC 182,500 Foothill Dr, Salt Lake City, UT 84148 USA.	Jonathan.Nebeker@hsc.utah.edu	Barach, paul/B-9915-2016; Barach, Paul/AAX-5315-2020	Barach, paul/0000-0002-7906-698X; Barach, Paul/0000-0002-7906-698X				Ahmad SR, 2003, J GEN INTERN MED, V18, P57, DOI 10.1046/j.1525-1497.2003.20130.x; Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; [Anonymous], 2003, INT C HARM TECHN REQ; Bates DW, 1996, DRUG SAFETY, V15, P303, DOI 10.2165/00002018-199615050-00001; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; COBERT BL, 2002, PHARMACOVIGILANCE A; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; ENBEKER JR, 2002, J AM MED INFORM AS S, V9, pS80; *EUR AG EV MED PRO, 1995, CLIN SAF DAT MAN DEF; Evans R S, 1992, Proc Annu Symp Comput Appl Med Care, P437; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Hofer T P, 2000, Eff Clin Pract, V3, P261; HURDLE JF, 2003, P AMIA S, P309; JOHNSTONE DM, 1995, AM J HEALTH-SYST PH, V52, P297, DOI 10.1093/ajhp/52.3.297; Kohn L., 1999, ERR IS HUMAN BUILDIN; KRAMER MS, 1979, JAMA-J AM MED ASSOC, V242, P623, DOI 10.1001/jama.242.7.623; Ladewski LA, 2003, J CLIN ONCOL, V21, P3859, DOI 10.1200/JCO.2003.04.537; LUCAS LM, 1992, WESTERN J MED, V156, P172; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; MICHEL DJ, 1986, AM J HOSP PHARM, V43, P1709, DOI 10.1093/ajhp/43.7.1709; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; National Coordinating Council for Medication Error Reporting and Prevention, 1998, WHAT IS MED ERR; Ross SD, 2001, ARCH INTERN MED, V161, P1041, DOI 10.1001/archinte.161.8.1041; SCHAFF T, 1991, NEAR MISS REPORTING; Schlienger RG, 1999, PHARM WORLD SCI, V21, P110, DOI 10.1023/A:1008631926100; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Sivaram CA, 1996, JOINT COMM J QUAL IM, V22, P259, DOI 10.1016/S1070-3241(16)30229-2; Tegeder I, 1999, BRIT J CLIN PHARMACO, V47, P557; THATCHER C, 2002, CAN PHARM J, V134, P11; *US FDA, 1992, GUID POSTM REP ADV D; Venulet J, 1996, INT J CLIN PHARM TH, V34, P112; Wood AJJ, 1998, NEW ENGL J MED, V339, P1851, DOI 10.1056/NEJM199812173392512	37	453	469	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2004	140	10					795	801		10.7326/0003-4819-140-10-200405180-00009	http://dx.doi.org/10.7326/0003-4819-140-10-200405180-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822EX	15148066				2022-12-01	WOS:000221520900004
J	DeWitt, AL; Gunn, SR; Hopkins, P; Streat, S				DeWitt, AL; Gunn, SR; Hopkins, P; Streat, S			Critical care medicine mailing list: growth of an online forum	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT		Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA 15261 USA; Bartimus Frickleton Robertson & Obetz, Jefferson City, MO 65101 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, London W12 0NN, England; Auckland City Hosp, Dept Crit Care Med, Auckland 1003, New Zealand	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; Auckland City Hospital	Gunn, SR (corresponding author), Univ Pittsburgh, Med Ctr, Dept Crit Care Med, 646B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	gunnsr@ccm.upmc.edu						Caldicott Committee Department of Health, 1997, REP REV PAT ID INF; Campbell D, 2000, CAN J ANAESTH, V47, P53, DOI 10.1007/BF03020733; Cassell J, 2003, CRIT CARE MED, V31, P1551, DOI 10.1097/00003246-200305000-00039; Crippen D, 1999, CRIT CARE CLIN, V15, P605, DOI 10.1016/S0749-0704(05)70074-9; Crippen Kileullen JK, 2002, 3 PATIENTS INT PERSP; HOPKINS P, 2002, CLIN INTENSIVE CARE, V13, P147; Nagappan R, 2000, CRIT CARE MED, V28, P2116, DOI 10.1097/00003246-200006000-00076; Porayko LD, 1999, CAN J ANAESTH, V46, P529, DOI 10.1007/BF03013542; PORAYKO LD, 1998, EUR J ANAESTH S, V15, P48; 2003, DOCTOR HONG KONG DEA	10	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2004	328	7449					1180	1180		10.1136/bmj.328.7449.1180	http://dx.doi.org/10.1136/bmj.328.7449.1180			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821XU	15142927	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000221497500028
J	Ives, AR; Cardinale, BJ				Ives, AR; Cardinale, BJ			Food-web interactions govern the resistance of communities after non-random extinctions	NATURE			English	Article							DENSITY COMPENSATION; BIODIVERSITY; PRODUCTIVITY; DIVERSITY; POPULATIONS; RESPONSES; DYNAMICS	Growing concern about how loss of biodiversity will affect ecosystems has stimulated numerous studies(1-5). Although most studies have assumed that species go extinct randomly(6-8), species often go extinct in order of their sensitivity to a stress that intensifies through time (such as climate change)(9). Here we show that the consequences of random and ordered extinctions differ. Both depend on food-web interactions that create compensation; that is, the increase of some species when their competitors and/or predators decrease in density due to environmental stress. Compensation makes communities as a whole more resistant to stress by reducing changes in combined species densities. As extinctions progress, the potential for compensation is depleted, and communities become progressively less resistant. For ordered extinctions, however, this depletion is offset and communities retain their resistance, because the surviving species have greater average resistance to the stress. Despite extinctions being ordered, changes in the food web with successive extinctions make it difficult to predict which species will show compensation in the future. This unpredictability argues for 'whole-ecosystem' approaches to biodiversity conservation, as seemingly insignificant species may become important after other species go extinct.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	arives@wisc.edu	Ives, Anthony/A-5698-2008; Cardinale, Bradley J/I-7076-2013	Ives, Anthony/0000-0001-9375-9523; 				CASE TJ, 1981, AM NAT, V118, P920, DOI 10.1086/283885; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Diaz S, 2003, TRENDS ECOL EVOL, V18, P140, DOI 10.1016/S0169-5347(03)00007-7; Ehrlich A.H., 1981, EXTINCTION; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Ives AR, 1999, ECOLOGY, V80, P1405, DOI 10.1890/0012-9658(1997)080[1405:CIWAZR]2.0.CO;2; Klug JL, 2000, ECOLOGY, V81, P387; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.1890/0012-9658(1998)079[0461:TCAEAT]2.0.CO;2; MacArthur R.H., 1972, pvii; May RM, 1974, SYST MAN CYBERN, DOI 10.2307/j.ctvs32rq4; McGrady-Steed J, 2000, ECOLOGY, V81, P361; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 1999, NATURE, V401, P653, DOI 10.1038/44297; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Pimm S.L., 1982, FOOD WEBS; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881; Yodzis P., 1989, INTRO THEORETICAL EC	30	170	174	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					174	177		10.1038/nature02515	http://dx.doi.org/10.1038/nature02515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141210				2022-12-01	WOS:000221356300039
J	Marshall, CB; Fletcher, GL; Davies, PL				Marshall, CB; Fletcher, GL; Davies, PL			Hyperactive antifreeze protein in a fish	NATURE			English	Editorial Material							WINTER FLOUNDER; ICE; POLYPEPTIDES; ADSORPTION		Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Mem Univ Newfoundland, Ctr Ocean Sci, St Johns, NF A1C 5S7, Canada	Queens University - Canada; Memorial University Newfoundland	Marshall, CB (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca	Marshall, Christopher/K-8943-2019	Marshall, Christopher/0000-0002-7571-5700				DAVIES PL, 1992, GENE, V112, P171, DOI 10.1016/0378-1119(92)90373-W; DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; HEW CL, 1986, EUR J BIOCHEM, V160, P267, DOI 10.1111/j.1432-1033.1986.tb09966.x; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Kuiper MJ, 2003, BIOCHEM BIOPH RES CO, V300, P645, DOI 10.1016/S0006-291X(02)02900-5; SCOTT GK, 1988, J MOL EVOL, V27, P29, DOI 10.1007/BF02099727; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; SLAUGHTER D, 1982, CAN J BIOCHEM CELL B, V60, P824, DOI 10.1139/o82-103; YANG DSC, 1988, NATURE, V333, P232, DOI 10.1038/333232a0	10	95	110	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					153	153		10.1038/429153a	http://dx.doi.org/10.1038/429153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141201	Bronze			2022-12-01	WOS:000221356300028
J	Quill, TE				Quill, TE			Retrospective - Dying and decision making - Evolution of end-of-life options	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIAN-ASSISTED SUICIDE; EUTHANASIA		Univ Rochester, Sch Med, Rochester, NY 14627 USA	University of Rochester	Quill, TE (corresponding author), Univ Rochester, Sch Med, Rochester, NY 14627 USA.							Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; QUILL TE, 1991, NEW ENGL J MED, V324, P691, DOI 10.1056/NEJM199103073241010; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811	4	29	29	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2004	350	20					2029	2032		10.1056/NEJMp038216	http://dx.doi.org/10.1056/NEJMp038216			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819ZB	15141040				2022-12-01	WOS:000221354000003
J	Glass, RI; Bresee, JS; Parashar, UD; Jiang, BM; Gentsch, J				Glass, RI; Bresee, JS; Parashar, UD; Jiang, BM; Gentsch, J			The future of rotavirus vaccines: a major setback leads to new opportunities	LANCET			English	Editorial Material							ORAL POLIO VACCINE; INTUSSUSCEPTION; INFANTS; ASSOCIATION; PROGRAM; DEATHS; TRENDS		CDCP, Viral Gastroenteritis Sect, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Glass, RI (corresponding author), CDC, Mailstop G04,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	rglass@cdc.gov						Andrews N, 2001, EUR J EPIDEMIOL, V17, P701, DOI 10.1023/A:1015691619745; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 42 INT C ANT AG CHEM; [Anonymous], 42 INT C ANT AG CHEM; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1007; CHERRY JD, 1989, CONT ISSUES INFECT D, V8, P47; Clark HF, 2003, PEDIATR INFECT DIS J, V22, P914, DOI 10.1097/01.inf.0000091887.48999.77; CLARK HF, 2004, VACCINES, P1327; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; Halsey NA, 1998, PEDIATRICS, V102, P1483, DOI 10.1542/peds.102.6.1483; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Melton L, 2000, LANCET, V356, P318, DOI 10.1016/S0140-6736(05)73604-7; Murphy BR, 2003, J INFECT DIS, V187, P1301, DOI 10.1086/367895; Murphy TV, 2003, J INFECT DIS, V187, P1309, DOI 10.1086/374420; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2000, PEDIATRICS, V106, P1413, DOI 10.1542/peds.106.6.1413; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Sardinas MAG, 2001, EUR J EPIDEMIOL, V17, P783, DOI 10.1023/A:1015675932509; Simonsen L, 2001, LANCET, V358, P1224, DOI 10.1016/S0140-6736(01)06346-2; STAAT MA, 2002, PED AC SOC M; Tucker AW, 1998, JAMA-J AM MED ASSOC, V279, P1371, DOI 10.1001/jama.279.17.1371; Weijer C, 2000, BRIT MED J, V321, P525, DOI 10.1136/bmj.321.7260.525; *WHO, 1997, REP CONS WORKSH ROT, P24	25	92	96	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2004	363	9420					1547	1550		10.1016/S0140-6736(04)16155-2	http://dx.doi.org/10.1016/S0140-6736(04)16155-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GK	15135605				2022-12-01	WOS:000221302700025
J	He, XL; Garcia, KC				He, XL; Garcia, KC			Structure of nerve growth factor complexed with the shared neurotrophin receptor p75	SCIENCE			English	Article							CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; P75(NTR); BINDING; ACTIVATION; SYSTEM	Neurotrophins are secreted growth factors critical for the development and maintenance of the vertebrate nervous system. Neurotrophins activate two types of cell surface receptors, the Trk receptor tyrosine kinases and the shared p75 neurotrophin receptor. We have determined the 2.4 Angstrom crystal structure of the prototypic neurotrophin, nerve growth factor (NGF), complexed with the extracellular domain of p75. Surprisingly, the complex is composed of an NGF homodimer asymmetrically bound to a single p75. p75 binds along the homodimeric interface of NGF, which disables NGF's symmetry-related second p75 binding site through an allosteric conformational change. Thus, neurotrophin signaling through p75 may occur by disassembly of p75 dimers and assembly of asymmetric 2: 1 neurotrophin/p75 complexes, which could potentially engage a Trk receptor to form a trimolecular signaling complex.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu						BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; GROB PM, 1985, J BIOL CHEM, V260, P8044; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IBANEZ CF, 1995, TRENDS BIOTECHNOL, V13, P217, DOI 10.1016/S0167-7799(00)88949-0; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Rabizadeh S, 2003, CYTOKINE GROWTH F R, V14, P225, DOI 10.1016/S1359-6101(03)00018-2; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; Wang JJL, 2000, J NEUROSCI RES, V60, P587, DOI 10.1002/(SICI)1097-4547(20000601)60:5<587::AID-JNR3>3.0.CO;2-1; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	23	218	249	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					870	875		10.1126/science.1095190	http://dx.doi.org/10.1126/science.1095190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131306				2022-12-01	WOS:000221243000044
J	Karim, QA				Karim, QA			HIV treatment in South Africa: overcoming impediments to get started	LANCET			English	Editorial Material									Univ Kwazulu Natal, CAPRISA, Nelson R Mandela Sch Med, ZA-4013 Durban, South Africa; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; Columbia University	Karim, QA (corresponding author), Univ Kwazulu Natal, CAPRISA, Nelson R Mandela Sch Med, ZA-4013 Durban, South Africa.	abdoolq2@nu.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X				*DEP HLTH RSA, 2002, 12 NAT HIV SURV WOM; KARIM SSA, 2001, AIDS CLIN CARE, V70, P63; Kasper Toby, 2003, ESSENT DRUGS MONIT, V32, P20	3	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1394	1394		10.1016/S0140-6736(04)16055-8	http://dx.doi.org/10.1016/S0140-6736(04)16055-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15112695	Green Submitted			2022-12-01	WOS:000220996300028
J	Koch, GW; Sillett, SC; Jennings, GM; Davis, SD				Koch, GW; Sillett, SC; Jennings, GM; Davis, SD			The limits to tree height	NATURE			English	Article							SHADE TOLERANCE; CONDUCTANCE; CALIFORNIA; PHYSIOLOGY; DROUGHT; XYLEM; CO2	Trees grow tall where resources are abundant, stresses are minor, and competition for light places a premium on height growth(1,2). The height to which trees can grow and the biophysical determinants of maximum height are poorly understood. Some models predict heights of up to 120 m in the absence of mechanical damage(3,4), but there are historical accounts of taller trees(5). Current hypotheses of height limitation focus on increasing water transport constraints in taller trees and the resulting reductions in leaf photosynthesis(6). We studied redwoods (Sequoia sempervirens), including the tallest known tree on Earth (112.7 m), in wet temperate forests of northern California. Our regression analyses of height gradients in leaf functional characteristics estimate a maximum tree height of 122-130 m barring mechanical damage, similar to the tallest recorded trees of the past. As trees grow taller, increasing leaf water stress due to gravity and path length resistance may ultimately limit leaf expansion and photosynthesis for further height growth, even with ample soil moisture.	No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Env Res, Flagstaff, AZ 86011 USA; Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; Pepperdine Univ, Div Nat Sci, Malibu, CA 90263 USA	Northern Arizona University; Northern Arizona University; California State University System; California State Polytechnic University, Humboldt; Pepperdine University	Koch, GW (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	george.koch@nau.edu						Bond BJ, 1999, OECOLOGIA, V120, P183, DOI 10.1007/s004420050847; Carder AC, 1995, FOREST GIANTS WORLD; Davis SD, 2002, AM J BOT, V89, P820, DOI 10.3732/ajb.89.5.820; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Friend A. D., 1993, P101; Hacke UG, 2003, PLANT CELL ENVIRON, V26, P303, DOI 10.1046/j.1365-3040.2003.00962.x; Jennings G. M., 2003, THESIS HUMBOLDT STAT; KING DA, 1990, AM NAT, V135, P809, DOI 10.1086/285075; Kramer, 1995, WATER RELATIONS PLAN; Kramer P.J., 1995, WATER RELATIONS PLAN; McDowell NG, 2002, TREE PHYSIOL, V22, P763, DOI 10.1093/treephys/22.11.763; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 1998, TREE PHYSIOL, V18, P681; PARKHURST DF, 1994, NEW PHYTOL, V126, P449, DOI 10.1111/j.1469-8137.1994.tb04244.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Sawyer JO, 2000, REDWOOD FOREST HIST, P81; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; tAiz l, 2002, PLANT PHYSIOL, V3rd, DOI 10.1071/PP9840361; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Van de Water PK, 2002, OECOLOGIA, V132, P332, DOI 10.1007/s00442-002-0973-x; Vogel J. C., 1993, Stable isotopes and plant carbon-water relations., P29; Waring R. H., 1985, FOREST ECOSYSTEMS; Warren CR, 2003, PLANT CELL ENVIRON, V26, P1215, DOI 10.1046/j.1365-3040.2003.01044.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; YODER BJ, 1994, FOREST SCI, V40, P513; Zimmermann M.H., 1984, XYLEM STRUCTURE ASCE, V26, P165	29	748	818	25	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					851	854		10.1038/nature02417	http://dx.doi.org/10.1038/nature02417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103376				2022-12-01	WOS:000220952300039
J	Muller, HM; Oberwalder, M; Fiegl, H; Morandell, M; Goebel, G; Zitt, M; Muhlthaler, M; Ofner, D; Margreiter, R; Widschwendter, M				Muller, HM; Oberwalder, M; Fiegl, H; Morandell, M; Goebel, G; Zitt, M; Muhlthaler, M; Ofner, D; Margreiter, R; Widschwendter, M			Methylation changes in faecal DNA: a marker for colorectal cancer screening?	LANCET			English	Article								DNA methylation is a common molecular alteration in colorectal cancer cells. We report an assessment of faecal DNA from patients with colorectal cancer and controls to determine the feasibility, sensitivity, and specificity of this approach. By use of MethyLight analysis of faecal DNA from three independent sets of patients, we identified SFRP2 methylation as a sensitive single DNA-based marker for identification of colorectal cancer in stool samples (sensitivity 90% [CI 56-100] and specificity 77% [46-95] in the training set [n=23]; sensitivity 77% [46-95] and specificity 77% [46-95] in an independent test set [n=26]). Whether a combination of genetic and epigenetic markers will identify colorectal cancer at an early stage remains to be shown.	Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria; Med Univ Innsbruck, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria; Med Univ Innsbruck, Dept Biostat & Documentat, A-6020 Innsbruck, Austria; St Vinzenz Hosp, Dept Gen Surg, Zams, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Widschwendter, M (corresponding author), Med Univ Innsbruck, Dept Obstet & Gynecol, Anichstr 35, A-6020 Innsbruck, Austria.	martin.widschwendter@uibk.ac.at	Goebel, Georg/P-6909-2015; Fiegl, Heidi/K-4445-2017	Fiegl, Heidi/0000-0002-1236-6806; Widschwendter, Martin/0000-0002-7778-8380				Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Muller HM, 2003, CANCER RES, V63, P7641; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tagore Kuldeep S, 2003, Clin Colorectal Cancer, V3, P47, DOI 10.3816/CCC.2003.n.011; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294	6	217	266	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1283	1285		10.1016/S0140-6736(04)16002-9	http://dx.doi.org/10.1016/S0140-6736(04)16002-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094274				2022-12-01	WOS:000220904900011
J	Tseng, CH; Gobell, JL; Sperling, G				Tseng, CH; Gobell, JL; Sperling, G			Long-lasting sensitization to a given colour after visual search	NATURE			English	Article							MOTION PERCEPTION; SPATIAL-FREQUENCY; ORIENTATION; DISCRIMINATION; AMPLIFICATION; PERSISTENCE; IMPROVEMENT; HYPERACUITY; ADAPTATION; ACUITY	Visual attention enables an observer to select specific visual information for processing. In an ambiguous motion task in which a coloured grating can be perceived as moving in either of two opposite directions depending on the relative salience of two colours in the display, attending to one of the colours influences the direction in which the grating appears to move(1). Here, we use this secondary effect of attention in a motion task to measure the effect of attending to a specific colour in a search task. Observers performed a search task in which they searched for a target letter in a 4x4 coloured matrix. Each of the 16 squares within a matrix was assigned one of four colours, and observers knew that the target letter would appear on only one of these colours throughout the experiment. Observers performed the ambiguous motion task before and after the search task. Attending to a particular colour for a brief period in the search task profoundly influenced the perceived direction of motion. This effect lasted for up to one month and in some cases had to be reversed by practising searches for the complementary colour, indicating a much longer-persisting effect of attention than has been observed previously.	Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Math Behav Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Tseng, CH (corresponding author), Rutgers State Univ, Ctr Cognit Sci, Piscataway, NJ 08854 USA.	CH_Tseng@alumni.uci.edu; Sperling@uci.edu						Anstis S. M., 1983, COLOUR VISION PHYSL, P155; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V1, P11; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FAVREAU OE, 1979, PERCEPT PSYCHOPHYS, V26, P187, DOI 10.3758/BF03199868; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; GILINSKY AS, 1968, J OPT SOC AM, V58, P13, DOI 10.1364/JOSA.58.000013; HEGGELUND P, 1976, VISION RES, V16, P1015, DOI 10.1016/0042-6989(76)90235-2; HOLLAND H. C., 1965, SPIRAL AFTER EFFECT; JONES PD, 1975, J EXP PSYCHOL HUMAN, V1, P323, DOI 10.1037/0096-1523.1.4.323; KALFIN K, 1972, VISION RES, V12, P359, DOI 10.1016/0042-6989(72)90128-9; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Lu ZL, 2001, VISION RES, V41, P2355, DOI 10.1016/S0042-6989(01)00106-7; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MASLAND RH, 1969, SCIENCE, V165, P819, DOI 10.1126/science.165.3895.819; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; WOLFE JM, 1986, INVEST OPHTH VIS SCI, V27, P538	25	22	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					657	660		10.1038/nature02443	http://dx.doi.org/10.1038/nature02443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071596				2022-12-01	WOS:000220697200045
J	McIsaac, WJ; Kellner, JD; Aufricht, P; Vanjaka, A; Low, DE				McIsaac, WJ; Kellner, JD; Aufricht, P; Vanjaka, A; Low, DE			Empirical validation of guidelines for the management of pharyngitis in children and adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	42nd Interscience Conference on Antimicrobial Agents and Chemotherapy	SEP 26-30, 2002	SAN DIEGO, CA				HEMOLYTIC STREPTOCOCCAL PHARYNGITIS; UNNECESSARY ANTIBIOTIC USE; GROUP-A STREPTOCOCCI; SORE THROAT; COST-EFFECTIVENESS; GENERAL-PRACTICE; RHEUMATIC-FEVER; PENICILLIN-V; STREP THROAT; DIAGNOSIS	Context Recent guidelines for management of pharyngitis vary in their recommendations concerning empirical antibiotic treatment and the need for laboratory confirmation of group A streptococcus (GAS). Objective To assess the impact of guideline recommendations and alternative approaches on identification and treatment of GAS pharyngitis in children and adults. Design, Setting, and Participants Throat cultures and rapid antigen tests were performed on 787 children and adults aged 3 to 69 years with acute sore throat attending a family medicine clinic in Calgary, Alberta, from September 1999 to August 2002. Recommendations from 2 guidelines (those of the Infectious Diseases Society of America and of the American College of Physicians-American Society of Internal Medicine/American Academy of Family Physicians/US Centers for Disease Control and Prevention) were compared with rapid testing alone, a clinical prediction rule (ie, the modified Centor score), and a criterion standard of treatment for positive throat culture results only. Main Outcome Measures Sensitivity and specificity of each strategy for identifying GAS pharyngitis, total antibiotics recommended, and unnecessary antibiotic prescriptions. Results In children, sensitivity for streptococcal infection ranged from 85.8% (133/155; 95% confidence interval [CI], 79.3%-90.0%) for rapid testing to 100% for culturing all. In adults, sensitivity ranged from 76.7% (56/73; 95% CI, 65.4%-85.8%) for rapid testing without culture confirmation of negative results to 100% for culturing all. In children, specificity ranged from 90.3% (270/299; 95% CI, 86.4%-93.4%) for use of modified Centor score and throat culture to 100% for culturing all. In adults, specificity ranged from 43.8% (114/260; 95% CI, 37.7%-50.1%) for empirical treatment based on a modified Centor score of 3 or 4 to 100% for culturing all. Total antibiotic prescriptions were lowest with rapid testing (24.7% [194/787]; 95% CI, 21.7%-27.8%) and highest with empirical treatment of high-risk adults (45.7% [360/787]; 95% CI, 42.2%-49.3%), due to a high rate of unnecessary prescriptions in adults (43.8% [146/333]; 95% CI, 38.4%-49.4%). Conclusions Guideline recommendations for the selective use of throat cultures but antibiotic treatment based only on positive rapid test or throat culture results can reduce unnecessary use of antibiotics for treatment of pharyngitis. However, empirical treatment of adults having a Centor score of 3 or 4 is associated with a high rate of unnecessary antibiotic use. In children, strategies incorporating throat culture or throat culture confirmation of negative rapid antigen test results are highly sensitive and specific. Throat culture of all adults or those selected on the basis of a clinical prediction rule had the highest sensitivity and specificity.	Mt Sinai Hosp, Ray D Wolfe Dept Family Med, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB T2T 5C7, Canada; Univ Calgary, Calgary, AB, Canada; Foothills Prov Gen Hosp, Dept Family Med, Calgary, AB T2N 2T9, Canada; Abbott Labs, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary	McIsaac, WJ (corresponding author), Mt Sinai Hosp, Ray D Wolfe Dept Family Med, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wmcisaac@mtsinai.on.ca	Low, Donald/B-1726-2012; Kellner, James Duncan/D-6358-2011	Kellner, James Duncan/0000-0002-9083-2980				Bisno AL, 2002, CLIN INFECT DIS, V35, P126, DOI 10.1086/342056; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; Dagnelie CF, 1996, BRIT J GEN PRACT, V46, P589; DAJANI A, 1995, PEDIATRICS, V96, P758; Dale JC, 2002, ARCH PATHOL LAB MED, V126, P1467; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Ehrlich JE, 2002, PREV MED, V35, P250, DOI 10.1006/pmed.2002.1062; ELDAHER NT, 1991, PEDIATR INFECT DIS J, V10, P126, DOI 10.1097/00006454-199102000-00010; Gerber MA, 1997, JAMA-J AM MED ASSOC, V277, P899, DOI 10.1001/jama.277.11.899; HART WJ, 1976, CAN FAM PHYSICIAN, V22, P34; KLJAKOVIC M, 1993, NEW ZEAL MED J, V106, P381; LAUBSCHER B, 1995, J CLIN MICROBIOL, V33, P260, DOI 10.1128/JCM.33.1.260-261.1995; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Mainous AG, 1996, PEDIATR INFECT DIS J, V15, P806, DOI 10.1097/00006454-199609000-00014; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; McIsaac WJ, 2000, MED DECIS MAKING, V20, P33, DOI 10.1177/0272989X0002000104; Neuner JM, 2003, ANN INTERN MED, V139, P113, DOI 10.7326/0003-4819-139-2-200307150-00011; POSES RM, 1985, JAMA-J AM MED ASSOC, V254, P925, DOI 10.1001/jama.254.7.925; RANDOLPH MF, 1985, J PEDIATR-US, V106, P870, DOI 10.1016/S0022-3476(85)80228-6; SHANK JC, 1984, J FAM PRACTICE, V18, P857; Stollerman GH, 2001, CLIN INFECT DIS, V33, P806, DOI 10.1086/322665; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251; Webb KH, 2000, J FAM PRACTICE, V49, P34	27	213	238	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1587	1595		10.1001/jama.291.13.1587	http://dx.doi.org/10.1001/jama.291.13.1587			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809PQ	15069046	Bronze			2022-12-01	WOS:000220649000023
J	Pinto, S; Roseberry, AG; Liu, HY; Diano, S; Shanabrough, M; Cai, XL; Friedman, JM; Horvath, TL				Pinto, S; Roseberry, AG; Liu, HY; Diano, S; Shanabrough, M; Cai, XL; Friedman, JM; Horvath, TL			Rapid rewiring of arcuate nucleus feeding circuits by leptin	SCIENCE			English	Article							PROOPIOMELANOCORTIN MESSENGER-RNA; OBESE GENE-PRODUCT; NEUROPEPTIDE-Y; SYNAPTIC PLASTICITY; OB/OB MICE; NEURONS; HYPOTHALAMUS; RECEPTOR; RATS; COEXPRESSION	The fat-derived hormone leptin regulates energy balance in part by modulating the activity of neuropeptide Y and proopiomelanocortin neurons in the hypothalamic arcuate nucleus. To study the intrinsic activity of these neurons and their responses to leptin, we generated mice that express distinct green fluorescent proteins in these two neuronal types. Leptin-deficient (ob/ob) mice differed from wild-type mice in the numbers of excitatory and inhibitory synapses and postsynaptic currents onto neuropeptide Y and proopiomelanocortin neurons. When leptin was delivered systemically to ob/ob mice, the synaptic density rapidly normalized, an effect detectable within 6 hours, several hours before leptin's effect on food intake. These data suggest that leptin-mediated plasticity in the ob/ob hypothalamus may underlie some of the hormone's behavioral effects.	Rockefeller Univ, Genet Mol Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Yale University; Yale University	Friedman, JM (corresponding author), Rockefeller Univ, Genet Mol Lab, 1230 York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu; tamas.horvath@yale.edu	Friedman, Jeffrey M/E-5784-2011	Roseberry, Aaron/0000-0003-0468-0333	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060711, R01DK061619, R01DK041096, F32DK061176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS046921] Funding Source: NIH RePORTER; NCRR NIH HHS [RR014451] Funding Source: Medline; NIDDK NIH HHS [R01 DK061619, R01 DK041096, DK060711, F32DK61176] Funding Source: Medline; NINDS NIH HHS [F32NS046921] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baskin DG, 1999, DIABETES, V48, P828, DOI 10.2337/diabetes.48.4.828; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DECAVEL C, 1990, J COMP NEUROL, V302, P1019, DOI 10.1002/cne.903020423; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; GARCIASEGURA LM, 1986, BRAIN RES, V366, P131, DOI 10.1016/0006-8993(86)91287-4; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Horvath TL, 1999, J NEUROSCI, V19, P1072; Hung AJ, 2003, EXP GERONTOL, V38, P53, DOI 10.1016/S0531-5565(02)00183-3; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Peters A., 1978, FINE STRUCTURE NERVO, V4, P588; Pinto S., UNPUB; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Stern JE, 1998, J NEUROSCI, V18, P841; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	757	768	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					110	115		10.1126/science.1089459	http://dx.doi.org/10.1126/science.1089459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15064421				2022-12-01	WOS:000220567900049
J	Trivedi, OA; Arora, P; Sridharan, V; Tickoo, R; Mohanty, D; Gokhale, RS				Trivedi, OA; Arora, P; Sridharan, V; Tickoo, R; Mohanty, D; Gokhale, RS			Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria	NATURE			English	Article							CRYSTAL-STRUCTURE; TUBERCULOSIS; SYNTHASE; GENE; SYNTHETASE; BIOSYNTHESIS; SUPERFAMILY; SPECIFICITY; ADJACENT; COENZYME	The metabolic repertoire in nature is augmented by generating hybrid metabolites from a limited set of gene products(1-3). In mycobacteria, several unique complex lipids are produced by the combined action of fatty acid synthases and polyketide synthases (PKSs)(4-6), although it is not clear how the covalently sequestered biosynthetic intermediates are transferred from one enzymatic complex to another. Here we show that some of the 36 annotated fadD genes, located adjacent to the PKS genes in the Mycobacterium tuberculosis genome, constitute a new class of long-chain fatty acyl-AMP ligases (FAALs). These proteins activate long-chain fatty acids as acyl-adenylates, which are then transferred to the multifunctional PKSs for further chain extension. This mode of activation and transfer of fatty acids is contrary to the previously described universal mechanism involving the formation of acyl-coenzyme A thioesters. Similar mechanisms may operate in the biosynthesis of other lipid-containing metabolites and could have implications in engineering novel hybrid products.	Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gokhale, RS (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	rsg@nii.res.in	Mohanty, Debasisa/A-1428-2009	arora, pooja/0000-0002-4037-7406; MOHANTY, DEBASISA/0000-0002-3374-0588; Shrivastava, Rashmi/0000-0002-2988-4693				Admiraal SJ, 2001, BIOCHEMISTRY-US, V40, P6116, DOI 10.1021/bi010080z; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; Dieckmann R, 1999, J MOL BIOL, V288, P129, DOI 10.1006/jmbi.1999.2671; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fitzmaurice AM, 1997, J BACTERIOL, V179, P2608, DOI 10.1128/jb.179.8.2608-2615.1997; Fitzmaurice AM, 1998, J BIOL CHEM, V273, P8033, DOI 10.1074/jbc.273.14.8033; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Gokhale RS, 2001, BIOTECHNOLOGY, P341; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; KELLER U, 1984, BIOCHEMISTRY-US, V23, P1479, DOI 10.1021/bi00302a022; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; Rindi L, 2002, MICROBIOL-SGM, V148, P3873, DOI 10.1099/00221287-148-12-3873; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; Tosato V, 1997, MICROBIOL-UK, V143, P3443, DOI 10.1099/00221287-143-11-3443; Yadav G, 2003, NUCLEIC ACIDS RES, V31, P3654, DOI 10.1093/nar/gkg607; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8	27	219	243	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					441	445		10.1038/nature02384	http://dx.doi.org/10.1038/nature02384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042094				2022-12-01	WOS:000220404300046
J	Wolfe, ND; Switzer, WM; Carr, JK; Bhullar, VB; Shanmugam, V; Tamoufe, U; Prosser, AT; Torimiro, JN; Wright, A; Mpoudi-Ngole, E; McCutchan, FE; Birx, DL; Folks, TM; Burke, DS; Heneine, W				Wolfe, ND; Switzer, WM; Carr, JK; Bhullar, VB; Shanmugam, V; Tamoufe, U; Prosser, AT; Torimiro, JN; Wright, A; Mpoudi-Ngole, E; McCutchan, FE; Birx, DL; Folks, TM; Burke, DS; Heneine, W			Naturally acquired simian retrovirus infections in central African hunters	LANCET			English	Article							FOAMY VIRUS-INFECTION; IMMUNODEFICIENCY VIRUS; NONHUMAN-PRIMATES; LABORATORY WORKER; IDENTIFICATION; TRANSMISSION; POPULATIONS; HEALTH; RISK	Background Hunting and butchering of wild non-human primates infected with simian immunodeficiency virus (SIV) is thought to have sparked the HIV pandemic. Although SIV and other primate retroviruses infect laboratory workers and zoo workers, zoonotic retrovirus transmission has not been documented in natural settings. We investigated zoonotic infection in individuals living in central Africa. Methods We obtained behavioural data, plasma samples, and peripheral blood lymphocytes from individuals living in rural villages in Cameroon. We did serological testing, PCR, and sequence analysis to obtain evidence of retrovirus infection. Findings Zoonotic infections with simian foamy virus (SFV), a retrovirus endemic in most Old World primates, were identified in people living in central African forests who reported direct contact with blood and body fluids of wild non-human primates. Ten (1%) of 1099 individuals had antibodies to SFV. Sequence analysis from these individuals revealed three geographically-independent human SFV infections, each of which was acquired from a distinct non-human primate lineage: De Brazza's guenon (Cercopithecus neglectus), mandrill (Mandrillus sphinx), and gorilla (Gorilla gorilla), two of which (De Brazza's guenon and mandrill) are naturally infected with SIV. Interpretation Our findings show that retroviruses are actively crossing into human populations, and demonstrate that people in central Africa are currently infected with SFV. Contact with non-human primates, such as happens during hunting and butchering, can play a part in the emergence of human retroviruses and the reduction of primate bushmeat hunting has the potential to decrease the frequency of. disease emergence.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div AIDS Sexually Transmitted Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, TB Lab Res, Natl Ctr HIV AIDS Sexually Transmitted Dis & TB P, Atlanta, GA USA; Henry M Jackson Fdn, Rockville, MD USA; Army Hlth Res Ctr, Yaounde, Cameroon; Walter Reed Army Inst Res, Rockville, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Wolfe, ND (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St E7132, Baltimore, MD 21205 USA.	nwolfe@jhsph.edu		/0000-0002-5704-8094				Ali M, 1996, AIDS RES HUM RETROV, V12, P1473, DOI 10.1089/aid.1996.12.1473; BEINIASZ PD, 1995, VIROLOGY, V207, P217; Brooks JI, 2002, LANCET, V360, P387, DOI 10.1016/S0140-6736(02)09597-1; Broussard SR, 1997, VIROLOGY, V237, P349, DOI 10.1006/viro.1997.8797; Groves CP., 2001, PRIMATE TAXONOMY; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Hu JJ, 2003, J VIROL, V77, P4867, DOI 10.1128/JVI.77.8.4867-4880.2003; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; KHABBAZ RF, 1994, NEW ENGL J MED, V330, P172, DOI 10.1056/NEJM199401203300304; KHABBAZ RF, 1992, LANCET, V340, P271, DOI 10.1016/0140-6736(92)92358-M; Lerche NW, 2001, J VIROL, V75, P1783, DOI 10.1128/JVI.75.4.1783-1789.2001; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7; SCHWEIZER M, 1995, AIDS RES HUM RETROV, V11, P161, DOI 10.1089/aid.1995.11.161; Schweizer M, 1997, J VIROL, V71, P4821, DOI 10.1128/JVI.71.6.4821-4824.1997; Sotir M, 1997, J MED PRIMATOL, V26, P233, DOI 10.1111/j.1600-0684.1997.tb00217.x; SWITZER WM, 1995, J VIROL, V69, P621, DOI 10.1128/JVI.69.2.621-632.1995; Switzer WM, 2001, TRANSPLANTATION, V71, P959, DOI 10.1097/00007890-200104150-00022; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202	22	280	294	3	80	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 20	2004	363	9413					932	937		10.1016/S0140-6736(04)15787-5	http://dx.doi.org/10.1016/S0140-6736(04)15787-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804OS	15043960				2022-12-01	WOS:000220308600009
J	Winkler, WC; Nahvi, A; Roth, A; Collins, JA; Breaker, RR				Winkler, WC; Nahvi, A; Roth, A; Collins, JA; Breaker, RR			Control of gene expression by a natural metabolite-responsive ribozyme	NATURE			English	Article							MESSENGER-RNA STRUCTURE; INTRINSIC TRANSCRIPTION TERMINATION; ALLOSTERIC RIBOZYMES; MOLECULAR SWITCHES; MECHANISM; RIBOSWITCHES; SELECTION; BACTERIA; INTRONS	Most biological catalysts are made of protein; however, eight classes of natural ribozymes have been discovered that catalyse fundamental biochemical reactions. The central functions of ribozymes in modern organisms support the hypothesis that life passed through an 'RNA world' before the emergence of proteins and DNA. We have identified a new class of ribozymes that cleaves the messenger RNA of the glmS gene in Gram-positive bacteria. The ribozyme is activated by glucosamine-6-phosphate (GlcN6P), which is the metabolic product of the GlmS enzyme. Additional data indicate that the ribozyme serves as a metabolite-responsive genetic switch that represses the glmS gene in response to rising GlcN6P concentrations. These findings demonstrate that ribozyme switches may have functioned as metabolite sensors in primitive organisms, and further suggest that modern cells retain some of these ancient genetic control systems.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Breaker, Ronald/0000-0002-2165-536X				ABRASH HI, 1967, BIOCHEMISTRY-US, V6, P1303; BARRICK JE, UNPUB P NATL ACAD SC; Breaker RR, 1997, CHEM REV, V97, P371, DOI 10.1021/cr960008k; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Breaker RR, 2003, RNA, V9, P949, DOI 10.1261/rna.5670703; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; Emilsson GM, 2003, RNA, V9, P907, DOI 10.1261/rna.5680603; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Koizumi M, 1999, NAT STRUCT BIOL, V6, P1062; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Milewski S, 2002, BBA-PROTEIN STRUCT M, V1597, P173, DOI 10.1016/S0167-4838(02)00318-7; MILLER JH, 1992, SHORT COURSE BACTERI, V72; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Ptashne M., 2002, GENES SIGNALS; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Silverman SK, 2003, RNA, V9, P377, DOI 10.1261/rna.2200903; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Soukup GA, 2001, RNA, V7, P524, DOI 10.1017/S1355838201002175; Soukup GA, 2000, CURR OPIN STRUC BIOL, V10, P318, DOI 10.1016/S0959-440X(00)00090-7; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	40	648	711	4	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					281	286		10.1038/nature02362	http://dx.doi.org/10.1038/nature02362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029187				2022-12-01	WOS:000220250200034
J	Wang, ZG; Wang, DZ; Hockemeyer, D; McAnally, J; Nordheim, A; Olson, EN				Wang, ZG; Wang, DZ; Hockemeyer, D; McAnally, J; Nordheim, A; Olson, EN			Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression	NATURE			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; CELL-DIFFERENTIATION; FACTOR ELK-1; DOMAIN; COACTIVATOR; ACTIVATION; PROMOTER; PROTEIN; SM22-ALPHA	Smooth muscle cells switch between differentiated and proliferative phenotypes in response to extracellular cues(1), but the transcriptional mechanisms that confer such phenotypic plasticity remain unclear. Serum response factor (SRF) activates genes involved in smooth muscle differentiation and proliferation by recruiting muscle-restricted cofactors, such as the transcriptional coactivator myocardin, and ternary complex factors (TCFs) of the ETS-domain family, respectively(2-9). Here we show that growth signals repress smooth muscle genes by triggering the displacement of myocardin from SRF by Elk-1, a TCF that acts as a myogenic repressor. The opposing influences of myocardin and Elk-1 on smooth muscle gene expression are mediated by structurally related SRF-binding motifs that compete for a common docking site on SRF. A mutant smooth muscle promoter, retaining responsiveness to myocardin and SRF but defective in TCF binding, directs ectopic transcription in the embryonic heart, demonstrating a role for TCFs in suppression of smooth muscle gene expression in vivo. We conclude that growth and developmental signals modulate smooth muscle gene expression by regulating the association of SRF with antagonistic cofactors.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ N Carolina, Dept Cell & Dev Biol, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; Univ Tubingen, Dept Mol Biol, Inst Cell Biol, D-72704 Tubingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; Eberhard Karls University of Tubingen	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Eric.Olson@utsouthwestern.edu	Wang, Zhigao/ABE-9411-2021	Wang, Zhigao/0000-0002-6544-4302; Hockemeyer, Dirk/0000-0002-5598-5092				Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Ling Y, 1998, J BIOL CHEM, V273, P10506, DOI 10.1074/jbc.273.17.10506; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Mack CP, 1999, CIRC RES, V84, P852; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; OWENS GK, 1995, PHYSIOL REV, V75, P487; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Shore P, 1996, MOL CELL BIOL, V16, P3338; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09	29	436	456	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					185	189		10.1038/nature02382	http://dx.doi.org/10.1038/nature02382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014501				2022-12-01	WOS:000220103600050
J	Temiakov, D; Patlan, V; Anikin, M; McAllister, WT; Yokoyama, S; Vassylyev, DG				Temiakov, D; Patlan, V; Anikin, M; McAllister, WT; Yokoyama, S; Vassylyev, DG			Structural basis for substrate selection by T7 RNA polymerase	CELL			English	Article							ACTIVE-SITE MUTANTS; I KLENOW FRAGMENT; DNA-POLYMERASE; ELONGATION COMPLEX; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; TRANSCRIPTION ELONGATION; NUCLEOSIDE TRIPHOSPHATES; INITIATION COMPLEX; ALLOSTERIC BINDING	The mechanism by which nucleotide polymerases select the correct substrate is of fundamental importance to the fidelity of DNA replication and transcription. During the nucleotide addition cycle, pol I DNA polymerases undergo the transition from a catalytically inactive "open" to an active "closed" conformation. All known determinants of substrate selection are associated with the "closed" state. To elucidate if this mechanism is conserved in homologous single subunit RNA polymerases (RNAPs), we have determined the structure of T7 RNAP elongation complex with the incoming substrate analog. Surprisingly, the substrate specifically binds to RNAP in the "open" conformation, where it is base paired with the acceptor template base, while Tyr639 provides discrimination of ribose versus deoxyribose substrates. The structure therefore suggests a novel mechanism, in which the substrate selection occurs prior to the isomerization to the catalytically active conformation. Modeling of multisubunit RNAPs suggests that this mechanism might be universal for all RNAPs.	RIKEN, Harima Inst Spring 8, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst Spring 8, Structurome Res Grp, Sayo, Hyogo 6795148, Japan; SUNY Hlth Sci Ctr, Morse Inst Mol Genet, Dept Microbiol, Brooklyn, NY 11203 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; RIKEN; University of Tokyo	Yokoyama, S (corresponding author), RIKEN, Harima Inst Spring 8, Cellular Signaling Lab, 1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp; dmitry@yumiyoshi.harima.riken.go.jp	Patlan, Vsevolod/K-1825-2013; Yokoyama, Shigeyuki/N-6911-2015; Vassylyev, Dmitry/A-9005-2008	Yokoyama, Shigeyuki/0000-0003-3133-7338; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38147, R01 GM038147-14S1, R01 GM038147] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; BONNER G, 1994, J BIOL CHEM, V269, P25120; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; Brieba LG, 2000, BIOCHEMISTRY-US, V39, P919, DOI 10.1021/bi992324+; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Huang Y, 1997, BIOCHEMISTRY-US, V36, P13718, DOI 10.1021/bi971609o; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KOSTYUK DA, 1995, FEBS LETT, V369, P165, DOI 10.1016/0014-5793(95)00732-O; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ma KY, 2002, J BIOL CHEM, V277, P43206, DOI 10.1074/jbc.M206658200; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; MCALLISTER WT, 1997, NUCL ACIDS MOL BIOL, V11, P15; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Minnick DT, 2002, P NATL ACAD SCI USA, V99, P1194, DOI 10.1073/pnas.032457899; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; OSUMIDAVIS PA, 1992, J MOL BIOL, V226, P37, DOI 10.1016/0022-2836(92)90122-Z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Shinkai A, 2001, J BIOL CHEM, V276, P46759, DOI 10.1074/jbc.M104780200; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2003, ACTA CRYSTALLOGR D, V59, P185, DOI 10.1107/S0907444902019777; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Tosaka A, 2001, J BIOL CHEM, V276, P27562, DOI 10.1074/jbc.M010635200; Tunitskaya VL, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1124, DOI 10.1023/A:1020911223250; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Woody AYM, 1998, BIOCHEMISTRY-US, V37, P15958, DOI 10.1021/bi9805801; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	54	156	167	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					381	391		10.1016/S0092-8674(04)00059-5	http://dx.doi.org/10.1016/S0092-8674(04)00059-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016373	Bronze			2022-12-01	WOS:000188825800007
J	Muto, A; Tashiro, S; Nakajima, O; Hoshino, H; Takahashi, S; Sakoda, E; Ikebe, D; Yamamoto, M; Igarashi, K				Muto, A; Tashiro, S; Nakajima, O; Hoshino, H; Takahashi, S; Sakoda, E; Ikebe, D; Yamamoto, M; Igarashi, K			The transcriptional programme of antibody class switching involves the repressor Bach2	NATURE			English	Article							PLASMA-CELL DIFFERENTIATION; GERMINAL-CENTER FORMATION; SMALL MAF PROTEINS; SOMATIC HYPERMUTATION; MATURE B; RECOMBINATION; MECHANISM; BLIMP-1; EXPRESSION; ACTIVATION	Activated B cells differentiate to plasma cells to secrete IgM or, after undergoing class switch recombination (CSR), to secrete other classes of immunoglobulins(1-4). Diversification of antibody function by CSR is important for humoral immunity. However, it remains unclear how the decision for the bifurcation is made. Bach2 is a B-cell-specific transcription repressor interacting with the small Maf proteins whose expression is high only before the plasma cell stage(5-7). Here we show that Bach2 is critical for CSR and somatic hypermutation (SHM)(2,4,8) of immunoglobulin genes. Genetic ablation of Bach2 in mice revealed that Bach2 was required for both T-cell-independent and T-cell-dependent IgG responses and SHM. When stimulated in vitro, Bach2-deficient B cells produced IgM, as did wild-type cells, and abundantly expressed Blimp-1 (refs 9, 10) and XBP-1 (ref. 11), critical regulators of the plasmacytic differentiation(12), indicating that Bach2 was not required for the plasmacytic differentiation itself. However, they failed to undergo efficient CSR. These findings define Bach2 as a key regulator of antibody response and provide an insight into the orchestration of CSR and SHM during plasma cell differentiation.	Hiroshima Univ, Dept Biomed Chem, Grad Sch Biomed Sci, Hiroshima 7348551, Japan; Hiroshima Univ, Leukemia Program Project, Grad Sch Biomed Sci, Hiroshima 7348551, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Environm Response Project, Tsukuba, Ibaraki 3058577, Japan	Hiroshima University; Hiroshima University; University of Tsukuba; University of Tsukuba	Igarashi, K (corresponding author), Hiroshima Univ, Dept Biomed Chem, Grad Sch Biomed Sci, Hiroshima 7348551, Japan.	igarak@hiroshima-u.ac.jp	Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Igarashi, Kazuhiko/0000-0002-2470-2475				ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MONROE JG, 1988, J IMMUNOL, V140, P1454; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; Sun BW, 2001, CHEM LETT, P2, DOI 10.1246/cl.2001.2; Sun JY, 2001, J BIOCHEM, V130, P385, DOI 10.1093/oxfordjournals.jbchem.a002997; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	28	216	222	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2004	429	6991					566	571		10.1038/nature02596	http://dx.doi.org/10.1038/nature02596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825OL	15152264	Green Submitted			2022-12-01	WOS:000221767700041
J	Thomas, SG; Franklin-Tong, VE				Thomas, SG; Franklin-Tong, VE			Self-incompatibility triggers programmed cell death in Papaver pollen	NATURE			English	Article							CASPASE INHIBITORS; DNA FRAGMENTATION; ARABIDOPSIS; ACTIVATION; PROTEIN; RHOEAS; ACTIN; TUBES	Sexual reproduction in many angiosperm plants involves self-incompatibility ( SI), which is one of the most important mechanisms to prevent inbreeding. SI is genetically controlled by the S-locus, and involves highly specific interactions during pollination between pollen and the pistil on which it lands. This results in the rejection of incompatible ('self') pollen, whereas compatible ('non-self') pollen is allowed to fertilize the plant(1). In Papaver rhoeas, S-proteins encoded by the stigma component of the S-locus interact with incompatible pollen, triggering a Ca2+-dependent signalling network(2-7), resulting in the inhibition of pollen-tube growth. Programmed cell death (PCD) is a mechanism used by many organisms to destroy unwanted cells in a precisely regulated manner(8-10). Here we show that PCD is triggered by SI in an S-specific manner in incompatible pollen. This provides a demonstration of a SI system using PCD, revealing a novel mechanism to prevent self-fertilization. Furthermore, our data reveal that the response is biphasic; rapid inhibition of pollen-tube growth is followed by PCD, which is involved in a later 'decision-making' phase, making inhibition irreversible.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Franklin-Tong, VE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	v.e.franklin-tong@bham.ac.uk	Franklin-Tong, Vernonica E/D-1287-2012	Franklin-Tong, Noni/0000-0003-1782-8413; Thomas, Steven/0000-0001-8733-7842				Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; Balk J, 1999, FEBS LETT, V463, P151, DOI 10.1016/S0014-5793(99)01611-7; Danon A, 2004, J BIOL CHEM, V279, P779, DOI 10.1074/jbc.M304468200; DICKINSON H, 1994, NATURE, V367, P517, DOI 10.1038/367517a0; Franklin-Tong N, 2003, TRENDS PLANT SCI, V8, P598, DOI 10.1016/j.tplants.2003.10.008; Franklin-Tong VE, 2002, PLANT J, V29, P333, DOI 10.1046/j.1365-313X.2002.01219.x; FRANKLINTONG VE, 1993, PLANT J, V4, P163, DOI 10.1046/j.1365-313X.1993.04010163.x; FranklinTong VE, 1996, PLANT CELL, V8, P1305, DOI 10.1105/tpc.8.8.1305; Fukuda H, 2000, PLANT MOL BIOL, V44, P245, DOI 10.1023/A:1026532223173; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Geitmann A, 2000, PLANT CELL, V12, P1239, DOI 10.1105/tpc.12.7.1239; HODGKIN T, 1988, NEW PHYTOL, V110, P557, DOI 10.1111/j.1469-8137.1988.tb00296.x; Jordan ND, 2000, PLANT J, V23, P471, DOI 10.1046/j.1365-313x.2000.00811.x; Kakeda K, 1998, PLANT CELL, V10, P1723, DOI 10.1105/tpc.10.10.1723; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPINIEC L, 1995, FEBS LETT, V364, P103, DOI 10.1016/0014-5793(95)00335-7; Mittler R, 1996, TRENDS MICROBIOL, V4, P10, DOI 10.1016/0966-842X(96)81499-5; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Richael C, 2001, PHYSIOL MOL PLANT P, V59, P213, DOI 10.1006/pmpp.2001.0359; Rudd JJ, 1996, PLANT CELL, V8, P713, DOI 10.1105/tpc.8.4.713; Rudd JJ, 2003, FEBS LETT, V547, P223, DOI 10.1016/S0014-5793(03)00710-5; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338	30	187	205	1	47	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					305	309		10.1038/nature02540	http://dx.doi.org/10.1038/nature02540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152254				2022-12-01	WOS:000221505900045
J	Casolari, JM; Brown, CR; Komili, S; West, J; Hieronymus, H; Silver, PA				Casolari, JM; Brown, CR; Komili, S; West, J; Hieronymus, H; Silver, PA			Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization	CELL			English	Article							PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; NUCLEOCYTOPLASMIC TRANSPORT; DISTINCT DOMAINS; MESSENGER-RNAS; GENE RCC1; YEAST; PROTEIN; BINDING; TELOMERES	The association of genes with the nuclear pore complex (NPC) and nuclear transport factors has been implicated in transcriptional regulation. We therefore examined the association of components of the nuclear transport machinery including karyopherins, nucleoporins, and the Ran guanine-nucleotide exchange factor (RanGEF) with the Saccharomyces cerevisiae genome. We find that most nucleoporins and karyopherins preferentially associate with a subset of highly transcribed genes and with genes that possess Rap1 binding sites whereas the RanGEF preferentially associates with transcriptionally inactive genes. Consistent with coupling of transcription to the nuclear pore, we show that transcriptional activation of the GAL genes results in their association with nuclear pore proteins, relocation to the nuclear periphery, and loss of RanGEF association. Taken together, these results indicate that the organization of the genome is coupled via transcriptional state to the nuclear transport machinery.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@dfci.harvard.edu	West, Jason/I-4445-2014	West, Jason/0000-0002-7252-8651; Brown, Christopher/0000-0001-6076-4035				AEBI M, 1990, MOL GEN GENET, V224, P72, DOI 10.1007/BF00259453; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; AMATI B, 1990, EMBO J, V9, P4007, DOI 10.1002/j.1460-2075.1990.tb07622.x; AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma Y, 2000, CURR OPIN CELL BIOL, V12, P302, DOI 10.1016/S0955-0674(00)00093-4; Becskei A, 2003, P NATL ACAD SCI USA, V100, P1717, DOI 10.1073/pnas.252766999; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CLARK KL, 1991, CELL REGUL, V2, P781, DOI 10.1091/mbc.2.10.781; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Emtage JLT, 1997, J CELL SCI, V110, P911; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; FORRESTER W, 1992, GENE DEV, V6, P1914, DOI 10.1101/gad.6.10.1914; FREEMAN KB, 1992, MOL CELL BIOL, V12, P5455, DOI 10.1128/MCB.12.12.5455; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gotta M, 1999, METHOD ENZYMOL, V304, P663; Gotta M, 1996, EXPERIENTIA, V52, P1136, DOI 10.1007/BF01952113; GRAHAM IR, 1994, NUCLEIC ACIDS RES, V22, P124, DOI 10.1093/nar/22.2.124; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hood JK, 2000, J CELL SCI, V113, P1471; Huang L, 2002, MOL CELL PROTEOMICS, V1, P434, DOI 10.1074/mcp.M200027-MCP200; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Idrissi FZ, 1999, BIOCHEM J, V341, P477, DOI 10.1042/0264-6021:3410477; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343; Krebber H, 1999, GENE DEV, V13, P1994, DOI 10.1101/gad.13.15.1994; Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marcand S, 1996, GENE DEV, V10, P1297, DOI 10.1101/gad.10.11.1297; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SCHNEITER S, 1994, J CELL BIOL, V126, P649; Shore D, 1997, TRENDS BIOCHEM SCI, V22, P233, DOI 10.1016/S0968-0004(97)01082-7; STAVENHAGEN JB, 1994, GENE DEV, V8, P1411, DOI 10.1101/gad.8.12.1411; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Teixeira MT, 1999, J BIOL CHEM, V274, P32439, DOI 10.1074/jbc.274.45.32439; Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yu Q, 2003, NUCLEIC ACIDS RES, V31, P1224, DOI 10.1093/nar/gkg200	64	469	479	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2004	117	4					427	439		10.1016/S0092-8674(04)00448-9	http://dx.doi.org/10.1016/S0092-8674(04)00448-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137937	Bronze			2022-12-01	WOS:000221458000004
J	Kobayashi, T; Horiuchi, T; Tongaonkar, P; Vu, L; Nomura, M				Kobayashi, T; Horiuchi, T; Tongaonkar, P; Vu, L; Nomura, M			SIR2 regulates recombination between different rDNA repeats, but not recombination within individual rRNA genes in yeast	CELL			English	Article							REPLICATION FORK BLOCKING; SISTER-CHROMATID COHESION; TRANSCRIPTION FACTOR UAF; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; POLYMERASE-I; LIFE-SPAN; DEACETYLASE ACTIVITY; SHUTTLE VECTORS; PROTEIN FAMILY	It is known that mutations in gene SIR2 increase and those in FOB1 decrease recombination within rDNA repeats as assayed by marker loss or extrachromosomal rDNA circle formation. SIR2-dependent chromatin structures have been thought to inhibit access and/or function of recombination machinery in rDNA. We measured the frequency of FOB1-dependent arrest of replication forks, consequent DNA double-strand breaks, and formation of DNA molecules with Holliday junction structures, and found no significant difference between sir2Delta and SIR2 strains. Formal genetic experiments measuring mitotic recombination rates within individual rRNA genes also showed no significant difference between these two strains. Instead, we found a significant decrease in the association of cohesin subunit Mcd1p (Scc1p) to rDNA in sir2Delta relative to SIR2 strains. From these and other experiments, we conclude that SIR2 prevents unequal sister-chromatid recombination, probably by forming special cohesin structures, without significant effects on re-combinational events within individual rRNA genes.	Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Adv Studies, Hayama 2400193, Japan; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; University of California System; University of California Irvine	Kobayashi, T (corresponding author), Natl Inst Basic Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	koba@nibb.ac.jp; mnomura@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035949, R37GM035949] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35949] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gangloff S, 1996, EMBO J, V15, P1715, DOI 10.1002/j.1460-2075.1996.tb00517.x; Gerber JK, 1997, CELL, V90, P559, DOI 10.1016/S0092-8674(00)80515-2; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; HAWLEY RS, 1989, ANNU REV GENET, V23, P87, DOI 10.1146/annurev.ge.23.120189.000511; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Johzuka K, 2002, GENES CELLS, V7, P99, DOI 10.1046/j.1356-9597.2001.00508.x; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaiser C., 1994, METHODS YEAST GENETI; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2003; KOBAYASHI T, 1992, MOL GEN GENET, V233, P355, DOI 10.1007/BF00265431; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; LITTLE RD, 1993, MOL CELL BIOL, V13, P6600, DOI 10.1128/MCB.13.10.6600; Meluh PB, 2002, EUR J BIOCHEM, V269, P2300, DOI 10.1046/j.1432-1033.2002.02886.x; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Mohanty BK, 2004, J BIOL CHEM, V279, P1932, DOI 10.1074/jbc.M309078200; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Park PU, 1999, MOL CELL BIOL, V19, P3848; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Rothstein R, 2000, GENE DEV, V14, P1; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Vu L, 1999, P NATL ACAD SCI USA, V96, P4390, DOI 10.1073/pnas.96.8.4390; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	54	197	200	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2004	117	4					441	453		10.1016/S0092-8674(04)00414-3	http://dx.doi.org/10.1016/S0092-8674(04)00414-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821KB	15137938	Bronze			2022-12-01	WOS:000221458000005
J	Kraytsberg, Y; Schwartz, M; Brown, TA; Ebralidse, K; Kunz, WS; Clayton, DA; Vissing, J; Khrapko, K				Kraytsberg, Y; Schwartz, M; Brown, TA; Ebralidse, K; Kunz, WS; Clayton, DA; Vissing, J; Khrapko, K			Recombination of human mitochondrial DNA	SCIENCE			English	Article							INHERITANCE		Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Natl Univ Hosp Rigshosp, Dept Clin Genet, Copenhagen, Denmark; Natl Univ Hosp Rigshosp, Dept Neurol, Copenhagen, Denmark; Natl Univ Hosp Rigshosp, Copenhagen Muscle Res Ctr, Copenhagen, Denmark; Howard Hughes Med Inst, Chevy Chase, MD USA; Univ Bonn, Med Ctr, Dept Epileptol, D-5300 Bonn, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Howard Hughes Medical Institute; University of Bonn	Khrapko, K (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	khrapko@hms.harvard.edu	Kunz, Wolfram S./K-1232-2019; Khrapko, Konstantin/A-3244-2009	Kunz, Wolfram S./0000-0003-1113-3493; Brown, Timothy/0000-0001-8941-7678	NIA NIH HHS [AG18388, AG19787] Funding Source: Medline; NIEHS NIH HHS [ES11343] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019787, R01AG018388] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BROWN TB, UNPUB; Hagelberg E, 2003, TRENDS GENET, V19, P84, DOI 10.1016/S0168-9525(02)00048-3; Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536; Yauk CL, 2003, EMBO J, V22, P1389, DOI 10.1093/emboj/cdg136	7	206	217	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					981	981		10.1126/science.1096342	http://dx.doi.org/10.1126/science.1096342			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143273				2022-12-01	WOS:000221383300038
J	Felis, T; Lohmann, G; Kuhnert, H; Lorenz, SJ; Scholz, D; Patzold, J; Al-Rousan, SA; Al-Moghrabi, SM				Felis, T; Lohmann, G; Kuhnert, H; Lorenz, SJ; Scholz, D; Patzold, J; Al-Rousan, SA; Al-Moghrabi, SM			Increased seasonality in Middle East temperatures during the last interglacial period	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; CLIMATE; VARIABILITY; TELECONNECTIONS; RECONSTRUCTION; SIMULATION; EVOLUTION; CORALS; TRENDS; ENSO	The last interglacial period ( about 125,000 years ago) is thought to have been at least as warm as the present climate(1). Owing to changes in the Earth's orbit around the Sun, it is thought that insolation in the Northern Hemisphere varied more strongly than today on seasonal timescales(2), which would have led to corresponding changes in the seasonal temperature cycle(3). Here we present seasonally resolved proxy records using corals from the northernmost Red Sea, which record climate during the last interglacial period, the late Holocene epoch and the present. We find an increased seasonality in the temperature recorded in the last interglacial coral. Today, climate in the northern Red Sea is sensitive to the North Atlantic Oscillation(4,5), a climate oscillation that strongly influences winter temperatures and precipitation in the North Atlantic region. From our coral records and simulations with a coupled atmosphere - ocean circulation model, we conclude that a tendency towards the high-index state of the North Atlantic Oscillation during the last interglacial period, which is consistent with European proxy records(6-8), contributed to the larger amplitude of the seasonal cycle in the Middle East.	Univ Bremen, DFG Forschszentrum Ozeanrander, D-28359 Bremen, Germany; Univ Bremen, Fachbereich Geowissensch, D-28359 Bremen, Germany; Max Planck Inst Meteorol, D-20146 Hamburg, Germany; Heidelberger Akad Wissensch, D-69120 Heidelberg, Germany; Univ Jordan, Marine Sci Stn, Aqaba 77110, Jordan; Yarmouk Univ, Aqaba 77110, Jordan	University of Bremen; University of Bremen; Max Planck Society; Ruprecht Karls University Heidelberg; University of Jordan; Yarmouk University	Felis, T (corresponding author), Univ Bremen, DFG Forschszentrum Ozeanrander, D-28359 Bremen, Germany.	tfelis@allgeo.uni-bremen.de	Scholz, Denis/G-1861-2016; Lohmann, Gerrit/M-7453-2016; Al-Rousan, Saber/K-9031-2015; Felis, Thomas/G-6670-2011; Patzold, Jurgen/D-5111-2017	Scholz, Denis/0000-0002-0055-8915; Lohmann, Gerrit/0000-0003-2089-733X; Al-Rousan, Saber/0000-0001-8773-2113; Felis, Thomas/0000-0003-1417-9657; Patzold, Jurgen/0000-0001-8074-4103; Kuhnert, Henning/0000-0001-5242-4495				Aalbersberg G, 1998, J QUATERNARY SCI, V13, P367, DOI 10.1002/(SICI)1099-1417(1998090)13:5<367::AID-JQS400>3.0.CO;2-I; Bar-Matthews M, 2000, CHEM GEOL, V169, P145, DOI 10.1016/S0009-2541(99)00232-6; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Eshel G, 2000, J CLIMATE, V13, P339, DOI 10.1175/1520-0442(2000)013<0339:TPBLIA>2.0.CO;2; Felis T, 2003, CORAL REEFS, V22, P328, DOI 10.1007/s00338-003-0324-3; Felis T, 2000, PALEOCEANOGRAPHY, V15, P679, DOI 10.1029/1999PA000477; Fyfe JC, 1999, GEOPHYS RES LETT, V26, P1601, DOI 10.1029/1999GL900317; GENIN A, 1995, NATURE, V377, P507, DOI 10.1038/377507a0; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Held IM, 2002, J CLIMATE, V15, P2125, DOI 10.1175/1520-0442(2002)015<2125:NWSWTA>2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Keigwin LD, 1999, SCIENCE, V286, P520, DOI 10.1126/science.286.5439.520; Klotz S, 2003, GLOBAL PLANET CHANGE, V36, P277, DOI 10.1016/S0921-8181(02)00222-9; Kukla GJ, 2002, QUATERNARY RES, V58, P2, DOI 10.1006/qres.2001.2316; Legutke S., 1999, 21 DTSCH KLIM; LORENZ SJ, UNPUB CLIM DYN; Marshall JF, 2002, GEOCHIM COSMOCHIM AC, V66, P3263, DOI 10.1016/S0016-7037(02)00926-2; Montoya M, 2000, J CLIMATE, V13, P1057, DOI 10.1175/1520-0442(2000)013<1057:CSFKBW>2.0.CO;2; Noren AJ, 2002, NATURE, V419, P821, DOI 10.1038/nature01132; Rimbu N, 2003, J CLIMATE, V16, P1414, DOI 10.1175/1520-0442-16.9.1414; Rimbu N, 2001, GEOPHYS RES LETT, V28, P2959, DOI 10.1029/2001GL013083; Rogers JC, 2002, CLIM DYNAM, V19, P599, DOI 10.1007/s00382-002-0247-7; Scholz D, 2004, EARTH PLANET SC LETT, V218, P163, DOI 10.1016/S0012-821X(03)00647-2; Shindell DT, 1999, NATURE, V399, P452, DOI 10.1038/20905; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Zagwijn WH, 1996, QUATERNARY SCI REV, V15, P451, DOI 10.1016/0277-3791(96)00011-X	30	203	212	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					164	168		10.1038/nature02546	http://dx.doi.org/10.1038/nature02546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141207	Green Published			2022-12-01	WOS:000221356300036
J	Aronson, NE; Santosham, M; Comstock, GW; Howard, RS; Moulton, LH; Rhoades, ER; Harrison, LH				Aronson, NE; Santosham, M; Comstock, GW; Howard, RS; Moulton, LH; Rhoades, ER; Harrison, LH			Long-term efficacy of BCG vaccine in American Indians and Alaska natives - A 60-year follow-up study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CALMETTE-GUERIN VACCINATION; PUBLISHED LITERATURE; 20-YEAR EVALUATION; MUSCOGEE COUNTY; TUBERCULOSIS; PREVENTION; METAANALYSIS; STRAINS; DECLINE; GEORGIA	Context The duration of protection from tuberculosis of BCG vaccines is not known. Objective To determine the long-term duration of protection of a BCG vaccine that was previously found to be efficacious. Design Retrospective record review using Indian Health Service records, tuberculosis registries, death certificates, and supplemental interviews with trial participants. Setting and Participants Follow-up for the period 1948-1998 among American Indians and Alaska Natives who participated in a placebo-controlled BCG vaccine trial during 1935-1938 and who were still at risk of developing tuberculosis. Data from 1483 participants in the BCG vaccine group and 1309 in the placebo group were analyzed. Main Outcome Measures Efficacy of BCG vaccine, calculated for each 10-year interval using a Cox regression model with time-dependent variables based on tuberculosis events occurring after December 31, 1947 (end of prospective case finding). Results The overall incidence of tuberculosis was 66 and 138 cases per 100000 person-years in the BCG vaccine and placebo groups, respectively, for an estimate of vaccine efficacy of 52 % (95% confidence interval, 27%-69%). Adjustments for age at vaccination, tribe, subsequent BCG vaccination, chronic medical illness, isoniazid use, and bacille Calmette-Guerin strain did not substantially affect vaccine efficacy. There was slight but not statistically significant waning of the efficacy of BCG vaccination over time, greater among men than women. Conclusion In this trial, BCG vaccine efficacy persisted for 50 to 60 years, suggesting that a single dose of an effective BCG vaccine can have a long duration of protection.	Uniformed Serv Univ Hlth Sci, Dept Med, Div Infect Dis, Bethesda, MD 20814 USA; Walter Reed Army Med Ctr, Dept Med, Infect Dis Serv, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Dept Clin Invest, Washington, DC 20307 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian & Alaska Native Hlth, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Univ Oklahoma, Coll Publ Hlth, Native Amer Prevent Res Ctr, Oklahoma City, OK USA; Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Pittsburgh, PA USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aronson, NE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Div Infect Dis, Room A3058,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	naronson@usuhs.mil		Moulton, Lawrence/0000-0001-7041-7387	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI052788] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21670] Funding Source: Medline; NIAID NIH HHS [K24 AI52788] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARONSON JD, 1958, ARCH INTERN MED, V101, P881, DOI 10.1001/archinte.1958.00260170037006; ARONSON JD, 1948, AM REV TUBERC PULM, V58, P255; ARONSON JD, 1948, AM REV TUBERC PULM, V57, P96; ARONSON JD, 1952, JAMA-J AM MED ASSOC, V149, P334, DOI 10.1001/jama.1952.02930210018006; ARONSON JD, 1946, PUBLIC HEALTH REP, V61, P802, DOI 10.2307/4585699; ARONSON JOSEPH D., 1940, AMER REV TUBERC, V42, P651; Baik SH, 1999, DIABETES RES CLIN PR, V46, P91, DOI 10.1016/S0168-8227(99)00079-0; Baily G V, 1980, Indian J Med Res, V72 Suppl, P1; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; Classen JB, 1999, AUTOIMMUNITY, V31, P43, DOI 10.3109/08916939908993858; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMSTOCK GW, 1969, AM REV RESPIR DIS, V100, P839; COMSTOCK GW, 1976, PUBLIC HEALTH REP, V91, P276; COMSTOCK GW, 1974, AM J PUBLIC HEALTH, V64, P283, DOI 10.2105/AJPH.64.3.283; COMSTOCK GW, 1994, CONTROL CLIN TRIALS, V15, P247, DOI 10.1016/0197-2456(94)90042-6; DAHLQUIST G, 1995, DIABETOLOGIA, V38, P873, DOI 10.1007/BF03035306; Datta M, 1999, INDIAN J MED RES, V110, P56; FERGUSON R. G., 1949, TUBERCLE, V30, P5, DOI 10.1016/S0041-3879(49)80055-9; FINE PEM, 2001, TUBERCULOSIS COMPREH, P503; Frimodt-Moller J, 1973, Bull Int Union Tuberc, V48, P40; FRIMODT-MOLLER J., 1964, BULL WORLD HEALTH ORGAN, V30, P545; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; LAKEY JRT, 1994, TRANSPLANTATION, V57, P1213, DOI 10.1097/00007890-199404270-00013; *MASS CYT, 2001, STATX 5; *MED RES COUNC, 1972, B WORLD HEALTH ORGAN, V46, P371; Meinert CL, 1986, CLIN TRIALS DESIGN C, P214; MORI MA, 1992, ARCH INTERN MED, V152, P547, DOI 10.1001/archinte.152.3.547; Parent ME, 1997, DIABETES CARE, V20, P767, DOI 10.2337/diacare.20.5.767; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; ROSENTHAL S, 1961, AM REV RESPIR DIS, V84, P690; ROSENTHAL S, 1961, PEDIATRICS, V28, P622; SHEHADEH N, 1994, LANCET, V343, P706, DOI 10.1016/S0140-6736(94)91583-0; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; STEIN SC, 1953, AM REV TUBERC PULM, V68, P695; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; SUTHERLAND I, 1979, TUBERCLE, V60, P225, DOI 10.1016/0041-3879(79)90003-5; TOWNSEND J. G., 1942, AMER REV TUBERC, V45, P41	40	229	240	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2004	291	17					2086	2091		10.1001/jama.291.17.2086	http://dx.doi.org/10.1001/jama.291.17.2086			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JR	15126436	Bronze			2022-12-01	WOS:000221174300025
J	Lee, JH; Paull, TT				Lee, JH; Paull, TT			Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex	SCIENCE			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DNA-DAMAGE RESPONSE; TELANGIECTASIA-LIKE DISORDER; S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA; DEPENDENT PHOSPHORYLATION; IONIZING-RADIATION; HISTONE H2AX; NBS1; REPAIR	The complex containing the Mre11, Rad50, and Nbs1 proteins (MRN) is essential for the cellular response to DNA double-strand breaks, integrating DNA repair with the activation of checkpoint signaling through the protein kinase ATM ( ataxia telangiectasia mutated). We demonstrate that MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates. Phosphorylation of Nbs1 is critical for MRN stimulation of ATM activity toward Chk2, but not p53. Kinase-deficient ATM inhibits wild-type ATM phosphorylation of Chk2, consistent with the dominant-negative effect of kinase-deficient ATM in vivo.	Univ Texas, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, 1 Univ Stn,A4800, Austin, TX 78712 USA.	tpaull@icrnb.utexas.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X	NATIONAL CANCER INSTITUTE [R01CA094008] Funding Source: NIH RePORTER; NCI NIH HHS [CA94008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Lee J.-S., UNPUB; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2003, MOL CANCER RES, V1, P674; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; McGowan CH, 2002, BIOESSAYS, V24, P502, DOI 10.1002/bies.10101; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	29	568	587	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					93	96		10.1126/science.1091496	http://dx.doi.org/10.1126/science.1091496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15064416				2022-12-01	WOS:000220567900044
J	Floyd, SK; Bowman, JL				Floyd, SK; Bowman, JL			Gene regulation: Ancient microRNA target sequences in plants	NATURE			English	Editorial Material							ARABIDOPSIS; EXPRESSION		Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Floyd, SK (corresponding author), Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA.	jlbowman@ucdavis.edu		Bowman, John/0000-0001-7347-3691				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baima S, 1995, DEVELOPMENT, V121, P4171; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Lang A, 2002, MOVEMENT DISORD, V17, P1, DOI 10.1002/mds.10108; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	12	313	349	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					485	486		10.1038/428485a	http://dx.doi.org/10.1038/428485a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15057819				2022-12-01	WOS:000220540100028
J	Derdeyn, CA; Decker, JM; Bibollet-Ruche, F; Mokili, JL; Muldoon, M; Denham, SA; Heil, ML; Kasolo, F; Musonda, R; Hahn, BH; Shaw, GM; Korber, BT; Allen, S; Hunter, E				Derdeyn, CA; Decker, JM; Bibollet-Ruche, F; Mokili, JL; Muldoon, M; Denham, SA; Heil, ML; Kasolo, F; Musonda, R; Hahn, BH; Shaw, GM; Korber, BT; Allen, S; Hunter, E			Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; DISCORDANT COUPLES; CD4 INDEPENDENCE; INFECTION; GP120; VARIANTS; ANTIBODIES; EMERGENCE; ESCAPE	Heterosexual transmission accounts for the majority of human immunodeficiency virus-1 (HIV-1) infections worldwide, yet the viral properties that determine transmission fitness or outgrowth have not been elucidated. Here we show, for eight heterosexual transmission pairs, that recipient viruses were monophyletic, encoding compact, glycan-restricted envelope glycoproteins. These viruses were also uniquely sensitive to neutralization by antibody from the transmitting partner. Thus, the exposure of neutralizing epitopes, which are lost in chronic infection because of immune escape, appears to be favored in the newly infected host. This reveals characteristics of the envelope glycoprotein that influence HIV-1 transmission and may have implications for vaccine design.	Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Los Alamos Natl Lab, HIV Sequence Database, Los Alamos, NM 87544 USA; Univ Manchester, Inst Sci & Technol, Inst Math, Manchester M60 1QD, Lancs, England; Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Birmingham Ctr AIDS Res, Birmingham, AL 35294 USA; Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia; Trop Dis Res Ctr, Ndola, Zambia; Santa Fe Inst, Santa Fe, NM 87501 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Manchester; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Zambia; The Santa Fe Institute	Hunter, E (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	ehunter@uab.edu	Muldoon, Mark R/C-7505-2009; Muldoon, Mark/T-9192-2019	Muldoon, Mark/0000-0002-5004-7195; Hahn, Beatrice/0000-0002-9400-9887; Korber, Bette/0000-0002-2026-5757	NIAID NIH HHS [AI-51231, AI-40951, U01-AI-41530] Funding Source: Medline; PHS HHS [N01-85338] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051231, R01AI040951, R01AI051231, U01AI041530] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DERDEYN CA, UNPUB; Edwards TG, 2001, J VIROL, V75, P5230, DOI 10.1128/JVI.75.11.5230-5239.2001; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Johnson WE, 2002, J VIROL, V76, P2075, DOI 10.1128/JVI.76.5.2075-2086.2002; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kolchinsky P, 2001, J VIROL, V75, P3435, DOI 10.1128/JVI.75.7.3435-3443.2001; KUIKEN CL, 2002, HIV SEQUENCE COMPEND; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; KWONG PD, COMMUNICATION; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Long EM, 2000, NAT MED, V6, P71; Ly A, 2000, J VIROL, V74, P6769, DOI 10.1128/JVI.74.15.6769-6776.2000; McKenna SL, 1997, AIDS, V11, pS103; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	34	488	508	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2019	2022		10.1126/science.1093137	http://dx.doi.org/10.1126/science.1093137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	806JI	15044802				2022-12-01	WOS:000220429800042
J	Liljegren, SJ; Roeder, AHK; Kempin, SA; Gremski, K; Ostergaard, L; Guimil, S; Reyes, DK; Yanofsky, MF				Liljegren, SJ; Roeder, AHK; Kempin, SA; Gremski, K; Ostergaard, L; Guimil, S; Reyes, DK; Yanofsky, MF			Control of fruit patterning in Arabidopsis by INDEHISCENT	CELL			English	Article							LOOP-HELIX PROTEIN; BHLH-PAS PROTEIN; BRASSICA-NAPUS L; MADS-BOX GENES; CNS MIDLINE; DNA-BINDING; TRANSCRIPTION; ENCODES; DEHISCENCE; IDENTITY	The Arabidopsis seedpod opens through a spring-loaded mechanism known as pod shatter, which is essential for dispersal of the seeds. Here, we identify INDEHISCIENT (IND), an atypical bHLH protein, that is necessary for fruit opening and is involved in patterning each of the three fruit cell types required for seed dispersal. Previous studies suggested that FRUITFULL (FUL), a member of the MADS-domain transcription factor family, is required for fruit growth since ful mutant fruit fail to undergo the dramatic enlargement that normally occurs after fertilization. Here we show, however, that FUL is not directly required for fruit elongation and instead is required to prevent ectopic activity of IND. Our molecular and genetic studies suggest a model for the regulatory interactions among the genes that control fruit development and the mechanism that results in the expression of IND in a narrow stripe of cells.	Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Yanofsky, MF (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr,Dept 0116, La Jolla, CA 92093 USA.	marty@ucsd.edu	Roeder, Adrienne/ABF-5334-2021; Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X; Roeder, Adrienne/0000-0001-6685-2984				Alvarez J, 1999, DEVELOPMENT, V126, P2377; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; CAL M, 1990, CELL, V61, P437; Child RD, 1998, J EXP BOT, V49, P829, DOI 10.1093/jexbot/49.322.829; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Gu Q, 1998, DEVELOPMENT, V125, P1509; Heisler MGB, 2001, DEVELOPMENT, V128, P1089; Kempin SA, 1997, NATURE, V389, P802, DOI 10.1038/39770; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MacLeod J., 1981, Oilseed rape book., P107; MEAKIN PJ, 1990, J EXP BOT, V41, P995, DOI 10.1093/jxb/41.8.995; MEAKIN PJ, 1990, J EXP BOT, V41, P1003, DOI 10.1093/jxb/41.8.1003; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; PEARSONWHITE SH, 1991, NUCLEIC ACIDS RES, V19, P1148, DOI 10.1093/nar/19.5.1148; Rajani S, 2001, CURR BIOL, V11, P1914, DOI 10.1016/S0960-9822(01)00593-0; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tsugeki R, 1996, PLANT J, V10, P479, DOI 10.1046/j.1365-313X.1996.10030479.x; WHARTON KA, 1994, J CELL BIOCHEM, P55; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	36	279	307	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					843	853		10.1016/S0092-8674(04)00217-X	http://dx.doi.org/10.1016/S0092-8674(04)00217-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035986	Bronze			2022-12-01	WOS:000221499900010
J	Xu, Q; Wang, YS; Dabdoub, A; Smallwood, PM; Williams, J; Woods, C; Kelley, MW; Jiang, L; Tasman, W; Zhang, K; Nathans, J				Xu, Q; Wang, YS; Dabdoub, A; Smallwood, PM; Williams, J; Woods, C; Kelley, MW; Jiang, L; Tasman, W; Zhang, K; Nathans, J			Vascular development in the retina and inner ear: Control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair	CELL			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; SIGNALING PATHWAY; ANGIOGENESIS; PROTEIN; LOCALIZATION; BINDING; MEMBER; LRP5	Incomplete retinal vascularization occurs in both Norrie disease and familial exudative vitreoretinopathy (FEVR). Norrin, the protein product of the Norrie disease gene, is a secreted protein of unknown biochemical function. One form of FEVR is caused by defects in Frizzled-4 (Fz4), a presumptive Writ receptor. We show here that Norrin and Fz4 function as a ligand-receptor pair based on (1) the similarity in vascular phenotypes caused by Norrin and Fz4 mutations in humans and mice, (2) the specificity and high affinity of Norrin-Fz4 binding, (3) the high efficiency with which Norrin induces Fz4- and Lrp-dependent activation of the classical Wnt pathway, and (4) the signaling defects displayed by disease-associated variants of Norrin and Fz4. These data define a Norrin-Fz4 signaling system that plays a central role in vascular development in the eye and ear, and they indicate that ligands unrelated to Writs can act through Fz receptors.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Baltimore, MD 21218 USA; NIDCD, Sect Dev Neurosci, NIH, Rockville, MD 20850 USA; Univ Utah, Program Human Mol Biol & Gneet, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA; Wills Eye Hosp & Res Inst, Dept Ophthalmol, Philadelphia, PA 19107 USA	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Utah System of Higher Education; University of Utah; Jefferson University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21218 USA.	jnathans@jhmi.edu	Jiang, Li/C-9537-2012; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697; Dabdoub, Alain/0000-0002-4259-2425; Nathans, Jeremy/0000-0001-8106-5460	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000059, ZIADC000059] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERGER W, 2001, METABOLIC MOL BASES, P5977; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; CONNOLLY SE, 1988, MICROVASC RES, V36, P275, DOI 10.1016/0026-2862(88)90028-3; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hartzer MK, 1999, BRAIN RES BULL, V49, P355, DOI 10.1016/S0361-9230(99)00071-4; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kondo H, 2003, BRIT J OPHTHALMOL, V87, P1291, DOI 10.1136/bjo.87.10.1291; LANG R, 1994, DEVELOPMENT, V120, P3395; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Pendergast SD, 1998, OPHTHALMOLOGY, V105, P1015, DOI 10.1016/S0161-6420(98)96002-X; Perez-Vilar J, 1997, J BIOL CHEM, V272, P33410, DOI 10.1074/jbc.272.52.33410; Ramulu P, 2001, J BIOL CHEM, V276, P25127, DOI 10.1074/jbc.M011712200; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Rusch A, 2001, J NEUROSCI, V21, P9792, DOI 10.1523/JNEUROSCI.21-24-09792.2001; Shima DT, 2000, CURR OPIN GENET DEV, V10, P536, DOI 10.1016/S0959-437X(00)00124-6; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Stone J, 1997, PROG RETIN EYE RES, V16, P157, DOI 10.1016/S1350-9462(96)00019-5; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang YS, 2002, J NEUROSCI, V22, P8563; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6	39	624	672	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					883	895		10.1016/S0092-8674(04)00216-8	http://dx.doi.org/10.1016/S0092-8674(04)00216-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035989	Bronze			2022-12-01	WOS:000221499900013
J	Yan, LL; Loukoianov, A; Blechl, A; Tranquilli, G; Ramakrishna, W; SanMiguel, P; Bennetzen, JL; Echenique, V; Dubcovsky, J				Yan, LL; Loukoianov, A; Blechl, A; Tranquilli, G; Ramakrishna, W; SanMiguel, P; Bennetzen, JL; Echenique, V; Dubcovsky, J			The wheat VRN2 gene is a flowering repressor down-regulated by vernalization	SCIENCE			English	Article							ARABIDOPSIS; TIME; PROTEIN; ENCODES; BARLEY	Plants with a winter growth habit flower earlier when exposed for several weeks to cold temperatures, a process called vernalization. We report here the positional cloning of the wheat vernalization gene VRN2, a dominant repressor of flowering that is down-regulated by vernalization. Loss of function of VRN2, whether by natural mutations or deletions, resulted in spring lines, which do not require vernalization to flower. Reduction of the RNA level of VRN2 by RNA interference accelerated the flowering time of transgenic winter-wheat plants by more than a month.	Univ Calif Davis, Dept Agron & Range Sci, Davis, CA 95616 USA; ARS, USDA, Albany, CA 94710 USA; Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; Purdue Univ, Purdue Univ Genom Core, W Lafayette, IN 47907 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); Michigan Technological University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Georgia; University of Georgia	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Agron & Range Sci, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu	Ramakrishna, Wusirika/M-6646-2017; Dubcovsky, Jorge/T-5214-2019; SanMiguel, Phillip J/I-2196-2015; Dubcovsky, Jorge/A-4969-2008; Echenique, Viviana/GRX-7389-2022; Wusirika, Ramakrishna/O-9116-2019	Ramakrishna, Wusirika/0000-0002-8571-5827; SanMiguel, Phillip J/0000-0002-3742-9527; Dubcovsky, Jorge/0000-0002-7571-4345; Echenique, Viviana/0000-0003-3755-9062	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		CHEN CL, 2002, THESIS U CALIFORNIA; Clayton W.D., 1986, GENERA GRAMINUM GRAS; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kurup S, 2000, PLANT J, V21, P143, DOI 10.1046/j.1365-313x.2000.00663.x; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Lijavetzky D, 1999, GENOME, V42, P1176, DOI 10.1139/gen-42-6-1176; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; TAKAHASHI R, 1971, P 2 INT BARL GEN S W, P388; TAKAHASHI R, 1983, CATALOGUE BARLEY GER; Tranquilli G, 2000, J HERED, V91, P304, DOI 10.1093/jhered/91.4.304; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; YAN L, UNPUB	21	728	821	6	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1640	1644		10.1126/science.1094305	http://dx.doi.org/10.1126/science.1094305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15016992	Green Accepted			2022-12-01	WOS:000220151400035
J	Earl, PL; Americo, JL; Wyatt, LS; Eller, LA; Whitbeck, JC; Cohen, GH; Eisenberg, RJ; Hartmann, CJ; Jackson, DL; Kulesh, DA; Martinez, MJ; Miller, DM; Mucker, EM; Shamblin, JD; Zwiers, SH; Huggins, JW; Jahrling, PB; Moss, B				Earl, PL; Americo, JL; Wyatt, LS; Eller, LA; Whitbeck, JC; Cohen, GH; Eisenberg, RJ; Hartmann, CJ; Jackson, DL; Kulesh, DA; Martinez, MJ; Miller, DM; Mucker, EM; Shamblin, JD; Zwiers, SH; Huggins, JW; Jahrling, PB; Moss, B			Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox	NATURE			English	Article							VIRUS PROPAGATION; STRAIN MVA; PROTEIN; NEUTRALIZATION; IMMUNIZATION; ANTIBODIES; CHALLENGE; INFECTION; VARIOLA; VECTOR	The potential use of smallpox as a biological weapon has led to the production and stockpiling of smallpox vaccine and the immunization of some healthcare workers. Another public health goal is the licensing of a safer vaccine that could benefit the millions of people advised not to take the current one because they or their contacts have increased susceptibility to severe vaccine side effects(1). As vaccines can no longer be tested for their ability to prevent smallpox, licensing will necessarily include comparative immunogenicity and protection studies in non-human primates. Here we compare the highly attenuated modified vaccinia virus Ankara (MVA)(2) with the licensed Dryvax vaccine in a monkey model. After two doses of MVA or one dose of MVA followed by Dryvax, antibody binding and neutralizing titres and T-cell responses were equivalent or higher than those induced by Dryvax alone. After challenge with monkeypox virus, unimmunized animals developed more than 500 pustular skin lesions and became gravely ill or died, whereas vaccinated animals were healthy and asymptomatic, except for a small number of transient skin lesions in animals immunized only with MVA.	NIAID, NIH, Bethesda, MD 20892 USA; Henry M Jackson Fdn, Rockville, MD 20850 USA; Univ Penn, Sch Dent, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Pennsylvania; University of Pennsylvania	Moss, B (corresponding author), NIAID, NIH, Bethesda, MD 20892 USA.	bmoss@nih.gov		Moss, Bernard/0000-0002-2154-8564; Mucker, Eric/0000-0002-4656-5379; Miller, David/0000-0002-5746-3909	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000416, ZIAAI000416] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; APPLEYARD G, 1971, J GEN VIROL, V13, P9, DOI 10.1099/0022-1317-13-1-9; ARITA I, 1985, AM J TROP MED HYG, V34, P781, DOI 10.4269/ajtmh.1985.34.781; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Breman JG, 1998, NEW ENGL J MED, V339, P556, DOI 10.1056/NEJM199808203390811; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Galmiche MC, 1999, VIROLOGY, V254, P71, DOI 10.1006/viro.1998.9516; HOCHSTEI.V, 1972, ZENTRALBL BAKTER PAR, V156, P30; HOCHSTEINMINTZEL V, 1975, ZBL BAKT-INT J MED M, V230, P283; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Law M, 2002, J GEN VIROL, V83, P209, DOI 10.1099/0022-1317-83-1-209; Law M, 2001, VIROLOGY, V280, P132, DOI 10.1006/viro.2000.0750; LeDuc JW, 2002, EMERG INFECT DIS, V8, P743, DOI 10.3201/eid0807.020032; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mayr A, 1999, BERL MUNCH TIERARZTL, V112, P322; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Speller SA, 2002, J IMMUNOL METHODS, V262, P167, DOI 10.1016/S0022-1759(02)00025-X; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	30	282	292	10	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					182	185		10.1038/nature02331	http://dx.doi.org/10.1038/nature02331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014500				2022-12-01	WOS:000220103600049
J	Sharp, D				Sharp, D			Highs and lows of cannabis	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 1963, LANCET, V2, P989; Arseneault L, 2002, BRIT MED J, V325, P1212, DOI 10.1136/bmj.325.7374.1212; Baker D, 2003, LANCET NEUROL, V2, P291, DOI 10.1016/S1474-4422(03)00381-8; BOGGAN S, 2004, TIMES LONDON    0107, P4; BOOTH M, 2003, CANNABIS HIST, P354; Buggy DJ, 2003, PAIN, V106, P169, DOI 10.1016/S0304-3959(03)00331-2; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Degenhardt Louisa, 2002, Curr Psychiatry Rep, V4, P191, DOI 10.1007/s11920-002-0026-5; DYER G, 2003, FINANCIAL TIMES 1017, P15; *FED BUR INV, 2003, UN CRIM REP 2002; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; Iversen L, 2003, BRAIN, V126, P1252, DOI 10.1093/brain/awg143; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1	14	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2004	363	9406					344	344		10.1016/S0140-6736(04)15474-3	http://dx.doi.org/10.1016/S0140-6736(04)15474-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070561				2022-12-01	WOS:000188590900006
J	Wang, ZH; Shen, D; Parsons, DW; Bardelli, A; Sager, J; Szabo, S; Ptak, J; Silliman, N; Peters, BA; van der Heijden, MS; Parmigiani, G; Yan, H; Wang, TL; Riggins, G; Powell, SM; Willson, JKV; Markowitz, S; Kinzler, KW; Vogelstein, B; Velculescu, VE				Wang, ZH; Shen, D; Parsons, DW; Bardelli, A; Sager, J; Szabo, S; Ptak, J; Silliman, N; Peters, BA; van der Heijden, MS; Parmigiani, G; Yan, H; Wang, TL; Riggins, G; Powell, SM; Willson, JKV; Markowitz, S; Kinzler, KW; Vogelstein, B; Velculescu, VE			Mutational analysis of the tyrosine phosphatome in colorectal cancers	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; BREAST-CANCER; BETA-CATENIN; PHOSPHORYLATION; GROWTH; CELLS; IDENTIFICATION; DISEASE; KINASES; PTPRG	Tyrosine phosphorylation, regulated by protein tyrosine phosphatases (PTPs) and kinases (PTKs), is important in signaling pathways underlying tumorigenesis. A mutational analysis of the tyrosine phosphatase gene superfamily in human cancers identified 83 somatic mutations in six PTPs (PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, PTPN14), affecting 26% of colorectal cancers and a smaller fraction of lung, breast, and gastric cancers. Fifteen mutations were nonsense, frameshift, or splice-site alterations predicted to result in truncated proteins lacking phosphatase activity. Five missense mutations in the most commonly altered PTP ( PTPRT) were biochemically examined and found to reduce phosphatase activity. Expression of wild-type but not a mutant PTPRT in human cancer cells inhibited cell growth. These observations suggest that the mutated tyrosine phosphatases are tumor suppressor genes, regulating cellular pathways that may be amenable to therapeutic intervention.	Johns Hopkins Univ Med Inst, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; UVA Hlth Syst, Div Gastroenterol Hepatol, Charlottesville, VA 22908 USA; Univ Hosp Cleveland, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ireland Canc Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Howard Hughes Medical Institute; University Hospitals of Cleveland; University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University	Velculescu, VE (corresponding author), Johns Hopkins Univ Med Inst, Howard Hughes Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	velculescu@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Jin, Ning/B-7956-2011; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501; BARDELLI, Alberto/0000-0003-1647-5070; Peters, Brock/0000-0002-5137-3902	NCI NIH HHS [CA 43460, CA 57345, CA 62924] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043460, R37CA057345, R37CA043460, R01CA057345, P50CA062924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Ayalon O, 1997, J CELL SCI, V110, P547; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bompard G, 2002, J BIOL CHEM, V277, P47861, DOI 10.1074/jbc.M208950200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DRUCK T, 1995, CANCER RES, V55, P5348; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Freiss G, 1998, MOL ENDOCRINOL, V12, P568, DOI 10.1210/me.12.4.568; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Kastury K, 1996, GENOMICS, V32, P225, DOI 10.1006/geno.1996.0109; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; LAFORGIA S, 1991, P NATL ACAD SCI USA, V88, P5036, DOI 10.1073/pnas.88.11.5036; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; McAndrew PE, 1998, J COMP NEUROL, V391, P444, DOI 10.1002/(SICI)1096-9861(19980222)391:4<444::AID-CNE3>3.0.CO;2-0; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Panagopoulos I, 1996, CANCER RES, V56, P4871; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806	28	420	443	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1164	1166		10.1126/science.1096096	http://dx.doi.org/10.1126/science.1096096			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155950				2022-12-01	WOS:000221524500045
J	Vendrasco, MJ; Wood, TE; Runnegar, BN				Vendrasco, MJ; Wood, TE; Runnegar, BN			Articulated Palaeozoic fossil with 17 plates greatly expands disparity of early chitons	NATURE			English	Article							NORTH GREENLAND; HALKIERIIDS; AFFINITIES; SCLERITES; GROWTH	Modern chitons (Mollusca: Polyplacophora) possess a highly conserved skeleton of eight shell plates ( valves) surrounded by spicules or scales, and fossil evidence suggests that the chiton skeleton has changed little since the first appearance of the class in the Late Cambrian period ( about 500 million years before present, Myr BP). However, the Palaeozoic problematic taxon Multiplacophora(1-5), in spite of having a more complex skeleton, shares several derived characters with chitons. The enigmatic status of the Multiplacophora is due in part to the fact that its members had an exoskeleton of numerous calcium carbonate valves that usually separated after death. A new articulated specimen from the Carboniferous period (about 335 Myr BP) of Indiana reveals that multiplacophorans had a dorsal protective surface composed of head and tail valves, left and right columns of overlapping valves (five on each side), and a central zone of five smaller valves, all surrounded by an annulus of large spines. Here we describe and name the articulated specimen and present evidence that multiplacophorans were chitons. Thus the highly conserved body plan of living chitons belies the broad disparity of this clade during the Palaeozoic era.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Indiana Univ, Dept Biol, JH 142, Bloomington, IN 47405 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Indiana University System; Indiana University Bloomington	Vendrasco, MJ (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	mikev@ess.ucla.edu	Wood, Troy/F-7302-2010					ADRAIN JM, 1992, ALCHERINGA, V16, P15, DOI 10.1080/03115519208619031; Aurivillius CWS, 1892, KUNGLIGA SVENSKA VET, V18, P1; BAXTER JM, 1981, J MAR BIOL ASSOC UK, V61, P65, DOI 10.1017/S0025315400045914; Cohen BL, 2003, PALAEONTOLOGY, V46, P59, DOI 10.1111/1475-4983.00287; DZIK J, 1986, PROBLEMATIC FOSSIL T, P116; EERNISSE DJ, 1994, MICROSCOPIC ANATOMY, V5, P55; HALL J, 1888, GEOLOGICAL SURVEY ST, V7, P1; Haszprunar G, 2000, AM MALACOL BULL, V15, P115; HOARE R D, 1976, Ohio Journal of Science, V76, P116; Hoare RD, 2000, J PALEONTOL, V74, P976, DOI 10.1666/0022-3360(2000)074<0976:NDOTGD>2.0.CO;2; Hoare RD, 1996, J PALEONTOL, V70, P341, DOI 10.1017/S0022336000038282; Hoare Richard D., 1995, Acta Palaeontologica Polonica, V40, P111; KNIPRATH E, 1980, ROUX ARCH DEV BIOL, V189, P97, DOI 10.1007/BF00848498; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; MORRIS SC, 1990, NATURE, V345, P802, DOI 10.1038/345802a0; Pojeta J, 2003, J PALEONTOL, V77, P646, DOI 10.1666/0022-3360(2003)077<0646:EDANSO>2.0.CO;2; RUNNEGAR B, 1979, J PALEONTOL, V53, P1374; Scheltema AH, 2002, INVERTEBR BIOL, V121, P1; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; SUTTON MD, IN PRESS PALAEONTOLO; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Van Name W. G., 1925, American Museum Novitates, Vno. 197, P1; VAN NAME WILLARD G., 1926, AMER MUS NOVITATES, V227, P1; Williams A, 2002, PALAEONTOLOGY, V45, P845, DOI 10.1111/1475-4983.00264; WITHERS TH, 1915, GEOLOGICAL MAGAZINE, V6, P112	25	54	58	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					288	291		10.1038/nature02548	http://dx.doi.org/10.1038/nature02548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152250				2022-12-01	WOS:000221505900040
J	Isabel, G; Pascual, A; Preat, T				Isabel, G; Pascual, A; Preat, T			Exclusive consolidated memory phases in Drosophila	SCIENCE			English	Article							MUSHROOM BODIES; OLFACTORY MEMORY; TERM-MEMORY; BRAIN; LOCALIZATION; ACQUISITION; DISSECTION; EXPRESSION; RETENTION	Two types of consolidated memory have been described in Drosophila, anesthesia-resistant memory (ARM), a shorter-lived form, and stabilized long-term memory (LTM). Until now, it has been thought that ARM and LTM coexist. On the contrary, we show that LTM formation leads to the extinction of ARM. Flies devoid of mushroom body vertical lobes cannot form LTM, but spaced conditioning can still erase their ARM, resulting in a remarkable situation: The more these flies are trained, the less they remember. We propose that ARM acts as a gating mechanism that ensures that LTM is formed only after repetitive and spaced training.	CNRS, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	preat@iaf.cnrs-gif.fr	IBIS, NEURONAL/O-9910-2015; Pascual, Alberto P/E-9609-2015; Isabel, Guillaume/U-7405-2017; Pascual, Alberto/L-2014-2019	Pascual, Alberto P/0000-0001-5459-6207; Pascual, Alberto/0000-0001-5459-6207; Preat, Thomas/0000-0001-9976-1763				Armstrong JD, 1998, LEARN MEMORY, V5, P102; Boquet I, 2000, J NEUROBIOL, V42, P33; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1988, J COMP PHYSIOL A, V162, P101, DOI 10.1007/BF01342707; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Kim JJ, 2001, TRENDS NEUROSCI, V24, P324, DOI 10.1016/S0166-2236(00)01818-X; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1990, COLD SPRING HARB SYM, V55, P203; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	26	215	221	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					1024	1027		10.1126/science.1094932	http://dx.doi.org/10.1126/science.1094932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143285				2022-12-01	WOS:000221383300053
J	Horsburgh, CR				Horsburgh, CR			Priorities for the treatment of latent tuberculosis infection in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ISONIAZID PREVENTIVE THERAPY; CONTROLLED TRIAL; GOLD MINERS; DRUG-USERS; RISK; EPIDEMIOLOGY; MORBIDITY; SILICOSIS; DISEASE	BACKGROUND: The prevention of active tuberculosis through the treatment of latent tuberculosis infection is a major element of the national strategy for eliminating tuberculosis in the United States. Targeted treatment for persons who are at the highest risk for reactivation tuberculosis will be needed to achieve this goal. A more precise assessment of the lifetime risk of reactivation tuberculosis, usually estimated at 5 to 10 percent, could help to identify patients who are at the highest risk and motivate them to complete treatment. Currently, the rate of completion of treatment is low. METHODS: Published reports were reviewed to obtain estimates of the risk of tuberculosis among persons with a positive tuberculin skin test. Using these data, I constructed a model to estimate the lifetime risk of tuberculosis among persons with specific medical conditions. RESULTS: The lifetime risk of reactivation tuberculosis is 20 percent or more among most persons with induration of 10 mm or more on a tuberculin skin test and either human immunodeficiency virus infection or evidence of old, healed tuberculosis. The lifetime risk is 10 to 20 percent among persons with recent conversion of a tuberculin skin test and among most persons younger than 35 years of age who are receiving infliximab therapy and have induration of 15 mm or more on a tuberculin skin test. The risk is also 10 to 20 percent among children five years of age or younger who have induration of 10 mm or more on a tuberculin skin test. CONCLUSIONS: Persons with these characteristics should be targeted for intensive efforts to ensure full treatment of latent tuberculosis. Improved rates of completion of treatment among such persons could help to eliminate tuberculosis in the United States.	Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA	Boston University	Horsburgh, CR (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, 715 Albany St,T-3E, Boston, MA 02118 USA.	rhorsbu@bu.edu		Horsburgh, C./0000-0001-6838-7895				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; ARIAS E, 2000, NATL VITAL STAT REPO, V51; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bock NM, 1999, AM J RESP CRIT CARE, V159, P295, DOI 10.1164/ajrccm.159.1.9807020; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; COMSTOCK GW, 1966, AM REV RESPIR DIS, V93, P171; COMSTOCK GW, 1975, AM J EPIDEMIOL, V101, P363, DOI 10.1093/oxfordjournals.aje.a112105; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; EDWARDS LB, 1971, ARCH ENVIRON HEALTH, V22, P106, DOI 10.1080/00039896.1971.10665820; FEREBEE SH, 1963, AM REV RESPIR DIS, V88, P161; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; GEITER L, 2000, ENDING NEGLECT ELMIN; Gilroy SA, 2000, CLIN INFECT DIS, V31, P826, DOI 10.1086/314037; Gourevitch MN, 1998, INT J TUBERC LUNG D, V2, P531; Horsburgh CR, 2004, TUBERCULOSIS, P31; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kleinschmidt I, 1997, OCCUP ENVIRON MED, V54, P636, DOI 10.1136/oem.54.9.636; Kohn MR, 1996, ARCH PEDIAT ADOL MED, V150, P727, DOI 10.1001/archpedi.1996.02170320073012; LOWELL AM, 1969, TUBERCULOSIS; Miller FJW, 1963, TUBERCULOSIS CHILDRE; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nolan CM, 1997, AM J RESP CRIT CARE, V155, P583, DOI 10.1164/ajrccm.155.2.9032198; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; PALMER CE, 1957, AM REV TUBERC PULM, V76, P517; Poss J E, 2000, Nurs Res, V49, P20, DOI 10.1097/00006199-200001000-00004; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; STEIGER Z, 1976, AM J SURG, V131, P668, DOI 10.1016/0002-9610(76)90174-4; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; THORN PA, 1956, BMJ-BRIT MED J, V4967, P603; Tulsky JP, 1998, AM J PUBLIC HEALTH, V88, P223, DOI 10.2105/AJPH.88.2.223; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Ziv E, 2001, AM J EPIDEMIOL, V153, P381, DOI 10.1093/aje/153.4.381	40	450	462	2	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2004	350	20					2060	2067		10.1056/NEJMsa031667	http://dx.doi.org/10.1056/NEJMsa031667			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819ZB	15141044				2022-12-01	WOS:000221354000007
J	Little, MP; Breitling, LP; Basanez, MG; Alley, ES; Boatin, BA				Little, MP; Breitling, LP; Basanez, MG; Alley, ES; Boatin, BA			Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study	LANCET			English	Article							RIVER-BLINDNESS; WEST-AFRICA; PATHOGENESIS; EPILEPSY; VOLVULUS; INFECTION; INTENSITY; SAVANNA; GROWTH	Background Infection with the parasitic filarial nematode Onchocerca volvulus can lead to severe visual impairment and ultimately blindness. Excess mortality has been noted among people with onchocerciasis, but it is not clear whether this effect is entirely due to blindness, or mediated by some more direct effects of the infection. Methods We assessed the relations between infection with O volvulus, visual acuity, and host mortality with data obtained by the Onchocerciasis Control Programme in West Africa from 2315 villages in 11 countries. Findings 297 756 people were eligible for follow-up, and accumulated 2579449 person-years of follow-up from 1971 through 2001. 24517 people died during this period; 1283 (5.2%) of these deaths were due to onchocerciasis. Mortality of the human host was significantly and positively associated with increasing microfilarial burden (p<0.00001), but not with blindness after adjustment for microfilarial load and other variables. Overall, after adjustment for microfilarial load and other variables, female individuals had a risk of death about 7.5% lower than males (p<0.00001). Rates of mortality peaked in the mid 1980s but generally decreased thereafter. Interpretation We have shown a direct relation between O volvulus microfilarial load and host mortality in a comprehensive dataset and in both sexes.	Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; WHO, Reg Off Africa, Brazzaville, Rep Congo; WHO, Onchocerciasis Control Programme, Ouagadougou, Burkina Faso	Imperial College London; Imperial College London; World Health Organization; World Health Organization	Little, MP (corresponding author), Imperial Coll Fac Med, Dept Epidemiol & Publ Hlth, St Marys Campus,Norfolk Pl, London W2 1PG, England.	mark.little@imperial.ac.uk	Breitling, Lutz/C-7377-2008	Basanez, Maria-Gloria/0000-0001-5031-3361; Little, Mark/0000-0003-0980-7567				[Anonymous], 1995, World Health Organ Tech Rep Ser, V852, P1; Basanez MG, 2001, TRENDS PARASITOL, V17, P430, DOI 10.1016/S1471-4922(01)02013-X; Borsboom GJJM, 2003, FILARIA J, V2, P1; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BURNHAM GM, 1991, T ROY SOC TROP MED H, V85, P497, DOI 10.1016/0035-9203(91)90234-P; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Dietz K., 1982, P209; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Duerr HP, 2003, PARASITOLOGY, V126, P87, DOI 10.1017/S0031182002002561; Duke BOL, 1998, T ROY SOC TROP MED H, V92, P236, DOI 10.1016/S0035-9203(98)90763-5; EVANS TG, 1995, B WORLD HEALTH ORGAN, V73, P495; HABBEMA JDF, 1996, PUBLICATIONS NEWTON, P360; Hall LR, 1999, CLIN MICROBIOL REV, V12, P445, DOI 10.1128/CMR.12.3.445; Hoerauf A, 2002, TRENDS PARASITOL, V18, P25, DOI 10.1016/S1471-4922(01)02173-0; Hougard JM, 2001, J INFECT DIS, V184, P497, DOI 10.1086/322789; KIPP W, 1994, LANCET, V343, P183, DOI 10.1016/S0140-6736(94)90980-6; KIRKWOOD B, 1983, T ROY SOC TROP MED H, V77, P862, DOI 10.1016/0035-9203(83)90308-5; LITTLE MP, IN PRESS J INFECT DI; McCullagh P, 2019, GEN LINEAR MODELS; MOLYNEUX DH, 1995, PARASITOL TODAY, V11, P399, DOI 10.1016/0169-4758(95)80016-6; Molyneux DH, 1997, PARASITOL TODAY, V13, P418, DOI 10.1016/S0169-4758(97)00142-7; Moreau J.-P., 1978, Medecine Tropicale, V38, P43; Newell ED, 1997, T ROY SOC TROP MED H, V91, P525, DOI 10.1016/S0035-9203(97)90009-2; OTTESEN EA, 1995, J INFECT DIS, V171, P659, DOI 10.1093/infdis/171.3.659; Pearlman E, 2000, PARASITE IMMUNOL, V22, P625, DOI 10.1046/j.1365-3024.2000.00345.x; Pion SDS, 2002, ANN TROP MED PARASIT, V96, P181, DOI 10.1179/000349802125000718; PRESTON SH, 1985, POP B UN, V18, P34; Prost A., 1978, Medecine Tropicale, V38, P519; PROST A, 1981, B WORLD HEALTH ORGAN, V59, P773; PROST A, 1986, T ROY SOC TROP MED H, V80, P525, DOI 10.1016/0035-9203(86)90129-X; PROST A, 1979, TROPENMED PARASITOL, V30, P477; Prost A, 1975, ONCHOWP7514 WHO; REMME J, 1989, TROP MED PARASITOL, V40, P340; Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2; *S PLUS, 2001, S PLUS 6 0 PROF REL; Saint Andre AV, 2002, SCIENCE, V295, P1892, DOI 10.1126/science.1068732; Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X; STEEL C, 1993, J IMMUNOL, V150, P5511; THYLEFORS B, 1977, WHO, V55, P115	39	78	82	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2004	363	9420					1514	1521		10.1016/S0140-6736(04)16151-5	http://dx.doi.org/10.1016/S0140-6736(04)16151-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GK	15135599				2022-12-01	WOS:000221302700011
J	Pimm, SL; Brown, JH				Pimm, SL; Brown, JH			Domains of diversity	SCIENCE			English	Editorial Material							SPECIES RICHNESS PATTERNS; LATITUDINAL GRADIENTS		Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27713 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	Duke University; University of New Mexico	Pimm, SL (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27713 USA.	stuartpimm@aol.com; jhbrown@unm.edu	pimm, stuart/ABF-1082-2020					Bokma F, 2001, ECOGRAPHY, V24, P43, DOI 10.1034/j.1600-0587.2001.240106.x; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; GOTELLI NJ, 1966, NULL MODELS ECOLOGY; Keynes RichardD., 1979, BEAGLE RECORD SELECT; KINEMAN J, 1992, GLOBAL ECOSYSTEMS DA; LEWIN R, 1983, SCIENCE, V221, P636, DOI 10.1126/science.221.4611.636; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROY K, 2003, GEOL SOC AM ABST, V34, P84; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Wallace AR, 1878, TROPICAL NATURE OTHE; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zapata FA, 2003, J ANIM ECOL, V72, P677, DOI 10.1046/j.1365-2656.2003.00741.x	14	76	85	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					831	833		10.1126/science.1095332	http://dx.doi.org/10.1126/science.1095332			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15131295				2022-12-01	WOS:000221243000029
J	Dor, Y; Brown, J; Martinez, OI; Melton, DA				Dor, Y; Brown, J; Martinez, OI; Melton, DA			Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation	NATURE			English	Article							LIVER-REGENERATION; ISLET VOLUME; IN-VIVO; MICE; RATS; NEOGENESIS; MOUSE; MASS; ENDOCRINE; EXOCRINE	How tissues generate and maintain the correct number of cells is a fundamental problem in biology. In principle, tissue turnover can occur by the differentiation of stem cells, as is well documented for blood, skin and intestine, or by the duplication of existing differentiated cells. Recent work on adult stem cells has highlighted their potential contribution to organ maintenance and repair. However, the extent to which stem cells actually participate in these processes in vivo is not clear. Here we introduce a method for genetic lineage tracing to determine the contribution of stem cells to a tissue of interest. We focus on pancreatic beta-cells, whose postnatal origins remain controversial. Our analysis shows that pre-existing beta-cells, rather than pluripotent stem cells, are the major source of new beta-cells during adult life and after pancreatectomy in mice. These results suggest that terminally differentiated beta-cells retain a significant proliferative capacity in vivo and cast doubt on the idea that adult stem cells have a significant role in beta-cell replenishment.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@mcb.harvard.edu	Dor, Yuval/C-2405-2011; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Alison MR, 2002, SEMIN CELL DEV BIOL, V13, P385, DOI 10.1016/S1084952102001246; ARKLE S, 1986, Q J EXP PHYSIOL CMS, V71, P249, DOI 10.1113/expphysiol.1986.sp002982; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2002, J PATHOL, V197, P519, DOI 10.1002/path.1158; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; BUNNAG SC, 1966, DIABETES, V15, P480, DOI 10.2337/diab.15.7.480; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Finegood DT, 1999, AM J PHYSIOL-ENDOC M, V276, pE822, DOI 10.1152/ajpendo.1999.276.5.E822; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; FONG I, 1992, PANCREAS, V7, P453, DOI 10.1097/00006676-199207000-00006; Freshney R.I., 2010, CULTURE ANIMAL CELLS, P200; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hardikar AA, 1999, J ENDOCRINOL, V162, P189, DOI 10.1677/joe.0.1620189; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; LEBLOND C. P., 1964, NAT CANCER INST MONOGR, V14, P119; Lin YQ, 2001, DIABETOLOGIA, V44, P1026, DOI 10.1007/s001250100597; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; Oh SH, 2002, SEMIN CELL DEV BIOL, V13, P405, DOI 10.1016/S1084952102001271; Paris M, 2003, ENDOCRINOLOGY, V144, P2717, DOI 10.1210/en.2002-221112; Rooman I, 2002, DIABETES, V51, P686, DOI 10.2337/diabetes.51.3.686; Skau M, 2001, DIABETES, V50, P1763, DOI 10.2337/diabetes.50.8.1763; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; TSUBOUCHI S, 1987, ANAT REC, V218, P111, DOI 10.1002/ar.1092180203; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021; ZAJICEK G, 1990, DIABETES RES CLIN EX, V13, P121; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	38	1731	1839	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					41	46		10.1038/nature02520	http://dx.doi.org/10.1038/nature02520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129273	Bronze			2022-12-01	WOS:000221222100037
J	Meigs, JB; Hu, FB; Rifai, N; Manson, JE				Meigs, JB; Hu, FB; Rifai, N; Manson, JE			Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; INSULIN-RESISTANCE; DEPENDENT VASODILATION; ATHEROSCLEROSIS RISK; LIFE-STYLE; E-SELECTIN; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; BLOOD-FLOW	Context Endothelial dysfunction occurs in diagnosed type 2 diabetes mellitus but may also precede development of diabetes. Objective To determine whether elevated plasma levels of biomarkers reflecting endothelial dysfunction (E-selectin; intercellular adhesion molecule 1 [ICAM-1]; and vascular cell adhesion molecule 1 [VCAM-1]) predict development of type 2 diabetes in initially nondiabetic women. Design and Setting Prospective, nested case-control study within the Nurses' Health Study, an ongoing US study initiated in 1976. Participants Of 121700 women initially enrolled, 32826 provided blood samples in 1989-1990; of those free of diabetes, cardiovascular disease, or cancer at baseline, 737 developed incident diabetes by 2000. Controls (n = 785) were selected according to matched age, fasting status, and race. Main Outcome Measure Risk of confirmed clinically diagnosed type 2 diabetes by baseline levels of E-selectin, ICAM-1, and VCAM-1. Results Baseline median levels of the biomarkers were significantly higher among cases than among controls (E-selectin, 61.2 vs 45.4 ng/mL; ICAM-1, 264.9 vs 247.0 ng/mL; VCAM-1, 545.4 vs 526.0 ng/mL [all P values less than or equal to .004]). Elevated E-selectin and ICAM-1 levels predicted incident diabetes in logistic regression models conditioned on matching criteria and adjusted for body mass index (BMI), family history of diabetes, smoking, diet score, alcohol intake, activity index, and postmenopausal hormone use. The adjusted relative risks for incident diabetes in the top quintile vs the bottom quintiles were 5.43 for E-selectin (95% confidence interval [CI], 3.47-8.50), 3.56 for ICAM-1 (95% Cl, 2.28-5.58), and 1.12 for VCAM-1 (95% Cl, 0.76-1.66). Adjustment for waist circumference instead of BMI or further adjustment for baseline levels of C-reactive protein, fasting insulin, and hemoglobin A(1c) or exclusion of cases diagnosed during the first 4 years of follow-up did not alter these associations. Conclusion Endothelial dysfunction predicts type 2 diabetes in women independent of other known risk factors, including obesity and subclinical inflammation.	Massachusetts Gen Hosp, Gen Internal Med Unit, Div Gen Med, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Meigs, JB (corresponding author), Massachusetts Gen Hosp, Gen Internal Med Unit, Div Gen Med, Dept Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	jmeigs@partners.org	CLIHON, Residencia Medica/K-4896-2013; Meigs, James/P-3927-2019	CLIHON, Residencia Medica/0000-0001-6734-2513; Meigs, James/0000-0002-2439-2657	NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK58845, DK36798, DK46519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, R01DK036798, R01DK046519] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albertini JP, 1998, DIABETES CARE, V21, P1008, DOI 10.2337/diacare.21.6.1008; Arcaro G, 2002, CIRCULATION, V105, P576, DOI 10.1161/hc0502.103333; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; BARON AD, 1994, INSULIN RESISTANCE, P961; Bonadonna RC, 1998, CIRCULATION, V98, P234, DOI 10.1161/01.CIR.98.3.234; Brevetti G, 2001, THROMB HAEMOSTASIS, V85, P63; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; Caballero AE, 2003, METABOLISM, V52, P173, DOI 10.1053/meta.2003.50023; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; CHAPMAN DG, 1968, BIOMETRICS, V24, P315, DOI 10.2307/2528037; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; Cominacini L, 1998, DIABETES, V47, P130, DOI 10.2337/diabetes.47.1.130; Duncan BB, 1999, DIABETES CARE, V22, P767, DOI 10.2337/diacare.22.5.767; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Ferri C, 1998, DIABETES, V47, P660, DOI 10.2337/diabetes.47.4.660; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Freeman DJ, 2001, CIRCULATION, V103, P357; Gavin JR, 1997, DIABETES CARE, V20, P1183; GIMBRONE MA, 1990, ANN NY ACAD SCI, V598, P77, DOI 10.1111/j.1749-6632.1990.tb42279.x; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; HANKINSON SE, 1989, CLIN CHEM, V35, P2313; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hogikyan RV, 1998, J CLIN ENDOCR METAB, V83, P1946, DOI 10.1210/jc.83.6.1946; Holmlund A, 2002, ATHEROSCLEROSIS, V165, P271, DOI 10.1016/S0021-9150(02)00234-4; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; Hwang SJ, 1997, CIRCULATION, V96, P4219; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mather KJ, 2001, J AM COLL CARDIOL, V37, P1344, DOI 10.1016/S0735-1097(01)01129-9; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; MILES PDG, 1995, DIABETES, V44, P947, DOI 10.2337/diabetes.44.8.947; Nawawi H, 2003, ATHEROSCLEROSIS, V169, P283, DOI 10.1016/S0021-9150(03)00193-X; O'Driscoll G, 1999, J AM COLL CARDIOL, V33, P1506, DOI 10.1016/S0735-1097(99)00065-0; Pinkney JH, 1997, DIABETES, V46, pS9, DOI 10.2337/diab.46.2.S9; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Ruige JB, 1998, CIRCULATION, V97, P996; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Serne EH, 1999, CIRCULATION, V99, P896, DOI 10.1161/01.CIR.99.7.896; Serne EH, 2002, DIABETES, V51, P1515, DOI 10.2337/diabetes.51.5.1515; Tan KCB, 2002, J CLIN ENDOCR METAB, V87, P563, DOI 10.1210/jc.87.2.563; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vehkavaara S, 1999, DIABETES CARE, V22, P2055, DOI 10.2337/diacare.22.12.2055; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W., 1990, NUTR EPIDEMIOLOGY; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882	56	458	487	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1978	1986		10.1001/jama.291.16.1978	http://dx.doi.org/10.1001/jama.291.16.1978			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113816				2022-12-01	WOS:000221062000029
J	Webster, SM; del Camino, D; Dekker, JP; Yellen, G				Webster, SM; del Camino, D; Dekker, JP; Yellen, G			Intracellular gate opening in Shaker K+ channels defined by high-affinity metal bridges	NATURE			English	Article							POTASSIUM CHANNEL; ACTIVATION GATE; INACTIVATION GATE; CRYSTAL-STRUCTURE; S6 SEGMENT; PORE; MUTATIONS; S4; COOPERATIVITY; CONDUCTANCE	Voltage-gated potassium channels such as Shaker help to control electrical signalling in neurons by regulating the passage of K+ across cell membranes. Ion flow is controlled by a voltage-dependent gate at the intracellular side of the pore, formed by the crossing of four alpha-helices-the inner-pore helices. The prevailing model of gating is based on a comparison of the crystal structures of two bacterial channels-KcsA in a closed state and MthK in an open state-and proposes a hinge motion at a conserved glycine that splays the inner-pore helices wide open(1). We show here that two types of intersubunit metal bridge, involving cysteines placed near the bundle crossing, can occur simultaneously in the open state. These bridges provide constraints on the open Shaker channel structure, and on the degree of movement upon opening. We conclude that, unlike predictions from the structure of MthK, the inner-pore helices of Shaker probably maintain the KcsA-like bundle-crossing motif in the open state, with a bend in this region at the conserved proline motif (Pro-X-Pro) not found in the bacterial channels. A narrower opening of the bundle crossing in Shaker K+ channels may help to explain why Shaker has an approximately tenfold lower conductance than its bacterial relatives.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	gary_yellen@hms.harvard.edu		Yellen, Gary/0000-0003-4228-7866; Webster, Sarah/0000-0003-3269-2948	NINDS NIH HHS [R01 NS029693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2002, J GEN PHYSIOL, V120, P87, DOI 10.1085/jgp.20028611; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Forman SA, 1999, BIOCHEMISTRY-US, V38, P14559, DOI 10.1021/bi9914457; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	28	167	179	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					864	868		10.1038/nature02468	http://dx.doi.org/10.1038/nature02468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103379				2022-12-01	WOS:000220952300043
J	Lal, R; Griffin, M; Apt, J; Lave, L; Morgan, MG				Lal, R; Griffin, M; Apt, J; Lave, L; Morgan, MG			Ecology - Managing soil carbon	SCIENCE			English	Editorial Material							ORGANIC-MATTER; SEQUESTRATION RATES; CROPPING SYSTEMS; TILLAGE; PRODUCTIVITY; EROSION; MANURE		Ohio State Univ, Sch Nat Resources, Carbon Management & Sequestrat Ctr, Columbus, OH 43210 USA; Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	University System of Ohio; Ohio State University; Carnegie Mellon University; Carnegie Mellon University	Lal, R (corresponding author), Ohio State Univ, Sch Nat Resources, Carbon Management & Sequestrat Ctr, 2021 Coffey Rd, Columbus, OH 43210 USA.	lal.1@osu.edu	Griffin, William/M-2943-2014; Lal, Rattan/D-2505-2013; Apt, Jay/AFN-6031-2022	Griffin, William/0000-0002-1709-4280; 				BAUER A, 1994, SOIL SCI SOC AM J, V58, P185, DOI 10.2136/sssaj1994.03615995005800010027x; Dalal RC, 1995, AUST J EXP AGR, V35, P903, DOI 10.1071/EA9950903; DERPSCH R, 2003, 2 WORLD C CONS AGR 1; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Hobbs P, 2004, SUSTAINABLE AGR INT; JENKINSON DS, 1991, AGRON J, V83, P2, DOI 10.2134/agronj1991.00021962008300010008x; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R., 1999, Progress in Environmental Science, V1, P307; LAL R, 2000, SOIL SCI, V165; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Sa JCD, 2001, SOIL SCI SOC AM J, V65, P1486, DOI 10.2136/sssaj2001.6551486x; Smith P, 2000, SCIENCE, V287, P428; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Uhlen G., 1995, Norwegian Journal of Agricultural Sciences, V9, P143; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930	17	236	278	6	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					393	393		10.1126/science.1093079	http://dx.doi.org/10.1126/science.1093079			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087532				2022-12-01	WOS:000220845400029
J	Valk, PJM; Verhaak, RGW; Beijen, MA; Erpelinck, CAJ; van Doorn-Khosrovani, SBV; Boer, JM; Beverloo, HB; Moorhouse, MJ; van der Spek, PJ; Lowenberg, B; Delwel, R				Valk, PJM; Verhaak, RGW; Beijen, MA; Erpelinck, CAJ; van Doorn-Khosrovani, SBV; Boer, JM; Beverloo, HB; Moorhouse, MJ; van der Spek, PJ; Lowenberg, B; Delwel, R			Prognostically useful gene-expression profiles in acute myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; MUTATIONS; CANCER; FLT3; AML; CLASSIFICATION; REARRANGEMENTS; ABNORMALITIES; SURVIVAL; DISTINCT	Background: In patients with acute myeloid leukemia (AML) a combination of methods must be used to classify the disease, make therapeutic decisions, and determine the prognosis. However, this combined approach provides correct therapeutic and prognostic information in only 50 percent of cases. Methods: We determined the gene-expression profiles in samples of peripheral blood or bone marrow from 285 patients with AML using Affymetrix U133A GeneChips containing approximately 13,000 unique genes or expression-signature tags. Data analyses were carried out with Omniviz, significance analysis of microarrays, and prediction analysis of microarrays software. Statistical analyses were performed to determine the prognostic significance of cases of AML with specific molecular signatures. Results: Unsupervised cluster analyses identified 16 groups of patients with AML on the basis of molecular signatures. We identified the genes that defined these clusters and determined the minimal numbers of genes needed to identify prognostically important clusters with a high degree of accuracy. The clustering was driven by the presence of chromosomal lesions (e.g., t(8;21), t(15;17), and inv(16)), particular genetic mutations (CEBPA), and abnormal oncogene expression (EVI1). We identified several novel clusters, some consisting of specimens with normal karyotypes. A unique cluster with a distinctive gene-expression signature included cases of AML with a poor treatment outcome. Conclusions: Gene-expression profiling allows a comprehensive classification of AML that includes previously identified genetically defined subgroups and a novel cluster with an adverse prognosis.	Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam ZH, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 GE Rotterdam ZH, Netherlands; Erasmus Univ, Med Ctr, Dept Bioinformat, NL-3015 GE Rotterdam ZH, Netherlands; Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Valk, PJM (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, Ee13,Dr Molewaterpl 50, NL-3015 GE Rotterdam ZH, Netherlands.	p.valk@erasmusmc.nl	Valk, Peter/AAX-2823-2020; Boer, Judith/A-7546-2010; Verhaak, Roel/ABE-7058-2020	Boer, Judith/0000-0003-4848-7789; Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar/0000-0003-1239-9867				Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Barjesteh van Waalwijk van Doorn-Khosrovani S, 2003, HEMATOL J, V4, P31; Boeckx N, 2002, LEUKEMIA, V16, P368, DOI 10.1038/sj.leu.2402387; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Care RS, 2003, BRIT J HAEMATOL, V121, P775, DOI 10.1046/j.1365-2141.2003.04362.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Debernardi S, 2003, GENE CHROMOSOME CANC, V37, P149, DOI 10.1002/gcc.10198; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kiyoi H, 1999, BLOOD, V93, P3074; LILLY M, 1992, ONCOGENE, V7, P727; LOCOCO F, 1989, BRIT J HAEMATOL, V73, P480; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg B, 1997, J CLIN ONCOL, V15, P3496; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; OSSENKOPPELE GJ, IN PRESS BLOOD; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; TOUW I, 1991, LEUKEMIA, V5, P687; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, HAEMATOLOGICA, V89, P106; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459	28	1060	1135	0	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1617	1628		10.1056/NEJMoa040465	http://dx.doi.org/10.1056/NEJMoa040465			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084694	Green Published			2022-12-01	WOS:000220819800006
J	Van Camp, G; Flamez, A; Cosyns, B; Weytjens, C; Muyldermans, L; Van Zandijcke, M; De Sutter, J; Santens, P; Decoodt, P; Moerman, C; Schoors, D				Van Camp, G; Flamez, A; Cosyns, B; Weytjens, C; Muyldermans, L; Van Zandijcke, M; De Sutter, J; Santens, P; Decoodt, P; Moerman, C; Schoors, D			Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease	LANCET			English	Article							PRIMARY PULMONARY-HYPERTENSION; RETROPERITONEAL FIBROSIS; 5-HT2B RECEPTORS; FENFLURAMINE; DETERMINANTS; VALVULOPATHY; PATIENT	Background Restrictive valvular heart disease has been reported in patients with Parkinson's disease treated with pergolide. However, few data are available on frequency, severity, dose dependency, and reversibility of pergolide-induced disease, nor on the pulmonary pressures of these patients. We aimed to clarify these characteristics in a large group of patients. Methods 78 patients with Parkinson's disease treated with pergolide and 18 never treated with an ergot-derived dopamine agonist (controls) were evaluated by echocardiography. A valvular scoring system was used, ranging from I (proven ergot-like restrictive valvular heart disease) to 4 (no disease). For the mitral valve, tenting areas and tenting distances were measured. Systolic pulmonary artery pressures were derived from the tricuspid regurgitant jet. Findings Restrictive valvular heart disease of any type was present in 26 (33%) patients in the pergolide group and none in controls (p=0.0025). Important disease (score 1 or 2) was present in 15 (19%) patients in the pergolide group and none in controls (p=0.066). Mean tenting distances and tenting areas of the mitral valve were 1.08 cm (range 0.55-2.66) and 2.39 cm(2) (0.88-4.59) in the restrictive mitral valve group versus 0.63 cm (0.22-1.20) and 1.39 cm(2) (0.39-3.23) in the non-restrictive group (p=0.003 and p<0.0001, respectively). Significant correlation was noted between cumulative doses of pergolide and tenting areas of the mitral valves (r=0.412, p=0.017). Mean systolic pulmonary artery pressures were 39.3 mm Hg (range 25-71) in the high-dose group versus 38.5 mm Hg (20-65) in the low-dose group (p=0.76) and 31 mm Hg (25-40) in controls (p=0.02 vs all patients given pergolide). In six patients, pergolide treatment was stopped because of restrictive valvular heart disease, in two of whom regression of disease was shown. Interpretation Restrictive valvular heart disease is not a rare finding in patients treated with pergolide. Clinicians should consider changing to a non-ergot drug if this disease is diagnosed.	Free Univ Brussels, Akad Ziekenhuis, Dept Cardiol, B-1090 Brussels, Belgium; Free Univ Brussels, Akad Ziekenhuis, Dept Neurol, B-1090 Brussels, Belgium; AZ St Jan Brugge, Dept Cardiol, Brugge, Belgium; AZ St Jan Brugge, Dept Neurol, Brugge, Belgium; UZ Gent, Dept Cardiol, Ghent, Belgium; UZ Gent, Dept Neurol, Ghent, Belgium; CHU Brugmann, Dept Neurol, Brussels, Belgium; CHU Brugmann, Dept Cardiol, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Van Camp, G (corresponding author), Free Univ Brussels, Akad Ziekenhuis, Dept Cardiol, Laarbeeklaan 101, B-1090 Brussels, Belgium.	guy.vancamp@az.vub.ac.be	santens, patrick/O-2505-2013; Flamez, Anja/AAJ-5530-2020	Santens, Patrick/0000-0002-8886-9776				Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Blanpain C, 2003, CARDIOVASC RES, V60, P518, DOI 10.1016/j.cardiores.2003.09.015; Danoff SK, 2001, CHEST, V120, P313, DOI 10.1378/chest.120.1.313; Delcroix M, 1998, EUR RESPIR J, V12, P271, DOI 10.1183/09031936.98.12020271; *FDA, 2003 SAF AL PERM PER; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Flowers CM, 2003, MAYO CLIN PROC, V78, P730, DOI 10.4065/78.6.730; JIMENEZJIMENEZ FJ, 1995, CLIN NEUROPHARMACOL, V18, P277, DOI 10.1097/00002826-199506000-00009; Lancellotti P, 2003, J AM COLL CARDIOL, V42, P1921, DOI 10.1016/j.jacc.2003.04.002; Mondal BK, 2000, INT J CLIN PRACT, V54, P403; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Rahimtoola SH, 2002, MAYO CLIN PROC, V77, P1275, DOI 10.4065/77.12.1275; Rothman RB, 2000, CIRCULATION, V102, P2836; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Shaunak S, 1999, J NEUROL NEUROSUR PS, V66, P79, DOI 10.1136/jnnp.66.1.79; Shively BK, 1999, CIRCULATION, V100, P2161, DOI 10.1161/01.CIR.100.21.2161; *US FDA, 1997, MMWR-MORBID MORTAL W, V46, P1061; Van Camp G, 2003, NEUROLOGY, V61, P859, DOI 10.1212/01.WNL.0000083985.00343.F2	18	251	258	0	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1179	1183		10.1016/S0140-6736(04)15945-X	http://dx.doi.org/10.1016/S0140-6736(04)15945-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081648				2022-12-01	WOS:000220748100006
J	Murry, CE; Soonpaa, MH; Reinecke, H; Nakajima, H; Nakajima, HO; Rubart, M; Pasumarthi, KBS; Virag, JI; Bartelmez, SH; Poppa, V; Bradford, G; Dowell, JD; Williams, DA; Field, LJ				Murry, CE; Soonpaa, MH; Reinecke, H; Nakajima, H; Nakajima, HO; Rubart, M; Pasumarthi, KBS; Virag, JI; Bartelmez, SH; Poppa, V; Bradford, G; Dowell, JD; Williams, DA; Field, LJ			Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts	NATURE			English	Article							MARROW-DERIVED CELLS; BONE-MARROW; PROGENITOR CELLS; IN-VIVO; CARDIOMYOCYTES; TRANSPLANTATION; HEART; REGENERATION; MUSCLE; MICE	The mammalian heart has a very limited regenerative capacity and, hence, heals by scar formation(1). Recent reports suggest that haematopoietic stem cells can transdifferentiate into unexpected phenotypes such as skeletal muscle(2,3), hepatocytes(4), epithelial cells(5), neurons(6,7), endothelial cells(8) and cardiomyocytes(8,9), in response to tissue injury or placement in a new environment. Furthermore, transplanted human hearts contain myocytes derived from extra-cardiac progenitor cells(10-12), which may have originated from bone marrow(8,13-15). Although most studies suggest that transdifferentiation is extremely rare under physiological conditions, extensive regeneration of myocardial infarcts was reported recently after direct stem cell injection(9), prompting several clinical trials(16,17). Here, we used both cardiomyocyte-restricted and ubiquitously expressed reporter transgenes to track the fate of haematopoietic stem cells after 145 transplants into normal and injured adult mouse hearts. No transdifferentiation into cardiomyocytes was detectable when using these genetic techniques to follow cell fate, and stem-cell-engrafted hearts showed no overt increase in cardiomyocytes compared to sham-engrafted hearts. These results indicate that haematopoietic stem cells do not readily acquire a cardiac phenotype, and raise a cautionary note for clinical studies of infarct repair.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Indiana Univ, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Indiana University System; Indiana University-Purdue University Indianapolis; University of Washington; University of Washington Seattle	Murry, CE (corresponding author), Univ Washington, Dept Pathol, Box 357470,Room D-514 HSB, Seattle, WA 98195 USA.	murry@u.washington.edu; ljfield@iupui.edu	Virag, Jitka Amira Ismail/AAW-7427-2020; Virag, Jitka/AAW-6690-2020	Virag, Jitka Amira Ismail/0000-0003-3321-9861; Pasumarthi, Kishore/0000-0001-9317-076X				Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2; Ferrari G, 1998, SCIENCE, V281, P923; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6; Kuramochi Y, 2003, PEDIATR RES, V54, P319, DOI 10.1203/01.PDR.0000078275.14079.77; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Mallory GK, 1939, AM HEART J, V18, P647; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Reinecke Hans, 2003, Methods Mol Biol, V219, P97; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5	30	1642	1829	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					664	668		10.1038/nature02446	http://dx.doi.org/10.1038/nature02446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15034593				2022-12-01	WOS:000220697200047
J	Rodrigues, ASL; Andelman, SJ; Bakarr, MI; Boitani, L; Brooks, TM; Cowling, RM; Fishpool, LDC; da Fonseca, GAB; Gaston, KJ; Hoffmann, M; Long, JS; Marquet, PA; Pilgrim, JD; Pressey, RL; Schipper, J; Sechrest, W; Stuart, SN; Underhill, LG; Waller, RW; Watts, MEJ; Yan, X				Rodrigues, ASL; Andelman, SJ; Bakarr, MI; Boitani, L; Brooks, TM; Cowling, RM; Fishpool, LDC; da Fonseca, GAB; Gaston, KJ; Hoffmann, M; Long, JS; Marquet, PA; Pilgrim, JD; Pressey, RL; Schipper, J; Sechrest, W; Stuart, SN; Underhill, LG; Waller, RW; Watts, MEJ; Yan, X			Effectiveness of the global protected area network in representing species diversity	NATURE			English	Article							CONSERVATION TARGETS; BIODIVERSITY; EXTINCTION; PATTERNS; ECOLOGY; PARKS	The Fifth World Parks Congress in Durban, South Africa, announced in September 2003 that the global network of protected areas now covers 11.5% of the planet's land surface(1). This surpasses the 10% target proposed a decade earlier, at the Caracas Congress(2), for 9 out of 14 major terrestrial biomes(1). Such uniform targets based on percentage of area have become deeply embedded into national and international conservation planning(3). Although politically expedient, the scientific basis and conservation value of these targets have been questioned(4,5). In practice, however, little is known of how to set appropriate targets, or of the extent to which the current global protected area network fulfils its goal of protecting biodiversity. Here, we combine five global data sets on the distribution of species and protected areas to provide the first global gap analysis assessing the effectiveness of protected areas in representing species diversity. We show that the global network is far from complete, and demonstrate the inadequacy of uniform-that is, 'one size fits all'-conservation targets.	Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Conservat Int, IUCN SSCCI CABS Biodivers Assessement Unit, Washington, DC 20036 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; World Agroforestry Ctr ICRAF, Gigiri Nairobi, Kenya; Univ Roma La Sapienza, Dipartimento Biol Anim & Uomo, I-00185 Rome, Italy; Univ Port Elizabeth, Dept Bot, Terr Ecol Res Unit, ZA-6000 Port Elizabeth, South Africa; BirdLife Int, Cambridge CB3 0NA, England; Univ Fed Minas Gerais, Dept Zool, BR-31270 Belo Horizonte, MG, Brazil; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England; Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; New S Wales Dept Environm & Conservat, Armidale, NSW 2350, Australia; Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID 83844 USA; Univ Cape Town, Dept Stat Sci, Avian Demog Unit, ZA-7701 Rondebosch, South Africa; Chinese Acad Sci, Inst Zool, Beijing 100080, Peoples R China	Conservation International; Conservation International; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; CGIAR; World Agroforestry (ICRAF); Sapienza University Rome; Nelson Mandela University; BirdLife International; Universidade Federal de Minas Gerais; University of Sheffield; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Office of Environment & Heritage - New South Wales; Idaho; University of Idaho; University of Cape Town; Chinese Academy of Sciences; Institute of Zoology, CAS	Rodrigues, ASL (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA.	a.rodrigues@conservation.org	Rodrigues, Ana/GYQ-6273-2022; Pressey, Bob/C-8370-2013; Rodrigues, Ana S.L./A-5914-2009; Cowling, Richard/AFU-6261-2022; Marquet, Pablo A/B-7732-2009; Hoffmann, Michael/E-6419-2010	Pressey, Bob/0000-0003-2740-0330; Rodrigues, Ana S.L./0000-0003-4775-0127; Marquet, Pablo A/0000-0001-6369-9339; Hoffmann, Michael/0000-0003-4785-2254; Brooks, Thomas/0000-0001-8159-3116; Underhill, Les/0000-0002-8758-1527; Watts, Matthew/0000-0002-9094-1335				Andelman SJ, 2003, ECOL LETT, V6, P818, DOI 10.1046/j.1461-0248.2003.00503.x; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Birdlife International, 2000, THREAT BIRDS WORLD; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chape S., 2003, UN LIST PROTECTED AR; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Green M., 1997, STATE WORLDS PROTECT; IUCN (The World Conservation Union), 1994, GUID PROT AR MAN CAT; IUCN (World Conservation Union), 2003, IUCN RED LIST THREAT; Iverson JB, 2003, EMYSYSTEM WORLD TURT; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Kamdem-Toham A, 2003, SCIENCE, V299, P346, DOI 10.1126/science.299.5605.346; Lacher Thomas E. Jr, 1998, P199; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Rodrigues ASL, 2001, ECOL LETT, V4, P602, DOI 10.1046/j.1461-0248.2001.00275.x; Sattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.2307/3061007; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; *WORLD CONS UN, 1993, 4 WORLD C NAT PARK P; *WORLD DAT PROT AR, 2003, WORLD DAT PROT AR	30	955	1051	22	730	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					640	643		10.1038/nature02422	http://dx.doi.org/10.1038/nature02422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071592	Green Accepted			2022-12-01	WOS:000220697200040
J	Lilford, R; Mohammed, MA; Spiegelhalter, D; Thomson, R				Lilford, R; Mohammed, MA; Spiegelhalter, D; Thomson, R			Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma	LANCET			English	Article							ADJUSTED SURGICAL OUTCOMES; PROSPECTIVE PAYMENT SYSTEM; NEW-YORK-STATE; INTENSIVE-CARE; MORTALITY-RATES; MYOCARDIAL-INFARCTION; CLINICAL GOVERNANCE; QUALITY IMPROVEMENT; RISK ADJUSTMENT; CARDIAC-SURGERY	The history of monitoring the outcomes of health care by external agencies can be traced to ancient times. However, the danger, now as then, is that in the search for improvement, comparative measures of mortality and morbidity are often overinterpreted, resulting in judgments about the underlying quality of care. Such judgments can translate into performance management strategies in the form of capricious sanctions (such as star ratings) and unjustified rewards (such as special freedoms or financial allocations). The resulting risk of stigmatising an entire institution injects huge tensions into health-care organisations and can divert attention from genuine improvement towards superficial improvement or even gaming behaviour (ie, manipulating the system). These dangers apply particularly to measures of outcome and throughput. We argue that comparative outcome data (league tables) should not be used by external agents to make judgments about quality of hospital care. Although they might provide a reasonable measure of quality in some high-risk surgical situations, they have little validity in acute medical settings. Their use to support a system of reward and punishment is unfair and, unsurprisingly, often resisted by clinicians and managers. We argue further that although outcome data are useful for research and monitoring trends within an organisation, those who wish to improve care for patients and not penalise doctors and managers, should concentrate on direct measurement of adherence to clinical and managerial standards.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England; Univ Newcastle, Sch Populat & Hlth Sci Epidemiol & Publ Hlth, Newcastle Upon Tyne, Tyne & Wear, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Birmingham; University of Birmingham; Newcastle University - UK; MRC Biostatistics Unit; University of Cambridge	Lilford, R (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	R.J.Lilford@Bham.ac.uk						Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; [Anonymous], 2001, SUNDAY TIMES; ASH AS, 1997, RISK ADJUSTMENT MEAS, P427; Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; Baker R, 2003, BRIT MED J, V326, P274, DOI 10.1136/bmj.326.7383.274; BATES DW, 1995, MED CARE, V33, P452, DOI 10.1097/00005650-199505000-00002; BEST WR, 1994, MED CARE, V32, P390, DOI 10.1097/00005650-199404000-00007; Blumberg M S, 1986, Med Care Rev, V43, P351, DOI 10.1177/107755878604300205; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Carey J S, 1998, Bull Am Coll Surg, V83, P24; Carmel S, 2001, Curr Opin Crit Care, V7, P284, DOI 10.1097/00075198-200108000-00013; Carthey J, 2003, SAFETY SCI, V41, P409, DOI 10.1016/S0925-7535(01)00076-5; Chambler AFW, 1997, ANN ROY COLL SURG, V79, P174; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; Daley J, 2001, ANNU REV MED, V52, P275, DOI 10.1146/annurev.med.52.1.275; Daley J, 1997, J AM COLL SURGEONS, V185, P341, DOI 10.1016/S1072-7515(01)00940-1; DALEY J, 1997, RISK ADJUSTMENT MEAS, P331; DAVIES HTO, 1995, BRIT MED J, V311, P766, DOI 10.1136/bmj.311.7008.766; Deming W.E., 1986, OUT CRISIS; *DEP HLTH, 2002, NAT SURV NHS PAT CAN; DUBOIS RW, 1987, NEW ENGL J MED, V317, P1674, DOI 10.1056/NEJM198712243172626; Dunn PM, 1998, BRIT MED J, V317, P1144; Ebrahim S, 2000, BRIT MED J, V320, P1155, DOI 10.1136/bmj.320.7243.1155; Edhouse JA, 1996, J ACCID EMERG MED, V13, P123; ELLWOOD PM, 1988, NEW ENGL J MED, V318, P1549, DOI 10.1056/NEJM198806093182329; EPSTEIN AM, 1990, NEW ENGL J MED, V323, P266, DOI 10.1056/NEJM199007263230410; FEY CF, 2000, SERIES BUSINESS ADM, V2000; Freeman C, 2002, QUAL SAF HEALTH CARE, V11, P239, DOI 10.1136/qhc.11.3.239; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gibbs J, 2001, INT J QUAL HEALTH C, V13, P187, DOI 10.1093/intqhc/13.3.187; Glance LG, 2002, CRIT CARE MED, V30, P1976, DOI 10.1097/00003246-200209000-00005; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; Gunning K, 1999, BRIT MED J, V319, P241, DOI 10.1136/bmj.319.7204.241; Gupta N, 2002, J INTENSIVE CARE MED, V17, P211, DOI 10.1177/088506602237105; HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768; HARTZ AJ, 1994, AM J PUBLIC HEALTH, V84, P1609, DOI 10.2105/AJPH.84.10.1609; HAYWARD RA, 1993, MED CARE, V31, P394, DOI 10.1097/00005650-199305000-00002; HENDERSON J, 1992, J EPIDEMIOL COMMUN H, V46, P297, DOI 10.1136/jech.46.3.297; HUSELID MA, 1995, ACAD MANAGE J, V38, P635, DOI 10.2307/256741; Iezzoni L., 2012, RISK ADJUSTMENT MEAS; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Inquiry. BRI Inquiry Panel, 2001, LEARN BRIST REP PUBL; Institute of Medicine, 2001, CROSSING QUALITY CHA; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P3611, DOI 10.1001/jama.260.24.3611; Julious SA, 2000, BRIT J SURG, V87, P8, DOI 10.1046/j.1365-2168.2000.01328.x; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1969, DOI 10.1001/jama.264.15.1969; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; Kaska SC, 1998, SPINE, V23, P629, DOI 10.1097/00007632-199803010-00019; Khuri SF, 2002, ARCH SURG-CHICAGO, V137, P20, DOI 10.1001/archsurg.137.1.20; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Koch MJ, 1996, STRATEGIC MANAGE J, V17, P335; Krumholz HM, 2002, JAMA-J AM MED ASSOC, V287, P1277, DOI 10.1001/jama.287.10.1277; KUHN EM, 1994, MED CARE, V32, P1098, DOI 10.1097/00005650-199411000-00003; Landrum MB, 2000, HLTH SERVICES OUTCOM, V1, P23, DOI [10.1023/A:1010093701870, DOI 10.1023/A:1010093701870]; LEHRER S, 1979, EXPLORERS BODY; Lilford R J, 2003, Health Serv Manage Res, V16, P147, DOI 10.1258/095148403322167906; Lilford RJ, 2003, QUAL SAF HEALTH CARE, V12, pII8, DOI 10.1136/qhc.12.suppl_2.ii8; Mant J, 2001, INT J QUAL HEALTH C, V13, P475, DOI 10.1093/intqhc/13.6.475; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Mason S, 2002, BRIT MED J, V324, P419, DOI 10.1136/bmj.324.7334.419; McKee M, 1995, Qual Health Care, V4, P5, DOI 10.1136/qshc.4.1.5; McNaughton H, 2003, STROKE, V34, P713, DOI 10.1161/01.STR.0000057580.23952.0D; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; MULLEY A, 1994, OUTCOMES CLIN PRACTI, P13; Neale G, 2001, J ROY SOC MED, V94, P322, DOI 10.1177/014107680109400702; Nelson EC, 1998, ANN INTERN MED, V128, P460, DOI 10.7326/0003-4819-128-6-199803150-00007; NORMAND SL, 1997, JAMA-J AM MED ASSOC, V92, P802; PARK RE, 1990, JAMA-J AM MED ASSOC, V264, P484; Pfeffer J., 1995, ACAD MANAGE EXEC, V9, P55; Pronovost P J, 2001, Curr Opin Crit Care, V7, P297, DOI 10.1097/00075198-200108000-00014; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; Shahian DM, 2001, ANN THORAC SURG, V72, P2155, DOI 10.1016/S0003-4975(01)03222-2; Sirio CA, 1999, CHEST, V115, P793, DOI 10.1378/chest.115.3.793; Spiegelhalter D, 2003, INT J QUAL HEALTH C, V15, P7, DOI 10.1093/intqhc/15.1.7; Spiegelhalter DJ, 1999, J ROY STAT SOC A STA, V162, P45, DOI 10.1111/1467-985X.00120; *STAT OFF, 2002, 1 STAT OFF; THOMAS JW, 1993, INQUIRY-J HEALTH CAR, V30, P6; Thomas JW, 1998, MED CARE RES REV, V55, P371, DOI 10.1177/107755879805500401; Thomson RG, 2000, QUAL HEALTH CARE, V9, P201, DOI 10.1136/qhc.9.4.201; Treasure Tom, 2002, Health Care Manag Sci, V5, P243, DOI 10.1023/A:1020373921395; Vaughan-Sarrazin MS, 2002, JAMA-J AM MED ASSOC, V288, P1859, DOI 10.1001/jama.288.15.1859; WEST MA, 2002, INT J HUMAN RES MANA, V13, P1310; Wilson B, 2002, INT J QUAL HEALTH C, V14, P175, DOI 10.1093/oxfordjournals.intqhc.a002609; Young M P, 2000, Eff Clin Pract, V3, P284	90	336	342	1	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2004	363	9415					1147	1154		10.1016/S0140-6736(04)15901-1	http://dx.doi.org/10.1016/S0140-6736(04)15901-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808VB	15064036				2022-12-01	WOS:000220595500025
J	Paddison, PJ; Silva, JM; Conklin, DS; Schlabach, M; Li, MM; Aruleba, S; Balija, V; O'Shaughnessy, A; Gnoj, L; Scobie, K; Chang, K; Westbrook, T; Cleary, M; Sachidanandam, R; McCombie, WR; Elledge, SJ; Hannon, GJ				Paddison, PJ; Silva, JM; Conklin, DS; Schlabach, M; Li, MM; Aruleba, S; Balija, V; O'Shaughnessy, A; Gnoj, L; Scobie, K; Chang, K; Westbrook, T; Cleary, M; Sachidanandam, R; McCombie, WR; Elledge, SJ; Hannon, GJ			A resource for large-scale RNA-interference-based screens in mammals	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; PROTEASOME; CELLS; EXPRESSION; SHRNAS; GENES	Gene silencing by RNA interference (RNAi) in mammalian cells using small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs) has become a valuable genetic tool(1-10). Here, we report the construction and application of a shRNA expression library targeting 9,610 human and 5,563 mouse genes. This library is presently composed of about 28,000 sequence-verified shRNA expression cassettes contained within multi-functional vectors, which permit shRNA cassettes to be packaged in retroviruses, tracked in mixed cell populations by means of DNA 'bar codes', and shuttled to customized vectors by bacterial mating. In order to validate the library, we used a genetic screen designed to report defects in human proteasome function. Our results suggest that our large-scale RNAi library can be used in specific, genetic applications in mammals, and will become a valuable resource for gene analysis and discovery.	Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Biochem, Houston, TX 77030 USA; Rosetta Inpharmat, Kirkland, WA 98034 USA	Cold Spring Harbor Laboratory; Baylor College of Medicine; Howard Hughes Medical Institute; Merck & Company	Hannon, GJ (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	selledge@genetics.med.harvard.edu; hannon@cshl.org	sachidanandam, ravi/Q-6916-2019; Hannon, Gregory/AAB-3568-2019	sachidanandam, ravi/0000-0001-9844-4459; McCombie, W. Richard/0000-0003-1899-0682; Conklin, Douglas/0000-0003-4922-4307				Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Coux O, 2003, BIOCHEM SOC T, V31, P465, DOI 10.1042/BST0310465; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GHODA L, 1992, MOL CELL BIOL, V12, P2178, DOI 10.1128/MCB.12.5.2178; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2003, CURR OPIN MOL THER, V5, P217; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	19	559	626	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					427	431		10.1038/nature02370	http://dx.doi.org/10.1038/nature02370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042091				2022-12-01	WOS:000220404300043
J	Wilson, JF				Wilson, JF			Risks from microbes on the rise: Reasons why and ways to prevent future epidemics	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2004	140	6					497	500		10.7326/0003-4819-140-6-200403160-00040	http://dx.doi.org/10.7326/0003-4819-140-6-200403160-00040			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803AU	15023731				2022-12-01	WOS:000220204800029
J	Walburger, A; Koul, A; Ferrari, G; Nguyen, L; Prescianotto-Baschong, C; Huygen, K; Klebl, B; Thompson, C; Bacher, G; Pieters, J				Walburger, A; Koul, A; Ferrari, G; Nguyen, L; Prescianotto-Baschong, C; Huygen, K; Klebl, B; Thompson, C; Bacher, G; Pieters, J			Protein kinase G from pathogenic mycobacteria promotes survival within macrophages	SCIENCE			English	Article							INTRACELLULAR SURVIVAL; PHAGOSOME MATURATION; TUBERCULOSIS PHAGOSOME; EARLY ENDOSOMES; MICE; INHIBITORS; BIOGENESIS; SEQUENCE; ARREST; FUSION	Pathogenic mycobacteria resist lysosomal delivery after uptake into macrophages, allowing them to survive intracellularly. We found that the eukaryotic-like serine/threonine protein kinase G from pathogenic mycobacteria was secreted within macrophage phagosomes, inhibiting phagosome-lysosome fusion and mediating intracellular survival of mycobacteria. Inactivation of protein kinase G by gene disruption or chemical inhibition resulted in lysosomal localization and mycobacterial cell death in infected macrophages. Besides identifying a target for the control of mycobacterial infections, these findings suggest that pathogenic mycobacteria have evolved eukaryotic-like signal transduction mechanisms capable of modulating host cell trafficking pathways.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Axxima Pharmaceut AG, D-81377 Munich, Germany; Inst Pasteur, B-1180 Brussels, Belgium	University of Basel	Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	jean.pieters@unibas.ch		Huygen, Kris/0000-0001-7808-0512; Nguyen, Liem/0000-0002-1523-1472; Pieters, Jean/0000-0002-5284-9757				Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DENIS M, 1990, J LEUKOCYTE BIOL, V47, P25, DOI 10.1002/jlb.47.1.25; Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hasan Z, 1998, ELECTROPHORESIS, V19, P1179, DOI 10.1002/elps.1150190719; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ogawara H, 1999, MICROBIOL-UK, V145, P3343, DOI 10.1099/00221287-145-12-3343; Russell DG, 1997, PHILOS T ROY SOC B, V352, P1303, DOI 10.1098/rstb.1997.0114; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1111/j.1574-6976.1998.tb00369.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326	34	428	457	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1800	1804		10.1126/science.1099384	http://dx.doi.org/10.1126/science.1099384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15155913				2022-12-01	WOS:000222089500045
J	Syrjala, KL; Langer, SL; Abrams, JR; Storer, B; Sanders, JE; Flowers, MED; Martin, PJ				Syrjala, KL; Langer, SL; Abrams, JR; Storer, B; Sanders, JE; Flowers, MED; Martin, PJ			Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; BONE-MARROW-TRANSPLANTATION; FOLLOW-UP; ADULT RECIPIENTS; HEALTH; REHABILITATION; COMPLICATIONS; SURVIVORS; DISTRESS; DEATHS	Context Hematopoietic cell transplantation (HCT) is an effective and widely used treatment for hematologic malignancies. The rate and predictors of physical and emotional recovery after HCT have not been adequately defined in prospective long-term studies. Objective To examine the course of recovery and return to work after HCT. Design, Setting, and Patients Prospective, longitudinal cohort study at a US academic center specializing in HCT. Function was assessed from pretransplantation to 5-year follow-up for 319 adults who had myeloablative HCT for treatment of leukemia or lymphoma and spoke English. Of the 99 long-term survivors who had no recurrent malignancy, 94 completed 5-year follow-up. Main Outcome Measures Physical limitations, return to work, depression, and distress related to treatment or disease were evaluated before transplantation, at 90 days, and at 1, 3, and 5 years after HCT. Results Physical recovery occurred earlier than psychological or work recovery. Only 21 patients (19%) recovered on all outcomes at 1 year. The proportion without major limitations increased to 63% (n = 57) by 5 years. Among survivors without recurrent malignancy, 84% (n = 74) returned to full-time work by 5 years. Patients with slower physical recovery had higher medical risk and were more depressed before HCT (Pless than or equal to.001). Patients with chronic graft-vs-host disease (P = .01), with less social support before HCT (P = .001), and women (P <.001) were more depressed after transplantation. Transplant-related distress was slower to recover for allogeneic transplant recipients and those with less social support before HCT (P <=.01). Patients who had more experience with cancer treatment before beginning HCT had more rapid recovery from depression (P = .04) and treatment-related distress (P = .009). Conclusions Full recovery after HCT is a 3- to 5-year process. Recovery might be accelerated by more effective interventions to increase work-related capabilities, improve social support, and manage depression.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Syrjala, KL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,D5-220, Seattle, WA 98109 USA.	ksyrjala@fhcrc.org		Langer, Shelby L/0000-0002-6034-1830	NCI NIH HHS [CA 38522, CA78990, CA 18029, CA 63030, CA 36444] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA038522, R01CA078990, R01CA063030, P01CA018029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRYKOWSKI MA, 1995, BONE MARROW TRANSPL, V15, P837; [Anonymous], 1999, Oncology (Williston Park), V13, P113; APPELBAUM FR, 1985, CANCER-AM CANCER SOC, V55, P2202, DOI 10.1002/1097-0142(19850501)55:9+<2202::AID-CNCR2820551424>3.0.CO;2-S; BAKER F, 1994, BONE MARROW TRANSPL, V13, P589; Beck A.T., 1979, COGNITIVE THERAPY DE; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Broers S, 2000, J PSYCHOSOM RES, V48, P11, DOI 10.1016/S0022-3999(99)00059-8; Bush NE, 2000, BIOL BLOOD MARROW TR, V6, P576, DOI 10.1016/S1083-8791(00)70067-X; BUSH NE, 1995, SOC SCI MED, V40, P479, DOI 10.1016/0277-9536(94)00153-K; Chiodi S, 2000, BRIT J HAEMATOL, V110, P614, DOI 10.1046/j.1365-2141.2000.02053.x; Curtis RE, 1997, NEW ENGL J MED, V336, P897, DOI 10.1056/NEJM199703273361301; DEEG HJ, 1990, HEMATOL ONCOL CLIN N, V4, P641; Detry JMR, 2001, J CARDIOVASC RISK, V8, P355, DOI 10.1097/00043798-200112000-00004; Diggle P. J., 2003, ANAL LONGITUDINAL DA; Duell T, 1997, ANN INTERN MED, V126, P184, DOI 10.7326/0003-4819-126-3-199702010-00002; DUNKELSCHETTER C, 1984, J SOC ISSUES, V40, P77, DOI 10.1111/j.1540-4560.1984.tb01108.x; Fife BL, 2000, J CLIN ONCOL, V18, P1539, DOI 10.1200/JCO.2000.18.7.1539; Haberman M, 1993, Oncol Nurs Forum, V20, P1545; Heinonen H, 2001, ANN HEMATOL, V80, P137, DOI 10.1007/s002770000249; Hensel M, 2002, ANN ONCOL, V13, P209, DOI 10.1093/annonc/mdf031; Hjermstad MJ, 1999, J CLIN ONCOL, V17, P706, DOI 10.1200/JCO.1999.17.2.706; HOROWITZ MM, 1999, HEMATOPOIETIC CELL T, P12; La Rosa AM, 2001, CLIN INFECT DIS, V32, P871, DOI 10.1086/319352; Lee SJ, 2001, J CLIN ONCOL, V19, P242, DOI 10.1200/JCO.2001.19.1.242; Loberiza FR, 2002, J CLIN ONCOL, V20, P2118, DOI 10.1200/JCO.2002.08.757; McQuellon RP, 1998, BONE MARROW TRANSPL, V21, P477, DOI 10.1038/sj.bmt.1701115; Prieto JM, 1996, BONE MARROW TRANSPL, V17, P1133; Schulz-Kindermann F, 2002, BONE MARROW TRANSPL, V29, P341, DOI 10.1038/sj.bmt.1703385; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Socie G, 2001, BLOOD, V98, P3569, DOI 10.1182/blood.V98.13.3569; Socie G, 2001, BRIT J HAEMATOL, V113, P194, DOI 10.1046/j.1365-2141.2001.02678.x; Stern JM, 2001, BIOL BLOOD MARROW TR, V7, P257, DOI 10.1053/bbmt.2001.v7.pm11400947; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; SULLIVAN KM, 1989, ORGAN TRANSPLANTATIO, P91; SYRJALA KL, 1993, BONE MARROW TRANSPL, V11, P319; SYRJALA KL, 1995, PAIN, V61, P69, DOI 10.1016/0304-3959(94)00153-6; VOSE JM, 1992, CANCER, V69, P784, DOI 10.1002/1097-0142(19920201)69:3<784::AID-CNCR2820690328>3.0.CO;2-M; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; WITHERSPOON RP, 2003, NEW ENGL J MED, V321, P784	39	237	243	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2004	291	19					2335	2343		10.1001/jama.291.19.2335	http://dx.doi.org/10.1001/jama.291.19.2335			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821JD	15150205	Bronze			2022-12-01	WOS:000221455400021
J	Otto, SP; Nuismer, SL				Otto, SP; Nuismer, SL			Species interactions and the evolution of sex	SCIENCE			English	Article							DISEASE RESISTANCE; MUTATION ACCUMULATION; GENETIC ARCHITECTURE; RED QUEEN; RECOMBINATION; MAINTENANCE; PARASITISM; COEVOLUTION; ARABIDOPSIS; POPULATION	The Red Queen hypothesis posits that sex has evolved in response to the shifting adaptive landscape generated by the evolution of interacting species. Previous studies supporting the Red Queen hypothesis have considered a narrow region of parameter space and only a subset of ecological and genetic interactions. Here, we develop a population genetics model that circumscribes a broad array of ecological and genetic interactions among species and derive the first general analytical conditions for the impact of species interactions on the evolution of sex. Our results show that species interactions typically select against sex. We conclude that, although the Red Queen favors sex under certain circumstances, it alone does not account for the ubiquity of sex.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	University of British Columbia; Idaho; University of Idaho	Otto, SP (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	otto@zoology.ubc.ca	Otto, Sarah Perin/K-5625-2012	Otto, Sarah Perin/0000-0003-3042-0818	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM065620] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM65620-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; BELL G, 1987, NATURE, V328, P66, DOI 10.1038/328066a0; Bell G., 1982, MASTERPIECE NATURE E; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI 10.1111/j.1558-5646.1998.tb01833.x; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; Howard RS, 1998, EVOLUTION, V52, P604, DOI [10.1111/j.1558-5646.1998.tb01658.x, 10.2307/2411094]; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Kover PX, 2001, MOL ECOL, V10, P1, DOI 10.1046/j.1365-294X.2001.01124.x; LADLE RJ, 1993, P ROY SOC B-BIOL SCI, V253, P155, DOI 10.1098/rspb.1993.0096; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; PARKER MA, 1994, EVOL ECOL, V8, P560, DOI 10.1007/BF01238258; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Young ND, 2000, CURR OPIN PLANT BIOL, V3, P285, DOI 10.1016/S1369-5266(00)00081-9	19	168	170	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2004	304	5673					1018	1020		10.1126/science.1094072	http://dx.doi.org/10.1126/science.1094072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143283				2022-12-01	WOS:000221383300051
J	Cipollone, F; Toniato, E; Martinotti, S; Fazia, M; Iezzi, A; Cuccurullo, C; Pini, B; Ursi, S; Vitullo, G; Averna, M; Arca, M; Montali, A; Campagna, F; Ucchino, S; Spigonardo, F; Taddei, S; Virdis, A; Ciabattoni, G; Notarbartolo, A; Cuccurullo, F; Mezzetti, A				Cipollone, F; Toniato, E; Martinotti, S; Fazia, M; Iezzi, A; Cuccurullo, C; Pini, B; Ursi, S; Vitullo, G; Averna, M; Arca, M; Montali, A; Campagna, F; Ucchino, S; Spigonardo, F; Taddei, S; Virdis, A; Ciabattoni, G; Notarbartolo, A; Cuccurullo, F; Mezzetti, A		INES Study Grp	A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROTIC PLAQUES; THROMBOXANE BIOSYNTHESIS; UNSTABLE ANGINA; INFLAMMATORY RESPONSE; PROSTANOID FORMATION; ASPIRIN; INHIBITION; RISK; PROSTACYCLIN	Context Myocardial infarction (MI) and ischemic stroke are thought to be caused by matrix digestion by metalloproteinases (MMPs) leading to rupture of atherosclerotic plaques. Production of macrophage MMP-2 and MMP-9 is induced by cyclooxygenase 2 (COX-2) and prostaglandin E-2 synthesis. Although COX-2 expression may be genetically determined, the relation between COX-2 polymorphisms and the risk of MI and stroke is unclear. Objective To investigate the relationship between the -765G-->C polymorphism of the COX-2 gene and clinically evident plaque rupture. Design, Setting, and Participants Prospective, matched case-control study conducted between March 2002 and October 2003 among 864 patients with first MI or atherothrombotic ischemic stroke and 864 hospitalized controls. The groups were matched for age, sex, body mass index, smoking, hypertension, hypercholesterolemia, and diabetes. The -765G-->C variant of the COX-2 gene was genotyped by restriction endonuclease digestion of polymerase chain reaction products. Main Outcome Measures Presence of the -765G-->C polymorphism of the COX-2 gene; COX-2, MMP-2, and MMP-9 expression and activity in plaques and in peripheral monocytes; urinary 6-keto PGF(1alpha) (marker of endothelial prostacyclin); and endothelium-dependent and -independent forearm blood flow vasodilation. Results The prevalence of -765GC was 2.41 times higher among controls than among cases (43.3% vs 17.9%; P<.001). The prevalence of -765CC homozygosity was 5.81 times higher (6.4% vs 1.1%; P=.04). Among participants carrying the -765GC and -765CC genotypes, the prevalence ratios for MI or stroke were 0.48 (95% CI, 0.36-0.68) and 0.33 (95% CI, 0.24-0.55), respectively. Expression of COX-2 and MMPs was significantly lower in atherosclerotic plaques from participants carrying the -765C allele, while the -765G&RARR;C polymorphism did not affect endothelial prostacyclin biosynthesis or endothelium-dependent vasodilation in vivo. In subgroup analyses (n=224 cases), serum high-sensitivity C-reactive protein was significantly lower in patients carrying the -765C allele (mean [SD], 0.78 [0.1] vs 2.56 [0.4] mg/L; P=.04). Conclusions We found that the -765G&RARR;C polymorphism of the COX-2 gene is associated with a decreased risk of MI and stroke. Detection of this genotype may be useful for predicting genetic risk of MI and stroke.	G Dannunzio Univ Chieti, Chieti, Italy; G Dannunzio Univ Fdn, Chieti, Italy; Univ Palermo, Palermo, Italy; Univ Roma La Sapienza, Rome, Italy; Univ Pisa, Pisa, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Palermo; Sapienza University Rome; University of Pisa	Mezzetti, A (corresponding author), Nuovo Policlin SS Annunziata, Ctr Reg Prevenz Aterosclerosis, Via Vestini 66, I-66013 Chieti, Italy.	mezzetti@unich.it	Averna, Maurizio/U-9527-2017; ARCA, Marcello/AAC-3883-2022; Virdis, Agostino/K-5315-2016; Cipollone, Francesco/AAC-5698-2022; Taddei, Stefano/AAB-2828-2019	ARCA, Marcello/0000-0003-3786-0883; Averna, Maurizio/0000-0003-3558-9209; Cipollone, Francesco/0000-0002-5993-9341				ANDERSON RN, 1997, MONTHLY VITAL STAT R, V45, P2; Cipollone F, 2004, CIRCULATION, V109, P1482, DOI 10.1161/01.CIR.0000121735.52471.AC; Cipollone F, 2003, CIRCULATION, V107, P1479, DOI 10.1161/01.CIR.0000056530.03783.81; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Cipollone F, 2003, CIRCULATION, V107, P55, DOI 10.1161/01.CIR.0000043260.82447.62; Cipollone F, 2002, ARTERIOSCL THROM VAS, V22, P1516, DOI 10.1161/01.ATV.0000035402.68085.A0; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P246, DOI 10.1161/01.ATV.0000104005.92603.f2; Cipollone F, 1997, CIRCULATION, V96, P1109, DOI 10.1161/01.CIR.96.4.1109; Cipollone F, 2000, CIRCULATION, V102, P1007, DOI 10.1161/01.CIR.102.9.1007; Cullen L, 1998, J PHARMACOL EXP THER, V287, P578; De Caterina R, 2002, CIRCULATION, V106, P2543, DOI 10.1161/01.CIR.0000038500.43292.D7; de Vries HE, 1999, ARTERIOSCL THROM VAS, V19, P638, DOI 10.1161/01.ATV.19.3.638; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Goto K, 2000, HYPERTENSION, V36, P581, DOI 10.1161/01.HYP.36.4.581; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; MAENBER ME, 1994, NEW ENGL J MED, V330, P1041; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; PATRONO C, 1982, J CLIN INVEST, V69, P231, DOI 10.1172/JCI110435; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI200113418; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; RICKER PM, 2000, NEW ENGL J MED, V342, P836; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	33	210	229	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2004	291	18					2221	2228		10.1001/jama.291.18.2221	http://dx.doi.org/10.1001/jama.291.18.2221			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GR	15138244	Green Published, hybrid			2022-12-01	WOS:000221303500024
J	Lloyd-Jones, DM; Nam, BH; D'Agostino, RB; Levy, D; Murabito, JM; Wang, TJ; Wilson, PWF; O'Donnell, CJ				Lloyd-Jones, DM; Nam, BH; D'Agostino, RB; Levy, D; Murabito, JM; Wang, TJ; Wilson, PWF; O'Donnell, CJ			Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults - A prospective study of parents and offspring	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; NEWCASTLE FAMILY-HISTORY; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; HIGH PREVALENCE; ARTERY DISEASE; ACCURACY; DEATH; MEN	Context Whether parental cardiovascular disease confers increased risk independent of other risk factors remains controversial. Prior studies relied on offspring report, without complete validation of parental events. Objective To determine whether parental cardiovascular disease predicts offspring events independent of traditional risk factors, using a prospective design for both parents and offspring, and uniform criteria to validate events. Design Inception cohort study. Setting Framingham Heart Study, a US population-based epidemiologic cohort begun in 1948 with the offspring cohort established in 1971. Participants All Framingham Offspring Study participants (aged greater than or equal to30 years) who were free of cardiovascular disease and both parents in the original Framingham cohort. Main Outcome Measures We examined the association of parental cardiovascular disease with 8-year risk of offspring cardiovascular disease, using pooled logistic regression. Results Among 2302 men and women (mean age, 44 years), 164 men and 79 women had cardiovascular events during follow-up. Compared with participants with no parental cardiovascular disease, those with at least 1 parent with premature cardiovascular disease (onset age <55 years in father, <65 years in mother) had greater risk for events, with age-adjusted odds ratios of 2.6 (95% confidence interval [CI], 1.7-4.1) for men and 2.3 (95% CI, 1.3-4.3) for women. Multivariable adjustment resulted in odds ratios of 2.0 (95% CI, 1.2-3.1) for men and 1.7 (95% CI, 0.9-3.1) for women. Nonpremature parental cardiovascular disease and parental coronary disease were weaker predictors. Addition of parental information aided in discriminating event rates, notably among offspring with intermediate levels of cholesterol and blood pressure, as well as intermediate predicted multivariable risk. Conclusions Using validated events, we found that parental cardiovascular disease independently predicted future offspring events in middle-aged adults. Addition of parental information may help clinicians and patients with primary prevention of cardiovascular disease, when treatment decisions may be difficult in patients at intermediate risk based on levels of single or multiple risk factors. These data also support further research into genetic determinants of cardiovascular risk.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL USA; Northwestern Univ, Dept Prevent Med, Chicago, IL USA; Boston Univ, Dept Epidemiol & Prevent Med, Stat & Consulting Unit, Boston, MA 02215 USA; Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Northwestern University; Feinberg School of Medicine; Northwestern University; Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	O'Donnell, CJ (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	codonnell@nih.gov	Wilson, Peter W.F./J-2455-2016; Levy, Daniel/ABB-2752-2021; Lloyd-Jones, Donald M/C-5899-2009; Levy, Daniel/ABF-6873-2021	Levy, Daniel/0000-0003-1843-8724; Murabito, Joanne/0000-0002-0192-7516; Lloyd-Jones, Donald/0000-0003-0847-6110	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004253] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott RD, 1987, FRAMINGHAM STUDY EPI; Allen JK, 1998, AM HEART J, V135, P428, DOI 10.1016/S0002-8703(98)70318-7; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; Becker DM, 1998, AM J CARDIOL, V82, P1046, DOI 10.1016/S0002-9149(98)00553-0; Bensen JT, 1999, GENET EPIDEMIOL, V16, P165, DOI 10.1002/(SICI)1098-2272(1999)16:2<165::AID-GEPI4>3.0.CO;2-H; Bensen JT, 1999, GENET EPIDEMIOL, V17, P141, DOI 10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q; Blumenthal RS, 2003, CIRCULATION, V107, P702, DOI 10.1161/01.CIR.0000048127.93169.88; Califf RM, 1996, J AM COLL CARDIOL, V27, P1007, DOI 10.1016/0735-1097(96)87733-3; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clarkson P, 1997, CIRCULATION, V96, P3378; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; COLDITZ GA, 1991, AM J CARDIOL, V67, P933, DOI 10.1016/0002-9149(91)90163-F; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; De Backer G, 1999, J CARDIOVASC RISK, V6, P183; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; FRIEDLANDER Y, 1985, BRIT HEART J, V53, P382; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jousilahti P, 1996, J CLIN EPIDEMIOL, V49, P497, DOI 10.1016/0895-4356(95)00581-1; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; KHAW KT, 1986, AM J EPIDEMIOL, V123, P59, DOI 10.1093/oxfordjournals.aje.a114224; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Leander K, 2001, EPIDEMIOLOGY, V12, P215, DOI 10.1097/00001648-200103000-00014; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Margaglione M, 2000, ARTERIOSCL THROM VAS, V20, P198, DOI 10.1161/01.ATV.20.1.198; Mills JD, 2002, ARTERIOSCL THROM VAS, V22, P704, DOI 10.1161/hq0402.105902; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K; Pankow JS, 1997, THROMB HAEMOSTASIS, V77, P87; PHILLIPS AN, 1988, EUR HEART J, V9, P243, DOI 10.1093/oxfordjournals.eurheartj.a062492; Pohjola-Sintonen S, 1998, EUR HEART J, V19, P235, DOI 10.1053/euhj.1997.0543; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; RONCAGLIONI MC, 1992, CIRCULATION, V85, P2065, DOI 10.1161/01.CIR.85.6.2065; Sdringola S, 2001, CIRCULATION, V103, P496, DOI 10.1161/01.CIR.103.4.496; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; SHOLTZ RI, 1975, AM J EPIDEMIOL, V102, P350, DOI 10.1093/oxfordjournals.aje.a112171; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1123; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; THELLE DS, 1979, AM J EPIDEMIOL, V110, P708, DOI 10.1093/oxfordjournals.aje.a112851; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Wang TJ, 2003, CIRCULATION, V108, P572, DOI 10.1161/01.CIR.0000081764.35431.DE; Watt G, 2000, J EPIDEMIOL COMMUN H, V54, P859, DOI 10.1136/jech.54.11.859; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	51	490	506	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2004	291	18					2204	2211		10.1001/jama.291.18.2204	http://dx.doi.org/10.1001/jama.291.18.2204			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GR	15138242	Bronze			2022-12-01	WOS:000221303500022
J	Ozaki, K; Inoue, K; Sato, H; Iida, A; Ohnishi, Y; Sekine, A; Sato, H; Odashiro, K; Nobuyoshi, M; Hori, M; Nakamura, Y; Tanaka, T				Ozaki, K; Inoue, K; Sato, H; Iida, A; Ohnishi, Y; Sekine, A; Sato, H; Odashiro, K; Nobuyoshi, M; Hori, M; Nakamura, Y; Tanaka, T			Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro	NATURE			English	Article							GENE; ATHEROSCLEROSIS; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; MECHANISMS; DISEASE; SNPS	Myocardial infarction (MI) has become one of the leading causes of death in the world. Its pathogenesis includes chronic formation of plaque inside the vessel wall of the coronary artery and acute rupture of the artery, implicating a number of inflammation-mediating molecules, such as the cytokine lymphotoxin-alpha (LTA)(1). Functional variations in LTA are associated with susceptibility to MI2. Here we show that LTA protein binds to galectin-2, a member of the galactose-binding lectin family(3). Our case - control association study in a Japanese population showed that a single nucleotide polymorphism in LGALS2 encoding galectin-2 is significantly associated with susceptibility to MI. This genetic substitution affects the transcriptional level of galectin-2 in vitro, potentially leading to altered secretion of LTA, which would then affect the degree of inflammation; however, its relevance to other populations remains to be clarified. Smooth muscle cells and macrophages in the human atherosclerotic lesions expressed both galectin-2 and LTA. Our findings thus suggest a link between the LTA cascade and the pathogenesis of MI.	RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Cardiovasc Dis, Tokyo 1088639, Japan; Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka 8028555, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan	RIKEN; Kokura Memorial Hospital; Osaka University; RIKEN; University of Tokyo	Tanaka, T (corresponding author), RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Cardiovasc Dis, Tokyo 1088639, Japan.	toshitan@ims.u-tokyo.ac.jp	Iida, Aritoshi/CAA-1373-2022; Tanaka, Toshihiro/J-9310-2014	Iida, Aritoshi/0000-0001-7538-1651; Tanaka, Toshihiro/0000-0001-6201-9784; Odashiro, Keita/0000-0003-0347-6330; Ozaki, Kouichi/0000-0003-0028-1570				den Dunnen JT, 2000, HUM MUTAT, V15, P7; GITT MA, 1992, J BIOL CHEM, V267, P10601; Iida A, 2001, J HUM GENET, V46, P668, DOI 10.1007/s100380170019; Liu LB, 2003, J BIOL CHEM, V278, P30157, DOI 10.1074/jbc.M301511200; Minami M, 2001, ARTERIOSCL THROM VAS, V21, P1796, DOI 10.1161/hq1001.096652; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Subramanian VS, 2003, J BIOL CHEM, V278, P3976, DOI 10.1074/jbc.M210717200; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789	13	189	200	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					72	75		10.1038/nature02502	http://dx.doi.org/10.1038/nature02502			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129282	Bronze			2022-12-01	WOS:000221222100046
J	Reissman, DB; Whitney, EAS; Taylor, TH; Hayslett, JA; Dull, PM; Arias, I; Ashford, DA; Bresnitz, EA; Tan, C; Rosenstein, N; Perkins, BA				Reissman, DB; Whitney, EAS; Taylor, TH; Hayslett, JA; Dull, PM; Arias, I; Ashford, DA; Bresnitz, EA; Tan, C; Rosenstein, N; Perkins, BA			One-year health assessment of adult survivors of Bacillus anthracis infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; SOMATIC SYMPTOMS; LYME-DISEASE; PREVALENCE	Context Little is known about potential long-term health effects of bioterrorism-related Bacillus anthracis infection. Objective To describe the relationship between anthrax infection and persistent somatic symptoms among adults surviving bioterrorism-related anthrax disease approximately 1 year after illness onset in 2001. Design, Setting, and Participants Cross-sectional study of 15 of 16 adult survivors from September through December 2002 using a clinical interview, a medical review-of-system questionnaire, 2 standardized self-administered questionnaires, and a review of available medical records. Main Outcome Measures Health complaints summarized by the body system affected and by symptom categories; psychological distress measured by the Revised 90-Item Symptom Checklist; and health-related quality-of-life indices by the Medical Outcomes Study 36-Item Short-Form Health Survey (version 2). Results The anthrax survivors reported symptoms affecting multiple body systems, significantly greater overall psychological distress (P<.001), and significantly reduced health-related quality-of-life indices compared with US referent populations. Eight survivors (53%) had not returned to work since their infection. Comparing disease manifestations, inhalational survivors reported significantly lower overall physical health than cutaneous survivors (mean scores, 30 vs 41; P = .02). Available medical records could not explain the persisting health complaints. Conclusion The anthrax survivors continued to report significant health problems and poor life adjustment 1 year after onset of bioterrorism-related anthrax disease.	CDCP, Off Director, Atlanta, GA 30341 USA; CDCP, Epidemiol & Surveillance Branch, Atlanta, GA 30341 USA; CDCP, Epidemiol & Surveillance Branch, Atlanta, GA 30341 USA; CDCP, Div Violence Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; CDCP, Bioterrorism Preparedness & Response Program, Off Director, Natl Ctr Infect Dis, Atlanta, GA 30341 USA; CDCP, Meningitis & Special Pathogens Branch, Atlanta, GA 30341 USA; CDCP, Biostat Informat Branch, Atlanta, GA 30341 USA; CDCP, Div Bacterial & Mycot Dis,Natl Ctr Infect Dis, Epidem Intelligence Serv Program, Div Appl Publ Hlth Training,Epidemiol Program Off, Atlanta, GA 30341 USA; New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; New Jersey Department of Health & Senior Services	Reissman, DB (corresponding author), CDCP, Off Director, 4770 Buford Hwy NE,Mailstop K68, Atlanta, GA 30341 USA.	DReissman@cdc.gov						Bales ME, 2002, EMERG INFECT DIS, V8, P1163, DOI 10.3201/eid0810.020223; Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; Bromet EJ, 2002, ENVIRON HEALTH PERSP, V110, P625, DOI 10.1289/ehp.02110s4625; Derogatis L.R., 1994, SCL 90 R SYMPTOM CHE; ENGEL CC, 2003, TRAUMA HLTH PHYS HLT, P191; ESCOBAR JI, 1992, AM J PSYCHIAT, V149, P965; FALLON BA, 1994, AM J PSYCHIAT, V151, P1571, DOI 10.1176/ajp.151.11.1571; Friedman Matthew J., 1995, P507; Hall Molly J, 2003, Biosecur Bioterror, V1, P139, DOI 10.1089/153871303766275817; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; Lettinga KD, 2002, CLIN INFECT DIS, V35, P11, DOI 10.1086/340738; McCarroll JE, 2002, PSYCHOSOM MED, V64, P29, DOI 10.1097/00006842-200201000-00005; Miller TR, 1994, CRIME US VICTIM COST; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Pfefferbaum B, 2001, Public Health Rev, V29, P271; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Ware JE, 2000, SF 36 HLTH SURVEY MA	21	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1994	1998		10.1001/jama.291.16.1994	http://dx.doi.org/10.1001/jama.291.16.1994			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113818	Bronze			2022-12-01	WOS:000221062000031
J	Yaziji, H; Goldstein, LC; Barry, TS; Werling, R; Hwang, H; Ellis, GK; Gralow, JR; Livingston, RB; Gown, AM				Yaziji, H; Goldstein, LC; Barry, TS; Werling, R; Hwang, H; Ellis, GK; Gralow, JR; Livingston, RB; Gown, AM			HER-2 testing in breast cancer using parallel tissue-based methods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-SITU HYBRIDIZATION; SURGICAL ADJUVANT BREAST; UNITED-STATES FOOD; GENE AMPLIFICATION; TRASTUZUMAB THERAPY; MONOCLONAL-ANTIBODY; BOWEL PROJECT; IMMUNOHISTOCHEMISTRY; OVEREXPRESSION; CARCINOMA	Context Testing for HER-2 oncogene in breast cancer has increased because of its role as a prognostic and predictive factor. Some advocate gene testing by fluorescence in situ hybridization (FISH) vs protein testing by immunohistochemistry as the method which most accurately evaluates and predicts response to the anti-HER-2 antibody, trastuzumab. However, critical examination of FISH on a screening basis has yet to be performed. Objectives To determine the correlation between FISH and immunohistochemistry results by determining HER-2/neu gene status on tumor sections with indeterminate immunohistochemistry results (2+ score), confirm gene amplification on tumor sections with positive results (3+ score), and verify gene status on tumor sections with negative results (0 or 1 + score). Design, Setting, and Patients A quality control and quality assurance program for HER-2 testing by FISH, which used tumor specimens from 2963 patients (median age, 56 years) with breast cancer received from 135 hospitals and cancer centers in 29 states, was performed at a reference laboratory from January 1, 1999, to May 15, 2003. Every specimen evaluated by FISH was parallel tested with immunohistochemistry tests. Main Outcome Measures With FISH as the presumed standard testing method, the positive and negative predictive values and sensitivity and specificity of immunohistochemistry were calculated. Results A total of 3260 clinical HER-2 tests by FISH were performed on 2963 serially referred breast cancer specimens. Of these, 2933 tests were successful and 2913 breast cancer specimens had both FISH and immunohistochemistry results available. With FISH as the standard testing method, the positive predictive value of positive immunohistochemistry score (3+) was 91.6%, and the negative predictive value of negative immunohistochemistry score (0 or 1+) was 97.2%. The sensitivity of immunohistochemistry tests, including tumor sections with scores of 2+ or 3+, was 92.6% and the specificity of immunohistochemistry tests with scores of 3+ was 98.8%. The FISH test had a significantly higher failure rate (5% vs 0.08%) and reagent cost ($140 vs $10), and longer testing (36 hours vs 4 hours) and interpretation times (7 minutes vs 45 seconds) vs immunohistochemistry tests. Conclusions A testing algorithm for HER-2 determination is most efficient by using immunohistochemistry as the method of choice, with FISH performed for cancers with indeterminate results (2+ score). Successful quality control and quality assurance programs are a prerequisite for such approaches.	Phenopath Labs, Seattle, WA 98103 USA; Univ Washington, Sch Med, Div Med Oncol, Seattle, WA USA	PhenoPath Laboratories; University of Washington; University of Washington Seattle	Gown, AM (corresponding author), Phenopath Labs, 551 N 34th St,Suite 100, Seattle, WA 98103 USA.	gown@phenopath.com						Ambros IM, 2003, J CLIN ONCOL, V21, P2077, DOI 10.1200/JCO.2003.03.025; Baselga J, 1999, SEMIN ONCOL, V26, P78; Bilous M, 2003, MODERN PATHOL, V16, P173, DOI 10.1097/01.MP.0000052102.90815.82; Birner P, 2001, CLIN CANCER RES, V7, P1669; Cianciulli AM, 2002, CANCER GENET CYTOGEN, V133, P66, DOI 10.1016/S0165-4608(01)00559-3; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Couturier J, 2000, MODERN PATHOL, V13, P1238, DOI 10.1038/modpathol.3880228; *CTR BIOL EV RES, 2001, HER 2 NEU BRIEFING D; Field AS, 2001, PATHOLOGY, V33, P278; Fornier M, 2002, ONCOLOGY-NY, V16, P1340; FORNIER M, 2002, ONCOLOGY, V16, P1351; Hanna WM, 2001, MODERN PATHOL, V14, P677, DOI 10.1038/modpathol.3880372; Jacobs TW, 1999, J CLIN ONCOL, V17, P1974, DOI 10.1200/JCO.1999.17.7.1974; Jacobs TW, 1999, J CLIN ONCOL, V17, P1983, DOI 10.1200/JCO.1999.17.7.1983; Kakar S, 2000, MOL DIAGN, V5, P199, DOI 10.2165/00066982-200005030-00006; Larsimont D, 2002, ANTICANCER RES, V22, P2485; Lebeau A, 2001, J CLIN ONCOL, V19, P354, DOI 10.1200/JCO.2001.19.2.354; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; Onody P, 2001, ARCH PATHOL LAB MED, V125, P746; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; PAIK S, 2002, SAN ANT BREAST CANC; Paik SM, 1998, JNCI-J NATL CANCER I, V90, P1361, DOI 10.1093/jnci/90.18.1361; Pauletti G, 2000, J CLIN ONCOL, V18, P3651, DOI 10.1200/JCO.2000.18.21.3651; Pauletti G, 1996, ONCOGENE, V13, P63; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Ridolfi RL, 2000, MODERN PATHOL, V13, P866, DOI 10.1038/modpathol.3880154; Roche PC, 2002, JNCI-J NATL CANCER I, V94, P855, DOI 10.1093/jnci/94.11.855; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; Sjogren S, 1998, J CLIN ONCOL, V16, P462; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; Tsuda H, 2001, PATHOL INT, V51, P26, DOI 10.1046/j.1440-1827.2001.01163.x; Tubbs RR, 2001, J CLIN ONCOL, V19, P2714, DOI 10.1200/JCO.2001.19.10.2714; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; YARDLEY DA, 2002, ANN M AM SOC CLIN ON	40	350	374	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1972	1977		10.1001/jama.291.16.1972	http://dx.doi.org/10.1001/jama.291.16.1972			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113815	Bronze			2022-12-01	WOS:000221062000028
J	Ren, SJ; Rollins, BJ				Ren, SJ; Rollins, BJ			Cyclin C/Cdk3 promotes Rb-dependent G0 exit	CELL			English	Article							RNA-POLYMERASE-II; CELL-CYCLE REENTRY; RETINOBLASTOMA PROTEIN; KINASE PARTNER; E2F FAMILY; C-MYC; PHOSPHORYLATION; G1; YEAST; P130	G0 is a physiological state occupied by resting or terminally differentiated cells that have exited the cell cycle. In contrast to the well-characterized cyclin/cdk-mediated inactivation of pRb that controls the G1/S transition, little is known about regulation of the G0/G1 transition. However, pRb is likely to participate in this process because its acute somatic inactivation is sufficient for G0-arrested cells to reenter the cell cycle. One physiological regulator of this event may be cyclin C because its highest mRNA levels occur during G0 exit. Here we show that a non-cdk8-associated cellular pool of cyclin C combines with cdk3 to stimulate pRb phosphorylation at S807/811 during the G0/G1 transition, and that this phosphorylation is required for cells to exit G0 efficiently. Thus, G1 entry is regulated in an analogous fashion to S phase entry, but involves a distinct cyclin/cdk combination.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rollins, BJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.	barrett_rollins@dfci.harvard.edu			NCI NIH HHS [CA72573] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072573] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Brantey MA, 2000, CANCER RES, V60, P4320; Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DARZYNKIEWICZ Z, 1990, FLOW CYTOMETRY SORTI, P469; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Farkas T, 2002, J BIOL CHEM, V277, P26741, DOI 10.1074/jbc.M200381200; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; KUCHIN S, 1995, P NATL ACAD SCI USA, V92, P4006, DOI 10.1073/pnas.92.9.4006; Ladd AC, 1997, BLOOD, V90, P658, DOI 10.1182/blood.V90.2.658.658_658_668; LAJTHA LG, 1963, J CELL COMPAR PHYSL, V62, P143; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; LEOPOLD P, 1991, CELL, V66, P1207, DOI 10.1016/0092-8674(91)90043-X; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Liu ZJ, 1998, BLOOD, V92, P4700; Liu ZJ, 1998, MOL CELL BIOL, V18, P3445, DOI 10.1128/MCB.18.6.3445; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Mayol X, 1996, ONCOGENE, V13, P237; MAYOL X, 1995, ONCOGENE, V11, P801; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Moberg K, 1996, MOL CELL BIOL, V16, P1436; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Rickert P, 1996, ONCOGENE, V12, P2631; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Sherr CJ, 2000, CANCER RES, V60, P3689; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918	48	216	228	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					239	251		10.1016/S0092-8674(04)00300-9	http://dx.doi.org/10.1016/S0092-8674(04)00300-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084261	Bronze			2022-12-01	WOS:000220913400011
J	Steffan, JS; Agrawal, N; Pallos, J; Rockabrand, E; Trotman, LC; Slepko, N; Illes, K; Lukacsovich, T; Zhu, YZ; Cattaneo, E; Pandolfi, PP; Thompson, LM; Marsh, JL				Steffan, JS; Agrawal, N; Pallos, J; Rockabrand, E; Trotman, LC; Slepko, N; Illes, K; Lukacsovich, T; Zhu, YZ; Cattaneo, E; Pandolfi, PP; Thompson, LM; Marsh, JL			SUMO modification of Huntingtin and Huntington's disease pathology	SCIENCE			English	Article							INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE AGGREGATION; NUCLEAR INCLUSIONS; UBIQUITIN; PROTEIN; LOCALIZATION; DROSOPHILA; NEURODEGENERATION; PATHOGENESIS; INTERACTS	Huntington's disease (HD) is characterized by the accumulation of a pathogenic protein, Huntingtin (Htt), that contains an abnormal polyglutamine expansion. Here, we report that a pathogenic fragment of Htt (Httex1p) can be modified either by small ubiquitin-like modifier (SUMO)-1 or by ubiquitin on identical lysine residues. In cultured cells, SUMOylation stabilizes Httex1p, reduces its ability to form aggregates, and promotes its capacity to repress transcription. In a Drosophila model of HD, SUMOylation of Httex1p exacerbates neurodegeneration, whereas ubiquitination of Httex1p abrogates neurodegeneration. Lysine mutations that prevent both SUMOylation and ubiquitination of Httex1p reduce HD pathology, indicating that the contribution of SUMOylation to HD pathology extends beyond preventing Htt ubiquitination and degradation.	Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Milan; University of California System; University of California Irvine	Marsh, JL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 4444 McGaugh Hall, Irvine, CA 92697 USA.	jlmarsh@uci.edu	Pallos, Judit/AAE-6833-2020	CATTANEO, ELENA/0000-0002-0755-4917; , Namita/0000-0002-9459-385X	NCI NIH HHS [CA-62203] Funding Source: Medline; NICHD NIH HHS [HD36049, HD36081] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036049, R01HD036081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazantsev A, 2002, NAT GENET, V30, P367, DOI 10.1038/ng864; Li YH, 2003, P NATL ACAD SCI USA, V100, P9102, DOI 10.1073/pnas.1533062100; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Luthi-Carter R, 2003, CLIN NEUROSCI RES, V3, P165, DOI 10.1016/S1566-2772(03)00059-8; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Pountney DL, 2003, EXP NEUROL, V184, P436, DOI 10.1016/j.expneurol.2003.07.004; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Steffan JS, 2003, EXPERT OPIN THER TAR, V7, P201, DOI 10.1517/14728222.7.2.201; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Terashima T, 2002, NEUROREPORT, V13, P2359, DOI 10.1097/00001756-200212030-00038; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Ueda H, 2002, BIOCHEM BIOPH RES CO, V293, P307, DOI 10.1016/S0006-291X(02)00211-5; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	43	526	549	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					100	104		10.1126/science.1092194	http://dx.doi.org/10.1126/science.1092194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15064418	Green Submitted			2022-12-01	WOS:000220567900046
J	Lipton, SA				Lipton, SA			Turning down, but not off	NATURE			English	Editorial Material							MEMANTINE		Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA.			Lipton, Stuart/0000-0002-3490-1259				CHEN HSV, 1992, J NEUROSCI, V12, P4427; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 2004, CELL DEATH DIFFER, V11, P18, DOI 10.1038/sj.cdd.4401344; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128	4	56	59	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2004	428	6982					473	473		10.1038/428473a	http://dx.doi.org/10.1038/428473a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15057811				2022-12-01	WOS:000220540100021
J	Shulenin, S; Nogee, LM; Annilo, T; Wert, SE; Whitsett, JA; Dean, M				Shulenin, S; Nogee, LM; Annilo, T; Wert, SE; Whitsett, JA; Dean, M			ABCA3 gene mutations in newborns with fatal surfactant deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CASSETTE TRANSPORTER 1; PROTEIN-B DEFICIENCY; TANGIER-DISEASE; STARGARDT-DISEASE; MEMBRANE-PROTEIN; II CELLS; ACCUMULATION; LUNG; SITOSTEROLEMIA; DYSTROPHY	BACKGROUND: Pulmonary surfactant forms a lipid-rich monolayer that coats the airways of the lung and is essential for proper inflation and function of the lung. Surfactant is produced by alveolar type II cells, stored intracellularly in organelles known as lamellar bodies, and secreted by exocytosis. The gene for ATP-binding cassette transporter A3 (ABCA3) is expressed in alveolar type II cells, and the protein is localized to lamellar bodies, suggesting that it has an important role in surfactant metabolism. METHODS: We sequenced each of the coding exons of the ABCA3 gene in blood DNA from 21 racially and ethnically diverse infants with severe neonatal surfactant deficiency for which the etiologic process was unknown. Lung tissue from four patients was examined by high-resolution light and electron microscopy. RESULTS: Nonsense and frameshift mutations, as well as mutations in highly conserved residues and in splice sites of the ABCA3 gene were identified in 16 of the 21 patients (76 percent). In five consanguineous families with mutations, each pair of siblings was homozygous for the same mutation and each mutation was found in only one family. Markedly abnormal lamellar bodies were observed by ultrastructural examination of lung tissue from four patients with different ABCA3 mutations, including nonsense, splice-site, and missense mutations. CONCLUSIONS: Mutation of the ABCA3 gene causes fatal surfactant deficiency in newborns. ABCA3 is critical for the proper formation of lamellar bodies and surfactant function and may also be important for lung function in other pulmonary diseases. Since it is closely related to ABCA1 and ABCA4, proteins that transport phospholipids in macrophages and photoreceptor cells, it may have a role in surfactant phospholipid metabolism.	NCI, Human Genet Sect, Lab Genom Divers, Frederick, MD 21702 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Dean, M (corresponding author), NCI, Human Genet Sect, Lab Genom Divers, Bldg 560,Rm 21-18, Frederick, MD 21702 USA.	dean@ncifcrf.gov	Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Annilo, Tarmo/J-2900-2013	Dean, Michael C/0000-0003-2234-0631; Annilo, Tarmo/0000-0002-9588-3058	NATIONAL CANCER INSTITUTE [Z01BC005725, ZIABC005725] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054703, R29HL054703, P01HL056387, P50HL056387] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54703, HL-56387] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Connors TD, 1997, GENOMICS, V39, P231, DOI 10.1006/geno.1996.4500; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DEMELLO DE, 1994, AM J RESP CELL MOL, V11, P230, DOI 10.1165/ajrcmb.11.2.8049084; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Na C.-L, 1998, Microscopy and Microanalysis, V4, P852, DOI 10.1017/S1431927600024387; Nogee LM, 2000, AM J RESP CRIT CARE, V161, P973, DOI 10.1164/ajrccm.161.3.9903153; Nogee LM, 1997, CHEST, V111, pS129, DOI 10.1378/chest.111.6_Supplement.129S-a; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tredano M, 2003, AM J MED GENET A, V119A, P324, DOI 10.1002/ajmg.a.20058; Tryka AF, 2000, PEDIATR DEVEL PATHOL, V3, P335, DOI 10.1007/s100249910048; Wood PG, 2000, AM J PHYSIOL-REG I, V278, pR611, DOI 10.1152/ajpregu.2000.278.3.R611; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	26	460	488	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2004	350	13					1296	1303		10.1056/NEJMoa032178	http://dx.doi.org/10.1056/NEJMoa032178			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805VN	15044640				2022-12-01	WOS:000220393900007
J	Jeri, C; Gilman, RH; Lescano, AG; Mayta, H; Ramirez, ME; Gonzalez, AE; Nazerali, R; Garcia, HH				Jeri, C; Gilman, RH; Lescano, AG; Mayta, H; Ramirez, ME; Gonzalez, AE; Nazerali, R; Garcia, HH			Species identification after treatment for human taeniasis	LANCET			English	Article							SOLIUM; INFECTIONS	Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0.0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.	Inst Ciencias Neurol, Cysticercosis Unit, Lima 1, Peru; Univ Peruana Cayetano Heredia San Martin de Porra, Sch Sci, Dept Microbiol, Lima, Peru; Univ Peruana Cayetano Heredia San Martin de Porra, Sch Publ Hlth & Adm, Lima, Peru; Asociac Benefica PRISMA, Lima, Peru; Naval Med Res Ctr Detachment, Global Emerging Infect Syst, Lima, Peru; Univ Nacl Mayor San Marcos, Sch Vet Med, Lima 14, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos	Garcia, HH (corresponding author), Inst Ciencias Neurol, Cysticercosis Unit, Jiron Ancash 1271,Barrios Altos, Lima 1, Peru.	hgarcia@jhsph.edu	Mayta, Holger/ABA-4755-2020; Lescano, Andres G./M-9849-2019; Lescano, Andres G/B-8479-2008	Mayta, Holger/0000-0001-5306-628X; Lescano, Andres G./0000-0001-9779-633X; Lescano, Andres G/0000-0001-9779-633X; Gonzalez, Armando/0000-0003-1909-1873; Jeri, Cesar/0000-0002-3368-4918	NIAID NIH HHS [P01 AI51976, U01 AI35894] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051976, U01AI035894] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Mayta H, 2000, J CLIN MICROBIOL, V38, P133; PEARSON RD, 1985, ANN INTERN MED, V102, P550, DOI 10.7326/0003-4819-102-4-550; Sanchez AL, 1997, ANN TROP MED PARASIT, V91, P163, DOI 10.1080/00034983.1997.11813126	5	48	50	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2004	363	9413					949	950		10.1016/S0140-6736(04)15791-7	http://dx.doi.org/10.1016/S0140-6736(04)15791-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804OS	15043964				2022-12-01	WOS:000220308600013
J	Johnson, SJ; Beese, LS				Johnson, SJ; Beese, LS			Structures of mismatch replication errors observed in a DNA polymerase	CELL			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; NUCLEOTIDE INCORPORATION; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; TERNARY COMPLEXES; TEMPLATE-PRIMERS; ALPHA HOLOENZYME; BASE-PAIRS; FIDELITY	Accurate DNA replication is essential for genomic stability. One mechanism by which high-fidelity DNA polymerases maintain replication accuracy involves stalling of the polymerase in response to covalent incorporation of mismatched base pairs, thereby favoring subsequent mismatch excision. Some polymerases retain a "short-term memory" of replication errors, responding to mismatches up to four base pairs in from the primer terminus. Here we a present a structural characterization of all 12 possible mismatches captured at the growing primer terminus in the active site of a polymerase. Our observations suggest four mechanisms that lead to mismatch-induced stalling of the polymerase. Furthermore, we have observed the effects of extending a mismatch up to six base pairs from the primer terminus and find that long-range distortions in the DNA transmit the presence of the mismatch back to the enzyme active site, suggesting the structural basis for the short-term memory of replication errors.	Duke Univ, Ctr Med, Dept Biochem, Durham, NC 27710 USA	Duke University	Beese, LS (corresponding author), Duke Univ, Ctr Med, Dept Biochem, Durham, NC 27710 USA.	lsb@biochem.duke.edu	Johnson, Sean/G-8191-2012; beese, lorena/G-4993-2010; Classen, Scott/AAY-8176-2020	Johnson, Sean/0000-0001-7992-2494; 	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA92584] Funding Source: Medline; NCRR NIH HHS [RR07707] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BAEYENS KJ, 1995, NAT STRUCT BIOL, V2, P56, DOI 10.1038/nsb0195-56; BECKMAN RA, 1993, Q REV BIOPHYS, V26, P225, DOI 10.1017/S0033583500002869; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; CARVER TE, 1994, P NATL ACAD SCI USA, V91, P10670, DOI 10.1073/pnas.91.22.10670; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; HUNTER WN, 1986, NATURE, V320, P552, DOI 10.1038/320552a0; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; JOYCE CM, 1992, J BIOL CHEM, V267, P24485; JOYCE CM, 1989, J BIOL CHEM, V264, P10858; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.biochem.63.1.777; KENNARD O, 1989, Q REV BIOPHYS, V22, P327, DOI 10.1017/S0033583500002997; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; NG L, 1989, J BIOL CHEM, V264, P13018; PATEL DJ, 1987, CONFORMATION DNA BAS; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PERRINO FW, 1989, P NATL ACAD SCI USA, V86, P3085, DOI 10.1073/pnas.86.9.3085; Saenger W., 1989, J MOL BIOL, V205, P787; SKELLY JV, 1993, P NATL ACAD SCI USA, V90, P804, DOI 10.1073/pnas.90.3.804; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; WEISS SJ, 1992, J BIOL CHEM, V267, P18520; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	39	240	242	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					803	816		10.1016/S0092-8674(04)00252-1	http://dx.doi.org/10.1016/S0092-8674(04)00252-1			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035983	Bronze			2022-12-01	WOS:000221499900007
J	Hsu, LC; Park, JM; Zhang, KZ; Luo, JL; Maeda, S; Kaufman, RJ; Eckmann, L; Guiney, DG; Karin, M				Hsu, LC; Park, JM; Zhang, KZ; Luo, JL; Maeda, S; Kaufman, RJ; Eckmann, L; Guiney, DG; Karin, M			The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4	NATURE			English	Article							TOLL-LIKE RECEPTORS; IKK-BETA; MICE; INTERFERONS; DISRUPTION; INDUCTION; INFECTION; IRF-3	Macrophages are pivotal constituents of the innate immune system, vital for recognition and elimination of microbial pathogens(1). Macrophages use Toll-like receptors (TLRs) to detect pathogen-associated molecular patterns - including bacterial cell wall components, such as lipopolysaccharide or lipoteichoic acid, and viral nucleic acids, such as double-stranded (ds) RNA and in turn activate effector functions, including anti-apoptotic signalling pathways(2). Certain pathogens, however, such as Salmonella spp., Shigellae spp. and Yersiniae spp., use specialized virulence factors to overcome these protective responses and induce macrophage apoptosis(3). We found that the anthrax bacterium, Bacillus anthracis, selectively induces apoptosis of activated macrophages(4) through its lethal toxin, which prevents activation of the anti-apoptotic p38 mitogen-activated protein kinase(4). We now demonstrate that macrophage apoptosis by three different bacterial pathogens depends on activation of TLR4. Dissection of anti- and pro-apoptotic signalling events triggered by TLR4 identified the dsRNA responsive protein kinase PKR as a critical mediator of pathogen-induced macrophage apoptosis. The pro-apoptotic actions of PKR are mediated both through inhibition of protein synthesis and activation of interferon response factor 3.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Michigan, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Luo, Jun-Li/0000-0002-7625-4766; Zhang, Kezhong/0000-0002-6062-235X; Hsu, Li-Chung/0000-0001-7206-5231				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Durbin RK, 2002, VIRAL IMMUNOL, V15, P41, DOI 10.1089/088282402317340224; Heylbroeck C, 2000, J VIROL, V74, P3781, DOI 10.1128/JVI.74.8.3781-3792.2000; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lehner M, 2001, BLOOD, V98, P736, DOI 10.1182/blood.V98.3.736; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003	30	301	320	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					341	345		10.1038/nature02405	http://dx.doi.org/10.1038/nature02405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029200	Green Published			2022-12-01	WOS:000220250200049
J	Nishibayashi, Y; Saito, M; Uemura, S; Takekuma, S; Takekuma, H; Yoshida, Z				Nishibayashi, Y; Saito, M; Uemura, S; Takekuma, S; Takekuma, H; Yoshida, Z			Buckminsterfullerenes - A non-metal system for nitrogen fixation	NATURE			English	Editorial Material							DINITROGEN; REDUCTION; AMMONIA; C-60		Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Sakyo Ku, Kyoto, Japan; Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Osaka 5778502, Japan	Kyoto University; Kindai University (Kinki University)	Nishibayashi, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Sakyo Ku, Kyoto, Japan.	uemura@scl.kyoto-u.ac.jp	Nishibayashi, Yoshiaki/E-9230-2010	Nishibayashi, Yoshiaki/0000-0001-9739-9588				Appl, 1999, AMMONIA; CHATT J, 1975, NATURE, V253, P39, DOI 10.1038/253039b0; Guldi DM, 2000, ACCOUNTS CHEM RES, V33, P695, DOI 10.1021/ar990144m; Nishibayashi Y, 1998, SCIENCE, V279, P540, DOI 10.1126/science.279.5350.540; Postgate J., 1998, NITROGEN FIXATION; Solari E, 2001, ANGEW CHEM INT EDIT, V40, P3907, DOI 10.1002/1521-3773(20011015)40:20<3907::AID-ANIE3907>3.0.CO;2-#; Takekuma S, 2000, TETRAHEDRON LETT, V41, P2929, DOI 10.1016/S0040-4039(00)00312-9; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326; YOSHIDA ZI, 1994, ANGEW CHEM INT EDIT, V33, P1597, DOI 10.1002/anie.199415971	9	98	105	4	102	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					279	280		10.1038/428279b	http://dx.doi.org/10.1038/428279b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	803SG	15029186				2022-12-01	WOS:000220250200031
J	Whitby, EH; Griffiths, PD; Rutter, S; Smith, MF; Sprigg, A; Ohadike, P; Davies, NP; Rigby, AS; Paley, MN				Whitby, EH; Griffiths, PD; Rutter, S; Smith, MF; Sprigg, A; Ohadike, P; Davies, NP; Rigby, AS; Paley, MN			Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors	LANCET			English	Article							INFLICTED HEAD-INJURY; HEMATOMAS; NEUROPATHOLOGY	Background Subdural haematomas are thought to be uncommon in babies born at term. This view is mainly based on findings in symptomatic neonates and babies in whom subdural haemorrhages are detected fortuitously. We aimed to establish the frequency of subdural haemorrhages in asymptomatic term neonates; to study the natural history of such subdural haematomas; and to ascertain which obstetric factors, if any, are associated with presence of subdural haematoma. Methods We did a prospective study in babies who were born in the Jessop wing of the Central Sheffield University Hospitals between March, 2001, and November, 2002. We scanned neonates with a 0.2 T magnetic resonance machine. Findings 111 babies underwent MRI in this study. 49 were born by normal vertex delivery without instrumentation, 25 by caesarean section, four with forceps, 13 ventouse, 18 failed ventouse leading to forceps, one failed ventouse leading to caesarean section, and one failed forceps leading to caesarean section. Nine babies had subdural haemorrhages: three were normal vaginal deliveries (risk 6.1%), five were delivered by forceps after an attempted ventouse delivery (27.8%), and one had a traumatic ventouse delivery (7.7%). All babies with subdural haemorrhage were assessed clinically but no intervention was needed. All were rescanned at 4 weeks and haematomas had completely resolved. Interpretation Presence of unilateral and bilateral subdural haemorrhage is not necessarily indicative of excessive birth trauma.	Univ Sheffield, Sect Acad Radiol, Sheffield, S Yorkshire, England; Sheffield Childrens Hosp, Dept Radiol, Sheffield, S Yorkshire, England; Univ Hull, Dept Cardiol, Kingston Upon Hull, Yorks, England; Cent Sheffield Teaching Hosp, Dept Obstet & Gynaecol, Sheffield, S Yorkshire, England; Cent Sheffield Teaching Hosp, Reg Neonatal Intens Care Unit, Sheffield, S Yorkshire, England	University of Sheffield; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Hull	Whitby, EH (corresponding author), Royal Hallamshire Hosp, MRI Dept, Floor C,Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	e.whitby@sheffield.ac.uk	Whitby, Elspeth/G-5517-2010; Rigby, Alan/AFM-1194-2022	Rigby, Alan/0000-0001-8331-3907; Whitby, Elspeth/0000-0002-8912-8013				BARKOVICH AJ, 2000, PEDIAT NEUROIMAGING, P239; Breningstall GN, 2000, PEDIATR RADIOL, V30, P630, DOI 10.1007/s002470000256; BROOKS RA, 1989, J COMPUT ASSIST TOMO, V13, P194, DOI 10.1097/00004728-198903000-00002; Chamnanvanakij S, 2002, PEDIATR NEUROL, V26, P301, DOI 10.1016/S0887-8994(01)00420-9; Doward W, 2001, PEDIATR NEUROSURG, V35, P335, DOI 10.1159/000050448; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Kemp AM, 2002, ARCH DIS CHILD, V86, P98, DOI 10.1136/adc.86.2.98; Pollina J, 2001, PEDIATR NEUROSURG, V35, P113, DOI 10.1159/000050403; Stephens RP, 1997, PEDIATRICS, V99, P619, DOI 10.1542/peds.99.4.619; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Whitby EH, 2003, ARCH DIS CHILD-FETAL, V88, P203	14	200	205	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2004	363	9412					846	851		10.1016/S0140-6736(04)15730-9	http://dx.doi.org/10.1016/S0140-6736(04)15730-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803LB	15031028				2022-12-01	WOS:000220231500009
J	Lahdenpera, M; Lummaa, V; Helle, S; Tremblay, M; Russell, AF				Lahdenpera, M; Lummaa, V; Helle, S; Tremblay, M; Russell, AF			Fitness benefits of prolonged post-reproductive lifespan in women	NATURE			English	Article							EVOLUTIONARY-THEORY; GRANDMOTHERS; SURVIVAL; HELPERS; HISTORY; SUCCESS	Most animals reproduce until they die, but in humans, females can survive long after ceasing reproduction(1,2). In theory, a prolonged post-reproductive lifespan will evolve when can gain greater fitness by increasing the success of their offspring than by continuing to breed themselves(3-6). Although reproductive success is known to decline in old age(1-6), it is unknown whether women gain fitness by prolonging lifespan post-reproduction. Using complete multi-generational demographic records, we show that women with a prolonged post-reproductive lifespan have more grandchildren, and hence greater fitness, in pre-modern populations of both Finns and Canadians. This fitness benefit arises because post-reproductive mothers enhance the lifetime reproductive success of their offspring by allowing them to breed earlier, more frequently and more successfully. Finally, the fitness benefits of prolonged lifespan diminish as the reproductive output of offspring declines. This suggests that in female humans, selection for deferred ageing should wane when one's own offspring become post-reproductive and, correspondingly, we show that rates of female mortality accelerate as their offspring terminate reproduction.	Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Quebec Chicoutimi, Interdisciplinary Res Grp Demog & Genet Epidemiol, Chicoutimi, PQ G7H 2B1, Canada	University of Turku; University of Sheffield; University of Cambridge; University of Quebec; University of Quebec Chicoutimi	Lahdenpera, M (corresponding author), Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland.	mipayl@utu.fi	Lummaa, Virpi/AHB-0181-2022	Russell, Andy/0000-0002-1299-8555; Lahdenpera, Mirkka/0000-0003-0062-6284				BOUCHARD G, 1995, INFORMATION KNOWLEDG, P201; Bouchard Gerard, 1996, QUELQUES ARPENTS AM; BROWN JL, 1982, SCIENCE, V215, P421, DOI 10.1126/science.215.4531.421; Clutton-Brock TH, 2001, SCIENCE, V293, P2446, DOI 10.1126/science.1061274; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; EMLEN ST, 1991, J ANIM ECOL, V60, P309, DOI 10.2307/5462; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Gille H, 1949, POP STUD-J DEMOG, V3, P3, DOI 10.2307/2172491; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Jamison CS, 2002, AM J PHYS ANTHROPOL, V119, P67, DOI 10.1002/ajpa.10070; Karskela S, 2001, SUKUTUTKIJAN TIETOKI; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; Lummaa V, 2003, P ROY SOC B-BIOL SCI, V270, P2355, DOI 10.1098/rspb.2003.2507; Luther G., 1993, SUOMEN TILASTOTOIMEN; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; MORING B, 1993, J FAM HIST, V18, P395, DOI 10.1177/036319909301800407; Russell AF, 2003, BEHAV ECOL, V14, P486, DOI 10.1093/beheco/arg022; SCHALL R, 1991, BIOMETRIKA, V78, P719; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2003, EVOL HUM BEHAV, V24, P25, DOI 10.1016/S1090-5138(02)00105-8; Shanley DP, 2001, BIOESSAYS, V23, P282, DOI 10.1002/1521-1878(200103)23:3<282::AID-BIES1038>3.0.CO;2-9; Soininen AM, 1974, OLD TRADITIONAL AGR; Voland E, 2002, BEHAV ECOL SOCIOBIOL, V52, P435, DOI 10.1007/s00265-002-0539-2; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	29	316	321	2	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					178	181		10.1038/nature02367	http://dx.doi.org/10.1038/nature02367			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014499	Green Accepted			2022-12-01	WOS:000220103600048
J	Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG; Haluska, FG; Louis, DN; Christiani, DC; Settleman, J; Haber, DA				Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG; Haluska, FG; Louis, DN; Christiani, DC; Settleman, J; Haber, DA			Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; PHASE-II TRIAL; EGF RECEPTOR; ZD1839; COMBINATION; EFFICACY; IRESSA; SAFETY; GENE; SKIN	BACKGROUND: Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EGFR). However, about 10 percent of patients have a rapid and often dramatic clinical response. The molecular mechanisms underlying sensitivity to gefitinib are unknown. METHODS: We searched for mutations in the EGFR gene in primary tumors from patients with non-small-cell lung cancer who had a response to gefitinib, those who did not have a response, and those who had not been exposed to gefitinib. The functional consequences of identified mutations were evaluated after the mutant proteins were expressed in cultured cells. RESULTS: Somatic mutations were identified in the tyrosine kinase domain of the EGFR gene in eight of nine patients with gefitinib-responsive lung cancer, as compared with none of the seven patients with no response (P<0.001). Mutations were either small, in-frame deletions or amino acid substitutions clustered around the ATP-binding pocket of the tyrosine kinase domain. Similar mutations were detected in tumors from 2 of 25 patients with primary non-small-cell lung cancer who had not been exposed to gefitinib (8 percent). All mutations were heterozygous, and identical mutations were observed in multiple patients, suggesting an additive specific gain of function. In vitro, EGFR mutants demonstrated enhanced tyrosine kinase activity in response to epidermal growth factor and increased sensitivity to inhibition by gefitinib. CONCLUSIONS: A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene, which correlate with clinical responsiveness to the tyrosine kinase inhibitor gefitinib. These mutations lead to increased growth factor signaling and confer susceptibility to the inhibitor. Screening for such mutations in lung cancers may identify patients who will have a response to gefitinib.	Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Lynch, TJ (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.				NATIONAL CANCER INSTITUTE [R01CA092824, P50CA090578] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA0516, P50 CA 090578, R01 CA 092824] Funding Source: Medline; PHS HHS [P01 95281] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.2002.20.1.110; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Frederick L, 2000, CANCER RES, V60, P1383; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2002, J CLIN ONCOL, V20, P3815, DOI 10.1200/JCO.2002.03.038; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Li B, 2003, CANCER RES, V63, P7443; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pegram M D, 2000, Cancer Treat Res, V103, P57; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wakeling AE, 2002, CANCER RES, V62, P5749	28	8866	9451	23	1250	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2004	350	21					2129	2139		10.1056/NEJMoa040938	http://dx.doi.org/10.1056/NEJMoa040938			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821XM	15118073	Green Accepted			2022-12-01	WOS:000221496700005
J	Ravelo, AC; Andreasen, DH; Lyle, M; Lyle, AO; Wara, MW				Ravelo, AC; Andreasen, DH; Lyle, M; Lyle, AO; Wara, MW			Regional climate shifts caused by gradual global cooling in the Pliocene epoch	NATURE			English	Article							WATER CIRCULATION; PLIOPLEISTOCENE; VARIABILITY; GLACIATION; DELTA-O-18; TROPICS; SEAWAY	The Earth's climate has undergone a global transition over the past four million years, from warm conditions with global surface temperatures about 3degreesC warmer than today, smaller ice sheets and higher sea levels to the current cooler conditions. Tectonic changes and their influence on ocean heat transport have been suggested as forcing factors for that transition, including the onset of significant Northern Hemisphere glaciation similar to2.75 million years ago, but the ultimate causes for the climatic changes are still under debate. Here we compare climate records from high latitudes, subtropical regions and the tropics, indicating that the onset of large glacial/interglacial cycles did not coincide with a specific climate reorganization event at lower latitudes. The regional differences in the timing of cooling imply that global cooling was a gradual process, rather than the response to a single threshold or episodic event as previously suggested. We also find that high-latitude climate sensitivity to variations in solar heating increased gradually, culminating after cool tropical and subtropical upwelling conditions were established two million years ago. Our results suggest that mean low-latitude climate conditions can significantly influence global climate feedbacks.	Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Boise State Univ, Ctr Geophys Invest Shallow Subsurface, Boise, ID 83725 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Idaho; Boise State University	Ravelo, AC (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	acr@es.ucsc.edu		Ravelo, Ana Christina/0000-0003-3929-677X				ANDREASEN DH, 2001, THESIS U CALIFORNIA; BERGER WH, 1993, P OCEAN DRILLING PRO, V0130; Billups K, 1999, GEOLOGY, V27, P319, DOI 10.1130/0091-7613(1999)027<0319:LBOHTT>2.3.CO;2; Billups K, 1998, PALEOCEANOGRAPHY, V13, P459, DOI 10.1029/98PA02262; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Cane MA, 2000, SCIENCE, V290, P1107, DOI 10.1126/science.290.5494.1107; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cannariato KG, 1997, PALEOCEANOGRAPHY, V12, P805, DOI 10.1029/97PA02514; Chaisson W.P., 1997, Proceedings of the Ocean Drilling Program Scientific Results, V154, P255; Chaisson WP, 2000, PALEOCEANOGRAPHY, V15, P497, DOI 10.1029/1999PA000442; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Dowsett H, 1996, MAR MICROPALEONTOL, V27, P13, DOI 10.1016/0377-8398(95)00050-X; Driscoll NW, 1998, SCIENCE, V282, P436, DOI 10.1126/science.282.5388.436; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Harper S, 2000, TELLUS A, V52, P330, DOI 10.1034/j.1600-0870.2000.d01-7.x; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Haywood AM, 2000, GLOBAL PLANET CHANGE, V25, P239, DOI 10.1016/S0921-8181(00)00028-X; Jansen E., 1993, PROC OCEAN DRILL SCI, V130, P349; Kwiek PB, 1999, PALAEOGEOGR PALAEOCL, V154, P191, DOI 10.1016/S0031-0182(99)00111-X; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Lear CH, 2003, EARTH PLANET SC LETT, V210, P425, DOI 10.1016/S0012-821X(03)-00164-X; Lyle M., 1997, P ODP INIT REPTS, V167, P175, DOI [10. 2973/odp. proc. ir. 167. 1997, DOI 10.2973/ODP.PROC.IR.167.1997]; Lyle M., 2000, P OCEAN DRILL PROGRA, V167, P163, DOI DOI 10.2973/ODP.PROC.SR.167.214.2000; Marlow JR, 2000, SCIENCE, V290, P2288; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Norris Richard D., 1998, Proceedings of the Ocean Drilling Program Scientific Results, V159, P539; OKADA H, 1973, DEEP-SEA RES, V20, P355, DOI 10.1016/0011-7471(73)90059-4; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Ravelo AC, 1997, PALEOCEANOGRAPHY, V12, P729, DOI 10.1029/97PA02525; Ravelo AC, 2000, GEOPHYS RES LETT, V27, P1001, DOI 10.1029/1999GL007000; Raymo ME, 1990, PALEOCEANOGRAPHY, V5, P367, DOI 10.1029/PA005i003p00367; Raymo ME, 1992, PALEOCEANOGRAPHY, V7, P645, DOI 10.1029/92PA01609; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Raymo ME, 1998, SCIENCE, V281, P1467, DOI 10.1126/science.281.5382.1467; Rind D, 2000, QUATERNARY SCI REV, V19, P381, DOI 10.1016/S0277-3791(99)00070-0; RUDDIMAN WF, 1988, PHILOS T ROY SOC B, V318, P411, DOI 10.1098/rstb.1988.0017; SALTZMAN B, 1993, CLIM DYNAM, V9, P1, DOI 10.1007/BF00208010; Sautter LR, 1991, PALEOCEANOGRAPHY, V6, P307, DOI 10.1029/91PA00385; SHACKLETON NJ, 1995, P ODP SCI RESULTS, V138, P73, DOI DOI 10.2973/0DP.PR0C.SR.138.106.1995; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; WARA MW, 2003, THESIS U CALIFORNIA; Yin JH, 2001, J CLIMATE, V14, P565, DOI 10.1175/1520-0442(2001)014<0565:TIOTSS>2.0.CO;2	48	486	515	6	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2004	429	6989					263	267		10.1038/nature02567	http://dx.doi.org/10.1038/nature02567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822AO	15152244				2022-12-01	WOS:000221505900034
J	Daumke, O; Weyand, M; Chakrabarti, PP; Vetter, IR; Wittinghofer, A				Daumke, O; Weyand, M; Chakrabarti, PP; Vetter, IR; Wittinghofer, A			The GTPase-activating protein Rap1GAP uses a catalytic asparagine	NATURE			English	Article							TUBEROUS-SCLEROSIS; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; ARGININE-FINGER; TSC2 GENE; GAP; HYDROLYSIS; BINDING; COMPLEX; DOMAIN	Rap1 is a Ras-like guanine-nucleotide-binding protein ( GNBP) that is involved in a variety of signal-transduction processes(1,2). It regulates integrin-mediated cell adhesion and might activate extracellular signal-regulated kinase. Like other Ras-like GNBPs, Rap1 is regulated by guanine-nucleotide-exchange factors ( GEFs) and GTPase-activating proteins ( GAPs). These GAPs increase the slow intrinsic GTPase reaction of Ras-like GNBPs by many orders of magnitude and allow tight regulation of signalling. The activation mechanism involves stabilization of the catalytic glutamine of the GNBP and, in most cases, the insertion of a catalytic arginine of GAP into the active site(3). Rap1 is a close homologue of Ras but does not possess the catalytic glutamine essential for GTP hydrolysis in all other Ras-like and Galpha proteins. Furthermore, RapGAPs are not related to other GAPs and apparently do not use a catalytic arginine residue(4). Here we present the crystal structure of the catalytic domain of the Rap1-specific Rap1GAP at 2.9 Angstrom. By mutational analysis, fluorescence titration and stopped-flow kinetic assay, we demonstrate that Rap1GAP provides a catalytic asparagine to stimulate GTP hydrolysis. Implications for the disease tuberous sclerosis are discussed.	Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Otto Hahnstr 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de						Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; Daumke O, 2004, ACTA CRYSTALLOGR D, V60, P752, DOI 10.1107/S0907444904002392; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Gao QS, 2001, J VIROL, V75, P4459, DOI 10.1128/JVI.75.9.4459-4466.2001; Gao QS, 1999, MOL CELL BIOL, V19, P733; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Graham DL, 1999, BIOCHEMISTRY-US, V38, P14981, DOI 10.1021/bi991358e; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; Kraemer A, 2002, J MOL BIOL, V324, P763, DOI 10.1016/S0022-2836(02)01136-1; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Xu XM, 1997, BIOCHEMISTRY-US, V36, P626, DOI 10.1021/bi962059h	30	110	114	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					197	201		10.1038/nature02505	http://dx.doi.org/10.1038/nature02505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141215				2022-12-01	WOS:000221356300045
J	Weiss, KM				Weiss, KM			The unkindest cup	LANCET			English	Editorial Material							LACTASE PERSISTENCE		Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Weiss, KM (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	kmw4@psu.edu						Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Durham W. H., 1991, COEVOLUTION GENES CU; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Risch N, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031	10	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 8	2004	363	9420					1489	1490		10.1016/S0140-6736(04)16195-3	http://dx.doi.org/10.1016/S0140-6736(04)16195-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819GK	15135593				2022-12-01	WOS:000221302700005
J	Compton, WM; Grant, BF; Colliver, JD; Glantz, MD; Stinson, FS				Compton, WM; Grant, BF; Colliver, JD; Glantz, MD; Stinson, FS			Prevalence of marijuana use disorders in the United States - 1991-1992 and 2001-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALCOHOL-USE DISORDER; INTERVIEW SCHEDULE AUDADIS; DSM-III-R; DRUG-USE; PSYCHIATRIC-DISORDERS; ICD-10 ALCOHOL; SUBSTANCE USE; RELIABILITY; DISABILITIES; IV	Context Among illicit substance use disorders, marijuana use disorders are the most prevalent in the population. Yet, information about the prevalence of current Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) marijuana use disorders and how prevalence has changed is lacking. Objective To examine changes in the prevalence of marijuana use, abuse, and dependence in the United States between 1991-1992 and 2001-2002. Design, Setting, and Participants Face-to-face interviews were conducted in 2 large national surveys conducted 10 years apart: the 1991-1992 National Longitudinal Alcohol Epidemiologic Survey ([NLAES] n=42862) and the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions ([NESARC] n =43 093). Main Outcome Measures Rates of past year marijuana use, abuse, and dependence. Results Among the adult US population, the prevalence of marijuana use remained stable at about 4.0% over the past decade. In contrast, the prevalence of DSM-IV marijuana abuse or dependence significantly (P=.01) increased between 1991-1992 (1.2%) and 2001-2002 (1.5%), with the greatest increases observed among young black men and women (P<.001) and young Hispanic men (P=.006). Further, marijuana use disorders among marijuana users significantly increased (P=.002) in the absence of increased frequency and quantity of marijuana use, suggesting that the concomitant increase in potency of delta-9-tetrahydrocannabinol (Delta(9)-THC) may have contributed to the rising rates. Conclusions Despite the stability in the overall prevalence of marijuana use, more adults in the United States had a marijuana use disorder in 2001-2002 than in 1991-1992. Increases in the prevalence of marijuana use disorders were most notable among young black men and women and young Hispanic men. Although rates of marijuana abuse and dependence did not increase among young white men and women, their rates have remained high. The results of this study underscore the need to develop and implement new prevention and intervention programs targeted at youth, particularly minority youth.	NIDA, Div Epidemiol Serv & Prevent Res, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; NIAAA, Lab Epidemiol & Biometry, Div Intramural Clin & Biol Res, NIH,Dept Hlth & Human Serv, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Compton, WM (corresponding author), NIDA, Div Epidemiol Serv & Prevent Res, NIH, Dept Hlth & Human Serv, 6001 Execut Blvd,MSC 9589, Bethesda, MD 20892 USA.	wcompton@nida.nih.gov	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213	CLINICAL CENTER [Z01CL060060, ZIACL060060] Funding Source: NIH RePORTER	CLINICAL CENTER		American Psychiatric Association, 1991, DSM 4 OPT BOOK; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; Bachman JG, 1998, AM J PUBLIC HEALTH, V88, P887, DOI 10.2105/AJPH.88.6.887; Brook JS, 1998, J AM ACAD CHILD PSY, V37, P322, DOI 10.1097/00004583-199803000-00018; Brook JS, 2002, PSYCHOL MED, V32, P79, DOI 10.1017/S0033291701004809; Budney AJ, 1999, ADDICTION, V94, P1311, DOI 10.1046/j.1360-0443.1999.94913114.x; Budney AJ, 2001, ARCH GEN PSYCHIAT, V58, P917, DOI 10.1001/archpsyc.58.10.917; Canino G, 1999, J STUD ALCOHOL, V60, P790, DOI 10.15288/jsa.1999.60.790; Chatterji S, 1997, DRUG ALCOHOL DEPEN, V47, P171, DOI 10.1016/S0376-8716(97)00088-4; Chen CY, 2002, SOC PSYCH PSYCH EPID, V37, P199, DOI 10.1007/s00127-002-0541-z; Cottler LB, 1997, DRUG ALCOHOL DEPEN, V47, P195, DOI 10.1016/S0376-8716(97)00090-2; DiNardo J, 2001, J HEALTH ECON, V20, P991, DOI 10.1016/S0167-6296(01)00102-3; ElSohly MA, 2000, J FORENSIC SCI, V45, P24; Gledhill-Hoyt J, 2000, ADDICTION, V95, P1655, DOI 10.1046/j.1360-0443.2000.951116556.x; Grant B F, 1995, J Subst Abuse, V7, P481, DOI 10.1016/0899-3289(95)90017-9; Grant B. F., 2001, ALCOHOL USE DISORDER; Grant B. F., 2003, SOURCE ACCURACY STAT, P52; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant BF, 1996, J SUBST ABUSE, V8, P195, DOI 10.1016/S0899-3289(96)90249-7; Grant BF, 1996, ALCOHOL CLIN EXP RES, V20, P1481, DOI 10.1111/j.1530-0277.1996.tb01152.x; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; Grant BF, 1992, ALCOHOL HEALTH RES W, V18, P243; Hasin D, 1997, DRUG ALCOHOL DEPEN, V47, P217, DOI 10.1016/S0376-8716(97)00092-6; Hasin D, 1997, DRUG ALCOHOL DEPEN, V44, P133, DOI 10.1016/S0376-8716(97)01332-X; Johnston L, 2003, MONITORING FUTURE NA; LEHMAN WEK, 1992, J APPL PSYCHOL, V77, P309, DOI 10.1037/0021-9010.77.3.309; Lynskey M, 2000, ADDICTION, V95, P1621, DOI 10.1046/j.1360-0443.2000.951116213.x; Lynskey MT, 2003, JAMA-J AM MED ASSOC, V289, P427, DOI 10.1001/jama.289.4.427; Mittleman MA, 2001, CIRCULATION, V103, P2805; *NAT CTR DEV NAT P, 2003, Q REP POT MON PROJ M; National Highway Traffic Safety Administration, 2001, TRAFF SAF FACTS 2001; Nelson CB, 1999, ADDICTION, V94, P843, DOI 10.1046/j.1360-0443.1999.9468438.x; Ortega AN, 2000, J NERV MENT DIS, V188, P728, DOI 10.1097/00005053-200011000-00002; POLEN MR, 1993, WESTERN J MED, V158, P596; Pull CB, 1997, DRUG ALCOHOL DEPEN, V47, P207, DOI 10.1016/S0376-8716(97)00091-4; Research Triangle Institute, 2002, SOFTW SURV DAT AN SU; *SUBST AB MENT HLT, 2002, NHSDA SER H, V17; TASHKIN DP, 1990, WESTERN J MED, V152, P525; *US DEP ED, 2001, 2001 FALL ENR COLL U; Ustun B, 1997, DRUG ALCOHOL DEPEN, V47, P161, DOI 10.1016/S0376-8716(97)00087-2; Vega WA, 1998, ARCH GEN PSYCHIAT, V55, P771, DOI 10.1001/archpsyc.55.9.771; Vrasti R, 1998, EUR ADDICT RES, V4, P144, DOI 10.1159/000018947; Zhang ZF, 1999, CANCER EPIDEM BIOMAR, V8, P1071	45	445	449	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2004	291	17					2114	2121		10.1001/jama.291.17.2114	http://dx.doi.org/10.1001/jama.291.17.2114			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	817JR	15126440	Bronze			2022-12-01	WOS:000221174300029
J	Dunkle, KL; Jewkes, RK; Brown, HC; Gray, GE; McIntryre, JA; Harlow, SD				Dunkle, KL; Jewkes, RK; Brown, HC; Gray, GE; McIntryre, JA; Harlow, SD			Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; PARTNER VIOLENCE; AMERICAN WOMEN; REPRODUCTIVE HEALTH; DOMESTIC VIOLENCE; SEXUAL ABUSE; INEQUALITIES; BEHAVIORS; SURVIVORS	Background Gender-based violence and gender inequality are increasingly cited as important determinants of women's HIV risk: yet empirical research on possible connections remains limited. No study on women has yet assessed gender-based violence as a risk factor for HIV after adjustment for women's own high-risk behaviours, although these are known to be associated with experience of violence. Methods We did a cross-sectional study of 1366 women presenting for antenatal care at four health centres in Soweto. South Africa, who accepted routine antenatal HIV testing. Private face-to-face interviews were done in local languages and included assessement of sociodemographic characteristics, experience of gender-based violence, the South African adaptation of the Sexual Relationship Power Scale (SRPS). and risk behaviours including multiple, concurrent. and casual male partners, and transactional sex. Findings After adjustment for age and current relationship status and women's risk behaviour, intimate partner violence (odds ratio 1.48. 95% Cl 1.15-1-89) and high levels of male control in a woman's current relationship as measured by the SRPS (1.52, 1.13-2.04) were associated with HIV seropositivity. Child sexual assault, forced first intercourse, and adult sexual assault by non-partners were not associated with HIV serostatus. Interpretation Women with violent or controlling male partners are at increased risk of HIV infection. We postulate that abusive men are more likely to have HIV and impose risky sexual practices on partners. Research on connections between social constructions of masculinity, intimate partner violence, male dominance in relationships, and HIV risk behaviours in men. as well as effective interventions, are urgently needed.	MRC, Gender & Hlth Grp, ZA-0001 Pretoria, South Africa; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Witwatersrand, Chris Hani Baragwanath Hosp, Reprod Hlth Res Unit, ZA-2050 Wits, South Africa; Univ Witwatersrand, Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, ZA-2050 Wits, South Africa; Univ Witwatersrand, Chris Hani Baragwanath Hosp, Dept Obstet & Gynaecol, ZA-2050 Wits, South Africa	University of Michigan System; University of Michigan; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Dunkle, KL (corresponding author), MRC, Gender & Hlth Grp, Private Bag X385, ZA-0001 Pretoria, South Africa.	kdunkle@umich.edu	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Jewkes, Rachel/0000-0002-4330-6267				ABRAHAMS N, 2002, THESIS U CAPE TOWN C; [Anonymous], 2002, WORLD REP VIOL HLTH; Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; CHOI KH, 1998, AIDS BEHAV, V2, P33, DOI DOI 10.1023/A:1022355206905; El-Bassel N, 2000, J FAM VIOLENCE, V15, P209, DOI 10.1023/A:1007532917759; El-Bassel N, 1998, Violence Vict, V13, P377; El-Bassel N, 2001, J SUBST ABUSE, V13, P29, DOI 10.1016/S0899-3289(01)00068-2; Garcia-Moreno C, 2000, AIDS, V14, pS253; HALL W, 1993, ADDICTION, V88, P1627, DOI 10.1111/j.1360-0443.1993.tb02037.x; He H, 1998, WOMEN HEALTH, V27, P161, DOI 10.1300/J013v27n01_10; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Kalichman SC, 1998, J WOMENS HEALTH, V7, P371, DOI 10.1089/jwh.1998.7.371; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; PIOT P, 1999, HIV AIDS VIOLENCE WO; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; RAOGUPTA G, 13 INT AIDS C 2000 D; *S AFR DEP HLTH, 1999, S AFR DEM HLTH SURV; *UNAIDS WHO, 2002, AIDS EP UPD; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Wingood GM, 2000, AM J PREV MED, V19, P270, DOI 10.1016/S0749-3797(00)00228-2; Wingood GM, 1997, AM J PREV MED, V13, P380, DOI 10.1016/S0749-3797(18)30158-2; Wingood GM, 1998, J WOMENS HEALTH, V7, P77, DOI 10.1089/jwh.1998.7.77; ZIERLER S, 1991, AM J PUBLIC HEALTH, V81, P572, DOI 10.2105/AJPH.81.5.572; Zierler S, 1996, AM J PREV MED, V12, P304, DOI 10.1016/S0749-3797(18)30283-6; Zierler S, 1997, ANNU REV PUBL HEALTH, V18, P401, DOI 10.1146/annurev.publhealth.18.1.401	29	879	891	0	129	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1415	1421		10.1016/S0140-6736(04)16098-4	http://dx.doi.org/10.1016/S0140-6736(04)16098-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816ST	15121402				2022-12-01	WOS:000221130300006
J	Horn, M; Collingro, A; Schmitz-Esser, S; Beier, CL; Purkhold, U; Fartmann, B; Brandt, P; Nyakatura, GJ; Droege, M; Frishman, D; Rattei, T; Mewes, HW; Wagner, M				Horn, M; Collingro, A; Schmitz-Esser, S; Beier, CL; Purkhold, U; Fartmann, B; Brandt, P; Nyakatura, GJ; Droege, M; Frishman, D; Rattei, T; Mewes, HW; Wagner, M			Illuminating the evolutionary history of chlamydiae	SCIENCE			English	Article							ORDER CHLAMYDIALES; GENOME SEQUENCES; TRACHOMATIS; PNEUMONIAE; GENES; PARACHLAMYDIACEAE; IDENTIFICATION; ACANTHAMOEBA; SECRETION; DIVERSITY	Chlamydiae are the major cause of preventable blindness and sexually transmitted disease. Genome analysis of a chlamydia-related symbiont of free-living amoebae revealed that it is twice as large as any of the pathogenic chlamydiae and had few signs of recent lateral gene acquisition. We showed that about 700 million years ago the last common ancestor of pathogenic and symbiotic chlamydiae was already adapted to intracellular survival in early eukaryotes and contained many virulence factors found in modern pathogenic chlamydiae, including a type III secretion system. Ancient chlamydiae appear to be the originators of mechanisms for the exploitation of eukaryotic cells.	Univ Vienna, Inst Ecol & Conservat Biol, Dept Microbial Ecol, A-1090 Vienna, Austria; MWG Biotech AG, D-85560 Ebersberg, Germany; Tech Univ Munich, Wissensch Zentrum Weihenstephan, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany	University of Vienna; Technical University of Munich	Horn, M (corresponding author), Univ Vienna, Inst Ecol & Conservat Biol, Dept Microbial Ecol, Althanstr 14, A-1090 Vienna, Austria.	horn@microbial-ecology.net	Collingro, Astrid/ABA-2082-2021; Frishman, Dmitrij/AAT-7815-2020; Rattei, Thomas/F-1366-2011; Schmitz-Esser, Stephan/AAA-7287-2019; Wagner, Michael/A-7801-2011; Horn, Matthias/G-1136-2011; Mewes, Hans-Werner/A-8204-2019	Collingro, Astrid/0000-0002-4100-832X; Rattei, Thomas/0000-0002-0592-7791; Schmitz-Esser, Stephan/0000-0002-1907-0709; Wagner, Michael/0000-0002-9778-7684; Horn, Matthias/0000-0002-8309-5855; Mewes, Hans-Werner/0000-0002-9713-6398				Amann R, 1997, APPL ENVIRON MICROB, V63, P115, DOI 10.1128/AEM.63.1.115-121.1997; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fritsche TR, 2000, APPL ENVIRON MICROB, V66, P2613, DOI 10.1128/AEM.66.6.2613-2619.2000; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Hatch TP, 1999, CHLAMYDIA, P29; Horn M, 2000, MICROBIOL-SGM, V146, P1231, DOI 10.1099/00221287-146-5-1231; Horn M, 2001, FEMS MICROBIOL LETT, V204, P71, DOI 10.1111/j.1574-6968.2001.tb10865.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; McClarty G, 1999, CHLAMYDIA, P69; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Ossewaarde JM, 1999, MICROBIOL-SGM, V145, P411, DOI 10.1099/13500872-145-2-411; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Schachter J, 1999, CHLAMYDIA, P139; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Shirai M, 2000, NUCLEIC ACIDS RES, V28, P2311, DOI 10.1093/nar/28.12.2311; Stephens RS, 1999, CHLAMYDIA, P9; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; WEISBURG WG, 1986, J BACTERIOL, V167, P570, DOI 10.1128/jb.167.2.570-574.1986; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	26	324	576	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2004	304	5671					728	730		10.1126/science.1096330	http://dx.doi.org/10.1126/science.1096330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15073324				2022-12-01	WOS:000221105300043
J	Langer, P; Hogendoorn, K; Keller, L				Langer, P; Hogendoorn, K; Keller, L			Tug-of-war over reproduction in a social bee	NATURE			English	Article							EXONEURA-BICOLOR HYMENOPTERA; ALLODAPINE BEE; SKEW MODELS; ANIMAL SOCIETIES; EVOLUTION; ASSOCIATIONS; RELATEDNESS; BEHAVIOR; TESTS	One of the main transitions in evolution is the shift from solitary organisms to societies with reproductive division of labour(1,2). Understanding social evolution requires us to determine how ecological, social and genetic factors jointly influence group stability and partitioning of reproduction between group members(3-8). Here we test the role of the three key factors predicted to influence social evolution by experimentally manipulating them in a social allodapine bee. We show that increased relatedness between nestmates results in more even reproduction among group members and a greater productivity per individual. By contrast, the degree of reproductive skew is not influenced by the opportunity for solitary breeding or by the potential benefits of cooperation. Relatedness also has a positive effect on group stability and overall productivity. These findings are in line with predictions of the tug-of-war models, in which the degree of reproductive division of labour is determined primarily by selfish competition between group members. The alternative view, where the degree of reproductive skew is the outcome of a social contract between potential breeders, was not supported by the data.	Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	University of Lausanne; Flinders University South Australia	Langer, P (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biol Bldg, CH-1015 Lausanne, Switzerland.	Philipp.Langer@ie-zea.unil.ch; Laurent.Keller@ie-zea.unil.ch	keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953				Bull NJ, 1996, BEHAV ECOL SOCIOBIOL, V39, P267, DOI 10.1007/s002650050289; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; Field J, 1998, AM NAT, V151, P545, DOI 10.1086/286140; Fournier D, 2001, ANIM BEHAV, V62, P1039, DOI 10.1006/anbe.2001.1848; GADAGKAR R, 1993, EXPERIENTIA, V49, P714, DOI 10.1007/BF01923958; Haydock J, 2002, P NATL ACAD SCI USA, V99, P7178, DOI 10.1073/pnas.102624199; Hogendoorn K, 2001, INSECT SOC, V48, P392, DOI 10.1007/PL00001796; Johnstone RA, 1999, P ROY SOC B-BIOL SCI, V266, P275, DOI 10.1098/rspb.1999.0633; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Keller L, 1999, LEVELS SELECTION EVO; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P265, DOI 10.1098/rspb.2002.2238; LANGER P, IN PRESS MOL ECOL NO; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Reeve H.K., 1991, P99; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; REEVE HK, 1995, AM NAT, V145, P119, DOI 10.1086/285731; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Reeve Hudson K., 1993, P45; Schwarz MP, 1998, INSECT SOC, V45, P349, DOI 10.1007/s000400050095; SCHWARZ MP, 1994, EVOLUTION, V48, P1684, DOI 10.1111/j.1558-5646.1994.tb02205.x; SCHWARZ MP, 1986, INSECT SOC, V33, P258, DOI 10.1007/BF02224245; Silberbauer L. X., 1992, Australian Zoologist, V28, P67; SILBERBAUER LX, 1995, INSECT SOC, V42, P201, DOI 10.1007/BF01242455; STEVENS MI, 1997, THESIS FLINDERS U S; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X	30	85	87	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					844	847		10.1038/nature02431	http://dx.doi.org/10.1038/nature02431			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103374	Green Published			2022-12-01	WOS:000220952300037
J	Patek, SN; Korff, WL; Caldwell, RL				Patek, SN; Korff, WL; Caldwell, RL			Biomechanics: Deadly strike mechanism of a mantis shrimp - This shrimp packs a punch powerful enough to smash its prey's shell underwater	NATURE			English	Editorial Material							SNAPPING SHRIMP; HEMISQUILLA; BUBBLES; MUSCLE		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Patek, SN (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	patek@socrates.berkeley.edu		Patek, S. N./0000-0001-9738-882X; Korff, Wyatt/0000-0001-8396-1533				Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Bennet-Clark H.C., 1976, pUnpaginated; Brennen C.E., 1995, CAVITATION BUBBLE DY, DOI [10.1017/S0022112096230599, DOI 10.1017/S0022112096230599]; BURROWS M, 1972, J EXP ZOOL, V179, P379, DOI 10.1002/jez.1401790309; BURROWS M, 1969, Z VERGL PHYSIOL, V62, P361, DOI 10.1007/BF00299261; CURREY JD, 1982, J MATER SCI, V37, P1939; Gronenberg W, 1996, J COMP PHYSIOL A, V178, P727, DOI 10.1007/BF00225821; Lohse D, 2001, NATURE, V413, P477, DOI 10.1038/35097152; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114	10	203	213	22	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					819	820		10.1038/428819a	http://dx.doi.org/10.1038/428819a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103366				2022-12-01	WOS:000220952300029
J	Vogel, EK; Machizawa, MG				Vogel, EK; Machizawa, MG			Neural activity predicts individual differences in visual working memory capacity	NATURE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; BRAIN-REGIONS; ATTENTION; TASK; STORAGE; CONJUNCTIONS; PATTERNS; FEATURES; ROLES	Contrary to our rich phenomenological visual experience, our visual short-term memory system can maintain representations of only three to four objects at any given moment(1,2). For over a century, the capacity of visual memory has been shown to vary substantially across individuals, ranging from 1.5 to about 5 objects(3-7). Although numerous studies have recently begun to characterize the neural substrates of visual memory processes(8-12), a neurophysiological index of storage capacity limitations has not yet been established. Here, we provide electrophysiological evidence for lateralized activity in humans that reflects the encoding and maintenance of items in visual memory. The amplitude of this activity is strongly modulated by the number of objects being held in the memory at the time, but approaches a limit asymptotically for arrays that meet or exceed storage capacity. Indeed, the precise limit is determined by each individual's memory capacity, such that the activity from low-capacity individuals reaches this plateau much sooner than that from high-capacity individuals. Consequently, this measure provides a strong neurophysiological predictor of an individual's capacity, allowing the demonstration of a direct relationship between neural activity and memory capacity.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Vogel, EK (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, 530 Wilson Hall, Nashville, TN 37203 USA.	vogel@darkwing.uoregon.edu	Vogel, Edward K/AAW-9466-2021; Machizawa, Maro G/B-5918-2008	Machizawa, Maro G/0000-0002-5727-1421				Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; Engle R. W., 1999, MODELS WORKING MEMOR, P102, DOI [10.1017/CBO9781139174909.007, DOI 10.1017/CBO9781139174909.007]; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; FUSTER JM, 1982, J NEUROSCI, V2, P361; Gratton G, 1998, PSYCHOPHYSIOLOGY, V35, P638, DOI 10.1111/1469-8986.3560638; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; KYLLONEN PC, 1990, INTELLIGENCE, V14, P398; Logie R. H., 1995, VISUOSPATIAL WORKING; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Ruchkin DS, 1997, NEUROPSYCHOLOGIA, V35, P195, DOI 10.1016/S0028-3932(96)00068-1; RUCHKIN DS, 1995, PSYCHOPHYSIOLOGY, V32, P399, DOI 10.1111/j.1469-8986.1995.tb01223.x; RUCHKIN DS, 1990, ELECTROEN CLIN NEURO, V76, P419, DOI 10.1016/0013-4694(90)90096-3; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Sperling G., 1960, PSYCHOL MONOGRAPHS, V74, DOI [10.1037/h0093759, DOI 10.1037/H0093759]; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698	30	1200	1224	16	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2004	428	6984					748	751		10.1038/nature02447	http://dx.doi.org/10.1038/nature02447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812EW	15085132				2022-12-01	WOS:000220823800039
J	Moore, JH; Ritchie, MD				Moore, JH; Ritchie, MD			The challenges of whole-genome approaches to common diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; GENE-GENE INTERACTIONS; NEURAL-NETWORK ARCHITECTURE; ENVIRONMENT; BREAST; CANCER		Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Vanderbilt University	Moore, JH (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.		Moore, Jason H./AAV-9645-2021	Moore, Jason H./0000-0002-5015-1099	NHLBI NIH HHS [HL65234, HL65962] Funding Source: Medline; NIA NIH HHS [AG19085, AG20135] Funding Source: Medline; NIGMS NIH HHS [GM31304] Funding Source: Medline; NLM NIH HHS [LM007450] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, U19HL065962, R01HL065234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM031304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135, R01AG019085] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007450] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bellman R.E., 1961, ADAPTIVE CONTROL PRO, DOI 10.1515/9781400874668; EASTON DF, 1995, AM J HUM GENET, V56, P265; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; HAHN LW, 2004, IN SILICO BIOL, V4, P16; Hastie T., 2001, ELEMENTS STAT LEARNI; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Lucek PR, 1997, GENET EPIDEMIOL, V14, P1101, DOI 10.1002/(SICI)1098-2272(1997)14:6<1101::AID-GEPI90>3.0.CO;2-K; Marinov M, 2001, HUM HERED, V51, P169, DOI 10.1159/000053338; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Moore JH, 2003, BIOSYSTEMS, V72, P177, DOI 10.1016/S0303-2647(03)00142-4; North BV, 2003, ANN HUM GENET, V67, P348, DOI 10.1046/j.1469-1809.2003.00030.x; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Williams SM, 2004, BIOESSAYS, V26, P170, DOI 10.1002/bies.10401; Wu C. H., 2000, NEURAL NETWORKS GENO	20	97	107	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2004	291	13					1642	1643		10.1001/jama.291.13.1642	http://dx.doi.org/10.1001/jama.291.13.1642			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809PQ	15069055				2022-12-01	WOS:000220649000032
J	Turchyn, AV; Schrag, DP				Turchyn, AV; Schrag, DP			Oxygen isotope constraints on the sulfur cycle over the past 10 million years	SCIENCE			English	Article							DEEP-SEA SEDIMENTS; SULFATE REDUCTION; GEOCHEMICAL CYCLES; CARBON; WATER; DISPROPORTIONATION; FRACTIONATION; OXIDATION; OCEAN; IRON	Oxygen isotopes in marine sulfate (delta(18)O(SO4)) measured in marine barite show variability over the past 10 million years, including a 5 per mil decrease during the Plio-Pleistocene, with near-constant values during the Miocene that are slightly enriched over the modern ocean. A numerical model suggests that sea level fluctuations during Plio-Pleistocene glacial cycles affected the sulfur cycle by reducing the area of continental shelves and increasing the oxidative weathering of pyrite. The data also require that sulfate concentrations were 10 to 20% lower in the late Miocene than today.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Turchyn, AV (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	avan@fas.harvard.edu		Turchyn, Alexandra/0000-0002-9298-2173				Alt JC, 2003, GEOCHIM COSMOCHIM AC, V67, P641, DOI 10.1016/S0016-7037(02)01142-0; Bottcher ME, 2001, GEOCHIM COSMOCHIM AC, V65, P1601, DOI 10.1016/S0016-7037(00)00628-1; Bottcher ME, 2001, GEOCHIM COSMOCHIM AC, V65, P1573, DOI 10.1016/S0016-7037(00)00622-0; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; CANFIELD DE, 1991, AM J SCI, V291, P177, DOI 10.2475/ajs.291.2.177; CANFIELD DE, 1996, NATURE, V382, P697; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Derry LA, 1996, PALEOCEANOGRAPHY, V11, P267, DOI 10.1029/95PA03839; FRITZ P, 1989, CHEM GEOL, V79, P99, DOI 10.1016/0168-9622(89)90012-2; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HOLSER WT, 1979, CHEM GEOL, V25, P1, DOI 10.1016/0009-2541(79)90079-2; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kasten S., 2000, MARINE GEOCHEMISTRY, P263, DOI [10.1007/978-3-662-04242-7-8, DOI 10.1007/978-3-662-04242-7_8, DOI 10.1007/978-3-662-04242-7-8]; Krouse H.R., 2000, ENV TRACERS SUBSURFA, P195, DOI DOI 10.1007/978-1-4615-4557-61; KUKASABE M, 1968, GEOCHIM COSMOCHIM AC, V41, P1033; LIN S, 1991, AM J SCI, V291, P55, DOI 10.2475/ajs.291.1.55; LLOYD RM, 1968, J GEOPHYS RES, V73, P6099, DOI 10.1029/JB073i018p06099; LONGINELLI A, 1967, SCIENCE, V156, P56, DOI 10.1126/science.156.3771.56; MCDUFF RE, 1982, EARTH PLANET SC LETT, V57, P117, DOI 10.1016/0012-821X(82)90178-9; MEYBECK M, 1979, REV GEOL DYN GEOGR, V21, P215; Niewohner C, 1998, GEOCHIM COSMOCHIM AC, V62, P455, DOI 10.1016/S0016-7037(98)00055-6; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; PAYTAN A, 1993, NATURE, V366, P445, DOI 10.1038/366445a0; Petsch ST, 1998, AM J SCI, V298, P246, DOI 10.2475/ajs.298.3.246; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Strauss H, 1999, CHEM GEOL, V161, P89, DOI 10.1016/S0009-2541(99)00082-0; THAMDRUP B, 1994, GEOCHIM COSMOCHIM AC, V58, P5115, DOI 10.1016/0016-7037(94)90298-4; VANSTEMPVOORT DR, 1994, ENV GEOCHEMISTRY SUL, P446; VONDAMM KL, 1995, SEAFLOOR HYDROTHERMA, P173; WALKER JCG, 1986, MAR GEOL, V70, P159, DOI 10.1016/0025-3227(86)90093-9; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	33	92	95	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2004	2007		10.1126/science.1092296	http://dx.doi.org/10.1126/science.1092296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044800				2022-12-01	WOS:000220429800038
J	Mundy, NI; Badcock, NS; Hart, T; Scribner, K; Janssen, K; Nadeau, NJ				Mundy, NI; Badcock, NS; Hart, T; Scribner, K; Janssen, K; Nadeau, NJ			Conserved genetic basis of a quantitative plumage trait involved in mate choice	SCIENCE			English	Article							GOOSE ANSER-CAERULESCENS; ADAPTIVE MELANISM; POCKET MICE; POLYMORPHISM; PIGMENTATION; MUTATIONS	A key question in evolutionary genetics is whether shared genetic mechanisms underlie the independent evolution of similar phenotypes across phylogenetically divergent lineages. Here we show that in two classic examples of melanic plumage polymorphisms in birds, lesser snow geese (Anser c. caerulescens) and arctic skuas (Stercorarius parasiticus), melanism is perfectly associated with variation in the melanocortin-1 receptor (MC1R) gene. In both species, the degree of melanism correlates with the number of copies of variant MC1R alleles. Phylogenetic reconstructions of variant MC1R alleles in geese and skuas show that melanism is a derived trait that evolved in the Pleistocene.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Tromso, Dept Mol Biotechnol, N-9037 Tromso, Norway; Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Univ Oxford, Dept Biol Anthropol, Oxford OX2 6QS, England	University of Cambridge; UiT The Arctic University of Tromso; Michigan State University; Michigan State University; University of Oxford	Mundy, NI (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	nim21@cam.ac.uk	Nadeau, Nicola J./E-1149-2011	Nadeau, Nicola J./0000-0002-9319-921X				AVISE JC, 1992, EVOLUTION, V46, P1084, DOI 10.1111/j.1558-5646.1992.tb00621.x; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohen BL, 1997, P ROY SOC B-BIOL SCI, V264, P181, DOI 10.1098/rspb.1997.0026; COOKE F, 1988, AUK, V105, P467, DOI 10.1093/auk/105.3.467; COOKE F, 1968, EVOLUTION, V22, P289, DOI 10.1111/j.1558-5646.1968.tb05897.x; COOKE F, 1976, BEHAV GENET, V6, P127, DOI 10.1007/BF01067143; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Griffiths RC, 1999, ANN APPL PROBAB, V9, P567; Hoekstra HE, 2003, MOL ECOL, V12, P1185, DOI 10.1046/j.1365-294X.2003.01788.x; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; King M. K., 2003, EUR J BIOCHEM, V270, P1441; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; O'Donald P., 1987, P433; Phillips RA, 1998, J ZOOL, V245, P245, DOI 10.1017/S0952836998007018; Quinn TW, 1992, MOL ECOL, V1, P105, DOI 10.1111/j.1365-294X.1992.tb00162.x; RATTRAY B, 1984, ZOOL J LINN SOC-LOND, V80, P437, DOI 10.1111/j.1096-3642.1984.tb02554.x; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROCKWELL RF, 1985, EVOLUTION, V39, P178, DOI 10.1111/j.1558-5646.1985.tb04090.x; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1308, P164, DOI 10.1016/0167-4781(96)00100-5; TEMPLETON AR, 1992, GENETICS, V132, P619; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0	23	211	221	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2004	303	5665					1870	1873		10.1126/science.1093834	http://dx.doi.org/10.1126/science.1093834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	15031505				2022-12-01	WOS:000220281600056
J	Azam, F; Worden, AZ				Azam, F; Worden, AZ			Microbes, molecules, and marine ecosystems	SCIENCE			English	Editorial Material							DIVERSITY; BACTERIA; CORAL; VIRUSES; GENOME		Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Miami	Azam, F (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	fazam@ucsd.edu; aworden@rsmas.miami.edu	Azam, Farooq/A-2306-2012; Worden, Alexandra Z./AAD-6567-2019	Worden, Alexandra/0000-0002-9888-9324	PHS HHS [R01 A146600] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bidle KD, 2002, SCIENCE, V298, P1980, DOI 10.1126/science.1076076; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Moran MA, 2003, GEOMICROBIOL J, V20, P375, DOI 10.1080/01490450303901; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; PANEIK B, 2003, NATURE, V424, P1037; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; *PEW FDN OC COMM, 2003, PEW FDN OC COMM REP; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; SEIJE N, 2004, NATURE, V427, P445; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	27	118	130	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1622	1624		10.1126/science.1093892	http://dx.doi.org/10.1126/science.1093892			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15016987				2022-12-01	WOS:000220151400030
J	Hensch, TK; Stryker, MP				Hensch, TK; Stryker, MP			Columnar architecture sculpted by GABA circuits in developing cat visual cortex	SCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; GAMMA-AMINOBUTYRIC-ACID; STRIATE CORTEX; CELLS; ORIENTATION; VARIABILITY; CONDUCTANCE; SUBTYPES; PATTERN	The mammalian visual cortex is organized into columns. Here, we examine cortical influences upon developing visual afferents in the cat by altering intrinsic gamma-aminobutyric acid (GABA)-mediated inhibition with benzodiazepines. Local enhancement by agonist (diazepam) infusion did not perturb visual responsiveness, but did widen column spacing. An inverse agonist (DMCM) produced the opposite effect. Thus, intracortical inhibitory circuits shape the geometry of incoming thalamic arbors, suggesting that cortical columnar architecture depends on neuronal activity.	RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan; Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	RIKEN; University of California System; University of California San Francisco	Hensch, TK (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hensch@postman.riken	Hensch, Takao/L-4182-2019	Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R37 EY002874, R37 EY002874-24S1] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; CAPOGNA M, 1994, NEUROPHARMACOLOGY, V33, P875, DOI 10.1016/0028-3908(94)90185-6; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Crowley JC, 2002, CURR OPIN NEUROBIOL, V12, P104, DOI 10.1016/S0959-4388(02)00297-0; DAW N, 1995, VISUAL DEV; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Horton JC, 1996, J NEUROSCI, V16, P7228; Kaschube M, 2003, EUR J NEUROSCI, V18, P3251, DOI 10.1111/j.1460-9568.2003.02979.x; Kaschube M, 2002, J NEUROSCI, V22, P7206; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; LOWEL S, 1994, J NEUROSCI, V14, P7451; LOWEL S, 1987, EXP BRAIN RES, V68, P661; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; ROE AW, 1995, SOC NEUR ABSTR, V121; SHAW C, 1987, DEV BRAIN RES, V37, P67, DOI 10.1016/0165-3806(87)90229-X; SHIROKAWA T, 1992, BRAIN RES, V589, P157, DOI 10.1016/0006-8993(92)91177-G; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SILLITO AM, 1980, EXP BRAIN RES, V41, P1; SOMERS DC, 1995, J NEUROSCI, V15, P5448; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087	30	130	136	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1678	1681		10.1126/science.1091031	http://dx.doi.org/10.1126/science.1091031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15017001	Green Accepted			2022-12-01	WOS:000220151400046
J	Lee, DM; Yeoman, RR; Battaglia, DE; Stouffer, RL; Zelinski-Wooten, B; Fanton, JW; Wolf, DP				Lee, DM; Yeoman, RR; Battaglia, DE; Stouffer, RL; Zelinski-Wooten, B; Fanton, JW; Wolf, DP			Live birth after ovarian tissue transplant	NATURE			English	Editorial Material							NONHUMAN-PRIMATES; FERTILIZATION; FERTILITY		Oregon Hlth & Sci Univ, Dept Obstet & Gynecol Pediat Physiol & Pharmacol, Oregon Natl Primate Res Ctr, Div Reprod Sci, Portland, OR 97201 USA	Oregon Health & Science University; Oregon National Primate Research Center	Lee, DM (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol Pediat Physiol & Pharmacol, Oregon Natl Primate Res Ctr, Div Reprod Sci, Portland, OR 97201 USA.	leedavi@ohsu.edu		Zelinski, Mary/0000-0002-8513-1549				Duffy DM, 2002, HUM REPROD, V17, P2825, DOI 10.1093/humrep/17.11.2825; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; LEPORRIER M, 1987, CANCER, V60, P2201, DOI 10.1002/1097-0142(19871101)60:9<2201::AID-CNCR2820600915>3.0.CO;2-Z; LUTJEN P, 1984, NATURE, V307, P174, DOI 10.1038/307174a0; Oktay K, 2001, JAMA-J AM MED ASSOC, V286, P1490, DOI 10.1001/jama.286.12.1490; Ouhibi N, 2001, CONT ENDOCRINOL, P253; PARROTT DMV, 1960, J REPROD FERTIL, V1, P230, DOI 10.1530/jrf.0.0010230; Schnorr J, 2002, HUM REPROD, V17, P612, DOI 10.1093/humrep/17.3.612	8	139	155	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2004	428	6979					137	138		10.1038/428137a	http://dx.doi.org/10.1038/428137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014485				2022-12-01	WOS:000220103600032
J	Yin, YW; Steitz, TA				Yin, YW; Steitz, TA			The structural mechanism of translocation and helicase activity in T7 RNA polymerase	CELL			English	Article							3.3 ANGSTROM RESOLUTION; FAMILY DNA-POLYMERASE; I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; LESION-BYPASS; POWER STROKE; ELONGATION COMPLEX; ERROR-PRONE; REVERSE-TRANSCRIPTASE; SINGLE MOLECULES	RNA polymerase functions like a molecular motor that can convert chemical energy into the work of strand separation and translocation along the DNA during transcription. The structures of phage T7 RNA polymerase in an elongation phase substrate complex that includes the incoming nucleoside triphosphate and a pretranslocation product complex that includes the product pyrophosphate (PPi) are described here. These structures and the previously determined posttranslocation elongation complex demonstrate that two enzyme conformations exist during a cycle of single nucleotide addition. One orientation of a five-helix subdomain is stabilized by the phosphates of either the incoming NTP or by the product PPi. A second orientation of this subdomain is stable in their absence and is associated with translocation of the heteroduplex product as well as strand separation of the downstream DNA. We propose that the dissociation of the product PPi after nucleotide addition produces the protein conformational change resulting in translocation and strand separation.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57510] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Boudsocq F, 2002, DNA REPAIR, V1, P343, DOI 10.1016/S1568-7864(02)00019-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen CJ, 1999, ACTA CRYSTALLOGR D, V55, P1188, DOI 10.1107/S0907444999004400; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DEDRICK RL, 1987, J BIOL CHEM, V262, P9098; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Guajardo R, 1998, J MOL BIOL, V281, P777, DOI 10.1006/jmbi.1998.1988; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; JIANG MY, 1994, BIOESSAYS, V16, P531, DOI 10.1002/bies.950160803; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; KRAKOW JS, 1969, J BIOL CHEM, V244, P5988; KUHKO E, 1986, EUR J BIOCHEM, V127, P347; KUKKOKALSKE E, 1989, J BACTERIOL, V171, P4498, DOI 10.1128/JB.171.8.4498-4500.1989; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Marx A, 2002, CHEMBIOCHEM, V3, P405, DOI 10.1002/1439-7633(20020503)3:5<405::AID-CBIC405>3.0.CO;2-4; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Oster G, 2003, TRENDS CELL BIOL, V13, P114, DOI 10.1016/S0962-8924(03)00004-7; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Reedy MC, 2000, J CELL SCI, V113, P3551; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133; Wang HY, 1998, BIOPHYS J, V74, P1186, DOI 10.1016/S0006-3495(98)77834-8; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Yeagle PL, 2003, BIOCHEMISTRY-US, V42, P1365, DOI 10.1021/bi0270539; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	68	258	268	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					393	404		10.1016/S0092-8674(04)00120-5	http://dx.doi.org/10.1016/S0092-8674(04)00120-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016374	Bronze			2022-12-01	WOS:000188825800008
J	Berrington de Gonzalez, A; Darby, S				Berrington de Gonzalez, A; Darby, S			Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries	LANCET			English	Article							RADIATION; CT	Background Diagnostic X-rays are the largest man-made source of radiation exposure to the general population, contributing about 14% of the total annual exposure worldwide from all sources. Although diagnostic X-rays provide great benefits, that their use involves some small risk of developing cancer is generally accepted. Our aim was to estimate the extent of this risk on the basis of the annual number of diagnostic X-rays undertaken in the UK and in 14 other developed countries. Methods We combined data on the frequency of diagnostic X-ray use, estimated radiation doses from X-rays to individual body organs, and risk models, based mainly on the Japanese atomic bomb survivors, with population-based cancer incidence rates and mortality rates for all causes of death, using life table methods. Findings Our results indicate that in the UK about 0.6% of the cumulative risk of cancer to age 75 years could be attributable to diagnostic X-rays. This percentage is equivalent to about 700 cases of cancer per year. In 13 other developed countries, estimates of the attributable risk ranged from 0.6% to 1.8%, whereas in Japan, which had the highest estimated annual exposure frequency in the world, it was more than 3%. Interpretation We provide detailed estimates of the cancer risk from diagnostic X-rays. The calculations involved a number of assumptions and so are inevitably subject to considerable uncertainty. The possibility that we have overestimated the risks cannot be ruled out, but that we have underestimated them substantially seems unlikely.	Univ Oxford, Radcliffe Infirm, Canc Res UK Epidemiol Unit, Oxford OX2 6HE, England; Univ Oxford, Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Oxford, Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England	Cancer Research UK; Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford	Berrington de Gonzalez, A (corresponding author), Univ Oxford, Radcliffe Infirm, Canc Res UK Epidemiol Unit, Gibson Bldg, Oxford OX2 6HE, England.	amy.berrington@cancer.org.uk	de gonzalez, amy berrington/L-7017-2017	de gonzalez, amy berrington/0000-0002-7332-8387				Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; *DEP HLTH, 2003, STAT B BREAST SCREEN; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Golding SJ, 2002, BRIT J RADIOL, V75, P1, DOI 10.1259/bjr.75.889.750001; Hart D., 2002, DOSES PATIENTS MED X; Hart D, 2002, RAD EXPOSURE UK POPU; International Agency for Research on Cancer, 2002, BREAST CANC SCREEN; Kaul A, 1997, EUR RADIOL, V7, P1127, DOI 10.1007/s003300050267; KENDALL GM, 1980, FREQUENCY SURVEY RAD; Khursheed A, 2002, BRIT J RADIOL, V75, P819, DOI 10.1259/bjr.75.898.750819; Maitino AJ, 2003, RADIOLOGY, V227, P113, DOI 10.1148/radiol.2272020617; Mooney R, 1998, BRIT J RADIOL, V71, P852, DOI 10.1259/bjr.71.848.9828798; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pierce DA, 2003, RADIAT RES, V159, P511, DOI 10.1667/0033-7587(2003)159[0511:JEORAS]2.0.CO;2; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; RANNIKO S, 1997, PATIENT POPULATION D; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Royal College of Radiologists, 2003, MAK BEST US DEP CLIN, V5th; Shiralkar S, 2003, BRIT MED J, V327, P371, DOI 10.1136/bmj.327.7411.371; SHRIMPTON PC, 1991, SURVEY CT PRACTICE U; SHRIMPTON PC, 1991, SURVEY CT PRACTICE U, V2; TANNER RJ, 2000, FREQUENCY MED DENT E; THOMAS D, 1992, HEALTH PHYS, V63, P259, DOI 10.1097/00004032-199209000-00001; United Nations Scientific Committee on the Effect of Atomic Radiation, 1993, SOURC EFF ION RAD; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD; Upton AC, 2003, HEALTH PHYS, V85, P15, DOI 10.1097/00004032-200307000-00005; *WHO, STAT INF SYST; YOUNG KC, 2002, BRIT J RADIOL, V73, P278	30	1096	1118	1	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2004	363	9406					345	351		10.1016/S0140-6736(04)15433-0	http://dx.doi.org/10.1016/S0140-6736(04)15433-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070562				2022-12-01	WOS:000188590900007
J	Minn, AH; Kayton, M; Lorang, D; Hoffmann, SC; Harlan, DM; Libutti, SK; Shalev, A				Minn, AH; Kayton, M; Lorang, D; Hoffmann, SC; Harlan, DM; Libutti, SK; Shalev, A			Insulinomas and expression of an insulin splice variant	LANCET			English	Article							HUMAN PANCREATIC-ISLETS; TRANSLATIONAL CONTROL; PROINSULIN BIOSYNTHESIS; BETA-CELL; GLUCOSE; GENE; INITIATION; MUTATIONS	Background Insulinomas are beta-cell tumours characterised by uncontrolled insulin secretion even in the presence of hypoglycaemia. However, the mechanisms allowing such excessive insulin secretion are not known. Insulin secretion can occur only when the beta-cell insulin stores have been replenished by insulin biosynthesis, which is mainly controlled by translation. Such specific translational regulation often involves the 5' untranslated region. We have identified an insulin splice variant in isolated human pancreatic islets of non-diabetic donors that retains 26 bp of intron 1 and thereby changes the 5' untranslated region, but leaves the coding region unchanged. This splice variant has increased translation efficiency in vitro and in vivo compared with native insulin mRNA. However, splice variant expression is less than 1% of native insulin mRNA in normal islets. Methods To test whether this splice variant is involved in insulin production by human insulinomas, we extracted RNA from nine laser-captured surgical insulinoma samples and from isolated islets of nine donors who did not have diabetes. We then determined the ratio of splice variant to native insulin mRNA by quantitative real-time RT-PCR. Findings The mean ratio of the splice variant to native insulin mRNA was increased more than 50-fold in insulinomas compared with normal islets, and this difference was present in all nine human insulinomas. Overexpression of the splice variant therefore seems to be a general characteristic of insulinomas and is estimated to contribute about 90% to insulin synthesis by these tumours. Interpretation Overexpression of the insulin splice variant with increased translation efficiency in insulinomas might explain how these tumours maintain high levels of insulin synthesis and secretion leading to hyperinsulinaemia-the hallmark of this disease.	Univ Wisconsin, Dept Med, Endocrinol Sect, Madison, WI 53792 USA; NCI, NIH, DHHS, Bethesda, MD 20892 USA; NIDDKD, NIH, DHHS, Bethesda, MD 20892 USA	University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Shalev, A (corresponding author), Univ Wisconsin, Dept Med, Endocrinol Sect, H4-526 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	as7@medicine.wisc.edu			NATIONAL CANCER INSTITUTE [Z01SC010368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK062000] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Creutzfeldt W, 1976, Horm Metab Res, VSuppl 6, P7; FLATT PR, 1990, BIOCHEM SOC T, V18, P124, DOI 10.1042/bst0180124; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; GORDEN P, 1995, J CLIN ENDOCR METAB, V80, P2884, DOI 10.1210/jc.80.10.2884; Hirshberg B, 2000, J CLIN ENDOCR METAB, V85, P3222, DOI 10.1210/jc.85.9.3222; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; Kozak M, 2000, GENOMICS, V70, P396, DOI 10.1006/geno.2000.6412; Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688; Lou H, 2001, ENDOCR REV, V22, P205, DOI 10.1210/er.22.2.205; Pannett AAJ, 2001, J CLIN ENDOCR METAB, V86, P4371, DOI 10.1210/jc.86.9.4371; Pavelic K, 1996, ANTICANCER RES, V16, P1707; Pelengaris S, 2001, ENDOCR-RELAT CANCER, V8, P307, DOI 10.1677/erc.0.0080307; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Rhodes Christopher J., 1996, P27; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; SERVICE FJ, 1991, MAYO CLIN PROC, V66, P711, DOI 10.1016/S0025-6196(12)62083-7; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Skelly RH, 1996, DIABETES, V45, P37, DOI 10.2337/diabetes.45.1.37; VESSEY SJR, 1994, CLIN SCI, V87, P493, DOI 10.1042/cs0870493; VISCHER U, 1987, BIOCHEM J, V241, P249, DOI 10.1042/bj2410249; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Wang XQ, 2001, J BIOL CHEM, V276, P1311, DOI 10.1074/jbc.M005191200; WELSH M, 1986, BIOCHEM J, V235, P459, DOI 10.1042/bj2350459; Wilder RM, 1927, J AMER MED ASSOC, V89, P348, DOI 10.1001/jama.1927.02690050014007; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2	29	19	22	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2004	363	9406					363	367		10.1016/S0140-6736(04)15438-X	http://dx.doi.org/10.1016/S0140-6736(04)15438-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070567				2022-12-01	WOS:000188590900012
J	Hughen, KA; Eglinton, TI; Xu, L; Makou, M				Hughen, KA; Eglinton, TI; Xu, L; Makou, M			Abrupt tropical vegetation response to rapid climate changes	SCIENCE			English	Article							CARBON-ISOTOPE ANALYSES; YOUNGER DRYAS CHRON; LAST DEGLACIATION; LATE QUATERNARY; POLAR ICE; ATLANTIC; RADIOCARBON; AFRICA; EVENT; LAKE	Identifying leads and lags between high- and low-latitude abrupt climate shifts is needed to understand where and how such events were triggered. Vascular plant biomarkers preserved in Cariaco basin sediments reveal rapid vegetation changes in northern South America during the last deglaciation, 15,000 to 10,000 years ago. Comparing the biomarker records to climate proxies from the same sediment core provides a precise measure of the relative timing of changes in different regions. Abrupt deglacial climate shifts in tropical and high- latitude North Atlantic regions were synchronous, whereas changes in tropical vegetation consistently lagged climate shifts by several decades.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Hughen, KA (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	khughen@whoi.edu		Eglinton, Timothy/0000-0001-5060-2155				ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Bonnefille R, 1995, QUATERNARY SCI REV, V14, P917, DOI 10.1016/0277-3791(95)00071-2; BRADLEY RS, 1999, PALEOCLIMATOLOGY, P358; Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Brook EJ, 1996, SCIENCE, V273, P1087, DOI 10.1126/science.273.5278.1087; Conte MH, 2002, NATURE, V417, P639, DOI 10.1038/nature00777; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Finkel RC, 1997, J GEOPHYS RES-OCEANS, V102, P26699, DOI 10.1029/97JC01282; Fogel M.L., 1993, ORGANIC GEOCHEMISTRY, P73, DOI DOI 10.1007/978-1-4615-2890-6_3; Freeman KH, 2001, GEOCHIM COSMOCHIM AC, V65, P1439, DOI 10.1016/S0016-7037(00)00573-1; FRIEDRICH M, IN PRESS RADIOCARBON; HAYES JM, 1993, MAR GEOL, V113, P111, DOI 10.1016/0025-3227(93)90153-M; Huang YS, 2000, GEOCHIM COSMOCHIM AC, V64, P3505, DOI 10.1016/S0016-7037(00)00445-2; Huang YS, 1999, GEOCHIM COSMOCHIM AC, V63, P1383, DOI 10.1016/S0016-7037(99)00074-5; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Hughen KA, 1998, NATURE, V391, P65, DOI 10.1038/34150; HUGHEN KA, IN PRESS RADIOCARBON; ISLEBE GA, 1995, PALAEOGEOGR PALAEOCL, V117, P73, DOI 10.1016/0031-0182(95)00124-5; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W; LEYDEN BW, 1985, ECOLOGY, V66, P1279, DOI 10.2307/1939181; Marchitto TM, 1998, NATURE, V393, P557, DOI 10.1038/31197; Meyers PA, 1997, ORG GEOCHEM, V27, P213, DOI 10.1016/S0146-6380(97)00049-1; Ohkouchi N, 1997, ORG GEOCHEM, V27, P173, DOI 10.1016/S0146-6380(97)00080-6; Ramsey CB, 2001, RADIOCARBON, V43, P381; RIELEY G, 1991, NATURE, V352, P425, DOI 10.1038/352425a0; RINALDI M, 1996, 30 INT GEOL C BEIJ 4; SALTZMAN U, 2002, QUATERNARY RES, V58, P73; Schefuss E, 2003, GEOCHIM COSMOCHIM AC, V67, P1757, DOI 10.1016/S0016-7037(02)01414-X; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Stager JC, 2002, PALAEOGEOGR PALAEOCL, V183, P169, DOI 10.1016/S0031-0182(01)00468-0; van't Veer R, 2000, QUATERNARY SCI REV, V19, P1821, DOI 10.1016/S0277-3791(00)00093-7; Yarincik KM, 2000, PALEOCEANOGRAPHY, V15, P210; Zhao MX, 2000, ORG GEOCHEM, V31, P919, DOI 10.1016/S0146-6380(00)00027-9; [No title captured]	37	194	216	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2004	304	5679					1955	1959		10.1126/science.1092995	http://dx.doi.org/10.1126/science.1092995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832BG	15155911				2022-12-01	WOS:000222241600043
J	Brawley, C; Matunis, E				Brawley, C; Matunis, E			Regeneration of male germline stem cells by spermatogonial dedifferentiation in vivo	SCIENCE			English	Article							DROSOPHILA FUSOME; SELF-RENEWAL; DIFFERENTIATION; LINE	Although the ability of engrafted stem cells to regenerate tissue has received much attention, the molecular mechanisms controlling regeneration are poorly understood. In the Drosophila male germline, local activation of the Janus kinase-signal transducer and activator of transcription (Jak-STAT) pathway maintains stem cells; germline stem cells lacking Jak-STAT signaling differentiate into spermatogonia without self-renewal. By conditionally manipulating Jak-STAT signaling, we find that spermatogonia that have initiated differentiation and are undergoing limited mitotic (transit-amplifying) divisions can repopulate the niche and revert to stem cell identity. Thus, in the appropriate microenvironment, transit-amplifying cells dedifferentiate, becoming functional stem cells during tissue regeneration.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	matunis@jhmi.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD40307] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baksa K, 2002, DEV BIOL, V243, P166, DOI 10.1006/dbio.2001.0539; BRAWLEY C, UNPUB; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Hime GR, 1996, J CELL SCI, V109, P2779; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; LIN HF, 1994, DEVELOPMENT, V120, P947; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	12	306	322	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1331	1334		10.1126/science.1097676	http://dx.doi.org/10.1126/science.1097676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15143218				2022-12-01	WOS:000221669600057
J	Ke, AL; Zhou, KH; Ding, F; Cate, JHD; Doudna, JA				Ke, AL; Zhou, KH; Ding, F; Cate, JHD; Doudna, JA			A conformational switch controls hepatitis delta virus ribozyme catalysis	NATURE			English	Article							GENOMIC HDV RIBOZYME; CRYSTAL-STRUCTURE; SELF-CLEAVAGE; METAL-IONS; CYTOSINE; STEP; RNA	Ribozymes enhance chemical reaction rates using many of the same catalytic strategies as protein enzymes. In the hepatitis delta virus (HDV) ribozyme, site-specific self-cleavage of the viral RNA phosphodiester backbone(1-3) requires both divalent cations and a cytidine nucleotide(4-6). General acid - base catalysis(7-12), substrate destabilization(1,13) and global and local conformational changes(14,15) have all been proposed to contribute to the ribozyme catalytic mechanism. Here we report ten crystal structures of the HDV ribozyme in its pre-cleaved state, showing that cytidine is positioned to activate the 2'-OH nucleophile in the precursor structure. This observation supports its proposed role as a general base in the reaction mechanism. Comparison of crystal structures of the ribozyme in the pre- and post-cleavage states reveals a significant conformational change in the RNA after cleavage and that a catalytically critical divalent metal ion from the active site is ejected. The HDV ribozyme has remarkable chemical similarity to protein ribonucleases and to zymogens for which conformational dynamics are integral to biological activity. This finding implies that RNA structural rearrangements control the reactivity of ribozymes and ribonucleoprotein enzymes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94705 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94705 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94705 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94705 USA.	doudna@uclink.berkeley.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Dunham CM, 2003, J MOL BIOL, V332, P327, DOI 10.1016/S0022-2836(03)00843-X; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Harris DA, 2002, BIOCHEMISTRY-US, V41, P12051, DOI 10.1021/bi026101m; Jeong S, 2003, BIOCHEMISTRY-US, V42, P7727, DOI 10.1021/bi034627g; Luptak A, 2001, J AM CHEM SOC, V123, P8447, DOI 10.1021/ja016091x; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; Murray JB, 2002, J MOL BIOL, V315, P121, DOI 10.1006/jmbi.2001.5145; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nakano S, 2001, BIOCHEMISTRY-US, V40, P12022, DOI 10.1021/bi011253n; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyelere AK, 2002, BIOCHEMISTRY-US, V41, P3667, DOI 10.1021/bi011816v; Oyelere AK, 2001, NUCLEOS NUCLEOT NUCL, V20, P1851, DOI 10.1081/NCN-100107196; Pereira MJB, 2002, BIOCHEMISTRY-US, V41, P730, DOI 10.1021/bi011963t; PERROTTA AT, 1991, NATURE, V350, P434, DOI 10.1038/350434a0; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pyle AM, 2002, J BIOL INORG CHEM, V7, P679, DOI 10.1007/s00775-002-0387-6; Reid CE, 2000, P NATL ACAD SCI USA, V97, P424, DOI 10.1073/pnas.97.1.424; ROSENSTEIN SP, 1990, BIOCHEMISTRY-US, V29, P8011, DOI 10.1021/bi00487a002; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Shih I, 2001, P NATL ACAD SCI USA, V98, P1489, DOI 10.1073/pnas.98.4.1489; Shih IH, 2002, ANNU REV BIOCHEM, V71, P887, DOI 10.1146/annurev.biochem.71.110601.135349; Shih IH, 2001, EMBO J, V20, P4884, DOI 10.1093/emboj/20.17.4884; SUH YA, 1993, NUCLEIC ACIDS RES, V21, P3277, DOI 10.1093/nar/21.14.3277; TANNER NK, 1994, CURR BIOL, V4, P488, DOI 10.1016/S0960-9822(00)00109-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839	30	215	228	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					201	205		10.1038/nature02522	http://dx.doi.org/10.1038/nature02522			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141216				2022-12-01	WOS:000221356300046
J	Saleh, M; Vaillancourt, JP; Graham, RK; Huyck, M; Srinivasula, SM; Alnemri, ES; Steinberg, MH; Nolan, V; Baldwin, CT; Hotchkiss, RS; Buchman, TG; Zehnbauer, BA; Hayden, MR; Farrer, LA; Roy, S; Nicholson, DW				Saleh, M; Vaillancourt, JP; Graham, RK; Huyck, M; Srinivasula, SM; Alnemri, ES; Steinberg, MH; Nolan, V; Baldwin, CT; Hotchkiss, RS; Buchman, TG; Zehnbauer, BA; Hayden, MR; Farrer, LA; Roy, S; Nicholson, DW			Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms	NATURE			English	Article							KAPPA-B; ACTIVATION; APOPTOSIS; SEPSIS; MUTATIONS; DISEASE; DEATH; BETA; ASC	Caspases mediate essential key proteolytic events in inflammatory cascades and the apoptotic cell death pathway. Human caspases functionally segregate into two distinct subfamilies: those involved in cytokine maturation (caspase-1, -4 and -5) and those involved in cellular apoptosis (caspase-2, -3, -6, -7, -8, -9 and -10)(1,2). Although caspase-12 is phylogenetically related to the cytokine maturation caspases, in mice it has been proposed as a mediator of apoptosis induced by endoplasmic reticulum stress including amyloid-beta cytotoxicity, suggesting that it might contribute to the pathogenesis of Alzheimer's disease(3). Here we show that a single nucleotide polymorphism in caspase-12 in humans results in the synthesis of either a truncated protein (Csp12-S) or a full-length caspase proenzyme (Csp12-L). The read-through single nucleotide polymorphism encoding Csp12-L is confined to populations of African descent and confers hypo-responsiveness to lipopolysaccharide-stimulated cytokine production in ex vivo whole blood, but has no significant effect on apoptotic sensitivity. In a preliminary study, we find that the frequency of the Csp12-L allele is increased in African American individuals with severe sepsis. Thus, Csp12-L attenuates the inflammatory and innate immune response to endotoxins and in doing so may constitute a risk factor for developing sepsis.	Merck Frosst Ctr Therapeut Res, Dept Biochem Mol Biol & Pharmacol, Montreal, PQ H9H 3L1, Canada; Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Genet Program, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Hematol Oncol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Merck & Company; University of British Columbia; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Jefferson University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Nicholson, DW (corresponding author), Merck Frosst Ctr Therapeut Res, Dept Biochem Mol Biol & Pharmacol, Montreal, PQ H9H 3L1, Canada.	donald_nicholson@merck.com	Alnemri, Emad S/B-4526-2010; Hayden, Michael R/D-8581-2011; Graham, Rona K/R-7358-2018; Farrer, Lindsay/AAS-1035-2020	Hayden, Michael R/0000-0001-5159-1419; Graham, Rona K/0000-0003-3722-6241; Farrer, Lindsay/0000-0001-5533-4225; Steinberg, Martin/0000-0001-8800-8020; Baldwin, Clinton/0000-0002-3275-9463; Buchman, Timothy/0000-0001-7350-5921; Saleh, Maya/0000-0003-1538-9146	NATIONAL CANCER INSTITUTE [Z01BC010629, ZIABC010629] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Chan SL, 2002, NEUROBIOL DIS, V11, P2, DOI 10.1006/nbdi.2002.0542; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Freeman BD, 2002, J MOL DIAGN, V4, P209, DOI 10.1016/S1525-1578(10)60705-2; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mouw G, 2003, NEUROREPORT, V14, P183, DOI 10.1097/00001756-200302100-00004; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Shibata M, 2003, NEUROSCIENCE, V118, P491, DOI 10.1016/S0306-4522(02)00910-7; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304	18	323	342	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2004	429	6987					75	79		10.1038/nature02451	http://dx.doi.org/10.1038/nature02451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129283	Bronze			2022-12-01	WOS:000221222100047
J	Richeldi, L; Ewer, K; Losi, M; Hansell, DM; Roversi, P; Fabbri, LM; Lalvani, A				Richeldi, L; Ewer, K; Losi, M; Hansell, DM; Roversi, P; Fabbri, LM; Lalvani, A			Early diagnosis of subclinical multi drug-resistant tuberculosis	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; INFECTION; ENUMERATION; ASSAY	Background: Tuberculosis control hinges on prompt diagnosis of active cases and screening of contacts by tuberculin skin testing. Rapid blood tests for Mycobacterium tuberculosis infection are a new alternative to the tuberculin skin test, but whether they improve clinical outcomes is unknown. Objective: To describe how a novel T-cell-based test for M. tuberculosis infection helped diagnose tuberculosis in an asymptomatic, immunosuppressed adult with a negative result on a tuberculin skin test. Design: Case report. Setting: Household contact. Patients: Asymptomatic man receiving maintenance azathioprine therapy for Crohn disease whose wife had multidrug-resistant pulmonary tuberculosis. Measurements: Enzyme-linked immunospot (ELISPOT) assay, computed tomography, and bronchoalveolar lavage cultures. Results: The man had a negative tuberculin skin test result and a positive ELISPOT assay result. High-resolution computed tomography of the chest showed consolidation with early cavitation. Bronchoalveolar lavage and culture confirmed multidrug-resistant tuberculosis. Limitations: This single case report is a proof of concept and is not a formal evaluation of clinical utility. Conclusions: A positive ELISPOT assay result helped diagnose subclinical active tuberculosis in an immunosuppressed patient with a false-negative tuberculin skin test result. Large prospective studies that compare benefits and costs of this alternative to tuberculin skin testing are needed.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Modena, I-41100 Modena, Italy; Azienda Osped Policlin Modena, I-41100 Modena, Italy; Royal Brompton Hosp, London SW3 6LY, England	University of Oxford; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Royal Brompton Hospital	Lalvani, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Level 7, Oxford OX3 9DU, England.	ajit.lalvani@ndm.ox.ac.uk	Ewer, Katie J/B-4328-2011; Richeldi, Luca/ABF-2486-2020; Richeldi, Luca/B-6243-2019; Fabbri, Leonardo M/I-4055-2012; Losi, Monica/A-7028-2010	Ewer, Katie J/0000-0001-9827-9836; Richeldi, Luca/0000-0001-8594-1448; Fabbri, Leonardo M/0000-0001-8894-1689; Lalvani, Ajit/0000-0002-2396-246X				Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Organization WH, 1998, LAB SERVICES TUBERCU; Schluger NW, 2001, AM J RESP CRIT CARE, V164, P2020, DOI 10.1164/ajrccm.164.11.2008100; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993	13	50	54	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2004	140	9					709	713		10.7326/0003-4819-140-9-200405040-00010	http://dx.doi.org/10.7326/0003-4819-140-9-200405040-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816XR	15126254				2022-12-01	WOS:000221143100004
J	Davis, S; Begon, M; De Bruyn, L; Ageyev, VS; Klassovskiy, NL; Pole, SB; Viljugrein, H; Stenseth, NC; Leirs, H				Davis, S; Begon, M; De Bruyn, L; Ageyev, VS; Klassovskiy, NL; Pole, SB; Viljugrein, H; Stenseth, NC; Leirs, H			Predictive thresholds for plague in Kazakhstan	SCIENCE			English	Article							POPULATION-DYNAMICS; INFECTION; ECOLOGY; VIRUS	In Kazakhstan and elsewhere in central Asia, the bacterium Yersinia pestis circulates in natural populations of gerbils, which are the source of human cases of bubonic plague. Our analysis of field data collected between 1955 and 1996 shows that plague invades, fades out, and reinvades in response to fluctuations in the abundance of its main reservoir host, the great gerbil (Rhombomys opimus). This is a rare empirical example of the two types of abundance thresholds for infectious disease-invasion and persistence-operating in a single wildlife population. We parameterized predictive models that should reduce the costs of plague surveillance in central Asia and thereby encourage its continuance.	Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; Danish Pest Infestat Lab, DK-2800 Kongens Lyngby, Denmark; Univ Liverpool, Sch Biol Sci, Populat & Evolutionary Biol Res Grp, Liverpool L69 3BX, Merseyside, England; Univ Liverpool, Ctr Comparat Infect Dis, Liverpool L69 3BX, Merseyside, England; Inst Nat Conservat, B-1070 Brussels, Belgium; M Aikimbaevs Kazakh Sci Ctr Quarantine & Zoonot D, Alma Ata 480074, Kazakhstan; Univ Oslo, Dept Biol, CEES, N-0316 Oslo, Norway	University of Antwerp; Aarhus University; University of Liverpool; University of Liverpool; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; University of Oslo	Leirs, H (corresponding author), Univ Antwerp, Dept Biol, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	herwig.leirs@ua.ac.be	Leirs, Herwig/B-8197-2008; Stenseth, Nils Chr./G-5212-2016; De Bruyn, Luc/C-7030-2008; Viljugrein, Hildegunn/N-6657-2015	Leirs, Herwig/0000-0002-7612-5024; Stenseth, Nils Chr./0000-0002-1591-5399; De Bruyn, Luc/0000-0002-8968-8862; Viljugrein, Hildegunn/0000-0002-3798-5267; Begon, Mike/0000-0003-1715-5327				ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Begon M, 2003, J ANIM ECOL, V72, P343, DOI 10.1046/j.1365-2656.2003.00705.x; Biggins DE, 2001, J MAMMAL, V82, P906, DOI 10.1644/1545-1542(2001)082&lt;0906:IOIPON&gt;2.0.CO;2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; Hess G.R., 2002, P102; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; Keeling MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2219, DOI 10.1098/rspb.2000.1272; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Tikhomirov E., 1999, PLAGUE MANUAL EPIDEM, P11; [No title captured]; [No title captured]; [No title captured]; [No title captured]	16	148	156	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					736	738		10.1126/science.1095854	http://dx.doi.org/10.1126/science.1095854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118163				2022-12-01	WOS:000221105300046
J	Pischon, T; Girman, CJ; Hotamisligil, GS; Rifai, N; Hu, FB; Rimm, EB				Pischon, T; Girman, CJ; Hotamisligil, GS; Rifai, N; Hu, FB; Rimm, EB			Plasma adiponectin levels and risk of myocardial infarction in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLEMENT-RELATED PROTEIN; FATTY-ACID OXIDATION; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; BINDING PROTEIN; ADIPOSE; ASSOCIATION; EXPRESSION	Context Adiponectin, a recently discovered adipocyte-derived peptide, is involved in the regulation of insulin sensitivity and lipid oxidation and, purportedly, in the development of atherosclerosis and coronary heart disease in humans. Objective To assess prospectively whether plasma adiponectin concentrations are associated with risk of myocardial infarction (MI). Design, Setting, and Participants Nested case-control study among 18225 male participants of the Health Professionals Follow-up Study aged 40 to 75 years who were free of diagnosed cardiovascular disease at the time of blood draw (199371995). During 6 years of follow-up through January 31, 2000, 266 men subsequently developed nonfatal MI or fatal coronary heart disease. Using risk set sampling, controls were selected in a 2:1 ratio matched for age, date of blood draw, and smoking status (n=532). Main Outcome Measure Incidence of nonfatal MI and fatal coronary heart disease by adiponectin level. Results After adjustment for matched variables, participants in the highest compared with the lowest quintile of adiponectin levels had a significantly decreased risk of MI (relative risk [RR], 0.39; 95% confidence interval [CI], 0.23-0.64; P for trend <.001). Additional adjustment for family history of MI, body mass index, alcohol consumption, physical activity, and history of diabetes and hypertension did not substantively affect this relationship (RR, 0.41; 95% Cl, 0.24-0.70; P for trend <.001). Further adjustment for hemoglobin A(1c) or C-reactive protein levels also had little impact, but additional adjustment for low- and high-density lipoprotein cholesterol levels modestly attenuated this association (RR, 0.56; 95% Cl, 0.32-0.99; P for trend=.02). Conclusions High plasma adiponectin concentrations are associated with lower risk of MI in men. This relationship can be only partly explained by differences in blood lipids and is independent of inflammation and glycemic status.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Humboldt Univ, Charite, Franz Volhard Clin, Berlin, Germany; Merck Res Labs, Dept Epidemiol, West Point, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Merck & Company	Pischon, T (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	tpischon@hsph.harvard.edu	Adiels, Martin/C-9278-2011; Hu, Frank/C-1919-2013	Pischon, Tobias/0000-0003-1568-767X	NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/en.143.3.998; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; *DEP AGR, 1992, COMP FOODS RAW PROC; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halleux CM, 2001, BIOCHEM BIOPH RES CO, V288, P1102, DOI 10.1006/bbrc.2001.5904; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Kazumi T, 2002, DIABETES CARE, V25, P971, DOI 10.2337/diacare.25.6.971; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Kojima S, 2003, HEART, V89, P667, DOI 10.1136/heart.89.6.667; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]; Lindsay R, 2003, DIABETES, V52, pA161; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsubara M, 2003, EUR J ENDOCRINOL, V148, P657, DOI 10.1530/eje.0.1480657; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.1093/biomet/65.1.153; Rifai N, 1998, CLIN CHEM, V44, P1242; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P93; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; STINSHOFF K, 1977, CLIN CHEM, V23, P1029; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134; [No title captured]	58	1376	1444	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1730	1737		10.1001/jama.291.14.1730	http://dx.doi.org/10.1001/jama.291.14.1730			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811RJ	15082700	Bronze			2022-12-01	WOS:000220788700030
J	Gibbs, RA; Weinstock, GM; Metzker, ML; Muzny, DM; Sodergren, EJ; Scherer, S; Scott, G; Steffen, D; Worley, KC; Burch, PE; Okwuonu, G; Hines, S; Lewis, L; DeRamo, C; Delgado, O; Dugan-Rocha, S; Miner, G; Morgan, M; Hawes, A; Gill, R; Holt, RA; Adams, MD; Amanatides, PG; Baden-Tillson, H; Barnstead, M; Chin, S; Evans, CA; Ferriera, S; Fosler, C; Glodek, A; Gu, ZP; Jennings, D; Kraft, CL; Nguyen, T; Pfannkoch, CM; Sitter, C; Sutton, GG; Venter, JC; Woodage, T; Smith, D; Lee, HM; Gustafson, E; Cahill, P; Kana, A; Doucette-Stamm, L; Weinstock, K; Fechtel, K; Weiss, RB; Dunn, DM; Green, ED; Blakesley, RW; Bouffard, GG; de Jong, J; Osoegawa, K; Zhu, BL; Marra, M; Schein, J; Bosdet, I; Fjell, C; Jones, S; Krzywinski, M; Mathewson, C; Siddiqui, A; Wye, N; McPherson, J; Zhao, SY; Fraser, CM; Shetty, J; Shatsman, S; Geer, K; Chen, YX; Abramzon, S; Nierman, WC; Gibbs, RA; Weinstock, GM; Havlak, PH; Chen, R; Durbin, KJ; Egan, A; Ren, YR; Song, XZ; Li, BS; Liu, Y; Qin, X; Cawley, S; Weinstock, GM; Worley, KC; Cooney, AJ; Gibbs, RA; D'Souza, LM; Martin, K; Wu, JQ; Gonzalez-Garay, ML; Jackson, AR; Kalafus, KJ; McLeod, MP; Milosavljevic, A; Virk, D; Volkov, A; Wheeler, DA; Zhang, ZD; Bailey, JA; Eichler, EE; Tuzun, E; Birney, E; Mongin, E; Ureta-Vidal, A; Woodwark, C; Zdobnov, E; Bork, P; Suyama, M; Torrents, D; Alexandersson, M; Trask, BJ; Young, JM; Smith, D; Huang, H; Fechtel, K; Wang, HJ; Xing, HM; Weinstock, K; Daniels, S; Gietzen, D; Schmidt, J; Stevens, K; Vitt, U; Wingrove, J; Camara, F; Schmidt, J; Stevens, K; Vitt, U; Wingrove, J; Camara, F; Alba, MM; Abril, JF; Guigo, R; Smit, A; Dubchak, I; Rubin, EM; Couronne, O; Poliakov, A; Hubner, N; Ganten, D; Goesele, C; Hummel, O; Kreitler, T; Lee, YA; Monti, J; Schulz, H; Zimdahl, H; Himmelbauer, H; Lehrach, H; Jacob, HJ; Bromberg, S; Gullings-Handley, J; Jensen-Seaman, MI; Kwitek, AE; Lazar, J; Pasko, D; Tonellato, PJ; Twigger, S; Ponting, P; Duarte, JM; Rice, S; Goodstadt, L; Beatson, SA; Emes, RD; Winter, EE; Webber, C; Brandt, P; Nyakatura, G; Adetobi, M; Chiaromonte, F; Elnitski, L; Eswara, P; Hardison, RC; Hou, MM; Kolbe, D; Makova, K; Miller, W; Nekrutenko, A; Riemer, C; Schwartz, S; Taylor, J; Yang, S; Zhang, Y; Lindpaintner, K; Andrews, TD; Caccamo, M; Clamp, M; Clarke, L; Curwen, V; Durbin, R; Eyras, E; Searle, SM; Cooper, GM; Batzoglou, S; Brudno, M; Sidow, A; Stone, EA; Venter, JC; Payseur, BA; Bourque, G; Lopez-Otin, C; Puente, XS; Chakrabarti, K; Chatterji, S; Dewey, C; Pachter, L; Bray, N; Yap, VB; Caspi, A; Tesler, G; Pevzner, PA; Haussler, D; Roskin, KM; Baertsch, R; Clawson, H; Furey, TS; Hinrichs, AS; Karolchik, D; Kent, WJ; Rosenbloom, KR; Trumbower, H; Weirauch, M; Cooper, DN; Stenson, PD; Ma, B; Brent, M; Arumugam, M; Shteynberg, D; Copley, RR; Taylor, MS; Riethman, H; Mudunuri, U; Peterson, J; Guyer, M; Felsenfeld, A; Old, S; Mockrin, S; Collins, F				Gibbs, RA; Weinstock, GM; Metzker, ML; Muzny, DM; Sodergren, EJ; Scherer, S; Scott, G; Steffen, D; Worley, KC; Burch, PE; Okwuonu, G; Hines, S; Lewis, L; DeRamo, C; Delgado, O; Dugan-Rocha, S; Miner, G; Morgan, M; Hawes, A; Gill, R; Holt, RA; Adams, MD; Amanatides, PG; Baden-Tillson, H; Barnstead, M; Chin, S; Evans, CA; Ferriera, S; Fosler, C; Glodek, A; Gu, ZP; Jennings, D; Kraft, CL; Nguyen, T; Pfannkoch, CM; Sitter, C; Sutton, GG; Venter, JC; Woodage, T; Smith, D; Lee, HM; Gustafson, E; Cahill, P; Kana, A; Doucette-Stamm, L; Weinstock, K; Fechtel, K; Weiss, RB; Dunn, DM; Green, ED; Blakesley, RW; Bouffard, GG; de Jong, J; Osoegawa, K; Zhu, BL; Marra, M; Schein, J; Bosdet, I; Fjell, C; Jones, S; Krzywinski, M; Mathewson, C; Siddiqui, A; Wye, N; McPherson, J; Zhao, SY; Fraser, CM; Shetty, J; Shatsman, S; Geer, K; Chen, YX; Abramzon, S; Nierman, WC; Gibbs, RA; Weinstock, GM; Havlak, PH; Chen, R; Durbin, KJ; Egan, A; Ren, YR; Song, XZ; Li, BS; Liu, Y; Qin, X; Cawley, S; Weinstock, GM; Worley, KC; Cooney, AJ; Gibbs, RA; D'Souza, LM; Martin, K; Wu, JQ; Gonzalez-Garay, ML; Jackson, AR; Kalafus, KJ; McLeod, MP; Milosavljevic, A; Virk, D; Volkov, A; Wheeler, DA; Zhang, ZD; Bailey, JA; Eichler, EE; Tuzun, E; Birney, E; Mongin, E; Ureta-Vidal, A; Woodwark, C; Zdobnov, E; Bork, P; Suyama, M; Torrents, D; Alexandersson, M; Trask, BJ; Young, JM; Smith, D; Huang, H; Fechtel, K; Wang, HJ; Xing, HM; Weinstock, K; Daniels, S; Gietzen, D; Schmidt, J; Stevens, K; Vitt, U; Wingrove, J; Camara, F; Schmidt, J; Stevens, K; Vitt, U; Wingrove, J; Camara, F; Alba, MM; Abril, JF; Guigo, R; Smit, A; Dubchak, I; Rubin, EM; Couronne, O; Poliakov, A; Hubner, N; Ganten, D; Goesele, C; Hummel, O; Kreitler, T; Lee, YA; Monti, J; Schulz, H; Zimdahl, H; Himmelbauer, H; Lehrach, H; Jacob, HJ; Bromberg, S; Gullings-Handley, J; Jensen-Seaman, MI; Kwitek, AE; Lazar, J; Pasko, D; Tonellato, PJ; Twigger, S; Ponting, P; Duarte, JM; Rice, S; Goodstadt, L; Beatson, SA; Emes, RD; Winter, EE; Webber, C; Brandt, P; Nyakatura, G; Adetobi, M; Chiaromonte, F; Elnitski, L; Eswara, P; Hardison, RC; Hou, MM; Kolbe, D; Makova, K; Miller, W; Nekrutenko, A; Riemer, C; Schwartz, S; Taylor, J; Yang, S; Zhang, Y; Lindpaintner, K; Andrews, TD; Caccamo, M; Clamp, M; Clarke, L; Curwen, V; Durbin, R; Eyras, E; Searle, SM; Cooper, GM; Batzoglou, S; Brudno, M; Sidow, A; Stone, EA; Venter, JC; Payseur, BA; Bourque, G; Lopez-Otin, C; Puente, XS; Chakrabarti, K; Chatterji, S; Dewey, C; Pachter, L; Bray, N; Yap, VB; Caspi, A; Tesler, G; Pevzner, PA; Haussler, D; Roskin, KM; Baertsch, R; Clawson, H; Furey, TS; Hinrichs, AS; Karolchik, D; Kent, WJ; Rosenbloom, KR; Trumbower, H; Weirauch, M; Cooper, DN; Stenson, PD; Ma, B; Brent, M; Arumugam, M; Shteynberg, D; Copley, RR; Taylor, MS; Riethman, H; Mudunuri, U; Peterson, J; Guyer, M; Felsenfeld, A; Old, S; Mockrin, S; Collins, F		Rat Genome Sequencing Project Cons	Genome sequence of the Brown Norway rat yields insights into mammalian evolution	NATURE			English	Review							ARTIFICIAL CHROMOSOME LIBRARY; RECENT SEGMENTAL DUPLICATIONS; MURINE ENDOGENOUS RETROVIRUS; EMBRYONIC EPSILON-GLOBIN; GENE PREDICTION; ANIMAL-MODEL; DNA-SEQUENCE; MULTIPLE ALIGNMENT; DRAFT SEQUENCE; ALU ELEMENTS	The laboratory rat (Rattus norvegicus) is an indispensable tool in experimental medicine and drug development, having made inestimable contributions to human health. We report here the genome sequence of the Brown Norway (BN) rat strain. The sequence represents a high-quality 'draft' covering over 90% of the genome. The BN rat sequence is the third complete mammalian genome to be deciphered, and three-way comparisons with the human and mouse genomes resolve details of mammalian evolution. This first comprehensive analysis includes genes and proteins and their relation to human disease, repeated sequences, comparative genome-wide studies of mammalian orthologous chromosomal regions and rearrangement breakpoints, reconstruction of ancestral karyotypes and the events leading to existing species, rates of variation, and lineage-specific and lineage-independent evolutionary events such as expansion of gene families, orthology relations and protein evolution.	Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Celera, Rockville, MD 20850 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Computat Gen, Cleveland, OH 44106 USA; DSM Pharmaceut Inc, Greenville, NC 27834 USA; Inst Biol Energy Alternat, Rockville, MD 20850 USA; Intronn Inc, Gaithersburg, MD 20878 USA; Ctr Advancement Gen TCAG, Rockville, MD 20850 USA; Avalon Pharmaceut, Germantown, MD 20876 USA; NIAID, Basic Immunol Branch, Div Allergy Immunol & Transplantat, NIH,DHHS, Bethesda, MD 20892 USA; DynPort Vaccine Co LLC, Frederick, MD 21702 USA; Genome Therapeut Corp, Waltham, MA 02453 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; NHGRI, NIH, Intramural Sequencing Ctr, NISC, Bethesda, MD 20892 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Inst Gen Res, Rockville, MD 20850 USA; Affymetrix, Oakland, CA 94608 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; EBI, Hinxton CB10 1SD, Cambs, England; European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Fraunhofer Chalmers Res Ctr Ind Math, S-41288 Gothenburg, Sweden; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Incyte Corp, Palo Alto, CA 94304 USA; Univ Pompeu Fabra, Inst Municipal Invest Med, Grp Rec Informat Biomedia, Barcelona 08003, Spain; Ctr Regulacio Gen, Programa Bioinformat & Gen, Barcelona 08003, Spain; Inst Syst Biol, Computat Biol Grp, Seattle, WA 98103 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Gen Div, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Med Coll Wisconsin, Human & Mol Genet Ctr, Bioinformat Res Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Bioinformat Res Ctr, Rat Genome Database, Milwaukee, WI 53226 USA; Univ Oxford, MRC, Funct Genet Unit, Dept Human Anat & Genet, Oxford OX1 3QX, England; MWG Biotech, D-85560 Ebersberg, Germany; Penn State Univ, Dept Biol, Huck Inst Life Sci, Ctr Comparat Gen & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; Penn State Univ, Dept Hlth Evaluat Sci, University Pk, PA 16802 USA; F Hoffmann La Roche Ltd, Roche Genet & Roche Ctr Med Gen, CH-4070 Basel, Switzerland; Sanger Inst, Hinxton CB10 1SA, Cambs, England; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Comp Sci, James H Clark Ctr S256, Stanford, CA 94305 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Univ Montreal, Ctr Rech Math, Montreal, PQ H3T 1J8, Canada; Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Calif Berkeley, Bioengn Grad Grp, Berkeley, CA 94720 USA; Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Univ Calif Santa Cruz, Baskin Sch Engn, Ctr Biomol Sci & Engn, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Baskin Sch Engn, Ctr Biomol Sci & Engn, Genome Bioinformat Grp, Santa Cruz, CA 95064 USA; Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; Univ Western Ontario, Dept Comp Sci, London, ON N6A 5B7, Canada; Washington Univ, Lab Computat Gen, St Louis, MO 63130 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; NHGRI, US NIH, Bethesda, MD 20892 USA; NHLBI, US NIH, Bethesda, MD 20892 USA; Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; British Columbia Cancer Agency; Case Western Reserve University; Case Western Reserve University; DSM NV; J. Craig Venter Institute; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Washington University (WUSTL); Affymetrix; Baylor College of Medicine; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Chalmers University of Technology; Fraunhofer-Chalmers Research Centre for Industrial Mathematics; Fred Hutchinson Cancer Center; Incyte; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institute for Systems Biology (ISB); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Max Planck Society; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Roche Holding; Wellcome Trust Sanger Institute; Stanford University; Stanford University; Stanford University; University of Arizona; Universite de Montreal; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Cardiff University; Western University (University of Western Ontario); Washington University (WUSTL); University of Oxford; Wellcome Centre for Human Genetics; The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baylor College of Medicine	Gibbs, RA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, MS BCM226,1 Baylor Plaza, Houston, TX 77030 USA.	agibbs@bcm.tmc.edu	Beatson, Scott/B-6985-2013; Ferreira, Francisco Câmara/G-9841-2015; Durbin, Richard/AAE-7178-2019; Wheeler, David A/M-9740-2018; Arumugam, Manimozhiyan/E-1211-2011; Eduardo, Eyras/L-1053-2014; Arumugam, Manimozhiyan/AAJ-2394-2020; Schein, Jacquie E/G-3674-2015; Cooper, Gregory/D-6914-2011; López-Otín, Carlos/AAB-2106-2020; Andrews, Dan/ABG-4815-2020; Bourque, Guillaume/AFR-2927-2022; Hinrichs, Angie S./H-9159-2019; Zdobnov, Evgeny/AAB-2745-2022; Driemeier, David/H-3461-2012; Clawson, Hiram/ABE-6101-2020; Guigo, Roderic/D-1303-2010; McPherson, John D/D-2633-2017; Puente, Xosé S./ADB-0672-2022; Jones, Steven J/C-3621-2009; Li, Bingshan/H-1944-2011; Stone, Eric/Q-7840-2016; Holt, Robert A/C-3303-2009; Gasull, Martina/J-4076-2019; Bork, Peer/F-1813-2013; Duarte, Jose M/I-6178-2018; Emes, Richard D/C-5341-2008; Weinstock, George M/C-6314-2013; Alba, Mar/B-4793-2009; Ponting, Chris/AAV-2621-2021; Tuzun, Eray/B-5949-2018; Ma, Bin/C-7550-2013; Eyras, Eduardo/A-1560-2010; Taylor, Martin S/C-3825-2009; Taylor, James/F-1026-2011; Tuzun, Eray/AAD-7282-2021; Hardison, Ross C/G-1142-2010; Cooper, David N/H-4384-2011; Brent, Michael/AAK-3702-2020; Marra, Marco A/B-5987-2008; Weirauch, Matthew/M-5459-2019; Ferrando, Josep F Abril/B-3877-2014; Zdobnov, Evgeny M/K-1133-2012; Couronne, Olivier Couronne/G-1244-2012; Elnitski, Laura/AAD-3595-2021; Eyras, Eduardo/ABG-7144-2020; Torrents, David/G-5785-2015	Beatson, Scott/0000-0002-1806-3283; Ferreira, Francisco Câmara/0000-0002-1971-5466; Durbin, Richard/0000-0002-9130-1006; Wheeler, David A/0000-0002-9056-6299; Arumugam, Manimozhiyan/0000-0002-0886-9101; Eduardo, Eyras/0000-0003-0793-6218; Arumugam, Manimozhiyan/0000-0002-0886-9101; Cooper, Gregory/0000-0001-5509-9923; López-Otín, Carlos/0000-0001-6964-1904; Bourque, Guillaume/0000-0002-3933-9656; Hinrichs, Angie S./0000-0002-1697-1130; Zdobnov, Evgeny/0000-0002-5178-1498; Driemeier, David/0000-0003-3766-0654; Guigo, Roderic/0000-0002-5738-4477; McPherson, John D/0000-0001-8049-9347; Puente, Xosé S./0000-0001-9525-1483; Jones, Steven J/0000-0003-3394-2208; Holt, Robert A/0000-0002-7259-1247; Bork, Peer/0000-0002-2627-833X; Duarte, Jose M/0000-0002-9544-5621; Emes, Richard D/0000-0001-6855-5481; Weinstock, George M/0000-0002-2997-4592; Alba, Mar/0000-0002-7963-7375; Tuzun, Eray/0000-0002-5550-7816; Taylor, Martin S/0000-0001-7656-330X; Taylor, James/0000-0001-5079-840X; Tuzun, Eray/0000-0002-5550-7816; Hardison, Ross C/0000-0003-4084-7516; Cooper, David N/0000-0002-8943-8484; Brent, Michael/0000-0002-8689-0299; Marra, Marco A/0000-0001-7146-7175; Ferrando, Josep F Abril/0000-0001-7793-589X; Eyras, Eduardo/0000-0003-0793-6218; Fraser, Claire/0000-0003-1462-2428; Stone, Eric/0000-0002-2725-4209; Himmelbauer, Heinz/0000-0001-8897-2928; Suyama, Mikita/0000-0001-9526-3193; Pachter, Lior/0000-0002-9164-6231; Ponting, Chris/0000-0003-0202-7816; Xing, Heming/0000-0002-2253-0163; Delgado, Oliver/0000-0003-2547-5857; Furey, Terry/0000-0001-5546-9672; Axelson-Fisk, Marina/0000-0003-3068-9593; Torrents, David/0000-0002-6086-9037; Twigger, Simon/0000-0001-5659-3632; Nguyen, Dac-Trung/0000-0003-2591-9948; Andrews, Dan/0000-0003-3922-6376; Clarke, Laura/0000-0002-5989-6898; Worley, Kim/0000-0002-0282-1000; Fjell, Christopher/0000-0001-6304-2628; Kwitek, Anne/0000-0003-1024-4116; Clawson, Hiram/0000-0002-0480-0545; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Webber, Caleb/0000-0001-8063-7674; Birney, Ewan/0000-0001-8314-8497; Elnitski, Laura/0000-0003-1065-019X; Nekrutenko, Anton/0000-0002-5987-8032	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002939, U01HG002137, Z01HG000196, Z01HG000060] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002939, U01 HG002137, U01 HG002137-02S2] Funding Source: Medline; NHLBI NIH HHS [R01 HL064541] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Alba MM, 1999, MOL BIOL EVOL, V16, P1641, DOI 10.1093/oxfordjournals.molbev.a026077; Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Alexandersson M, 2003, GENOME RES, V13, P496, DOI 10.1101/gr.424203; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves A, 2003, SURGERY, V133, P669, DOI 10.1067/msy.2003.152; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barnett SA, 2002, STORY RATS THEIR IMP, P17; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; Benit L, 1997, J VIROL, V71, P5652; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bourque G, 2002, GENOME RES, V12, P26; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Brudno M, 2004, GENOME RES, V14, P685, DOI 10.1101/gr.2067704; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Cai L, 1997, GENOMICS, V39, P385, DOI 10.1006/geno.1996.4494; CANBY TY, 1977, NAT GEOGR        JUL, P60; Cantrell MA, 2001, GENETICS, V158, P769; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Chakrabarti K, 2004, GENOME RES, V14, P716, DOI 10.1101/gr.1957004; CHANG BHJ, 1994, P NATL ACAD SCI USA, V91, P827, DOI 10.1073/pnas.91.2.827; CHANG BHJ, 1995, J MOL EVOL, V40, P70, DOI 10.1007/BF00166597; Chen R, 2004, GENOME RES, V14, P679, DOI 10.1101/gr.2171704; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; CHIAROMONTE F, IN PRESS COLD SPRING; CLARK AJ, 1984, EMBO J, V3, P2055, DOI 10.1002/j.1460-2075.1984.tb02091.x; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Costas J, 2003, J MOL EVOL, V56, P181, DOI 10.1007/s00239-002-2392-3; Crisci AR, 2002, ULTRASOUND MED BIOL, V28, P1335, DOI 10.1016/S0301-5629(02)00576-8; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; DARWIN C, 1859, ORIGIN SPECIES, P108; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dewey C, 2004, GENOME RES, V14, P661, DOI 10.1101/gr.1939804; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Emes RD, 2004, GENOME RES, V14, P591, DOI 10.1101/gr.1940604; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Felsenfeld A, 1999, GENOME RES, V9, P1; Flicek P, 2003, GENOME RES, V13, P46, DOI 10.1101/gr.830003; Forte A, 2003, CARDIOVASC RES, V60, P654, DOI 10.1016/j.cardiores.2003.08.015; Fray MJ, 2003, J MED CHEM, V46, P3514, DOI 10.1021/jm0308038; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GARCIAMEUNIER P, 1993, MAMM GENOME, V4, P695, DOI 10.1007/BF00357792; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Graves JAM, 2002, CYTOGENET GENOME RES, V99, P141, DOI 10.1159/000071585; GREEN H, 1994, P NATL ACAD SCI USA, V91, P4298, DOI 10.1073/pnas.91.10.4298; Green P, 2002, P NATL ACAD SCI USA, V99, P4143, DOI 10.1073/pnas.082095999; Greenhouse DD, 1990, GENETIC MONITORING I, P410; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Gurates B, 2002, J CLIN ENDOCR METAB, V87, P4369, DOI 10.1210/jc.2002-020522; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Haldi ML, 1997, MAMM GENOME, V8, P284, DOI 10.1007/s003359900412; HARDISON R, 1993, NUCLEIC ACIDS RES, V21, P1265, DOI 10.1093/nar/21.5.1265; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hayward BE, 1997, GENETICS, V146, P641; HEDRICH HJ, 2000, HDB EXPT ANIMALS LAB, P3; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; HUANG H, UNPUB GENOME BIOL; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; HUGHES AL, 1999, ADAPTIVE EVOLUTION G, P143; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Hussar P, 2001, ANN CHIR GYNAECOL, V90, P271; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jin XQ, 2003, ATHEROSCLEROSIS, V169, P225, DOI 10.1016/S0021-9150(03)00159-X; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Kitagawa K, 2002, TRANSPLANT P, V34, P1030, DOI 10.1016/S0041-1345(02)02702-1; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Komamura K, 2003, CARDIOVASC DRUG THER, V17, P303, DOI 10.1023/A:1027352703783; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kostrubsky VE, 2003, TOXICOL SCI, V76, P220, DOI 10.1093/toxsci/kfg217; Krzywinski M, 2004, GENOME RES, V14, P766, DOI 10.1101/gr.2336604; Kuntz C, 2002, SURG ENDOSC, V16, P1175, DOI 10.1007/s00464-001-9159-6; Kwitek AE, 2004, GENOME RES, V14, P750, DOI 10.1101/gr.1968704; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li XM, 2003, GENOME RES, V13, P1916, DOI 10.1101/gr.1251803; Lindon JC, 2003, TOXICOL APPL PHARM, V187, P137, DOI 10.1016/S0041-008X(02)00079-0; Lindsey J. R., 1979, The laboratory rat. Volume I. Biology and diseases., P1; Liu MY, 2003, CANCER RES, V63, P2675; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; McBride MW, 2004, J PHYSIOL-LONDON, V554, P56, DOI 10.1113/jphysiol.2003.049361; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Montoya-Burgos JI, 2003, TRENDS GENET, V19, P128, DOI 10.1016/S0168-9525(03)00021-0; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murphy William J., 2003, Human Genomics, V1, P30; Murphy WJ, 1999, GENOME RES, V9, P1223, DOI 10.1101/gr.9.12.1223; Murphy WJ, 2003, GENOME RES, V13, P1880, DOI 10.1101/gr.1022303; Myers EW, 2002, P NATL ACAD SCI USA, V99, P4145, DOI 10.1073/pnas.092136699; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Nekrutenko A, 2003, TRENDS GENET, V19, P306, DOI 10.1016/S0168-9525(03)00114-8; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; NEKRUTENKO A, IN PRESS GENOME RES; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Ness SR, 2002, BIOINFORMATICS, V18, P484, DOI 10.1093/bioinformatics/18.3.484; *NIH, 2000, NETW LARG SCAL SEQ R; Oh B, 1997, DEVELOPMENT, V124, P493; Ohno S., 1970, P1; Osoegawa K, 2004, GENOME RES, V14, P780, DOI 10.1101/gr.2033904; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ozkan O, 2002, ANN PLAS SURG, V49, P532, DOI 10.1097/01.SAP.0000015434.56344.A7; Parra G, 2003, GENOME RES, V13, P108, DOI 10.1101/gr.871403; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Petratos PB, 2003, PLAST RECONSTR SURG, V111, P1988, DOI 10.1097/01.PRS.0000056831.87062.4B; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; PHILIPSEN S, 1993, EMBO J, V12, P1077, DOI 10.1002/j.1460-2075.1993.tb05749.x; Prak ETL, 2000, NAT REV GENET, V1, P134; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; QUENTIN Y, 1994, NUCLEIC ACIDS RES, V22, P2222, DOI 10.1093/nar/22.12.2222; Ravingerova TA, 2003, MOL CELL BIOCHEM, V249, P167, DOI 10.1023/A:1024751109196; REDDY PMS, 1991, P NATL ACAD SCI USA, V88, P8676, DOI 10.1073/pnas.88.19.8676; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; Robinson R., 1965, GENETICS NORWAY RAT; ROSKIN KM, 2003, P 7 ANN INT C RES CO, P257, DOI DOI 10.1145/640075.640109; Rothenburg S, 2002, J MOL EVOL, V55, P251, DOI 10.1007/s00239-002-2322-4; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Roy-Engel AM, 2002, J MOL BIOL, V316, P1033, DOI 10.1006/jmbi.2001.5380; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salem AH, 2003, P NATL ACAD SCI USA, V100, P12787, DOI 10.1073/pnas.2133766100; Salem AH, 2003, MOL BIOL EVOL, V20, P1349, DOI 10.1093/molbev/msg150; Sauve Y, 2002, NEUROSCIENCE, V114, P389, DOI 10.1016/S0306-4522(02)00271-3; Scarborough PE, 1999, DRUG METAB REV, V31, P205, DOI 10.1081/DMR-100101915; Schein Jacqueline, 2004, Methods Mol Biol, V255, P143; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smyth MD, 2002, EPILEPSY RES, V50, P251, DOI 10.1016/S0920-1211(02)00051-7; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SOLOVYEV VV, 1995, INTELLIGENT SYSTEMS, V3, P367; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stanyon R, 2003, GENOMICS, V82, P245, DOI 10.1016/S0888-7543(03)00109-5; Steen RG, 1999, GENOME RES, V9, pAP1; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Strassmann B I, 1992, Hum Nat, V3, P89, DOI 10.1007/BF02692249; Sundstrom H, 2003, GENETICS, V164, P259; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Tam RC, 2000, ANTIMICROB AGENTS CH, V44, P1276, DOI 10.1128/AAC.44.5.1276-1283.2000; Taylor JR, 2002, AM J PSYCHIAT, V159, P657, DOI 10.1176/appi.ajp.159.4.657; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thomas JW, 2003, GENOME RES, V13, P55, DOI 10.1101/gr.791403; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Trenite DGAKN, 2003, EPILEPTIC DISORD, V5, pS39; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Vitt U, 2004, GENOME RES, V14, P640, DOI 10.1101/gr.1932304; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang H, 2003, TRANSPLANTATION, V75, P1475, DOI 10.1097/01.TP.0000057245.59998.95; Watanabe TK, 1999, NAT GENET, V22, P27, DOI 10.1038/8737; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Waterston RH, 2003, P NATL ACAD SCI USA, V100, P3022, DOI 10.1073/pnas.0634129100; Waterston RH, 2002, P NATL ACAD SCI USA, V99, P3712, DOI 10.1073/pnas.042692499; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; WOLFE KH, 1993, J MOL EVOL, V37, P441, DOI 10.1007/BF00178874; Woon PY, 1998, GENOMICS, V50, P306, DOI 10.1006/geno.1998.5319; Wu JQ, 2004, GENOME RES, V14, P665, DOI 10.1101/gr.1959604; Yang S, 2004, GENOME RES, V14, P517, DOI 10.1101/gr.1984404; Yang TD, 2002, ADV SPACE RES, V30, P751, DOI 10.1016/S0273-1177(02)00391-5; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yap VB, 2004, GENOME RES, V14, P574, DOI 10.1101/gr.1967904; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Youssef AF, 2003, REPROD TOXICOL, V17, P109, DOI 10.1016/S0890-6238(02)00099-0; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	225	1540	2515	4	213	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					493	521		10.1038/nature02426	http://dx.doi.org/10.1038/nature02426			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15057822	Bronze			2022-12-01	WOS:000220540100032
J	Tsuchida, T; Koga, R; Fukatsu, T				Tsuchida, T; Koga, R; Fukatsu, T			Host plant specialization governed by facultative symbiont	SCIENCE			English	Editorial Material							PEA APHID; POPULATIONS		Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Tsuchida, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan.							Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7	5	412	450	3	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2004	303	5666					1989	1989		10.1126/science.1094611	http://dx.doi.org/10.1126/science.1094611			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044797				2022-12-01	WOS:000220429800032
J	Poggio, T; Rifkin, R; Mukherjee, S; Niyogi, P				Poggio, T; Rifkin, R; Mukherjee, S; Niyogi, P			General conditions for predictivity in learning theory	NATURE			English	Article							BOUNDS	Developing theoretical foundations for learning is a key step towards understanding intelligence. 'Learning from examples' is a paradigm in which systems ( natural or artificial) learn a functional relationship from a training set of examples. Within this paradigm, a learning algorithm is a map from the space of training sets to the hypothesis space of possible functional solutions. A central question for the theory is to determine conditions under which a learning algorithm will generalize from its finite training set to novel examples. A milestone in learning theory(1-5) was a characterization of conditions on the hypothesis space that ensure generalization for the natural class of empirical risk minimization (ERM) learning algorithms that are based on minimizing the error on the training set. Here we provide conditions for generalization in terms of a precise stability property of the learning process: when the training set is perturbed by deleting one example, the learned hypothesis does not change much. This stability property stipulates conditions on the learning map rather than on the hypothesis space, subsumes the classical theory for ERM algorithms, and is applicable to more general algorithms. The surprising connection between stability and predictivity has implications for the foundations of learning theory and for the design of novel algorithms, and provides insights into problems as diverse as language learning and inverse problems in physics and engineering.	MIT, Brain Sci Dept, McGovern Inst Comp Sci, Artificial Intelligence Lab,Ctr Biol & Computat L, Cambridge, MA 02139 USA; Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Canc Genom Grp, Cambridge, MA 02139 USA; Honda Res Inst USA Inc, Boston, MA 02111 USA	Massachusetts Institute of Technology (MIT); University of Chicago; University of Chicago; Massachusetts Institute of Technology (MIT); Whitehead Institute; Honda Motor Company	Poggio, T (corresponding author), MIT, Brain Sci Dept, McGovern Inst Comp Sci, Artificial Intelligence Lab,Ctr Biol & Computat L, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tp@ai.mit.edu		Mukherjee, Sayan/0000-0002-6715-3920				Alon N, 1997, J ACM, V44, P615, DOI 10.1145/263867.263927; [Anonymous], 2003, NOTICES AM MATH SOC; BOTTOU L, 1992, NEURAL COMPUT, V4, P888, DOI 10.1162/neco.1992.4.6.888; Bousquet O, 2002, J MACH LEARN RES, V2, P499, DOI 10.1162/153244302760200704; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chomsky N., 1995, LECT GOVT BINDING; Cucker F, 2002, B AM MATH SOC, V39, P1; DEVROYE LP, 1979, IEEE T INFORM THEORY, V25, P601, DOI 10.1109/TIT.1979.1056087; DONOHO DL, 1989, ANN STAT, V17, P58, DOI 10.1214/aos/1176347004; Dudley R. M., 1991, J THEORET PROBAB, V4, P485, DOI DOI 10.1007/BF01210321; Dudley R. M., 1999, UNIFORM CENTRAL LIMI; Engl H.W., 1996, REGULARIZATION INVER; Evgeniou T, 2000, ADV COMPUT MATH, V13, P1, DOI 10.1023/A:1018946025316; EVGENIOU T, IN PRESS MACHINE LEA; Fix E., 1951, DISCRIMINATORY ANAL; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Hastie T., 2004, ELEMENTS STAT LEARNI, V27, P83, DOI [10.1007/BF02985802, 10.1007/978-0-387-21606-5, DOI 10.1007/978-0-387-21606-5, DOI 10.1007/978-0-387-84858-7]; Kearns M, 1999, NEURAL COMPUT, V11, P1427, DOI 10.1162/089976699300016304; KUTIN S, 2002, P UNCERTAINTY AI; Mukherjee S., 2003, 223 CBCL MIT; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; STONE CJ, 1986, ANN STAT, V14, P590, DOI 10.1214/aos/1176349940; Tikhonov A.N., 1977, SOLUTIONS ILL POSED; VALIANT LG, 1984, COMMUN ACM, V27, P1134, DOI 10.1145/1968.1972; Vapnik N.V, 1991, PATTERN RECOGNIT IMA, V1, P283; Vapnik V., 1998, STAT LEARNING THEORY, V1, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wahba G., 1990, SERIES APPL MATH, V59; Zhou DX, 2002, J COMPLEXITY, V18, P739, DOI 10.1006/jcom.2002.0635	29	167	174	1	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					419	422		10.1038/nature02341	http://dx.doi.org/10.1038/nature02341			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042089				2022-12-01	WOS:000220404300041
J	Kuwabara, T; Hsieh, J; Nakashima, K; Taira, K; Gage, FH				Kuwabara, T; Hsieh, J; Nakashima, K; Taira, K; Gage, FH			A small modulatory dsRNA specifies the fate of adult neural stem cells	CELL			English	Article							SODIUM-CHANNEL GENE; TRANSCRIPTION FACTOR; HISTONE DEACETYLASE; TARGET GENES; IN-VIVO; EXPRESSION; REST; RNA; REPRESSION; DIFFERENTIATION	Discovering the molecular mechanisms that regulate neuron-specific gene expression remains a central challenge for CNS research. Here, we report that small, noncoding double-stranded [ds) RNAs play a critical role in mediating neuronal differentiation. The sequence defined by this dsRNA is NRSE/RE1, which is recognized by NRSF/REST, known primarily as a negative transcriptional regulator that restricts neuronal gene expression to neurons. The NRSE dsRNA can trigger gene expression of neuron-specific genes through interaction with NRSF/REST transcriptional machinery, resulting in the transition from neural stem cells with neuron-specific genes silenced by NRSF/REST into cells with neuronal identity that can express neuronal genes. The mechanism of action appears to be mediated through a dsRNA/protein interaction, rather than through siRNA or miRNA. The discovery of small modulatory dsRNAs (smRNAs) extends the important contribution of noncoding RNAs as key regulators of cell behavior at both transcriptional and posttranscriptional levels.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Natl Inst Adv Ind Sci & Technol, Gene Funct Res Ctr, Tsukuba, Ibaraki 3058562, Japan; Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Modulat, Kumamoto 8600811, Japan	Salk Institute; National Institute of Advanced Industrial Science & Technology (AIST); Kumamoto University	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Kuwabara, Tomoko/M-1639-2018	Kuwabara, Tomoko/0000-0002-7668-0896				Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; ECKSTEIN F, 1996, NUCL ACIDS MOL BIOL; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Finerty PJ, 1999, BIOCHEMISTRY-US, V38, P4001, DOI 10.1021/bi9825293; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; HOOVERS JMN, 1992, GENOMICS, V12, P254, DOI 10.1016/0888-7543(92)90372-Y; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Koseki S, 1999, J VIROL, V73, P1868, DOI 10.1128/JVI.73.3.1868-1877.1999; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Myers SJ, 1998, J NEUROSCI, V18, P6723; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Palm K, 1998, J NEUROSCI, V18, P1280; Pasquinelli AE, 2002, TRENDS GENET, V18, P171, DOI 10.1016/S0168-9525(01)02624-5; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Timmusk T, 1999, J BIOL CHEM, V274, P1078; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Warashina M, 2000, CURR OPIN BIOTECH, V11, P354, DOI 10.1016/S0958-1669(00)00110-5	37	344	390	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					779	793		10.1016/S0092-8674(04)00248-X	http://dx.doi.org/10.1016/S0092-8674(04)00248-X			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035981	Green Submitted, Bronze			2022-12-01	WOS:000221499900005
J	Turney, CSM; Kershaw, AP; Clemens, SC; Branch, N; Moss, PT; Fifield, LK				Turney, CSM; Kershaw, AP; Clemens, SC; Branch, N; Moss, PT; Fifield, LK			Millennial and orbital variations of El Nino/Southern Oscillation and high-latitude climate in the last glacial period	NATURE			English	Article							SOUTHERN-OSCILLATION; VARIABILITY; AUSTRALIA; PATTERNS; RECORD; OCEAN; ENSO; NINO	The El Nino/Southern Oscillation (ENSO) phenomenon is believed to have operated continuously over the last glacial interglacial cycle(1). ENSO variability has been suggested to be linked to millennial-scale oscillations in North Atlantic climate during that time(2,3), but the proposals disagree on whether increased frequency of El Nino events, the warm phase of ENSO, was linked to North Atlantic warm or cold periods. Here we present a high-resolution record of surface moisture, based on the degree of peat humification and the ratio of sedges to grass, from northern Queensland, Australia, covering the past 45,000 yr. We observe millennial-scale dry periods, indicating periods of frequent El Nino events ( summer precipitation declines in El Nino years in northeastern Australia). We find that these dry periods are correlated to the Dansgaard - Oeschger events - millennial-scale warm events in the North Atlantic climate record - although no direct atmospheric connection from the North Atlantic to our site can be invoked. Additionally, we find climatic cycles at a semiprecessional timescale (, 11,900 yr). We suggest that climate variations in the tropical Pacific Ocean on millennial as well as orbital timescales, which determined precipitation in northeastern Australia, also exerted an influence on North Atlantic climate through atmospheric and oceanic teleconnections.	Queens Univ Belfast, Sch Archaeol & Paleoecol, Belfast BT7 1NN, Antrim, North Ireland; Monash Univ, Sch Geog & Environm Sci, Clayton, Vic 3800, Australia; Brown Univ, Providence, RI 02912 USA; Univ London Royal Holloway & Bedford New Coll, Dept Geog, Egham TW20 0EX, Surrey, England; Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Nucl Phys, Canberra, ACT 0200, Australia	Queens University Belfast; Monash University; Brown University; University of London; Royal Holloway University London; University of Wisconsin System; University of Wisconsin Madison; Australian National University	Turney, CSM (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia.	cturney@uow.edu.au	Moss, Patrick/AFM-9408-2022; Turney, Chris S M/P-8701-2018	Turney, Chris S M/0000-0001-6733-0993; Moss, Patrick/0000-0003-1546-9242; Fifield, Leslie/0000-0003-2866-4944; Kershaw, Peter/0000-0002-9478-0567				Blackford J., 1993, INT PEAT J, V5, P7; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Clement AC, 2001, J CLIMATE, V14, P2369, DOI 10.1175/1520-0442(2001)014<2369:AODTSF>2.0.CO;2; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; Godfred-Spenning CR, 2002, INT J CLIMATOL, V22, P509, DOI 10.1002/joc.710; GROUSSET FE, 1993, PALEOCEANOGRAPHY, V8, P175, DOI 10.1029/92PA02923; Hendy IL, 2003, QUATERNARY SCI REV, V22, P673, DOI 10.1016/S0277-3791(02)00186-5; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Jenkins G.M., 1968, SPECTRAL ANAL ITS AP; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; KERSHAW AP, 1978, NATURE, V272, P159, DOI 10.1038/272159a0; Kukla GJ, 2002, QUATERNARY RES, V58, P27, DOI 10.1006/qres.2002.2327; Laj C, 2002, EARTH PLANET SC LETT, V200, P177, DOI 10.1016/S0012-821X(02)00618-0; MACAYEAL DR, 1993, EOS, V74, P359; MCGLONE MS, 1992, EL NINO HIST PALEOCL, P435; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; NANSON GC, 1992, GEOLOGY, V20, P791, DOI 10.1130/0091-7613(1992)020<0791:WADOAO>2.3.CO;2; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; ROGNON P, 1977, PALAEOGEOGR PALAEOCL, V21, P285, DOI 10.1016/0031-0182(77)90040-2; SCHULZ M, 2002, GEOPHYS RES LETT, V29; Spero HJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000814; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Turney CSM, 2001, J QUATERNARY SCI, V16, P767, DOI 10.1002/jqs.643; Voelker AHL, 2000, RADIOCARBON, V42, P437, DOI 10.1017/S0033822200030368; Wang H, 2000, GEOLOGY, V28, P771, DOI 10.1130/0091-7613(2000)28<771:IEOPNO>2.0.CO;2; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618	30	164	170	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					306	310		10.1038/nature02386	http://dx.doi.org/10.1038/nature02386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029193				2022-12-01	WOS:000220250200040
J	Wendel, HG; de Stanchina, E; Fridman, JS; Malina, A; Ray, S; Kogan, S; Cordon-Cardo, C; Pelletier, J; Lowe, SW				Wendel, HG; de Stanchina, E; Fridman, JS; Malina, A; Ray, S; Kogan, S; Cordon-Cardo, C; Pelletier, J; Lowe, SW			Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy	NATURE			English	Article							TRANSLATIONAL CONTROL; MTOR; PTEN; P53; PROTEIN; CHEMORESISTANCE; INHIBITION; APOPTOSIS; RAPAMYCIN; TUMORS	Evading apoptosis is considered to be a hallmark of cancer, because mutations in apoptotic regulators invariably accompany tumorigenesis(1). Many chemotherapeutic agents induce apoptosis, and so disruption of apoptosis during tumour evolution can promote drug resistance(2). For example, Akt is an apoptotic regulator that is activated in many cancers and may promote drug resistance in vitro(3). Nevertheless, how Akt disables apoptosis and its contribution to clinical drug resistance are unclear. Using a murine lymphoma model, we show that Akt promotes tumorigenesis and drug resistance by disrupting apoptosis, and that disruption of Akt signalling using the mTOR inhibitor rapamycin reverses chemoresistance in lymphomas expressing Akt, but not in those with other apoptotic defects. eIF4E, a translational regulator that acts downstream of Akt and mTOR, recapitulates Akt's action in tumorigenesis and drug resistance, but is unable to confer sensitivity to rapamycin and chemotherapy. These results establish Akt signalling through mTOR and eIF4E as an important mechanism of oncogenesis and drug resistance in vivo, and reveal how targeting apoptotic programmes can restore drug sensitivity in a genotype-dependent manner.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; McGill Univ, Montreal, PQ H3G 1Y6, Canada; Univ Calif San Francisco, San Francisco, CA 94143 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; McGill University; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Clovis, Jeff/C-1020-2009	Kogan, Scott/0000-0002-2395-8479; Malina, Abba/0000-0002-8511-9005	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Grunwald V, 2002, CANCER RES, V62, P6141; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P637; Hosoi H, 1999, CANCER RES, V59, P886; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Polunovsky VA, 2000, J BIOL CHEM, V275, P24776, DOI 10.1074/jbc.M001938200; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206	30	813	847	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					332	337		10.1038/nature02369	http://dx.doi.org/10.1038/nature02369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029198				2022-12-01	WOS:000220250200047
J	Langhorne, P; Dennis, MS				Langhorne, P; Dennis, MS			Stroke units: the next 10 years	LANCET			English	Editorial Material							CARE; EXPERIENCE; SERVICES		Royal Infirm, Acad Sect Geriatr Med, Glasgow G4 0SF, Lanark, Scotland; Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Langhorne, P (corresponding author), Royal Infirm, Acad Sect Geriatr Med, Glasgow G4 0SF, Lanark, Scotland.	P.Langhorne@clinmed.gla.ac.uk						Asplund K, 2003, CEREBROVASC DIS, V15, P5, DOI 10.1159/000068203; Bereczki W, 2003, CEREBROVASC DIS, V15, P23, DOI 10.1159/000068208; Brainin M, 2003, CEREBROVASC DIS, V15, P29, DOI 10.1159/000068211; Busse O, 2003, CEREBROVASC DIS, V15, P8, DOI 10.1159/000068212; Czlonkowska A, 2003, CEREBROVASC DIS, V15, P14, DOI 10.1159/000068209; Hommel M, 2003, CEREBROVASC DIS, V15, P11, DOI 10.1159/000068206; Indredavik B, 2003, CEREBROVASC DIS, V15, P19, DOI 10.1159/000068213; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Melo TP, 2003, CEREBROVASC DIS, V15, P21, DOI 10.1159/000068205; Sterzi R, 2003, CEREBROVASC DIS, V15, P16, DOI 10.1159/000068210; *STROK UN TRIAL CO, 2003, COCHR LIB; Sulter G, 2003, STROKE, V34, P101, DOI 10.1161/01.STR.0000048148.09143.6C; 2003, HLTH WHICH       AUG, P16	14	39	42	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2004	363	9412					834	835		10.1016/S0140-6736(04)15771-1	http://dx.doi.org/10.1016/S0140-6736(04)15771-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803LB	15031023				2022-12-01	WOS:000220231500004
J	Herwald, H; Cramer, H; Morgelin, M; Russell, W; Sollenberg, U; Norrby-Teglund, A; Flodgaard, H; Lindbom, L; Bjorck, L				Herwald, H; Cramer, H; Morgelin, M; Russell, W; Sollenberg, U; Norrby-Teglund, A; Flodgaard, H; Lindbom, L; Bjorck, L			M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage	CELL			English	Article							A STREPTOCOCCAL INFECTIONS; HEPARIN-BINDING PROTEIN; HUMAN NEUTROPHILS; CYSTEINE PROTEINASE; SURFACE-PROTEINS; PATHOGENESIS; ACTIVATION; GENERATION; SECRETION; INSERTION	Increased vascular permeability is a key feature of inflammatory conditions. In severe infections, leakage of plasma from the vasculature induces a life-threatening hypotension. Streptococcus pyogenes, a major human bacterial pathogen, causes a toxic shock syndrome (STSS) characterized by excessive plasma leakage and multi-organ failure. Here we find that M protein, released from the streptococcal surface, forms complexes with fibrinogen, which by binding to beta(2) integrins of neutrophils, activate these cells. As a result, neutrophils release heparin binding protein, an inflammatory mediator inducing vascular leakage. in mice, injection of M protein or subcutaneous infection with S. pyogenes causes severe pulmonary damage characterized by leakage of plasma and blood cells. These lesions were prevented by treatment with a beta(2) integrin antagonist. In addition, M protein/fibrinogen complexes were identified in tissue biopsies from a patient with necrotizing fasciitis and STSS, further underlining the pathogenic significance of such complexes in severe streptococcal infections.	Lund Univ, Dept Cell & Mol Biol, S-22184 Lund, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Ctr Infect Med, S-14186 Huddinge, Sweden; Leukotech AS, DK-2100 Copenhagen, Denmark	Lund University; Karolinska Institutet; Karolinska Institutet	Herwald, H (corresponding author), Lund Univ, Dept Cell & Mol Biol, Tornavagen 10, S-22184 Lund, Sweden.	heiko.herwald@medkem.lu.se	Herwald, Heiko/AAN-3708-2021	Herwald, Heiko/0000-0002-8111-2842; Lindbom, Lennart/0000-0001-9243-257X				AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Altieri DC, 1999, THROMB HAEMOSTASIS, V82, P781; Axelsson L, 2000, EXP CELL RES, V256, P257, DOI 10.1006/excr.2000.4816; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; Crockett-Torabi E, 1998, J LEUKOCYTE BIOL, V63, P1; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Dib K, 2000, FRONT BIOSCI-LANDMRK, V5, pD438, DOI 10.2741/Pathology; Edens HA, 2003, CURR OPIN HEMATOL, V10, P25, DOI 10.1097/00062752-200301000-00005; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; FLODGAARD H, 1991, EUR J BIOCHEM, V197, P535, DOI 10.1111/j.1432-1033.1991.tb15942.x; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; HARBAUGH MP, 1993, MOL MICROBIOL, V8, P981, DOI 10.1111/j.1365-2958.1993.tb01642.x; Herwald H, 2003, J THROMB HAEMOST, V1, P284, DOI 10.1046/j.1538-7836.2003.00105.x; HOLM SE, 1992, J INFECT DIS, V166, P31, DOI 10.1093/infdis/166.1.31; KANTOR FS, 1965, J EXP MED, V121, P849, DOI 10.1084/jem.121.5.849; Kihlberg BM, 1995, MICROB PATHOGENESIS, V19, P299, DOI 10.1016/S0882-4010(96)80003-9; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCEFIE.RC, 1969, J GEN MICROBIOL, V55, P161, DOI 10.1099/00221287-55-2-161; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Lindmark A, 1999, J LEUKOCYTE BIOL, V66, P634, DOI 10.1002/jlb.66.4.634; LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Norrby-Teglund A, 2001, J INFECT DIS, V184, P853, DOI 10.1086/323443; Norrby-Teglund A, 2000, EUR J IMMUNOL, V30, P3247, DOI 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D; Ooe K, 1999, CLIN INFECT DIS, V28, P1317, DOI 10.1086/514785; Persson K, 2003, J BIOL CHEM, V278, P31884, DOI 10.1074/jbc.M302522200; Rasmussen PB, 1996, FEBS LETT, V390, P109, DOI 10.1016/0014-5793(96)00639-4; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; RUF A, 1995, BRIT J HAEMATOL, V90, P791, DOI 10.1111/j.1365-2141.1995.tb05197.x; Stevens Dennis L., 2003, Curr Infect Dis Rep, V5, P379, DOI 10.1007/s11908-003-0017-7; STEVENS DL, 1995, EMERG INFECT DIS, V1, P69, DOI 10.3201/eid0103.950301; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; Yan SR, 1995, J INFLAMM, V45, P297	40	250	268	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					367	379		10.1016/S0092-8674(04)00057-1	http://dx.doi.org/10.1016/S0092-8674(04)00057-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016372	Bronze			2022-12-01	WOS:000188825800006
J	Kobayashi, S; Goto-Yamamoto, N; Hirochika, H				Kobayashi, S; Goto-Yamamoto, N; Hirochika, H			Retrotransposon-induced mutations in grape skin color	SCIENCE			English	Article							ANTHOCYANIN BIOSYNTHESIS; GENES		Natl Inst Fruit Tree Sci, Dept Grape & Persimmon Res, Hiroshima 7292494, Japan; Natl Res Inst Brewing, Hiroshima 7390046, Japan; Natl Inst Agrobiol Sci, Dept Mol Genet, Tsukuba, Ibaraki 3058602, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan	Kobayashi, S (corresponding author), Natl Inst Fruit Tree Sci, Dept Grape & Persimmon Res, Hiroshima 7292494, Japan.	skobaya@affrc.go.jp		KOBAYASHI, SHOZO/0000-0001-6306-9273				Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; KOBAYASHI S, UNPUB; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Mullins MG., 1992, BIOL GRAPEVINE BIOL; ROEDER GS, 1980, CELL, V21, P239, DOI 10.1016/0092-8674(80)90131-2	6	656	756	13	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					982	982		10.1126/science.1095011	http://dx.doi.org/10.1126/science.1095011			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143274				2022-12-01	WOS:000221383300039
J	Verlinsky, Y; Rechitsky, S; Sharapova, T; Morris, R; Taranissi, M; Kuliev, A				Verlinsky, Y; Rechitsky, S; Sharapova, T; Morris, R; Taranissi, M; Kuliev, A			Preimplantation HLA testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIAGNOSIS; MUTATION	Context Preimplantation genetic diagnosis (PGD) has become an option for couples for whom termination of an affected pregnancy identified by traditional prenatal diagnosis is unacceptable and is applicable to indications beyond those of prenatal diagnosis, such as HLA matching to affected siblings to provide stem cell transplantation. Objective To describe preimplantation HLA typing, not involving identification of a causative gene, for couples who had children with bone marrow disorders at need for HLA-matched stem cell transplantation. Design, Setting, and Participants HLA matching procedures conducted at a single site during 2002-2003 in an in vitro fertilization program for 9 couples with children affected by acute lymphoid leukemia, acute myeloid leukemia, or Diamond-Blackfan anemia requiring HLA-matched stem cell transplantation. In 13 clinical cycles, DNA in single blastomeres removed from 8-cell embryos following in vitro fertilization was analyzed for HLA genes simultaneously with analysis for short tandem repeats in the HLA region to select and transfer only those embryos that were HLA matched to affected siblings. Main Outcome Measures Results of HLA matching and pregnancy outcome. Results As a result of testing a total of 199 embryos, 45 (23%) HLA-matched embryos were selected, of which 28 were transferred in 12 clinical cycles, resulting in 5 singleton pregnancies and birth of 5 HILA-matched healthy children. Conclusion This is the first known experience of preimplantation HLA typing performed without PGD for a causative gene, providing couples with a realistic option of having HLA-matched offspring to serve as potential donors of stem cells for their affected siblings.	Inst Reprod Genet, Chicago, IL 60657 USA; Assisted Reprod & Gynaecol Ctr, London, England		Kuliev, A (corresponding author), Inst Reprod Genet, 2825 N Halsted St, Chicago, IL 60657 USA.	anverkuliev@hotmail.com	Kuliev, Anver/P-5666-2018	Kuliev, Anver/0000-0002-2486-9339				Abou-Sleiman PM, 2002, MOL HUM REPROD, V8, P304, DOI 10.1093/molehr/8.3.304; Adamson GD, 2000, FERTIL STERIL, V74, P641; Damewood MD, 2001, JAMA-J AM MED ASSOC, V285, P3143, DOI 10.1001/jama.285.24.3143; De Boer K, 2000, HUM REPROD, V15, P2673; Edwards R G, 2003, Reprod Biomed Online, V6, P170; Foissac A, 2000, TISSUE ANTIGENS, V55, P477, DOI 10.1034/j.1399-0039.2000.550601.x; *INT WORK GROUP PR, 2001, REPROD BIOMED ONLINE, V3, P49; KULIEV A, 2002, REPROD BIOMED ONLINE, V5, P296; Munne Santiago, 2002, Reprod Biomed Online, V4, P183; Rechitsky S, 1999, J ASSIST REPROD GEN, V16, P192, DOI 10.1023/A:1020312823155; Rechitsky Svetlana, 2002, Reprod Biomed Online, V5, P148; Verlinsky Y, 2003, NEW ENGL J MED, V348, P1449, DOI 10.1056/NEJMoa022652; Verlinsky Y, 2002, JAMA-J AM MED ASSOC, V287, P1018, DOI 10.1001/jama.287.8.1018; Verlinsky Y, 2001, JAMA-J AM MED ASSOC, V285, P3130, DOI 10.1001/jama.285.24.3130; VERLINSKY Y, 2000, ATLAS PREIMPLANTATIO; VERLINSKY Y, IN PRESS FERTIL STER; DIAMOND BLACKFAN ANE; 1998, B WHO, V76, P313	18	114	119	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2004	291	17					2079	2085		10.1001/jama.291.17.2079	http://dx.doi.org/10.1001/jama.291.17.2079			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JR	15126435	Bronze			2022-12-01	WOS:000221174300024
J	Sandri, M; Sandri, C; Gilbert, A; Skurk, C; Calabria, E; Picard, A; Walsh, K; Schiaffino, S; Lecker, SH; Goldberg, AL				Sandri, M; Sandri, C; Gilbert, A; Skurk, C; Calabria, E; Picard, A; Walsh, K; Schiaffino, S; Lecker, SH; Goldberg, AL			Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy	CELL			English	Article							NF-KAPPA-B; GENE-EXPRESSION; PROTEASOME PATHWAY; MAMMALIAN-CELLS; GROWTH; HYPERTROPHY; DAF-16; FKHR; DIFFERENTIATION; IDENTIFICATION	Skeletal muscle atrophy is a debilitating response to fasting, disuse, cancer, and other systemic diseases. In atrophying muscles, the ubiquitin ligase, atrogin-1 (MAFbx), is dramatically induced, and this response is necessary for rapid atrophy. Here, we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogrin-1 induction. IGF-1 treatment or AKT overexpression inhibits Foxo and atrogin-1 expression. Moreover, constitutively active Foxo3 acts on the atrogin-1 promoter to cause atrogin-1 transcription and dramatic atrophy of myotubes and muscle fibers. When Foxo activation is blocked by a dominant-negative construct in myotubes or by RNAi in mouse muscles in vivo, atrogin-1 induction during starvation and atrophy of myotubes induced by glucocorticoids are prevented. Thus, forkhead factor(s) play a critical role in the development of muscle atrophy, and inhibition of Foxo factors is an attractive approach to combat muscle wasting.	Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Venetian Inst Mol Med, Dept Biomed Sci, I-35129 Padua, Italy; Boston Univ, Sch Med, Inst Cardiovasc Res, Boston, MA 02118 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Veneto Institute Molecular Medicine; Boston University	Lecker, SH (corresponding author), Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA.	slecker@bidmc.harvard.edu; alfred_goldberg@hms.harvard.edu	Calabria, Elisa/K-3849-2014	Calabria, Elisa/0000-0001-6557-0379; Schiaffino, Stefano/0000-0002-5607-6421; Walsh, Kenneth/0000-0001-7580-2276	NIAMS NIH HHS [R01 AR040197] Funding Source: Medline; NIA NIH HHS [R01 AG015052] Funding Source: Medline; NIDDK NIH HHS [DK02707, R01 DK062307, DK62307] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002707, R01DK062307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SACHECK J, 2004, AM J PHYSL; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; STITT TN, 2004, IN PRESS MOL CELL; TRAN H, 2003, SCI STKE; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293	41	2074	2177	10	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					399	412		10.1016/S0092-8674(04)00400-3	http://dx.doi.org/10.1016/S0092-8674(04)00400-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109499	Green Accepted, Bronze			2022-12-01	WOS:000221176400013
J	Serhan, CN				Serhan, CN			Clues for new therapeutics in osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIPID MEDIATORS; INFLAMMATION; MICE		Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Serhan, CN (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Goh J, 2003, GASTROENTEROLOGY, V124, P1043, DOI 10.1053/gast.2003.50154; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Kobayashi T, 2002, PROSTAG OTH LIPID M, V68-9, P557, DOI 10.1016/S0090-6980(02)00055-2; Krieg P, 2001, GENOMICS, V73, P323, DOI 10.1006/geno.2001.6519; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856	5	4	5	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1902	1903		10.1056/NEJMcibr040318	http://dx.doi.org/10.1056/NEJMcibr040318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115837				2022-12-01	WOS:000221080300016
J	Fischer, MA; Avorn, J				Fischer, MA; Avorn, J			Economic implications of evidence-based prescribing for hypertension - Can better care cost less?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIHYPERTENSIVE THERAPY; SYSTOLIC HYPERTENSION; DRUG COVERAGE; PRESCRIPTION; OUTCOMES; MEDICATIONS; PREVENTION; MANAGEMENT; ACCURACY; LOSARTAN	Context Deviation from evidence-based guidelines in hypertension treatment is common, but its economic impact has not been rigorously studied. Suboptimal prescribing patterns contribute to the high cost of medications for elderly patients as well as the difficulty in providing affordable prescription drug benefits for older. Americans. Objective To calculate the potential savings from the perspective of healthcare payers that would result from increased adherence to evidence-based recommendations for managing hypertension in patients older than 65 years. Design Comparative analysis of medications prescribed vs potential regimens suggested by evidence-based guidelines tailored to each patient's medical history, with calculation of the costs of both the actual and the evidence-based regimens. Setting and Patients A total of 133624 patients being treated for hypertension during 2001 who were enrolled in a large state pharmaceutical assistance program that provides prescription drug insurance for elderly persons. Main Outcome Measure Cost difference between medications actually prescribed and regimens suggested by evidence-based guidelines. Results The patients studied filled more than 2.05 million prescriptions for antihypertensive medications in 2001, at an annual program cost of $48.5 million ($363 per patient). We identified 815316 prescriptions (40%) for which an alternative regimen appeared more appropriate according to evidence-based recommendations. Such changes would have reduced the costs to payers in 2001 by $11.6 million (nearly a quarter of program spending on anti hypertensive medications), as well as being more clinically appropriate overall. Replacement of calcium channel blockers resulted in the largest potential savings. Use of pricing limits similar to those in the Medicaid program would have resulted in even larger potential savings of $20.5 million (42% of program costs). Conclusions Adherence to evidence-based prescribing guidelines for hypertension could result in substantial savings in prescription costs for elderly patients with hypertension that would amount to savings of about $1.2 billion nationally. Identification of similar areas in which prescribing can be improved will be critical for the affordability of prescription drug benefit programs.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fischer, MA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	mfischer@partners.org			NATIONAL INSTITUTE ON AGING [R03AG018395] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; *AM HEART ASS, 2001, 2002 HEART STROK STA; [Anonymous], HLTH US 2000 AD HLTH; [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Avorn J, 2004, POWERFUL MED BENEFIT; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Blustein J, 2000, HEALTH AFFAIR, V19, P219, DOI 10.1377/hlthaff.19.2.219; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHRISTENSEN DB, 1994, ANN PHARMACOTHER, V28, P99, DOI 10.1177/106002809402800119; Cutler Jeffrey A, 2003, J Clin Hypertens (Greenwich), V5, P192, DOI 10.1111/j.1524-6175.2003.02521.x; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Davis BR, 2002, ANN INTERN MED, V137, P313, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00006; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; Ferrara A, 2001, DIABETES CARE, V24, P1144, DOI 10.2337/diacare.24.7.1144; Franse LV, 2000, HYPERTENSION, V35, P1025, DOI 10.1161/01.HYP.35.5.1025; FREID VM, 2003, CHARTBOOK TRENDS HLT; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Giles TD, 1999, AM J CARDIOL, V84, p25K; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; *HJ KAIS FAM FDN, 2001, MED PRESCR DRUGS; Hodgson TA, 2001, MED CARE, V39, P599, DOI 10.1097/00005650-200106000-00008; Knight EL, 2001, ANN INTERN MED, V135, P703, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00009; LASCHOBER MA, 2002, HLTH AFF MILLWOOD, pW127; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MANOLIO TA, 1995, ARCH INTERN MED, V155, P829, DOI 10.1001/archinte.155.8.829; MARRE M, 1988, BMJ-BRIT MED J, V297, P1092, DOI 10.1136/bmj.297.6656.1092; Maselli JH, 2001, J CLIN EPIDEMIOL, V54, P196, DOI 10.1016/S0895-4356(00)00269-9; Monane M, 1996, AM J PUBLIC HEALTH, V86, P1805, DOI 10.2105/AJPH.86.12.1805; Monane M, 1997, AM J HYPERTENS, V10, P697, DOI 10.1016/S0895-7061(97)00056-3; *NAT PHARM COUNC, 2001, PHARM BEN STAT MED A; PEAR R, 2004, NY TIMES        0130, pA1; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Ramsey S D, 1999, J Am Board Fam Pract, V12, P105; *SAS I INC, 2003, SAS VERS 8 2 COMP PR; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Solomon DH, 2003, AM J MED, V115, P398, DOI 10.1016/S0002-9343(03)00357-7; Solomon DH, 2003, AM J MED, V115, P715, DOI 10.1016/j.amjmed.2003.08.025; Steinman MA, 2001, J GEN INTERN MED, V16, P793, DOI 10.1046/j.1525-1497.2001.10412.x; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	48	141	147	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1850	1856		10.1001/jama.291.15.1850	http://dx.doi.org/10.1001/jama.291.15.1850			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100203	Bronze			2022-12-01	WOS:000220871200025
J	Wright, EB; Holcombe, C; Salmon, P				Wright, EB; Holcombe, C; Salmon, P			Doctors communication of trust, care, and respect in breast cancer: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT COMMUNICATION; PATIENTS PERSPECTIVE; DECISION-MAKING; BAD-NEWS; SKILLS; WOMEN; TRIAL	Objective To determine how patients with breast cancer want their doctors to communicate With them. Design Qualitative study. Setting Breast unit and patients' homes. Participants 39 Women with breast cancer. Main outcome measure Patients' reports of doctors' characteristics or behaviour that they valued or deprecated. Results Patients were not primarily concerned With doctors' communication skills. Instead they emphasised doctors' enduring characteristics. Specifically, they valued doctors whom they believed were technically expert, had formed individual relationships with diem, and respected them. They therefore valued forms of communication that are currently not emphasised in training and research and did not intrinsically value others that are currently thought important, including provision of information and choice. Conclusions Women with breast cancer seek to regard their doctors as attachment figures who will care for them. They seek communication that does not compromise this view and that enhances confidence that they are cared for. Testing and elaborating our analysis will help to focus communication research and teaching on what patients need rather than on what Professionals think they need.	Univ Liverpool, Dept Clin Psychol, Liverpool L69 3GB, Merseyside, England; Royal Liverpool Univ Hosp, Linda McCartney Ctr, Liverpool L7 8XP, Merseyside, England	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Salmon, P (corresponding author), Univ Liverpool, Dept Clin Psychol, Liverpool L69 3GB, Merseyside, England.	psalmon@liv.ac.uk	Salmon, Peter/H-5289-2018; Wright, Emma Burkitt/X-6623-2019	Salmon, Peter/0000-0001-6450-5209; 				BOWLBY J, 1998, MAKING BREAKING AFFE; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Butow PN, 2002, SUPPORT CARE CANCER, V10, P161, DOI 10.1007/s005200100290; Cegala DJ, 2002, MED EDUC, V36, P1004, DOI 10.1046/j.1365-2923.2002.01331.x; de Haes H, 2003, PATIENT EDUC COUNS, V50, P43, DOI 10.1016/S0738-3991(03)00079-X; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fallowfield L, 1997, PATIENT EDUC COUNS, V30, P209, DOI 10.1016/S0738-3991(96)00947-0; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; Guba EG, 1989, 4 GENERATION EVALUAT; Henman MJ, 2002, PSYCHO-ONCOLOGY, V11, P295, DOI 10.1002/pon.566; Hulsman RL, 2002, MED EDUC, V36, P125, DOI 10.1046/j.1365-2923.2002.01074.x; Jefford M, 2002, LANCET ONCOL, V3, P629, DOI 10.1016/S1470-2045(02)00877-X; Larsson G, 1998, J ADV NURS, V27, P855, DOI 10.1046/j.1365-2648.1998.00583.x; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Maguire P, 1999, EUR J CANCER, V35, P2058, DOI 10.1016/S0959-8049(99)00301-9; McWilliam CL, 2000, PATIENT EDUC COUNS, V39, P191, DOI 10.1016/S0738-3991(99)00040-3; Rankin N, 2000, EUR J CANCER CARE, V9, P97; Rutter DR, 1996, PSYCHOL HEALTH, V12, P57, DOI 10.1080/08870449608406922; Salander P, 1996, SOC SCI MED, V42, P985, DOI 10.1016/0277-9536(95)00204-9; Salander P, 2002, SOC SCI MED, V55, P721, DOI 10.1016/S0277-9536(01)00198-8; Schofield PE, 2001, ANN ONCOL, V12, P365, DOI 10.1023/A:1011100524076; TARTERSALL MHN, 2002, HEMATOL ONCOL CLIN N, V16, P731; Tattersall MHN, 2002, HEMATOL ONCOL CLIN N, V16, P731, DOI 10.1016/S0889-8588(02)00022-9	24	187	188	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2004	328	7444					864	867		10.1136/bmj.38046.771308.7C	http://dx.doi.org/10.1136/bmj.38046.771308.7C			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812XE	15054034	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000220871400015
J	Mann, J				Mann, J			Free sugars and human health: sufficient evidence for action?	LANCET			English	Editorial Material							SERUM-LIPIDS; BODY-WEIGHT; SUCROSE; CONSUMPTION		Univ Otago, Dept Human Nutr, Dunedin, New Zealand; Univ Otago, Dept Med, Dunedin, New Zealand; Univ Otago, Edgar Natl Ctr Diabet Res, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.	beth.gray@stonebow.otago.ac.nz						[Anonymous], 2004, LANCET, V363, P339; Brynes AE, 2003, BRIT J NUTR, V89, P207, DOI 10.1079/BJN2002769; Institute of Medicine, DIET REF INT EN CARB; *JOINT FAO WHO EXP, 66 UN FAOWHO EXP CON; *JOINT FAO WHO EXP, 2003, DIET NUTR PREV CHRON; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Mann JI, 2000, EUR J CLIN NUTR, V54, P353, DOI 10.1038/sj.ejcn.1600962; MANN JI, 1970, LANCET, V1, P870; *OXFAM, 27 OXFAM; Poppitt SD, 2002, AM J CLIN NUTR, V75, P11, DOI 10.1093/ajcn/75.1.11; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; Saris WHM, 2000, INT J OBESITY, V24, P1310, DOI 10.1038/sj.ijo.0801451; Smith JB, 1996, EUR J CLIN NUTR, V50, P498; Steyn NP, 2003, B WORLD HEALTH ORGAN, V81, P599; *USDA, SUG SWEET DAT TABL	16	25	30	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 27	2004	363	9414					1068	1070		10.1016/S0140-6736(04)15844-3	http://dx.doi.org/10.1016/S0140-6736(04)15844-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15051288				2022-12-01	WOS:000220497300023
J	Kirkup, BC; Riley, MA				Kirkup, BC; Riley, MA			Antibiotic-mediated antagonism leads to a bacterial game of rock-paper-scissors in vivo	NATURE			English	Article							MOUSE LARGE-INTESTINE; ESCHERICHIA-COLI K-12; PROMOTES BIODIVERSITY; STREPTOMYCIN; COLICINOGENY; COLONIZATION; MICE	Colicins are narrow-spectrum antibiotics produced by and active against Escherichia coli and its close relatives. Colicin-producing strains cannot coexist with sensitive or resistant strains in a well-mixed culture, yet all three phenotypes are recovered in natural populations(1). Recent in vitro results conclude that strain diversity can be promoted by colicin production in a spatially structured, non-transitive interaction(2), as in the classic nontransitive model rock - paper - scissors (RPS). In the colicin version of the RPS model, strains that produce colicins (C) kill sensitive (S) strains, which outcompete resistant (R) strains, which outcompete C strains. Pairwise in vitro competitions between these three strains are resolved in a predictable order ( C beats S, S beats R, and R beats C), but the complete system of three strains presents the opportunity for dynamic equilibrium(2). Here we provide conclusive evidence of an in vivo antagonistic role for colicins and show that colicins ( and potentially other bacteriocins) may promote, rather than eliminate, microbial diversity in the environment.	Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA	Yale University	Kirkup, BC (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA.	bckirkup@post.harvard.edu	Riley, Margaret Ann/AAB-9743-2022; Kirkup, Benjamin/C-3610-2009	Kirkup, Benjamin/0000-0002-8722-6218				BERRY RJ, 1981, S ZOOLOGICAL SOC LON, V47, P395; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Feldgarden M, 1999, EVOLUTION, V53, P1019, DOI 10.1111/j.1558-5646.1999.tb04517.x; FREDERICQ P, 1957, ANNU REV MICROBIOL, V11, P7, DOI 10.1146/annurev.mi.11.100157.000255; Gordon DM, 1999, MICROBIOL-SGM, V145, P655, DOI 10.1099/13500872-145-3-655; Gordon DM, 1998, MICROBIOL-SGM, V144, P2233, DOI 10.1099/00221287-144-8-2233; HARDY KG, 1975, BACTERIOL REV, V39, P464, DOI 10.1128/MMBR.39.4.464-515.1975; HENTGES D J, 1990, Microbial Ecology in Health and Disease, V3, P105; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LAU CYY, 1976, BIOLOGY, P89; Maynard Smith J., 1982, EVOLUTION THEORY GAM; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; MYHAL ML, 1983, J GEN MICROBIOL, V129, P1549; Pugsley A, 1987, METHODS STUDYING COL; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P369; QUE JU, 1986, INFECT IMMUN, V53, P116, DOI 10.1128/IAI.53.1.116-123.1986; ROWE FP, 1981, S ZOOL SOC LOND, V47, P575; Sweeney NJ, 1996, INFECT IMMUN, V64, P3497, DOI 10.1128/IAI.64.9.3497-3503.1996; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Weibull J.W., 1997, EVOLUTIONARY GAME TH; WILSON KH, 1997, GASTROINTESTINAL MIC, P680	26	354	358	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	2004	428	6981					412	414		10.1038/nature02429	http://dx.doi.org/10.1038/nature02429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042087				2022-12-01	WOS:000220404300039
J	Allen, TM; Cullis, PR				Allen, TM; Cullis, PR			Drug delivery systems: Entering the mainstream	SCIENCE			English	Article							PEGYLATED LIPOSOMAL DOXORUBICIN; AMPHOTERICIN-B AMBISOME; PHASE-I; POLYETHYLENE-GLYCOL; TRIAL; RELEASE; PHARMACOKINETICS; LOCALIZATION; THERAPEUTICS; PERMEABILITY	Drug delivery systems (DDS) such as lipid- or polymer-based nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs administered parenterally. Many of the early problems that hindered the clinical applications of particulate DDS have been overcome, with several DDS formulations of anticancer and antifungal drugs now approved for clinical use. Furthermore, there is considerable interest in exploiting the advantages of DDS for in vivo delivery of new drugs derived from proteomics or genomics research and for their use in ligand-targeted therapeutics.	Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Inex Pharmaceut Corp, Burnaby, BC V5J 5J8, Canada	University of Alberta; University of British Columbia	Allen, TM (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada.	terry.allen@ualberta.ca						ADLERMOORE J, 1994, BONE MARROW TRANSPL, V14, pS3; Alberts DS, 1997, DRUGS, V54, P30, DOI 10.2165/00003495-199700544-00007; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Batist G, 2001, J CLIN ONCOL, V19, P1444, DOI 10.1200/JCO.2001.19.5.1444; Bolotin Elijah M., 1994, Journal of Liposome Research, V4, P455, DOI 10.3109/08982109409037057; BORY C, 1991, ADV EXP MED BIOL, V309, P173; Bressler NM, 2002, AM J OPHTHALMOL, V133, P168, DOI 10.1016/S0002-9394(01)01237-5; Cabanes A, 1998, INT J ONCOL, V12, P1035; Chowdhary RK, 2003, J PHARM PHARM SCI, V6, P13; Cullis PR, 1997, BBA-REV BIOMEMBRANES, V1331, P187, DOI 10.1016/S0304-4157(97)00006-3; DAVIDSON RN, 1994, Q J MED, V87, P75; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Edens HA, 2002, J IMMUNOL, V169, P476, DOI 10.4049/jimmunol.169.1.476; Fang J, 2003, ADV EXP MED BIOL, V519, P29; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Gelmon KA, 1999, J CLIN ONCOL, V17, P697, DOI 10.1200/JCO.1999.17.2.697; Glantz MJ, 1999, J CLIN ONCOL, V17, P3110, DOI 10.1200/JCO.1999.17.10.3110; Glantz MJ, 1999, CLIN CANCER RES, V5, P3394; Glue P, 2000, HEPATOLOGY, V32, P647, DOI 10.1053/jhep.2000.16661; Guo X, 2003, ACCOUNTS CHEM RES, V36, P335, DOI 10.1021/ar9703241; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Huwyler J, 1996, P NATL ACAD SCI USA, V93, P14164, DOI 10.1073/pnas.93.24.14164; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Kaminski MS, 2001, J CLIN ONCOL, V19, P3918, DOI 10.1200/JCO.2001.19.19.3918; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; Liu MJ, 2000, J CONTROL RELEASE, V65, P121, DOI 10.1016/S0168-3659(99)00245-X; Lotem M, 2000, ARCH DERMATOL, V136, P1475, DOI 10.1001/archderm.136.12.1475; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Mehvar Reza, 2003, Current Pharmaceutical Biotechnology, V4, P283, DOI 10.2174/1389201033489685; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Muggia F, 2001, EUR J CANCER, V37, pS15; Nabhan C, 2002, CLIN LYMPHOMA, V2, pS19, DOI 10.3816/CLM.2002.s.004; Netti PA, 1996, MICROVASC RES, V52, P27, DOI 10.1006/mvre.1996.0041; Northfelt DW, 1996, J CLIN PHARMACOL, V36, P55, DOI 10.1002/j.1552-4604.1996.tb04152.x; Ogris Manfred, 2002, Somatic Cell and Molecular Genetics, V27, P85, DOI 10.1023/A:1022988008131; Olsen E, 2001, J CLIN ONCOL, V19, P376, DOI 10.1200/JCO.2001.19.2.376; Pastorino F, 2003, CLIN CANCER RES, V9, P4595; PETERS BG, 1995, FORMULARY, V30, P388; SAMUELS BL, 1987, CANCER TREAT REP, V71, P971; Schiffelers RM, 2001, PHARMACEUT RES, V18, P780, DOI 10.1023/A:1011080211226; Semple SC, 1996, BIOCHEMISTRY-US, V35, P2521, DOI 10.1021/bi950414i; Senter PD, 2001, ADV DRUG DELIVER REV, V53, P247, DOI 10.1016/S0169-409X(01)00206-X; Seymour LW, 1998, INT J ONCOL, V12, P1217; Siena S, 2003, ONCOL REP, V10, P715; Smith DH, 2002, ANN ONCOL, V13, P1590, DOI 10.1093/annonc/mdf275; Szebeni J, 2002, J LIPOSOME RES, V12, P165, DOI 10.1081/LPR-120004790; Tardi P, 2000, CANCER RES, V60, P3389; Templeton NS, 2003, EXPERT OPIN BIOL TH, V3, P57, DOI 10.1517/eobt.3.1.57.20953; Terwogt JMM, 2002, CANCER CHEMOTH PHARM, V49, P201, DOI 10.1007/s002800100371; TOLLEMAR J, 1992, MYCOSES, V35, P215, DOI 10.1111/j.1439-0507.1992.tb00850.x; TREAT J, 2000, P AN M AM SOC CLIN, V19, pA225; UZIELY B, 1995, J CLIN ONCOL, V13, P1777, DOI 10.1200/JCO.1995.13.7.1777; Vasey PA, 1999, CLIN CANCER RES, V5, P83; Wiseman GA, 2002, BLOOD, V99, P4336, DOI 10.1182/blood.V99.12.4336	56	3401	3544	26	1972	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2004	303	5665					1818	1822		10.1126/science.1095833	http://dx.doi.org/10.1126/science.1095833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	15031496				2022-12-01	WOS:000220281600044
J	Stevens, CJ; Dise, NB; Mountford, JO; Gowing, DJ				Stevens, CJ; Dise, NB; Mountford, JO; Gowing, DJ			Impact of nitrogen deposition on the species richness of grasslands	SCIENCE			English	Article							SEMINATURAL GRASSLANDS; VEGETATION; LIMITATION; SWEDEN; TRENDS	A transect of 68 acid grasslands across Great Britain, covering the lower range of ambient annual nitrogen deposition in the industrialized world ( 5 to 35 kg N ha(-1) year(-1)), indicates that long-term, chronic nitrogen deposition has significantly reduced plant species richness. Species richness declines as a linear function of the rate of inorganic nitrogen deposition, with a reduction of one species per 4-m(2) quadrat for every 2.5 kg N ha(-1) year(-1) of chronic nitrogen deposition. Species adapted to infertile conditions are systematically reduced at high nitrogen deposition. At the mean chronic nitrogen deposition rate of central Europe (17 kgNha(-1) year(-1)), there is a 23% species reduction compared with grasslands receiving the lowest levels of nitrogen deposition.	Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England; Villanova Univ, Dept Biol, Villanova, PA 19085 USA; NERC, Ctr Ecol & Hydrol, Huntingdon PE17 2LS, England	Open University - UK; Open University - UK; Villanova University; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Stevens, CJ (corresponding author), Open Univ, Dept Earth Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	c.j.stevens@open.ac.uk		Stevens, Carly/0000-0002-2390-1763				AERTS R, 1990, OIKOS, V57, P310, DOI 10.2307/3565959; Baumgardner RE, 2002, ENVIRON SCI TECHNOL, V36, P2614, DOI 10.1021/es011146g; Berendse F., 1990, Perspectives on plant competition., P93; Blake L, 1999, EUR J SOIL SCI, V50, P401, DOI 10.1046/j.1365-2389.1999.00253.x; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; *CTR EC HYDR, 2001, TRANSB AIR POLL AC E; Diekmann M, 1999, PLANT BIOLOGY, V1, P471, DOI 10.1111/j.1438-8677.1999.tb00730.x; DIRKSE GM, 1992, BIOL CONSERV, V59, P155, DOI 10.1016/0006-3207(92)90576-9; Galloway JN, 1995, WATER AIR SOIL POLL, V85, P15, DOI 10.1007/BF00483685; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Goulding KWT, 1998, NEW PHYTOL, V139, P49, DOI 10.1046/j.1469-8137.1998.00182.x; HALL J, 1998, STATUS CRITICAL LOAD; HALLINGBACK T, 1992, BIOL CONSERV, V59, P163, DOI 10.1016/0006-3207(92)90577-A; Hill M.O., 1999, ELLENBERGS INDICATOR; Kent M., 2012, VEGETATION DESCRIPTI; Lee JA, 1998, NEW PHYTOL, V139, P127, DOI 10.1046/j.1469-8137.1998.00165.x; MORECROFT MD, 1994, J ECOL, V82, P475, DOI 10.2307/2261256; MOUNTFORD JO, 1993, J APPL ECOL, V30, P321, DOI 10.2307/2404634; Phoenix GK, 2003, GLOBAL CHANGE BIOL, V9, P1309, DOI 10.1046/j.1365-2486.2003.00660.x; RODWELL JS, 1992, GRASSLANDS MONTANE C; SILVERTOWN J, 1980, J APPL ECOL, V17, P491, DOI 10.2307/2402344; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Wright RF, 2001, HYDROL EARTH SYST SC, V5, P299, DOI 10.5194/hess-5-299-2001; 1992, 9243EEC; [No title captured]	26	1025	1158	32	874	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2004	303	5665					1876	1879		10.1126/science.1094678	http://dx.doi.org/10.1126/science.1094678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	15031507				2022-12-01	WOS:000220281600058
J	Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Harvey, K; Gispert, S; Ali, Z; Del Turco, D; Bentivoglio, AR; Healy, DG; Albanese, A; Nussbaum, R; Gonzalez-Maldonaldo, R; Deller, T; Salvi, S; Cortelli, P; Gilks, WP; Latchman, DS; Harvey, RJ; Dallapiccola, B; Auburger, G; Wood, NW				Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Harvey, K; Gispert, S; Ali, Z; Del Turco, D; Bentivoglio, AR; Healy, DG; Albanese, A; Nussbaum, R; Gonzalez-Maldonaldo, R; Deller, T; Salvi, S; Cortelli, P; Gilks, WP; Latchman, DS; Harvey, RJ; Dallapiccola, B; Auburger, G; Wood, NW			Hereditary early-onset Parkinson's disease caused by mutations in PINK1	SCIENCE			English	Article							ALPHA-SYNUCLEIN; NEURODEGENERATION; APOPTOSIS; NEURONS	Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.	IRCCS, CSS, Mendel Inst, I-00198 Rome, Italy; Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00187 Rome, Italy; Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Goethe Univ Frankfurt, Inst Expt Neurobiol, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Sect Mol Neurogenet, Neurol Clin, D-60590 Frankfurt, Germany; Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy; Natl Neurol Inst Carlo Besta, I-20133 Milan, Italy; NHGRI, NIH, Bethesda, MD 20892 USA; Hosp Univ San Cecilio, Dept Neurol, Granada 18012, Spain; Univ Modena & Reggio Emilia, Dept Neurosci, I-41100 Modena, Italy; Univ London Birkbeck Coll, London WC1E 7HX, England	IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of London; University College London; Sapienza University Rome; University of London; University College London; University of London; University College London; University of London School of Pharmacy; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Neurologico Besta; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Hospital Universitario San Cecilio; Universita di Modena e Reggio Emilia; University of London; Birkbeck University London	Valente, EM (corresponding author), IRCCS, CSS, Mendel Inst, Viale Regina Margherita 261, I-00198 Rome, Italy.	e.valente@css-mendel.it; auburger@em.uni-frankfurt.de; n.wood@ion.ucl.ac.uk	Valente, Enza Maria/G-2942-2017; Bentivoglio, Anna Rita/K-3752-2018; Cortelli, Pietro/K-6063-2016; Wood, Nicholas W/C-2505-2009; Harvey, Robert J/D-3994-2016; Gilks, William/P-9137-2015; Albanese, Alberto/K-7396-2016; Dallapiccola, Bruno/K-8692-2016	Valente, Enza Maria/0000-0002-0600-6820; Wood, Nicholas W/0000-0002-9500-3348; Harvey, Robert J/0000-0001-5956-6664; Gilks, William/0000-0001-7814-3173; Albanese, Alberto/0000-0002-5864-0006; Cortelli, Pietro/0000-0002-3633-8818; Ali, Zeeshan/0000-0002-1668-8634; Muqit, Miratul/0000-0001-9733-2404; Dallapiccola, Bruno/0000-0002-5031-1013; Bentivoglio, Anna Rita/0000-0002-9663-095X	Parkinson&apos;s UK [G-4029] Funding Source: Medline; Telethon [GGP02089] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER	Parkinson&apos;s UK(Parkinson&apos;s UK); Telethon(Fondazione Telethon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Sherer TB, 2002, J NEUROSCI, V22, P7006; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2002, ANN NEUROL, V51, P14, DOI 10.1002/ana.10053; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522	16	2454	2543	8	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1158	1160		10.1126/science.1096284	http://dx.doi.org/10.1126/science.1096284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15087508				2022-12-01	WOS:000221524500043
J	Hoerger, TJ; Harris, R; Hicks, KA; Donahue, K; Sorensen, S; Engelgau, M				Hoerger, TJ; Harris, R; Hicks, KA; Donahue, K; Sorensen, S; Engelgau, M			Screening for type 2 diabetes mellitus: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							LOWER-EXTREMITY AMPUTATION; BLOOD-PRESSURE CONTROL; DIRECT MEDICAL COSTS; MICROVASCULAR COMPLICATIONS; LIFE-STYLE; NIDDM; HYPERTENSION; PREVALENCE; UTILITIES; MORTALITY	Background: No randomized, controlled trial of screening for diabetes has been conducted. in the absence of direct evidence, cost-effectiveness models may provide guidance about preferred screening strategies. Objective: To estimate the incremental cost-effectiveness of 2 diabetes screening strategies: screening targeted to people with hypertension and universal screening. Design: Markov model. Data Sources: United Kingdom Prospective Diabetes Study, Hypertension Optimal Treatment trial, and recent cost data. Target Population: General primary care population in the United States. Time Horizon: Lifetime. Perspective: Health care system. Interventions: Diabetes screening targeted to people with hypertension and universal screening. Outcome Measures: Cost per quality-adjusted life-year (QALY) gained. Costs (in 1997 U.S. dollars) and QALYs discounted at a 3% annual rate. Results of Base-Case Analysis: At all ages, incremental cost-effectiveness ratios were more favorable for screening targeted to people with hypertension than for universal screening. For example, at age 55 years, the cost per QALY for targeted screening compared with no screening was $34 375, whereas the cost per QALY for universal screening compared with targeted screening was $360 966. Screening was more cost-effective for ages 55 to 75 years than for younger ages. Results of Sensitivity Analysis: in single-way and probabilistic sensitivity analyses, findings were robust to therapy costs, screening costs, screening lead time, reduced effectiveness of intensive antihypertensive therapy, and increased relative risk reduction for stroke attributable to intensive hypertension control. Limitations: We did not consider screening targeted to persons with dyslipidemia, and we used studies of people whose diabetes was detected clinically to estimate screening benefits. Conclusions: Diabetes screening targeted to people with hypertension is more cost-effective than universal screening. The most cost-effective strategy is targeted screening at age 55 to 75 years.	Res Triangle Inst, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Hoerger, TJ (corresponding author), Res Triangle Inst, POB 12194,3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	tjh@rti.org	Donahue, Katrina/E-7486-2012	Donahue, Katrina/0000-0003-4075-2875; Hoerger, Thomas/0000-0003-4154-7806; Hicks, Katherine/0000-0002-1058-3401	PHS HHS [200-97-0621, 290-97-0011] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P5; *AM DIAB ASS, 2001, DIABETES CARE, V24, pS 21; Brown JB, 1999, ARCH INTERN MED, V159, P1873, DOI 10.1001/archinte.159.16.1873; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DAVIDSON MB, 2001, BMJ US, V1, P297; DONG F, 1997, EC EVALUATION APPROA; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; ECKMAN MH, 1995, JAMA-J AM MED ASSOC, V273, P712, DOI 10.1001/jama.273.9.712; Elliott WJ, 2000, ARCH INTERN MED, V160, P1277, DOI 10.1001/archinte.160.9.1277; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Engelgau MM, 2000, DIABETES CARE, V23, P1563, DOI 10.2337/diacare.23.10.1563; ENGELGAU MM, 1995, DIABETES CARE, V18, P1606, DOI 10.2337/diacare.18.12.1606; Estacio RO, 2000, DIABETES CARE, V23, pB54; Goyder E, 1998, BMJ-BRIT MED J, V317, P1644, DOI 10.1136/bmj.317.7173.1644; Goyder EC, 2000, DIABETIC MED, V17, P469, DOI 10.1046/j.1464-5491.2000.00308.x; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HARRIS MI, 1994, DIABETES CARE, V17, P440, DOI 10.2337/diacare.17.5.440; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HARRIS PR, 2003, SYSTEMATIC EVIDENCE, V19; *HLTH CAR FIN ADM, 1998, 1999 MED CAR DIAGN L; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hofer TP, 2000, INT J TECHNOL ASSESS, V16, P822, DOI 10.1017/S0266462300102090; Huang ES, 2001, AM J MED, V111, P633, DOI 10.1016/S0002-9343(01)00978-0; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; HUMPHREY LL, 1994, ARCH INTERN MED, V154, P885, DOI 10.1001/archinte.154.8.885; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Marshall KG, 1999, CAN MED ASSOC J, V160, P1592; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; *NAT CTR HLTH STAT, 1997, NHANES 3, V11; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; NEASE RF, 1995, JAMA-J AM MED ASSOC, V273, P1185, DOI 10.1001/jama.273.15.1185; O'Brien JA, 1998, DIABETES CARE, V21, P1122, DOI 10.2337/diacare.21.7.1122; *RED BOOK, 1997, 1997 DRUG TOP; REIBER GE, 1995, NIH PUBLICATION, P409; Rolka DB, 2001, DIABETES CARE, V24, P1899, DOI 10.2337/diacare.24.11.1899; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US PREV SERV TASK, 2003, GUIDE CLIN PREVENTIV, P287; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Wingard DL, 1995, NIH PUBLICATION; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551; 1997, RELATIVE VALUE STUDI, pR1	52	112	117	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2004	140	9					689	699		10.7326/0003-4819-140-9-200405040-00008	http://dx.doi.org/10.7326/0003-4819-140-9-200405040-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816XR	15126252				2022-12-01	WOS:000221143100002
J	You, J; Croyle, JL; Nishimura, A; Ozato, K; Howley, PM				You, J; Croyle, JL; Nishimura, A; Ozato, K; Howley, PM			Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes	CELL			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; NUCLEAR ANTIGEN; BROMODOMAIN PROTEIN; EPISOMAL MAINTENANCE; VIRUS PLASMIDS; REPLICATION; CHROMATIN; CELLS; TRANSACTIVATION; TRANSCRIPTION	The papillomavirus E2 protein tethers viral genomes to host mitotic chromosomes to ensure genome maintenance. We have identified the bromodomain protein Brd4 as a major cellular interacting partner of the bovine papillomavirus E2. Brd4 associates with mitotic chromosomes and colocalizes with E2 on mitotic chromosomes. The site of E2 binding maps to the C-terminal domain of Brd4. Expression of this C-terminal Brd4 domain functions in a dominant-negative manner to abrogate the colocalization of E2 with Brd4 on mitotic chromosomes, to block association of the viral episomes with Brd4, and to inhibit BPV-1 DNA-mediated cellular transformation. Brd4 also associates with HPV16 E2, indicating that Brd4 binding may be a shared property of all papillomavirus E2 proteins. The interaction of E2 with Brd4 is required to ensure the tethering of viral genomes to the host mitotic chromosomes for persistence of viral episomes in PV-infected cells.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Howley, PM (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	peter_howley@hms.harvard.edu		Howley, Peter/0000-0002-8668-9579	NCI NIH HHS [R01 CA77385, P01 CA50661] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA050661, R01CA077385] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bastien N, 2000, VIROLOGY, V270, P124, DOI 10.1006/viro.2000.0265; BEDELL MA, 1991, J VIROL, V65, P2254, DOI 10.1128/JVI.65.5.2254-2260.1991; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; GILBERT DM, 1987, CELL, V50, P59, DOI 10.1016/0092-8674(87)90662-3; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Howley PM., 2001, FIELDS VIROLOGY, V2, P2197; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Kapoor P, 2003, J VIROL, V77, P6946, DOI 10.1128/JVI.77.12.6946-6956.2003; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Kurg R, 1999, J VIROL, V73, P4670, DOI 10.1128/JVI.73.6.4670-4677.1999; LAW MF, 1981, P NATL ACAD SCI-BIOL, V78, P2727, DOI 10.1073/pnas.78.5.2727; Lehman CW, 1998, P NATL ACAD SCI USA, V95, P4338, DOI 10.1073/pnas.95.8.4338; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Niki H, 1997, CELL, V90, P951, DOI 10.1016/S0092-8674(00)80359-1; NORDSTROM K, 1989, ANNU REV GENET, V23, P37, DOI 10.1146/annurev.genet.23.1.37; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Piirsoo M, 1996, EMBO J, V15, P1; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Sakai H, 1996, J VIROL, V70, P1602, DOI 10.1128/JVI.70.3.1602-1611.1996; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shire K, 1999, J VIROL, V73, P2587, DOI 10.1128/JVI.73.4.2587-2595.1999; Skiadopoulos MH, 1998, J VIROL, V72, P2079, DOI 10.1128/JVI.72.3.2079-2088.1998; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; Stubenrauch F, 1998, J VIROL, V72, P8115, DOI 10.1128/JVI.72.10.8115-8123.1998; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	36	297	332	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					349	360		10.1016/S0092-8674(04)00402-7	http://dx.doi.org/10.1016/S0092-8674(04)00402-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109495	Bronze			2022-12-01	WOS:000221176400009
J	Engel, A; Thoms, S; Riebesell, U; Rochelle-Newall, E; Zondervan, I				Engel, A; Thoms, S; Riebesell, U; Rochelle-Newall, E; Zondervan, I			Polysaccharide aggregation as a potential sink of marine dissolved organic carbon	NATURE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; MATTER; FLUXES; PARTICULATE; RESPIRATION; NITROGEN; TEP	The formation and sinking of biogenic particles mediate vertical mass fluxes and drive elemental cycling in the ocean(1). Whereas marine sciences have focused primarily on particle production by phytoplankton growth, particle formation by the assembly of organic macromolecules has almost been neglected(2,3). Here we show, by means of a combined experimental and modelling study, that the formation of polysaccharide particles is an important pathway to convert dissolved into particulate organic carbon during phytoplankton blooms, and can be described in terms of aggregation kinetics. Our findings suggest that aggregation processes in the ocean cascade from the molecular scale up to the size of fast-settling particles, and give new insights into the cycling and export of biogeochemical key elements such as carbon, iron and thorium.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Stn Zool, Lab Oceanog Villefrance Mer, F-06234 Villefranche Sur Mer, France	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; UDICE-French Research Universities; Sorbonne Universite	Engel, A (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	anja.engel@stonybrook.edu; sthoms@awi-bremerhaven.de	Riebesell, Ulf/AAC-9717-2020	Engel, Anja/0000-0002-1042-1955; Riebesell, Ulf/0000-0002-9442-452X; Rochelle-Newall, Emma/0000-0003-0951-8650				AMON RMW, 1994, NATURE, V369, P549, DOI 10.1038/369549a0; ASPER VL, 1992, NATURE, V357, P670, DOI 10.1038/357670a0; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078, DOI 10.4319/lo.1991.36.6.1078; Benner R., 2002, BIOGEOCHEMISTRY MARI, P59, DOI [10.1016/B978-012323841-2/50005-1, DOI 10.1016/B978-012323841-2/50005-1]; Biddanda B, 1997, LIMNOL OCEANOGR, V42, P506, DOI 10.4319/lo.1997.42.3.0506; CARLSON CA, 2002, BIOGEOCHEMISTRY MARI, P59; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Engel A, 2004, AQUAT MICROB ECOL, V34, P93, DOI 10.3354/ame034093; Engel A, 2000, J PLANKTON RES, V22, P485, DOI 10.1093/plankt/22.3.485; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Mari X, 1999, MAR ECOL PROG SER, V183, P59, DOI 10.3354/meps183059; MCCAVE IN, 1975, DEEP-SEA RES, V22, P491, DOI 10.1016/0011-7471(75)90022-4; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; Myklestad SM, 1997, MAR CHEM, V56, P279, DOI 10.1016/S0304-4203(96)00074-6; Nanninga HJ, 1996, J MARINE SYST, V9, P67, DOI 10.1016/0924-7963(96)00017-6; Nielsen MV, 1997, J PHYCOL, V33, P818, DOI 10.1111/j.0022-3646.1997.00818.x; PAKULSKI JD, 1994, LIMNOL OCEANOGR, V39, P930, DOI 10.4319/lo.1994.39.4.0930; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Ruiz J, 2002, DEEP-SEA RES PT I, V49, P495, DOI 10.1016/S0967-0637(01)00072-3; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; von Smoluchowski M, 1917, Z PHYS CHEM-STOCH VE, V92, P129; WELLS ML, 1992, MAR CHEM, V40, P5, DOI 10.1016/0304-4203(92)90045-C; Wells ML, 1998, NATURE, V391, P530, DOI 10.1038/35248; Wu JF, 2001, SCIENCE, V293, P847, DOI 10.1126/science.1059251; ZIFF RM, 1980, J CHEM PHYS, V73, P3492, DOI 10.1063/1.440502	30	276	283	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					929	932		10.1038/nature02453	http://dx.doi.org/10.1038/nature02453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118723	Green Published			2022-12-01	WOS:000221083000037
J	Reis, T; Edgar, BA				Reis, T; Edgar, BA			Negative regulation kinases of dE2F1 by cyclin-dependent kinases cell cycle timing	CELL			English	Article							RETINOBLASTOMA FAMILY PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; DROSOPHILA EMBRYOGENESIS; S-PHASE; TRANSCRIPTION FACTOR; DNA-REPLICATION; IMAGINAL DISCS; FISSION YEAST; G(1)-S TRANSITION; E2F	Many types of cells compensate for induced alterations in the length of one cell cycle phase (G1, S, or G2) by altering the lengths of the other phases. Here we show that, when cells in Drosophila wing discs are delayed in G1, they maintain normal division rates by accelerating passage through S and G2. Similarly, when G2-M progression is retarded, G1-S progression accelerates. This compensation mechanism employs negative feedback in which the cyclin-dependent kinases Cdk1 and Cdk2 downregulate the transcription factor dE2F1. dE2F1, in turn, positively regulates cyclin E and string/cdc25, which activate the Cdks to drive cell cycle progression. This homeostatic mechanism coordinates rates of G1-S and G2-M progression, maintaining normal rates of proliferation when cell cycle controls are perturbed (e.g., by ectopic Dacapo, dWee1, dMyc, or Rheb). Without dE2F1, the compensatory mechanism fails, and treatments that alter Cdk activity cause aberrant cell cycle timing and cell death.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Gulbenkian Inst Sci, Programa Gulbenkian Doutoramento Biol & Med, P-2781901 Oeiras, Portugal	Fred Hutchinson Cancer Center	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bedgar@fhcrc.org		Reis, Tania/0000-0001-6879-1265	NIGMS NIH HHS [GM51186] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Bartkova J, 1996, CANCER RES, V56, P5475; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Brook A, 1996, EMBO J, V15, P3676, DOI 10.1002/j.1460-2075.1996.tb00737.x; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; CAMPBELL SD, 1995, MOL BIOL CELL, V6, P1333, DOI 10.1091/mbc.6.10.1333; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; DESALLE LM, 1996, FEBS LETT, V490, P1237; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Duronio RJ, 1996, GENE DEV, V10, P2505, DOI 10.1101/gad.10.19.2505; Duronio RJ, 1998, MOL CELL BIOL, V18, P141, DOI 10.1128/MCB.18.1.141; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Heriche JK, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-9; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Johnston LA, 1996, DEVELOPMENT, V122, P3519; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Kylsten P, 1997, DEV BIOL, V192, P509, DOI 10.1006/dbio.1997.8770; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Martelli F, 1999, P NATL ACAD SCI USA, V96, P2858, DOI 10.1073/pnas.96.6.2858; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NURSE P, 1980, GENETICS, V96, P627; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; Pignoni F, 1997, DEVELOPMENT, V124, P271; Price D, 2000, GENETICS, V155, P159; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Thacker SA, 2003, CURR BIOL, V13, P53, DOI 10.1016/S0960-9822(02)01400-8; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weng L, 2003, EMBO J, V22, P3865, DOI 10.1093/emboj/cdg373; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4	65	103	104	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					253	264		10.1016/S0092-8674(04)00247-8	http://dx.doi.org/10.1016/S0092-8674(04)00247-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084262	Bronze			2022-12-01	WOS:000220913400012
J	Willis, KJ; Gillson, L; Brncic, TM				Willis, KJ; Gillson, L; Brncic, TM			How "virgin" is virgin rainforest?	SCIENCE			English	Editorial Material							AGRICULTURE; ECOLOGY		Univ Oxford, Sch Geog & Environm, Biodivers Res Grp, Oxford Long Term Ecol Lab, Oxford OX1 3TB, England	University of Oxford	Willis, KJ (corresponding author), Univ Oxford, Sch Geog & Environm, Biodivers Res Grp, Oxford Long Term Ecol Lab, Oxford OX1 3TB, England.	kathy.willis@geog.ox.ac.uk	Gillson, Lindsey/AAR-6531-2020	Gillson, Lindsey/0000-0001-9607-6760; Willis, Katherine/0000-0002-6763-2489				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Bayliss-Smith T, 2003, AMBIO, V32, P346, DOI 10.1639/0044-7447(2003)032[0346:RCAHOH]2.0.CO;2; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Foster DR, 2002, J BIOGEOGR, V29, P1269, DOI 10.1046/j.1365-2699.2002.00791.x; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; KEALHOFER L, 2003, ASIAN PERSPECT, V42, P72; Mbida VM, 2000, J ARCHAEOL SCI, V27, P151, DOI 10.1006/jasc.1999.0447; MYERS N, 2002, PROTECTING PROTECT M, P46; Oslisly R., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P101; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; White L. J. T., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P3	13	191	205	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					402	403		10.1126/science.1093991	http://dx.doi.org/10.1126/science.1093991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087539				2022-12-01	WOS:000220845400036
J	Zipfel, C; Robatzek, S; Navarro, L; Oakeley, EJ; Jones, JDG; Felix, G; Boller, T				Zipfel, C; Robatzek, S; Navarro, L; Oakeley, EJ; Jones, JDG; Felix, G; Boller, T			Bacterial disease resistance in Arabidopsis through flagellin perception	NATURE			English	Article							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-5; GENOME-WIDE ANALYSIS; EXTRACELLULAR ALKALINIZATION; SUBNANOMOLAR CONCENTRATIONS; CAENORHABDITIS-ELEGANS; ELICITOR FLAGELLIN; DEFENSE RESPONSES; TOMATO CELLS; PLANT	Plants and animals recognize microbial invaders by detecting pathogen-associated molecular patterns (PAMPs)(1-5) such as flagellin(6-10). However, the importance of flagellin perception for disease resistance has, until now, not been demonstrated(7-11). Here we show that treatment of plants with flg22, a peptide representing the elicitor-active epitope of flagellin(6), induces the expression of numerous defence-related genes and triggers resistance to pathogenic bacteria in wild-type plants, but not in plants carrying mutations in the flagellin receptor gene FLS2. This induced resistance seems to be independent of salicylic acid, jasmonic acid and ethylene signalling. Wild-type and fls2 mutants both display enhanced resistance when treated with crude bacterial extracts, even devoid of elicitor-active flagellin, indicating the existence of functional perception systems for PAMPs other than flagellin. Although fls2 mutant plants are as susceptible as the wild type when bacteria are infiltrated into leaves, they are more susceptible to the pathogen Pseudomonas syringae pv. tomato DC3000 when it is sprayed on the leaf surface. Thus, flagellin perception restricts bacterial invasion, probably at an early step, and contributes to the plant's disease resistance.	John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Friedrich Miescher Institute for Biomedical Research	Boller, T (corresponding author), Univ Basel, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	thomas.boller@unibas.ch	Robatzek, Silke/B-6844-2013; Boller, Thomas/G-3500-2012; Bruening, Stefan/B-8505-2011; ZIPFEL, CYRIL/ABD-5076-2021; ZIPFEL, CYRIL B/D-7103-2011; Jones, Jonathan DG/J-5129-2012	Boller, Thomas/0000-0001-6768-7503; ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583; Jones, Jonathan DG/0000-0002-4953-261X				Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.pp.46.060195.001201; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; GRANADO J, 1995, PLANT PHYSIOL, V107, P485, DOI 10.1104/pp.107.2.485; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Katagiri F., 2002, ARABIDOPSIS BOOK; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; NAVARRO L, IN PRESS PLANT PHYSL; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1	30	1170	1223	12	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					764	767		10.1038/nature02485	http://dx.doi.org/10.1038/nature02485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085136				2022-12-01	WOS:000220823800043
J	Reconditi, M; Linari, M; Lucii, L; Stewart, A; Sun, YB; Boesecke, P; Narayanan, T; Fischetti, RF; Irving, T; Piazzesi, G; Irving, M; Lombardi, V				Reconditi, M; Linari, M; Lucii, L; Stewart, A; Sun, YB; Boesecke, P; Narayanan, T; Fischetti, RF; Irving, T; Piazzesi, G; Irving, M; Lombardi, V			The myosin motor in muscle generates a smaller and slower working stroke at higher load	NATURE			English	Article							FORCE GENERATION; SINGLE; CONTRACTION; FILAMENTS; HEADS; ACTIN; EXTENSIBILITY; REFLECTIONS; TRANSIENTS; DEPENDENCE	Muscle contraction is driven by the motor protein myosin II, which binds transiently to an actin filament, generates a unitary filament displacement or 'working stroke', then detaches and repeats the cycle. The stroke size has been measured previously using isolated myosin II molecules at low load, with rather variable results(1-4), but not at the higher loads that the motor works against during muscle contraction. Here we used a novel X-ray-interference technique(5,6) to measure the working stroke of myosin II at constant load(7) in an intact muscle cell, preserving the native structure and function of the motor. We show that the stroke is smaller and slower at higher load. The stroke size at low load is likely to be set by a structural limit(8,9); at higher loads, the motor detaches from actin before reaching this limit. The load dependence of the myosin II stroke is the primary molecular determinant of the mechanical performance and efficiency of skeletal muscle.	Univ Florence, DBAG, Lab Fisiol, I-50134 Florence, Italy; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02545 USA; Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; European Synchrotron Radiat Facil, F-38043 Grenoble, France; BioCAT Adv Photon Source, Argonne, IL 60439 USA	University of Florence; Brandeis University; University of London; King's College London; European Synchrotron Radiation Facility (ESRF); United States Department of Energy (DOE); Argonne National Laboratory	Lombardi, V (corresponding author), Univ Florence, DBAG, Lab Fisiol, I-50134 Florence, Italy.	vincenzo.lombardi@unifi.it	Sun, Yin-Biao/F-9988-2018	Sun, Yin-Biao/0000-0002-4992-8198; LINARI, MARCO/0000-0001-6512-4897; Narayanan, Theyencheri/0000-0003-1957-1041; RECONDITI, MASSIMO/0000-0001-5065-924X	Telethon [945] Funding Source: Medline	Telethon(Fondazione Telethon)		BOSECKE P, 1995, REV SCI INSTRUM, V66, P1636, DOI 10.1063/1.1145868; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; HASELGROVE JC, 1975, J MOL BIOL, V92, P113, DOI 10.1016/0022-2836(75)90094-7; Huxley AF, 1996, J MUSCLE RES CELL M, V17, P507, DOI 10.1007/BF00123366; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; Huxley HE, 2003, BIOPHYS J, V84, p139A; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; Irving TC, 2000, NUCL INSTRUM METH A, V448, P250, DOI 10.1016/S0168-9002(99)00732-9; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; KUSHMERICK MJ, 1969, PROC R SOC SER B-BIO, V174, P315, DOI 10.1098/rspb.1969.0096; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Phillips WC, 2002, J SYNCHROTRON RADIAT, V9, P36; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; PIAZZESI G, 1995, BIOPHYS J, V68, pS92; PODOLSKY RJ, 1960, NATURE, V188, P666, DOI 10.1038/188666a0; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Sun YB, 2001, J PHYSIOL-LONDON, V531, P781, DOI 10.1111/j.1469-7793.2001.0781h.x; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5	28	151	159	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					578	581		10.1038/nature02380	http://dx.doi.org/10.1038/nature02380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15058307				2022-12-01	WOS:000220540100046
J	Li, JS; Ishii, T; Feinstein, P; Mombaerts, P				Li, JS; Ishii, T; Feinstein, P; Mombaerts, P			Odorant receptor gene choice is reset by nuclear transfer from mouse olfactory sensory neurons	NATURE			English	Article							EMBRYONIC STEM-CELLS; MICE; VOMERONASAL; DEFICIENT; GLOMERULI; PROTEINS; CLONING; CODES	Of the,1,000 odorant receptor ( OR) genes in the mouse genome, an olfactory sensory neuron (OSN) is thought to express one gene, from one allele. This is reminiscent of immunoglobulin and T-cell receptor genes, which undergo DNA rearrangements in lymphocytes. Here, we test the hypothesis that OR gene choice is controlled by DNA rearrangements in OSNs. Using permanent genetic marking, we show that the choice by an OSN to express an allele of the OR gene M71 is irreversible. Using M71-expressing OSNs as donors for nuclear transfer, we generate blastocysts, embryonic stem (ntES) cell lines and clonal mice. DNA analysis of these cell lines, whose genome is clonally derived from an M71-expressing OSN, does not reveal DNA rearrangements or sequence alterations at the M71 locus. OSNs that differentiate from ntES cells after injection into blastocysts are not restricted to expression of M71 but can express other OR genes. Thus, M71 gene choice is irreversible but is reset upon nuclear transfer, and is not accompanied by genomic alterations.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	peter@rockefeller.edu		li, jin song/0000-0003-3456-662X				Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Hamana H, 2003, CHEM SENSES, V28, P87, DOI 10.1093/chemse/28.2.87; HIROTA S, 1992, MOL BRAIN RES, V15, P47, DOI 10.1016/0169-328X(92)90150-A; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2003, P NATL ACAD SCI USA, V100, P11924, DOI 10.1073/pnas.1934141100; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; NAGY A, 1990, DEVELOPMENT, V110, P815; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; SAUER B, 1990, New Biologist, V2, P441; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; TONEGAWA S, 1988, CELL DEV BIOL, V24, P235; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; ZHANG X, 2003, GENOMICS, DOI DOI 10.1016/J.YGEN3.2003.10.009; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	39	200	211	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					393	399		10.1038/nature02433	http://dx.doi.org/10.1038/nature02433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15042081				2022-12-01	WOS:000220404300033
J	Hess, C; Altfeld, M; Thomas, SY; Addo, MM; Rosenberg, ES; Allen, TM; Draenert, R; Eldrige, RL; van Lunzen, J; Stellbrink, HJ; Walker, BD; Luster, AD				Hess, C; Altfeld, M; Thomas, SY; Addo, MM; Rosenberg, ES; Allen, TM; Draenert, R; Eldrige, RL; van Lunzen, J; Stellbrink, HJ; Walker, BD; Luster, AD			HIV-1 specific CD8+T cells with an effector phenotype and control of viral replication	LANCET			English	Article							T-LYMPHOCYTES	Most people infected with HIV-1 cannot control viral replication despite the presence of virus-specific CD8+ T cells. It has been postulated that this inability is related to the failure of these cells to mature into fully differentiated effector cells. We tested this hypothesis by comparing the maturation phenotype of virus-specific CD8+ T cells in people who could control viral replication off anti-retroviral therapy with those who could not; In five patients with treated acute HIV-1-infection, structured treatment interruption (STI) induced control of viral replication was associated with expansion of virus-specific CD8+ T cells with a fully differentiated effector phenotype. These effector cells were also expanded in treatment-naive chronically infected individuals who spontaneously controlled viral replication, and augmented expression of perforin was noted in both settings. Our data show that full maturation of virus-specific CD8+ T cells is possible in the context of HIV-1-infection, and suggest that such maturation might be important in viral control.	Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Partners AIDS Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Div AIDS, Cambridge, MA 02138 USA; Univ Hamburg, Hosp Eppendorf, Infect Dis Outpatient Clin, Hamburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; University of Hamburg	Luster, AD (corresponding author), Massachusetts Gen Hosp E, Bldg 149,13th St, Charlestown, MA 02482 USA.	luster@helix.mgh.harvard.edu	Addo, Marylyn M./GNP-2548-2022; Luster, Andrew/ABE-6504-2020; Altfeld, Marcus/AAE-7306-2019; Allen, Todd/F-5473-2011	Luster, Andrew/0000-0001-9679-7912; Altfeld, Marcus/0000-0001-5972-2997; Allen, Todd/0000-0002-6609-1318; Thomas, Seddon/0000-0003-0075-0744; Addo, Marylyn/0000-0003-2836-9224				Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385	5	90	94	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2004	363	9412					863	866		10.1016/S0140-6736(04)15735-8	http://dx.doi.org/10.1016/S0140-6736(04)15735-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803LB	15031033				2022-12-01	WOS:000220231500014
J	Finnerty, JR; Pang, K; Burton, P; Paulson, D; Martindale, MQ				Finnerty, JR; Pang, K; Burton, P; Paulson, D; Martindale, MQ			Origins of bilateral symmetry: Hox and dpp expression in a sea anemone	SCIENCE			English	Article							PARAHOX GENES; EVOLUTION; CONSERVATION; HOMEOBOXES	Over 99% of modern animals are members of the evolutionary lineage Bilateria. The evolutionary success of Bilateria is credited partly to the origin of bilateral symmetry. Although animals of the phylum Cnidaria are not within the Bilateria, some representatives, such as the sea anemone Nematostella vectensis, exhibit bilateral symmetry. We show that Nematostella uses homologous genes to achieve bilateral symmetry: Multiple Hox genes are expressed in a staggered fashion along its primary body axis, and the transforming growth factor-beta gene decapentaplegic (dpp) is expressed in an asymmetric fashion about its secondary body axis. These data suggest that bilateral symmetry arose before the evolutionary split of Cnidaria and Bilateria.	Boston Univ, Dept Biol, Boston, MA 02215 USA; Univ Hawaii, Kewalo Marine Lab, Pacific Biomed Res Ctr, Honolulu, HI 96813 USA	Boston University; University of Hawaii System	Finnerty, JR (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	jrf3@bu.edu	Finnerty, John R/B-6564-2011					Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Beklemishev VN., 1969, PRINCIPLES COMP ANAT; Brusca R. C., 2003, INVERTEBRATES; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Campbell N. A., 2004, ESSENTIAL BIOL; Collins AG, 2001, EVOL DEV, V3, P432, DOI 10.1046/j.1525-142X.2001.01048.x; Ferguson EL, 1996, CURR OPIN GENET DEV, V6, P424, DOI 10.1016/S0959-437X(96)80063-3; Finnerty JR, 1998, CURR OPIN GENET DEV, V8, P681, DOI 10.1016/S0959-437X(98)80037-3; Finnerty JR, 1997, BIOL BULL-US, V193, P62, DOI 10.2307/1542736; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Finnerty JR, 2001, AM ZOOL, V41, P608, DOI 10.1668/0003-1569(2001)041[0608:CRISIT]2.0.CO;2; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; Glaessner M. F., 1966, Palaeontology, V9, P599; Hadzi J, 1963, EVOLUTION METAZOA; Haeckel E, 1874, Q J MICROSC SCI, V14, P142; HANSON ED, 1963, LOWER METAZOA, P7; HATSCHEK B, 1891, LEHRBUCH ZOOLOGIE; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Hyman L. H., 1940, INVERTEBRATES PROTOZ; JAGERSTEN GOSTA, 1955, ZOOL BIDRAG UPPSALA, V30, P321; Johnson GB., 2003, LIVING WORLD; Kourakis MJ, 2000, J EXP ZOOL, V288, P175, DOI 10.1002/1097-010X(20000815)288:2<175::AID-JEZ8>3.0.CO;2-N; Martinez DE, 1998, NATURE, V393, P748, DOI 10.1038/31616; Masuda-Nakagawa LM, 2000, DEV GENES EVOL, V210, P151, DOI 10.1007/s004270050022; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; SALVINIPLAWEN LV, 1978, Z ZOOL SYST EVOL, V16, P40; Siewing R., 1980, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V103, P439; STEPHENSON TA, 1926, BRIT SEA ANEMONES, V1; Weatherbee, 2001, DNA DIVERSITY MOL GE; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; Willmer P, 1990, INVERTEBRATE RELATIO; Yanze N, 2001, DEV BIOL, V236, P89, DOI 10.1006/dbio.2001.0299	33	282	291	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1335	1337		10.1126/science.1091946	http://dx.doi.org/10.1126/science.1091946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15131263				2022-12-01	WOS:000221669600058
J	Parker, HG; Kim, LV; Sutter, NB; Carlson, S; Lorentzen, TD; Malek, TB; Johnson, GS; DeFrance, HB; Ostrander, EA; Kruglyak, L				Parker, HG; Kim, LV; Sutter, NB; Carlson, S; Lorentzen, TD; Malek, TB; Johnson, GS; DeFrance, HB; Ostrander, EA; Kruglyak, L			Genetic structure of the purebred domestic dog	SCIENCE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; MICROSATELLITE MARKERS; HUMAN GENOME; BREEDS; DISTANCES; INFERENCE; SEQUENCE; ORIGIN; LOCI	We used molecular markers to study genetic relationships in a diverse collection of 85 domestic dog breeds. Differences among breeds accounted for similar to 30% of genetic variation. Microsatellite genotypes were used to correctly assign 99% of individual dogs to breeds. Phylogenetic analysis separated several breeds with ancient origins from the remaining breeds with modern European origins. We identified four genetic clusters, which predominantly contained breeds with similar geographic origin, morphology, or role in human activities. These results provide a genetic classification of dog breeds and will aid studies of the genetics of phenotypic breed differences.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Missouri System; University of Missouri Columbia; Howard Hughes Medical Institute	Ostrander, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, POB 19024,1100 Fairview Ave N,D4-100, Seattle, WA 98109 USA.	eostrand@fhcrc.org	Kim, Lev V./G-7691-2016; Carlson, Scott/E-4606-2010; Parker, Heidi/C-6954-2008; Fiumefreddo, Andrea/T-2977-2019	Carlson, Scott/0000-0003-1996-0012; Ostrander, Elaine/0000-0001-6075-9738; Parker, Heidi G./0000-0002-9707-6380	NATIONAL CANCER INSTITUTE [K05CA090754] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NCI NIH HHS [K05 CA90754] Funding Source: Medline; NHGRI NIH HHS [T32 HG00035] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CROWLEY J., 1998, COMPLETE DOG BOOK OF; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fogel B, 1995, ENCY DOG; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Koskinen MT, 2003, ANIM GENET, V34, P297, DOI 10.1046/j.1365-2052.2003.01005.x; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; Ostrander EA, 2000, GENOME RES, V10, P1271, DOI 10.1101/gr.155900; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; PATTERSON DF, 1988, J AM VET MED ASSOC, V193, P1131; Piazza A., 1994, HIST GEOGRAPHY HUMAN; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Rogers CA, 1995, INT ENCY DOGS; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2001, GENETICS, V159, P699; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wilcox B, 1995, ATLAS DOG BREEDS WOR; YAMAZAKI T, 1995, LEGACY DOG ULTIMATE	29	519	544	1	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1160	1164		10.1126/science.1097406	http://dx.doi.org/10.1126/science.1097406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15155949				2022-12-01	WOS:000221524500044
J	Ralston, JD; Revere, D; Robins, LS; Goldberg, HI				Ralston, JD; Revere, D; Robins, LS; Goldberg, HI			Patients' experience with a diabetes support programme based on an interactive electronic medical record: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED-TRIAL; CHRONIC ILLNESS; CARE; OUTCOMES; MANAGEMENT	Objective To describe the experiences of patients with type 2 diabetes in a web based disease management programme based on an interactive electronic medical record. Design Qualitative analysis of semistructured interviews with patients enrolled in a diabetes care module that included access to their electronic medical record, secure email, ability to upload blood glucose readings, an education site with endorsed content, and an interactive online diary for entering exercise, diet, and medication. Setting Patients' homes in Washington state, United States. Participants Nine participants aged 45-65 completed interviews before and after they used the programme. Results Six themes emerged: feeling that non-acute concerns are uniquely valued; enhanced sense of security about health and health care; frustration with unmet expectations; feeling more able to manage; valuing feedback; and difficulty fitting the programme into activities of daily life. Three themes-valuing non-acute concerns, feeling secure, and unmet expectations-have particular relevance to the design and use of web based tools for care of patients with diabetes and chronic medical conditions. Conclusion Participants' experiences support further study of open access to the electronic medical record and online communication between patients and their care providers. The development of web based disease management programmes should take into account the specific needs and expectations of patients, and patients and providers should have candid discussions about what web based care can and cannot provide.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ralston, JD (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	ralston.j@ghc.org		Revere, Debra/0000-0002-3863-7774	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE010002] Funding Source: NIH RePORTER; BHP HRSA HHS [5-T-32 PE-10002-10] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); BHP HRSA HHS		Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Bell RA, 2002, J GEN INTERN MED, V17, P817, DOI 10.1046/j.1525-1497.2002.10319.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Brim J.A., 1974, RES DESIGN ANTHR PAR; Bronson D L, 1978, QRB Qual Rev Bull, V4, P2; BRONSON DL, 1986, J GEN INTERN MED, V1, P34, DOI 10.1007/BF02596322; BRONSON DL, 1986, MED CARE, V24, P332, DOI 10.1097/00005650-198604000-00004; Clever SL, 2002, J GEN INTERN MED, V17, P893, DOI 10.1046/j.1525-1497.2002.20921.x; Denzin Norman, 1998, STRATEGIES QUALITATI; Giorgi A., 1985, PHENOMENOLOGY PSYCHO; Glasgow RE, 2003, PREV MED, V36, P410, DOI 10.1016/S0091-7435(02)00056-7; Goldberg Harold I, 2003, Jt Comm J Qual Saf, V29, P443; Goldberg HI, 1998, LANCET, V351, P1811, DOI 10.1016/S0140-6736(05)78772-9; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kawachi I, 2000, SOCIAL EPIDEMIOLOGY; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Maly RC, 1999, J FAM PRACTICE, V48, P356; Morse J.M., 1995, QUALITATIVE RES METH; Rachmani R, 2002, DIABETIC MED, V19, P385, DOI 10.1046/j.1464-5491.2002.00701.x; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	22	107	107	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2004	328	7449					1159	1162		10.1136/bmj.328.7449.1159	http://dx.doi.org/10.1136/bmj.328.7449.1159			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821XU	15142919	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000221497500019
J	Thomas, H; Bozec, Y; Elkalay, K; de Baar, HJW				Thomas, H; Bozec, Y; Elkalay, K; de Baar, HJW			Enhanced open ocean storage of CO2 from shelf sea pumping	SCIENCE			English	Article							GAS-EXCHANGE; CARBON; SINKS; PCO(2)	Seasonal field observations show that the North Sea, a Northern European shelf sea, is highly efficient in pumping carbon dioxide from the atmosphere to the North Atlantic Ocean. The bottom topography-controlled strati. cation separates production and respiration processes in the North Sea, causing a carbon dioxide increase in the subsurface layer that is ultimately exported to the North Atlantic Ocean. Globally extrapolated, the net uptake of carbon dioxide by coastal and marginal seas is about 20% of the world ocean's uptake of anthropogenic carbon dioxide, thus enhancing substantially the open ocean carbon dioxide storage.	Netherlands Inst Sea Res, Dept Marine Chem & Geol, NL-1790 AB Den Burg, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Thomas, H (corresponding author), Netherlands Inst Sea Res, Dept Marine Chem & Geol, POB 59, NL-1790 AB Den Burg, Netherlands.	hthomas@nioz.nl	Elkalay, khalid/ABT-7140-2022					Borges AV, 1999, J MARINE SYST, V19, P251, DOI 10.1016/S0924-7963(98)00093-1; Borges AV, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000571; Chen CTA, 2003, GLO CH IGBP, P53; Chen CTA, 1999, J GEOPHYS RES-OCEANS, V104, P20675, DOI 10.1029/1999JC900055; de Haas H, 2002, CONT SHELF RES, V22, P691, DOI 10.1016/S0278-4343(01)00093-0; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; KEMPE S, 1991, TELLUS B, V43, P224, DOI 10.1034/j.1600-0889.1991.00015.x; Kortzinger A, 1996, MAR CHEM, V52, P133, DOI 10.1016/0304-4203(95)00083-6; Liss P. S, 1986, ROLE AIR SEA EXCHANG, V185, P113, DOI DOI 10.1007/978-94-009-4738-2_5; Liu K.-K., 2000, EOS T AM GEOPHYS UN, V81, P641, DOI [DOI 10.1029/E0081I052P00641-01, 10.1029/EO081i052p00641-01, DOI 10.1029/EO081I052P00641-01]; LIU KK, 2000, CHANGING OCEAN CARBO, P187; Nightingale PD, 2000, GEOPHYS RES LETT, V27, P2117, DOI 10.1029/2000GL011541; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; Osterroht C, 2000, J MARINE SYST, V25, P33, DOI 10.1016/S0924-7963(00)00007-5; OTTO L, 1990, NETH J SEA RES, V26, P161, DOI 10.1016/0077-7579(90)90091-T; Sarmiento JL, 2002, PHYS TODAY, V55, P30, DOI 10.1063/1.1510279; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Thomas H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017937; Thomas H, 1999, J MARINE SYST, V22, P53, DOI 10.1016/S0924-7963(99)00030-5; Thomas H, 1999, LIMNOL OCEANOGR, V44, P1999, DOI 10.4319/lo.1999.44.8.1999; THOMAS H, IN PRESS CARBON NUTR; THOMAS H, 2002, SHIPBOARD REPORT RV; Tsunogai S, 1999, TELLUS B, V51, P701, DOI 10.1034/j.1600-0889.1999.t01-2-00010.x; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363	25	370	391	15	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					1005	1008		10.1126/science.1095491	http://dx.doi.org/10.1126/science.1095491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143279	Green Submitted			2022-12-01	WOS:000221383300047
J	Fairman, ME; Maroney, PA; Wang, W; Bowers, HA; Gollnick, P; Nilsen, TW; Jankowsky, E				Fairman, ME; Maroney, PA; Wang, W; Bowers, HA; Gollnick, P; Nilsen, TW; Jankowsky, E			Protein displacement by DExH/D "RNA helicases" without duplex unwinding	SCIENCE			English	Article							BINDING ATTENUATION PROTEIN; SINGLE-STRANDED-DNA; SPLICEOSOME; TRANSLATION; REQUIREMENT; INITIATION; DISRUPTION; UPSTREAM; MOTORS; ATPASE	Members of the DExH/D superfamily of nucleic acid-activated nucleotide triphosphatases are essential for virtually all aspects of RNA metabolism, including pre-messenger RNA splicing, RNA interference, translation, and nucleocytoplasmic trafficking. Physiological substrates for these enzymes are thought to be regions of double-stranded RNA, because several DExH/D proteins catalyze strand separation in vitro. These "RNA helicases" can also disrupt RNA-protein interactions, but it is unclear whether this activity is coupled to duplex unwinding. Here we demonstrate that two unrelated DExH/D proteins catalyze protein displacement independently of duplex unwinding. Therefore, the essential functions of DExH/D proteins are not confined to RNA duplexes but can be exerted on a wide range of ribonucleoprotein substrates.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	Case Western Reserve University; Case Western Reserve University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Nilsen, TW (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	twn@po.cwru.edu; exj13@po.cwru.edu		Jankowsky, Eckhard/0000-0001-7677-7412	NIGMS NIH HHS [R01 GM067700] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Hesson T, 2000, BIOCHEMISTRY-US, V39, P2619, DOI 10.1021/bi992127a; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kadare G, 1997, J VIROL, V71, P2583; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Maroney PA, 2000, RNA, V6, P1905, DOI 10.1017/S1355838200001308; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; PAUSE A, 1993, CURR OPIN STRUC BIOL, V3, P953, DOI 10.1016/0959-440X(93)90161-D; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Will CL, 2001, SCIENCE, V291, P1916, DOI 10.1126/science.1059682	26	198	201	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					730	734		10.1126/science.1095596	http://dx.doi.org/10.1126/science.1095596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118161				2022-12-01	WOS:000221105300044
J	McVean, GAT; Myers, SR; Hunt, S; Deloukas, P; Bentley, DR; Donnelly, P				McVean, GAT; Myers, SR; Hunt, S; Deloukas, P; Bentley, DR; Donnelly, P			The fine-scale structure of recombination rate variation in the human genome	SCIENCE			English	Article							HIGH-RESOLUTION ANALYSIS; CLASS-II REGION; LINKAGE-DISEQUILIBRIUM; MEIOTIC RECOMBINATION; HAPLOTYPE DIVERSITY; GC-CONTENT; HOTSPOT; BLOCKS; CROSSOVER; EVOLUTION	The nature and scale of recombination rate variation are largely unknown for most species. In humans, pedigree analysis has documented variation at the chromosomal level, and sperm studies have identified specific hotspots in which crossing-over events cluster. To address whether this picture is representative of the genome as a whole, we have developed and validated a method for estimating recombination rates from patterns of genetic variation. From extensive single-nucleotide polymorphism surveys in European and African populations, we find evidence for extreme local rate variation spanning four orders in magnitude, in which 50% of all recombination events take place in less than 10% of the sequence. We demonstrate that recombination hotspots are a ubiquitous feature of the human genome, occurring on average every 200 kilobases or less, but recombination occurs preferentially outside genes.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Oxford; Wellcome Trust Sanger Institute	McVean, GAT (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	mcvean@stats.ox.ac.uk	Peng, Bo/A-6920-2009; Myers, Simon R/A-6792-2015; Deloukas, Panos/B-2922-2013	Peng, Bo/0000-0001-8225-2284; Myers, Simon R/0000-0002-2585-9626; Deloukas, Panos/0000-0001-9251-070X; Donnelly, Peter/0000-0001-9495-3408; Hunt, Sarah/0000-0002-8350-1235				Aquadro CF, 1997, CURR OPIN GENET DEV, V7, P835, DOI 10.1016/S0959-437X(97)80048-2; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cullen M, 1997, AM J HUM GENET, V60, P397; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; Fearnhead P, 2001, GENETICS, V159, P1299; Filatov DA, 2003, GENE, V317, P67, DOI 10.1016/S0378-1119(03)00697-8; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galtier N, 2001, GENETICS, V159, P907; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li N, 2003, GENETICS, V165, P2213; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; MCVEAN GAT, UNPUB; Myers S. L., UNPUB; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; SMITH GR, 1994, EXPERIENTIA, V50, P234, DOI 10.1007/BF01924006; Smith RA, 1998, BLOOD, V92, P4415, DOI 10.1182/blood.V92.11.4415.423a07_4415_4421; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	39	700	722	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					581	584		10.1126/science.1092500	http://dx.doi.org/10.1126/science.1092500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105499				2022-12-01	WOS:000220975100047
J	Kono, T; Obata, Y; Wu, QL; Niwa, K; Ono, Y; Yamamoto, Y; Park, ES; Seo, JS; Ogawa, H				Kono, T; Obata, Y; Wu, QL; Niwa, K; Ono, Y; Yamamoto, Y; Park, ES; Seo, JS; Ogawa, H			Birth of parthenogenetic mice that can develop to adulthood	NATURE			English	Article							MAMMALIAN DEVELOPMENT; IMPRINTED GENES; OOCYTE GROWTH; MOUSE; H19; EXPRESSION; GENOME; DELETION; METHYLATION; IGF2	Only mammals have relinquished parthenogenesis, a means of producing descendants solely from maternal germ cells. Mouse parthenogenetic embryos die by day 10 of gestation(1-4). Bi-parental reproduction is necessary because of parent-specific epigenetic modification of the genome during gametogenesis(5-8). This leads to unequal expression of imprinted genes from the maternal and paternal alleles(9). However, there is no direct evidence that genomic imprinting is the only barrier to parthenogenetic development. Here we show the development of a viable parthenogenetic mouse individual from a reconstructed oocyte containing two haploid sets of maternal genome, derived from non-growing and fully grown oocytes. This development was made possible by the appropriate expression of the Igf2 and H19 genes with other imprinted genes, using mutant mice with a 13-kilobase deletion in the H19 gene(10) as non-growing oocytes donors. This full-term development is associated with a marked reduction in aberrantly expressed genes. The parthenote developed to adulthood with the ability to reproduce offspring. These results suggest that paternal imprinting prevents parthenogenesis, ensuring that the paternal contribution is obligatory for the descendant.	Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; Tokyo Univ Agr, Dept Appl Sci, Setagaya Ku, Tokyo 1568502, Japan; Biooriented Technol Res Adv Inst, Minato Ku, Tokyo 1050001, Japan; MacroGen Inc, Seoul 110061, South Korea; Seoul Natl Univ, Coll Med, Dept Biochem, Seoul 110799, South Korea	Tokyo University of Agriculture; Tokyo University of Agriculture; Macrogen, Inc.; Seoul National University (SNU)	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan.	tomohiro@nodai.ac.jp	Seo, Jeong-Sun/J-2763-2012					Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FEIL R, 1994, DEVELOPMENT, V120, P2933; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Georgiades P, 2001, P NATL ACAD SCI USA, V98, P4522, DOI 10.1073/pnas.081540898; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kobayashi S, 2000, GENES CELLS, V5, P1029, DOI 10.1046/j.1365-2443.2000.00390.x; Kono T, 2002, DEV BIOL, V243, P294, DOI 10.1006/dbio.2001.0561; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Mann JR, 2001, STEM CELLS, V19, P287, DOI 10.1634/stemcells.19-4-287; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Obata Y, 1998, DEVELOPMENT, V125, P1553; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Schmidt JV, 2000, GENE DEV, V14, P1997; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SURANI MAH, 1983, SCIENCE, V222, P1034, DOI 10.1126/science.6648518; THEILER K, 1989, HOUSE MOUSE ATLAS EM, P122; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0	30	349	387	5	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					860	864		10.1038/nature02402	http://dx.doi.org/10.1038/nature02402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103378				2022-12-01	WOS:000220952300042
J	Ko, DT; Mamdani, M; Alter, DA				Ko, DT; Mamdani, M; Alter, DA			Lipid-lowering therapy with statins in high-risk elderly patients - The treatment-risk paradox	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY EVENTS; HEART-FAILURE; OLDER; AGE; ONTARIO; CARE; MEN; PRAVASTATIN	Context The benefits of cardiovascular therapies such as statins for secondary prevention have been well documented, although they may not be optimally used in patients most likely to benefit. ideally, aggressiveness in the use of these beneficial therapies should correlate with baseline cardiovascular risk. Objective To examine the association between physicians' treatment aggressiveness and baseline cardiovascular risk. Design, Setting, and Patients Retrospective cohort study incorporating the use of multiple linked health care administrative databases covering more than 1.4 million elderly residents of Ontario. We included 396 077 patients aged 66 years or older who had a history of cardiovascular disease or diabetes while undergoing medical treatment and who were alive on April 1, 1998. Baseline cardiovascular risk was derived using a risk-adjustment index in which we modeled probability of death after 3 years of follow-up. Main Outcome Measure Likelihood of statin use, stratified by baseline cardiovascular risk, after adjusting for age, sex, socioeconomic status, and rural or urban residence. Results Only 75617 patients (19.1%)in this secondary prevention cohort were prescribed statins. In patients 66 to 74 years old, the adjusted probabilities of statin prescription were 37.7%, 26.7%, and 23.4% in the categories of low, intermediate, and high baseline risk, respectively. The likelihood of statin prescription was 6.4% lower (adjusted odds ratio, 0.94; 95% confidence interval, 0.93-0.95) for each year of increase in age and each 1% increase in predicted 3-year mortality risk. The influence of age also interacted synergistically with baseline risk on the prescription of statins (P<.001). Conclusions We found that prescription of statins diminished progressively as baseline cardiovascular risk and future probability of death increased. Since the benefits of a therapy are dependent on the baseline risk, the maximum benefits of statins may not be fully realized until implementation of therapy includes patients at highest risk.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Toronto, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Alter, DA (corresponding author), Inst Clin Evaluat Sci, G-106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca		Ko, Dennis/0000-0001-6840-8051				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; Alter DA, 2003, DIABETES CARE, V26, P1427, DOI 10.2337/diacare.26.5.1427; Anderson RT, 2000, CONTROL CLIN TRIALS, V21, p171S, DOI 10.1016/S0197-2456(00)00075-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Elad Y, 2002, J AM COLL CARDIOL, V39, P826, DOI 10.1016/S0735-1097(01)01817-4; Fonarow GC, 2001, CIRCULATION, V103, P38; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Gottlieb SS, 1997, LANCET, V349, P662, DOI 10.1016/S0140-6736(97)22010-6; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Krumholz HM, 1996, ANN INTERN MED, V124, P292, DOI 10.7326/0003-4819-124-3-199602010-00002; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lemaitre RN, 1998, ARCH INTERN MED, V158, P1761, DOI 10.1001/archinte.158.16.1761; Levy AR, 2003, CAN J CARDIOL, V19, P665; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; PEDERSEN TR, 1994, LANCET, V344, P1383; Rathore SS, 2003, AM J MED, V114, P307, DOI 10.1016/S0002-9343(02)01531-0; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 2000, LANCET, V356, P639, DOI 10.1016/S0140-6736(00)02606-4; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; Wang TJ, 2001, AM HEART J, V141, P957, DOI 10.1067/mhj.2001.115587; Whincup PH, 2002, HEART, V88, P25, DOI 10.1136/heart.88.1.25	36	318	323	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1864	1870		10.1001/jama.291.15.1864	http://dx.doi.org/10.1001/jama.291.15.1864			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100205	Bronze			2022-12-01	WOS:000220871200027
J	Chiu, CH; Su, LH; Chu, C; Chia, JH; Wu, TL; Lin, TY; Lee, YS; Ou, JT				Chiu, CH; Su, LH; Chu, C; Chia, JH; Wu, TL; Lin, TY; Lee, YS; Ou, JT			Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin	LANCET			English	Article							BETA-LACTAMASE; EMERGENCE		Chang Gung Univ Coll Med, Dept Microbiol & Immunol, Taoyuan 333, Taiwan; Chang Gung Childrens Hosp, Dept Paediat, Div Paediat Infect Dis, Taoyuan, Taiwan; Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Ou, JT (corresponding author), Chang Gung Univ Coll Med, Dept Microbiol & Immunol, 259 Wenhua 1st Rd, Taoyuan 333, Taiwan.	jontou@mail.cgu.edu.tw						BERGSTROM S, 1983, J BACTERIOL, V155, P1297; Chiu CH, 2002, NEW ENGL J MED, V346, P413, DOI 10.1056/NEJMoa012261; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Koeck JL, 1997, FEMS MICROBIOL LETT, V152, P255, DOI 10.1111/j.1574-6968.1997.tb10436.x; Morosini MI, 2000, ANTIMICROB AGENTS CH, V44, P3137, DOI 10.1128/AAC.44.11.3137-3143.2000	5	58	62	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1285	1286		10.1016/S0140-6736(04)16003-0	http://dx.doi.org/10.1016/S0140-6736(04)16003-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094275				2022-12-01	WOS:000220904900012
J	Hamrahian, AH; Oseni, TS; Arafah, BM				Hamrahian, AH; Oseni, TS; Arafah, BM			Measurements of serum free cortisol in critically ill patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	82nd Annual Meeting of the Endocrine-Society	JUN 21-24, 2000	TORONTO, CANADA	Endocrine Soc			CORTICOSTEROID-BINDING GLOBULIN; SEPTIC SHOCK; ADRENAL INSUFFICIENCY; PLASMA-LEVELS; INFLAMMATION; TRANSCORTIN; MODULATION; SURGERY; CORTICOTROPIN; SENSITIVITY	Background: Because more than 90 percent of circulating cortisol in human serum is protein-bound, changes in the binding proteins can alter measured serum total cortisol concentrations without influencing free concentrations of this hormone. We investigated the effect of decreased amounts of cortisol-binding proteins on serum total and free cortisol concentrations during critical illness, when glucocorticoid secretion is maximally stimulated. Methods: Base-line serum total cortisol, cosyntropin-stimulated serum total cortisol, aldosterone, and free cortisol concentrations were measured in 66 critically ill patients and 33 healthy volunteers in groups that were similar with regard to sex and age. Of the 66 patients, 36 had hypoproteinemia (albumin concentration, 2.5 g per deciliter or less), and 30 had near-normal serum albumin concentrations (above 2.5 g per deciliter). Results: Base-line and cosyntropin-stimulated serum total cortisol concentrations were lower in the patients with hypoproteinemia than in those with near-normal serum albumin concentrations (P<0.001). However, the mean (+/- SD) base-line serum free cortisol concentrations were similar in the two groups of patients (5.1 +/- 4.1 and 5.2 +/- 3.5 microg per deciliter [140.7 +/- 113.1 and 143.5 +/- 96.6 nmol per liter]) and were several times higher than the values in controls (0.6 +/- 0.3 microg per deciliter [16.6 +/- 8.3 nmol per liter], P<0.001 for both comparisons). Cosyntropin-stimulated serum total cortisol concentrations were subnormal (18.5 microg per deciliter [510.4 nmol per liter] or less) in 14 of the patients, all of whom had hypoproteinemia. In all 66 patients, including these 14 who had hypoproteinemia, the base-line and cosyntropin-stimulated serum free cortisol concentrations were high-normal or elevated. Conclusions: During critical illness, glucocorticoid secretion markedly increases, but the increase is not discernible when only the serum total cortisol concentration is measured. In this study, nearly 40 percent of critically ill patients with hypoproteinemia had subnormal serum total cortisol concentrations, even though their adrenal function was normal. Measuring serum free cortisol concentrations in critically ill patients with hypoproteinemia may help prevent the unnecessary use of glucocorticoid therapy.	Univ Hosp Cleveland, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	University Hospitals of Cleveland; Case Western Reserve University	Arafah, BM (corresponding author), Univ Hosp Cleveland, Div Clin & Mol Endocrinol, 11100 Euclid Ave, Cleveland, OH 44106 USA.	bxa@po.cwru.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR000080] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; ARAFAH BM, 1990, J CLIN ENDOCR METAB, V71, P60, DOI 10.1210/jcem-71-1-60; BAXTER JD, 1979, MONOGRAPHS ENDOCRINO, V12, P25; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bernier J, 1998, CRIT CARE MED, V26, P452, DOI 10.1097/00003246-199803000-00014; BRIEN TG, 1981, CLIN ENDOCRINOL, V14, P193, DOI 10.1111/j.1365-2265.1981.tb00616.x; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; EKINS RP, 1982, MONOCLONAL ANTIBODIE, P73; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Garrel DR, 1996, HORM RES, V45, P245, DOI 10.1159/000184796; GEISELER D, 1983, ANAL BIOCHEM, V132, P174, DOI 10.1016/0003-2697(83)90444-X; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; HAMANAKA Y, 1970, ACTA ENDOCRINOL-COP, V64, P439, DOI 10.1530/acta.0.0640439; KEANE PM, 1969, J ENDOCRINOL, V43, P571, DOI 10.1677/joe.0.0430571; KEHLET H, 1974, ACTA ENDOCRINOL-COP, V75, P119, DOI 10.1530/acta.0.0750119; KIDESS AI, 1993, MAYO CLIN PROC, V68, P435, DOI 10.1016/S0025-6196(12)60188-8; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; le Roux CW, 2003, J CLIN ENDOCR METAB, V88, P2045, DOI 10.1210/jc.2002-021532; MILLS IH, 1962, BRIT MED BULL, V18, P127, DOI 10.1093/oxfordjournals.bmb.a069953; MOLIJN GJ, 1995, J CLIN ENDOCR METAB, V80, P1799, DOI 10.1210/jc.80.6.1799; MUELLER UW, 1981, BIOCHEM PHARMACOL, V30, P727, DOI 10.1016/0006-2952(81)90158-1; Nasrallah MP, 2003, J CLIN ENDOCR METAB, V88, P5293, DOI 10.1210/jc.2003-030449; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; OGAWA K, 1983, J CLIN ENDOCR METAB, V56, P121, DOI 10.1210/jcem-56-1-121; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PUGEAT M, 1989, CLIN CHEM, V35, P1675; ROSNER W, 1983, CLIN CHEM, V29, P1389; SAVU L, 1981, BIOCHEM BIOPH RES CO, V102, P411, DOI 10.1016/0006-291X(81)91536-9; SMITH JB, 1980, CLIN CHIM ACTA, V108, P435, DOI 10.1016/0009-8981(80)90351-4; TAYLOR KM, 1976, J THORAC CARDIOV SUR, V72, P57; ZOUAGHI H, 1983, ACTA ENDOCRINOL-COP, V102, P277, DOI 10.1530/acta.0.1020277	38	492	512	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1629	1638		10.1056/NEJMoa020266	http://dx.doi.org/10.1056/NEJMoa020266			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	812DI	15084695				2022-12-01	WOS:000220819800007
J	Yasuda, S; Oceguera-Yanez, F; Kato, T; Okamoto, M; Yonemura, S; Terada, Y; Ishizaki, T; Narumiya, S				Yasuda, S; Oceguera-Yanez, F; Kato, T; Okamoto, M; Yonemura, S; Terada, Y; Ishizaki, T; Narumiya, S			Cdc42 and mDia3 regulate microtubule attachment to kinetochores	NATURE			English	Article							MITOTIC SPINDLE; MAMMALIAN HOMOLOG; RHO-GTPASES; HELA-CELLS; CENP-A; CYTOKINESIS; CHECKPOINT; PROTEINS; MGCRACGAP; PATHWAY	During mitosis, the mitotic spindle, a bipolar structure composed of microtubules (MTs) and associated motor proteins(1,2), segregates sister chromatids to daughter cells. Initially some MTs emanating from one centrosome attach to the kinetochore at the centromere of one of the duplicated chromosomes. This attachment allows rapid poleward movement of the bound chromosome. Subsequent attachment of the sister kinetochore to MTs growing from the other centrosome results in the bi-orientation of the chromosome, in which interactions between kinetochores and the plus ends of MTs are formed and stabilized(2). These processes ensure alignment of chromosomes during metaphase and their correct segregation during anaphase. Although many proteins constituting the kinetochore have been identified and extensively studied, the signalling responsible for MT capture and stabilization is unclear(1,2). Small GTPases of the Rho family regulate cell morphogenesis by organizing the actin cytoskeleton and regulating MT alignment and stabilization(3). We now show that one member of this family, Cdc42, and its effector, mDia3, regulate MT attachment to kinetochores.	Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Horizontal Med Res Org, Kyoto 6068501, Japan; RIKEN, Lab Cellular Morphogenesis, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Kyoto University; Kyoto University; RIKEN; University of Minnesota System; University of Minnesota Twin Cities	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan.	snaru@mfour.med.kyoto-u.ac.jp						Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; ANDREASSEN PR, 1991, J CELL SCI, V99, P523; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Eda M, 2001, J CELL SCI, V114, P3273; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kato T, 2001, J CELL SCI, V114, P775; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Pellman D, 2001, SCIENCE, V291, P2555, DOI 10.1126/science.1057337; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.E02-04-0236; Van de Putte T, 2001, MECH DEVELOP, V102, P33, DOI 10.1016/S0925-4773(01)00279-9; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	30	147	148	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					767	771		10.1038/nature02452	http://dx.doi.org/10.1038/nature02452			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085137				2022-12-01	WOS:000220823800044
J	Murchison, CF; Zhang, XY; Zhang, WP; Ming, OY; Lee, A; Thomas, SA				Murchison, CF; Zhang, XY; Zhang, WP; Ming, OY; Lee, A; Thomas, SA			A distinct role for norepinephrine in memory retrieval	CELL			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DOPAMINE-BETA-HYDROXYLASE; LONG-TERM POTENTIATION; CONTEXTUAL FEAR; LOCUS-COERULEUS; ALZHEIMERS-DISEASE; RETROGRADE-AMNESIA; CONDITIONED FEAR; SPATIAL MEMORY; HIPPOCAMPAL CIRCUITRY	A role for norepinephrine in learning and memory has been elusive and controversial. A longstanding hypothesis states that the adrenergic nervous system mediates enhanced memory consolidation of emotional events. We tested this hypothesis in several learning tasks using mutant mice conditionally lacking norepinephrine and epinephrine, as well as control mice and rats treated with adrenergic receptor agonists and antagonists. We find that adrenergic signaling is critical for the retrieval of intermediate-term contextual and spatial memories, but is not necessary for the retrieval or consolidation of emotional memories in general. The role of norepinephrine in retrieval requires signaling through the beta(1)-adrenergic receptor in the hippocampus. The results demonstrate that mechanisms of memory retrieval can vary over time and can be different from those required for acquisition or consolidation. These findings may be relevant to symptoms in several neuropsychiatric disorders as well as the treatment of cardiac failure with beta blockers.	Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Thomas, SA (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	thomas@pharm.med.upenn.edu						Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Alaniz RC, 1999, P NATL ACAD SCI USA, V96, P2274, DOI 10.1073/pnas.96.5.2274; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; Bergles DE, 1996, J NEUROSCI, V16, P572; Bevilaqua L, 1997, BEHAV PHARMACOL, V8, P331, DOI 10.1097/00008877-199708000-00006; BLIN N, 1994, BRIT J PHARMACOL, V112, P911, DOI 10.1111/j.1476-5381.1994.tb13167.x; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; CROW TJ, 1968, NATURE, V219, P736, DOI 10.1038/219736a0; DAVIS M, 1979, PSYCHOPHARMACOLOGY, V65, P111, DOI 10.1007/BF00433036; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; DEVAUGES V, 1991, BEHAV BRAIN RES, V43, P93, DOI 10.1016/S0166-4328(05)80056-7; Elrod R, 1997, AM J PSYCHIAT, V154, P25; FAMULARO R, 1988, AM J DIS CHILD, V142, P1244, DOI 10.1001/archpedi.1988.02150110122036; Frankland KBJ, 1997, MOUSE BRAIN STEREOTA; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; GALA RR, 1986, NEUROENDOCRINOLOGY, V43, P115, DOI 10.1159/000124517; GALLAGHER M, 1977, SCIENCE, V198, P423, DOI 10.1126/science.20664; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; GORMAN AL, 1993, PHARMACOL BIOCHEM BE, V45, P1; HAGAN JJ, 1983, BEHAV BRAIN RES, V9, P83, DOI 10.1016/0166-4328(83)90015-3; Hensbroek RA, 2003, BEHAV BRAIN RES, V138, P215, DOI 10.1016/S0166-4328(02)00243-7; HICKS PE, 1987, J PHARMACOL EXP THER, V242, P1025; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; Holt W, 1999, J NEUROSCI, V19, P9054, DOI 10.1523/JNEUROSCI.19-20-09054.1999; Homewood J, 1999, ALCOHOL, V19, P75, DOI 10.1016/S0741-8329(99)00027-0; Hoogendijk WJG, 1999, ANN NEUROL, V45, P82, DOI 10.1002/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T; ILSLEY JE, 1995, J AFFECT DISORDERS, V35, P1, DOI 10.1016/0165-0327(95)00032-I; IVERSEN LL, 1983, NEUROSCI LETT, V39, P95, DOI 10.1016/0304-3940(83)90171-4; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kety S. S., 1970, NEUROSCIENCES 2 STUD, P324; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kolb LC, 1984, POSTTRAUMATIC STRESS, P98; LEE EHY, 1993, SYNAPSE, V14, P144, DOI 10.1002/syn.890140207; Lee HJ, 2001, NEUROSCI LETT, V303, P123, DOI 10.1016/S0304-3940(01)01733-5; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCENTEE WJ, 1978, SCIENCE, V202, P905, DOI 10.1126/science.715450; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MIDDLEMISS DN, 1984, EUR J PHARMACOL, V101, P289, DOI 10.1016/0014-2999(84)90173-0; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; Moser MB, 1998, J NEUROSCI, V18, P7535; Munro CAM, 2001, HIPPOCAMPUS, V11, P322, DOI 10.1002/hipo.1046; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; O'Carroll RE, 1999, J PSYCHOPHARMACOL, V13, P32, DOI 10.1177/026988119901300104; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Ressler KJ, 1999, BIOL PSYCHIAT, V46, P1219, DOI 10.1016/S0006-3223(99)00127-4; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Robbins TW, 1997, BIOL PSYCHOL, V45, P57, DOI 10.1016/S0301-0511(96)05222-2; ROBINSON MB, 1992, PEDIATR RES, V32, P483, DOI 10.1203/00006450-199210000-00021; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sallach JA, 2003, ANN MED, V35, P259, DOI 10.1080/14734220310011716; SARA SJ, 1985, ANN NY ACAD SCI, V444, P178, DOI 10.1111/j.1749-6632.1985.tb37588.x; SARA SJ, 1991, PROG BRAIN RES, V88, P571; Schroeter S, 2000, J COMP NEUROL, V420, P211; SEGAL M, 1991, PROG BRAIN RES, V88, P323; SELDEN NRW, 1990, J NEUROSCI, V10, P531; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shouse MN, 2000, BRAIN RES, V860, P181, DOI 10.1016/S0006-8993(00)02013-8; SOLOMON S, 1983, ARCH GEN PSYCHIAT, V40, P1109; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Thomas SA, 1997, BEHAV NEUROSCI, V111, P579, DOI 10.1037/0735-7044.111.3.579; Thomas SA, 1997, CELL, V91, P583, DOI 10.1016/S0092-8674(00)80446-8; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; TRICKLEBANK MD, 1987, EUR J PHARMACOL, V133, P47, DOI 10.1016/0014-2999(87)90204-4; WAELBROECK M, 1983, MOL PHARMACOL, V24, P174; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; YOKOO H, 1990, BRAIN RES, V536, P305, DOI 10.1016/0006-8993(90)90039-E; ZHANG WP, 2004, IN PRESS NEUROPHARMA	93	287	292	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					131	143		10.1016/S0092-8674(04)00259-4	http://dx.doi.org/10.1016/S0092-8674(04)00259-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066288	Bronze			2022-12-01	WOS:000221500300014
J	Danesh, J; Wheeler, JG; Hirschfield, GM; Eda, S; Eiriksdottir, G; Rumley, A; Lowe, GDO; Pepys, MB; Gudnason, V				Danesh, J; Wheeler, JG; Hirschfield, GM; Eda, S; Eiriksdottir, G; Rumley, A; Lowe, GDO; Pepys, MB; Gudnason, V			C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERYTHROCYTE SEDIMENTATION-RATE; CARDIOVASCULAR RISK-FACTORS; VON-WILLEBRAND-FACTOR; NESTED CASE-CONTROL; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; CHOLESTEROL LEVELS; FOLLOW-UP; MEN; MORTALITY	BACKGROUND: C-reactive protein is an inflammatory marker believed to be of value in the prediction of coronary events. We report data from a large study of C-reactive protein and other circulating inflammatory markers, as well as updated meta-analyses, to evaluate their relevance to the prediction of coronary heart disease. METHODS: Measurements were made in samples obtained at base line from up to 2459 patients who had a nonfatal myocardial infarction or died of coronary heart disease during the study and from up to 3969 controls without a coronary heart disease event in the Reykjavik prospective study of 18,569 participants. Measurements were made in paired samples obtained an average of 12 years apart from 379 of these participants in order to quantify within-person fluctuations in inflammatory marker levels. RESULTS: The long-term stability of C-reactive protein values (within-person correlation coefficient, 0.59; 95 percent confidence interval, 0.52 to 0.66) was similar to that of both blood pressure and total serum cholesterol. After adjustment for base-line values for established risk factors, the odds ratio for coronary heart disease was 1.45 (95 percent confidence interval, 1.25 to 1.68) in a comparison of participants in the top third of the group with respect to base-line C-reactive protein values with those in the bottom third, and similar overall findings were observed in an updated meta-analysis involving a total of 7068 patients with coronary heart disease. By comparison, the odds ratios in the Reykjavik Study for coronary heart disease were somewhat weaker for the erythrocyte sedimentation rate (1.30; 95 percent confidence interval, 1.13 to 1.51) and the von Willebrand factor concentration (1.11; 95 percent confidence interval, 0.97 to 1.27) but generally stronger for established risk factors, such as an increased total cholesterol concentration (2.35; 95 percent confidence interval, 2.03 to 2.74) and cigarette smoking (1.87; 95 percent confidence interval, 1.62 to 2.16). CONCLUSIONS: C-reactive protein is a relatively moderate predictor of coronary heart disease. Recommendations regarding its use in predicting the likelihood of coronary heart disease may need to be reviewed.	Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, London, England; Roche Diagnost, Tokyo, Japan; Iceland Heart Assoc, Kopavogur, Iceland; Univ Glasgow, Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland	University of Cambridge; University of London; University College London; UCL Medical School; Roche Holding; Icelandic Heart Association; Royal Infirmary of Edinburgh; University of Glasgow	Danesh, J (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Strangeways Site, Cambridge CB1 8RN, England.		Gudnason, Vilmundur/AAE-7126-2019; Hirschfield, Gideon M/M-2143-2015; Gudnason, Vilmundur/K-6885-2015	Gudnason, Vilmundur/0000-0001-5696-0084; Hirschfield, Gideon M/0000-0002-6736-2255; Gudnason, Vilmundur/0000-0001-5696-0084				Agewall S, 1998, J HYPERTENS, V16, P537, DOI 10.1097/00004872-199816040-00016; Andresdottir MB, 2003, AM J EPIDEMIOL, V158, P844, DOI 10.1093/aje/kwg222; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Danesh J, 2000, EUR HEART J, V21, P515, DOI 10.1053/euhj.1999.1699; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Erikssen G, 2000, EUR HEART J, V21, P1614, DOI 10.1053/euhj.2000.2148; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Gram J, 2000, J INTERN MED, V247, P205, DOI 10.1046/j.1365-2796.2000.00604.x; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P3071, DOI 10.1161/01.ATV.19.12.3071; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kayaba K, 2000, JPN CIRC J, V64, P303, DOI 10.1253/jcj.64.303; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Koenig W, 2003, AM J EPIDEMIOL, V158, P357, DOI 10.1093/aje/kwg135; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; LOWE GDO, 1999, BLOOD COAGUL FIBRI S, V10, pS92; Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982; Ockene IS, 2001, CLIN CHEM, V47, P444; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2003, J CLIN INVEST, V112, P299, DOI 10.1172/JCI200318921C; Pirro M, 2001, ARCH INTERN MED, V161, P2474, DOI 10.1001/archinte.161.20.2474; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Roberts WL, 2001, CLIN CHEM, V47, P980; Roberts WL, 2001, CLIN CHEM, V47, P418; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman K.J., 1986, MODERN EPIDEMIOLOGY, P237; SHINE B, 1981, CLIN CHIM ACTA, V117, P13, DOI 10.1016/0009-8981(81)90005-X; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237; Witherell H, 1999, GASTROENTEROLOGY, V116, pA355	42	2276	2398	1	121	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1387	1397		10.1056/NEJMoa032804	http://dx.doi.org/10.1056/NEJMoa032804			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070788				2022-12-01	WOS:000220562500005
J	Grimwood, J; Gordon, LA; Olsen, A; Terry, A; Schmutz, J; Lamerdin, J; Hellsten, U; Goodstein, D; Couronne, O; Gyamfi, MT; Aerts, A; Altherr, M; Ashworth, L; Bajorek, E; Black, S; Branscomb, E; Caenepeel, S; Carrano, A; Caoile, C; Chan, YM; Christensen, M; Cleland, CA; Copeland, A; Dalin, E; Dehal, P; Denys, M; Detter, JC; Escobar, J; Flowers, D; Fotopulos, D; Garcia, C; Georgescu, AM; Glavina, T; Gomez, M; Gonzales, E; Groza, M; Hammon, N; Hawkins, T; Haydu, L; Ho, I; Huang, W; Israni, S; Jett, J; Kadner, K; Kimball, H; Kobayashi, A; Larionov, V; Leem, SH; Lopez, F; Lou, YL; Lowry, S; Malfatti, S; Martinez, D; McCready, P; Medina, C; Morgan, J; Nelson, K; Nolan, M; Ovcharenko, I; Pitluck, S; Pollard, M; Popkie, AP; Predki, P; Quan, G; Ramirez, L; Rash, S; Retterer, J; Rodriguez, A; Rogers, S; Salamov, A; Salazar, A; She, XW; Smith, D; Slezak, T; Solovyev, V; Thayer, N; Tice, H; Tsai, M; Ustaszewska, A; Vo, N; Wagner, M; Wheeler, J; Wu, K; Xie, G; Yang, J; Dubchak, I; Furey, TS; DeJong, P; Dickson, M; Gordon, D; Eichler, EE; Pennacchio, LA; Richardson, P; Stubbs, L; Rokhsar, DS; Myers, RM; Rubin, EM; Lucas, SM				Grimwood, J; Gordon, LA; Olsen, A; Terry, A; Schmutz, J; Lamerdin, J; Hellsten, U; Goodstein, D; Couronne, O; Gyamfi, MT; Aerts, A; Altherr, M; Ashworth, L; Bajorek, E; Black, S; Branscomb, E; Caenepeel, S; Carrano, A; Caoile, C; Chan, YM; Christensen, M; Cleland, CA; Copeland, A; Dalin, E; Dehal, P; Denys, M; Detter, JC; Escobar, J; Flowers, D; Fotopulos, D; Garcia, C; Georgescu, AM; Glavina, T; Gomez, M; Gonzales, E; Groza, M; Hammon, N; Hawkins, T; Haydu, L; Ho, I; Huang, W; Israni, S; Jett, J; Kadner, K; Kimball, H; Kobayashi, A; Larionov, V; Leem, SH; Lopez, F; Lou, YL; Lowry, S; Malfatti, S; Martinez, D; McCready, P; Medina, C; Morgan, J; Nelson, K; Nolan, M; Ovcharenko, I; Pitluck, S; Pollard, M; Popkie, AP; Predki, P; Quan, G; Ramirez, L; Rash, S; Retterer, J; Rodriguez, A; Rogers, S; Salamov, A; Salazar, A; She, XW; Smith, D; Slezak, T; Solovyev, V; Thayer, N; Tice, H; Tsai, M; Ustaszewska, A; Vo, N; Wagner, M; Wheeler, J; Wu, K; Xie, G; Yang, J; Dubchak, I; Furey, TS; DeJong, P; Dickson, M; Gordon, D; Eichler, EE; Pennacchio, LA; Richardson, P; Stubbs, L; Rokhsar, DS; Myers, RM; Rubin, EM; Lucas, SM			The DNA sequence and biology of human chromosome 19	NATURE			English	Article							SITU HYBRIDIZATION MAP; THYMINE DIMERS; GENE-CLUSTER; LDL RECEPTOR; CHROMOSOME; ORGANIZATION; EVOLUTION; EXPANSION; MOUSE	Chromosome 19 has the highest gene density of all human chromosomes, more than double the genome-wide average. The large clustered gene families, corresponding high G+C content, CpG islands and density of repetitive DNA indicate a chromosome rich in biological and evolutionary significance. Here we describe 55.8 million base pairs of highly accurate finished sequence representing 99.9% of the euchromatin portion of the chromosome. Manual curation of gene loci reveals 1,461 protein-coding genes and 321 pseudogenes. Among these are genes directly implicated in mendelian disorders, including familial hypercholesterolaemia and insulin-resistant diabetes. Nearly one-quarter of these genes belong to tandemly arranged families, encompassing more than 25% of the chromosome. Comparative analyses show a fascinating picture of conservation and divergence, revealing large blocks of gene orthology with rodents, scattered regions with more recent gene family expansions and deletions, and segments of coding and non-coding conservation with the distant fish species Takifugu.	Stanford Univ, Sch Med, Dept Genet, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; DOEs Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; NCI, Lab Biosyst & Canc, NIH, Bethesda, MD 20892 USA; Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Childrens Hosp Oakland, Oakland, CA 94609 USA; Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Seattle, WA 98195 USA	Stanford University; United States Department of Energy (DOE); Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Grimwood, J (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford Human Genome Ctr, 975 Calif Ave, Palo Alto, CA 94304 USA.	jane@shgc.stanford.edu; emrubin@lbl.gov	Couronne, Olivier Couronne/G-1244-2012; Terry, Astrid Y/A-2538-2011; Solovyev, Victor/C-4614-2013; Grimwood, Jane/ABD-5737-2021; Schmutz, Jeremy/N-3173-2013	Terry, Astrid Y/0000-0002-5234-1224; Solovyev, Victor/0000-0001-8885-493X; Schmutz, Jeremy/0000-0001-8062-9172; Malfatti, Stephanie/0000-0003-4225-9857; christoffersen, catherine/0000-0003-1816-9747; Rokhsar, Daniel/0000-0002-8704-2224; Goodstein, David/0000-0001-6287-2697; Furey, Terry/0000-0001-5546-9672; Pennacchio, Len/0000-0002-8748-3732; Stubbs, Lisa/0000-0002-9556-1972	NATIONAL CANCER INSTITUTE [Z01BC010413, ZIABC010413] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; BRANDRIFF BF, 1994, GENOMICS, V23, P582, DOI 10.1006/geno.1994.1546; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eichler EE, 1998, GENOME RES, V8, P791, DOI 10.1101/gr.8.8.791; Felsenfeld A, 1999, GENOME RES, V9, P1; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; GORDON LA, 1995, GENOMICS, V30, P187, DOI 10.1006/geno.1995.9886; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hoffman SMG, 2001, PHARMACOGENETICS, V11, P687, DOI 10.1097/00008571-200111000-00007; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; JUVONEN E, 1991, BLOOD, V78, P3066; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis S.E., 2002, GENOME BIOL, V3; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; MOHRENWEISER HW, 1989, CYTOGENET CELL GENET, V52, P11, DOI 10.1159/000132829; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Newman T, 2003, GENOME RES, V13, P781, DOI 10.1101/gr.769003; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; Patrinos A, 1997, J Am Med Womens Assoc (1972), V52, P8; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SETLOW RB, 1962, P NATL ACAD SCI USA, V48, P1250, DOI 10.1073/pnas.48.7.1250; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; SOLOVYEV VV, 2002, BIOINFORMATICS GENOM, V1, P59; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	48	218	1152	1	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					529	535		10.1038/nature02399	http://dx.doi.org/10.1038/nature02399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15057824	Bronze, Green Submitted			2022-12-01	WOS:000220540100034
J	Mukherjee, J				Mukherjee, J			Basing treatment on rights rather than ability to pay: 3 by 5	LANCET			English	Editorial Material							HEALTH		Partners Hlth, Boston, MA 02115 USA	Partners Healthcare System	Mukherjee, J (corresponding author), Partners Hlth, 641 Huntington Ave, Boston, MA 02115 USA.	jmukherjee@pih.org						*GLOB FUND FIGHT A, TUB MAL PLEDG; Hall JJ, 2003, MED J AUSTRALIA, V178, P17, DOI 10.5694/j.1326-5377.2003.tb05033.x; Kritski AL, 2000, INT J TUBERC LUNG D, V4, P622; Wendo C, 2003, LANCET, V361, P942, DOI 10.1016/S0140-6736(03)12794-8; *WHO, TREAT 3 MILL 2005 MA	5	13	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 27	2004	363	9414					1071	1072		10.1016/S0140-6736(04)15846-7	http://dx.doi.org/10.1016/S0140-6736(04)15846-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15065564				2022-12-01	WOS:000220497300025
J	Shen, K; Fetter, RD; Bargmann, CI				Shen, K; Fetter, RD; Bargmann, CI			Synaptic specificity is generated by the synaptic guidepost protein SYG-2 and its receptor, SYG-1	CELL			English	Article							C-ELEGANS; GENETIC PATHWAY; NEPHRIN; EXPRESSION; MOLECULES; VESICLES; RST	Synaptic connections in the nervous system are directed onto specific cellular and subcellular targets. Synaptic guidepost cells in the C. elegans vulval epithelium drive synapses from the HSNL motor neuron onto adjacent target neurons and muscles. Here, we show that the transmembrane immunoglobulin superfamily protein SYG-2 is a central component of the synaptic guidepost signal. SYG-2 is expressed transiently by primary vulval epithelial cells during synapse formation. SYG-2 binds SYG-1, the receptor on HSNL, and directs SYG-1 accumulation and synapse formation to adjacent regions of HSNL. syg-1 and syg-2 mutants have defects in synaptic specificity; the HSNL neuron forms fewer synapses onto its normal targets and forms ectopic synapses onto inappropriate targets. Misexpression of SYG-2 in secondary epithelial cells causes aberrant accumulation of SYG-1 and synaptic markers in HSNL adjacent to the SYG-2-expressing cells. Our results indicate that local interactions between immunoglobulin superfamily proteins can determine specificity during synapse formation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu		Bargmann, Cornelia/0000-0002-8484-0618				ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRENNER S, 1974, GENETICS, V77, P71; Burdine RD, 1998, DEVELOPMENT, V125, P1083; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; Dworak HA, 2001, DEVELOPMENT, V128, P4265; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Gupta BP, 2003, DEVELOPMENT, V130, P2589, DOI 10.1242/dev.00500; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khoshnoodi J, 2001, EXP NEPHROL, V9, P355; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reist NE, 1998, J NEUROSCI, V18, P7662; Rose D, 2000, MICROSC RES TECHNIQ, V49, P3, DOI 10.1002/(SICI)1097-0029(20000401)49:1<3::AID-JEMT2>3.0.CO;2-E; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	36	214	225	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2004	116	6					869	881		10.1016/S0092-8674(04)00251-X	http://dx.doi.org/10.1016/S0092-8674(04)00251-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YS	15035988	Bronze			2022-12-01	WOS:000221499900012
J	Wennberg, JE; Fisher, ES; Stukel, TA; Skinner, JS; Sharp, SM; Bronner, KK				Wennberg, JE; Fisher, ES; Stukel, TA; Skinner, JS; Sharp, SM; Bronner, KK			Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE; NEW-HAVEN; MEDICARE BENEFICIARIES; REGIONAL-VARIATIONS; SERVICES; BOSTON; DELIVERY; DEATH	Objective To evaluate the use of healthcare resources during the last six months of life among patients of US hospitals with strong reputations for high quality care in managing chronic illness. Design Retrospective cohort study based on claims data from the US Medicare programme. Participants Cohorts receiving most of their hospital care from 77 hospitals that appeared on the 2001 US News and World Report "best hospitals" list for heart and pulmonary disease, cancer, and geriatric services. Main outcome measures Use of healthcare resources in the last six months of life: number of days spent in hospital and in intensive care units; number of physician visits; percentage of patients seeing 10 or more physicians; percentage enrolled in hospice. Terminal care: percentage of deaths occurring in hospital; percentage of deaths occurring in association with a stay in an intensive care unit. Results Extensive variation in each measure existed among the 77 hospital cohorts. Days in hospital per decedent ranged from 9.4 to 27.1 (interquartile range 11.6-16.1); days in intensive care units ranged from 1.6 to 9.5 (2.6-4.5); number of physician visits ranged from 17.6 to 76.2 (25.5-39.5); percentage of patients seeing 10 or more physicians ranged from 16.9% to 58.5% (29.4-43.4%); and hospice enrolment ranged from 10.8% to 43.8% (22.0-32.0%). The percentage of deaths occurring in hospital ranged from 15.9% to 55.6% (35.4-43.1%), and the percentage of deaths associated with a stay in intensive care ranged from 8.4% to 36.8% (20.2-27.1%). Conclusion Striking variation exists in the utilisation of end of life care among US medical centres with strong national reputations for clinical care.	Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH 03755 USA; VA Outcomes Grp, White River Jct, VT 05001 USA; Inst Clin Evaluat Sci, Toronto, ON, Canada; Dartmouth Coll, Hanover, NH 03755 USA	Dartmouth College; VA Outcomes Group; University of Toronto; Dartmouth College	Wennberg, JE (corresponding author), Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, 7251 Strasenburgh, Hanover, NH 03755 USA.	john.wennberg@Dartmouth.edu		Stukel, Therese/0000-0002-2951-1360	NIA NIH HHS [1PO1AG19783-01, P01 AG019783-04, P01 AG019783] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; McCullagh P, 2019, GEN LINEAR MODELS; MILLER DAF, 1993, ADOLESCENCE, V28, P621; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; SINGER DE, 1983, NEW ENGL J MED, V309, P1155, DOI 10.1056/NEJM198311103091905; STRAUSS MJ, 1986, JAMA-J AM MED ASSOC, V255, P1143, DOI 10.1001/jama.255.9.1143; WASSON J, 1992, JAMA-J AM MED ASSOC, V267, P1788, DOI 10.1001/jama.267.13.1788; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706; WENNBERG JE, 2002, GEOGRAPHY DEBATE MED; WENNBERG JE, HLTH AFFAIRS; Wennberg JE, 1999, QUALITY MED CARE US; 2001, US NEWS WORLD REPORT, V131	22	216	219	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2004	328	7440					607	610A		10.1136/bmj.328.7440.607	http://dx.doi.org/10.1136/bmj.328.7440.607			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803CB	15016692	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000220208100015
J	Hasson, U; Nir, Y; Levy, I; Fuhrmann, G; Malach, R				Hasson, U; Nir, Y; Levy, I; Fuhrmann, G; Malach, R			Intersubject synchronization of cortical activity during natural vision	SCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; HUMAN NEURAL SYSTEM; HUMAN VISUAL-CORTEX; FACE PERCEPTION; RECEPTIVE-FIELDS; OBJECTS; REPRESENTATION; SCENES; AREAS; MOVEMENTS	To what extent do all brains work alike during natural conditions? We explored this question by letting Five subjects freely view half an hour of a popular movie while undergoing functional brain imaging. Applying an unbiased analysis in which spatiotemporal activity patterns in one brain were used to "model" activity in another brain, we found a striking level of voxel-by-voxel synchronization between individuals, not only in primary and secondary visual and auditory areas but also in association cortices. The results reveal a surprising tendency of individual brains to "tick collectively" during natural vision. The intersubject synchronization consisted of a widespread cortical activation pattern correlated with emotionally arousing scenes and regionally selective components. The characteristics of these activations were revealed with the use of an open-ended "reverse-correlation" approach, which inverts the conventional analysis by letting the brain signals themselves "pick up" the optimal stimuli for each specialized cortical area.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Tel Aviv Univ, Dept Comp Sci, IL-61390 Tel Aviv, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Tel Aviv University; Hebrew University of Jerusalem	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@weizmann.ac.il		Fuhrmann Alpert, Galit/0000-0003-4778-3754; Levy, Ifat/0000-0001-7851-9070; Hasson, Uri/0000-0002-3599-7168; Nir, Yuval/0000-0002-5433-6349				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Damasio A, 2000, FEELING WHAT HAPPENS; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; HASSON U, UNPUB; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Press WA, 2001, VISION RES, V41, P1321, DOI 10.1016/S0042-6989(01)00074-8; Puce A, 1998, J NEUROSCI, V18, P2188; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rolls ET, 2003, J NEUROSCI, V23, P339; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; VINCENZONI L, 1966, GOOD BAD UGLY; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	38	973	989	15	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1634	1640		10.1126/science.1089506	http://dx.doi.org/10.1126/science.1089506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15016991				2022-12-01	WOS:000220151400034
J	Murphy, RT; Mogensen, J; Shaw, A; Kubo, T; Hughes, S; McKenna, WJ				Murphy, RT; Mogensen, J; Shaw, A; Kubo, T; Hughes, S; McKenna, WJ			Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy	LANCET			English	Article								Idiopathic dilated cardiomyopathy is a common cause of heart failure. Half of cases are believed to be hereditary, and mutations in cardiac sarcomeric contractile protein genes have been reported with autosomal dominant inheritance. We used mutation analysis suitable for identification of both dominant and recessive mutations to investigate the sarcomeric gene for cardiac troponin I (TNNI3) in 235 patients with dilated cardiomyopathy. We identified a novel TNNI3 mutation in a family with recessive disease. Functional studies showed impairment of troponin interactions that could lead to diminished myocardial contractility. TNNI3 is the first recessive gene identified for this condition, and we suggest that other such genes could be pinpointed by mutation analyses designed to identify homozygous mutations.	Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Kochi Med Sch, Dept Med & Geriatr, Kochi, Japan	St Georges University London; Kochi University	Mogensen, J (corresponding author), Skejby Univ Hosp, Dept Cardiol, Brendstupgaardsvej, DK-8200 Aarhus N, Denmark.	jens.mogensen@dadlnet.dk	McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460; Mogensen, Jens/0000-0002-8813-573X				Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; Mogensen J, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e59; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; Rarick HM, 1999, J MOL CELL CARDIOL, V31, P363, DOI 10.1006/jmcc.1998.0870; Towbin J. A., 2001, Current Molecular Medicine (Hilversum), V1, P81, DOI 10.2174/1566524013364077	5	125	133	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2004	363	9406					371	372		10.1016/S0140-6736(04)15468-8	http://dx.doi.org/10.1016/S0140-6736(04)15468-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15070570				2022-12-01	WOS:000188590900015
J	Murphy, NF; MacIntyre, K; Capewell, S; Stewart, S; Pell, J; Chalmers, P; Redpath, A; Frame, S; Boyd, J; McMurray, JJV				Murphy, NF; MacIntyre, K; Capewell, S; Stewart, S; Pell, J; Chalmers, P; Redpath, A; Frame, S; Boyd, J; McMurray, JJV			Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CASE-FATALITY RATES; MORTALITY		Western Infirm & Associated Hosp, Dept Cardiol, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England; Univ S Australia, Div Hlth Sci, Adelaide, SA 5000, Australia; Greater Glasgow Hlth Board, Glasgow G3 8YU, Lanark, Scotland; Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland	University of Glasgow; University of Liverpool; University of South Australia	McMurray, JJV (corresponding author), Western Infirm & Associated Hosp, Dept Cardiol, Glasgow G12 8QQ, Lanark, Scotland.	j.mcmurrray@bio.gla.ac.uk	Stewart, Simon/M-3316-2016; Macintyre, Kate/J-7174-2014; mcmurray, John/B-2467-2013	Stewart, Simon/0000-0001-9032-8998; Macintyre, Kate/0000-0003-2741-0467; mcmurray, John/0000-0002-6317-3975; Pell, Jill/0000-0002-8898-7035; Boyd, James/0000-0002-8925-8811				Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Marques-Vidal P, 2000, HEART, V84, P171, DOI 10.1136/heart.84.2.171; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x	5	36	36	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2004	328	7453					1413	1414		10.1136/bmj.38111.650741.F7	http://dx.doi.org/10.1136/bmj.38111.650741.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	830IB	15155470	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000222114400021
J	Benn, CS; Melbye, M; Wohlfahrt, J; Bjorksten, B; Aaby, P				Benn, CS; Melbye, M; Wohlfahrt, J; Bjorksten, B; Aaby, P			Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life	BRITISH MEDICAL JOURNAL			English	Article							FAMILY-SIZE; HAY-FEVER; RESPIRATORY-INFECTIONS; BIRTH COHORT; CHILDREN; ASTHMA; PREVALENCE; ALLERGY; DETERMINANTS; ANTIBODIES	Objectives To determine whether early infectious diseases could explain the association between number of siblings and other markers of microbial exposure and the development of atopic dermatitis before the age of 18 months. Design Cohort study. Information on atopic dermatitis, infectious diseases occurring before 6 months of age, number of siblings, early day care, pet keeping, farm residence, and background factors was collected in telephone interviews. Setting Danish national birth cohort. Participants 24341 mother-child pairs. Main outcome measures Incidence rate ratios of atopic dermatitis. Results 13070 children (54%) had at least one clinically apparent infectious disease before 6 months of age. At age 18 months, 2638 (10.8%) of the children had had atopic dermatitis. The risk of atopic dermatitis increased with each infectious disease before 6 months of age (incidence rate ratio 1.08,95% confidence interval 1.04 to 1.13). The risk of atopic dermatitis decreased with each additional exposure to three or more siblings, day care, pet ownership, and farm residence (0.86, 0.81 to 0.93). Conclusions Early infections do not seem to protect against allergic diseases. The protective effect of number of siblings, day care, pet ownership, and farm residence remained after adjustment for clinically apparent infectious diseases, suggesting that the effect is established independently early in life.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark; Projecto Saude Bandim, Bissau, Guinea Bissau; Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Stockholm, Sweden	Aarhus University; Statens Serum Institut; Karolinska Institutet; Karolinska Institutet	Benn, CS (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark.	C.Benn.cb@ssi.dk		melbye, mads/0000-0001-8264-6785; Aaby, Peter/0000-0001-8331-1389				Benn CS, 2003, ACTA DERM-VENEREOL, V83, P347; Bjorksten B, 1999, J ALLERGY CLIN IMMUN, V104, P1119; Bodner C, 1998, THORAX, V53, P28, DOI 10.1136/thx.53.1.28; Bohme M, 2002, ACTA DERM-VENEREOL, V82, P98, DOI 10.1080/00015550252948112; Devereux G, 2002, CLIN EXP ALLERGY, V32, P43, DOI 10.1046/j.0022-0477.2001.01267.x; Forastiere F, 1997, EPIDEMIOLOGY, V8, P566, DOI 10.1097/00001648-199709000-00015; Harris JM, 2001, BRIT J DERMATOL, V144, P795, DOI 10.1046/j.1365-2133.2001.04135.x; Kalliomaki M, 2003, CURR OPIN ALLERGY CL, V3, P15, DOI 10.1097/01.all.0000053262.39029.a1; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Karmaus W, 2001, AM J EPIDEMIOL, V154, P909, DOI 10.1093/aje/154.10.909; Linneberg A, 2003, J ALLERGY CLIN IMMUN, V111, P847, DOI 10.1067/mai.2003.1335; Matricardi PM, 2001, CURR OPIN ALLERGY CL, V1, P413, DOI 10.1097/00130832-200110000-00006; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; McKeever TM, 2002, J ALLERGY CLIN IMMUN, V109, P43, DOI 10.1067/mai.2002.121016; Nafstad P, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e38; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ponsonby AL, 1999, THORAX, V54, P664, DOI 10.1136/thx.54.8.664; RYSTEDT I, 1986, BRIT J DERMATOL, V114, P575, DOI 10.1111/j.1365-2133.1986.tb04064.x; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; Strannegard O, 2001, ALLERGY, V56, P91, DOI 10.1034/j.1398-9995.2001.056002091.x; Wickens KL, 1999, EPIDEMIOLOGY, V10, P699, DOI 10.1097/00001648-199911000-00009	23	134	135	2	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 22	2004	328	7450					1223	1226		10.1136/bmj.38069.512245.FE	http://dx.doi.org/10.1136/bmj.38069.512245.FE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15121716	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000221677200015
J	Lee, JLC; Everitt, BJ; Thomas, KL				Lee, JLC; Everitt, BJ; Thomas, KL			Independent cellular processes for hippocampal memory consolidation and reconsolidation	SCIENCE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; RETROGRADE-AMNESIA; REACTIVATED MEMORY; PROTEIN-SYNTHESIS; RAT HIPPOCAMPUS; RECOGNITION MEMORY; REGULATED KINASE; MESSENGER-RNA; FEAR MEMORIES	The idea that new memories undergo a time-dependent consolidation process after acquisition has received considerable experimental support. More controversial has been the demonstration that established memories, once recalled, become labile and sensitive to disruption, requiring "reconsolidation" to become permanent. By infusing antisense oligodeoxynucleotides into the hippocampus of rats, we show that consolidation and reconsolidation are doubly dissociable component processes of memory. Consolidation involves brain-derived neurotrophic factor ( BDNF) but not the transcription factor Zif268, whereas reconsolidation recruits Zif268 but not BDNF. These findings confirm a requirement for BDNF specifically in memory consolidation and also resolve the role of Zif268 in brain plasticity, learning, and memory.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Thomas, KL (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales.	thomaskl5@cf.ac.uk	Lee, Jonathan LC/A-9629-2008; Thomas, Kerrie L/A-6509-2010	Lee, Jonathan LC/0000-0002-2284-2482; Thomas, Kerrie L/0000-0003-3355-9583; Everitt, Barry/0000-0003-4431-6536	Medical Research Council [G9537855] Funding Source: Medline; MRC [G9537855] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GORDON WC, 1977, PHYSIOL BEHAV, V18, P95, DOI 10.1016/0031-9384(77)90099-3; GORDON WC, 1977, AM J PSYCHOL, V90, P231, DOI 10.2307/1422045; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hebb D.O., 2002, CLIN PSYCHOL; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelly A, 2003, J NEUROSCI, V23, P5354; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Malkani S, 2000, NEUROSCIENCE, V97, P693, DOI 10.1016/S0306-4522(00)00058-0; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Miller RR, 2000, NAT REV NEUROSCI, V1, P214, DOI 10.1038/35044578; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; Nadel L, 2000, NAT REV NEUROSCI, V1, P209, DOI 10.1038/35044572; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; OVERTON DA, 1964, J COMP PHYSIOL PSYCH, V57, P3, DOI 10.1037/h0048023; Pilzecker, 1900, Z PSYCHOL, V1, P1; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; RICHARDSON CL, 1992, BRAIN RES, V580, P147, DOI 10.1016/0006-8993(92)90938-6; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	45	600	622	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					839	843		10.1126/science.1095760	http://dx.doi.org/10.1126/science.1095760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15073322				2022-12-01	WOS:000221243000034
J	Dornan, D; Wertz, I; Shimizu, H; Arnott, D; Frantz, GD; Dowd, P; O' Rourke, K; Koeppen, H; Dixit, VM				Dornan, D; Wertz, I; Shimizu, H; Arnott, D; Frantz, GD; Dowd, P; O' Rourke, K; Koeppen, H; Dixit, VM			The ubiquitin ligase COP1 is a critical negative regulator of p53	NATURE			English	Article							LIGHT CONTROL; TRANSCRIPTION; MDM2; EXPRESSION; REPRESSION; PROMOTES; SWITCH; JUN	COP1 ( constitutively photomorphogenic 1) is a RING-finger-containing protein that functions to repress plant photomorphogenesis, the light-mediated programme of plant development. Mutants of COP1 are constitutively photomorphogenic, and this has been attributed to their inability to negatively regulate the proteins LAF1 (ref. 1) and HY5 ( ref. 2). The role of COP1 in mammalian cells is less well characterized(3). Here we identify the tumour-suppressor protein p53 as a COP1-interacting protein. COP1 increases p53 turnover by targeting it for degradation by the proteasome in a ubiquitin-dependent fashion, independently of MDM2 or Pirh2, which are known to interact with and negatively regulate p53. Moreover, COP1 serves as an E3 ubiquitin ligase for p53 in vitro and in vivo, and inhibits p53-dependent transcription and apoptosis. Depletion of COP1 by short interfering RNA ( siRNA) stabilizes p53 and arrests cells in the G1 phase of the cell cycle. Furthermore, we identify COP1 as a p53-inducible gene, and show that the depletion of COP1 and MDM2 by siRNA cooperatively sensitizes U2-OS cells to ionizing-radiation-induced cell death. Overall, these results indicate that COP1 is a critical negative regulator of p53 and represents a new pathway for maintaining p53 at low levels in unstressed cells.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Univ Calif Davis, Dept Human Physiol, Davis, CA 95616 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Davis	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Doonan J, 1996, NATURE, V380, P481, DOI 10.1038/380481a0; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Hardtke CS, 2000, PLANT PHYSIOL, V124, P1548, DOI 10.1104/pp.124.4.1548; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jin SK, 2001, J CELL SCI, V114, P4139; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Ma LG, 2002, PLANT CELL, V14, P2383, DOI 10.1105/tpc.004416; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Neff MM, 2000, GENE DEV, V14, P257; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shimizu H, 2003, TRENDS BIOCHEM SCI, V28, P346, DOI 10.1016/S0968-0004(03)00140-3; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yi CL, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-30	24	497	521	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					86	92		10.1038/nature02514	http://dx.doi.org/10.1038/nature02514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15103385				2022-12-01	WOS:000221222100050
J	Correge, T; Gagan, MK; Beck, JW; Burr, GS; Cabioch, G; Le Cornec, F				Correge, T; Gagan, MK; Beck, JW; Burr, GS; Cabioch, G; Le Cornec, F			Interdecadal variation in the extent of South Pacific tropical waters during the Younger Dryas event	NATURE			English	Article							SEA-SURFACE TEMPERATURE; THERMAL STRUCTURE; CLIMATE-CHANGE; OCEAN; CORAL; ENSO; DEGLACIATION; CIRCULATION; RECORD	During the Younger Dryas event, about 12,000 years ago, the Northern Hemisphere cooled by between 2 and 10 degreesC (refs 1, 2) whereas East Antarctica experienced warming(3). But the spatial signature of the event in the southern mid-latitudes and tropics is less well known, as records are sparse and inconclusive(4-16). Here we present high-resolution analyses of skeletal Sr/Ca and O-18/O-16 ratios for a giant fossil Diploastrea heliopora coral that was preserved in growth position on the raised reef terraces of Espiritu Santo Island, Vanuatu, in the southwestern tropical Pacific Ocean(17). Our data indicate that sea surface temperatures in Vanuatu were on average 4.5 +/- 1.3 degreesC cooler during the Younger Dryas event than today, with a significant interdecadal modulation. The amplified annual cycle of sea surface temperatures, relative to today, indicates that cooling was caused by the compression of tropical waters towards the Equator. The positive correlation in our record between the oxygen isotope ratios of sea water and sea surface temperatures suggests that the South Pacific convergence zone, which brings O-18-depleted precipitation to the area today, was not active during the Younger Dryas period.	Inst Rech Dev, Noumea, New Caledonia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Arizona, NSF, Arizona AMS Facil, Tucson, AZ 85721 USA; Inst Rech Dev, F-93143 Bondy, France	Institut de Recherche pour le Developpement (IRD); Australian National University; National Science Foundation (NSF); University of Arizona; Institut de Recherche pour le Developpement (IRD)	Correge, T (corresponding author), Inst Rech Dev, UR 055 Paleotrop,BPA5, Noumea, New Caledonia.	thierry.correge@noumea.ird.nc	Gagan, Michael/L-5014-2018	Gagan, Michael/0000-0002-8279-323X; Burr, George/0000-0003-0068-7589				An SI, 2000, J CLIMATE, V13, P2044, DOI 10.1175/1520-0442(2000)013<2044:ICOTSO>2.0.CO;2; Anderson DE, 1997, PROG PHYS GEOG, V21, P230, DOI 10.1177/030913339702100203; Andres MS, 2003, EARTH PLANET SC LETT, V216, P515, DOI 10.1016/S0012-821X(03)00556-9; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Bennett KD, 2000, SCIENCE, V290, P325, DOI 10.1126/science.290.5490.325; Burr GS, 1998, RADIOCARBON, V40, P1093, DOI 10.1017/S0033822200019147; CABIOCH G, 1998, IAS SPECIAL PUBLICAT, V25, P261; Correge T, 2000, PALEOCEANOGRAPHY, V15, P465, DOI 10.1029/1999PA000409; DELCROIX T, 1989, J MAR RES, V47, P777, DOI 10.1357/002224089785076046; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; GAGAN MK, 1994, EARTH PLANET SC LETT, V121, P549, DOI 10.1016/0012-821X(94)90090-6; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Guilderson TP, 2001, MAR GEOL, V172, P75, DOI 10.1016/S0025-3227(00)00115-8; Karspeck AR, 2002, J PHYS OCEANOGR, V32, P2350, DOI 10.1175/1520-0485(2002)032<2350:TPCSIA>2.0.CO;2; Kienast M, 2001, SCIENCE, V291, P2132, DOI 10.1126/science.1057131; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; Patrick A, 1997, PALEOCEANOGRAPHY, V12, P649, DOI 10.1029/97PA01553; PETEET D, 1995, QUATERN INT, V28, P93, DOI 10.1016/1040-6182(95)00049-O; Ren L, 2003, GEOCHIM COSMOCHIM AC, V67, P1609, DOI 10.1016/S0016-7037(02)00917-1; Rodbell DT, 2000, QUATERNARY RES, V54, P328, DOI 10.1006/qres.2000.2177; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Singer C, 1998, SCIENCE, V281, P812, DOI 10.1126/science.281.5378.812; Stoll HM, 1998, GEOCHIM COSMOCHIM AC, V62, P1107, DOI 10.1016/S0016-7037(98)00042-8; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; Thunell RC, 1996, QUATERNARY RES, V46, P72, DOI 10.1006/qres.1996.0045; Watanabe O, 2003, NATURE, V422, P509, DOI 10.1038/nature01525; Watanabe T, 2003, GEOCHIM COSMOCHIM AC, V67, P1349, DOI 10.1016/S0016-7037(02)01221-8	30	89	93	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2004	428	6986					927	929		10.1038/nature02506	http://dx.doi.org/10.1038/nature02506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118722				2022-12-01	WOS:000221083000036
J	Armbrecht, I; Perfecto, I; Vandermeer, J				Armbrecht, I; Perfecto, I; Vandermeer, J			Enigmatic biodiversity correlations: Ant diversity responds to diverse resources	SCIENCE			English	Article							SPECIES-DIVERSITY; COMMUNITIES	A pattern noted in ecology is that diversity at one level begets diversity at other levels. In the case of consumers competing for similar resources, the diversity of those resources is thought to provide some degree of niche diversification in which a diverse set of consumer species can coexist. If, however, the diverse resources are not sufficiently distinct from one another, from the standpoint of the consumer species, such niche diversification will not exist. We experimentally show that a diverse array of twigs attracted 80% more species of twig-nesting ants than a monospecific collection of twigs. The specific tree species from which the twigs were derived did not explain the pattern. It appears that diversity per se at one level ( twigs) creates conditions that promote diversity at another level ( nesting ants).	Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Univ Valle, Dept Biol, Cali 25360, Colombia; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidad del Valle; University of Michigan System; University of Michigan	Armbrecht, I (corresponding author), Univ Michigan, Sch Nat Resources & Environm, 430 E Univ, Ann Arbor, MI 48109 USA.	inge@univalle.edu.co						ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; BYRNE MM, 1994, BIOTROPICA, V26, P61, DOI 10.2307/2389111; Cameron T, 2002, TRENDS ECOL EVOL, V17, P495, DOI 10.1016/S0169-5347(02)02618-6; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; DELAVEAU P, 1988, B SOC BOT FR-ACTUAL, V135, P25, DOI 10.1080/01811789.1988.10826899; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Gause G.F., 1934, STRUGGLE EXISTENCE; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hubbell Stephen P., 2001, V32, pi; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huston MA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P47; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Kaspari M, 1996, OIKOS, V76, P443, DOI 10.2307/3546338; LEVINGS S C, 1981, Psyche (Cambridge), V88, P265, DOI 10.1155/1981/20795; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; MURDOCH WW, 1972, ECOLOGY, V53, P819, DOI 10.2307/1934297; Perez-Morales J.V., 1977, SCI FUNGORUM, V11, P99, DOI [10.33885/sf.1977.2.466, DOI 10.33885/SF.1977.2.466]; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SOULE ME, 1991, SCIENCE, V253, P744, DOI 10.1126/science.253.5021.744; Vandermeer J, 2002, P NATL ACAD SCI USA, V99, P8731, DOI 10.1073/pnas.142073599; WILSON EO, 1959, ECOLOGY, V40, P437, DOI 10.2307/1929761	23	138	146	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					284	286		10.1126/science.1094981	http://dx.doi.org/10.1126/science.1094981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073375				2022-12-01	WOS:000220719400045
J	Roesch, MR; Olson, CR				Roesch, MR; Olson, CR			Neuronal activity related to reward value and motivation in primate frontal cortex	SCIENCE			English	Article							SUPPLEMENTARY EYE FIELD; ORBITOFRONTAL CORTEX; PREFRONTAL NEURONS; PARIETAL CORTEX; EXPECTED REWARD; LIMBIC SYSTEM; MONKEY; STRIATUM; PREMOTOR; SIGNALS	In several areas of the macaque brain, neurons. re during delayed-response tasks at a rate determined by the value of the reward expected at the end of the trial. The activity of these neurons might be related to the value of the expected reward or to the degree of motivation induced by expectation of the reward. We describe results indicating that the nature of reward-dependent activity varies across areas. Neuronal activity in orbitofrontal cortex represents the value of the expected reward, whereas neuronal activity in premotor cortex reflects the degree of motivation.	Mellon Inst, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roesch, MR (corresponding author), Mellon Inst, Ctr Neural Basis Cognit, Room 115,4400 5th Ave, Pittsburgh, PA 15213 USA.	roesch@cnbc.cmu.edu			NCRR NIH HHS [P41RR03631] Funding Source: Medline; NEI NIH HHS [EY11831, EY08098] Funding Source: Medline; NIMH NIH HHS [MH45156] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003631] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008098, R01EY011831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Glimcher PW, 2002, NEURON, V36, P323, DOI 10.1016/S0896-6273(02)00962-5; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Martin-Soelch C, 2001, BRAIN RES REV, V36, P139, DOI 10.1016/S0165-0173(01)00089-3; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Ono T, 2000, J NEUROL, V247, P23, DOI 10.1007/PL00007780; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla Robert A, 2003, Span J Psychol, V6, P185; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Stellar E., 1982, PHYSL MECH MOTIVATIO, P377; Stellar J. R., 1985, NEUROBIOLOGY MOTIVAT; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Watanabe M, 1998, REV NEUROSCIENCE, V9, P225; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	29	390	396	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					307	310		10.1126/science.1093223	http://dx.doi.org/10.1126/science.1093223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073380				2022-12-01	WOS:000220719400052
J	Everall, I; Grant, I				Everall, I; Grant, I			Proteomic pointers in HIV neurocognitive disorder	LANCET			English	Editorial Material									Kings Coll London, Inst Psychiat, Sect Expt Neuropathol & Psychiat, London SE5 8AF, England; Univ Calif San Diego, HIV Neurobehav Res Ctr, La Jolla, CA 92093 USA	University of London; King's College London; University of California System; University of California San Diego	Everall, I (corresponding author), Kings Coll London, Inst Psychiat, Sect Expt Neuropathol & Psychiat, London SE5 8AF, England.	i.everall@iop.kcl.ac.uk		Everall, Ian/0000-0003-3957-3861				Cherner M, 2002, NEUROLOGY, V59, P1563, DOI 10.1212/01.WNL.0000034175.11956.79; Everall IP, 1999, BRAIN PATHOL, V9, P209; GRANT I, 2002, ENCY HUMAN BRAIN, V2, P475; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Liu ZJ, 2000, J MOL MODEL, V6, P1, DOI 10.1007/PL00010720; Luo X, 2003, NEUROLOGY, V60, P1931, DOI 10.1212/01.WNL.0000064396.54554.26; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618	7	3	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 3	2004	363	9415					1091	1092		10.1016/S0140-6736(04)15932-1	http://dx.doi.org/10.1016/S0140-6736(04)15932-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808VB	15064024				2022-12-01	WOS:000220595500005
J	Mazina, OM; Mazin, AV; Nakagawa, T; Kolodner, RD; Kowalczykowski, SC				Mazina, OM; Mazin, AV; Nakagawa, T; Kolodner, RD; Kowalczykowski, SC			Saccharomyces cerevisiae MER3 helicase stimulates 3 '-5 ' Heteroduplex extension by Rad51: Implications for crossover control in meiotic recombination	CELL			English	Article							DNA STRAND EXCHANGE; REPLICATION PROTEIN-A; COLI RECA PROTEIN; CROSSING-OVER; NUCLEOPROTEIN FILAMENT; YEAST RAD51; COMPLEX-FORMATION; BRANCH MIGRATION; CHROMOSOME SYNAPSIS; MISMATCH CORRECTION	Crossover and noncrossover recombinants can form by two different pathways during meiotic recombination in Saccharomyces cerevisiae. The MER3 gene is known to affect selectively crossover, but not noncrossover, recombination. The Mer3 protein is a DNA helicase that unwinds duplex DNA in the 3' to 5' direction. To define the underlying molecular steps of meiotic recombination, we investigated the role of Mer3 helicase in DNA strand exchange promoted by Rad51 protein. We found that Mer3 helicase does not function as an initiator of DNA pairing events but, rather, it stimulates DNA heteroduplex extension in the 3' --> 5' direction relative to the incoming (or displaced) single-stranded DNA. Conversely, Mer3 helicase blocks DNA heteroduplex extension in the 5' --> 3' direction. Our results support the idea that Mer3 helicase stabilizes nascent joint molecules via DNA heteroduplex extension to permit capture of the second processed end of a double-stranded DNA break, a step which is required for crossover recombinant product formation.	Univ Calif Davis, Div Biol Sci, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular BIol, Ctr Genet & Dev, Davis, CA 95616 USA; Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19102 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California Davis; University of California System; University of California Davis; Drexel University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Div Biol Sci, Microbiol Sect, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Nakagawa, Takuro/A-1367-2017	Nakagawa, Takuro/0000-0003-3455-8224	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R37GM026017, R01GM026017, R01GM062653] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62653, GM26017] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; KAHN R, 1981, P NATL ACAD SCI-BIOL, V78, P4786, DOI 10.1073/pnas.78.8.4786; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Khazanehdari KA, 2000, CHROMOSOMA, V109, P94, DOI 10.1007/s004120050416; Kirkpatrick DT, 2000, GENETICS, V156, P1549; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LEBOWITZ J, 1985, THESIS J HOPKINS U B; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5937, DOI 10.1021/bi027232q; Nakagawa T, 1997, GENES CELLS, V2, P65, DOI 10.1046/j.1365-2443.1997.d01-283.x; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Nakagawa T, 1999, P NATL ACAD SCI USA, V96, P14186, DOI 10.1073/pnas.96.25.14186; Nakagawa T, 2002, J BIOL CHEM, V277, P28019, DOI 10.1074/jbc.M204165200; Nakagawa T, 2002, MOL CELL BIOL, V22, P3281, DOI 10.1128/MCB.22.10.3281-3291.2002; Nakagawa T, 2001, J BIOL CHEM, V276, P31487, DOI 10.1074/jbc.M104003200; Namsaraev E, 1997, MOL CELL BIOL, V17, P5359, DOI 10.1128/MCB.17.9.5359; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Namsaraev EA, 2000, J BIOL CHEM, V275, P3970, DOI 10.1074/jbc.275.6.3970; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; OGAWA T, 1993, COLD SPRING HARB SYM, V58, P567, DOI 10.1101/SQB.1993.058.01.063; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SALINAS F, 1995, CELL, V82, P111, DOI 10.1016/0092-8674(95)90057-8; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Solinger JA, 2001, P NATL ACAD SCI USA, V98, P8447, DOI 10.1073/pnas.121009898; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	72	79	82	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					47	56		10.1016/S0092-8674(04)00294-6	http://dx.doi.org/10.1016/S0092-8674(04)00294-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066281	Bronze			2022-12-01	WOS:000221500300007
J	Shattock, R; Solomon, S				Shattock, R; Solomon, S			Microbicides - aids to safer sex	LANCET			English	Editorial Material							HIV-1 TRANSMISSION; INDIA; WOMEN		St George Hosp, Sch Med, London SW17 0RE, England; VHS Tharamani, YR Gaitonde Ctr AIDS Res & Educ, Madras, Tamil Nadu, India	St Georges University London	Shattock, R (corresponding author), St George Hosp, Sch Med, London SW17 0RE, England.	Shattock@sghms.ac.uk						Baeten JM, 2003, CURR HIV RES, V1, P69, DOI 10.2174/1570162033352110; HU Q, IN PRESS J EXP MED; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Solomon S, 2003, NAT IMMUNOL, V4, P719, DOI 10.1038/ni0803-719; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; UNAIDS, 2003, AIDS EP UPD; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Watts C, 2001, AIDS, V15, pS43, DOI 10.1097/00002030-200102001-00064	11	37	37	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 27	2004	363	9414					1002	1003		10.1016/S0140-6736(04)15876-5	http://dx.doi.org/10.1016/S0140-6736(04)15876-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807JH	15051276				2022-12-01	WOS:000220497300002
J	Garkavtsev, I; Kozin, SV; Chernova, O; Xu, L; Winkler, F; Brown, E; Barnett, GH; Jain, RK				Garkavtsev, I; Kozin, SV; Chernova, O; Xu, L; Winkler, F; Brown, E; Barnett, GH; Jain, RK			The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis	NATURE			English	Article							INTERLEUKIN-8 EXPRESSION; P53 EXPRESSION; P33(ING1); FIBROBLASTS; INHIBITOR; CANCER; GENE	Gliomas are the most common primary tumours of the central nervous system, with nearly 15,000 diagnosed annually in the United States and a lethality approaching 80% within the first year of glioblastoma diagnosis(1). The marked induction of angiogenesis in glioblastomas suggests that it is a necessary part of malignant progression(2); however, the precise molecular mechanisms underlying the regulation of brain tumour growth and angiogenesis remain unresolved. Here we report that a candidate tumour suppressor gene, ING4, is involved in regulating brain tumour growth and angiogenesis. Expression of ING4 is significantly reduced in gliomas as compared with normal human brain tissue, and the extent of reduction correlates with the progression from lower to higher grades of tumours. In mice, xenografts of human glioblastoma U87MG, which has decreased expression of ING4, grow significantly faster and have higher vascular volume fractions than control tumours. We show that ING4 physically interacts with p65 ( RelA) subunit of nuclear factor NF-kappaB, and that ING4 regulates brain tumour angiogenesis through transcriptional repression of NF-kappaB-responsive genes. These results indicate that ING4 has an important role in brain tumour pathogenesis.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Radiat Oncol, Edwin L Steele Lab Tumour Biol, Boston, MA 02114 USA; Cleveland Clin Fdn, Brain Tumour Inst, Cleveland, OH 44195 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Cleveland Clinic Foundation	Garkavtsev, I (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dept Radiat Oncol, Edwin L Steele Lab Tumour Biol, Boston, MA 02114 USA.	igorg@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Xu, Lei/GRR-9174-2022	Jain, Rakesh K/0000-0001-7571-3548; Winkler, Frank/0000-0003-4892-6104	NCI NIH HHS [P01 CA080124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen B, 2003, INT J ONCOL, V22, P927; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Desbaillets I, 1999, ONCOGENE, V18, P1447, DOI 10.1038/sj.onc.1202424; Desbaillets I, 1997, J EXP MED, V186, P1201, DOI 10.1084/jem.186.8.1201; Garkavtsev I, 1997, MOL CELL BIOL, V17, P2014, DOI 10.1128/MCB.17.4.2014; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gunduz M, 2000, CANCER RES, V60, P3143; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Leung KM, 2002, CANCER RES, V62, P4890; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; Oki E, 1999, CANCER LETT, V147, P157, DOI 10.1016/S0304-3835(99)00288-8; PLATE KH, 1995, GLIA, V15, P339, DOI 10.1002/glia.440150313; Shiseki M, 2003, CANCER RES, V63, P2373; Skowyra D, 2001, J BIOL CHEM, V276, P8734, DOI 10.1074/jbc.M007664200; Toyama T, 1999, ONCOGENE, V18, P5187, DOI 10.1038/sj.onc.1202905; VAN MEIR EG, 1994, NAT GENET, V8, P171, DOI 10.1038/ng1094-171; Xu L, 1999, CANCER RES, V59, P5822	25	295	343	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					328	332		10.1038/nature02329	http://dx.doi.org/10.1038/nature02329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029197				2022-12-01	WOS:000220250200046
J	Jones, MH; Virtanen, C; Honjoh, D; Miyoshi, T; Satoh, Y; Okumura, S; Nakagawa, K; Nomura, H; Ishikawa, Y				Jones, MH; Virtanen, C; Honjoh, D; Miyoshi, T; Satoh, Y; Okumura, S; Nakagawa, K; Nomura, H; Ishikawa, Y			Two prognostically significant subtypes of high-grade lung neuroendocrine turnours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles	LANCET			English	Article							MONOCLONAL-ANTIBODY; CLASSIFICATION; DIAGNOSIS; SIGNATURE; TUMORS; CANCER; CYCLE	Background Classification of high-grade neuroendocrine tumours (HGNT) of the lung currently recognises large-cell neuroendocrine carcinoma (LCNEC) and small-cell lung carcinoma (SCLC) as distinct groups. However, a similarity in histology for these two carcinomas and uncertain clinical course have led to suggestions that a single HGNT classification would be more appropriate. Gene expression profiling, which can reproduce histopathological classification, and often defines new subclasses with prognostic significance, can be used to resolve HGNT classification. Methods We used cDNA microarrays with 40386 elements to analyse the gene expression profiles of 38 surgically resected samples of lung neuroendocrine tumours and 11 SCLC cell lines. Samples of large-cell carcinoma, adenocarcinoma, and normal lung were also included to give a total of 105 samples analysed. The data were subjected to filtering to yield informative genes before unsupervised hierarchical clustering that identified relatedness of tumour samples. Findings Distinct groups for carcinoids, large-cell carcinoma, adenocarcinoma, and normal lung were readily identified. However, we were unable to distinguish LCNEC from SCLC by gene expression profiling. Three independent rounds of unsupervised hierarchical clustering consistently divided SCLC samples into two main groups with LCNEC samples largely integrated with these groups. Furthermore, patients in one of the groups identified by clustering had a significantly better clinical outcome than the other (83% vs 12% survived for 5 years; p=0.0094. None of the highly proliferative SCLC cell lines subsequently analysed clustered with this good-prognosis group. Interpretation Our findings show that HGNT of the lung can be classified into two groups independent of SCLC and LCNEC. To this end, we have identified many genes, some of which encode well-characterised markers of cancer that distinguish the HGNT groups. These results have implications for the diagnosis, classification, and treatment of lung neuroendocrine tumours, and provide important insights into their underlying biology.	Univ Tokyo, Proliferat Signal Div, Chugai Pharmaceut Co Ltd, Tokyo, Japan; Invitrogen Japan, Tokyo, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 170, Japan; Canc Inst Hosp, Dept Chest Surg, Tokyo, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding; University of Tokyo; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Ishikawa, Y (corresponding author), 1-37-1 Kami Ikebukuro,Toshima Ku, Tokyo 1708455, Japan.	ishikawa@jfcr.or.jp		Jones, Michael/0000-0002-2251-1990				Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Cerilli L A, 2001, Am J Clin Pathol, V116 Suppl, pS65; Chan HM, 2001, ESSAYS BIOCHEM, V37, P87, DOI 10.1042/bse0370087; GRAUS F, 1997, J CLIN ONCOL, V15, P266; Holzinger A, 1996, HYBRIDOMA, V15, P49, DOI 10.1089/hyb.1996.15.49; Kaufmann O, 1997, HUM PATHOL, V28, P1373, DOI 10.1016/S0046-8177(97)90226-4; Kellner U, 2002, LANCET ONCOL, V3, P235, DOI 10.1016/S1470-2045(02)00715-5; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Marchevsky AM, 2001, AM J CLIN PATHOL, V116, P466; Mariani L, 2001, CANCER RES, V61, P4190; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Simon GR, 2003, CHEST, V123, p259S, DOI 10.1378/chest.123.1_suppl.259S; 't Hoen PAC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng020; Travis WD, 1999, WHO INT HISTOLOGICAL; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou Y, 2002, GENOMICS, V80, P465, DOI 10.1006/geno.2002.6860	22	178	185	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2004	363	9411					775	781		10.1016/S0140-6736(04)15693-6	http://dx.doi.org/10.1016/S0140-6736(04)15693-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801JK	15016488				2022-12-01	WOS:000220092000008
J	Shen, Q; Goderie, SK; Jin, L; Karanth, N; Sun, Y; Abramova, N; Vincent, P; Pumiglia, K; Temple, S				Shen, Q; Goderie, SK; Jin, L; Karanth, N; Sun, Y; Abramova, N; Vincent, P; Pumiglia, K; Temple, S			Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells	SCIENCE			English	Article							DIFFERENTIATION; ANGIOGENESIS; GENERATION; PRECURSORS; EXPRESSION; NICHE; BRAIN; HES1	Neural stem cells are reported to lie in a vascular niche, but there is no direct evidence for a functional relationship between the stem cells and blood vessel component cells. We show that endothelial cells but not vascular smooth muscle cells release soluble factors that stimulate the self-renewal of neural stem cells, inhibit their differentiation, and enhance their neuron production. Both embryonic and adult neural stem cells respond, allowing extensive production of both projection neuron and interneuron types in vitro. Endothelial coculture stimulates neuroepithelial cell contact, activating Notch and Hes1 to promote self-renewal. These findings identify endothelial cells as a critical component of the neural stem cell niche.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College; Albany Medical College; Albany Medical College	Temple, S (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	TempleS@mail.amc.edu		Pumiglia, Kevin/0000-0003-4655-0334	NCI NIH HHS [R01 CA081419] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081419] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BREIER G, 1992, DEVELOPMENT, V114, P521; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; SHEN Q, UNPUB; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0	18	1159	1255	4	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1338	1340		10.1126/science.1095505	http://dx.doi.org/10.1126/science.1095505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15060285				2022-12-01	WOS:000221669600059
J	Camille, N; Coricelli, G; Sallet, J; Pradat-Diehl, P; Duhamel, JR; Sirigu, A				Camille, N; Coricelli, G; Sallet, J; Pradat-Diehl, P; Duhamel, JR; Sirigu, A			The involvement of the orbitofrontal cortex in the experience of regret	SCIENCE			English	Article							DECISION-MAKING; EMOTION; REWARD; CONSEQUENCES; UNCERTAINTY; CHOICE	Facing the consequence of a decision we made can trigger emotions like satisfaction, relief, or regret, which reflect our assessment of what was gained as compared to what would have been gained by making a different decision. These emotions are mediated by a cognitive process known as counterfactual thinking. By manipulating a simple gambling task, we characterized a subject's choices in terms of their anticipated and actual emotional impact. Normal subjects reported emotional responses consistent with counterfactual thinking; they chose to minimize future regret and learned from their emotional experience. Patients with orbitofrontal cortical lesions, however, did not report regret or anticipate negative consequences of their choices. The orbitofrontal cortex has a fundamental role in mediating the experience of regret.	CNRS, Inst Cognit Sci, F-69675 Bron, France; Univ Siena, Dept Econ, I-53100 Siena, Italy; Hop La Pitie Salpetriere, Serv Med Phys & Readaptat, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); University of Siena; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Sirigu, A (corresponding author), CNRS, Inst Cognit Sci, 67 Blvd Pinel, F-69675 Bron, France.	sirigu@isc.cnrs.fr	Sirigu, Angela/L-4683-2017; , sallet/H-9761-2019; Duhamel, Jean-René/M-4723-2017	, sallet/0000-0002-7878-0209; Duhamel, Jean-René/0000-0003-0210-1027				Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Byrne RMJ, 2002, TRENDS COGN SCI, V6, P426, DOI 10.1016/S1364-6613(02)01974-5; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Elliott R, 2003, J NEUROSCI, V23, P303; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Roese Neal J., 1995, WHAT MIGHT HAVE BEEN; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Zeelenberg M, 1996, ORGAN BEHAV HUM DEC, V65, P148, DOI 10.1006/obhd.1996.0013; Zeelenberg M, 2000, COGNITION EMOTION, V14, P521, DOI 10.1080/026999300402781; Zeelenberg M., 2004, PSYCHOL COUNTERFACTU	19	422	438	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1167	1170		10.1126/science.1094550	http://dx.doi.org/10.1126/science.1094550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822FP	15155951				2022-12-01	WOS:000221524500046
J	Wernet, P; Nordlund, D; Bergmann, U; Cavalleri, M; Odelius, M; Ogasawara, H; Naslund, LA; Hirsch, TK; Ojamae, L; Glatzel, P; Pettersson, LGM; Nilsson, A				Wernet, P; Nordlund, D; Bergmann, U; Cavalleri, M; Odelius, M; Ogasawara, H; Naslund, LA; Hirsch, TK; Ojamae, L; Glatzel, P; Pettersson, LGM; Nilsson, A			The structure of the first coordination shell in liquid water	SCIENCE			English	Article							HYDROGEN-BOND DYNAMICS; MOLECULAR-DYNAMICS; AB-INITIO; SPECTROSCOPY; SCATTERING; SIMULATION; ICE	X-ray absorption spectroscopy and x-ray Raman scattering were used to probe the molecular arrangement in the first coordination shell of liquid water. The local structure is characterized by comparison with bulk and surface of ordinary hexagonal ice Ih and with calculated spectra. Most molecules in liquid water are in two hydrogen-bonded configurations with one strong donor and one strong acceptor hydrogen bond in contrast to the four hydrogen-bonded tetrahedral structure in ice. Upon heating from 25degreesC to 90degreesC, 5 to 10% of the molecules change from tetrahedral environments to two hydrogen-bonded configurations. Our findings are consistent with neutron and x-ray diffraction data, and combining the results sets a strong limit for possible local structure distributions in liquid water. Serious discrepancies with structures based on current molecular dynamics simulations are observed.	Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; BESSY, D-12489 Berlin, Germany; Stockholm Univ, FYSIKUM, S-10691 Stockholm, Sweden; Stockholm Univ, Dept Chem Phys, S-10691 Stockholm, Sweden; Linkoping Univ, Dept Chem, S-58183 Linkoping, Sweden; Univ Utrecht, Debye Inst, Dept Inorgan Chem & Catalysis, NL-3584 CA Utrecht, Netherlands	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Stockholm University; Stockholm University; Linkoping University; Utrecht University	Nilsson, A (corresponding author), Stanford Synchrotron Radiat Lab, POB 20450, Stanford, CA 94309 USA.	nilsson@slac.stanford.edu	Pettersson, Lars G.M./F-8428-2011; Pettersson, Lars GM/J-4925-2013; Nordlund, Dennis/A-8902-2008; Ogasawara, Hirohito/AGU-4579-2022; Ojamäe, Lars/C-4974-2015; Glatzel, Pieter/E-9958-2010; Wernet, Philippe/A-7085-2013; Ogasawara, Hirohito/AAC-8754-2020; Odelius, Michael/J-6142-2019; Odelius, Michael/A-7628-2014; Ogasawara, Hirohito/D-2105-2009; Cavalleri, Matteo/A-7689-2008; Nilsson, Anders/E-1943-2011	Pettersson, Lars GM/0000-0003-1133-9934; Nordlund, Dennis/0000-0001-9524-6908; Ogasawara, Hirohito/0000-0001-5338-1079; Ojamäe, Lars/0000-0002-5341-2637; Glatzel, Pieter/0000-0001-6532-8144; Wernet, Philippe/0000-0001-7011-9072; Odelius, Michael/0000-0002-7023-2486; Ogasawara, Hirohito/0000-0001-5338-1079; Nilsson, Anders/0000-0003-1968-8696; Cavalleri, Matteo/0000-0002-7925-928X	NCRR NIH HHS [RR-08630] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bergmann U, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.092107; Cavalleri M, 2002, CHEM PHYS LETT, V364, P363, DOI 10.1016/S0009-2614(02)00890-4; Chialvo AA, 1996, J PHYS CHEM-US, V100, P1309, DOI 10.1021/jp951445q; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Glebov A, 2000, J CHEM PHYS, V112, P11011, DOI 10.1063/1.481741; Head-Gordon T, 2002, CHEM REV, V102, P2651, DOI 10.1021/cr0006831; KUSALIK PG, 1994, SCIENCE, V265, P1219, DOI 10.1126/science.265.5176.1219; LIE GC, 1986, PHYS REV A, V33, P2679, DOI 10.1103/PhysRevA.33.2679; Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.0.CO;2-1; Luzar A, 1996, PHYS REV LETT, V76, P928, DOI 10.1103/PhysRevLett.76.928; Myneni S, 2002, J PHYS-CONDENS MAT, V14, pL213, DOI 10.1088/0953-8984/14/8/106; NARTEN AH, 1969, SCIENCE, V165, P447, DOI 10.1126/science.165.3892.447; NORDLUND D, UNPUB; Nyberg M, 2003, J CHEM PHYS, V119, P12577, DOI 10.1063/1.1625640; OJAMAE L, 1994, J PHYS CHEM-US, V98, P4271, DOI 10.1021/j100067a011; Silvestrelli PL, 1999, J CHEM PHYS, V111, P3572, DOI 10.1063/1.479638; Soper AK, 2000, CHEM PHYS, V258, P121, DOI 10.1016/S0301-0104(00)00179-8; SOPER AK, 1994, J CHEM PHYS, V101, P6888, DOI 10.1063/1.468318; Stenger J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.027401; STILLINGER FH, 1980, SCIENCE, V209, P451, DOI 10.1126/science.209.4455.451; Stohr J, 2013, SPRINGE SER SURF SCI; TOUKAN K, 1985, PHYS REV B, V31, P2643, DOI 10.1103/PhysRevB.31.2643; Weinhold F, 1998, J CHEM PHYS, V109, P373, DOI 10.1063/1.476574; Wilson KR, 2002, J PHYS-CONDENS MAT, V14, pL221, DOI 10.1088/0953-8984/14/8/107; Woutersen S, 1997, SCIENCE, V278, P658, DOI 10.1126/science.278.5338.658	25	1149	1170	12	529	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					995	999		10.1126/science.1096205	http://dx.doi.org/10.1126/science.1096205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15060287	Green Submitted			2022-12-01	WOS:000221383300044
J	McLean, RR; Jacques, PF; Selhub, J; Tucker, KL; Samelson, EJ; Broe, KE; Hannan, MT; Cupples, LA; Kiel, DP				McLean, RR; Jacques, PF; Selhub, J; Tucker, KL; Samelson, EJ; Broe, KE; Hannan, MT; Cupples, LA; Kiel, DP			Homocysteine as a predictive factor for hip fracture in older persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; METHYLENETETRAHYDROFOLATE-REDUCTASE; RISK FACTOR; OSTEOPOROTIC FRACTURES; PLASMA HOMOCYSTEINE; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; ALZHEIMERS-DISEASE; PERNICIOUS-ANEMIA; UNITED-STATES	BACKGROUND: The increased prevalence of osteoporosis among people with homocystinuria suggests that a high serum homocysteine concentration may weaken bone by interfering with collagen cross-linking, thereby increasing the risk of osteoporotic fracture. We examined the association between the total homocysteine concentration and the risk of hip fracture in men and women enrolled in the Framingham Study. METHODS: We studied 825 men and 1174 women, ranging in age from 59 to 91 years, from whom blood samples had been obtained between 1979 and 1982 to measure plasma total homocysteine. The participants in our study were followed from the time that the sample was obtained through June 1998 for incident hip fracture. Sex-specific, age-adjusted incidence rates of hip fracture were calculated for quartiles of total homocysteine concentrations. Cox proportional-hazards regression was used to calculate hazard ratios for quartiles of homocysteine values. RESULTS: The mean (+/-SD) plasma total homocysteine concentration was 13.4+/-9.1 micromol per liter in men and 12.1+/-5.3 micromol per liter in women. The median duration of follow-up was 12.3 years for men and 15.0 years for women. There were 41 hip fractures among men and 146 among women. The age-adjusted incidence rates per 1000 person-years for hip fracture, from the lowest to the highest quartile for total homocysteine, were 1.96 (95 percent confidence interval, 0.52 to 3.41), 3.24 (0.97 to 5.52), 4.43 (1.80 to 7.07), and 8.14 (4.20 to 12.08) for men and 9.42 (5.72 to 13.12), 7.01 (4.29 to 9.72), 9.58 (6.42 to 12.74), and 16.57 (11.84 to 21.30) for women. Men and women in the highest quartile had a greater risk of hip fracture than those in the lowest quartile - the risk was almost four times as high for men and 1.9 times as high for women. CONCLUSIONS: These findings suggest that the homocysteine concentration, which is easily modifiable by means of dietary intervention, is an important risk factor for hip fracture in older persons.	Hebrew Rehabil Ctr Aged, Res & Training Inst, Boston, MA 02131 USA; Tufts Univ, Jean Mayer Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Div Aging, Boston, MA USA	Tufts University; Boston University	McLean, RR (corresponding author), Framingham Study, 73 Mt Wayte Ave, Framingham, MA 01702 USA.	rmclean@mail.hrca.harvard.edu	Tucker, Katherine L/A-4545-2010	Samelson, Elizabeth/0000-0003-1086-1560; Kiel, Douglas/0000-0001-8474-0310; Tucker, Katherine/0000-0001-7640-662X; Hannan, Marian/0000-0002-9586-6928; Cupples, L. Adrienne/0000-0003-0273-7965	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54776, N01-HC-25195] Funding Source: Medline; NIAMS NIH HHS [R01 AR/AG 41398] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrahamsen B, 2003, J BONE MINER RES, V18, P723, DOI 10.1359/jbmr.2003.18.4.723; [Anonymous], 1996, FED REGISTER, V61, P8781; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BROWNER WS, 1991, LANCET, V338, P1470, DOI 10.1016/0140-6736(91)92782-W; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Clarke R, 2001, J CARDIOVASC RISK, V8, P363, DOI 10.1097/00043798-200112000-00005; Clarke R, 2002, INT J EPIDEMIOL, V31, P70, DOI 10.1093/ije/31.1.70; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dhonukshe-Rutten RAM, 2003, J NUTR, V133, P801, DOI 10.1093/jn/133.3.801; EASTELL R, 1992, CLIN SCI, V82, P681, DOI 10.1042/cs0820681; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOERSS JB, 1992, J BONE MINER RES, V7, P573; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; GOYETTE P, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551a; GRIECO AJ, 1977, AM J MED SCI, V273, P120, DOI 10.1097/00000441-197703000-00001; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; JETTE AM, 1988, J CLIN EPIDEMIOL, V41, P719, DOI 10.1016/0895-4356(88)90157-6; Johnson MA, 2003, AM J CLIN NUTR, V77, P211, DOI 10.1093/ajcn/77.1.211; Jorgensen HL, 2002, CALCIFIED TISSUE INT, V71, P386, DOI 10.1007/s00223-001-2126-3; KANG AH, 1973, J CLIN INVEST, V52, P2571, DOI 10.1172/JCI107449; KANNEL WB, 1988, NIH PUBLICATION; KIEL DP, 1990, AM J EPIDEMIOL, V132, P675, DOI 10.1093/oxfordjournals.aje.a115709; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; Lubec B, 1996, BBA-MOL BASIS DIS, V1315, P159, DOI 10.1016/0925-4439(95)00119-0; Masse PG, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-2; MCKUSICK VA, 1966, HERITABLE DISORDERS, P150; McLean RR, 2004, J BONE MINER RES, V19, P410, DOI 10.1359/JBMR.0301261; Miyao M, 2000, CALCIFIED TISSUE INT, V66, P190, DOI 10.1007/s002230010038; MORREELS CL, 1968, RADIOLOGY, V90, P1150, DOI 10.1148/90.6.1150; MUDD SH, 1985, AM J HUM GENET, V37, P1; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Nurk E, 2001, J NUTR, V131, P1214, DOI 10.1093/jn/131.4.1214; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; UELAND PM, 1993, CLIN CHEM, V39, P1764	41	420	438	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2004	350	20					2042	2049		10.1056/NEJMoa032739	http://dx.doi.org/10.1056/NEJMoa032739			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819ZB	15141042				2022-12-01	WOS:000221354000005
J	Earnshaw, JJ; Shaw, E; Whyman, MR; Poskitt, KR; Heather, BP				Earnshaw, JJ; Shaw, E; Whyman, MR; Poskitt, KR; Heather, BP			Screening for abdominal aortic aneurysms in men	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORTALITY-RATE; TRIAL		Gloucestershire Royal Hosp, Gloucester GL1 3NN, England; Cheltenham Gen Hosp, Cheltenham, Glos, England	Gloucestershire Royal Hospital; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Earnshaw, JJ (corresponding author), Gloucestershire Royal Hosp, Gloucester GL1 3NN, England.	Earnshaw@rudford.demon.co.uk						Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Beard JD, 2003, BRIT J SURG, V90, P515, DOI 10.1002/bjs.4140; Best VA, 2003, BRIT J SURG, V90, P1510, DOI 10.1002/bjs.4342; Bown MJ, 2002, BRIT J SURG, V89, P34; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Crow P, 2001, BRIT J SURG, V88, P941, DOI 10.1046/j.0007-1323.2001.01822.x; Gray JAM, 2003, BRIT J SURG, V90, P1165; Greenhalgh RM, 2002, BMJ-BRIT MED J, V325, P1123, DOI 10.1136/bmj.325.7373.1123; Heather BP, 2000, BRIT J SURG, V87, P750, DOI 10.1046/j.1365-2168.2000.01476.x; Hinchliffe RJ, 2003, EUR J VASC ENDOVASC, V25, P191, DOI 10.1053/ejvs.2002.1846; Irvine CD, 2000, EUR J VASC ENDOVASC, V20, P374, DOI 10.1053/ejvs.2000.1187; Jamrozik K, 2000, MED J AUSTRALIA, V173, P345, DOI 10.5694/j.1326-5377.2000.tb125684.x; Lindholt JS, 2002, EUR J VASC ENDOVASC, V23, P55, DOI 10.1053/ejvs.2001.1534; McCarthy RJ, 2003, BRIT J SURG, V90, P821, DOI 10.1002/bjs.4216; Michaels JA, 2003, BRIT J SURG, V90, P827, DOI 10.1002/bjs.4310; Office of Population Census and Surveys, 1995, MORT STAT CAUS ENGL; Prytherch DR, 2001, EUR J VASC ENDOVASC, V21, P477, DOI 10.1053/ejvs.2001.1369; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Thompson MM, 2003, BRIT J SURG, V90, P897, DOI 10.1002/bjs.4280; UK National Screening Committee, CRIT APPR VIAB EFF A; Vardulaki KA, 2002, BRIT J SURG, V89, P861, DOI 10.1046/j.1365-2168.2002.02133.x; *VASC SURG SOC GRE, NAT VASC DAT REP 200; Veith Frank J, 2003, Semin Vasc Surg, V16, P171, DOI 10.1016/S0895-7967(03)00003-6; WILSON JMG, 1968, 34 WORLD HLTH AUTH	25	46	47	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2004	328	7448					1122	1124		10.1136/bmj.328.7448.1122	http://dx.doi.org/10.1136/bmj.328.7448.1122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818YS	15130983	Green Published			2022-12-01	WOS:000221281000026
J	Pfeffer, S; Zavolan, M; Grasser, FA; Chien, MC; Russo, JJ; Ju, JY; John, B; Enright, AJ; Marks, D; Sander, C; Tuschl, T				Pfeffer, S; Zavolan, M; Grasser, FA; Chien, MC; Russo, JJ; Ju, JY; John, B; Enright, AJ; Marks, D; Sander, C; Tuschl, T			Identification of virus-encoded microRNAs	SCIENCE			English	Article							HOMOLOG; SYSTEM; BCL-2; BHRF1	RNA silencing processes are guided by small RNAs that are derived from double-stranded RNA. To probe for function of RNA silencing during infection of human cells by a DNA virus, we recorded the small RNA profile of cells infected by Epstein-Barr virus (EBV). We show that EBV expresses several microRNA (miRNA) genes. Given that miRNAs function in RNA silencing pathways either by targeting messenger RNAs for degradation or by repressing translation, we identified viral regulators of host and/or viral gene expression.	Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Univ Klin Homburg, Inst Mikrobiol & Hyg, Abt Virol, D-66421 Homburg, Germany; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Rockefeller University; University of Basel; Universitatsklinikum des Saarlandes; Columbia University; Memorial Sloan Kettering Cancer Center	Tuschl, T (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave,Box 186, New York, NY 10021 USA.	ttuschl@rockefeller.edu	Pfeffer, Sebastien/A-6512-2010; Pfeffer, Sébastien/H-3212-2019; Zavolan, Mihaela/S-3888-2016; Enright, Anton/F-3094-2011; Sander, Chris/H-1452-2011	Pfeffer, Sebastien/0000-0002-8458-348X; Pfeffer, Sébastien/0000-0002-8458-348X; Enright, Anton/0000-0002-6090-3100; Sander, Chris/0000-0001-6059-6270; Zavolan, Mihaela/0000-0002-8832-2041	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068476] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM068476-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Enright AJ, 2004, GENOME BIOL, V5; FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; KIEFF E, 2001, FIELDS VIROLOGY, P2511; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Middeldorp JM, 2003, CRIT REV ONCOL HEMAT, V45, P1, DOI 10.1016/S1040-8428(02)00078-1; Murray PG, 1996, BLOOD, V87, P706, DOI 10.1182/blood.V87.2.706.bloodjournal872706; OUDEJANS JJ, 1995, BLOOD, V86, P1893, DOI 10.1182/blood.V86.5.1893.bloodjournal8651893; TORSTEINSDOTTIR S, 1989, INT J CANCER, V43, P273, DOI 10.1002/ijc.2910430219; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; ZHANG CX, 1995, VIROLOGY, V208, P180, DOI 10.1006/viro.1995.1141	13	1199	1342	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					734	736		10.1126/science.1096781	http://dx.doi.org/10.1126/science.1096781			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118162				2022-12-01	WOS:000221105300045
J	Hujoel, PP; Bollen, AM; Noonan, CJ; del Aguila, MA				Hujoel, PP; Bollen, AM; Noonan, CJ; del Aguila, MA			Antepartum dental radiography and infant low birth weight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPRODUCTIVE OUTCOMES; RADIATION-EXPOSURE; CHILDHOOD-CANCER; POOLED ANALYSIS; THYROID-CANCER; PREGNANCY; CHILDREN; AUTOANTIBODIES; ABNORMALITIES; EPIDEMIOLOGY	Context Both high- and low-dose radiation exposures in women have been associated with low-birth-weight offspring. It is unclear if radiation affects the hypothalamus-pituitary-thyroid axis and thereby indirectly birth weight, or if the radiation directly affects the reproductive organs. Objective To investigate whether antepartum dental radiography is associated with low-birth-weight offspring. Design A population-based case-control study. Participants and Setting Enrollees of a dental insurance plan with live singleton births in Washington State between January 1993 and December 2000. Cases were 1117 women with low-birth-weight infants (<2500 g), of whom 336 were term low-birth-weight infants (1501-2499 g and gestation &GE;37 weeks). Four control pregnancies resulting in normal-birth-weight infants (&GE;2500 g) were randomly selected for each case (n = 4468). Main Outcome Measures Odds of low birth weight and term low birth weight by dental radiographic dose during gestation. Results An exposure higher than 0.4 milligray (mGy) during gestation occurred in 21 (1.9%) mothers of low-birth-weight infants and, when compared with women who had no known dental radiography, was associated with an adjusted odds ratio (OR) for a low-birth-weight infant of 2.27 (95% confidence interval [CI], 1.11-4.66, P = .03). Exposure higher than 0.4 mGy occurred in 10 (3%) term low-birth-weight pregnancies and was associated with an adjusted OR for a term low-birth-weight infant of 3.61 (95% Cl, 1.46-8.92, P = .005). Conclusion Dental radiography during pregnancy is associated with low birth weight, specifically with term low birth weight.	Univ Washington, Dept Dent Publ Hlth Sci, Sch Dent, Seattle, WA 98195 USA; Univ Washington, Dept Orthodont, Sch Dent, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; Univ Washington, Dept Gen Internal Med, Sch Med, Seattle, WA 98195 USA; Washington Dent Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hujoel, PP (corresponding author), Univ Washington, Dept Dent Publ Hlth Sci, Sch Dent, Box 357475, Seattle, WA 98195 USA.	hujoel@u.washington.edu	Bollen, Anne-Marie/ABC-4207-2021	Hujoel, Philippe/0000-0002-4040-104X				BANKVALL G, 1982, ORAL SURG ORAL MED O, V53, P532, DOI 10.1016/0030-4220(82)90472-8; Chang TC, 2001, INT J RADIAT BIOL, V77, P1117, DOI 10.1080/09553000110073420; Chiarelli AM, 2000, EPIDEMIOLOGY, V11, P161, DOI 10.1097/00001648-200003000-00013; Del Aguila MA, 2002, J AM DENT ASSOC, V133, P343, DOI 10.14219/jada.archive.2002.0174; Dietz PM, 1998, AM J EPIDEMIOL, V148, P1048; Gibbs S J, 1988, Dentomaxillofac Radiol, V17, P15; Gibbs S J, 1987, Dentomaxillofac Radiol, V16, P67; Gibbs S J, 1988, Dentomaxillofac Radiol, V17, P25; GLINOER D, 1991, J CLIN ENDOCR METAB, V73, P421, DOI 10.1210/jcem-73-2-421; Goldberg MS, 1998, EPIDEMIOLOGY, V9, P271, DOI 10.1097/00001648-199805000-00010; Green DM, 2002, J CLIN ONCOL, V20, P2506, DOI 10.1200/JCO.2002.07.159; Green DN, 2002, AM J OBSTET GYNECOL, V187, P1070, DOI 10.1067/mob.2002.126643; Grossman CM, 1999, EPIDEMIOLOGY, V10, P202, DOI 10.1097/00001648-199903000-00024; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HAMILTON PM, 1984, PUBLIC HEALTH REP, V99, P146; Iijima T, 1997, OBSTET GYNECOL, V90, P364, DOI 10.1016/S0029-7844(97)00283-4; KESSNER DM, 1973, INFANT DEATH ANAL MA; Lazarus JH, 2002, THYROID, V12, P861, DOI 10.1089/105072502761016485; Longstreth WT, 2004, CANCER-AM CANCER SOC, V100, P1026, DOI 10.1002/cncr.20036; MATTESON S R, 1991, General Dentistry, V39, P264; MILLER RW, 1972, LANCET, V2, P784; Pacini F, 1998, LANCET, V352, P763, DOI 10.1016/S0140-6736(97)11397-6; PARSHKOV E, 1999, EFF LOW VER LOW DOS; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Suleiman OH, 1999, J AM DENT ASSOC, V130, P1104, DOI 10.14219/jada.archive.1999.0345; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Taylor JMG, 2002, AM J EPIDEMIOL, V156, P774, DOI 10.1093/aje/kwf110; *US DEP HHS, 1993, NAT EV XRAY TRENDS N; Usenko V, 1999, EXP TOXICOL PATHOL, V51, P223, DOI 10.1016/S0940-2993(99)80100-6; WEBER J, 1989, DEUT ZAHNAERZTL Z, V44, P340; Wingren G, 1997, EUR J CANCER PREV, V6, P550, DOI 10.1097/00008469-199712000-00010; YAMAZAKI JN, 1990, JAMA-J AM MED ASSOC, V264, P605, DOI 10.1001/jama.264.5.605	33	70	71	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1987	1993		10.1001/jama.291.16.1987	http://dx.doi.org/10.1001/jama.291.16.1987			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113817				2022-12-01	WOS:000221062000030
J	Lowdon, D; McMurdo, M				Lowdon, D; McMurdo, M			Interactive case report - A 66 year old woman with breathlessness: case outcome	BRITISH MEDICAL JOURNAL			English	Review							HEART-FAILURE		Royal Victoria Hosp, Dundee DD2 1SP, Scotland; Univ Dundee, Ninewells Hosp, Div Med & Therapeut, Dundee DD1 9SY, Scotland	University of Dundee	Lowdon, D (corresponding author), Royal Victoria Hosp, Dundee DD2 1SP, Scotland.	douglas.lowdon@tpct.scot.nhs.uk						HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					944	944		10.1136/bmj.328.7445.944	http://dx.doi.org/10.1136/bmj.328.7445.944			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087344	Green Published			2022-12-01	WOS:000220994400028
J	Bishop, JKB; Wood, TJ; Davis, RE; Sherman, JT				Bishop, JKB; Wood, TJ; Davis, RE; Sherman, JT			Robotic observations of enhanced carbon biomass and export at 55 degrees S during SOFeX	SCIENCE			English	Article							SOUTHERN-OCEAN; IRON FERTILIZATION; PACIFIC; VERTEX	Autonomous. oats pro. ling in high-nitrate low-silicate waters of the Southern Ocean observed carbon biomass variability and carbon exported to depths of 100 m during the 2002 Southern Ocean Iron Experiment (SOFeX) to detect the effects of iron fertilization of surface water there. Control and "in-patch" measurements documented a greater than fourfold enhancement of carbon biomass in the iron-amended waters. Carbon export through 100 m increased two- to sixfold as the patch subducted below a front. The molar ratio of iron added to carbon exported ranged between 10(4) and 10(5). The biomass buildup and export were much higher than expected for iron-amended low-silicate waters.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Diego; Scripps Institution of Oceanography	Bishop, JKB (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, 1 Cyclotron Rd,MS 90-1116, Berkeley, CA 94720 USA.	JKBishop@lbl.gov		Bishop, James/0000-0002-8036-3017; Davis, Russ/0000-0003-1903-6313				Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; BISHOP JL, UNPUB; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Honjo S, 2000, DEEP-SEA RES PT II, V47, P3521, DOI 10.1016/S0967-0645(00)00077-1; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MARTIN JH, 1989, DEEP-SEA RES, V36, P649, DOI 10.1016/0198-0149(89)90144-1; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Siegel DA, 1997, DEEP-SEA RES PT I, V44, P1519, DOI 10.1016/S0967-0637(97)00028-9; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000	14	90	95	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					417	420		10.1126/science.1087717	http://dx.doi.org/10.1126/science.1087717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087544				2022-12-01	WOS:000220845400041
J	Tucker, WC; Weber, T; Chapman, ER				Tucker, WC; Weber, T; Chapman, ER			Reconstitution of Ca2+-regulated membrane fusion by synaptotagmin and SNAREs	SCIENCE			English	Article							PHOSPHOLIPID-BINDING; BOTULINUM TOXIN; T-SNARES; DOMAIN; EXOCYTOSIS; VESICLES; RELEASE; COMPLEX; CORE; CA2+	We investigated the effect of synaptotagmin I on membrane fusion mediated by neuronal SNARE proteins, SNAP-25, syntaxin, and synaptobrevin, which were reconstituted into vesicles. In the presence of Ca2+, the cytoplasmic domain of synaptotagmin I (syt) strongly stimulated membrane fusion when synaptobrevin densities were similar to those found in native synaptic vesicles. The Ca2+ dependence of syt-stimulated fusion was modulated by changes in lipid composition of the vesicles and by a truncation that mimics cleavage of SNAP-25 by botulinum neurotoxin A. Stimulation of fusion was abolished by disrupting the Ca2+-binding activity, or by severing the tandem C2 domains, of syt. Thus, syt and SNAREs are likely to represent the minimal protein complement for Ca2+-triggered exocytosis.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; CUNY Mt Sinai Sch Med, Carl C Icahn Ctr Gene Therapy & Mol Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA	University of Wisconsin System; University of Wisconsin Madison; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Chapman, ER (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Weber, Thomas/GLS-9125-2022; Weber, Thomas/A-2363-2008	Weber, Thomas/0000-0002-0494-0484; Weber, Thomas/0000-0002-0494-0484; Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066313, R01GM056827] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 66313, GM 56827] Funding Source: Medline; NIMH NIH HHS [MH 61876] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bagala C, 2003, BIOCHEM BIOPH RES CO, V310, P1041, DOI 10.1016/j.bbrc.2003.09.119; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Craxton M, 1999, FEBS LETT, V460, P417, DOI 10.1016/S0014-5793(99)01382-4; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V260, P177, DOI 10.1113/jphysiol.1976.sp011510; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Katz B., 1969, RELEASE NEURAL TRANS; LUNDH H, 1977, J NEUROL SCI, V32, P29, DOI 10.1016/0022-510X(77)90037-5; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tucker WC, 2002, BIOCHEM J, V366, P1, DOI 10.1042/BJ20020776; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	23	282	289	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					435	438		10.1126/science.1097196	http://dx.doi.org/10.1126/science.1097196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15044754				2022-12-01	WOS:000220845400047
J	McLean, D				McLean, D			Computed tomography doses in children	LANCET			English	Editorial Material							RADIATION; CT; CANCER; RISKS		Westmead Hosp, Sydney, NSW 2145, Australia	University of Sydney	McLean, D (corresponding author), Westmead Hosp, Sydney, NSW 2145, Australia.	rdmc@imag.wsahs.nsw.gov.au						Almen A., 1996, Journal of Radiological Protection, V16, P81, DOI 10.1088/0952-4746/16/2/004; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Huda W, 2000, RADIOLOGY, V217, P430, DOI 10.1148/radiology.217.2.r00nv35430; International Electrotechnical Commission, 2002, MED EL EQ 2 44; McLean Donald, 2003, Australas Radiol, V47, P135, DOI 10.1046/j.0004-8461.2003.01141.x; Pages J, 2003, BRIT J RADIOL, V76, P803, DOI 10.1259/bjr/92706933; Shrimpton PC, 2000, RADIAT PROT DOSIM, V90, P249, DOI 10.1093/oxfordjournals.rpd.a033130; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 2000, SOURC EFF ION RAD UN, VI; Wall BF, 2003, BRIT J RADIOL, V76, P763, DOI 10.1259/bjr/13405318; Wise K. N., 2003, Australasian Physical & Engineering Sciences in Medicine, V26, P53, DOI 10.1007/BF03178458; ZANKL M, 1993, TOMOGRAPHIC ANTHR 2	14	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1178	1178		10.1016/S0140-6736(04)15984-9	http://dx.doi.org/10.1016/S0140-6736(04)15984-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081647				2022-12-01	WOS:000220748100005
J	Traggiai, E; Chicha, L; Mazzucchelli, L; Bronz, L; Piffaretti, JC; Lanzavecchia, A; Manz, MG				Traggiai, E; Chicha, L; Mazzucchelli, L; Bronz, L; Piffaretti, JC; Lanzavecchia, A; Manz, MG			Development of a human adaptive immune system in cord blood cell-transplanted mice	SCIENCE			English	Article							RECEPTOR-GAMMA CHAIN; SCID-HU MICE; CD34(+) CELLS; NOD/SCID MICE; MOUSE MODEL; T-CELLS; ENGRAFTMENT; LYMPHOCYTES; SUBSETS; DEFICIENT	Because ethical restrictions limit in vivo studies of the human hematolymphoid system, substitute human to small animal xenotransplantation models have been employed. Existing models, however, sustain only limited development and maintenance of human lymphoid cells and rarely produce immune responses. Here we show that intrahepatic injection of CD34(+) human cord blood cells into conditioned newborn Rag2(-/-) gamma(c)(-/-) mice leads to de novo development of B, T, and dendritic cells; formation of structured primary and secondary lymphoid organs; and production of functional immune responses. This provides a valuable model to study development and function of the human adaptive immune system in vivo.	IRB, CH-6500 Bellinzona, Switzerland; Inst Pathol, CH-6600 Locarno, Switzerland; Osped San Giovanni Bellinzona, Dept Gynecol & Obstet, CH-6500 Bellinzona, Switzerland; Inst Microbiol, CH-6501 Bellinzona, Switzerland	Universita della Svizzera Italiana; Regional Hospital of Bellinzona & Valleys, San Giovanni	Manz, MG (corresponding author), IRB, Via Vela 6, CH-6500 Bellinzona, Switzerland.	manz@irb.unisi.ch	Manz, Markus G/C-7588-2011; Serei, Virian D/B-4616-2015; traggiai, elisabetta/A-2316-2009	Manz, Markus/0000-0002-4676-7931				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Carballido JM, 2000, NAT MED, V6, P103, DOI 10.1038/71434; Delhem N, 1998, J IMMUNOL, V161, P2060; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kerre TCC, 2002, BLOOD, V99, P1620, DOI 10.1182/blood.V99.5.1620; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; MANZ M, UNPUB; Mazurier F, 1999, J INTERF CYTOK RES, V19, P533, DOI 10.1089/107999099313983; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McCutchen D, 1996, EDUC PSYCHOL REV, V8, P187, DOI 10.1007/BF01464072; Mosier DE, 2000, VIROLOGY, V271, P215, DOI 10.1006/viro.2000.0336; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; Ramirez M, 1998, EXP HEMATOL, V26, P332; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SANDHU J, 1994, J IMMUNOL, V152, P3806; SHULTZ LD, 1995, J IMMUNOL, V154, P180	25	742	798	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					104	107		10.1126/science.1093933	http://dx.doi.org/10.1126/science.1093933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15064419				2022-12-01	WOS:000220567900047
J	Leung, C; Lingbeek, M; Shakhova, O; Liu, J; Tanger, E; Saremaslani, P; van Lohuizen, M; Marino, S				Leung, C; Lingbeek, M; Shakhova, O; Liu, J; Tanger, E; Saremaslani, P; van Lohuizen, M; Marino, S			Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas	NATURE			English	Article							SONIC HEDGEHOG; STEM-CELLS; N-MYC; C-MYC; PROLIFERATION; MICE; TRANSFORMATION; EXPRESSION; MUTATIONS; BIOLOGY	Overexpression of the polycomb group gene Bmi1 promotes cell proliferation and induces leukaemia through repression of Cdkn2a (also known as ink4a/Arf) tumour suppressors(1,2). Conversely, loss of Bmi1 leads to haematological defects and severe progressive neurological abnormalities in which de-repression of the ink4a/Arf locus is critically implicated(1,3). Here, we show that Bmi1 is strongly expressed in proliferating cerebellar precursor cells in mice and humans. Using Bmi1-null mice we demonstrate a crucial role for Bmi1 in clonal expansion of granule cell precursors both in vivo and in vitro. Deregulated proliferation of these progenitor cells, by activation of the sonic hedgehog (Shh) pathway, leads to medulloblastoma development(4). We also demonstrate linked overexpression of BMI1 and patched (PTCH), suggestive of SHH pathway activation, in a substantial fraction of primary human medulloblastomas. Together with the rapid induction of Bmi1 expression on addition of Shh or on overexpression of the Shh target Gli1 in cerebellar granule cell cultures, these findings implicate BMI1 overexpression as an alternative or additive mechanism in the pathogenesis of medulloblastomas, and highlight a role for Bmi1-containing polycomb complexes in proliferation of cerebellar precursor cells.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Univ Zurich, Dept Pathol, Inst Clin Pathol, CH-8091 Zurich, Switzerland	Netherlands Cancer Institute; University of Zurich	Marino, S (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl; silvia.marino@usz.ch		Marino, Silvia/0000-0002-9612-2883; Liu, James/0000-0002-1907-7150				Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dong J, 2000, Hum Mutat, V16, P89, DOI 10.1002/1098-1004(200007)16:1<89::AID-HUMU18>3.0.CO;2-7; Herms J, 2000, INT J CANCER, V89, P395; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Lee Y, 2003, CANCER RES, V63, P5428; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Marino S, 2000, GENE DEV, V14, P994; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pietsch T, 1997, CANCER RES, V57, P2085; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rubin JB, 2002, CANCER CELL, V2, P7, DOI 10.1016/S1535-6108(02)00090-9; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; TOMLINSON FH, 1994, MAYO CLIN PROC, V69, P359, DOI 10.1016/S0025-6196(12)62221-6; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	25	439	475	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2004	428	6980					337	341		10.1038/nature02385	http://dx.doi.org/10.1038/nature02385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	15029199				2022-12-01	WOS:000220250200048
J	Fagiolini, M; Fritschy, JM; Low, K; Mohler, H; Rudolph, U; Hensch, TK				Fagiolini, M; Fritschy, JM; Low, K; Mohler, H; Rudolph, U; Hensch, TK			Specific GABA(A) circuits for visual cortical plasticity	SCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; ACID(A) RECEPTOR SUBTYPES; ALPHA-SUBUNITS; PYRAMIDAL CELLS; CRITICAL-PERIOD; CORTEX; INHIBITION; MOUSE; LOCALIZATION; PHARMACOLOGY	Weak inhibition within visual cortex early in life prevents experience-dependent plasticity. Loss of responsiveness to an eye deprived of vision can be initiated prematurely by enhancing gamma-aminobutyric acid (GABA)-mediated transmission with benzodiazepines. Here, we use a mouse "knockin" mutation to alpha subunits that renders individual GABA type A(GABA(A)) receptors insensitive to diazepam to show that a particular inhibitory network controls expression of the critical period. Only alpha1-containing circuits were found to drive cortical plasticity, whereas alpha2-enriched connections separately regulated neuronal. ring. This dissociation carries implications for models of brain development and the safe design of benzodiazepines for use in infants.	RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan; Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8057 Zurich, Switzerland	RIKEN; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hensch, TK (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hensch@postmn.riken.go.jp	Hensch, Takao/L-4182-2019	fagiolini, michela/0000-0003-2807-803X; Fritschy, Jean-Marc/0000-0002-8552-3702; Low, Karin/0000-0002-5052-3892				Benson JA, 1998, FEBS LETT, V431, P400, DOI 10.1016/S0014-5793(98)00803-5; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bosman LWJ, 2002, J PHYSIOL-LONDON, V545, P169, DOI 10.1113/jphysiol.2002.026534; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; Chen L, 2001, MOL BRAIN RES, V88, P135, DOI 10.1016/S0169-328X(01)00042-0; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; DAW N, 1995, VISUAL DEV; Dunning DD, 1999, J NEUROPHYSIOL, V82, P3286, DOI 10.1152/jn.1999.82.6.3286; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NAT NEUROSCI, V3, P303, DOI 10.1038/73849; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Matsuda Yuji, UNPUB; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; SHAW C, 1987, DEV BRAIN RES, V37, P67, DOI 10.1016/0165-3806(87)90229-X; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1	29	352	355	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1681	1683		10.1126/science.1091032	http://dx.doi.org/10.1126/science.1091032			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	15017002				2022-12-01	WOS:000220151400047
J	Ravelli, RBG; Gigant, B; Curmi, PA; Jourdain, I; Lachkar, S; Sobel, A; Knossow, M				Ravelli, RBG; Gigant, B; Curmi, PA; Jourdain, I; Lachkar, S; Sobel, A; Knossow, M			Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain	NATURE			English	Article							ALPHA-BETA-TUBULIN; BINDING-SITE; IN-VITRO; PROTEIN; FAMILY; IDENTIFICATION; MODEL	Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions. Their dynamic instability is controlled by numerous compounds and proteins, including colchicine(1) and stathmin family proteins(2,3). The way in which microtubule instability is regulated at the molecular level has remained elusive, mainly because of the lack of appropriate structural data. Here, we present the structure, at 3.5 Angstrom resolution, of tubulin in complex with colchicine and with the stathmin-like domain (SLD) of RB3. It shows the interaction of RB3-SLD with two tubulin heterodimers in a curved complex capped by the SLD amino-terminal domain, which prevents the incorporation of the complexed tubulin into microtubules. A comparison with the structure of tubulin in protofilaments(4) shows changes in the subunits of tubulin as it switches from its straight conformation to a curved one. These changes correlate with the loss of lateral contacts and provide a rationale for the rapid microtubule depolymerization characteristic of dynamic instability. Moreover, the tubulin-colchicine complex sheds light on the mechanism of colchicine's activity: we show that colchicine binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.	CNRS, UPR 9063, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; UPMC, INSERM, U440, Inst Fer Moulin, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Knossow, M (corresponding author), CNRS, UPR 9063, Lab Enzymol & Biochim Struct, Batiment 34,1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	knossow@lebs.cnrs-gif.fr	CURMI, Patrick/G-4036-2013	Ravelli, Raimond/0000-0001-6056-5888; CURMI, Patrick A./0000-0001-5045-8501; Gigant, Benoit/0000-0002-5946-6759				Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Burling FT, 1996, SCIENCE, V271, P72, DOI 10.1126/science.271.5245.72; BURNS RG, 1992, FEBS LETT, V297, P205, DOI 10.1016/0014-5793(92)80538-R; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; PANDA D, 1995, BIOCHEMISTRY-US, V34, P9921, DOI 10.1021/bi00031a014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P894, DOI 10.1021/bi00170a007; SKOUFIAS DA, 1992, BIOCHEMISTRY-US, V31, P738, DOI 10.1021/bi00118a015; Steinman M, 2000, CHIM OGGI, V18, P19; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; WILSON L, 1974, FED PROC, V33, P158; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	30	1241	1269	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					198	202		10.1038/nature02393	http://dx.doi.org/10.1038/nature02393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014504				2022-12-01	WOS:000220103600053
J	Schmidt, MW; Spero, HJ; Lea, DW				Schmidt, MW; Spero, HJ; Lea, DW			Links between salinity variation in the Caribbean and North Atlantic thermohaline circulation	NATURE			English	Article							SEA-SURFACE TEMPERATURE; TROPICAL ATLANTIC; OCEAN; MG/CA; FORAMINIFERA; VARIABILITY; CLIMATE; ICE; AGE	Variations in the strength of the North Atlantic Ocean thermohaline circulation have been linked to rapid climate changes(1) during the last glacial cycle through oscillations in North Atlantic Deep Water formation and northward oceanic heat flux(2-4). The strength of the thermohaline circulation depends on the supply of warm, salty water to the North Atlantic, which, after losing heat to the atmosphere, produces the dense water masses that sink to great depths and circulate back south(2). Here we analyse two Caribbean Sea sediment cores, combining Mg/Ca palaeo-thermometry with measurements of oxygen isotopes in foraminiferal calcite in order to reconstruct tropical Atlantic surface salinity(5,6) during the last glacial cycle. We find that Caribbean salinity oscillated between saltier conditions during the cold oxygen isotope stages 2, 4 and 6, and lower salinities during the warm stages 3 and 5, covarying with the strength of North Atlantic Deep Water formation(7). At the initiation of the Bolling/Allerod warm interval, Caribbean surface salinity decreased abruptly, suggesting that the advection of salty tropical waters into the North Atlantic amplified thermohaline circulation and contributed to high-latitude warming.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Davis; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Schmidt, MW (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	schmidt@geology.ucdavis.edu		Spero, Howard/0000-0001-5465-8607				BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Boyle EA, 2000, QUATERNARY SCI REV, V19, P255, DOI 10.1016/S0277-3791(99)00065-7; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; BROECKER WS, 1990, CLIM DYNAM, V4, P73, DOI DOI 10.1007/BF00208902; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; CONKRIGHT M, 1998, NODC INTERNAL REPORT; Craig H., 1965, STABLE ISOTOPES OCEA, P9, DOI DOI 10.1109/ISSRE.1993.624301; Curry WB, 1997, PALEOCEANOGRAPHY, V12, P1, DOI 10.1029/96PA02413; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; DUPLESSY JC, 1992, NATURE, V358, P485, DOI 10.1038/358485a0; Durkoop A, 1997, PALEOCEANOGRAPHY, V12, P764, DOI 10.1029/97PA02270; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Hastings DW, 1998, PALEOCEANOGRAPHY, V13, P161, DOI 10.1029/97PA03147; Johns WE, 2002, DEEP-SEA RES PT I, V49, P211, DOI 10.1016/S0967-0637(01)00041-3; Jouzel J, 2000, QUATERNARY SCI REV, V19, P363, DOI 10.1016/S0277-3791(99)00069-4; Keigwin LD, 1999, PALEOCEANOGRAPHY, V14, P164, DOI 10.1029/1998PA900026; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Stidd C. K., 1967, J APPL METEOROL, V6, P255, DOI [10.1175/1520-0450(1967)006<0255:TUOEFC>2.0.CO;2, DOI 10.1175/1520-0450(1967)006<0255:TU0EFC>2.0.C0;2]; Thunell R, 1999, GEOLOGY, V27, P843, DOI 10.1130/0091-7613(1999)027<0843:SSTAAW>2.3.CO;2; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Vink A, 2001, PALEOCEANOGRAPHY, V16, P479, DOI 10.1029/2000PA000582; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Watanabe T, 2001, MAR GEOL, V173, P21, DOI 10.1016/S0025-3227(00)00166-3; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002	30	215	221	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					160	163		10.1038/nature02346	http://dx.doi.org/10.1038/nature02346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014495				2022-12-01	WOS:000220103600043
J	Elzinga, G; Raviglione, MC; Maher, D				Elzinga, G; Raviglione, MC; Maher, D			Scale up: meeting targets in global tuberculosis control	LANCET			English	Article							DOTS STRATEGY; PREVALENCE; COUNTRIES; HEALTH; MORTALITY; BURDEN	Despite great progress, global targets for tuberculosis case detection and cure might not be reached by 2005. In particular, there is a serious case-detection gap between estimated annual incident cases and those reported under the strategy for tuberculosis control branded as DOTS. Delays in reaching targets result in lack of effect on incidence of disease, which is of particular concern in regions where incidence is increasing-eg, sub-Saharan Africa and the former Soviet Union. Four key actions will speed up progress towards reaching global targets: 1) equipping national tuberculosis programmes to have a stewardship role in engaging all health providers in implementing the DOTS strategy; 2) establishing the feasibility of national certification systems of DOTS coverage; 3) promoting community action to contribute to patient care and to voice demand for the DOTS strategy; and 4) increasing support to sub-Saharan Africa for implementation of a strategy of expanded scope to counter HIV-1-fuelled tuberculosis.	WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland; Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands	World Health Organization; Netherlands National Institute for Public Health & the Environment	Raviglione, MC (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland.	raviglionem@who.int		Maher, Dermot/0000-0003-0466-1976; RAVIGLIONE, Mario/0000-0002-9331-2067				Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; Brugha R, 2001, BRIT MED J, V323, P152, DOI 10.1136/bmj.323.7305.152; Caldwell J. C., 1999, Resistances to behavioural change to reduce HIV/AIDS infection in predominantly heterosexual epidemics in Third World countries., P241; CHAKRABORTY AK, 1995, URBAN TUBERCULOSIS C; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Floyd K, 2002, SCIENCE, V295, P2040, DOI 10.1126/science.1069771; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Maher D, 1999, INT J TUBERC LUNG D, V3, P762; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Murthy KJR, 2001, INT J TUBERC LUNG D, V5, P354; Nyirenda T, 1998, INT J TUBERC LUNG D, V2, P944; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; Raviglione MC, 2002, LANCET, V359, P775, DOI 10.1016/S0140-6736(02)07880-7; Styblo K, 1991, SELECTED PAPERS, V24; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; *UNAIDS, 2002, REP GLOB HIV AIDS EP; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; *WHO, 2002, WHOCDSTB2002296WHOHI; *WHO, 2001, WHOCDSSTB200111; WHO, 1998, WHOTB98245; *WHO, 2003, WHOCDSTB2003312; *WHO, 2001, WHOCDSSTB200217; *WHO, 2000, 53 WORLD HLTH ASS RE; *WHO, 2002, WHOCDSSTB200116; WHO, 2000, WHOCDSSTB20006; *WHO, 2002, WHOCDSTR2002297; *WHO, 2001, WHOCDSSTD200110A; *WHO, 2001, WHOCDSTB2001290; *WHO, 2003, WHOCDSTB2003316; *WHO INT LAB OFF, 2003, WHOCDSTB2003323; World Health Organization, 1991, 44 WORLD HLTH ASS RE	40	66	72	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2004	363	9411					814	819		10.1016/S0140-6736(04)15698-5	http://dx.doi.org/10.1016/S0140-6736(04)15698-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801JK	15016493				2022-12-01	WOS:000220092000022
J	Xu, WH; Zheng, W; Xiang, YB; Ruan, ZM; Cheng, JR; Dai, Q; Gao, YT; Shu, XO				Xu, WH; Zheng, W; Xiang, YB; Ruan, ZM; Cheng, JR; Dai, Q; Gao, YT; Shu, XO			Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; PHYTOESTROGENS; ISOFLAVONES; ASSOCIATION; HORMONES; FIBER	Objective To evaluate the association of intake of soya food, a rich source of phytoestrogens, with the risk of endometrial cancer. Design Population based case-control study, with detailed information on usual soya food intake over the past five years collected by face to face interview using a food frequency questionnaire. Setting Urban Shanghai, China. Participants 832 incident cases of endometrial cancer in women aged 30 to 69 years diagnosed during 1997-2001 and identified from the Shanghai Cancer Registry; 846 control women frequency matched to cases on age and randomly selected from the Shanghai Residential Registry. Main outcome measures Odds ratios for risk of endometrial cancer in women with different intakes of soya foods. Results Regular consumption of soya foods, measured as amount of either soya protein or soya isoflavones, was inversely associated with the risk of endometrial cancer. Compared with women with the lowest quarter of intake, the adjusted odds ratio of endometrial cancer was reduced from 0.93 to 0.85 and 0.67 with increasing quarter of soya protein intake (P for trend 0.01). A similar inverse association was observed for soya isoflavones and soya fibre intake. The inverse association seemed to be more pronounced among women with high body mass index and waist:hip ratio. Conclusion Regular intake of soya foods is associated with a reduced risk of endometrial cancer.	Vanderbilt Univ, Vanderbilt Ctr Hlth Serv Res, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China	Vanderbilt University; Shanghai Jiao Tong University	Shu, XO (corresponding author), Vanderbilt Univ, Vanderbilt Ctr Hlth Serv Res, Vanderbilt Ingram Canc Ctr, Dept Med, 6009 Med Ctr E,1215 21st Ave S, Nashville, TN 37232 USA.	Yiao-Ou.Shu@vanderbilt.edu	zhang, weihua/GXV-1334-2022; Zheng, Wei/O-3351-2013	Zheng, Wei/0000-0003-1226-070X; xu, wanghong/0000-0003-2045-2218	NCI NIH HHS [R01CA92585] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092585] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLERCREUTZ H, 1991, AM J CLIN NUTR, V54, P1093, DOI 10.1093/ajcn/54.6.1093; Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; ADLERCREUTZ H, 1995, ENVIRON HEALTH PERSP, V103, P103, DOI 10.1289/ehp.95103s7103; ALELSON M, 1983, J ENDOCRINOL, V102, P49; AXELSON M, 1984, J ENDOCRINOL, V102, P49, DOI 10.1677/joe.0.1020049; Burton JL, 2002, J CLIN PATHOL, V55, P401, DOI 10.1136/jcp.55.6.401; Chen Z, 1999, NUTR CANCER, V33, P82, DOI 10.1080/01635589909514752; CHEN Z, 1909, NUTR CANC, V33, P2; *CHIN AC MED SCI, 1991, FOOD COMP TABL; Dai Q, 2001, BRIT J CANCER, V85, P372, DOI 10.1054/bjoc.2001.1873; GOLDIN BR, 1982, NEW ENGL J MED, V307, P1542, DOI 10.1056/NEJM198212163072502; Goodman MT, 1997, AM J EPIDEMIOL, V146, P294, DOI 10.1093/oxfordjournals.aje.a009270; Hale GE, 2002, J CLIN ENDOCR METAB, V87, P3, DOI 10.1210/jc.87.1.3; HENDERSON BE, 1982, CANCER RES, V42, P3232; Horn-Ross PL, 2003, J NATL CANCER I, V95, P1158, DOI 10.1093/jnci/djg015; KAKU T, 1993, INT J GYNECOL PATHOL, V12, P297, DOI 10.1097/00004347-199310000-00003; KELLY GE, 1995, P SOC EXP BIOL MED, V208, P40, DOI 10.3181/00379727-208-43829; Kumar NB, 2002, CANCER-AM CANCER SOC, V94, P1166, DOI 10.1002/cncr.10320; MARKIEWICZ L, 1993, J STEROID BIOCHEM, V45, P399, DOI 10.1016/0960-0760(93)90009-L; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; PARKIN DM, 1997, CANC INCIDENCE 5 CON, V7; Potischman N, 1996, JNCI-J NATL CANCER I, V88, P756, DOI 10.1093/jnci/88.11.756; Potischman N, 1996, J NATL CANCER I, V88, P1127, DOI 10.1093/jnci/88.16.1127; ROSE DP, 1990, NUTR CANCER, V13, P1, DOI 10.1080/01635589009514040; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; XIAO OS, 1993, AM J EPIDEMIOL, V137, P155, DOI 10.1093/oxfordjournals.aje.a116655	26	74	85	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2004	328	7451					1285	1288		10.1136/bmj.38093.646215.AE	http://dx.doi.org/10.1136/bmj.38093.646215.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826PN	15136343	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000221841100017
J	Terry, MB; Gammon, MD; Zhang, FF; Tawfik, H; Teitelbaum, SL; Britton, JA; Subbaramaiah, K; Dannenberg, AJ; Neugut, AI				Terry, MB; Gammon, MD; Zhang, FF; Tawfik, H; Teitelbaum, SL; Britton, JA; Subbaramaiah, K; Dannenberg, AJ; Neugut, AI			Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PREVENT COLORECTAL ADENOMAS; RANDOMIZED-TRIAL; CYCLOOXYGENASE-2; METAANALYSIS; AROMATASE; TARGET; TUMOR; STAGE; GENE	Context Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) has been associated with a decrease in the risk of several cancers, including breast cancer. NSAIDs inhibit cyclooxygenase activity and thereby reduce prostaglandin synthesis; prostaglandins stimulate aromatase gene expression and thereby stimulate estrogen biosynthesis. Given the importance of estrogen in the pathogenesis of breast cancer, the ability of aspirin and other NSAIDs to protect against breast cancer could vary according to hormone receptor status. Objectives To determine the association between the frequency and duration of use of aspirin and other NSAIDs and breast cancer risk and to investigate whether any observed association is more pronounced for women with hormone receptor-positive breast cancers. Design, Setting, and Patients Population-based case-control study of women with breast cancer, including in-person interviews conducted on Long Island, NY, during 1996-1997 (1442 cases and 1420 controls). Main Outcome Measure Incident invasive and in situ breast cancer by aspirin and NSAID use and hormone receptor status. Results Ever use of aspirin or other NSAIDs at least once per week for 6 months or longer was reported in 301 cases (20.9%) and 345 controls (24.3%) (odds ratio [OR], 0.80; 95% confidence interval [Cl], 0.66-0.97 for ever vs nonusers). The inverse association was most pronounced among frequent users (greater than or equal to7 tablets per week) (OR, 0.72; 95% Cl, 0.58-0.90). The results for ibuprofen, which was used by fewer women on a regular basis, were generally weaker (OR, 0.78; 95% Cl, 0.55-1.10 for <3 times per week vs OR, 0.92; 95% Cl, 0.70-1.22 for >= 3 times per week). Use of acetaminophen, an analgesic that does not inhibit prostaglandin synthesis, was not associated with a reduction in the incidence of breast cancer. The reduction in risk with aspirin use was seen among those with hormone receptor-positive tumors (OR, 0.74; 95% Cl, 0.60-0.93) but not for women with hormone receptor-negative tumors (OR, 0.97; 95% Cl, 0.67-1.40). Conclusion These data add to the growing evidence that supports the regular use of aspirin and other NSAIDs (which may operate through inhibition of estrogen biosynthesis) as effective chemopreventive agents for breast cancer.	Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; CUNY Mt Sinai Sch Med, Dept Community Med, New York, NY USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA; Strang Canc Prevent Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Cornell University	Neugut, AI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, 722 W 168th St, New York, NY 10032 USA.	ainq@columbia.edu		Terry, Mary Beth/0000-0002-4106-5033	NCI NIH HHS [U01 CA/ES66572, R01 CA89578, K05 CA89155, K07 CA90685-02] Funding Source: Medline; NIEHS NIH HHS [P30 ES10126] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089578, K07CA090685, U01CA066572, K05CA089155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Boolbol SK, 1996, CANCER RES, V56, P2556; Brueggemeier RW, 1999, CANCER LETT, V140, P27, DOI 10.1016/S0304-3835(99)00050-6; CARTER CA, 1983, CANCER RES, V43, P3559; Coogan PF, 1999, PREV MED, V29, P72, DOI 10.1006/pmed.1999.0518; Cotterchio M, 2001, CANCER EPIDEM BIOMAR, V10, P1213; Daniel W.W., 2013, BIOSTATISTICS FDN AN, V10 ed, P191; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Egan KM, 1996, J NATL CANCER I, V88, P988, DOI 10.1093/jnci/88.14.988; Elvin JA, 2000, P NATL ACAD SCI USA, V97, P10288, DOI 10.1073/pnas.180295197; Farrow DC, 1998, CANCER EPIDEM BIOMAR, V7, P97; Gammon MD, 2002, BREAST CANCER RES TR, V74, P235, DOI 10.1023/A:1016387020854; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Harris RE, 2003, CANCER RES, V63, P6096; HARRIS RE, 1995, PREV MED, V24, P119, DOI 10.1006/pmed.1995.1022; Harris RE, 1996, EPIDEMIOLOGY, V7, P203, DOI 10.1097/00001648-199603000-00017; Harris RE, 1999, ONCOL REP, V6, P71; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; Johnson TW, 2002, CANCER EPIDEM BIOMAR, V11, P1586; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; ROSENBERG L, 1995, PREV MED, V24, P107, DOI 10.1006/pmed.1995.1018; Rosenberg L, 1996, J NATL CANCER I, V88, P941, DOI 10.1093/jnci/88.14.941; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Sharpe CR, 2000, BRIT J CANCER, V83, P112; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739	32	213	224	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2004	291	20					2433	2440		10.1001/jama.291.20.2433	http://dx.doi.org/10.1001/jama.291.20.2433			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	823HB	15161893				2022-12-01	WOS:000221599700025
J	Grann, M; Fazel, S				Grann, M; Fazel, S			Substance misuse and violent crime: Swedish population study	BRITISH MEDICAL JOURNAL			English	Article									Karolinska Inst, Ctr Violence Prevent, SE-10435 Stockholm, Sweden; Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	Karolinska Institutet; University of Oxford	Grann, M (corresponding author), Karolinska Inst, Ctr Violence Prevent, POB 23000, SE-10435 Stockholm, Sweden.	martin.grann@cvp.se	Fazel, Seena/B-5307-2008	Fazel, Seena/0000-0002-5383-5365				Farrell M, 1998, BMJ-BRIT MED J, V316, P1399, DOI 10.1136/bmj.316.7142.1399; Gossop M, 2003, ADDICTION, V98, P291, DOI 10.1046/j.1360-0443.2003.00296.x; GRANN M, 1998, SCANDINAVIAN J FOREN, V3, P78; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393	5	80	83	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 22	2004	328	7450					1233	1234		10.1136/bmj.328.7450.1233	http://dx.doi.org/10.1136/bmj.328.7450.1233			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15155501	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000221677200019
J	Skeff, KM; Ezeji-Okoye, S; Pompei, P; Rockson, S				Skeff, KM; Ezeji-Okoye, S; Pompei, P; Rockson, S			Benefits of resident work hours regulation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PATIENT-CARE; MEDICINE; PROGRAM		Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Stanford University	Skeff, KM (corresponding author), Stanford Univ, Med Ctr, 300 Pasteur Dr,Room S101, Stanford, CA 94305 USA.			rockson, stanley/0000-0003-1253-474X				Baldwin DC, 2003, ACAD MED, V78, P1154, DOI 10.1097/00001888-200311000-00018; Berwick DM, 2003, QUAL SAF HEALTH CARE, V12, P448, DOI 10.1136/qhc.12.6.448; Clever LH, 2002, ANN INTERN MED, V136, P391, DOI 10.7326/0003-4819-136-5-200203050-00012; Cruess RL, 1999, ACAD MED, V74, P878, DOI 10.1097/00001888-199908000-00010; DaRosa DA, 2003, SURGERY, V133, P13, DOI 10.1067/msy.2003.67; GURJALA A, 2001, HRG PUBLICATION, V1570; Johnson T, 2003, ACAD MED, V78, P3, DOI 10.1097/00001888-200301000-00002; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Lawrence Hal C 3rd, 2003, Curr Womens Health Rep, V3, P487; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Souba WW, 2002, ACAD MED, V77, P139, DOI 10.1097/00001888-200202000-00008; Whang EE, 2003, J AM COLL SURGEONS, V197, P624, DOI 10.1016/S1072-7515(03)00602-1	14	29	29	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2004	140	10					816	817		10.7326/0003-4819-140-10-200405180-00012	http://dx.doi.org/10.7326/0003-4819-140-10-200405180-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822EX	15148069				2022-12-01	WOS:000221520900007
J	Huang, LR; Cox, EC; Austin, RH; Sturm, JC				Huang, LR; Cox, EC; Austin, RH; Sturm, JC			Continuous particle separation through deterministic lateral displacement	SCIENCE			English	Article							FIELD-FLOW FRACTIONATION; SIZE; DIFFUSION; DISPERSION	We report on a microfluidic particle-separation device that makes use of the asymmetric bifurcation of laminar flow around obstacles. A particle chooses its path deterministically on the basis of its size. All particles of a given size follow equivalent migration paths, leading to high resolution. The microspheres of 0.8, 0.9, and 1.0 micrometers that were used to characterize the device were sorted in 40 seconds with a resolution of similar to10 nanometers, which was better than the time and resolution of conventional flow techniques. Bacterial artificial chromosomes could be separated in 10 minutes with a resolution of similar to12%.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Princeton Inst Sci & Technol Mat, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Huang, LR (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.				NHGRI NIH HHS [HG01506] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001506] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARIS R, 1956, PROC R SOC LON SER-A, V235, P67, DOI 10.1098/rspa.1956.0065; Baba M, 2003, APPL PHYS LETT, V83, P1468, DOI 10.1063/1.1602555; Berg H. C., 1993, RANDOM WALKS BIOL, p[56, 83]; Blom MT, 2003, ANAL CHEM, V75, P6761, DOI 10.1021/ac034663l; Chou CF, 1999, P NATL ACAD SCI USA, V96, P13762, DOI 10.1073/pnas.96.24.13762; DiMarzio E. A., 1970, MACROMOLECULES, V3, P131, DOI DOI 10.1021/MA60014A005; Dupont AL, 2004, J CHROMATOGR A, V1026, P129, DOI 10.1016/j.chroma.2003.11.002; FEYNMAN RP, 1966, FEYNMAN LECT PHYS, V2, pCH41; GIDDINGS JC, 1959, NATURE, V184, P357, DOI 10.1038/184357a0; GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990; Happel J., 1983, LOW REYNOLDS NUMBER; HEFTMANN E, 1983, CHROMATOGRAPHY FUNDA; Huang LR, 2003, ANAL CHEM, V75, P6963, DOI 10.1021/ac0348524; Huang LR, 2002, NAT BIOTECHNOL, V20, P1048, DOI 10.1038/nbt733; Janca J, 2003, J COLLOID INTERF SCI, V260, P317, DOI 10.1016/S0021-9797(02)00216-3; KIM YS, 1995, ANAL CHEM, V67, P784, DOI 10.1021/ac00101a002; Osoegawa K, 2000, GENOME RES, V10, P116; PERKINS TK, 1963, SOC PETROL ENG J, V3, P70, DOI 10.2118/480-PA; ROUSSELET J, 1994, NATURE, V370, P446, DOI 10.1038/370446a0; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sano T, 2003, APPL PHYS LETT, V83, P4438, DOI 10.1063/1.1629379; SATTELLE DB, 1991, BIOCHEM SOC T, V19, P501, DOI 10.1042/bst0190501; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; van Oudenaarden A, 1999, SCIENCE, V285, P1046, DOI 10.1126/science.285.5430.1046	24	1188	1316	29	549	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					987	990		10.1126/science.1094567	http://dx.doi.org/10.1126/science.1094567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15143275				2022-12-01	WOS:000221383300041
J	Covert, MW; Knight, EM; Reed, JL; Herrgard, MJ; Palsson, BO				Covert, MW; Knight, EM; Reed, JL; Herrgard, MJ; Palsson, BO			Integrating high-throughput and computational data elucidates bacterial networks	NATURE			English	Article							IN-SILICO MODELS; ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; REGULATORY NETWORK; DISCOVERY; GENOTYPE; ROLES; ARCA; FNR	The flood of high-throughput biological data has led to the expectation that computational ( or in silico) models can be used to direct biological discovery, enabling biologists to reconcile heterogeneous data types, find inconsistencies and systematically generate hypotheses(1-3). Such a process is fundamentally iterative, where each iteration involves making model predictions, obtaining experimental data, reconciling the predicted outcomes with experimental ones, and using discrepancies to update the in silico model. Here we have reconstructed, on the basis of information derived from literature and databases, the first integrated genome-scale computational model of a transcriptional regulatory and metabolic network. The model accounts for 1,010 genes in Escherichia coli, including 104 regulatory genes whose products together with other stimuli regulate the expression of 479 of the 906 genes in the reconstructed metabolic network. This model is able not only to predict the outcomes of high-throughput growth phenotyping and gene expression experiments, but also to indicate knowledge gaps and identify previously unknown components and interactions in the regulatory and metabolic networks. We find that a systems biology approach that combines genome-scale experimentation and computation can systematically generate hypotheses on the basis of disparate data sources.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	palsson@ucsd.edu	Reed, Jennifer L/E-5137-2011	Reed, Jennifer L/0000-0001-7854-6220; Covert, Markus/0000-0002-5993-8912; Palsson, Bernhard/0000-0003-2357-6785				Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Burgard AP, 2001, BIOTECHNOL BIOENG, V74, P364, DOI 10.1002/bit.1127; COMPAN I, 1994, MOL MICROBIOL, V11, P955, DOI 10.1111/j.1365-2958.1994.tb00374.x; Cotter PA, 1997, MOL MICROBIOL, V25, P605, DOI 10.1046/j.1365-2958.1997.5031860.x; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Forster Jochen, 2003, OMICS A Journal of Integrative Biology, V7, P193, DOI 10.1089/153623103322246584; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Palsson B, 2000, NAT BIOTECHNOL, V18, P1147, DOI 10.1038/81125; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881	30	582	606	5	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					92	96		10.1038/nature02456	http://dx.doi.org/10.1038/nature02456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129285				2022-12-01	WOS:000221222100051
J	Polley, DB; Kvasnak, E; Frostig, RD				Polley, DB; Kvasnak, E; Frostig, RD			Naturalistic experience transforms sensory maps in the adult cortex of caged animals	NATURE			English	Article							DEPENDENT SYNAPTIC PLASTICITY; SOMATOSENSORY CORTEX; BARREL CORTEX; RAT; ORGANIZATION; STIMULATION; MOUSE; SI; ENVIRONMENTS; SUPPRESSION	Much of what is known about the functional organization and plasticity of adult sensory cortex is derived from animals housed in standard laboratory cages(1,2). Here we report that the transfer of adult rats reared in standard laboratory cages to a naturalistic habitat modifies the functional and morphological organization of the facial whisker representation in the somatosensory 'barrel' cortex. Cortical whisker representations, visualized with repeated intrinsic signal optical imaging in the same animals, contracted by 46% after four to six weeks of exposure to the naturalistic habitat. Acute, multi-site extracellular recordings demonstrated suppressed evoked neuronal responses and smaller, sharper constituent receptive fields in the upper cortical layers (II/III), but not in the thalamic recipient layer (IV), of rats with naturalistic experience. Morphological plasticity of the layer IV barrel field was observed, but on a substantially smaller scale than the functional plasticity. Thus, transferring animals to an environment that promotes the expression of natural, innate behaviours induces a large-scale functional refinement of cortical sensory maps.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Polley, DB (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, 513 Parnassus Ave, San Francisco, CA 94143 USA.	dpolley@phy.ucsf.edu	Kvasnak, Eugen/B-4207-2018	Kvasnak, Eugen/0000-0001-9855-6362; Polley, Daniel/0000-0002-5120-2409				ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; BEAULIEU C, 1990, DEV BRAIN RES, V53, P71, DOI 10.1016/0165-3806(90)90125-I; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Brett-Green BA, 2001, J NEUROSCI, V21, P9944, DOI 10.1523/JNEUROSCI.21-24-09944.2001; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Castro-Alamancos MA, 2002, J NEUROSCI, V22, P9651; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Chen-Bee CH, 2000, J NEUROSCI METH, V97, P157, DOI 10.1016/S0165-0270(00)00180-1; Coq JO, 1998, EXP BRAIN RES, V121, P191, DOI 10.1007/s002210050452; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; FOX K, 1992, J NEUROSCI, V12, P1826; FOX K, 1994, J NEUROSCI, V14, P7665; Frostig RD, 2002, METH NE FRO NEUROSCI, P21; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; GREEN EJ, 1983, BRAIN RES, V264, P233, DOI 10.1016/0006-8993(83)90821-1; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; KAAS JH, 2000, NEW COGNITIVE NEUROS, P223; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; KOSSUT M, 1988, J NEUROPHYSIOL, V60, P829, DOI 10.1152/jn.1988.60.2.829; LAND PW, 1985, J COMP NEUROL, V238, P225, DOI 10.1002/cne.902380209; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Prakash N, 1996, NATURE, V381, P702, DOI 10.1038/381702a0; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; UYLINGS HBM, 1978, EXP NEUROL, V62, P658, DOI 10.1016/0014-4886(78)90276-5; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WELKER E, 1992, J NEUROSCI, V12, P153; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZARZECKI P, 1993, J NEUROPHYSIOL, V69, P1422, DOI 10.1152/jn.1993.69.5.1422	30	118	123	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					67	71		10.1038/nature02469	http://dx.doi.org/10.1038/nature02469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129281				2022-12-01	WOS:000221222100045
J	Staba, SL; Escolar, ML; Poe, M; Kim, Y; Martin, PL; Szabolcs, P; Allison-Thacker, J; Wood, S; Wenger, DA; Rubinstein, P; Hopwood, JJ; Krivit, W; Kurtzberg, J				Staba, SL; Escolar, ML; Poe, M; Kim, Y; Martin, PL; Szabolcs, P; Allison-Thacker, J; Wood, S; Wenger, DA; Rubinstein, P; Hopwood, JJ; Krivit, W; Kurtzberg, J			Cord-blood transplants from unrelated donors in patients with Hurler's syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; MUCOPOLYSACCHARIDOSIS TYPE-I; ENZYME-REPLACEMENT THERAPY; CELL TRANSPLANTATION; STORAGE DISEASES; PLACENTAL BLOOD; RECONSTITUTION; ENGRAFTMENT; CHILDREN; DYSPLASIA	BACKGROUND Hurler's syndrome ( the most severe form of mucopolysaccharidosis type I) causes progressive deterioration of the central nervous system and death in childhood. Allogeneic bone marrow transplantation before the age of two years halts disease progression and prolongs life, but many children lack a bone marrow donor. We investigated the feasibility of using cord-blood transplants from unrelated donors and a myeloablative preparative regimen that did not involve total-body irradiation in young children with Hurler's syndrome. METHODS Between December 1995 and October 2002, 20 consecutive children with Hurler's syndrome received busulfan, cyclophosphamide, and antithymocyte globulin before receiving cord-blood transplants from unrelated donors. The children were subsequently evaluated for engraftment, adverse effects, and effects on disease symptoms. RESULTS Cord-blood donors had normal alpha-L-iduronidase activity ( mean number of cells, 10.53 x 10(7) per kilogram of body weight) and were discordant for up to three of six HLA markers. Neutrophil engraftment occurred a median of 24 days after transplantation. Five patients had grade II or grade III acute graft-versus-host disease; none had extensive chronic graft-versus-host disease. Seventeen of the 20 children were alive a median of 905 days after transplantation, with complete donor chimerism and normal peripheral-blood alpha-L-iduronidase activity (event-free survival rate, 85 percent). Transplantation improved neurocognitive performance and decreased somatic features of Hurler's syndrome. CONCLUSIONS Cord blood from unrelated donors appears to be an excellent source of stem cells for transplantation in patients with Hurler's syndrome. Sustained engraftment can be achieved without total-body irradiation. Cord-blood transplantation favorably altered the natural history of Hurler's syndrome and thus may be important to consider in young children with this form of the disease.	Duke Univ, Med Ctr, Pediat Stem Cell Transplant Program, Durham, NC 27710 USA; Univ N Carolina, Sch Med, Frank Porter Graham Child Dev Ctr, Chapel Hill, NC USA; Univ N Carolina, Sch Med, Ctr Dev & Learning, Chapel Hill, NC USA; Emmes Corp, Rockville, MD USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; New York Blood Ctr, Placental Blood Program, New York, NY 10021 USA; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emmes Corporation; Jefferson University; New York Blood Center; Womens & Childrens Hospital Australia; University of Minnesota System; University of Minnesota Twin Cities	Staba, SL (corresponding author), Duke Univ, Med Ctr, Pediat Stem Cell Transplant Program, Box 3350, Durham, NC 27710 USA.	staba001@mc.duke.edu	Poe, Michele/K-6615-2012; Escolar, Maria/J-3721-2016	Poe, Michele/0000-0001-9693-3638; 				ASHTON LJ, 1992, AM J HUM GENET, V50, P787; Braunlin EA, 2001, AM J CARDIOL, V88, P1075, DOI 10.1016/S0002-9149(01)01999-3; COWAN MJ, 1991, CLIN BIOCHEM, V24, P375, DOI 10.1016/0009-9120(91)80012-R; deCasperi R, 2000, BONE MARROW TRANSPL, V25, P541, DOI 10.1038/sj.bmt.1702185; Fleming D R, 1998, Pediatr Transplant, V2, P299; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Guffon N, 1998, J PEDIATR-US, V133, P119, DOI 10.1016/S0022-3476(98)70201-X; Hite SH, 2000, PEDIATR RADIOL, V30, P464, DOI 10.1007/s002470000210; HOBBS JR, 1981, LANCET, V2, P709; Jacobson P, 2001, BONE MARROW TRANSPL, V27, P855, DOI 10.1038/sj.bmt.1703010; Kakavanos R, 2003, LANCET, V361, P1608, DOI 10.1016/S0140-6736(03)13311-9; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Krivit W., 1995, Bone Marrow Transplantation, V15, pS182; Krivit W, 1999, Curr Opin Neurol, V12, P167, DOI 10.1097/00019052-199904000-00007; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Masterson EL, 1996, J PEDIATR ORTHOPED, V16, P731, DOI 10.1097/01241398-199611000-00006; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, V3, DOI DOI 10.1036/OMMBID.165; Odunusi E, 1999, J PEDIATR ORTHOPED, V19, P270, DOI 10.1097/00004694-199903000-00026; Peters C, 1996, BLOOD, V87, P4894, DOI 10.1182/blood.V87.11.4894.bloodjournal87114894; Peters C, 1998, BLOOD, V91, P2601, DOI 10.1182/blood.V91.7.2601.2601_2601_2608; Peters C, 1998, J PEDIATR-US, V133, P7, DOI 10.1016/S0022-3476(98)70170-2; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; RESNICK JM, 1992, BONE MARROW TRANSPL, V10, P273; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; RUBINSTEIN P, 1993, BLOOD, V81, P1679; SHAPIRO EG, 1995, J INHERIT METAB DIS, V18, P413, DOI 10.1007/BF00710053; SUMMERS CG, 1989, OPHTHALMOLOGY, V96, P977; VINALLONGA X, 1992, PEDIATR CARDIOL, V13, P107, DOI 10.1007/BF00798216; Wenger DA, 1991, TECHNIQUES DIAGNOSTI, P587; Whitley C B, 1986, Birth Defects Orig Artic Ser, V22, P7; WHITLEY CB, 1993, AM J MED GENET, V46, P209, DOI 10.1002/ajmg.1320460222; Wraith JE, 2001, J INHERIT METAB DIS, V24, P245, DOI 10.1023/A:1010379320378	33	340	362	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2004	350	19					1960	1969		10.1056/NEJMoa032613	http://dx.doi.org/10.1056/NEJMoa032613			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818AU	15128896	Green Published			2022-12-01	WOS:000221218800008
J	Madakamutil, LT; Christen, U; Lena, CJ; Wang-Zhu, YR; Attinger, A; Sundarrajan, M; Ellmeier, W; von Herrath, MG; Jensen, P; Littman, DR; Cheroutre, H				Madakamutil, LT; Christen, U; Lena, CJ; Wang-Zhu, YR; Attinger, A; Sundarrajan, M; Ellmeier, W; von Herrath, MG; Jensen, P; Littman, DR; Cheroutre, H			CD8 alpha alpha-mediated survival and differentiation of CD8 memory T cell precursors	SCIENCE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; DEVELOPING THYMOCYTES; CORECEPTOR FUNCTION; EXPRESSION; SELECTION; RECEPTOR; THYMUS; EFFECTOR; MODULATION; ACTIVATION	Memory T cells are long-lived antigen-experienced T cells that are generally accepted to be direct descendants of proliferating primary effector cells. However, the factors that permit selective survival of these T cells are not well established. We show that homodimeric alpha chains of the CD8 molecule (CD8alphaalpha) are transiently induced on a selected subset of CD8alphabeta(+) T cells upon antigenic stimulation. These CD8alphaalpha molecules promote the survival and differentiation of activated lymphocytes into memory CD8 T cells. Thus, memory precursors can be identified among primary effector cells and are selected for survival and differentiation by CD8alphaalpha.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomed Sci, New York, NY 10016 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	La Jolla Institute for Immunology; Howard Hughes Medical Institute; New York University; New York University; Emory University	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	hilde@liai.org	Christen, Urs/A-7338-2009	Christen, Urs/0000-0003-4165-7976; Ellmeier, Wilfried/0000-0001-8192-8481	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051973, R01AI033614, R37AI033614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK054451, R01DK054451] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33614, AI51973, AI50263] Funding Source: Medline; NIDDK NIH HHS [DK54451] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aranda R, 1997, J IMMUNOL, V158, P3464; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Barnden MJ, 1997, CELL IMMUNOL, V175, P111, DOI 10.1006/cimm.1996.1054; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chidgey A, 1997, INT IMMUNOL, V9, P1527, DOI 10.1093/intimm/9.10.1527; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; VANOERS NSC, 1993, J IMMUNOL, V151, P777	25	160	167	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					590	593		10.1126/science.1092316	http://dx.doi.org/10.1126/science.1092316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105501				2022-12-01	WOS:000220975100050
J	Angus, DC; Black, N				Angus, DC; Black, N			Improving care of the critically ill: institutional and health-care system approaches	LANCET			English	Article							PEDIATRIC INTENSIVE-CARE; MEDICAL-MALPRACTICE; ADVERSE EVENTS; UNITED-STATES; HOSPITAL MORTALITY; TRAUMA SYSTEM; SEPTIC SHOCK; OUTCOMES; QUALITY; IMPACT	Institutional and health-care system approaches complement bedside strategies to improve care of the critically ill. Focusing on the USA and the UK, we discuss seven approaches: education (especially of non-clinical managers, policy-makers, and the public), organisational guidelines, performance reporting, financial and sociobehavioural incentives to health-care professionals and institutions, regulation, legal requirements, and health-care system reorganisation. No single action is likely to have sustained effect and we recommend a combination of approaches. Several recent initiatives that hold promise tie performance reporting to financial incentives. Though performance reporting has been hampered by concerns over cost and accuracy, it remains an essential component and we recommend continued effort in this area. We also recommend more public education and use of organisational guidelines, such as admission criteria and staffing levels in intensive care units. Even if these endeavours are successful, with rising demand for services and continuing pressure to control costs, optimum care of the critically ill will not be realised without a fundamental reorganisation of services. In both the USA and UK, we recommend exploration of regionalised care, akin to US state trauma systems, and greater use of physician-extenders, such as nurse practitioners, to provide enhanced access to specialist care for critical illness.	Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; London School of Hygiene & Tropical Medicine	Angus, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Lab, 604 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	angusdc@ccm.upmc.edu	Angus, Derek C/E-9671-2012					Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Angus DC, 2001, AM J RESP CRIT CARE, V164, P1154, DOI 10.1164/ajrccm.164.7.2012126; ARROW KJ, 1963, AM ECON REV, V53, P941; *ASS PRESS, FLESH EAT BACT FORC; Audit Commission, 1999, CRIT SUCC PLAC EFF E; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Bion JF, 2004, LANCET, V363, P970, DOI 10.1016/S0140-6736(04)15793-0; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; BLACK N, 1990, LANCET, V335, P35, DOI 10.1016/0140-6736(90)90151-T; Black N, 2003, QUAL SAF HEALTH CARE, V12, P348, DOI 10.1136/qhc.12.5.348; Black Nick, 2004, J Health Serv Res Policy, V9 Suppl 1, P62, DOI 10.1258/135581904322724158; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2003, ANN INTERN MED, V139, P267, DOI 10.7326/0003-4819-139-4-200308190-00009; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carcillo JA, 2003, CRIT CARE CLIN, V19, P413, DOI 10.1016/S0749-0704(03)00013-7; Cawley James F, 2003, J Health Serv Res Policy, V8, P65, DOI 10.1258/135581903321466012; Committee on Quality of Health Care in America, 1999, ERR IS HUM BUILD SAF, P164; Cook DJ, 2004, LANCET, V363, P1224, DOI 10.1016/S0140-6736(04)15955-2; Coulter A, 1997, J Health Serv Res Policy, V2, P112; *DEP HLTH, 2002, NHS PERF RAT; DOMENIGHETTI G, 1988, LANCET, V2, P1470; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Egol A, 1999, CRIT CARE MED, V27, P633; ENTMAN SS, 1994, JAMA-J AM MED ASSOC, V272, P1588, DOI 10.1001/jama.272.20.1588; Evans R., 1974, EC HLTH MED CARE, P162, DOI 10.1007/978-1-349-63660-0_10; Evans R G, 1978, Hosp Trustee, V2, P6; Galvin R, 2002, NEW ENGL J MED, V347, P939, DOI 10.1056/NEJMsb012850; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Hannan E L, 1998, J Health Serv Res Policy, V3, P67; Herxheimer A, 2003, J ROY SOC MED, V96, P209, DOI 10.1258/jrsm.96.5.209; *JCAHO, JCAHO 2004 NAT PAT S; KELLEY MA, IN PRESS CHEST; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; *LEAPFR GROUP, FACTSH LEAPFR REG RO; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; MCGUIRE TG, 1991, J HEALTH ECON, V10, P385, DOI 10.1016/0167-6296(91)90022-F; McMullin J, 2003, UPD INT CAR, V39, P287; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Nicholl J, 1997, BRIT MED J, V315, P1349, DOI 10.1136/bmj.315.7119.1349; Nicholl J, 1998, BRIT MED J, V317, P1320; Pearson G, 2001, INTENS CARE MED, V27, P1670, DOI 10.1007/s001340101072; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Pronovost PJ, 2004, LANCET, V363, P1061, DOI 10.1016/S0140-6736(04)15843-1; Ratcliffe J, 1998, BMJ, V316, P1547; Reinhardt UE, 1999, JAMA-J AM MED ASSOC, V281, P462, DOI 10.1001/jama.281.5.462; Rosenbaum S, 2003, JAMA-J AM MED ASSOC, V289, P1546, DOI 10.1001/jama.289.12.1546; Rosenfeld BA, 2000, CRIT CARE MED, V28, P3925, DOI 10.1097/00003246-200012000-00034; ROWAN K, 2000, HLTH CARE UK     SPR, P42; ROWAN KR, 2004, BMJ             0223, DOI DOI 10.1136/BMJ.38007.694745.F7; SAMPALIS JS, 1995, J TRAUMA, V39, P232, DOI 10.1097/00005373-199508000-00008; Sanderson CFB, 1997, MED CARE, V35, P669, DOI 10.1097/00005650-199707000-00002; SCHROEDER SA, 1994, INQUIRY-J HEALTH CAR, V31, P266; SCHWARTZ GT, 1994, UCLA LAW REV, V42, P377; Sibbald Bonnie, 2004, J Health Serv Res Policy, V9 Suppl 1, P28, DOI 10.1258/135581904322724112; Sirio C A, 1994, New Horiz, V2, P321; Sirio CA, 1999, CHEST, V115, P793, DOI 10.1378/chest.115.3.793; SLOAN FA, 1995, MED CARE, V33, P700, DOI 10.1097/00005650-199507000-00006; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; Snyder J V, 1994, New Horiz, V2, P296; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; The Leapfrog Group, FACTSH ICU PHYS STAF; TOWSE A, 2003, REDUCING HARM PATIEN; Tse MM, 2003, GERIATR NURS, V24, P266, DOI 10.1016/S0197-4572(03)00251-9; *UK DEP HLTH, COMPR CRIT CAR REV A; *UK DEP HLTH, 2002, LEARN BRIST DEP HLTH; YOUNG C, 2002, CRITICAL CARE S1, V6, P117; NATL SERVICE FRAMEWO	84	57	57	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1314	1320		10.1016/S0140-6736(04)16007-8	http://dx.doi.org/10.1016/S0140-6736(04)16007-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813KB	15094279	Bronze, Green Published			2022-12-01	WOS:000220904900024
J	Jain, T; Missmer, SA; Hornstein, MD				Jain, T; Missmer, SA; Hornstein, MD			Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technology in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; MULTIPLE PREGNANCIES; INSURANCE-COVERAGE; RATES; RISK; BLASTOCYSTS; GESTATION; CULTURE; BIRTHS	Background: During the past decade in the United States, increasing attention has been paid to lowering the incidence of multiple gestations resulting from the use of assisted reproductive technology. To determine whether such efforts have been successful, we assessed national trends in embryo-transfer practice patterns and in outcomes after the use of assisted reproductive technology. Methods: We analyzed data on outcomes of assisted reproductive technology procedures as reported to the Centers for Disease Control and Prevention from 1995 to 2001 by fertility clinics in the United States. We also analyzed data from the National Center for Health Statistics on the rates of twin births and triplet or higher-order multiple births. Results: From 1995 to 2001 in the United States, the number of infertility clinics, the number of fresh-embryo cycles initiated, and the number of fresh-embryo transfers increased steadily. The average number of embryos transferred per cycle began decreasing in 1997, with the steepest decline (an 11.1 percent decrease) between 1998 and 1999. In contrast, the number of pregnancies and live births per cycle during the period from 1995 to 2001 steadily increased. Even though the percentage of pregnancies with twins did not change significantly between 1997 and 2001, the percentage of pregnancies with three or more fetuses significantly decreased every year, with the steepest decline (a 20.8 percent decrease) between 1998 and 1999, after the publication in 1998 of the American Society for Reproductive Medicine guidelines for embryo transfer. Conclusions: Since 1997 in the United States, there have been consistent decreases in both the number of embryos transferred per cycle and the percentage of pregnancies with three or more fetuses, as well as a consistent increase in the percentage of live births per cycle.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hornstein, MD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.	mhornstein@partners.org	Jain, Tarun/ABF-7304-2020	Jain, Tarun/0000-0002-8889-084X				*AM SOC REPR MED, 2000, MULT PREGN ASS INF T; American Society for Reproductive Medicine, 1999, GUID NUMB EMBR TRANS; American Society for Reproductive Medicine. Practice Committee Opinion, 1998, GUID NUMB EMBR TRANS; Andrews L, 1998, SCIENCE, V281, P651; Annas GJ, 1998, NEW ENGL J MED, V339, P935, DOI 10.1056/NEJM199809243391325; ASCHENGRAU A, 2003, ESSENTIALS EPIDEMIOL, P323; BALDWIN V, 2004, 2 GLOB C SOM MASS; BALEN AH, 1993, HUM REPROD, V8, P1324, DOI 10.1093/oxfordjournals.humrep.a138250; BERKOWITZ RL, 1988, NEW ENGL J MED, V318, P1043, DOI 10.1056/NEJM198804213181607; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; *CDCP, 2004, REPR HLTH INF SOURC; Coetsier T, 2001, HUM REPROD, V16, P790; Faber K, 1997, HUM REPROD, V12, P1614; Gardner DK, 1998, FERTIL STERIL, V69, P84, DOI 10.1016/S0015-0282(97)00438-X; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; Gerris J, 2000, HUM REPROD, V15, P1884, DOI 10.1093/humrep/15.9.1884; Jain T, 2003, FERTIL STERIL, V80, P27, DOI 10.1016/S0015-0282(03)00576-4; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Jones HW, 2003, FERTIL STERIL, V79, P17, DOI 10.1016/S0015-0282(02)04565-X; Jones HW, 2001, FERTIL STERIL, V76, pS5; Jones HW, 2001, FERTIL STERIL, V75, P11, DOI 10.1016/S0015-0282(00)01612-5; MARTIN JA, 2002, NATL VITAL STAT REPO, V51; Martin JA, 1999, NATL VITAL STAT REPO, V47; Nygren KG, 2002, HUM REPROD, V17, P3260; Reynolds MA, 2003, FERTIL STERIL, V80, P16, DOI 10.1016/S0015-0282(03)00572-7; Roest J, 1997, FERTIL STERIL, V67, P290, DOI 10.1016/S0015-0282(97)81913-9; Schieve LA, 1999, JAMA-J AM MED ASSOC, V282, P1832, DOI 10.1001/jama.282.19.1832; Soules MR, 2001, FERTIL STERIL, V75, P15, DOI 10.1016/S0015-0282(00)01726-X; STAESSEN C, 1993, HUM REPROD, V8, P1650, DOI 10.1093/oxfordjournals.humrep.a137907; TASDEMIR M, 1995, HUM REPROD, V10, P2155; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; 2000, JAMA, V284, P299; 2002, JAMA, V278, P1521	33	108	109	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1639	1645		10.1056/NEJMsa032073	http://dx.doi.org/10.1056/NEJMsa032073			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084696				2022-12-01	WOS:000220819800008
J	McNamara, JM; Barta, Z; Houston, AI				McNamara, JM; Barta, Z; Houston, AI			Variation in behaviour promotes cooperation in the Prisoner's Dilemma game	NATURE			English	Article							TIT-FOR-TAT; EVOLUTION; STRATEGIES; CHAOS	The Prisoner's Dilemma game(1-4) is widely used to investigate how cooperation between unrelated individuals can evolve by natural selection. In this game, each player can either 'cooperate' (invest in a common good) or 'defect' (exploit the other's investment). If the opponent cooperates, you get R if you cooperate and T if you defect. If the opponent defects, you get S if you cooperate and P if you defect. Here T > R > 0 and P > S, so that 'defect' is the best response to any action by the opponent. Thus in a single play of the game, each player should defect. In our game, a fixed maximum number of rounds of the Prisoner's Dilemma game is played against the same opponent. A standard argument based on working backwards from the last round(1,5) shows that defection on all rounds is the only stable outcome. In contrast, we show that if extrinsic factors maintain variation in behaviour, high levels of co-operation are stable. Our results highlight the importance of extrinsic variability in determining the outcome of evolutionary games.	Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	McNamara, JM (corresponding author), Univ Bristol, Dept Math, Univ Walk, Bristol BS8 1TW, Avon, England.	john.mcnamara@bristol.ac.uk		Barta, Zoltan/0000-0002-7121-9865				AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P379, DOI 10.1177/002200278002400301; BENDOR J, 1991, J CONFLICT RESOLUT, V35, P691, DOI 10.1177/0022002791035004007; BOYD R, 1989, J THEOR BIOL, V136, P47, DOI 10.1016/S0022-5193(89)80188-2; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; Brembs B, 1996, OIKOS, V76, P14, DOI 10.2307/3545744; Brockmann HJ, 2001, ADV STUD BEHAV, V30, P1, DOI 10.1016/S0065-3454(01)80004-8; Camerer C.F., 2003, BEHAV GAME THEORY; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Crowley PH, 1996, EVOL ECOL, V10, P499, DOI 10.1007/BF01237881; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fishman MA, 2001, J THEOR BIOL, V209, P87, DOI 10.1006/jtbi.2000.2248; FUDENBERG D, 1990, AM ECON REV, V80, P274; GIRALDEAU LA, 2000, MG BEH ECOL, P3; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Henson SA, 1997, ANNU REV ECOL SYST, V28, P571, DOI 10.1146/annurev.ecolsys.28.1.571; Lorberbaum JP, 2002, J THEOR BIOL, V214, P155, DOI 10.1006/jtbi.2001.2455; Luce R.D., 1957, GAMES DECIS; MCKELVEY RD, 1992, ECONOMETRICA, V60, P803, DOI 10.2307/2951567; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1995, J MATH BIOL, V33, P703; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; Sober E, 1998, UNTO OTHERS; Wahl LM, 1999, J THEOR BIOL, V200, P323, DOI 10.1006/jtbi.1999.0997; WU JZ, 1995, J CONFLICT RESOLUT, V39, P183, DOI 10.1177/0022002795039001008	30	134	135	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					745	748		10.1038/nature02432	http://dx.doi.org/10.1038/nature02432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812EW	15085131				2022-12-01	WOS:000220823800038
J	Jarman, B; Aylin, P; Bottle, A				Jarman, B; Aylin, P; Bottle, A			Dr Foster's case notes - Trends in admissions and deaths in English NHS hospitals	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Jarman, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011					0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					855	855		10.1136/bmj.328.7444.855	http://dx.doi.org/10.1136/bmj.328.7444.855			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073069	Green Published			2022-12-01	WOS:000220871400012
J	Vigne, JD; Guilaine, J; Debue, K; Haye, L; Gerard, P				Vigne, JD; Guilaine, J; Debue, K; Haye, L; Gerard, P			Early taming of the cat in Cyprus	SCIENCE			English	Article							MUS-MUSCULUS-DOMESTICUS; NEOLITHIC LATE 9TH; MILLENNIA CAL. BC; LEVANT		Museum Natl Hist Nat, Dept Ecol & Biodivers Management, CNRS, UMR 5197, F-75231 Paris 5, France; CNRS, EHESS, Ctr Anthropol, F-31000 Toulouse, France; Coll France, Chaire Civilisat Europe Neolith & Age Bronze, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Vigne, JD (corresponding author), Museum Natl Hist Nat, Dept Ecol & Biodivers Management, CNRS, UMR 5197, CP 56, F-75231 Paris 5, France.	vigne@mnhn.fr	Gérard, Patrice/A-1564-2011	Gerard, Patrice/0000-0002-6018-6092				AUFFRAY JC, 1988, CR ACAD SCI III-VIE, V307, P517; BOEKSCHOTEN GJ, 1972, PROC K NED AKAD B-PH, V75, P306; Clutton-Brock J., 1981, DOMESTICATED ANIMALS; CROFT P, 1998, CYPRUS, P5; CRUBEZY E, IN PRESS NEOLITHIQUE; Cucchi T, 2002, C R PALEVOL, V1, P235, DOI 10.1016/S1631-0683(02)00033-7; Davis S.J.M., 1987, ARCHAEOLOGY ANIMALS; Guilaine J, 2000, CR ACAD SCI II A, V330, P75, DOI 10.1016/S1251-8050(00)00105-1; Guilaine J., 2001, PALEORIENT, V26, P137; Malek J., 1993, CAT ANCIENT EGYPT; Peltenburg E, 2000, ANTIQUITY, V74, P844, DOI 10.1017/S0003598X0006049X; ROBINSON R, 1984, EVOLUTION DOMESTICAT, P217; Serjeantson D., 1990, ANTHROPOZOOLOGICA, V13, P7; Simmons AH., 2000, FAUNAL EXTINCTION IS; Tchernov E, 1997, J ARCHAEOL SCI, V24, P65, DOI 10.1006/jasc.1995.0096; VIGNE JD, 2000, ARCHAEOZOOLOGY NEAR, V4, P52; VIGNE JD, IN PRESS ANTROPOZOOL; Vigne Jean-Denis, 1999, P295; Woodman P, 1997, QUATERNARY SCI REV, V16, P129, DOI 10.1016/S0277-3791(96)00037-6	19	151	158	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					259	259		10.1126/science.1095335	http://dx.doi.org/10.1126/science.1095335			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	810QS	15073370				2022-12-01	WOS:000220719400037
J	Balsam, LB; Wagers, AJ; Christensen, JL; Kofidis, T; Weissman, IL; Robbins, RC				Balsam, LB; Wagers, AJ; Christensen, JL; Kofidis, T; Weissman, IL; Robbins, RC			Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium	NATURE			English	Article							FUSION; HEART; TRANSPLANTATION; CARDIOMYOCYTES; REGENERATION; INFARCTION; PHENOTYPE	Under conditions of tissue injury, myocardial replication and regeneration have been reported(1). A growing number of investigators have implicated adult bone marrow (BM) in this process, suggesting that marrow serves as a reservoir for cardiac precursor cells(2-6). It remains unclear which BM cell(s) can contribute to myocardium, and whether they do so by transdifferentiation or cell fusion. Here, we studied the ability of c-kit-enriched BM cells, Lin(-) c-kit(+) BM cells and c-kit(+) Thy1.1(lo) Lin(-) Sca-1(+) long-term reconstituting haematopoietic stem cells to regenerate myocardium in an infarct model. Cells were isolated from transgenic mice expressing green fluorescent protein (GFP) and injected directly into ischaemic myocardium of wild-type mice. Abundant GFP(+) cells were detected in the myocardium after 10 days, but by 30 days, few cells were detectable. These GFP(+) cells did not express cardiac tissue-specific markers, but rather, most of them expressed the haematopoietic marker CD45 and myeloid marker Gr-1. We also studied the role of circulating cells in the repair of ischaemic myocardium using GFP(+)-GFP(-) parabiotic mice. Again, we found no evidence of myocardial regeneration from blood-borne partner-derived cells. Our data suggest that even in the microenvironment of the injured heart, c-kit-enriched BM cells, Lin(-) c-kit(+) BM cells and c-kit(+) Thy1.1(lo) Lin(-) Sca-1(+) long-term reconstituting haematopoietic stem cells adopt only traditional haematopoietic fates.	Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Robbins, RC (corresponding author), Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA.	robbins@stanford.edu	Kofidis, Theodoros/B-9283-2011; Kofidis, Theodoros/B-9283-2011	Kofidis, Theodoros/0000-0002-9623-6450; Kofidis, Theodoros/0000-0002-8938-819X				Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	17	1335	1484	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					668	673		10.1038/nature02460	http://dx.doi.org/10.1038/nature02460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15034594				2022-12-01	WOS:000220697200048
J	Webby, RJ; Perez, DR; Coleman, JS; Guan, Y; Knight, JH; Govorkova, EA; McClain-Moss, LR; Peiris, JS; Rehg, JE; Tuomanen, EI; Webster, RG				Webby, RJ; Perez, DR; Coleman, JS; Guan, Y; Knight, JH; Govorkova, EA; McClain-Moss, LR; Peiris, JS; Rehg, JE; Tuomanen, EI; Webster, RG			Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines	LANCET			English	Article							A VIRUS; HONG-KONG; H5N1 VIRUS; GENERATION; PATHOGENICITY; HEMAGGLUTININ; RESCUE; SYSTEM; DNA	Background In response to the emergence of severe infection capable of rapid global spread, WHO will issue a pandemic alert. Such alerts are rare; however, on Feb 19, 2003, a pandemic alert was issued in response to human infections caused by an avian H5N1 influenza virus, A/Hong Kong/213/03. H5N1 had been noted once before in human beings in 1997 and killed a third (6/18) of infected people.(1,2) The 2003 variant seemed to have been transmitted directly from birds to human beings and caused fatal pneumonia in one of two infected individuals. Candidate vaccines were sought, but no avirulent viruses antigenically similar to the pathogen were available, and the isolate killed embryonated chicken eggs. Since traditional strategies of vaccine production were not viable, we sought to produce a candidate reference virus using reverse genetics. Methods We removed the polybasic aminoacids that are associated with high virulence from the haemagglutinin cleavage site of A/Hong Kong/213/03 using influenza reverse genetics techniques. A reference vaccine virus was then produced on an A/Puerto Rico/8/34 (PR8) backbone on WHO-approved Vero cells. We assessed this reference virus for pathogenicity in in-vivo and in-vitro assays. Findings A reference vaccine virus was produced in Good Manufacturing Practice (GMP)-grade facilities in less than 4 weeks from the time of virus isolation. This virus proved to be non-pathogenic in chickens and ferrets and was shown to be stable after multiple passages in embryonated chicken eggs. Interpretation The ability to produce a candidate reference virus in such a short period of time sets a new standard for rapid response to emerging infectious disease threats and clearly shows the usefulness of reverse genetics for influenza vaccine development. The same technologies and procedures are currently being used to create reference vaccine viruses against the 2004 H5N1 viruses circulating in Asia.	St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Therapeut Prod & Qual, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; Univ Hong Kong, Queen Mary Hosp, Dept Pathol & Microbiol, Hong Kong, Hong Kong, Peoples R China	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University System of Maryland; University of Maryland College Park; University of Hong Kong	Webby, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, MS 330,332 N Lauderdale St, Memphis, TN 38105 USA.	richard.webby@stjude.org	Webby, Richard J/N-5657-2018; Tuomanen, Elaine I/N-3081-2018; Perez, Daniel R./D-5044-2016; Rehg, Jerold E/N-8111-2018	Tuomanen, Elaine I/0000-0003-0349-8716; Perez, Daniel R./0000-0002-6569-5689; Govorkova, Elena/0000-0001-9067-5682; Guan, Yi/0000-0001-6057-9243	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA021765, CA21765] Funding Source: Medline; NIAID NIH HHS [N01AI95357, AI95357] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Brands R, 1999, Dev Biol Stand, V98, P93; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Halperin SA, 2002, VACCINE, V20, P1240, DOI 10.1016/S0264-410X(01)00428-5; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; KAWAOKA Y, 1987, VIROLOGY, V158, P218, DOI 10.1016/0042-6822(87)90256-X; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Kistner O, 1999, Dev Biol Stand, V98, P101; Li SQ, 1999, J INFECT DIS, V179, P1132, DOI 10.1086/314713; Liu M, 2003, VIROLOGY, V314, P580, DOI 10.1016/S0042-6822(03)00458-6; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ozaki H, 2004, J VIROL, V78, P1851, DOI 10.1128/JVI.78.4.1851-1857.2004; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Shortridge KF, 2000, VET MICROBIOL, V74, P141, DOI 10.1016/S0378-1135(00)00174-7; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Wood JM, 2001, PHILOS T R SOC B, V356, P1953, DOI 10.1098/rstb.2001.0981	23	199	273	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2004	363	9415					1099	1103		10.1016/S0140-6736(04)15892-3	http://dx.doi.org/10.1016/S0140-6736(04)15892-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808VB	15064027	Green Published, Bronze			2022-12-01	WOS:000220595500008
J	Hogg, T; Mechold, U; Malke, H; Cashel, M; Hilgenfeld, R				Hogg, T; Mechold, U; Malke, H; Cashel, M; Hilgenfeld, R			Conformational antagonism between opposing active sites in a bifunctional Re1A/SpoT homolog modulates (p)ppGpp metabolism during the stringent response	CELL			English	Article							DNA-POLYMERASE-BETA; RELA/SPOT HOMOLOGS; STATIONARY-PHASE; MECHANISM; RELA; EXPRESSION; SEQUENCES; GENE	Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by producing an intracellular signaling alarmone, (p)ppGpp, which triggers the so-called stringent response. Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. The 2.1 Angstrom crystal structure of the bifunctional catalytic fragment of the Rel/Spo homolog from Streptococcus dysgalactiae subsp. equisimilis, Rel(Seq), reveals two conformations of the enzyme corresponding to known reciprocal activity states: (p)ppGpp-hydrolase-OFF/(p)ppGpp-synthetase-ON and hydrolase-ON/synthetase-OFF. The hydrolase and synthetase domains bear remarkable similarities to the catalytic domains of the cyclic phosphodiesterase and nucleotidyltransferase superfamilies, respectively. The active sites, separated by more than 30 Angstrom, contain bound nucleotides including an unusual (p)ppGpp derivative, GDP-2':3'-cyclic monophosphate. Reciprocal regulation of the antagonistic catalytic activities, suggested by the structure, is supported by mutagenesis experiments and appears to involve ligand-induced signal transmission between the two active sites.	Med Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany; Univ Jena, Inst Mol Biotechnol, D-07745 Jena, Germany; Univ Jena, Inst Mol Biol, D-07745 Jena, Germany; NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	University of Lubeck; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Oklahoma System; University of Oklahoma Health Sciences Center	Hilgenfeld, R (corresponding author), Med Univ Lubeck, Inst Biochem, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	hilgenfeld@biochem.uni-luebeck.de	Hilgenfeld, Rolf/C-9675-2011; Mechold, Undine/GYV-3918-2022	Mechold, Undine/0000-0002-6019-0972	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000067] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000067] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Arndt JW, 2001, BIOCHEMISTRY-US, V40, P5368, DOI 10.1021/bi002176j; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Givens RM, 2004, J BIOL CHEM, V279, P7495, DOI 10.1074/jbc.M311573200; GOLDBETER A, 1987, J BIOL CHEM, V262, P4460; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Hendrickson W. A., 1970, Acta Crystallographica, Section B (Structural Crystallography and Crystal Chemistry), Vb26, P136, DOI 10.1107/S0567740870002078; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Hou ZL, 1999, J BIOL CHEM, V274, P17505, DOI 10.1074/jbc.274.25.17505; Huai Q, 2003, STRUCTURE, V11, P865, DOI 10.1016/S0969-2126(03)00123-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KITAMURA K, 1988, J BIOL CHEM, V263, P16796; Kuhar I, 2001, MOL MICROBIOL, V41, P207, DOI 10.1046/j.1365-2958.2001.02508.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mechold U, 1997, J BACTERIOL, V179, P2658, DOI 10.1128/jb.179.8.2658-2667.1997; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Mildvan AS, 1999, ADV ENZYMOL RAMB, V73, P183, DOI 10.1002/9780470123195.ch6; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAO CC, 1980, J BIOL CHEM, V255, P1830; PAO CC, 1981, BIOCHIM BIOPHYS ACTA, V677, P358, DOI 10.1016/0304-4165(81)90247-6; Riboldi-Tunnicliffe A, 1999, J APPL CRYSTALLOGR, V32, P1003, DOI 10.1107/S0021889899008584; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Steiner K, 2000, MOL MICROBIOL, V38, P1004, DOI 10.1046/j.1365-2958.2000.02203.x; Sun JH, 2001, J BACTERIOL, V183, P3488, DOI 10.1128/JB.183.11.3488-3498.2001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Wendrich TM, 2000, FEMS MICROBIOL LETT, V190, P195, DOI 10.1111/j.1574-6968.2000.tb09286.x; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu RX, 2000, SCIENCE, V288, P1822, DOI 10.1126/science.288.5472.1822	43	231	239	4	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2004	117	1					57	68		10.1016/S0092-8674(04)00260-0	http://dx.doi.org/10.1016/S0092-8674(04)00260-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YV	15066282	Bronze			2022-12-01	WOS:000221500300008
J	Kai, T; Spradling, A				Kai, T; Spradling, A			Differentiating germ cells can revert into functional stem cells in Drosophila melanogaster ovaries	NATURE			English	Article							MORPHOGENESIS; EXPRESSION; NICHES; SRC64	Many tissues including blood, skin, gut and germ cells are continuously maintained by tissue stem cells(1-2). Under certain conditions, however, other organs can undergo repair using stem-cell-like progenitors generated by cell de-differentiation(3). Cell fates have been broadened experimentally(4-7), but mechanisms allowing de-differentiation to a stem cell state are poorly known. Germline stem cells begin to differentiate by forming interconnected germ cell cysts (cystocytes), and under certain conditions male mouse cystocytes have been postulated to revert into functional progenitors(8,9). Here we report that four- and eight-cell Drosophila germline cystocytes generated either in second instar larval ovaries or in adults over-producing the BMP4-like stem cell signal Decapentaplegic efficiently convert into single stem-like cells. These de-differentiated cells can develop into functional germline stem cells and support normal fertility. Our results show that cystocytes represent a relatively abundant source of regenerative precursors that might help replenish germ cells after depletion by genotoxic chemicals, radiation or normal ageing. More generally, Drosophila cystocytes now provide a system for studying de-differentiation and its potential as a source of functional stem cells.	Carnegie Inst Washington, Dept Embryol, Howard Hughes Med Inst, Res Labs, Baltimore, MD 21210 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, A (corresponding author), Carnegie Inst Washington, Dept Embryol, Howard Hughes Med Inst, Res Labs, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	spradling@ciwemb.edu		Kai, Toshie/0000-0001-8675-8469	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; CLERMONT Y, 1968, AM J ANAT, V122, P237, DOI 10.1002/aja.1001220205; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; De Rooij DG, 2000, J ANDROL, V21, P776; Dodson GS, 1998, DEVELOPMENT, V125, P2883; GODT D, 1995, DEVELOPMENT, V121, P173; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kramerova IA, 1999, DEV DYNAM, V216, P349, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<349::AID-DVDY4>3.0.CO;2-X; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Prohaska SS, 2002, SEMIN IMMUNOL, V14, P377, DOI 10.1016/S1044532302000726; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; STOCUM DL, 2000, CURR TOP MICROBIOL I, V280, P1; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	24	252	268	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2004	428	6982					564	569		10.1038/nature02436	http://dx.doi.org/10.1038/nature02436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	807ZT	15024390				2022-12-01	WOS:000220540100043
J	Osta, MA; Christophides, GK; Kafatos, FC				Osta, MA; Christophides, GK; Kafatos, FC			Effects of mosquito genes on Plasmodium development	SCIENCE			English	Article							ANOPHELES-GAMBIAE; MOLECULAR-INTERACTIONS; MALARIA INFECTION; RESPONSES; RECOGNITION; PATHOGENS; RECEPTORS; LECTINS	Malaria parasites must complete a complex developmental cycle in an Anopheles mosquito vector before transmission to a vertebrate host. Sexual development of the parasite in the midgut is initiated in the lumen immediately after the mosquito ingests infected blood, and the resulting ookinetes must traverse the surrounding epithelial layer before transforming into oocysts. The innate immune system of the mosquito is activated during midgut invasion, but to date, no evidence has been published identifying mosquito immune genes that affect parasite development. Here, we show by gene silencing that an Anopheles gambiae leucine rich-repeat protein acts as an antagonist and two C-type lectines act as protective agonists on the development of Plasmodium ookinetes to oocysts.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Kafatos, FC (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	dg-office@ernbl.de		Christophides, George/0000-0002-3323-1687				Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; KAFATOS F, UNPUB; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; LEVASHINA EA, UNPUB; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; OSTA M, UNPUB; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Sinden RE, 2002, CELL MICROBIOL, V4, P713, DOI 10.1046/j.1462-5822.2002.00229.x; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; VLACHOU D, IN PRESS CELL MICROB; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X	24	333	346	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2030	2032		10.1126/science.1091789	http://dx.doi.org/10.1126/science.1091789			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	15044804				2022-12-01	WOS:000220429800045
J	Kelleher, RJ; Govindarajan, A; Jung, HY; Kang, HJ; Tonegawa, S				Kelleher, RJ; Govindarajan, A; Jung, HY; Kang, HJ; Tonegawa, S			Translational control by MAPK signaling in long-term synaptic plasticity and memory	CELL			English	Article							PROTEIN-SYNTHESIS; LATE-PHASE; CA1 REGION; POTENTIATION; HIPPOCAMPUS; CONSOLIDATION; KNOCKOUT; KINASES; PHOSPHORYLATION; TRANSCRIPTION	Enduring forms of synaptic plasticity and memory require new protein synthesis, but little is known about the underlying regulatory mechanisms. Here, we investigate the role of MAPK signaling in these processes. Conditional expression of a dominant-negative form of MEK1 in the postnatal murine forebrain inhibited ERK activation and caused selective deficits in hippocampal memory retention and the translation-dependent, transcription-independent phase of hippocampal L-LTP. In hippocampal neurons, ERK inhibition blocked neuronal activity-induced translation as well as phosphorylation of the translation factors elF4E, 4EBP1, and ribosomal protein S6. Correspondingly, protein synthesis and translation factor phosphorylation induced in control hippocampal slices by L-LTP-generating tetanization were significantly reduced in mutant slices. Translation factor phosphorylation induced in the control hippocampus by memory formation was similarly diminished in the mutant hippocampus. These results suggest a crucial role for translational control by MAPK signaling in long-lasting forms of synaptic plasticity and memory.	MIT, RIKEN,Dept Biol, Neurosci Res Ctr,Howard Hughes Med Inst, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Memory Disorders Unit, Boston, MA 02114 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Tonegawa, S (corresponding author), MIT, RIKEN,Dept Biol, Neurosci Res Ctr,Howard Hughes Med Inst, Picower Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu						Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Antoniadis EA, 2000, BEHAV BRAIN RES, V108, P1, DOI 10.1016/S0166-4328(99)00121-7; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Frey J U, 2001, Results Probl Cell Differ, V34, P27; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Godsil BP, 2000, LEARN MEMORY, V7, P353, DOI 10.1101/lm.32800; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Huang Y Y, 1994, Learn Mem, V1, P74; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; LIU G, 1995, NEUROPHARMACOLOGY, V34, P1407, DOI 10.1016/0028-3908(95)00143-T; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Schafe GE, 1999, LEARN MEMORY, V6, P97; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Williams SH, 1996, J NEUROSCI, V16, P3652; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	56	648	668	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					467	479		10.1016/S0092-8674(04)00115-1	http://dx.doi.org/10.1016/S0092-8674(04)00115-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016380	Bronze			2022-12-01	WOS:000188825800014
J	Miaczynska, M; Christoforidis, S; Giner, A; Shevchenko, A; Uttenweiler-Joseph, S; Habermann, B; Wilm, M; Parton, RG; Zerial, M				Miaczynska, M; Christoforidis, S; Giner, A; Shevchenko, A; Uttenweiler-Joseph, S; Habermann, B; Wilm, M; Parton, RG; Zerial, M			APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; HISTONE DEACETYLASE COMPLEXES; TGF-BETA RECEPTOR; NUCLEOTIDE EXCHANGE; ENDOCYTIC PATHWAY; MEMBRANE-FUSION; GTPASE ACTIVITY; IDENTIFICATION; KINASE; DOMAIN	Signals generated in response to extracellular stimuli at the plasma membrane are transmitted through cytoplasmic transduction cascades to the nucleus. We report the identification of a pathway directly linking the small GTPase Rab5, a key regulator of endocytosis, to signal transduction and mitogenesis. This pathway operates via APPL1 and APPL2, two Rab5 effectors, which reside on a subpopulation of endosomes. In response to extracellular stimuli such as EGF and oxidative stress, APPL1 translocates from the membranes to the nucleus where it interacts with the nucleosome remodeling and histone deacetylase multiprotein complex NuRD/MeCP1, an established regulator of chromatin structure and gene expression. Both APPL1 and APPL2 are essential for cell proliferation and their function requires Rab5 binding. Our findings identify an endosomal compartment bearing Rab5 and APPL proteins as an intermediate in signaling between the plasma membrane and the nucleus.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Queensland, Sch Biomed Sci, Ctr Microscopy & Microanal, Inst Mol Biosci, Brisbane, Qld 4006, Australia; Scion Comp Innovat GmbH, D-01307 Dresden, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL); University of Queensland	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Parton, Robert G/C-5673-2009; Habermann, Bianca/N-4886-2016	Parton, Robert G/0000-0002-7494-5248; Habermann, Bianca/0000-0002-2457-7504; Wilm, Matthias/0000-0002-5461-6834; Miaczynska, Marta/0000-0003-0031-5267; Uttenweiler, Sandrine/0000-0001-9019-4766; Christoforidis, Savvas/0000-0002-0210-0713				Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elliott K, 2000, ONCOGENE, V19, P4669, DOI 10.1038/sj.onc.1203681; Feng Q, 2001, GENE DEV, V15, P827; Fischer D, 1999, PROTEINS, P209; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Johannessen LE, 2000, EXP CELL RES, V260, P136, DOI 10.1006/excr.2000.5004; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; RYSECK RP, 1989, EXP CELL RES, V180, P537, DOI 10.1016/0014-4827(89)90080-3; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yarden Y, 2001, EUR J CANCER, V37, pS3; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	60	424	445	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2004	116	3					445	456		10.1016/S0092-8674(04)00117-5	http://dx.doi.org/10.1016/S0092-8674(04)00117-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	772DR	15016378	Bronze			2022-12-01	WOS:000188825800012
J	Ostermeier, GC; Miller, D; Huntriss, JD; Diamond, MP; Krawetz, SA				Ostermeier, GC; Miller, D; Huntriss, JD; Diamond, MP; Krawetz, SA			Reproductive biology - Delivering spermatozoan RNA to the oocyte	NATURE			English	Editorial Material							EXPRESSION; DEVELOP; EMBRYOS		Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA; Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Wayne State Univ, Ctr Comp Sci, Detroit, MI 48201 USA; Univ Leeds, Reprod & Early Dev Grp, Leeds LS2 9JT, W Yorkshire, England	Wayne State University; Wayne State University; Wayne State University; University of Leeds	Ostermeier, GC (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA.	steve@compbio.med.wayne.edu	Ostermeier, G. Charles/Y-1172-2019; krawetz, stephen/GQQ-3308-2022	Ostermeier, G. Charles/0000-0002-3951-512X; Diamond, Michael/0000-0001-6353-4489				Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Kono T, 2002, DEV BIOL, V243, P294, DOI 10.1006/dbio.2001.0561; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; OBRYAN MK, 1990, J CLIN INVEST, V85, P1477, DOI 10.1172/JCI114594; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; WONG P, 1994, EUR J BIOCHEM, V221, P917, DOI 10.1111/j.1432-1033.1994.tb18807.x; Ziyyat A, 2001, HUM REPROD, V16, P1449, DOI 10.1093/humrep/16.7.1449	13	410	435	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					154	154		10.1038/429154a	http://dx.doi.org/10.1038/429154a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15141202	Bronze			2022-12-01	WOS:000221356300029
J	Donley, JM; Sepulveda, CA; Konstantinidis, P; Gemballa, S; Shadwick, RE				Donley, JM; Sepulveda, CA; Konstantinidis, P; Gemballa, S; Shadwick, RE			Convergent evolution in mechanical design of lamnid sharks and tunas	NATURE			English	Article							MUSCLE DYNAMICS; HORIZONTAL SEPTUM; SCOMBRID FISHES; STEADY; LOCOMOTION; SPEED; PROPULSION	The evolution of 'thunniform' body shapes in several different groups of vertebrates, including whales, ichthyosaurs(1) and several species of large pelagic fishes(2) supports the view that physical and hydromechanical demands provided important selection pressures to optimize body design for locomotion during vertebrate evolution. Recognition of morphological similarities between lamnid sharks ( the most well known being the great white and the mako) and tunas has led to a general expectation that they also have converged in their functional design; however, no quantitative data exist on the mechanical performance of the locomotor system in lamnid sharks. Here we examine the swimming kinematics, in vivo muscle dynamics and functional morphology of the force-transmission system in a lamnid shark, and show that the evolutionary convergence in body shape and mechanical design between the distantly related lamnids and tunas is much more than skin deep; it extends to the depths of the myotendinous architecture and the mechanical basis for propulsive movements. We demonstrate that not only have lamnids and tunas converged to a much greater extent than previously known, but they have also developed morphological and functional adaptations in their locomotor systems that are unlike virtually all other fishes.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Univ Tubingen, Dept Zool, D-72076 Tubingen, Germany	University of California System; University of California San Diego; Scripps Institution of Oceanography; Eberhard Karls University of Tubingen	Donley, JM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	jdonley@ucsd.edu						ALTRINGHAM JD, 2001, TUNA PHYSL ECOLOGY E, P313; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Carey F.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P92; CAREY FG, 1971, AM ZOOL, V11, P137; Collette B.B., 1978, P7; Compagno L. J. V., 1998, FAO IDENTIFICATION G, P1274; Coughlin DJ, 1996, J EXP BIOL, V199, P459; Donley JM, 2003, J EXP BIOL, V206, P1117, DOI 10.1242/jeb.00206; Gemballa S, 2003, J EVOLUTION BIOL, V16, P966, DOI 10.1046/j.1420-9101.2003.00588.x; Gemballa S, 2003, P ROY SOC B-BIOL SCI, V270, P1229, DOI 10.1098/rspb.2003.2345; Graham JB, 2000, ZOOL J LINN SOC-LOND, V129, P419, DOI 10.1006/zjls.1998.0211; JAYNE BC, 1995, J EXP BIOL, V198, P585; Joseph J., 1988, P1; Katz SL, 2002, J EXP BIOL, V205, P2251; Katz SL, 1999, J EXP BIOL, V202, P529; Katz SL, 2001, NATURE, V410, P770, DOI 10.1038/35071170; Knower T., 1998, THESIS U CALIFORNIA; LIGHTHILL MJ, 1969, ANNU REV FLUID MECH, V1, P413, DOI 10.1146/annurev.fl.01.010169.002213; Lindsey C.C., 1978, FISH PHYSIOL, V7, P1, DOI DOI 10.1016/S1546-5098(08)60163-6; Magnuson J.J., 1979, FISH PHYSIOL, V7, P239, DOI DOI 10.1016/S1546-5098(08)60166-1; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; Reif W.-E., 1986, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V114, P221; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Shadwick RE, 1998, AM ZOOL, V38, P755; Shadwick RE, 1999, J EXP BIOL, V202, P2139; Webb P.W., 1975, B FISH RES BOARD CAN, V190, P1, DOI DOI 10.1002/RRA.1371; WESTNEAT MW, 1993, J MORPHOL, V217, P183, DOI 10.1002/jmor.1052170207	27	117	123	10	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2004	429	6987					61	65		10.1038/nature02435	http://dx.doi.org/10.1038/nature02435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129279				2022-12-01	WOS:000221222100043
J	Garcia-Bellido, DC; Collins, DH				Garcia-Bellido, DC; Collins, DH			Moulting arthropod caught in the act	NATURE			English	Editorial Material									Royal Ontario Museum, Dept Palaeobiol, Toronto, ON M5S 2C6, Canada; Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, E-28040 Madrid, Spain	Royal Ontario Museum; Complutense University of Madrid	Garcia-Bellido, DC (corresponding author), Royal Ontario Museum, Dept Palaeobiol, Toronto, ON M5S 2C6, Canada.	desc@rom.on.ca	Garcia-Bellido, Diego/AAF-9043-2021	Garcia-Bellido, Diego/0000-0003-1922-9836				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Brandt DS, 2002, ALCHERINGA, V26, P399, DOI 10.1080/03115510208619264; Edgecombe GD, 1999, J PALEONTOL, V73, P263, DOI 10.1017/S0022336000027761; KUNKEL JG, 1975, BIOL BULL, V148, P259, DOI 10.2307/1540546; Matsuda H, 2003, FISHERIES SCI, V69, P124, DOI 10.1046/j.1444-2906.2003.00596.x; Nielsen C, 2003, ZOOL SCR, V32, P475, DOI 10.1046/j.1463-6409.2003.00122.x; Valentine JW, 2000, EVOL DEV, V2, P152, DOI 10.1046/j.1525-142x.2000.00043.x; Whittington H.B., 1971, Bull geol Surv Can, VNo. 209, P1; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33	9	28	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					40	40		10.1038/429040a	http://dx.doi.org/10.1038/429040a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15129272				2022-12-01	WOS:000221222100034
J	Olsen, EM; Heino, M; Lilly, GR; Morgan, MJ; Brattey, J; Ernande, B; Dieckmann, U				Olsen, EM; Heino, M; Lilly, GR; Morgan, MJ; Brattey, J; Ernande, B; Dieckmann, U			Maturation trends indicative of rapid evolution preceded the collapse of northern cod	NATURE			English	Article							LIFE-HISTORY EVOLUTION; GADUS-MORHUA; REACTION NORMS; SIZE; AGE; REPRODUCTION; POPULATIONS; PLASTICITY; FISHERIES; PATTERN	Northern cod, comprising populations of Atlantic cod ( Gadus morhua) off southern Labrador and eastern Newfoundland, supported major fisheries for hundreds of years(1). But in the late 1980s and early 1990s, northern cod underwent one of the worst collapses in the history of fisheries(2-4). The Canadian government closed the directed fishing for northern cod in July 1992, but even after a decade-long offshore moratorium, population sizes remain historically low(4). Here we show that, up until the moratorium, the life history of northern cod continually shifted towards maturation at earlier ages and smaller sizes. Because confounding effects of mortality changes and growth-mediated phenotypic plasticity are accounted for in our analyses, this finding strongly suggests fisheries-induced evolution of maturation patterns in the direction predicted by theory(5,6). We propose that fisheries managers could use the method described here as a tool to provide warning signals about changes in life history before more overt evidence of population decline becomes manifest.	Int Inst Appl Syst Anal, Adapt Dynam Network, A-2361 Laxenburg, Austria; Inst Marine Res, N-5817 Bergen, Norway; Fisheries & Oceans Canada, Dept Fisheries & Oceans, St John, NF A1C 5X1, Canada	International Institute for Applied Systems Analysis (IIASA); Institute of Marine Research - Norway; Fisheries & Oceans Canada	Olsen, EM (corresponding author), Univ Oslo, Dept Biol, Div Marine Biol & Limnol, POB 1064, N-0316 Oslo, Norway.	espeom@bio.uio.no	Heino, Mikko P/C-7241-2009; Ernande, Bruno/C-1182-2008; Olsen, Esben Moland/B-1894-2012; Dieckmann, Ulf/E-1424-2011	Heino, Mikko P/0000-0003-2928-3940; Ernande, Bruno/0000-0002-0727-5774; Olsen, Esben Moland/0000-0003-3807-7524; Dieckmann, Ulf/0000-0001-7089-0393				ALM GUNNAR, 1959, REPT INST FRESHWATER RES DROTTNINGHOLM, V40, P5; BAROT S, 2003, IR03043 IIASA; Bishop C.A., 1994, Northwest Atlantic Fisheries Organization Scientific Council Studies, V21, P105; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Crnokrak P, 2000, J EVOLUTION BIOL, V13, P396, DOI 10.1046/j.1420-9101.2000.00188.x; Ernande B, 2004, P ROY SOC B-BIOL SCI, V271, P415, DOI 10.1098/rspb.2003.2519; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Haugen TO, 2001, GENETICA, V112, P475, DOI 10.1023/A:1013315116795; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V56, P1612, DOI 10.1139/cjfas-56-9-1612; HUTCHINGS JA, 1995, N ATLANTIC FISHERIES, P39; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; LEAR W H, 1984, Journal of Northwest Atlantic Fishery Science, V5, P143; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; MANLY FJ, 1997, RANDOMIZATION BOOTST; Morgan M. Joanne, 1997, Journal of Northwest Atlantic Fishery Science, V21, P51; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Ruzzante DE, 2001, CONSERV GENET, V2, P257, DOI 10.1023/A:1012247213644; SOHN JJ, 1977, SCIENCE, V195, P199, DOI 10.1126/science.831271; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Stokes T. M., 1993, EXPLOITATION EVOLVIN; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628	29	615	639	7	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					932	935		10.1038/nature02430	http://dx.doi.org/10.1038/nature02430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118724				2022-12-01	WOS:000221083000038
J	Shand, D				Shand, D			Pilates to pit	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Shand, D (corresponding author), The Lancet, London NW1 7BY, England.								0	8	8	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1340	1340		10.1016/S0140-6736(04)16085-6	http://dx.doi.org/10.1016/S0140-6736(04)16085-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110489				2022-12-01	WOS:000220996300006
J	Hu, MCT; Lee, DF; Xia, WY; Golfman, LS; Fu, OY; Yang, JY; Zou, YY; Bao, SL; Hanada, N; Saso, H; Kobayashi, R; Hung, MC				Hu, MCT; Lee, DF; Xia, WY; Golfman, LS; Fu, OY; Yang, JY; Zou, YY; Bao, SL; Hanada, N; Saso, H; Kobayashi, R; Hung, MC			I kappa B kinase promotes tumorigenesis through inhibition of forkhead FOXO3a	CELL			English	Article							CELL-CYCLE REGULATION; TRANSCRIPTION FACTORS; PROTEIN; DOWNSTREAM; RECEPTOR; PATHWAY; DEATH	Nuclear exclusion of the forkhead transcription factor FOXO3a by protein kinase Akt contributes to cell survival. We investigated the pathological relationship between phosphoylated-Akt (Akt-p) and FOXO3a in primary tumors. Surprisingly, FOXO3a was found to be excluded from the nuclei of some tumors lacking Akt-p, suggesting an Akt-independent mechanism of regulating FOXO3a localization. We provide evidence for such a mechanism by showing that IkappaB kinase (IKK) physically interacts with, phosphorylates, and inhibits FOXO3a independent of Akt and causes proteolysis of FOXO3a via the Ub-dependent proteasome pathway, Cytoplasmic FOXO3a correlates with expression of IKKbeta or Akt-p in many tumors and associates with poor survival in breast cancer. Further, constitutive expression of IKKbeta promotes cell proliferation and tumorigenesis that can be overridden by FOXO3a. These results suggest the negative regulation of FOXO factors by IKK as a key mechanism for promoting cell growth and tumorigenesis.	Univ Texas, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System	Hu, MCT (corresponding author), Univ Texas, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	michu@mdanderson.org; rnhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Lee, Dung-Fang/0000-0003-2387-597X	NCI NIH HHS [R01 CA58880, P01 CA99031, CA16772] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058880, P01CA099031] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	21	740	773	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					225	237		10.1016/S0092-8674(04)00302-2	http://dx.doi.org/10.1016/S0092-8674(04)00302-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084260	Bronze			2022-12-01	WOS:000220913400010
J	King, C; Ilic, A; Koelsch, K; Sarvetnick, N				King, C; Ilic, A; Koelsch, K; Sarvetnick, N			Homeostatic expansion of T cells during immune insufficiency generates autoimmunity	CELL			English	Article							NONOBESE DIABETIC MICE; COMMON GAMMA-CHAIN; NOD MICE; SYSTEMIC AUTOIMMUNITY; IL-21 RECEPTOR; CUTTING EDGE; EXPRESSION; BCL-2; APOPTOSIS; INFECTION	During illness and stress, the immune system can suffer a considerable loss of T cells (lymphopenia). The remaining T cells undergo vigorous compensatory expansion, known as homeostatic proliferation, to reconstitute the immune system. Interestingly, human diseases of autoimmune etiology often present with immune deficiencies such as lymphopenia. In this study, we show that reduced T cell numbers and the resulting exaggerated homeostatic-type proliferation of T cells generate autoimmunity. The cycling T cell population is short lived, and the depleted memory compartment fuels the generation of new effector T cells. A catalyst for these phenomena is the increased responses to the cytokine IL-21, a mediator that regulates T cell turnover. We conclude that poor T cell survival and lymphopenia precipitate autoimmune disease.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego	Sarvetnick, N (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noras@scripps.edu	Koelsch, Kersten/B-6745-2008; King, Cecile/Q-9794-2019	Koelsch, Kersten/0000-0002-6411-4248; King, Cecile/0000-0003-2193-2563	NIDDK NIH HHS [DK54063] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054063] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; ARMITAGE RJ, 1990, INT IMMUNOL, V2, P1039, DOI 10.1093/intimm/2.11.1039; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bateman HE, 1999, J RHEUMATOL, V26, P2482; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; DARDENNE M, 1989, EUR J IMMUNOL, V19, P889, DOI 10.1002/eji.1830190516; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; Di Sabatino A, 2001, IMMUNOLOGY, V103, P435, DOI 10.1046/j.1365-2567.2001.01245.x; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FOWELL D, 1991, IMMUNOL REV, V123, P37, DOI 10.1111/j.1600-065X.1991.tb00605.x; Gleeson PA, 1996, IMMUNOL REV, V149, P97, DOI 10.1111/j.1600-065X.1996.tb00901.x; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Greenhill J P, 1966, Int Surg, V45, P28; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Holt PG, 1998, ENVIRON HEALTH PERSP, V106, P795, DOI 10.2307/3434191; Isaacs JD, 2001, ARTHRITIS RHEUM, V44, P1998, DOI 10.1002/1529-0131(200109)44:9<1998::AID-ART348>3.0.CO;2-T; KAABA SA, 1995, IMMUNOL LETT, V47, P209, DOI 10.1016/0165-2478(95)00088-5; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kukreja A, 1999, J CLIN ENDOCR METAB, V84, P4371, DOI 10.1210/jc.84.12.4371; KWOH C K, 1992, Current Opinion in Rheumatology, V4, P138; La Gruta NL, 2000, EUR J IMMUNOL, V30, P3380; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Marrack P, 1998, IMMUNOL REV, V165, P279, DOI 10.1111/j.1600-065X.1998.tb01245.x; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Mendelsohn JA, 2002, HIST PHIL LIFE SCI, V24, P3, DOI 10.1080/03919710210001714293; Morgan DJ, 1996, J IMMUNOL, V157, P978; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Peacock CD, 2003, J IMMUNOL, V171, P655, DOI 10.4049/jimmunol.171.2.655; Permar SR, 2003, J VIROL, V77, P7872, DOI 10.1128/JVI.77.14.7872-7879.2003; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; RABINOVITCH A, 1994, DIABETES, V43, P613, DOI 10.2337/diabetes.43.5.613; Rietz C, 2003, SCAND J IMMUNOL, V57, P342, DOI 10.1046/j.1365-3083.2003.01244.x; ROCHA B, 1983, J IMMUNOL, V131, P2158; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; SAI P, 1994, CLIN EXP IMMUNOL, V97, P138; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; SATOH J, 1988, TOHOKU J EXP MED, V155, P151, DOI 10.1620/tjem.155.151; Schaller J G, 1975, Birth Defects Orig Artic Ser, V11, P173; Serreze DV, 2001, DIABETES, V50, P1992, DOI 10.2337/diabetes.50.9.1992; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Sitnicka E, 1996, BLOOD, V88, P82; Sleasman J W, 1996, Adv Dent Res, V10, P57; Snow JW, 2003, EXP HEMATOL, V31, P1253, DOI 10.1016/j.exphem.2003.09.014; Sprent J, 2003, IMMUNOL LETT, V85, P145, DOI 10.1016/S0165-2478(02)00221-3; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; Theofilopoulos AN, 2001, J CLIN INVEST, V108, P335, DOI 10.1172/JCI12173; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; TWAROG FJ, 1970, J IMMUNOL, V104, P1467; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267	66	529	557	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					265	277		10.1016/S0092-8674(04)00335-6	http://dx.doi.org/10.1016/S0092-8674(04)00335-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084263	Bronze			2022-12-01	WOS:000220913400013
J	Sabatier, C; Plump, AS; Ma, L; Brose, K; Tamada, A; Murakami, F; Lee, EYHP; Tessier-Lavigne, M				Sabatier, C; Plump, AS; Ma, L; Brose, K; Tamada, A; Murakami, F; Lee, EYHP; Tessier-Lavigne, M			The divergent Robo family protein Rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons	CELL			English	Article							RAT SPINAL-CORD; NERVOUS-SYSTEM; CNS MIDLINE; GUIDANCE RECEPTORS; DROSOPHILA; ROUNDABOUT; REPELLENT; ENCODES; CLONING; NEURONS	Commissural axons in vertebrates and insects are initially attracted to the nervous system midline, but once they reach this intermediate target they undergo a dramatic switch, becoming responsive to repellent Slit proteins at the midline, which expel them onto the next leg of their trajectory. We have unexpectedly implicated a divergent member of the Robo family, Rig-1 (or Robo3), in preventing premature Slit sensitivity in mammals. Expression of Rig-1 protein by commissural axons is inversely correlated with Slit sensitivity. Removal of Rig-1 results in a total failure of commissural axons to cross. Genetic and in vitro analyses indicate that Rig-1 functions to repress Slit responsiveness similarly to Commissureless (Comm) in Drosophila. Unlike Comm, however, Rig-1 does not produce its effect by downregulating Robo receptors on precrossing commissural axon membranes. These results identify a mechanism for regulating Slit repulsion that helps choreograph the precise switch from attraction to repulsion at a key intermediate axonal target.	Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, Stanford, CA 94305 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Natl Inst Basic Biol, Div Behav & Neurobiol, Okazaki, Aichi 4448585, Japan; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Genentech Inc, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of California System; University of California Irvine; University of California System; University of California Irvine; Roche Holding; Genentech	Tessier-Lavigne, M (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, Stanford, CA 94305 USA.	marctl@gene.com	Ma, Le/A-3733-2013	Ma, Le/0000-0003-2769-9416; Tamada, Atsushi/0000-0003-3677-6102				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LONG H, 2004, IN PRESS NEURON, V42; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	30	318	322	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					157	169		10.1016/S0092-8674(04)00303-4	http://dx.doi.org/10.1016/S0092-8674(04)00303-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084255	Bronze			2022-12-01	WOS:000220913400005
J	Wehrens, XHT; Lehnart, SE; Reiken, SR; Deng, SX; Vest, JA; Cervantes, D; Coromilas, J; Landry, DW; Marks, AR				Wehrens, XHT; Lehnart, SE; Reiken, SR; Deng, SX; Vest, JA; Cervantes, D; Coromilas, J; Landry, DW; Marks, AR			Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2	SCIENCE			English	Article							PHOSPHORYLATION; CHANNELS; FKBP12.6; LEAK; DRUG; CA2+; MG2+	Ventricular arrhythmias can cause sudden cardiac death (SCD) in patients with normal hearts and in those with underlying disease such as heart failure. In animals with heart failure and in patients with inherited forms of exercise-induced SCD, depletion of the channel-stabilizing protein calstabin2 (FKBP12.6) from the ryanodine receptor - calcium release channel (RyR2) complex causes an intracellular Ca2+ leak that can trigger fatal cardiac arrhythmias. A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias. Thus, enhancing the binding of calstabin2 to RyR2 may be a therapeutic strategy for common ventricular arrhythmias.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Mol Cardiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	arm42@columbia.edu	Wehrens, Xander/AAQ-9574-2020	Wehrens, Xander/0000-0001-5044-672X				Gilmour RF, 2003, DRUG DISCOV TODAY, V8, P162, DOI 10.1016/S1359-6446(02)02567-9; GINSBURG KS, 2004, J PHYSL LONDON  0114; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kaneko N., 1995, U.S. Patent, Patent No. 5416066; Kimura J, 1999, JPN J PHARMACOL, V79, P275, DOI 10.1254/jjp.79.275; Kohno M, 2003, AM J PHYSIOL-HEART C, V284, pH1035, DOI 10.1152/ajpheart.00722.2002; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; Marks AR, 2002, CIRCULATION, V106, P8, DOI 10.1161/01.CIR.0000021746.82888.83; Marks AR, 2001, J MOL CELL CARDIOL, V33, P615, DOI 10.1006/jmcc.2000.1343; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Most P, 2003, NAT MED, V9, P993, DOI 10.1038/nm0803-993; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; WEHRENS XH, UNPUB; Wehrens XHT, 2003, TRENDS BIOCHEM SCI, V28, P671, DOI 10.1016/j.tibs.2003.10.003; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xu L, 1996, CIRC RES, V79, P1100, DOI 10.1161/01.RES.79.6.1100; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	20	341	373	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					292	296		10.1126/science.1094301	http://dx.doi.org/10.1126/science.1094301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073377				2022-12-01	WOS:000220719400048
